[
  {
    "id": "chunk_00000",
    "text": "SPINE\nNEW\n2022\nFAMILY\nPLANNING\nA GLOBAL HANDBOOK FOR PROVIDERS\n2022 EDITION\nA\nGLOBAL\nHANDBOOK\nFOR\nPROVIDERS\nFAMILY\nPLANNING\n2022\nComparing\nEff\nectiveness\nof\nFamily\nPlanning\nMethods\nUNITED\nSTATES\nAGENCY\nFOR\nINTERNATIONAL\nDEVELOPMENT\nJOHN\u2019S\nHOPKINS\nBLOOMBERG\nSCHOOL\nOF\nPUBLIC\nHEALTH\nWORLD\nHEALTH\nORGANIZATION\nJOB AID",
    "page_number": 1,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 0
  },
  {
    "id": "chunk_00001",
    "text": "SPINE What\u2019s New in This Edition? JOB AID New y Women and girls at high risk of HIV can use all hormonal family planning contraceptive methods Pregnancy recommendations y Self-injection is an additional approach to offer clients Checklist from WHO who use DMPA-SC",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1
  },
  {
    "id": "chunk_00002",
    "text": "o offer clients Checklist from WHO who use DMPA-SC New chapters y Family Planning for Women at High Risk of HIV Ask the client questions 1\u20136. As soon as the client answers in this edition (Chapter 23) \u201cyes\u201d to any question, stop and follow the instructions below.",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2
  },
  {
    "id": "chunk_00003",
    "text": "question, stop and follow the instructions below. y Providing Family Planning Services During an Epidemic (Chapter 27) NO YES 1 Did your last monthly bleeding start within the New coverage y Gender Equality and Gender Inclusiveness (pp. xv\u2013xvii) past 7 days?*",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3
  },
  {
    "id": "chunk_00004",
    "text": "d Gender Inclusiveness (pp. xv\u2013xvii) past 7 days?* in this edition y Self-Injection Can Be an Option (in Chapter 4, p. 83\u201386) 2 Have you abstained from sexual intercourse y STI Signs and Symptoms (in Chapter 22, p. 343 since your last monthly bleeding, delivery,",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 4
  },
  {
    "id": "chunk_00005",
    "text": "p. 343 since your last monthly bleeding, delivery, y Screening and Treatment (in the section on Cervical abortion, or miscarriage? Cancer in Chapter 22, pp. 351\u2013354) 3 Have you been using a reliable contraceptive method consistently and correctly since your",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 5
  },
  {
    "id": "chunk_00006",
    "text": "ptive method consistently and correctly since your last monthly bleeding, delivery, abortion, or y Instructions on implant insertion and removal miscarriage? Expanded or (in Chapter 9, pp. 142\u2013148, pp. 157\u2013160) 4 Have you had a baby in the last 4 weeks?",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 6
  },
  {
    "id": "chunk_00007",
    "text": "57\u2013160) 4 Have you had a baby in the last 4 weeks? updated y Family Planning in Postabortion Care (in Chapter 25, coverage pp. 383\u2013387) 5 Did you have a baby less than 6 months ago, y Medical Eligibility Criteria for Contraceptive Use are you fully or nearly-fully breastfeeding, and",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 7
  },
  {
    "id": "chunk_00008",
    "text": "e are you fully or nearly-fully breastfeeding, and have you had no monthly bleeding since then? (Appendix D) 6 Have you had a miscarriage or abortion in the past 7 days?* * If the client is planning to use a copper-bearing IUD, the 7-day window is expanded to 12 days.",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 8
  },
  {
    "id": "chunk_00009",
    "text": "ring IUD, the 7-day window is expanded to 12 days. If the client answered If the client answered NO to all of the YES to at least one of questions, pregnancy the questions, you can be cannot be ruled out reasonably sure she is using the checklist. not pregnant. Rule out pregnancy by other means.",
    "page_number": 2,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 9
  },
  {
    "id": "chunk_00010",
    "text": "FAMILY PLANNING A GLOBAL HANDBOOK FOR PROVIDERS Evidence-based guidance developed through worldwide collaboration Updated 4th edition 2022 World Health Organization Johns Hopkins Department of Sexual and Bloomberg School of Public Health",
    "page_number": 3,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 10
  },
  {
    "id": "chunk_00011",
    "text": "nt of Sexual and Bloomberg School of Public Health Reproductive Health and Research Center for Communication Programs Knowledge for Health Project United States Agency for International Development Bureau for Global Health Office of Population and Reproductive Health",
    "page_number": 3,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 11
  },
  {
    "id": "chunk_00012",
    "text": "How to Obtain More Copies The Knowledge SUCCESS (Strengthening Use, Capacity, Collaboration, Exchange, Synthesis, and Sharing) Project at Johns Hopkins Center for Communication Programs offers copies of Family Planning: A Global Handbook for Providers free",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 12
  },
  {
    "id": "chunk_00013",
    "text": "ily Planning: A Global Handbook for Providers free of charge to readers in developing countries. All others, please contact the Knowledge SUCCESS Project for more information at orders@jhuccp.org. To order copies, please place an order here: http://www.fphandbook.org/ order-form.",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 13
  },
  {
    "id": "chunk_00014",
    "text": "order here: http://www.fphandbook.org/ order-form. The website http://www.fphandbook.org also offers downloads of printable files and files for e-readers in various languages of the Global Handbook and the updated wall chart, Do You Know Your Family Planning Choices?. The",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 14
  },
  {
    "id": "chunk_00015",
    "text": "rt, Do You Know Your Family Planning Choices?. The updates have been prepared in English. As they are translated into other languages, the translations will appear on the website. \u00a9 2007, 2008, 2011, 2018, 2022 World Health Organization and Johns Hopkins",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 15
  },
  {
    "id": "chunk_00016",
    "text": ", 2022 World Health Organization and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs Suggested citation: World Health Organization Department of Sexual and Reproductive Health and Research (WHO/SRH) and Johns Hopkins Bloomberg School of Public Health/",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 16
  },
  {
    "id": "chunk_00017",
    "text": "d Johns Hopkins Bloomberg School of Public Health/ Center for Communication Programs (CCP), Knowledge SUCCESS. Family Planning: A Global Handbook for Providers (2022 update). Baltimore and Geneva: CCP and WHO; 2022. Published with support from the United States Agency for International Development,",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 17
  },
  {
    "id": "chunk_00018",
    "text": "nited States Agency for International Development, through the Cooperative Agreement No. 7200AA19CA00001 with the Johns Hopkins University. Knowledge SUCCESS is supported by USAID\u2019s Bureau for Global Health, Office of Population and Reproductive Health and led by the Johns Hopkins Center for",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 18
  },
  {
    "id": "chunk_00019",
    "text": "ive Health and led by the Johns Hopkins Center for Communication Programs (CCP) in partnership with Amref Health Africa, The Busara Center for Behavioral Economics (Busara), and FHI 360. Opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID, The Johns",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 19
  },
  {
    "id": "chunk_00020",
    "text": "necessarily reflect the views of USAID, The Johns Hopkins University, or the World Health Organization. Requests to translate, adapt, or reprint: The publishers welcome requests to translate, adapt, reprint, or otherwise reproduce the material in this document for the purposes",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 20
  },
  {
    "id": "chunk_00021",
    "text": "uce the material in this document for the purposes of informing health care providers, their clients, and the general public and improving the quality of sexual and reproductive health care. Inquiries should be addressed to WHO",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 21
  },
  {
    "id": "chunk_00022",
    "text": "health care. Inquiries should be addressed to WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (fax: +41 22 791 48 06; e-mail: permissions@who.int) and the Knowledge SUCCESS Project, Center for Communication Programs, Johns Hopkins Bloomberg School of Public Health,",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 22
  },
  {
    "id": "chunk_00023",
    "text": ", Johns Hopkins Bloomberg School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202, USA (fax: +1 410 659-6266; e-mail: orders@jhuccp.org). Disclaimer: The mention of specific companies or of certain manufacturers\u2019 products",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 23
  },
  {
    "id": "chunk_00024",
    "text": "ic companies or of certain manufacturers\u2019 products does not imply that the World Health Organization, The Johns Hopkins University, or the United States Agency for International Development endorses or recommends them",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 24
  },
  {
    "id": "chunk_00025",
    "text": "ernational Development endorses or recommends them in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 25
  },
  {
    "id": "chunk_00026",
    "text": "ucts are distinguished by initial capital letters. The publishers have taken all reasonable precautions to verify the information in this publication. The published material is being distributed, however, without warranty of any",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 26
  },
  {
    "id": "chunk_00027",
    "text": "eing distributed, however, without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the publishers be liable for damages arising from its use. ii Family Planning: A Global Handbook for Providers",
    "page_number": 4,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 27
  },
  {
    "id": "chunk_00028",
    "text": "Family Planning A GLOBAL HANDBOOK FOR PROVIDERS Contents What\u2019s New in This Handbook? ................................................Inside front cover How to Obtain More Copies ..............................................................................ii",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 28
  },
  {
    "id": "chunk_00029",
    "text": "................................................ii Forewords ...........................................................................................................vi Acknowledgements .............................................................................................ix",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 29
  },
  {
    "id": "chunk_00030",
    "text": "................................................ix WHO\u2019s Family Planning Guidance ......................................................................xi Human Rights: Family Planning Providers\u2019 Contribution ......................................xiii",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 30
  },
  {
    "id": "chunk_00031",
    "text": "ibution ......................................xiii Gender Equality and Gender Inclusiveness .........................................................xv Collaborating and Supporting Organizations ....................................................xviii",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 31
  },
  {
    "id": "chunk_00032",
    "text": ".............................................xviii 1 Combined Oral Contraceptives ..............................................................1 2 Progestin-Only Pills ...............................................................................29",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 32
  },
  {
    "id": "chunk_00033",
    "text": "................................................29 3 Emergency Contraceptive Pills ..............................................................49 4 Progestin-Only Injectables ....................................................................65",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 33
  },
  {
    "id": "chunk_00034",
    "text": "................................................65 5 Monthly Injectables ...............................................................................97 6 Combined Patch ................................................................119",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 34
  },
  {
    "id": "chunk_00035",
    "text": "...............................................119 7 Combined Vaginal Ring ......................................................123 8 Progesterone-Releasing Vaginal Ring ..................................127",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 35
  },
  {
    "id": "chunk_00036",
    "text": "Vaginal Ring ..................................127 9 Implants ..............................................................................................131 10 Copper-Bearing Intrauterine Device ...................................................165",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 36
  },
  {
    "id": "chunk_00037",
    "text": "...............................................165 11 Levonorgestrel Intrauterine Device .....................................................191 12 Female Sterilization .............................................................................221",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 37
  },
  {
    "id": "chunk_00038",
    "text": "...............................................221 13 Vasectomy ..........................................................................................241 14 Male Condoms ...................................................................................257",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 38
  },
  {
    "id": "chunk_00039",
    "text": "...............................................257 15 Female Condoms ................................................................................271 16 Spermicides and Diaphragms ..............................................................281",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 39
  },
  {
    "id": "chunk_00040",
    "text": "...............................................281 17 Cervical Caps ....................................................................299 18 Fertility Awareness Methods ...............................................................301",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 40
  },
  {
    "id": "chunk_00041",
    "text": "...............................................301 19 Withdrawal .......................................................................317 20 Lactational Amenorrhea Method ........................................................319 Human Rights: Family Planning Providers\u2019 Contribution iii iii",
    "page_number": 5,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 41
  },
  {
    "id": "chunk_00042",
    "text": "21 Serving Diverse Groups ......................................................................329 Adolescents ................................................................................329 Men ............................................................................................333",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 42
  },
  {
    "id": "chunk_00043",
    "text": "...............................................333 Women Near Menopause .........................................................335 Clients with Disabilities .............................................................337",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 43
  },
  {
    "id": "chunk_00044",
    "text": "...............................................337 22 Sexually Transmitted Infections, Including HIV ....................................339 23 Family Planning for Adolescents and Women at High Risk for HIV .....357",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 44
  },
  {
    "id": "chunk_00045",
    "text": "dolescents and Women at High Risk for HIV .....357 24 Maternal and Newborn Health ...........................................................371 25 Reproductive Health Issues .................................................................383",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 45
  },
  {
    "id": "chunk_00046",
    "text": "...............................................383 Postabortion Family Planning ......................................................383 Violence Against Women ...........................................................388",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 46
  },
  {
    "id": "chunk_00047",
    "text": "...............................................388 Infertility .....................................................................................392 26 Family Planning Provision ....................................................................396 Importance of Selected Procedures for Providing",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 47
  },
  {
    "id": "chunk_00048",
    "text": "96 Importance of Selected Procedures for Providing Family Planning Methods .........................................................396 Successful Counseling .................................................................398",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 48
  },
  {
    "id": "chunk_00049",
    "text": "...............................................398 Who Provides Family Planning? ..................................................400 Infection Prevention in the Clinic ................................................404",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 49
  },
  {
    "id": "chunk_00050",
    "text": "...............................................404 Managing Contraceptive Supplies ...............................................408 27 Providing Family Planning Services During an Epidemic .......................410 Searchable online at www.fphandbook.org",
    "page_number": 6,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 50
  },
  {
    "id": "chunk_00051",
    "text": "BACK MATTER Appendix A. Contraceptive Effectiveness .....................................................415 Appendix B. Signs and Symptoms of Serious Health Conditions ..................416 Appendix C. Medical Conditions That Make Pregnancy",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 51
  },
  {
    "id": "chunk_00052",
    "text": "Appendix C. Medical Conditions That Make Pregnancy Especially Risky ........................................................................418 Appendix D. Medical Eligibility Criteria for Contraceptive Use ....................420",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 52
  },
  {
    "id": "chunk_00053",
    "text": "eria for Contraceptive Use ....................420 Glossary .......................................................................................................432 Methodology ................................................................................................440",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 53
  },
  {
    "id": "chunk_00054",
    "text": "...............................................440 WHO Guidance Documents .......................................................................442 References from Gender Equality and Inclusiveness Section .........................445",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 54
  },
  {
    "id": "chunk_00055",
    "text": "Inclusiveness Section .........................445 Illustration and Photo Credits ......................................................................446 JOB AIDS Comparing Contraceptives Comparing Combined Methods ..........................................................448",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 55
  },
  {
    "id": "chunk_00056",
    "text": "...............................................448 Comparing Injectables .........................................................................449 Comparing Implants ............................................................................450",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 56
  },
  {
    "id": "chunk_00057",
    "text": "...............................................450 Comparing Condoms ..........................................................................450 Comparing IUDs .................................................................................452",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 57
  },
  {
    "id": "chunk_00058",
    "text": "...............................................452 If You Miss Pills .............................................................................................453 Female Anatomy ..........................................................................................454",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 58
  },
  {
    "id": "chunk_00059",
    "text": "...............................................454 Male Anatomy ..............................................................................................457 Identifying Migraine Headaches and Auras ..................................................458",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 59
  },
  {
    "id": "chunk_00060",
    "text": "...............................................458 Ruling Out Pregnancy ...................................................................................461 How and When to Use the Pregnancy Checklist and",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 60
  },
  {
    "id": "chunk_00061",
    "text": "61 How and When to Use the Pregnancy Checklist and Pregnancy Tests ........................................................................................462 Pregnancy Checklist ...............................................................Inside back cover",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 61
  },
  {
    "id": "chunk_00062",
    "text": ".................................Inside back cover Effectiveness Chart...........................................................................Back cover Human Rights: Family Planning Providers\u2019 ConCtorinbtuetniotsn vv",
    "page_number": 7,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 62
  },
  {
    "id": "chunk_00063",
    "text": "Foreword From the World Health Organization The technology and products for sexual and reproductive health continue to evolve to improve the quality and safety of care, while meeting user needs and addressing considerations for access. Family planning providers",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 63
  },
  {
    "id": "chunk_00064",
    "text": "nsiderations for access. Family planning providers are at the core of health system responses to reduce persisting high levels of unmet need for family planning, including the challenges of responding to this need in the midst of humanitarian crises, epidemics, and other",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 64
  },
  {
    "id": "chunk_00065",
    "text": "midst of humanitarian crises, epidemics, and other contemporary global priorities. This Global Handbook for Providers offers clear, up-to-date information and advice to help family planning providers meet clients\u2019 needs, inform their choices, and support their use of contraception.",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 65
  },
  {
    "id": "chunk_00066",
    "text": "r choices, and support their use of contraception. The Handbook is also an excellent resource for training and can be used to reinforce supervision. The 2022 edition of the Handbook includes two chapters that were added to the web-based edition in February 2021\u2014Family Planning for Adolescents and",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 66
  },
  {
    "id": "chunk_00067",
    "text": "February 2021\u2014Family Planning for Adolescents and Women at High Risk for HIV and Providing Family Planning Services During an Epidemic. These chapters equip providers with the information and tools they need to maintain quality services in the context of epidemics and to integrate",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 67
  },
  {
    "id": "chunk_00068",
    "text": "vices in the context of epidemics and to integrate appropriate testing and preventative care in settings where HIV risk is high. In addition, the Handbook includes the latest guidance on cervical cancer and pre-cancer prevention, screening and treatment; syndromic management of",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 68
  },
  {
    "id": "chunk_00069",
    "text": ", screening and treatment; syndromic management of sexually transmitted infections; family planning in postabortion care; and the option of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) injectable contraceptives.",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 69
  },
  {
    "id": "chunk_00070",
    "text": "esterone acetate (DMPA) injectable contraceptives. Access to high-quality, affordable sexual and reproductive health services and information, including a full range of family planning methods, is fundamental to realizing the rights and well-being of women, girls, men, and boys. Universal",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 70
  },
  {
    "id": "chunk_00071",
    "text": "ll-being of women, girls, men, and boys. Universal access to effective contraception ensures that all people have a satisfying sexual life and can avoid the adverse health and socioeconomic consequences of unintended pregnancy. We are therefore delighted to release the 2022 edition",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 71
  },
  {
    "id": "chunk_00072",
    "text": "re therefore delighted to release the 2022 edition of the Global Handbook\u2014a key resource to help ensure the quality and safety of family planning services\u2014and recommend its use by national health systems and organizations providing family planning services.",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 72
  },
  {
    "id": "chunk_00073",
    "text": "organizations providing family planning services. We are exceedingly grateful for the contributions from a diverse range of dedicated experts (see Acknowledgements) who have supported the development of the 2022 edition of the Handbook. We also thank the Johns",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 73
  },
  {
    "id": "chunk_00074",
    "text": "2 edition of the Handbook. We also thank the Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs and the United States Agency for International Development for their collaboration on the production of the Handbook and their financial support. Pascale Allotey",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 74
  },
  {
    "id": "chunk_00075",
    "text": "dbook and their financial support. Pascale Allotey Director, Department of Sexual and Reproductive Health and Research World Health Organization vi Family Planning: A Global Handbook for Providers",
    "page_number": 8,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 75
  },
  {
    "id": "chunk_00076",
    "text": "Foreword From the United States Agency for International Development Access to voluntary family planning and reproductive health information and services advances and supports the sexual and reproductive health and rights of all individuals and can have positive economic, environmental, and social",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 76
  },
  {
    "id": "chunk_00077",
    "text": "have positive economic, environmental, and social benefits for families and communities. This Global Handbook provides updated, accurate, and practical guidance to support program managers and providers in delivering high-quality family",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 77
  },
  {
    "id": "chunk_00078",
    "text": "rs and providers in delivering high-quality family planning counseling, services, and care. Prior editions were widely used to support strong programs: over 500,000 copies have been distributed through USAID to governments and their partners. We anticipate this 2022 edition",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 78
  },
  {
    "id": "chunk_00079",
    "text": "nd their partners. We anticipate this 2022 edition will continue to help family planning providers across the globe to deliver client-centered counseling and services. Since the 2018 edition, two new chapters have been developed to reflect",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 79
  },
  {
    "id": "chunk_00080",
    "text": "n, two new chapters have been developed to reflect the current evidence base for family planning and to incorporate the WHO Consolidated Guideline on Self-Care Interventions, the WHO Recommendations on Adolescent Sexual and Reproductive Health and Rights, and also lessons",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 80
  },
  {
    "id": "chunk_00081",
    "text": "d Reproductive Health and Rights, and also lessons learned about service delivery during an epidemic. The Handbook now provides guidance on family planning for women and girls in high HIV-burden settings, aligning with the lessons from The Evidence for Contraceptive",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 81
  },
  {
    "id": "chunk_00082",
    "text": "th the lessons from The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial and the subsequent 2019 update of the World Health Organization (WHO) guidance and recommendations on contraceptive eligibility for women at high risk of HIV. New content",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 82
  },
  {
    "id": "chunk_00083",
    "text": "ibility for women at high risk of HIV. New content also focuses on contraceptive service delivery considerations for frontline providers in the context of epidemics and other emergencies, which was adapted from WHO guidance for humanitarian settings and learnings from",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 83
  },
  {
    "id": "chunk_00084",
    "text": "dance for humanitarian settings and learnings from the Ebola and Zika epidemics and the COVID-19 pandemic. The information gathered in this updated Handbook confirms that almost any family planning method can be used safely by all women, and that providing",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 84
  },
  {
    "id": "chunk_00085",
    "text": "an be used safely by all women, and that providing most methods is typically not complicated. Indeed, most methods can be provided even where resources are limited. This Handbook provides basic information that providers can use to assist",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 85
  },
  {
    "id": "chunk_00086",
    "text": "basic information that providers can use to assist individuals and couples to choose, use, and change family planning methods as they move through their lives. As always, program managers and providers play a central role in supporting clients to make voluntary and informed",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 86
  },
  {
    "id": "chunk_00087",
    "text": "supporting clients to make voluntary and informed choices from a range of safe and available methods. The client\u2013provider relationship, grounded in evidence-based and skillful counseling, can help inform the client\u2019s understanding of the benefits of family planning in general",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 87
  },
  {
    "id": "chunk_00088",
    "text": "ding of the benefits of family planning in general and of the chosen method in particular, including self-care practices such as self-injection, condom use, and exclusive breastfeeding. New clients may have a family planning method already in mind, but they may not be aware Forewords vii",
    "page_number": 9,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 88
  },
  {
    "id": "chunk_00089",
    "text": "of other options; continuing clients may have concerns about their current method, and knowledgeable counseling can help improve their satisfaction with that method or help them to switch methods effectively. With the information in this Handbook and the right resources, providers can ensure",
    "page_number": 10,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 89
  },
  {
    "id": "chunk_00090",
    "text": "book and the right resources, providers can ensure that a client\u2019s reproductive intentions, life situation, and preferences govern their voluntary family planning decisions. This update was developed in collaboration with WHO and experts from",
    "page_number": 10,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 90
  },
  {
    "id": "chunk_00091",
    "text": "veloped in collaboration with WHO and experts from many other organizations. USAID is proud to support its development and publication. We look forward to continuing the work with our many partners to empower individuals and couples, inclusive of all identities and abilities, to",
    "page_number": 10,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 91
  },
  {
    "id": "chunk_00092",
    "text": "les, inclusive of all identities and abilities, to plan their families and their futures. Ellen H. Starbird Director, Office of Population and Reproductive Health Bureau for Global Health United States Agency for International Development viii Family Planning: A Global Handbook for Providers",
    "page_number": 10,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 92
  },
  {
    "id": "chunk_00093",
    "text": "Acknowledgements The following people contributed to the revision of the Handbook: Florence Anam (WHO Advisory Group of Women Living with HIV, South Africa), Neeta Bhatnagar (Jhpiego, United States of America), Sharon Cameron (University of Edinburgh, United Kingdom of Great Britain",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 93
  },
  {
    "id": "chunk_00094",
    "text": "sity of Edinburgh, United Kingdom of Great Britain and Northern Ireland), Maria del Carmen Cravioto (Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico), Sophie Dilmitis (WHO Advisory Group of Women Living with HIV, Zimbabwe), Linda Eckert",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 94
  },
  {
    "id": "chunk_00095",
    "text": "of Women Living with HIV, Zimbabwe), Linda Eckert (University of Washington, USA), Alison Edelman (Oregon Health & Science University, USA), Mohammad Eslami (Ministry of Health and Education, Islamic Republic of Iran), Mwanaisha Juma Fakih (Nursing Council for",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 95
  },
  {
    "id": "chunk_00096",
    "text": "f Iran), Mwanaisha Juma Fakih (Nursing Council for Zanzibar, Zanzibar, United Republic of Tanzania), Carey Farquhar (University of Washington, USA), Kristina Gemzell Danielsson (Karolinska Institute, Sweden), Anna Glasier (University of Edinburgh, United Kingdom), Andy Gray",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 96
  },
  {
    "id": "chunk_00097",
    "text": "niversity of Edinburgh, United Kingdom), Andy Gray (University of KwaZulu-Natal, South Africa), Philip Hannaford (University of Aberdeen, United Kingdom), Margaret Happy (WHO Advisory Group of Women Living with HIV, Uganda), Natasha Kaoma (Copper Rose Zambia,",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 97
  },
  {
    "id": "chunk_00098",
    "text": "h HIV, Uganda), Natasha Kaoma (Copper Rose Zambia, Zambia), Nathalie Kapp (International Planned Parenthood Federation, United Kingdom), Seni Kouanda (Institute of Research in Health Sciences, Burkina Faso), Anita Makins (International Federation of Gynecology and",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 98
  },
  {
    "id": "chunk_00099",
    "text": "Makins (International Federation of Gynecology and Obstetrics, United Kingdom), Ernest Maya (University of Ghana, Ghana), Mari Ngai (National Center for Global Health and Medicine, Japan), Herbert Peterson (University of North Carolina, USA), Melanie Pleaner",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 99
  },
  {
    "id": "chunk_00100",
    "text": "niversity of North Carolina, USA), Melanie Pleaner (University of Witwatersrand, South Africa), Maria Rodriguez (Oregon Health & Sciences University, USA), Jenni Smit (University of Witwatersrand, South Africa), Carolina Sales Vieira (University of Sao Paulo, Brazil), and",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 100
  },
  {
    "id": "chunk_00101",
    "text": "ales Vieira (University of Sao Paulo, Brazil), and Rita Wahab (WHO Advisory Group of Women Living with HIV, Lebanon). The following people with the United States Agency for International Development (USAID) contributed to the technical review of this edition:",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 101
  },
  {
    "id": "chunk_00102",
    "text": "ntributed to the technical review of this edition: Afeefa Abdur-Rahman, Anita Dam, Kate Dieringer, Maria Carrasco, Amanda Cordova Gomez, Kate Howell, Itoro Inoyo, Apoorva Jadhav, Fatou Jallow, Joan Kraft, Patricia MacDonald, Jennifer Mason, Erin Mielke,",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 102
  },
  {
    "id": "chunk_00103",
    "text": ", Patricia MacDonald, Jennifer Mason, Erin Mielke, Kevin Peine, Abdulmumin Saad, Jane Schueller, Lee Sims, Tabitha Sripipatana, Ellen Starbird, Linda Sussman, and Julianne Weis. ix",
    "page_number": 11,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 103
  },
  {
    "id": "chunk_00104",
    "text": "WHO Headquarters and Regional Offices WHO Department of Sexual and Reproductive Health and Research \u2013 Pascale Allotey, Ian Askew, Anna Coates, Mary Lyn Gaffield, James Kiarie, Caron Kim, Abraham Sium, Petrus Steyn WHO Department of Global HIV, Hepatitis, and STI Programmes \u2013",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 104
  },
  {
    "id": "chunk_00105",
    "text": "ent of Global HIV, Hepatitis, and STI Programmes \u2013 Rachel Baggaley, Magdalena Barr-DiChiara, Maeve Brito de Mello, Shona Dalal, Cheryl Johnson, Niklaus Luhmann, Virginia MacDonald, Michelle Rodolph, Annette Verster, Marco Vitoria, Teodora Wi",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 105
  },
  {
    "id": "chunk_00106",
    "text": "odolph, Annette Verster, Marco Vitoria, Teodora Wi WHO Regional Office for Africa \u2013 Chilanga Asmani, Nancy Kidula, L\u00e9opold Ouedraogo WHO Regional Office for the Americas \u2013 Rodolfo G\u00f3mez Ponce de Le\u00f3n WHO Regional Office for the Eastern Mediterranean \u2013 Karima Gholbzouri",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 106
  },
  {
    "id": "chunk_00107",
    "text": "for the Eastern Mediterranean \u2013 Karima Gholbzouri WHO Regional Office for Europe \u2013 Oleg Kuzmenko Writing and Production of the 2022 Edition Neeta Bhatnagar drafted the update of Chapter 9 on implants. Maeve Brito de Mello drafted the updated sections in Chapter 22 focused on",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 107
  },
  {
    "id": "chunk_00108",
    "text": "fted the updated sections in Chapter 22 focused on sexual transmitted infections, and Linda Eckert drafted the cervical cancer information in the same chapter. Caron Kim and Abraham Sium updated the section on postabortion care within Chapter 25.",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 108
  },
  {
    "id": "chunk_00109",
    "text": "he section on postabortion care within Chapter 25. Chapter 23 titled Family Planning for Adolescents and Women at High Risk for HIV was drafted by Carey Farquhar, and Chapter 27 titled Providing Family Planning Services During an Epidemic was drafted by Maria Rodriguez.",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 109
  },
  {
    "id": "chunk_00110",
    "text": "During an Epidemic was drafted by Maria Rodriguez. Heather Johnson Finn (Knowledge 4 Success Project, Johns Hopkins Bloomberg School of Public Health, USA) directed the production and layout of the documents. Editing and proofreading was provided by Jane Patten of",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 110
  },
  {
    "id": "chunk_00111",
    "text": "ng and proofreading was provided by Jane Patten of Green Ink, United Kingdom (www.greenink.co.uk). Design and layout was supplied by Prographics Inc., Annapolis, Maryland, USA. WHO, USAID and Johns Hopkins University gratefully acknowledge",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 111
  },
  {
    "id": "chunk_00112",
    "text": "nd Johns Hopkins University gratefully acknowledge the authors and reviewers of previous editions of this Handbook. A full listing of contributors to all editions of the Handbook is available at http://www. fphandbook.org.",
    "page_number": 12,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 112
  },
  {
    "id": "chunk_00113",
    "text": "WHO\u2019s Family Planning Guidance The World Health Organization (WHO) develops guidance through a process that begins with systematic review and assessment of research evidence on key public health questions. Then, WHO convenes working groups of experts",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 113
  },
  {
    "id": "chunk_00114",
    "text": "ions. Then, WHO convenes working groups of experts from around the world. The working groups assess the implications of the evidence and make recommendations for health care services and practice. Policy-makers and program managers can use these recommendations to write",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 114
  },
  {
    "id": "chunk_00115",
    "text": "am managers can use these recommendations to write or update national guidelines and program policies. Using this process, the Department of Sexual and Reproductive Health and Research issues guidance on specific issues as important questions arise. It also",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 115
  },
  {
    "id": "chunk_00116",
    "text": "cific issues as important questions arise. It also maintains 2 sets of guidance that are updated and expanded periodically: y The Medical Eligibility Criteria for Contraceptive Use provides guidance on whether people with certain medical conditions can safely and effectively",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 116
  },
  {
    "id": "chunk_00117",
    "text": "tain medical conditions can safely and effectively use specific contraceptive methods. y The Selected Practice Recommendations for Contraceptive Use answers questions about how to use various contraceptive methods. This book, Family Planning: A Global Handbook for Providers, offers technical",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 117
  },
  {
    "id": "chunk_00118",
    "text": "A Global Handbook for Providers, offers technical information to help health care providers deliver family planning methods appropriately and effectively. It incorporates and reflects the Medical Eligibility Criteria and the Selected Practice Recommendations as well as other WHO",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 118
  },
  {
    "id": "chunk_00119",
    "text": "cted Practice Recommendations as well as other WHO guidance. This fourth edition brings the Global Handbook up to date with current WHO guidance on all topics covered. A thorough reference guide, the Handbook provides specific and practical guidance on 21 family planning",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 119
  },
  {
    "id": "chunk_00120",
    "text": "cific and practical guidance on 21 family planning methods. It also covers health issues that may arise in the context of family planning services. The intended primary audience for this Handbook is health care providers who offer family planning in resource-limited settings around",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 120
  },
  {
    "id": "chunk_00121",
    "text": "amily planning in resource-limited settings around the world. Health care managers, supervisors, and policy-makers also may find this book helpful. The Decision-Making Tool for Family Planning Clients and Providers incorporates WHO guidance into a tool that helps family planning providers and clients",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 121
  },
  {
    "id": "chunk_00122",
    "text": "l that helps family planning providers and clients to discuss family planning choices and helps clients make informed decisions. This flipchart tool leads provider and client through a structured yet tailored process that facilitates choosing and using a family planning method. The tool",
    "page_number": 13,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 122
  },
  {
    "id": "chunk_00123",
    "text": "Together, these 4 publications\u2014the Medical Eligibility Criteria, the Selected Practice Recommendations, the Global Handbook, and the Decision-Making Tool\u2014 are known as the 4 Cornerstones of WHO\u2019s family planning guidance. On the Internet: y Medical Eligibility Criteria for Contraceptive Use",
    "page_number": 14,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 123
  },
  {
    "id": "chunk_00124",
    "text": "Medical Eligibility Criteria for Contraceptive Use https://apps.who.int/iris/handle/10665/181468 y Selected Practice Recommendations for Contraceptive Use https://apps.who.int/iris/handle/10665/252267 y Family Planning: A Global Handbook for Providers www.fphandbook.org",
    "page_number": 14,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 124
  },
  {
    "id": "chunk_00125",
    "text": "A Global Handbook for Providers www.fphandbook.org y Decision-Making Tool for Family Planning Clients and Providers https://apps.who.int/iris/handle/10665/43225 xii Family Planning: A Global Handbook for Providers",
    "page_number": 14,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 125
  },
  {
    "id": "chunk_00126",
    "text": "Human Rights: Family Planning Providers\u2019 Contribution All people deserve the right to determine, as best they can, the course of their own lives. Whether and when to have children, how many, and with whom are important parts of this right. Family planning providers have the",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 126
  },
  {
    "id": "chunk_00127",
    "text": "of this right. Family planning providers have the privilege and responsibility to help people to make and carry out these decisions. Furthermore, programs that honor their clients\u2019 human rights contribute to positive sexual health outcomes.",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 127
  },
  {
    "id": "chunk_00128",
    "text": "hts contribute to positive sexual health outcomes. Thus, high-quality family planning services and the people who deliver them respect, protect, and fulfill the human rights of all their clients. Everyone working at every level of the health system plays an important part. Health",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 128
  },
  {
    "id": "chunk_00129",
    "text": "the health system plays an important part. Health care providers express their commitment to human rights every day in every contact with every client. Nine human rights principles guide family planning services. As a family planning provider, you contribute to all of them.",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 129
  },
  {
    "id": "chunk_00130",
    "text": "planning provider, you contribute to all of them. Principle 1 Non-discrimination What you can do: Welcome all clients equally. Respect every client\u2019s needs and wishes. Set aside personal judgments and any negative opinions. Promise yourself to give every client the best care you can.",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 130
  },
  {
    "id": "chunk_00131",
    "text": "urself to give every client the best care you can. Principle 2 Availability of contraceptive information and services What you can do: Know the family planning methods available and how to provide them. Help make sure that supplies stay in stock. Do not rule out any method for a",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 131
  },
  {
    "id": "chunk_00132",
    "text": "es stay in stock. Do not rule out any method for a client, and do not hold back information. Principle 3 Accessible information and services What you can do: Help make sure that everyone can use your facility, even if they have a physical disability. Participate in outreach, when possible. Do not ask",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 132
  },
  {
    "id": "chunk_00133",
    "text": "Participate in outreach, when possible. Do not ask clients, even young clients, to get someone else\u2019s permission to use family planning or a certain family planning method. xiii",
    "page_number": 15,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 133
  },
  {
    "id": "chunk_00134",
    "text": "Principle 4 Acceptable information and services What you can do: Be friendly and welcoming, and help make your facility that way. Put yourself in the client\u2019s shoes. Ask what is important to the clients\u2014what they want and how they want it provided. Principle 5 Quality",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 134
  },
  {
    "id": "chunk_00135",
    "text": "and how they want it provided. Principle 5 Quality What you can do: Keep your knowledge and skills up to date. Use good communication skills. Check that contraceptives you provide are not out-of-date. Principle 6 Informed decision-making What you can do: Explain family planning methods",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 135
  },
  {
    "id": "chunk_00136",
    "text": "g What you can do: Explain family planning methods clearly, including how to use them, how effective they are, and what side effects they may have, if any. Help clients consider what is important to them in a family planning method. Principle 7 Privacy and confidentiality",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 136
  },
  {
    "id": "chunk_00137",
    "text": "ng method. Principle 7 Privacy and confidentiality What you can do: Do not discuss your clients with others except with permission and as needed for their care. When talking with clients, find a place where others cannot hear. Do not tell others what your clients have said. Promptly put away",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 137
  },
  {
    "id": "chunk_00138",
    "text": "ers what your clients have said. Promptly put away clients\u2019 records. Principle 8 Participation What you can do: Ask clients what they think about family planning services. Act on what they say to improve care. Principle 9 Accountability What you can do: Hold yourself accountable for",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 138
  },
  {
    "id": "chunk_00139",
    "text": "ity What you can do: Hold yourself accountable for the care that you give clients and for their rights. These human rights principles guide WHO\u2019s work and serve as the framework for WHO\u2019s guidance on contraceptive methods. The full statement of these principles can be found in Ensuring human rights",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 139
  },
  {
    "id": "chunk_00140",
    "text": "e principles can be found in Ensuring human rights in the provision of contraceptive information and services: Guidance and recommendations; 2014 (http://www.who.int/reproductivehealth/publications/ family_planning/human-rights-contraception/en/). xiv Family Planning: A Global Handbook for Providers",
    "page_number": 16,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 140
  },
  {
    "id": "chunk_00141",
    "text": "Gender Equality and Gender Inclusiveness Gender Equality and Family Planning The neglect of women\u2019s reproductive rights severely limits their opportunities in public and private life, including opportunities for education and economic",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 141
  },
  {
    "id": "chunk_00142",
    "text": "including opportunities for education and economic and political empowerment (1). Gender equality and access to family planning are integrally related. As noted in the Human Rights section of the Introduction of this Handbook (p. xiii), people have a right to determine \u201cwhether and when",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 142
  },
  {
    "id": "chunk_00143",
    "text": "people have a right to determine \u201cwhether and when to have children, how many, and with whom\u201d. This is fundamental for every individual\u2019s empowerment and agency over their own bodies and lives. In order to implement gender-responsive care when applying the 9 human",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 143
  },
  {
    "id": "chunk_00144",
    "text": "t gender-responsive care when applying the 9 human rights principles presented in the Human Rights section (p. xiii), providers should particularly pay attention to empowering all women, men, and gender-diverse people to: y have full and equal access to sexual and reproductive health care,",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 144
  },
  {
    "id": "chunk_00145",
    "text": "ual access to sexual and reproductive health care, information, and education y make their own informed decisions regarding their own health care, use of contraceptives, and whether or not to consent to sexual intercourse with their partner; this includes the right to make decisions",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 145
  },
  {
    "id": "chunk_00146",
    "text": "partner; this includes the right to make decisions alone or with their partner. Key Gender Equality Definitions (2) \u2022 Sex refers to the different biological and physiological characteristics of males and females, such as reproductive organs, chromosomes, hormones, etc.",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 146
  },
  {
    "id": "chunk_00147",
    "text": "s reproductive organs, chromosomes, hormones, etc. \u2022 Gender refers to the socially constructed characteristics of women and men\u2014such as norms, roles, and relationships of and between groups of women and men. \u2022 Gender equality refers to equal chances or opportunities for women",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 147
  },
  {
    "id": "chunk_00148",
    "text": "refers to equal chances or opportunities for women and men to access and control social, economic, and political resources, including protection under the law (such as health services, education, and voting rights). \u2022 Gender equity refers to the different needs, preferences, and interests of",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 148
  },
  {
    "id": "chunk_00149",
    "text": "the different needs, preferences, and interests of women and men. This may mean that treatment differs to ensure equality of opportunity by considering the realities of women\u2019s and men\u2019s lives. \u2022 Gender-responsive policies, practices, and programs are ones that",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 149
  },
  {
    "id": "chunk_00150",
    "text": "ve policies, practices, and programs are ones that consider gender inequality and gender inequity and take measures to actively reduce their harmful effects. xv",
    "page_number": 17,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 150
  },
  {
    "id": "chunk_00151",
    "text": "Key Gender Inclusion and Diversity Definitions (2) \u2022 Gender identity refers to each person\u2019s deeply felt internal and individual experience of gender, which may or may not correspond with the sex assigned to them at birth. An individual\u2019s gender identity",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 151
  },
  {
    "id": "chunk_00152",
    "text": "to them at birth. An individual\u2019s gender identity is not necessarily confined to an identity that is completely male or completely female. \u2022 Transgender, nonbinary, gender fluid, and/or gender queer are terms used to describe an individual\u2019s gender identity when it differs from their assigned sex.",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 152
  },
  {
    "id": "chunk_00153",
    "text": "identity when it differs from their assigned sex. \u2022 Cisgender can be used to describe an individual\u2019s gender identity when it aligns with the sex assigned to them at birth. \u2022 Gender expression refers to the way one chooses to dress, speak, or",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 153
  },
  {
    "id": "chunk_00154",
    "text": "refers to the way one chooses to dress, speak, or generally conduct oneself socially. The way an individual expresses their gender is not always indicative of their gender identity. In doing so, providers need to be aware of the different needs and realities",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 154
  },
  {
    "id": "chunk_00155",
    "text": "d to be aware of the different needs and realities of women, men, and gender-diverse people\u2019s lives. Providers should consider how people\u2019s social, cultural, and economic circumstances, and particularly the harmful gender norms and inequalities they face, affect their",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 155
  },
  {
    "id": "chunk_00156",
    "text": "der norms and inequalities they face, affect their contraceptive decision-making, their access to care, and continued use of their chosen method. Providers\u2019 approaches to care should fully empower all women, men, and gender-diverse people regardless of these circumstances. Gender Inclusiveness",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 156
  },
  {
    "id": "chunk_00157",
    "text": "dless of these circumstances. Gender Inclusiveness Traditionally, family planning guidance and other related documents have only referred to \u201cwomen\u201d, viewing \u201ccisgender\u201d women as the norm, since in most settings they are the majority of those seeking family planning, and",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 157
  },
  {
    "id": "chunk_00158",
    "text": "the majority of those seeking family planning, and often these documents assume that these women are only in heterosexual relationships. However, there is increasing recognition of men\u2019s contraceptive needs (for example, use of male-controlled methods and men\u2019s support of",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 158
  },
  {
    "id": "chunk_00159",
    "text": "se of male-controlled methods and men\u2019s support of their female partners\u2019 contraceptive decision-making and use), as well as of the needs of people with diverse sexual orientations and gender identities, understanding that the binary categories of \u201cmen \u201cand \u201cwomen\u201d do not apply to all people.",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 159
  },
  {
    "id": "chunk_00160",
    "text": "s of \u201cmen \u201cand \u201cwomen\u201d do not apply to all people. Providers may come across transgender and gender-diverse people seeking family planning. Because of gender inequalities and inequities, transgender and gender-diverse people face systemic disadvantages, violence, stigma, and",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 160
  },
  {
    "id": "chunk_00161",
    "text": "face systemic disadvantages, violence, stigma, and discrimination in society and in health care settings (3,4,5). These can create barriers to access to health care, support, and information. It is important, xvi Family Planning: A Global Handbook for Providers",
    "page_number": 18,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 161
  },
  {
    "id": "chunk_00162",
    "text": "therefore, that providers recognize and address diversity so that all individual clients and couples seeking family planning can access them without stigma or discrimination and in ways that encourage them to make decisions that are safe, appropriate, and best meet their needs and their preferences.",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 162
  },
  {
    "id": "chunk_00163",
    "text": ", and best meet their needs and their preferences. Considerations for Transgender and Gender-Diverse Clients Gender incongruence is not a mental health condition. While some transgender people seek medical or surgical transition, others do not.",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 163
  },
  {
    "id": "chunk_00164",
    "text": "eek medical or surgical transition, others do not. Any social, psychological, behavioral, or medical (including hormonal treatment or surgeries) interventions designed to support and affirm an individual\u2019s gender identity can be termed \u201cgender-affirmative",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 164
  },
  {
    "id": "chunk_00165",
    "text": "gender identity can be termed \u201cgender-affirmative health care\u201d (6). Some transgender or gender-diverse people retain the reproductive capacity of the sex they were assigned at birth; for instance, a transgender man may require female contraceptives, cervical",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 165
  },
  {
    "id": "chunk_00166",
    "text": "er man may require female contraceptives, cervical screening, and antenatal care. In accordance with the human rights principles underpinning family planning, all transgender and nonbinary individuals should be able to access contraception, while having their gender identity respected.",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 166
  },
  {
    "id": "chunk_00167",
    "text": "ion, while having their gender identity respected. Specific considerations are important for family planning providers to bear in mind: y Affirm your client\u2019s gender identity, including, for example, by using their preferred name (whether or not it aligns with the name on their",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 167
  },
  {
    "id": "chunk_00168",
    "text": "e (whether or not it aligns with the name on their official documents) and pronouns. y Be aware of possible specific family planning needs; for example, interactions with hormone usage. Acknowledge any gaps in your knowledge regarding these needs and provide a referral to specialized",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 168
  },
  {
    "id": "chunk_00169",
    "text": "these needs and provide a referral to specialized care if necessary. y Obtain informed consent and pay attention to sensitivities surrounding physical examinations for gender-transitioning clients. y Do not to reveal a person\u2019s gender history without their consent,",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 169
  },
  {
    "id": "chunk_00170",
    "text": "l a person\u2019s gender history without their consent, including, for example, by listing gender transition surgery or other surgeries/treatment that would indicate their gender prior to their transition on medical records unless relevant to obtain a method.",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 170
  },
  {
    "id": "chunk_00171",
    "text": "edical records unless relevant to obtain a method. y Account for gender inequalities and social determinants that might affect the client\u2019s capacity and agency for decision-making about their reproductive health and other related issues (this is especially the case",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 171
  },
  {
    "id": "chunk_00172",
    "text": "other related issues (this is especially the case given that \u201ctransgender and gender-diverse people [often] live within social, legal, economic and political systems that place them at high risk of discrimination, exclusion, poverty and violence\u201d [7]).",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 172
  },
  {
    "id": "chunk_00173",
    "text": "rimination, exclusion, poverty and violence\u201d [7]). The list of references for this section can be found on p. 457. Gender Equality and Gender Inclusiveness xvii",
    "page_number": 19,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 173
  },
  {
    "id": "chunk_00174",
    "text": "Collaborating and Supporting Organizations Abt Associates CARE International African Population and Health CARE USA Research Center (APHRC) Carolina Population Center, University Afrihealth Optonet Association of North Carolina at Chapel Hill (CSOs Network), Nigeria Centers for Disease Control",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 174
  },
  {
    "id": "chunk_00175",
    "text": "CSOs Network), Nigeria Centers for Disease Control Al-Mustafa Welfare Association and Prevention (CSOs Network), Sindh Centre for the Development Amref Health Africa of People (CEDEP), Ghana Ansul-India Health & Management Centro de Investigaci\u00f3n y Promoci\u00f3n",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 175
  },
  {
    "id": "chunk_00176",
    "text": "h & Management Centro de Investigaci\u00f3n y Promoci\u00f3n Services (AIHMS) para Am\u00e9rica Central de Derechos Asesor\u00edas Internacionales en Salud Humanos \u2013 CIPAC, Costa Rica Integral y Desarrollo (ASID), Costa Rica Chemonics Asociaci\u00f3n Hondure\u00f1a de Planificaci\u00f3n CILSIDA, Togo de Familia (ASHONPLAFA)",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 176
  },
  {
    "id": "chunk_00177",
    "text": "lanificaci\u00f3n CILSIDA, Togo de Familia (ASHONPLAFA) Civil Society for Family Planning Asociaci\u00f3n Pro Bienestar de la in Nigeria (CiSFP) Familia de Guatemala (APROFAM) Concept Foundation Asociaci\u00f3n TAN UX\u2019IL, Guatemala Consortium of Reproductive Associa\u00e7\u00e3o Mo\u00e7ambicana de Obstetras",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 177
  },
  {
    "id": "chunk_00178",
    "text": "f Reproductive Associa\u00e7\u00e3o Mo\u00e7ambicana de Obstetras Health Associations (CORHA). e Ginecologistas (AMOG) CORE Group Association Burkinab\u00e8 pour le bien \u00eatre familal (ABBEF) du Burkina Faso Croatian Society for Reproductive Medicine and Gynecologic Endocrinology Association for the Well-Being of",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 178
  },
  {
    "id": "chunk_00179",
    "text": "ic Endocrinology Association for the Well-Being of of Croatian Medical Association the Colombian Family (Profamilia) Cultural Practice, LLC Association of Reproductive Health Professionals (ARHP) East European Institute for Reproductive Health Association for Reproductive",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 179
  },
  {
    "id": "chunk_00180",
    "text": "r Reproductive Health Association for Reproductive and Family Health EngenderHealth Balanced Stewardship Equilibres & Populations Development Association Family Guidance Association of Ethiopia Bill & Melinda Gates Institute for Family Planning Association of Swaziland",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 180
  },
  {
    "id": "chunk_00181",
    "text": "itute for Family Planning Association of Swaziland Population and Reproductive Health Federation of Obstetric & Bixby Center for Global Gynecological Societies of India Reproductive Health, University of California, San Francisco Female Health Company Bridges of Hope Training FHI 360",
    "page_number": 20,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 181
  },
  {
    "id": "chunk_00182",
    "text": "Foundation for Integrated Rural International Medical Corps Development (FIRD), Uganda International Planned Parenthood FP2020 Federation (IPPF) FUSA AC, Argentina International Planned Parenthood Federation/Western Hemisphere Georgetown University, Institute Region (IPPF/WHR) for Reproductive Health",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 182
  },
  {
    "id": "chunk_00183",
    "text": "nstitute Region (IPPF/WHR) for Reproductive Health IntraHealth International, Inc. Grameen Foundation USA (GF USA) Investigaci\u00f3n en Salud y Guttmacher Institute Demograf\u00eda, S.C. (INSAD) Health NGOs Network (HENNET) Ipas Africa Alliance Health, Development and Jhpiego Performance (HDP), Rwanda",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 183
  },
  {
    "id": "chunk_00184",
    "text": "Development and Jhpiego Performance (HDP), Rwanda John Snow, Inc (JSI) Hesperian Health Guides Johns Hopkins Bloomberg Hindustan Latex Family Planning School of Public Health Promotion Trust (HLFPPT) Kwa-Zulu Natal Maternal Women, Implementing Best Practices Child and Nutrition Directorate",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 184
  },
  {
    "id": "chunk_00185",
    "text": "ing Best Practices Child and Nutrition Directorate (IBP) Consortium Last Mile Health and Development Initiative Supporting Adolescents Association, Nigeria & Youths in Education and Sexual Health (ISAYES), Nigeria LiveWell Initiative LWI, Nigeria",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 185
  },
  {
    "id": "chunk_00186",
    "text": "(ISAYES), Nigeria LiveWell Initiative LWI, Nigeria Institute of Health Management, Management Sciences for Health (MSH) Pachod (IHMP) Marie Stopes International Institute of Tropical Medicine, Ministry of Health and Medical Antwerp, Belgium Services, Solomon Islands",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 186
  },
  {
    "id": "chunk_00187",
    "text": "Medical Antwerp, Belgium Services, Solomon Islands Instituto Nacional de Ciencias M\u00e9dicas Ministry of Health Belize y Nutrici\u00f3n Salvador Zubir\u00e1n. Ministry of Health of the Intensive Rescue Foundation Republic of Zambia International (IRFI) MOMENTUM Country and International Community of",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 187
  },
  {
    "id": "chunk_00188",
    "text": "I) MOMENTUM Country and International Community of Global Leadership Women Living with HIV Mozambican Association for Family International Community of Development (AMODEFA) Women Living with HIV \u2013 Eastern Africa (ICWEA) Muslim Family Counselling Services",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 188
  },
  {
    "id": "chunk_00189",
    "text": "Africa (ICWEA) Muslim Family Counselling Services International Confederation of Midwives National Population and Family Planning Board, Indonesia International Consortium for Emergency Contraception (ICEC) Network of People Living with HIV/ AIDS in Nigeria (NEPHWAN) International Federation of",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 189
  },
  {
    "id": "chunk_00190",
    "text": "S in Nigeria (NEPHWAN) International Federation of Gynecology and Obstetrics (FIGO) NGALAKERI International Islamic Center for Options Consultancy Services Population Studies and Research Overseas Strategic Consulting, Ltd (IICPSR) \u2013 Al Azhar University. Palladium",
    "page_number": 21,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 190
  },
  {
    "id": "chunk_00191",
    "text": "Pan African Positive Women\u2019s R\u00e9seau Siggil Jig\u00e9en S\u00e9n\u00e9gal Coalition, Zimbabwe Romanian Family Planning Network Pan American Health Organization, Rotarian Action Group for Population Latin American Center for Perinatology, & Development (RFPD) Women and Reproductive Health",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 191
  },
  {
    "id": "chunk_00192",
    "text": "& Development (RFPD) Women and Reproductive Health (CLAP/WR-PAHO/WHO) Salud y Famila PATH Save the Children Pathfinder International SOCOBA Inc. (Society for Children Orphaned by AIDS) PLAFAM, Asociaci\u00f3n Civil de Planificaci\u00f3n Familiar Trust Women Foundation",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 192
  },
  {
    "id": "chunk_00193",
    "text": "l de Planificaci\u00f3n Familiar Trust Women Foundation Plan International Tulane University School of Public Health and Tropical Medicine Planned Parenthood Association of Ghana (PPAG) Uganda Youth Alliance for Family Planning and Adolescent Planned Parenthood Association Health (UYAFPAH)",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 193
  },
  {
    "id": "chunk_00194",
    "text": "nt Planned Parenthood Association Health (UYAFPAH) of Zambia (PPAZ) United Nations Population Fund Planned Parenthood Global University of Gadjah Mada Population Council (UGM), Indonesia Population Foundation of India (PFI) University of North Carolina Gillings",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 194
  },
  {
    "id": "chunk_00195",
    "text": "India (PFI) University of North Carolina Gillings Population Media Center (PMC) School of Global Public Health Population Reference Bureau University of the Witwatersrand, Reproductive Health and HIV Institute Population Services International (PSI) University Research Co., LLC",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 195
  },
  {
    "id": "chunk_00196",
    "text": "s International (PSI) University Research Co., LLC Princeton University, Office of Population Research Venture Strategies for Health and Development PT Tunggal Idaman Abdi We Care Solar Public Health Informatics Foundation (PHIF) Wellbeing Foundation Africa",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 196
  },
  {
    "id": "chunk_00197",
    "text": "tics Foundation (PHIF) Wellbeing Foundation Africa Public Health Institute (PHI) West African Health Organization (WAHO) Real Agency for Community Development (RACD), Uganda WINGS/ALAS Guatemala Reproductive Health Supplies YLabs Coalition (RHSC) Zimbabwe National Family",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 197
  },
  {
    "id": "chunk_00198",
    "text": "es YLabs Coalition (RHSC) Zimbabwe National Family Reproductive Health Uganda (RHU) Planning Council (ZNFPC) xx Family Planning: A Global Handbook for Providers",
    "page_number": 22,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 198
  },
  {
    "id": "chunk_00199",
    "text": "1 1 sevitpecartnoC larO denibmoC CHAPTER 1 Combined Oral Contraceptives Key Points for Providers and Clients \ufffd Take one pill every day. For greatest effectiveness a woman must take pills daily and start each new pack of pills on time. \ufffd Take any missed pill as soon as possible. Missing pills risks",
    "page_number": 23,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 199
  },
  {
    "id": "chunk_00200",
    "text": "ssed pill as soon as possible. Missing pills risks pregnancy and may make some side effects worse. \ufffd Bleeding changes are common but not harmful. Typically, there is irregular bleeding for the first few months and then lighter and more regular bleeding.",
    "page_number": 23,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 200
  },
  {
    "id": "chunk_00201",
    "text": "months and then lighter and more regular bleeding. \ufffd Can be given to a woman at any time to start now or later. What Are Combined Oral Contraceptives? \ufffd Pills that contain low doses of 2 hormones\u2014a progestin and an estrogen\u2014like the natural hormones progesterone and estrogen in a woman\u2019s body.",
    "page_number": 23,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 201
  },
  {
    "id": "chunk_00202",
    "text": "mones progesterone and estrogen in a woman\u2019s body. \ufffd Combined oral contraceptives (COCs) are also called \u201cthe Pill,\u201d low-dose combined pills, OCPs, and OCs. \ufffd Work primarily by preventing the release of eggs from the ovaries (ovulation). How Effective?",
    "page_number": 23,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 202
  },
  {
    "id": "chunk_00203",
    "text": "eggs from the ovaries (ovulation). How Effective? Effectiveness depends on the user: Risk of pregnancy is greatest when a woman starts a new pill pack 3 or more days late, or misses 3 or more pills near the beginning or end of a pill pack.",
    "page_number": 23,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 203
  },
  {
    "id": "chunk_00204",
    "text": "More \ufffd As commonly used, about 7 pregnancies per 100 women using effective COCs over the first year. This means that 93 of every 100 women using COCs will not become pregnant. \ufffd When no pill-taking mistakes are made, less than 1 pregnancy per",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 204
  },
  {
    "id": "chunk_00205",
    "text": "aking mistakes are made, less than 1 pregnancy per 100 women using COCs over the first year (3 per 1,000 women). Return of fertility after COCs are stopped: No delay Protection against sexually transmitted infections (STIs): None Less effective Why Some Women Say They Like",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 205
  },
  {
    "id": "chunk_00206",
    "text": ": None Less effective Why Some Women Say They Like Combined Oral Contraceptives \ufffd Are controlled by the woman \ufffd Can be stopped at any time without a provider\u2019s help \ufffd Do not interfere with sex \ufffd Are easy to use \ufffd Easy to obtain, for example, in drug stores or pharmacies Side Effects, Health Benefits,",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 206
  },
  {
    "id": "chunk_00207",
    "text": "tores or pharmacies Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 20) Some users report the following: \ufffd Changes in bleeding patterns,\u2020 including: Bleeding changes \u2013 Lighter bleeding and fewer days of bleeding are normal and",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 207
  },
  {
    "id": "chunk_00208",
    "text": "bleeding and fewer days of bleeding are normal and \u2013 Irregular bleeding not harmful. If \u2013 Infrequent bleeding a woman finds them bothersome, \u2013 No monthly bleeding counseling and \ufffd Headaches support can help. \ufffd Dizziness \ufffd Nausea \ufffd Breast tenderness \ufffd Weight change (see Question 6, p. 25)",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 208
  },
  {
    "id": "chunk_00209",
    "text": "tenderness \ufffd Weight change (see Question 6, p. 25) \ufffd Mood changes \ufffd Acne (can improve or worsen, but usually improves) Other possible physical changes: \ufffd Blood pressure increases a few points (mm Hg). When increase is due to COCs, blood pressure declines quickly after use of COCs stops.",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 209
  },
  {
    "id": "chunk_00210",
    "text": "pressure declines quickly after use of COCs stops. \u2020 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. 2 Family Planning: A Global Handbook for Providers",
    "page_number": 24,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 210
  },
  {
    "id": "chunk_00211",
    "text": "1 3 sevitpecartnoC larO denibmoC Known Health Benefits Known Health Risks Help protect against: Very rare: \ufffd Risks of pregnancy \ufffd Blood clot in deep veins of legs or lungs (deep vein thrombosis \ufffd Cancer of the lining of the uterus or pulmonary embolism) (endometrial cancer) Extremely rare:",
    "page_number": 25,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 211
  },
  {
    "id": "chunk_00212",
    "text": "ary embolism) (endometrial cancer) Extremely rare: \ufffd Cancer of the ovary \ufffd Stroke \ufffd Symptomatic pelvic inflammatory disease \ufffd Heart attack May help protect against: \ufffd Ovarian cysts \ufffd Iron-deficiency anemia Reduce: \ufffd Menstrual cramps \ufffd Menstrual bleeding problems \ufffd Ovulation pain",
    "page_number": 25,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 212
  },
  {
    "id": "chunk_00213",
    "text": "mps \ufffd Menstrual bleeding problems \ufffd Ovulation pain \ufffd Excess hair on face or body \ufffd Symptoms of polycystic ovarian syndrome (irregular bleeding, acne, excess hair on face or body) \ufffd Symptoms of endometriosis (pelvic pain, irregular bleeding)",
    "page_number": 25,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 213
  },
  {
    "id": "chunk_00214",
    "text": "of endometriosis (pelvic pain, irregular bleeding) See also Facts About Combined Oral Contraceptives and Cancer, p. 4. Correcting Misunderstandings (see also Questions and Answers, p. 25) Combined oral contraceptives: \ufffd Do not build up hormones in a woman\u2019s body. Women do not need a",
    "page_number": 25,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 214
  },
  {
    "id": "chunk_00215",
    "text": "up hormones in a woman\u2019s body. Women do not need a \u201crest\u201d from taking COCs. \ufffd Must be taken every day, whether or not a woman has sex that day. \ufffd Do not make women infertile after they stop taking COCs. \ufffd Do not cause birth defects or multiple births. \ufffd Do not change women\u2019s sexual behavior.",
    "page_number": 25,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 215
  },
  {
    "id": "chunk_00216",
    "text": "e births. \ufffd Do not change women\u2019s sexual behavior. \ufffd Do not collect in the stomach. Instead, the pill dissolves each day. \ufffd Do not disrupt an existing pregnancy. Combined Oral Contraceptives",
    "page_number": 25,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 216
  },
  {
    "id": "chunk_00217",
    "text": "Facts About Combined Oral Contraceptives and Cancer Overall risk of developing cancer over a lifetime is similar among women who have used COCs and women who have not used COCs. COC users may have small increases in risk of some types of cancer, but they also have long-term",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 217
  },
  {
    "id": "chunk_00218",
    "text": "some types of cancer, but they also have long-term reductions in other types of cancer. Ovarian and endometrial cancer \ufffd Use of COCs helps protect users from 2 important kinds of cancer\u2014cancer of the ovaries and cancer of the lining of the uterus (endometrial cancer).",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 218
  },
  {
    "id": "chunk_00219",
    "text": "of the lining of the uterus (endometrial cancer). \ufffd This protection continues for 15 years or more after stopping use of COCs. Breast cancer \ufffd Research findings about COCs and breast cancer are difficult to interpret: \u2013 Studies find that women who used COCs more than 10 years ago face",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 219
  },
  {
    "id": "chunk_00220",
    "text": "at women who used COCs more than 10 years ago face the same risk of breast cancer as similar women who have never used COCs. In contrast, some studies find that current users of COCs and women who have used COCs within the past 10 years are slightly more",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 220
  },
  {
    "id": "chunk_00221",
    "text": "ed COCs within the past 10 years are slightly more likely to be diagnosed with breast cancer. On balance, there may be little difference in lifetime risk. It is unclear whether these findings are explained by earlier detection of existing breast cancers among COC users or by a",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 221
  },
  {
    "id": "chunk_00222",
    "text": "of existing breast cancers among COC users or by a biologic effect of COCs on breast cancer. \u2013 Previous use of COCs does not increase the risk of breast cancer later in life, when breast cancer is more common. \u2013 When a current or former COC user is diagnosed with breast cancer, the",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 222
  },
  {
    "id": "chunk_00223",
    "text": "rmer COC user is diagnosed with breast cancer, the cancers generally are less advanced than cancers diagnosed in other women. \u2013 COC use does not increase risk of breast cancer for women whose relatives have had breast cancer. Cervical cancer",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 223
  },
  {
    "id": "chunk_00224",
    "text": "relatives have had breast cancer. Cervical cancer \ufffd Cervical cancer is caused by certain types of human papillomavirus (HPV). HPV is a common sexually transmitted infection that usually clears on its own without treatment, but sometimes it persists and sometimes leads",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 224
  },
  {
    "id": "chunk_00225",
    "text": "ent, but sometimes it persists and sometimes leads to cervical cancer. A vaccine can help to prevent cervical cancer. (See the section on Cervical Cancer in Chapter 22, pp. 351\u2013354.) If cervical screening is available, providers can advise all women to be screened every 3 years (or",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 225
  },
  {
    "id": "chunk_00226",
    "text": "advise all women to be screened every 3 years (or as national guidelines recommend). \ufffd Use of COCs for 5 years or more appears to increase slightly the risk of cervical cancer. After a woman stops using COCs, this risk decreases. By 10 years after stopping COCs, a former COC user has the same risk",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 226
  },
  {
    "id": "chunk_00227",
    "text": "stopping COCs, a former COC user has the same risk of cervical cancer as a woman who has never used COCs. The number of cervical cancers associated with COC use is small. Other cancers \ufffd Use of COCs may decrease the risk of colorectal cancer.",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 227
  },
  {
    "id": "chunk_00228",
    "text": "f COCs may decrease the risk of colorectal cancer. \ufffd There is no clear evidence that COC use either decreases or increases the risk of any other type of cancer. 4 Family Planning: A Global Handbook for Providers",
    "page_number": 26,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 228
  },
  {
    "id": "chunk_00229",
    "text": "1 5 sevitpecartnoC larO denibmoC Who Can and Cannot Use Combined Oral Contraceptives Safe and Suitable for Nearly All Women Nearly all women can use COCs safely and effectively, including women who: \ufffd Have or have not had children \ufffd Are married or are not married",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 229
  },
  {
    "id": "chunk_00230",
    "text": "not had children \ufffd Are married or are not married \ufffd Are of any age, including adolescents and women over 40 years old \ufffd After childbirth and during breastfeeding, after a period of time \ufffd Have just had an abortion, miscarriage, or ectopic pregnancy \ufffd Smoke cigarettes\u2014if under 35 years old",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 230
  },
  {
    "id": "chunk_00231",
    "text": "pregnancy \ufffd Smoke cigarettes\u2014if under 35 years old \ufffd Have anemia now or had in the past \ufffd Have varicose veins \ufffd Are living with HIV, whether or not on antiretroviral therapy Avoid Unnecessary Procedures (see Importance of Selected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396)",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 231
  },
  {
    "id": "chunk_00232",
    "text": "in Chapter 26 \u2013 Family Planning Provision, p. 396) Women can begin using COCs: \ufffd Without a pelvic examination \ufffd Without any blood tests or other routine laboratory tests \ufffd Without cervical cancer screening \ufffd Without a breast examination \ufffd Without a pregnancy test. A woman can begin using COCs at any",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 232
  },
  {
    "id": "chunk_00233",
    "text": "regnancy test. A woman can begin using COCs at any time, even when she is not having monthly bleeding at the time, if it is reasonably certain she is not pregnant (see Pregnancy Checklist, inside back cover). Blood pressure measurement is desirable before starting a hormonal",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 233
  },
  {
    "id": "chunk_00234",
    "text": "easurement is desirable before starting a hormonal method. However, where the risks of pregnancy are high and few methods are available, a woman should not be denied a hormonal method simply because her blood pressure cannot be measured. If possible, she can",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 234
  },
  {
    "id": "chunk_00235",
    "text": "pressure cannot be measured. If possible, she can have her blood pressure measured later at a time and place convenient for her. Who Can and Cannot Use Combined Oral Contraceptives",
    "page_number": 27,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 235
  },
  {
    "id": "chunk_00236",
    "text": "Medical Eligibility Criteria for Combined Oral Contraceptives Ask the client the questions below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions, then she can start COCs if she wants. If she answers",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 236
  },
  {
    "id": "chunk_00237",
    "text": "en she can start COCs if she wants. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases she can still start COCs. These questions also apply for the combined patch (see p. 119) and the combined vaginal ring (see p. 123). 1. Are you breastfeeding a baby less than 6 months old?",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 237
  },
  {
    "id": "chunk_00238",
    "text": "e you breastfeeding a baby less than 6 months old? \u274f NO \u274f YES \ufffd If fully or nearly fully breastfeeding: Give her COCs and tell her to start taking them 6 months after giving birth or when breast milk is no longer the baby\u2019s main food\u2014whichever comes first (see Fully or nearly fully",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 238
  },
  {
    "id": "chunk_00239",
    "text": "d\u2014whichever comes first (see Fully or nearly fully breastfeeding, p. 11). \ufffd If partially breastfeeding: She can start COCs as soon as 6 weeks after childbirth (see Partially breastfeeding, p. 12). 2. Have you had a baby in the last 3 weeks and you are not breastfeeding?",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 239
  },
  {
    "id": "chunk_00240",
    "text": "in the last 3 weeks and you are not breastfeeding? \u274f NO \u274f YES Give her COCs now and tell her to start taking them 3 weeks after childbirth. (If there is an additional risk that she might develop a blood clot in a deep vein (deep vein thrombosis, or VTE), then she should not start COCs at",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 240
  },
  {
    "id": "chunk_00241",
    "text": "mbosis, or VTE), then she should not start COCs at 3 weeks after childbirth, but start at 6 weeks instead. These additional risk factors include previous VTE, thrombophilia, caesarean delivery, blood transfusion at delivery, postpartum hemorrhage, pre-eclampsia, obesity (_>30 kg/m2), smoking,",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 241
  },
  {
    "id": "chunk_00242",
    "text": "age, pre-eclampsia, obesity (_>30 kg/m2), smoking, and being bedridden for a prolonged time.) 3. Do you smoke cigarettes? \u274f NO \u274f YES If she is 35 years of age or older and smokes, do not provide COCs. Urge her to stop smoking and help her choose another method, but not patch or ring if",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 242
  },
  {
    "id": "chunk_00243",
    "text": "er choose another method, but not patch or ring if she smokes fewer than 15 cigarettes a day, and also not monthly injectables if more than 15 cigarettes a day. 6 Family Planning: A Global Handbook for Providers",
    "page_number": 28,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 243
  },
  {
    "id": "chunk_00244",
    "text": "1 7 sevitpecartnoC larO denibmoC 4. Do you have cirrhosis of the liver, a liver infection, or liver tumor? Have you ever had jaundice when using COCs? \u274f NO \u274f YES If she reports serious liver disease (such as severe cirrhosis or liver tumor), acute or flare of viral hepatitis,",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 244
  },
  {
    "id": "chunk_00245",
    "text": "r liver tumor), acute or flare of viral hepatitis, or ever had jaundice while using COCs, do not provide COCs. Help her choose a method without hormones. (She can use monthly injectables if she has had jaundice only with past COC use.) 5. Do you have high blood pressure?",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 245
  },
  {
    "id": "chunk_00246",
    "text": "past COC use.) 5. Do you have high blood pressure? \u274f NO \u274f YES If you cannot check blood pressure and she reports a history of high blood pressure, or if she is being treated for high blood pressure, do not provide COCs. Refer her for a blood pressure check if possible or help",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 246
  },
  {
    "id": "chunk_00247",
    "text": "her for a blood pressure check if possible or help her choose a method without estrogen. Check blood pressure if possible: \ufffd If her blood pressure is below 140/90 mm Hg, provide COCs. No need to retest before starting COCs. \ufffd If blood pressure is 160/100 mm Hg or higher, do not",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 247
  },
  {
    "id": "chunk_00248",
    "text": "blood pressure is 160/100 mm Hg or higher, do not provide COCs. Help her choose a method without estrogen, but not a progestin-only injectable. \ufffd If blood pressure is 140\u2013159/90\u201399 mm Hg, one measurement is not enough to diagnose high blood pressure. Give her a backup method* to use until she",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 248
  },
  {
    "id": "chunk_00249",
    "text": "essure. Give her a backup method* to use until she can return for another blood pressure measurement, or help her choose another method. \u2212 If her next blood pressure measurement is below 140/90 mm Hg, she can start COCs. \u2212 However, if her next blood pressure measurement",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 249
  },
  {
    "id": "chunk_00250",
    "text": "\u2212 However, if her next blood pressure measurement is 140/90 mm Hg or higher, do not provide COCs. Help her choose a method without estrogen, but not a progestin-only injectable if systolic blood pressure is 160 or higher or diastolic pressure is 100 or higher. (See also Question 18, p. 28.)",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 250
  },
  {
    "id": "chunk_00251",
    "text": "e is 100 or higher. (See also Question 18, p. 28.) (Continued on next page) * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 29,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 251
  },
  {
    "id": "chunk_00252",
    "text": "Medical Eligibility Criteria for Combined Oral Contraceptives (continued) 6. Have you had diabetes for more than 20 years or damage to your arteries, vision, kidneys, or nervous system caused by diabetes? \u274f NO \u274f YES Do not provide COCs. Help her choose a method",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 252
  },
  {
    "id": "chunk_00253",
    "text": "YES Do not provide COCs. Help her choose a method without estrogen but not progestin-only injectables. 7. Do you have gallbladder disease now or take medication for gallbladder disease? \u274f NO \u274f YES Do not provide COCs. Help her choose another method but not the combined patch or combined",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 253
  },
  {
    "id": "chunk_00254",
    "text": "ther method but not the combined patch or combined vaginal ring. 8. Have you ever had a stroke, blood clot in your leg or lungs, heart attack, or other serious heart problems? \u274f NO \u274f YES If she reports heart attack, heart disease due to blocked or narrowed arteries, or stroke, do not provide",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 254
  },
  {
    "id": "chunk_00255",
    "text": "ed or narrowed arteries, or stroke, do not provide COCs. Help her choose a method without estrogen but not progestin-only injectables. If she reports a current blood clot in the deep veins of the legs (not superficial clots) or lungs, help her choose a method without hormones.",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 255
  },
  {
    "id": "chunk_00256",
    "text": "lungs, help her choose a method without hormones. 9. Do you have or have you ever had breast cancer? \u274f NO \u274f YES Do not provide COCs. Help her choose a method without hormones. 10. Do you sometimes see a bright area of lost vision in the eye before a very bad headache (migraine aura)?",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 256
  },
  {
    "id": "chunk_00257",
    "text": "he eye before a very bad headache (migraine aura)? Do you get throbbing, severe head pain, often on one side of the head, that can last from a few hours to several days and can cause nausea or vomiting (migraine headaches)? Such headaches are often made worse by light, noise, or moving about.",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 257
  },
  {
    "id": "chunk_00258",
    "text": "often made worse by light, noise, or moving about. \u274f NO \u274f YES If she has migraine aura at any age, do not provide COCs. If she has migraine headaches without aura and is age 35 or older, do not provide COCs. Help these women choose a method without estrogen. If she",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 258
  },
  {
    "id": "chunk_00259",
    "text": "ese women choose a method without estrogen. If she is under 35 and has migraine headaches without aura, she can use COCs (see Identifying Migraine Headaches and Auras, pp. 458\u2013460). 8 Family Planning: A Global Handbook for Providers",
    "page_number": 30,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 259
  },
  {
    "id": "chunk_00260",
    "text": "1 9 sevitpecartnoC larO denibmoC 11. Are you taking medications for seizures? Are you taking rifampicin or rifabutin for tuberculosis or other illness? \u274f NO \u274f YES If she is taking barbiturates, carbamazepine, lamotrigine, oxcarbazepine, phenytoin, primidone,",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 260
  },
  {
    "id": "chunk_00261",
    "text": "lamotrigine, oxcarbazepine, phenytoin, primidone, topiramate, rifampicin, or rifabutin, do not provide COCs. They can make COCs less effective. Help her choose another method but not progestin-only pills, patch, or combined ring. If she is taking lamotrigine, help her choose",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 261
  },
  {
    "id": "chunk_00262",
    "text": "ing. If she is taking lamotrigine, help her choose a method without estrogen. 12. Are you planning major surgery that will keep you from walking for one week or more? \u274f NO \u274f YES If so, she can start COCs 2 weeks after she can move about again. Until she can start COCs, she should use a backup method.",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 262
  },
  {
    "id": "chunk_00263",
    "text": "he can start COCs, she should use a backup method. 13. Do you have several conditions that could increase your chances of heart disease (coronary artery disease) or stroke, such as older age, smoking, high blood pressure, or diabetes? \u274f NO \u274f YES Do not provide COCs. Help her choose a method",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 263
  },
  {
    "id": "chunk_00264",
    "text": "YES Do not provide COCs. Help her choose a method without estrogen but not progestin-only injectables. Also, women should not use COCs if they report having thrombogenic mutations or lupus with positive (or unknown) antiphospholipid antibodies. For complete classifications, see",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 264
  },
  {
    "id": "chunk_00265",
    "text": "ipid antibodies. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions that would make the method inadvisable, when",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 265
  },
  {
    "id": "chunk_00266",
    "text": "tions that would make the method inadvisable, when relevant to the client. Combined Oral Contraceptives for Women With HIV \ufffd Women living with HIV or on antiretroviral therapy can safely use COCs. \ufffd Urge these women to use condoms along with COCs. Used",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 266
  },
  {
    "id": "chunk_00267",
    "text": "e these women to use condoms along with COCs. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. Who Can and Cannot Use Combined Oral Contraceptives",
    "page_number": 31,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 267
  },
  {
    "id": "chunk_00268",
    "text": "Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not use COCs. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her, a qualified provider who can",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 268
  },
  {
    "id": "chunk_00269",
    "text": "or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use COCs. The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up.",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 269
  },
  {
    "id": "chunk_00270",
    "text": "itions, whether she will have access to follow-up. \ufffd Not breastfeeding and less than 3 weeks since giving birth, without additional risk that she might develop a blood clot in a deep vein (VTE) \ufffd Not breastfeeding and between 3 and 6 weeks postpartum with additional risk that she might develop VTE",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 270
  },
  {
    "id": "chunk_00271",
    "text": "um with additional risk that she might develop VTE \ufffd Primarily breastfeeding between 6 weeks and 6 months since giving birth \ufffd Age 35 or older and smokes fewer than 15 cigarettes a day \ufffd High blood pressure (systolic blood pressure between 140 and 159 mm Hg",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 271
  },
  {
    "id": "chunk_00272",
    "text": "(systolic blood pressure between 140 and 159 mm Hg or diastolic blood pressure between 90 and 99 mm Hg) \ufffd Controlled high blood pressure, where continuing evaluation is possible \ufffd History of high blood pressure, where blood pressure cannot be taken (including pregnancy-related high blood pressure)",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 272
  },
  {
    "id": "chunk_00273",
    "text": "(including pregnancy-related high blood pressure) \ufffd History of jaundice while using COCs in the past \ufffd Gallbladder disease (current or medically treated) \ufffd Age 35 or older and has migraine headaches without aura \ufffd Younger than age 35 and has migraine headaches without aura that have",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 273
  },
  {
    "id": "chunk_00274",
    "text": "and has migraine headaches without aura that have developed or have gotten worse while using COCs \ufffd Had breast cancer more than 5 years ago, and it has not returned \ufffd Diabetes for more than 20 years or damage to arteries, vision, kidneys, or nervous system caused by diabetes",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 274
  },
  {
    "id": "chunk_00275",
    "text": "ion, kidneys, or nervous system caused by diabetes \ufffd Multiple risk factors for arterial cardiovascular disease such as older age, smoking, diabetes, and high blood pressure \ufffd Taking barbiturates, carbamazepine, oxcarbazepine, phenytoin, primidone,",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 275
  },
  {
    "id": "chunk_00276",
    "text": "arbamazepine, oxcarbazepine, phenytoin, primidone, topiramate, rifampicin, or rifabutin. A backup contraceptive method should also be used because these medications reduce the effectiveness of COCs. \ufffd Taking lamotrigine. Combined hormonal methods may make lamotrigine less effective.",
    "page_number": 32,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 276
  },
  {
    "id": "chunk_00277",
    "text": "1 11 sevitpecartnoC larO denibmoC Providing Combined Oral Contraceptives When to Start IMPORTANT: A woman can start using COCs any time she wants if it is reasonably certain she is not pregnant. To be reasonably certain she is not",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 277
  },
  {
    "id": "chunk_00278",
    "text": "not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover). Also, a woman can be given COCs at any time and told when to start taking them. Woman\u2019s situation When to start Having menstrual Any time of the month cycles or",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 278
  },
  {
    "id": "chunk_00279",
    "text": "t Having menstrual Any time of the month cycles or \ufffd If she is starting within 5 days after the start of her switching from monthly bleeding, no need for a backup method. a nonhormonal method \ufffd If it is more than 5 days after the start of her monthly bleeding, she can start COCs any time",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 279
  },
  {
    "id": "chunk_00280",
    "text": "her monthly bleeding, she can start COCs any time it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.)",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 280
  },
  {
    "id": "chunk_00281",
    "text": "Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If she is switching from an IUD, she can start COCs immediately (see Switching From an IUD to Another Method, in Chapter 10 \u2013 Copper- Bearing Intrauterine Device, pp. 187\u2013188). Switching from \ufffd Immediately, if she has been using the hormonal",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 281
  },
  {
    "id": "chunk_00282",
    "text": "\ufffd Immediately, if she has been using the hormonal a hormonal method consistently and correctly or if it is method otherwise reasonably certain she is not pregnant. No need to wait for her next monthly bleeding. No need for a backup method. \ufffd If she is switching from injectables, she can begin",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 282
  },
  {
    "id": "chunk_00283",
    "text": "f she is switching from injectables, she can begin taking COCs when the repeat injection would have been given. No need for a backup method. * Backup methods include abstinence, male and female condoms, spermicides, and",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 283
  },
  {
    "id": "chunk_00284",
    "text": "tinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. Providing Combined Oral Contraceptives",
    "page_number": 33,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 284
  },
  {
    "id": "chunk_00285",
    "text": "Woman\u2019s situation When to start (continued) Fully or nearly fully breastfeeding Less than 6 \ufffd Give her COCs and tell her to start taking them months after 6 months after giving birth or when breast milk giving birth is no longer the baby\u2019s main food\u2014whichever comes first.",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 285
  },
  {
    "id": "chunk_00286",
    "text": "longer the baby\u2019s main food\u2014whichever comes first. More than 6 \ufffd If her monthly bleeding has not returned, she can months after start COCs any time it is reasonably certain she giving birth is not pregnant. She will need a backup method for the first 7 days of taking pills. (If you cannot",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 286
  },
  {
    "id": "chunk_00287",
    "text": "r the first 7 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If her monthly bleeding has returned, she can start COCs as advised for women having menstrual cycles (see previous page). Partially breastfeeding",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 287
  },
  {
    "id": "chunk_00288",
    "text": "ycles (see previous page). Partially breastfeeding Less than 6 weeks \ufffd Give her COCs and tell her to start taking them after giving birth 6 weeks after giving birth. \ufffd Also give her a backup method to use until 6 weeks since giving birth if her monthly bleeding returns before this time.",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 288
  },
  {
    "id": "chunk_00289",
    "text": "if her monthly bleeding returns before this time. More than 6 weeks \ufffd If her monthly bleeding has not returned, she can after giving birth start COCs any time it is reasonably certain she is not pregnant.\u2020 She will need a backup method for the first 7 days of taking pills. (If you cannot",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 289
  },
  {
    "id": "chunk_00290",
    "text": "r the first 7 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If her monthly bleeding has returned, she can start COCs as advised for women having menstrual cycles (see previous page).",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 290
  },
  {
    "id": "chunk_00291",
    "text": "women having menstrual cycles (see previous page). \u2020 Where a visit 6 weeks after childbirth is routinely recommended and other opportunities to obtain contraception are limited, some providers and programs may give COCs at the",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 291
  },
  {
    "id": "chunk_00292",
    "text": ", some providers and programs may give COCs at the 6-week visit, without further evidence that the woman is not pregnant, if her monthly bleeding has not yet returned. 12 Family Planning: A Global Handbook for Providers",
    "page_number": 34,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 292
  },
  {
    "id": "chunk_00293",
    "text": "1 13 sevitpecartnoC larO denibmoC Woman\u2019s situation When to start (continued) Not breastfeeding Less than 4 weeks \ufffd She can start COCs at any time on days 21\u201328 after giving birth after giving birth. Give her pills any time to start during these 7 days. No need for a backup",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 293
  },
  {
    "id": "chunk_00294",
    "text": "to start during these 7 days. No need for a backup method. (If additional risk for VTE, wait until 6 weeks. See Question 2, p. 6.) More than 4 weeks \ufffd If her monthly bleeding has not returned, after giving birth she can start COCs any time it is reasonably",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 294
  },
  {
    "id": "chunk_00295",
    "text": "birth she can start COCs any time it is reasonably certain she is not pregnant.\u2020 She will need a backup method for the first 7 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.)",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 295
  },
  {
    "id": "chunk_00296",
    "text": "Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If her monthly bleeding has returned, she can start COCs as advised for women having menstrual cycles (see p. 11). No monthly \ufffd She can start COCs any time it is reasonably bleeding (not certain she is not pregnant. She will need a",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 296
  },
  {
    "id": "chunk_00297",
    "text": "(not certain she is not pregnant. She will need a related to childbirth backup method for the first 7 days of taking pills. or breastfeeding) After miscarriage \ufffd Immediately. If she is starting within 7 days after or abortion first- or second-trimester miscarriage or abortion,",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 297
  },
  {
    "id": "chunk_00298",
    "text": "irst- or second-trimester miscarriage or abortion, no need for a backup method. \ufffd If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start COCs any time it is reasonably certain she is not pregnant. She will need a backup method for",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 298
  },
  {
    "id": "chunk_00299",
    "text": "is not pregnant. She will need a backup method for the first 7 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) Providing Combined Oral Contraceptives",
    "page_number": 35,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 299
  },
  {
    "id": "chunk_00300",
    "text": "Woman\u2019s situation When to start (continued) After taking After taking progestin-only or combined emergency ECPs: contraceptive \ufffd She can start or restart COCs immediately after pills (ECPs) she takes the ECPs. No need to wait for her next monthly bleeding. \u2013 A continuing user who needed ECPs due to",
    "page_number": 36,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 300
  },
  {
    "id": "chunk_00301",
    "text": "eeding. \u2013 A continuing user who needed ECPs due to pill-taking errors can continue where she left off with her current pack. \ufffd If she does not start immediately but returns for COCs, she can start at any time if it is reasonably certain she is not pregnant.",
    "page_number": 36,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 301
  },
  {
    "id": "chunk_00302",
    "text": "e if it is reasonably certain she is not pregnant. \ufffd All women will need to use a backup method for the first 7 days of taking pills. After taking ulipristal acetate (UPA) ECPs: \ufffd She can start or restart COCs on the 6th day after taking UPA-ECPs. No need to wait for her",
    "page_number": 36,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 302
  },
  {
    "id": "chunk_00303",
    "text": "day after taking UPA-ECPs. No need to wait for her next monthly bleeding. COCs and UPA interact. If COCs are started sooner, and thus both are present in the body, one or both may be less effective. \ufffd Give her a supply of pills and tell her to start them on the 6th day after taking the UPA-ECPs.",
    "page_number": 36,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 303
  },
  {
    "id": "chunk_00304",
    "text": "art them on the 6th day after taking the UPA-ECPs. \ufffd She will need to use a backup method from the time she takes the UPA-ECPs until she has been taking COCs for 7 days. \ufffd If she does not start on the 6th day but returns later for COCs, she may start at any time if it is",
    "page_number": 36,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 304
  },
  {
    "id": "chunk_00305",
    "text": "later for COCs, she may start at any time if it is reasonably certain she is not pregnant. SUN MON TUES WED THU FRI SAT WEEK 1 WEEK 2 WEEK 3 WEEK 4 28 DAY 14 Family Planning: A Global Handbook for Providers Take all colored pills before taking any white pills",
    "page_number": 36,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 305
  },
  {
    "id": "chunk_00306",
    "text": "1 15 sevitpecartnoC larO denibmoC Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes and other side effects is an important part of providing the method. Counseling about bleeding changes may be the most important help a woman needs",
    "page_number": 37,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 306
  },
  {
    "id": "chunk_00307",
    "text": "anges may be the most important help a woman needs to keep using the method without concern. Describe the \ufffd In the first few months, bleeding at unexpected most common times (irregular bleeding). Then lighter, shorter, side effects and more regular monthly bleeding.",
    "page_number": 37,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 307
  },
  {
    "id": "chunk_00308",
    "text": "r, side effects and more regular monthly bleeding. \ufffd Headaches, breast tenderness, weight change, and possibly other side effects. Explain about \ufffd Side effects are not signs of illness. these side effects \ufffd Most side effects usually become less or stop within the first few months of using COCs.",
    "page_number": 37,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 308
  },
  {
    "id": "chunk_00309",
    "text": "or stop within the first few months of using COCs. \ufffd Common, but some women do not have them. Explain what \ufffd Keep taking COCs. Skipping pills risks pregnancy to do in case and can make some side effects worse. of side effects \ufffd Take each pill at the same time every day to",
    "page_number": 37,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 309
  },
  {
    "id": "chunk_00310",
    "text": "cts \ufffd Take each pill at the same time every day to help reduce irregular bleeding and also help with remembering. \ufffd Take pills with food or at bedtime to help avoid nausea. \ufffd The client can come back for help if side effects bother her or if she has other concerns.",
    "page_number": 37,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 310
  },
  {
    "id": "chunk_00311",
    "text": "e effects bother her or if she has other concerns. WEEW K E 4EW K E 3EW K E 2EK 1SUNMONTUESWEDT 2H 8U DAYFRI sllip etihw ynS a gnikA at erofeT b sllip deroloc lla ekaT Providing Combined Oral Contraceptives",
    "page_number": 37,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 311
  },
  {
    "id": "chunk_00312",
    "text": "Explaining How to Use 1. Give pills \ufffd Give up to 1 year\u2019s supply (13 packs) depending on the woman\u2019s preference and planned use. 2. Explain pill pack \ufffd Show which kind of pack\u201421 pills or 28 pills. With 28-pill packs, point out that the last 7 pills are a different color and do not contain",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 312
  },
  {
    "id": "chunk_00313",
    "text": "t 7 pills are a different color and do not contain hormones (some brands may differ). \ufffd Show how to take the first pill from the pack and then how to follow the directions or arrows on the pack to take the rest of the pills. 3. Give key \ufffd Take one pill each day\u2014 instruction until the pack is empty.",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 313
  },
  {
    "id": "chunk_00314",
    "text": "ill each day\u2014 instruction until the pack is empty. \ufffd Discuss cues for taking a pill every day. Linking pill-taking to a daily activity\u2014such as cleaning her teeth\u2014may help her remember. \ufffd Taking pills at the same time each day helps to remember them. It also may help reduce some side effects.",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 314
  },
  {
    "id": "chunk_00315",
    "text": "r them. It also may help reduce some side effects. 4. Explain starting \ufffd 28-pill packs: When she finishes one pack, she next pack should take the first pill from the next pack on the very next day. \ufffd 21-pill packs: After she takes the last pill from one pack, she should wait 7 days\u2014no more\u2014",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 315
  },
  {
    "id": "chunk_00316",
    "text": "ill from one pack, she should wait 7 days\u2014no more\u2014 and then take the first pill from the next pack. \ufffd It is very important to start the next pack on time. Starting a pack late risks pregnancy. 5. Provide backup \ufffd Sometimes she may need to use a backup method and method, such as when she misses pills.",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 316
  },
  {
    "id": "chunk_00317",
    "text": "method and method, such as when she misses pills. explain use \ufffd Backup methods include abstinence, male or female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. Give her condoms, if possible.",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 317
  },
  {
    "id": "chunk_00318",
    "text": "traceptive methods. Give her condoms, if possible. \ufffd If she misses 3 or more hormonal pills, she can consider ECPs. 16 Family Planning: A Global Handbook for Providers",
    "page_number": 38,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 318
  },
  {
    "id": "chunk_00319",
    "text": "1 17 sevitpecartnoC larO denibmoC Supporting New and Continuing Users Managing Missed Pills It is easy to forget a pill or to be late in taking it. Adolescents are more likely to forget pills and so may need extra support and guidance.",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 319
  },
  {
    "id": "chunk_00320",
    "text": "pills and so may need extra support and guidance. COC users should know what to do if they forget to take pills. If a woman misses one or more pills, she should follow the instructions below. Use the job aid on p. 453 to help explain these instructions to the client.",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 320
  },
  {
    "id": "chunk_00321",
    "text": "to help explain these instructions to the client. Making Up Missed Pills With 30\u201335 \u00b5g Estrogen\u2021 Key message \ufffd Take a missed hormonal pill as soon as possible. \ufffd Keep taking pills as usual, one each day. (She may take 2 pills at the same time or on the same day.)",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 321
  },
  {
    "id": "chunk_00322",
    "text": "take 2 pills at the same time or on the same day.) Missed 1 or 2 pills? \ufffd Take a hormonal pill as soon as possible. Started new pack \ufffd Little or no risk of pregnancy. 1 or 2 days late? Missed pills 3 or \ufffd Take a hormonal pill as soon as possible. more days in a",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 322
  },
  {
    "id": "chunk_00323",
    "text": "hormonal pill as soon as possible. more days in a \ufffd Use a backup method for the next 7 days. row in the first or second week? \ufffd Also, if she had sex in the past 5 days, Started new pack she can consider ECPs (see Chapter 3 \u2013 3 or more days late? Emergency Contraceptive Pills).",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 323
  },
  {
    "id": "chunk_00324",
    "text": "or more days late? Emergency Contraceptive Pills). Missed 3 or more \ufffd Take a hormonal pill as soon as possible. pills in the third \ufffd Finish all hormonal pills in the pack. Throw week? away the 7 nonhormonal pills in a 28-pill pack. \ufffd Start a new pack the next day.",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 324
  },
  {
    "id": "chunk_00325",
    "text": "n a 28-pill pack. \ufffd Start a new pack the next day. \ufffd Use a backup method for the next 7 days. \ufffd Also, if she had sex in the past 5 days, she can consider ECPs (see Chapter 3). (Continued on next page) \u2021 For pills with 20 \u00b5g of estrogen or less, women missing one pill should follow the same",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 325
  },
  {
    "id": "chunk_00326",
    "text": "ess, women missing one pill should follow the same guidance as for missing one or two 30\u201335 \u00b5g pills. Women missing 2 or more pills should follow the same guidance as for missing 3 or more 30\u201335 \u00b5g pills. Supporting New and Continuing Users",
    "page_number": 39,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 326
  },
  {
    "id": "chunk_00327",
    "text": "(continued) Missed any non- \ufffd Discard the missed nonhormonal pill(s). hormonal pills? (last \ufffd Keep taking COCs, one each day. Start the 7 pills in 28-pill pack) new pack as usual. Severe vomiting or \ufffd If she vomits within 2 hours after taking a pill,",
    "page_number": 40,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 327
  },
  {
    "id": "chunk_00328",
    "text": "If she vomits within 2 hours after taking a pill, diarrhea she should take another pill from her pack as soon as possible, then keep taking pills as usual. \ufffd If she has vomiting or diarrhea for more than 2 days, follow instructions for 3 or more missed pills, above. How Can a Partner Help?",
    "page_number": 40,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 328
  },
  {
    "id": "chunk_00329",
    "text": "more missed pills, above. How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: \ufffd Support a woman\u2019s choice of COCs",
    "page_number": 40,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 329
  },
  {
    "id": "chunk_00330",
    "text": "le partner can: \ufffd Support a woman\u2019s choice of COCs \ufffd Help her to remember to take a pill each day and to start a new pack on time \ufffd Show understanding and support if she has side effects \ufffd Help her to make sure that she has a new pill pack on hand to start on time",
    "page_number": 40,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 330
  },
  {
    "id": "chunk_00331",
    "text": "t she has a new pill pack on hand to start on time \ufffd Help to make sure she has ECPs on hand in case she misses pills or starts a new pill pack late \ufffd Use condoms consistently in addition to COCs if he has an STI/HIV or thinks he may be at risk of an STI/HIV",
    "page_number": 40,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 331
  },
  {
    "id": "chunk_00332",
    "text": "1 19 sevitpecartnoC larO denibmoC \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she has any major change in health status; or she thinks she might be pregnant. Also if:",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 332
  },
  {
    "id": "chunk_00333",
    "text": "tus; or she thinks she might be pregnant. Also if: \ufffd She needs more pills. \ufffd She wants ECPs because she started a new pack 3 or more days late or missed 3 or more hormonal pills or, if she is using pills with 20 \u03bcg of estrogen or less, because she started a new pack 2 or more days late or",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 333
  },
  {
    "id": "chunk_00334",
    "text": "ause she started a new pack 2 or more days late or missed 2 or more hormonal pills. General health advice: Anyone who suddenly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 334
  },
  {
    "id": "chunk_00335",
    "text": "ould immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the nurse or doctor what method she is using. Planning the Next Visit 1. Encourage her to come back for more pills before she uses up her supply",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 335
  },
  {
    "id": "chunk_00336",
    "text": "back for more pills before she uses up her supply of pills. 2. An annual visit is recommended. 3. Some women can benefit from contact after 3 months of COC use. This offers an opportunity to answer any questions, help with any problems, and check on correct use. Repeat Visits",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 336
  },
  {
    "id": "chunk_00337",
    "text": "problems, and check on correct use. Repeat Visits 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss. 2. Ask especially if she is concerned about bleeding changes. Give her any",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 337
  },
  {
    "id": "chunk_00338",
    "text": "is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, next page). 3. Ask if she often has problems remembering to take a pill every day. If so, discuss ways to remember, making up missed pills, and ECPs, or choosing",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 338
  },
  {
    "id": "chunk_00339",
    "text": "ber, making up missed pills, and ECPs, or choosing another method. Adolescents may need extra support. 4. Give her more pill packs\u2014a full year\u2019s supply (13 packs), if possible. Plan her next resupply visit before she will need more pills.",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 339
  },
  {
    "id": "chunk_00340",
    "text": "xt resupply visit before she will need more pills. 5. Every year or so, check blood pressure if possible (see Medical Eligibility Criteria, Question 5, p. 7). 6. Ask a long-term client if she has had any new health problems since her",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 340
  },
  {
    "id": "chunk_00341",
    "text": "t if she has had any new health problems since her last visit. Address problems as appropriate. For new health problems that may require switching methods, see p. 22. 7. Ask a long-term client about major life changes that may affect her",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 341
  },
  {
    "id": "chunk_00342",
    "text": "lient about major life changes that may affect her needs\u2014particularly plans for having children and STI/HIV risk. Follow up as needed. Supporting New and Continuing Users",
    "page_number": 41,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 342
  },
  {
    "id": "chunk_00343",
    "text": "Managing Any Problems Problems Reported as Side Effects or Problems With Use May or may not be due to the method. \ufffd Problems with side effects affect women\u2019s satisfaction and use of COCs. They deserve the provider\u2019s attention. If the client reports side effects",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 343
  },
  {
    "id": "chunk_00344",
    "text": "er\u2019s attention. If the client reports side effects or problems, listen to her concerns, give her advice, and support, and, if appropriate, treat. Make sure she understands the advice and agrees. \ufffd Encourage her to keep taking a pill every day even if she has side effects.",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 344
  },
  {
    "id": "chunk_00345",
    "text": "ing a pill every day even if she has side effects. Missing pills can risk pregnancy and may make some side effects worse. \ufffd Many side effects will subside after a few months of use. For a woman whose side effects persist, give her a different COC formulation, if available, for at least 3 months.",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 345
  },
  {
    "id": "chunk_00346",
    "text": "formulation, if available, for at least 3 months. \ufffd Offer to help the client choose another method\u2014now, if she wishes, or if problems cannot be overcome. Missed pills \ufffd See Managing Missed Pills, p. 17. Irregular bleeding (bleeding at unexpected times that bothers the client)",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 346
  },
  {
    "id": "chunk_00347",
    "text": "eding at unexpected times that bothers the client) \ufffd Reassure her that many women using COCs experience irregular bleeding. It is not harmful and usually becomes less or stops after the first few months of use. \ufffd Other possible causes of irregular bleeding include: \u2013 Missed pills",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 347
  },
  {
    "id": "chunk_00348",
    "text": "uses of irregular bleeding include: \u2013 Missed pills \u2013 Taking pills at different times each day \u2013 Vomiting or diarrhea \u2013 Taking anticonvulsants, rifampicin, or rifabutin (see Starting treatment with anticonvulsants, rifampicin, or rifabutin, p. 23) \ufffd To reduce irregular bleeding:",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 348
  },
  {
    "id": "chunk_00349",
    "text": "rifabutin, p. 23) \ufffd To reduce irregular bleeding: \u2013 Urge her to take a pill each day and at the same time each day. \u2013 Teach her to make up for missed pills properly, including after vomiting or diarrhea (see Managing Missed Pills, p. 17).",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 349
  },
  {
    "id": "chunk_00350",
    "text": "ng or diarrhea (see Managing Missed Pills, p. 17). \u2013 For modest short-term relief, she can try 800 mg ibuprofen 3 times daily after meals for 5 days or other nonsteroidal anti-inflammatory drug (NSAID), beginning when irregular bleeding starts. NSAIDs provide",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 350
  },
  {
    "id": "chunk_00351",
    "text": "ing when irregular bleeding starts. NSAIDs provide some relief of irregular bleeding for implants, progestin-only injectables, and intrauterine devices (IUDs), and they may also help for COCs. \u2013 If she has been taking the pills for more than a few months and NSAIDs",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 351
  },
  {
    "id": "chunk_00352",
    "text": "ng the pills for more than a few months and NSAIDs do not help, give her a different COC formulation, if available. Ask her to try the new pills for at least 3 months. 20 Family Planning: A Global Handbook for Providers",
    "page_number": 42,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 352
  },
  {
    "id": "chunk_00353",
    "text": "1 21 sevitpecartnoC larO denibmoC \ufffd If irregular bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, next page).",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 353
  },
  {
    "id": "chunk_00354",
    "text": "e (see \u201cUnexplained vaginal bleeding\u201d, next page). No monthly bleeding \ufffd Ask if she is having any bleeding at all. (She may have just a small stain on her underclothing and not recognize it as monthly bleeding.) If she is, reassure her.",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 354
  },
  {
    "id": "chunk_00355",
    "text": "it as monthly bleeding.) If she is, reassure her. \ufffd Reassure her that some women using COCs stop having monthly bleeding, and this is not harmful. There is no need to lose blood every month. It is similar to not having monthly bleeding during pregnancy. She is not pregnant or infertile.",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 355
  },
  {
    "id": "chunk_00356",
    "text": "uring pregnancy. She is not pregnant or infertile. Blood is not building up inside her. (Some women are happy to be free from monthly bleeding, and for some women this may help prevent anemia.) \ufffd Ask if she has been taking a pill every day. If so, reassure her that she is not",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 356
  },
  {
    "id": "chunk_00357",
    "text": "ill every day. If so, reassure her that she is not likely to be pregnant. She can continue taking her COCs as before. \ufffd Did she skip the 7-day break between packs (21-day packs) or skip the 7 nonhormonal pills (28-day pack)? If so, reassure her that she is not pregnant. She can continue using COCs.",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 357
  },
  {
    "id": "chunk_00358",
    "text": "she is not pregnant. She can continue using COCs. \ufffd If she has missed hormonal pills or started a new pack late: \u2212 She can continue using COCs. \u2212 Tell a woman who has missed 3 or more pills or started a new pack 3 or more days late to return if she has signs and symptoms of early pregnancy.",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 358
  },
  {
    "id": "chunk_00359",
    "text": "if she has signs and symptoms of early pregnancy. \u2212 See p. 17 for instructions on how to make up for missed pills. Ordinary headaches (nonmigrainous) \ufffd Try the following (one at a time): \u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever.",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 359
  },
  {
    "id": "chunk_00360",
    "text": "aracetamol (325\u20131,000 mg), or other pain reliever. \u2013 Some women get headaches during the hormone-free week (the 7 days a woman does not take hormonal pills). Consider extended use (see Extended and Continuous Use of Combined Oral Contraceptives, p. 24).",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 360
  },
  {
    "id": "chunk_00361",
    "text": "nuous Use of Combined Oral Contraceptives, p. 24). \ufffd Any headaches that get worse or occur more often during COC use should be evaluated. Nausea or dizziness \ufffd For nausea, suggest taking COCs at bedtime or with food. If symptoms continue: \ufffd Consider locally available remedies.",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 361
  },
  {
    "id": "chunk_00362",
    "text": "s continue: \ufffd Consider locally available remedies. \ufffd Consider extended use if her nausea comes after she starts a new pill pack (see Extended and Continuous Use of Combined Oral Contraceptives, p. 24). Supporting New and Continuing Users",
    "page_number": 43,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 362
  },
  {
    "id": "chunk_00363",
    "text": "Breast tenderness \ufffd Recommend that she wear a supportive bra (including during strenuous activity and sleep). \ufffd Try hot or cold compresses. \ufffd Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. \ufffd Consider locally available remedies. Weight change",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 363
  },
  {
    "id": "chunk_00364",
    "text": "Consider locally available remedies. Weight change \ufffd Review diet and counsel as needed. Mood changes or changes in sex drive \ufffd Some women have changes in mood during the hormone-free week (the 7 days when a woman does not take hormonal pills). Consider",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 364
  },
  {
    "id": "chunk_00365",
    "text": "en a woman does not take hormonal pills). Consider extended use (see Extended and Continuous Use of Combined Oral Contraceptives, p. 24). \ufffd Ask about changes in her life that could affect her mood or sex drive, including changes in her relationship with her partner. Give her support as appropriate.",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 365
  },
  {
    "id": "chunk_00366",
    "text": "with her partner. Give her support as appropriate. \ufffd Clients who have serious mood changes such as major depression should be referred for care. \ufffd Consider locally available remedies. Acne \ufffd Acne usually improves with COC use. It may worsen for a few women.",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 366
  },
  {
    "id": "chunk_00367",
    "text": "roves with COC use. It may worsen for a few women. \ufffd If she has been taking pills for more than a few months and acne persists, give her a different COC formulation, if available. Ask her to try the new pills for at least 3 months. \ufffd Consider locally available remedies.",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 367
  },
  {
    "id": "chunk_00368",
    "text": "t 3 months. \ufffd Consider locally available remedies. New Problems That May Require Switching Methods May or may not be due to the method. Unexplained vaginal bleeding (that suggests a medical condition not related to the method) or heavy or prolonged bleeding",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 368
  },
  {
    "id": "chunk_00369",
    "text": "ated to the method) or heavy or prolonged bleeding \ufffd Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate. \ufffd She can continue using COCs while her condition is being evaluated. \ufffd If bleeding is caused by sexually transmitted infection or pelvic",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 369
  },
  {
    "id": "chunk_00370",
    "text": "caused by sexually transmitted infection or pelvic inflammatory disease, she can continue using COCs during treatment. 22 Family Planning: A Global Handbook for Providers",
    "page_number": 44,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 370
  },
  {
    "id": "chunk_00371",
    "text": "1 23 sevitpecartnoC larO denibmoC Starting treatment with anticonvulsants, rifampicin, or rifabutin \ufffd Barbiturates, carbamazepine, oxcarbazepine, phenytoin, primidone, topiramate, rifampicin, and rifabutin may make COCs, patch, and combined vaginal ring less effective. Combined hormonal methods,",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 371
  },
  {
    "id": "chunk_00372",
    "text": "al ring less effective. Combined hormonal methods, including combined pills and monthly injectables, may make lamotrigine less effective. If using these medications long-term, she may want a different method, such as a progestin-only injectable, implant, a copper-bearing IUD, or an LNG-IUD.",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 372
  },
  {
    "id": "chunk_00373",
    "text": "ble, implant, a copper-bearing IUD, or an LNG-IUD. \ufffd If using these medications short-term, she can use a backup method along with COCs for greater protection from pregnancy. Migraine headaches (see Identifying Migraine Headaches and Auras, p. 458)",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 373
  },
  {
    "id": "chunk_00374",
    "text": "Identifying Migraine Headaches and Auras, p. 458) \ufffd Regardless of her age, a woman who develops migraine headaches, with or without aura, or whose migraine headaches become worse while using COCs should stop using COCs. \ufffd Help her choose a method without estrogen.",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 374
  },
  {
    "id": "chunk_00375",
    "text": "COCs. \ufffd Help her choose a method without estrogen. Circumstances that will keep her from walking for one week or more \ufffd If she is having major surgery, or her leg is in a cast, or for other reasons she will be unable to move about for several weeks, she should:",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 375
  },
  {
    "id": "chunk_00376",
    "text": "nable to move about for several weeks, she should: \u2013 Tell her doctors that she is using COCs. \u2013 Stop taking COCs and use a backup method during this period. \u2013 Restart COCs 2 weeks after she can move about again. Certain serious health conditions (suspected heart or serious",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 376
  },
  {
    "id": "chunk_00377",
    "text": "ious health conditions (suspected heart or serious liver disease, high blood pressure, blood clots in deep veins of legs or lungs, stroke, breast cancer, damage to arteries, vision, kidneys, or nervous system caused by diabetes, or gallbladder disease). See Appendix B \u2013 Signs and Symptoms of Serious",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 377
  },
  {
    "id": "chunk_00378",
    "text": "e). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. \ufffd Tell her to stop taking COCs. \ufffd Give her a backup method to use until the condition is evaluated. \ufffd Refer for diagnosis and care if not already under care. Suspected pregnancy \ufffd Assess for pregnancy.",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 378
  },
  {
    "id": "chunk_00379",
    "text": "care. Suspected pregnancy \ufffd Assess for pregnancy. \ufffd Tell her to stop taking COCs if pregnancy is confirmed. \ufffd There are no known risks to a fetus conceived while a woman is taking COCs (see Question 5, p. 25). Supporting New and Continuing Users",
    "page_number": 45,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 379
  },
  {
    "id": "chunk_00380",
    "text": "Extended and Continuous Use of Combined Oral Contraceptives Some COC users do not follow the usual cycle of 3 weeks taking hormonal pills followed by one week without hormones. Some women take hormonal pills for 12 weeks without a break, followed by one week",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 380
  },
  {
    "id": "chunk_00381",
    "text": "for 12 weeks without a break, followed by one week of nonhormonal pills (or no pills). This is extended use. Other women take hormonal pills without any breaks at all. This is continuous use. Monophasic pills are recommended for such use (see Question 16, p. 27).",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 381
  },
  {
    "id": "chunk_00382",
    "text": "recommended for such use (see Question 16, p. 27). Women easily manage taking COCs in different ways when properly advised how to do so. Many women value controlling when they have monthly bleeding\u2014if any\u2014and tailoring pill use as they wish. Benefits of Extended and Continuous Use",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 382
  },
  {
    "id": "chunk_00383",
    "text": "they wish. Benefits of Extended and Continuous Use \ufffd Women have vaginal bleeding only 4 times a year or not at all. \ufffd Reduces how often some women suffer headaches, premenstrual syndrome, mood changes, and heavy or painful bleeding during the week without hormonal pills.",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 383
  },
  {
    "id": "chunk_00384",
    "text": "l bleeding during the week without hormonal pills. Disadvantages of Extended and Continuous Use \ufffd Irregular bleeding may last as long as the first 6 months of use\u2014 especially among women who have never before used COCs. \ufffd More supplies needed\u201415 to 17 packs every year instead of 13.",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 384
  },
  {
    "id": "chunk_00385",
    "text": "es needed\u201415 to 17 packs every year instead of 13. Extended Use Instructions \ufffd Take 84 hormonal pills in a row, one each day. (These are the hormonal pills in 4 monthly packs.) Users of 28-pill packs do not take the non-hormonal pills.",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 385
  },
  {
    "id": "chunk_00386",
    "text": "28-pill packs do not take the non-hormonal pills. \ufffd After 84 hormonal pills, wait 7 days and start the next pack of pills on the 8th day. (Users of 28-pill packs can take the nonhormonal pills in the 4th pack if they wish and start the hormonal pills the day after the",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 386
  },
  {
    "id": "chunk_00387",
    "text": "ish and start the hormonal pills the day after the last nonhormonal pill.) Expect some bleeding during this week of not taking the hormonal pills. Continuous Use Instructions A woman should take one hormonal pill every day for as long as she",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 387
  },
  {
    "id": "chunk_00388",
    "text": "ake one hormonal pill every day for as long as she wishes to use COCs. If bothersome irregular bleeding occurs, she can stop taking pills for 3 or 4 days and then start taking hormonal pills continuously again. 24 Family Planning: A Global Handbook for Providers",
    "page_number": 46,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 388
  },
  {
    "id": "chunk_00389",
    "text": "1 25 sevitpecartnoC larO denibmoC Questions and Answers About Combined Oral Contraceptives 1. Should a woman take a \u201crest\u201d from COCs after taking them for a time? No. There is no evidence that taking a \u201crest\u201d is helpful. In fact, taking a",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 389
  },
  {
    "id": "chunk_00390",
    "text": "that taking a \u201crest\u201d is helpful. In fact, taking a \u201crest\u201d from COCs can lead to unintended pregnancy. COCs can safely be used for many years without having to stop taking them periodically. 2. If a woman has been taking COCs for a long time, will she still be protected from pregnancy after she stops",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 390
  },
  {
    "id": "chunk_00391",
    "text": "still be protected from pregnancy after she stops taking COCs? No. A woman is protected only as long as she takes her pills regularly. 3. How long does it take to become pregnant after stopping COCs? Women who stop using COCs can become pregnant as quickly as",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 391
  },
  {
    "id": "chunk_00392",
    "text": "stop using COCs can become pregnant as quickly as women who stop nonhormonal methods. COCs do not delay the return of a woman\u2019s fertility after she stops taking them. The bleeding pattern a woman had before she used COCs generally returns after she",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 392
  },
  {
    "id": "chunk_00393",
    "text": "d before she used COCs generally returns after she stops taking them. Some women may have to wait a few months before their usual bleeding pattern returns. 4. Do COCs cause abortion? No. Research on COCs finds that they do not disrupt an existing pregnancy.",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 393
  },
  {
    "id": "chunk_00394",
    "text": "ds that they do not disrupt an existing pregnancy. They should not be used to try to cause an abortion. They will not do so. 5. Do COCs cause birth defects? Will the fetus be harmed if a woman accidentally takes COCs while she is pregnant?",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 394
  },
  {
    "id": "chunk_00395",
    "text": "man accidentally takes COCs while she is pregnant? No. Good evidence shows that COCs will not cause birth defects and will not otherwise harm the fetus if a woman becomes pregnant while taking COCs or accidentally starts to take COCs when she is already pregnant.",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 395
  },
  {
    "id": "chunk_00396",
    "text": "starts to take COCs when she is already pregnant. 6. Do COCs cause women to gain or lose a lot of weight? No. Most women do not gain or lose weight due to COCs. Weight changes naturally as life circumstances change and as people age. Because",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 396
  },
  {
    "id": "chunk_00397",
    "text": "fe circumstances change and as people age. Because these changes in weight are so common, many women think that COCs cause these gains or losses in weight. Studies find, however, that, on average, COCs do not affect weight. A few women experience sudden",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 397
  },
  {
    "id": "chunk_00398",
    "text": "o not affect weight. A few women experience sudden changes in weight when using COCs. These changes reverse after they stop taking COCs. It is not known why these women respond to COCs in this way. Questions and Answers about Combined Oral Contraceptives",
    "page_number": 47,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 398
  },
  {
    "id": "chunk_00399",
    "text": "7. Do COCs lower women\u2019s mood or sex drive? Generally, no. Some women using COCs report these complaints. The great majority of COC users do not report any such changes, however, and some report that both mood and sex drive improve. It is difficult",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 399
  },
  {
    "id": "chunk_00400",
    "text": "t both mood and sex drive improve. It is difficult to tell whether such changes are due to the COCs or to other reasons. Providers can help a client with these problems (see \u201cMood changes or changes in sex drive\u201d, p. 22). There is no evidence that COCs affect women\u2019s sexual behavior.",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 400
  },
  {
    "id": "chunk_00401",
    "text": "evidence that COCs affect women\u2019s sexual behavior. 8. What can a provider say to a client asking about COCs and breast cancer? The provider can point out that both COC users and women who do not use COCs can have breast cancer. In scientific studies breast cancer",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 401
  },
  {
    "id": "chunk_00402",
    "text": "breast cancer. In scientific studies breast cancer was slightly more common among women using COCs and those who had used COCs in the past 10 years than among other women. Scientists do not know whether or not COCs actually caused the slight increase",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 402
  },
  {
    "id": "chunk_00403",
    "text": "er or not COCs actually caused the slight increase in breast cancers. It is possible that the cancers were already there before COC use but were found sooner in COC users (see Facts About Combined Oral Contraceptives and Cancer, p. 4). 9. Can COCs be used as a pregnancy test?",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 403
  },
  {
    "id": "chunk_00404",
    "text": "r, p. 4). 9. Can COCs be used as a pregnancy test? No. A woman may experience some vaginal bleeding (a \u201cwithdrawal bleed\u201d) as a result of taking several COCs or one full cycle of COCs, but studies suggest that this practice does not accurately identify who is or is",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 404
  },
  {
    "id": "chunk_00405",
    "text": "practice does not accurately identify who is or is not pregnant. Thus, giving a woman COCs to see if she has bleeding later is not recommended as a way to tell if she is pregnant. COCs should not be given to women as a pregnancy test of sorts because they do not produce accurate results.",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 405
  },
  {
    "id": "chunk_00406",
    "text": "orts because they do not produce accurate results. 10. Must a woman have a pelvic examination before she can start COCs or at follow-up visits? No. A pelvic examination to check for pregnancy is not necessary. Instead, asking the right questions usually can help to make reasonably",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 406
  },
  {
    "id": "chunk_00407",
    "text": "ight questions usually can help to make reasonably certain that a woman is not pregnant (see Pregnancy Checklist, inside back cover). No other condition that could be detected by a pelvic examination rules out COC use. 11. Can women with varicose veins use COCs?",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 407
  },
  {
    "id": "chunk_00408",
    "text": "C use. 11. Can women with varicose veins use COCs? Yes. COCs are safe for women with varicose veins. Varicose veins are enlarged blood vessels close to the surface of the skin. They are not dangerous. They are not blood clots, nor are these veins the deep",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 408
  },
  {
    "id": "chunk_00409",
    "text": "are not blood clots, nor are these veins the deep veins in the legs where a blood clot can be dangerous (deep vein thrombosis). A woman who has or has had deep vein thrombosis should not use COCs. 26 Family Planning: A Global Handbook for Providers",
    "page_number": 48,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 409
  },
  {
    "id": "chunk_00410",
    "text": "1 27 sevitpecartnoC larO denibmoC 12. Can a woman safely take COCs throughout her life? Yes. There is no minimum or maximum age for COC use. COCs can be an appropriate method for most women from onset of monthly bleeding (menarche) to menopause (see Women Near Menopause in",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 410
  },
  {
    "id": "chunk_00411",
    "text": "enarche) to menopause (see Women Near Menopause in Chapter 21 \u2013 Serving Diverse Groups, p. 335). COCs can be an appropriate method for adolescents. Adolescents may need extra support and encouragement to use COCs consistently and effectively. 13. Can women who smoke use COCs safely?",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 411
  },
  {
    "id": "chunk_00412",
    "text": "ectively. 13. Can women who smoke use COCs safely? Women younger than age 35 who smoke can use COCs. Women age 35 and older who smoke should choose a method without estrogen or, if they smoke fewer than 15 cigarettes a day, monthly injectables. Older",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 412
  },
  {
    "id": "chunk_00413",
    "text": "an 15 cigarettes a day, monthly injectables. Older women who smoke can take the progestin-only pill if they prefer pills. All women who smoke should be urged to stop smoking. 14. What if a client wants to use COCs but it is not reasonably certain that she is not pregnant after using",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 413
  },
  {
    "id": "chunk_00414",
    "text": "nably certain that she is not pregnant after using the pregnancy checklist? A woman who answers \u201cNo\u201d to all 6 questions on the Pregnancy Checklist (see inside back cover) can still start taking COCs. Ask her to come back for a pregnancy test if her next monthly bleeding is late.",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 414
  },
  {
    "id": "chunk_00415",
    "text": "egnancy test if her next monthly bleeding is late. See Ruling Out Pregnancy, p. 461. 15. Can COCs be used as emergency contraceptive pills (ECPs) after unprotected sex? Yes. As soon as possible, but no more than 5 days after unprotected sex,",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 415
  },
  {
    "id": "chunk_00416",
    "text": "le, but no more than 5 days after unprotected sex, a woman can take COCs as ECPs (see Pill Formulations and Dosing for Emergency Contraception in Chapter 3 \u2013 Emergency Contraceptive Pills, p. 55). Progestin-only pills, however, are more effective and cause fewer",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 416
  },
  {
    "id": "chunk_00417",
    "text": "pills, however, are more effective and cause fewer side effects such as nausea and stomach upset. 16. What are the differences among monophasic, biphasic, and triphasic pills? Monophasic pills provide the same amount of estrogen and progestin in",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 417
  },
  {
    "id": "chunk_00418",
    "text": "ovide the same amount of estrogen and progestin in every hormonal pill. Biphasic and triphasic pills change the amount of estrogen and progestin at different points of the pill-taking cycle. For biphasic pills, the first 10 pills have one dosage, and then the next",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 418
  },
  {
    "id": "chunk_00419",
    "text": "first 10 pills have one dosage, and then the next 11 pills have another level of estrogen and progestin. For triphasic pills, the first 7 or so pills have one dosage, the next 7 pills have another dosage, and the last 7 hormonal pills have yet another dosage. All prevent",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 419
  },
  {
    "id": "chunk_00420",
    "text": "ormonal pills have yet another dosage. All prevent pregnancy in the same way. Differences in side effects, effectiveness, and continuation appear to be slight. Questions and Answers about Combined Oral Contraceptives",
    "page_number": 49,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 420
  },
  {
    "id": "chunk_00421",
    "text": "17. Is it important for a woman to take her COCs at the same time each day? A woman can take her COCs at different times of day, and they will still be effective. However, taking them at the same time each day can be helpful for 2 reasons. Some side effects may be reduced by taking the",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 421
  },
  {
    "id": "chunk_00422",
    "text": "ns. Some side effects may be reduced by taking the pill at the same time each day. Also, taking a pill at the same time each day can help women remember to take their pills more consistently. Linking pill taking with a daily activity also helps women remember to take their pills.",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 422
  },
  {
    "id": "chunk_00423",
    "text": "ity also helps women remember to take their pills. 18. Should women who choose COCs and certain other hormonal contraceptives be routinely tested for high blood pressure? It is desirable for all women to have blood pressure measurements taken",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 423
  },
  {
    "id": "chunk_00424",
    "text": "ll women to have blood pressure measurements taken routinely before starting a hormonal method of contraception. However, in some settings blood pressure measurements are unavailable. In many of these settings, pregnancy-related morbidity and mortality risks are",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 424
  },
  {
    "id": "chunk_00425",
    "text": "regnancy-related morbidity and mortality risks are high, and these methods are among the few methods that are widely available. In such settings women should not be denied use of these methods simply because their blood pressure cannot be measured.",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 425
  },
  {
    "id": "chunk_00426",
    "text": "y because their blood pressure cannot be measured. Women with high blood pressure or very high blood pressure should not use combined hormonal methods\u2014COCs, monthly injectables, patch, or combined ring. Where blood pressure cannot be measured,",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 426
  },
  {
    "id": "chunk_00427",
    "text": "ned ring. Where blood pressure cannot be measured, women with a history of high blood pressure should not use these methods. Women with very high blood pressure should not use progestin-only injectables. Women can use progestin-only pills (POPs),",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 427
  },
  {
    "id": "chunk_00428",
    "text": "tables. Women can use progestin-only pills (POPs), implants, and LNG-IUDs even if they have high or very high blood pressure readings or a history of high or very high blood pressure. High blood pressure is defined as systolic pressure 140 mm Hg or higher",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 428
  },
  {
    "id": "chunk_00429",
    "text": "s defined as systolic pressure 140 mm Hg or higher or diastolic pressure 90 mm Hg or higher. Very high blood pressure is defined as systolic pressure 160 mm Hg or higher or diastolic pressure 100 mm Hg or higher. For more guidance concerning blood pressure, see the Medical Eligibility",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 429
  },
  {
    "id": "chunk_00430",
    "text": "erning blood pressure, see the Medical Eligibility Criteria checklists in Chapter 1 on COCs, Chapter 4 on progestin-only injectables, and Chapter 5 on monthly injectables. 28 Family Planning: A Global Handbook for Providers",
    "page_number": 50,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 430
  },
  {
    "id": "chunk_00431",
    "text": "2 29 slliP ylnO-nitsegorP CHAPTER 2 Progestin-Only Pills This chapter on progestin-only pills focuses on breastfeeding women. Women who are not breastfeeding also can use progestin-only pills. Guidance that differs for women who are not breastfeeding is noted. Key Points for Providers and Clients",
    "page_number": 51,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 431
  },
  {
    "id": "chunk_00432",
    "text": "ing is noted. Key Points for Providers and Clients \ufffd Take one pill every day. No breaks between packs. \ufffd Safe for breastfeeding women and their babies. Progestin-only pills do not affect milk production. \ufffd Add to the contraceptive effect of breastfeeding.",
    "page_number": 51,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 432
  },
  {
    "id": "chunk_00433",
    "text": "Add to the contraceptive effect of breastfeeding. Together, they provide effective pregnancy protection. \ufffd Bleeding changes are common but not harmful. Typically, pills lengthen how long breastfeeding women have no monthly bleeding. For women having monthly bleeding, frequent",
    "page_number": 51,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 433
  },
  {
    "id": "chunk_00434",
    "text": "eding. For women having monthly bleeding, frequent or irregular bleeding is common. \ufffd Can be given to a woman at any time to start now or later. What Are Progestin-Only Pills? \ufffd Pills that contain very low doses of a progestin like the natural hormone progesterone in a woman\u2019s body.",
    "page_number": 51,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 434
  },
  {
    "id": "chunk_00435",
    "text": "he natural hormone progesterone in a woman\u2019s body. \ufffd Do not contain estrogen, and so can be used throughout breastfeeding and by women who cannot use methods with estrogen. \ufffd Progestin-only pills (POPs) are also called \u201cminipills\u201d and progestin-only oral contraceptives. \ufffd Work primarily by:",
    "page_number": 51,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 435
  },
  {
    "id": "chunk_00436",
    "text": "tin-only oral contraceptives. \ufffd Work primarily by: \u2013 Thickening cervical mucus (this blocks sperm from meeting an egg) \u2013 Disrupting the menstrual cycle, including preventing the release of eggs from the ovaries (ovulation)",
    "page_number": 51,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 436
  },
  {
    "id": "chunk_00437",
    "text": "How Effective? Effectiveness depends on the user: For women who have monthly bleeding, risk of pregnancy is greatest if pills are taken late or missed completely. Breastfeeding women: More effective \ufffd As commonly used, about 1 pregnancy per 100 women Breastfeeding",
    "page_number": 52,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 437
  },
  {
    "id": "chunk_00438",
    "text": "sed, about 1 pregnancy per 100 women Breastfeeding using POPs over the first year. This means that 99 of every 100 women will not become pregnant. Not breastfeeding \ufffd When pills are taken every day, less than 1 pregnancy per 100 women using POPs over the first year (3 per 1,000 women).",
    "page_number": 52,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 438
  },
  {
    "id": "chunk_00439",
    "text": "sing POPs over the first year (3 per 1,000 women). Less effective for women not breastfeeding: \ufffd As commonly used, about 7 pregnancies per 100 women using POPs over the first year. This Less means that 93 of every 100 women will not become effective pregnant.",
    "page_number": 52,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 439
  },
  {
    "id": "chunk_00440",
    "text": "very 100 women will not become effective pregnant. \ufffd When pills are taken every day at the same time, less than 1 pregnancy per 100 women using POPs over the first year (3 per 1,000 women). Return of fertility after POPs are stopped: No delay",
    "page_number": 52,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 440
  },
  {
    "id": "chunk_00441",
    "text": "turn of fertility after POPs are stopped: No delay Protection against sexually transmitted infections (STIs): None Why Some Women Say They Like Progestin-Only Pills \ufffd Can be used while breastfeeding \ufffd Can be stopped at any time without a provider\u2019s help \ufffd Do not interfere with sex",
    "page_number": 52,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 441
  },
  {
    "id": "chunk_00442",
    "text": "2 31 slliP ylnO-nitsegorP Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 42) Some users report the following: \ufffd Changes in bleeding patterns,\u2020 including: \u2013 For breastfeeding women, longer delay in return of monthly bleeding",
    "page_number": 53,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 442
  },
  {
    "id": "chunk_00443",
    "text": "women, longer delay in return of monthly bleeding after childbirth (lengthened postpartum amenorrhea) \u2013 Frequent bleeding \u2013 Irregular bleeding Bleeding changes are normal and not \u2013 Infrequent bleeding harmful. If a woman finds them bothersome, counseling and support can help. \u2013 Prolonged bleeding",
    "page_number": 53,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 443
  },
  {
    "id": "chunk_00444",
    "text": "nseling and support can help. \u2013 Prolonged bleeding \u2013 No monthly bleeding Breastfeeding also affects a woman\u2019s bleeding patterns. \ufffd Headaches \ufffd Dizziness \ufffd Mood changes \ufffd Breast tenderness \ufffd Abdominal pain \ufffd Nausea Other possible physical changes:",
    "page_number": 53,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 444
  },
  {
    "id": "chunk_00445",
    "text": "nal pain \ufffd Nausea Other possible physical changes: \ufffd For women not breastfeeding, enlarged ovarian follicles Known Health Benefits Known Health Risks Help protect against: None \ufffd Risks of pregnancy Correcting Misunderstandings (see also Questions and Answers, p. 46) Progestin-only pills:",
    "page_number": 53,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 445
  },
  {
    "id": "chunk_00446",
    "text": "uestions and Answers, p. 46) Progestin-only pills: \ufffd Do not cause a breastfeeding woman\u2019s milk to dry up \ufffd Must be taken every day, whether or not a woman has sex that day \ufffd Do not make women infertile \ufffd Do not cause diarrhea in breastfeeding babies \ufffd Reduce the risk of ectopic pregnancy",
    "page_number": 53,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 446
  },
  {
    "id": "chunk_00447",
    "text": "ding babies \ufffd Reduce the risk of ectopic pregnancy \u2020 F or definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. Side Effects, Health Benefits and Health Risks",
    "page_number": 53,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 447
  },
  {
    "id": "chunk_00448",
    "text": "Who Can and Cannot Use Progestin-Only Pills Safe and Suitable for Nearly All Women Nearly all women can use POPs safely and effectively, including women who: \ufffd Are breastfeeding (she can start immediately after childbirth) \ufffd Have or have not had children \ufffd Are married or are not married",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 448
  },
  {
    "id": "chunk_00449",
    "text": "not had children \ufffd Are married or are not married \ufffd Are of any age, including adolescents and women over 40 years old \ufffd Have just had an abortion, miscarriage, or ectopic pregnancy \ufffd Smoke cigarettes, regardless of woman\u2019s age or number of cigarettes smoked \ufffd Have anemia now or had in the past",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 449
  },
  {
    "id": "chunk_00450",
    "text": "rettes smoked \ufffd Have anemia now or had in the past \ufffd Have varicose veins \ufffd Are living with HIV, whether or not on antiretroviral therapy Avoid Unnecessary Procedures (see Importance of Selected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396) Women can begin using POPs:",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 450
  },
  {
    "id": "chunk_00451",
    "text": "ing Provision, p. 396) Women can begin using POPs: \ufffd Without a pelvic examination \ufffd Without any blood tests or other routine laboratory tests \ufffd Without cervical cancer screening \ufffd Without a breast examination \ufffd Without a pregnancy test. A woman can begin using POPs at any time,",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 451
  },
  {
    "id": "chunk_00452",
    "text": "cy test. A woman can begin using POPs at any time, even when she is not having monthly bleeding at the time, if it is reasonably certain she is not pregnant (see Pregnancy Checklist, inside back cover). Blood pressure measurement is desirable before starting a hormonal",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 452
  },
  {
    "id": "chunk_00453",
    "text": "easurement is desirable before starting a hormonal method. However, where the risks of pregnancy are high and few methods are available, a woman should not be denied a hormonal method simply because her blood pressure cannot be measured. If",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 453
  },
  {
    "id": "chunk_00454",
    "text": "because her blood pressure cannot be measured. If possible, she can have her blood pressure measured later at a time and place convenient for her. 32 Family Planning: A Global Handbook for Providers",
    "page_number": 54,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 454
  },
  {
    "id": "chunk_00455",
    "text": "2 33 slliP ylnO-nitsegorP Medical Eligibility Criteria for Progestin-Only Pills Ask the client the questions below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions, then she can start POPs if she wants. If she answers",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 455
  },
  {
    "id": "chunk_00456",
    "text": "en she can start POPs if she wants. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases she can still start POPs. 1. Do you have severe cirrhosis of the liver or severe tumor? NO YES If she severe cirrhosis or severe liver tumor, such as",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 456
  },
  {
    "id": "chunk_00457",
    "text": "he severe cirrhosis or severe liver tumor, such as liver cancer), do not provide POPs. Help her choose a method without hormones. 2. Do you have a serious problem now with a blood clot in your leg or lungs? NO YES If she reports a current blood clot in a leg (affecting",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 457
  },
  {
    "id": "chunk_00458",
    "text": "e reports a current blood clot in a leg (affecting deep veins, not superficial veins) or in a lung, and she is not on anticoagulant therapy, do not provide POPs. Help her choose a method without hormones. 3. Are you taking medication for seizures? Are you taking",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 458
  },
  {
    "id": "chunk_00459",
    "text": "you taking medication for seizures? Are you taking rifampicin or rifabutin for tuberculosis or other illness? NO YES If she is taking barbiturates, carbamazepine, oxcarbazepine, phenytoin, primidone, topiramate, rifampicin, or rifabutin, do not provide POPs.",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 459
  },
  {
    "id": "chunk_00460",
    "text": "te, rifampicin, or rifabutin, do not provide POPs. They can make POPs less effective. Help her choose another method but not combined oral contraceptives. 4. Do you have or have you ever had breast cancer? NO YES Do not provide POPs. Help her choose a method without hormones.",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 460
  },
  {
    "id": "chunk_00461",
    "text": "e POPs. Help her choose a method without hormones. Also, women should not use POPs if they report having thrombogenic mutations or lupus with positive (or unknown) antiphospholipid antibodies. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use.",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 461
  },
  {
    "id": "chunk_00462",
    "text": "edical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions that would make the method inadvisable, when relevant to the client.",
    "page_number": 55,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 462
  },
  {
    "id": "chunk_00463",
    "text": "Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not use POPs. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her, a qualified provider who can carefully assess",
    "page_number": 56,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 463
  },
  {
    "id": "chunk_00464",
    "text": "her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use POPs. The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up.",
    "page_number": 56,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 464
  },
  {
    "id": "chunk_00465",
    "text": "itions, whether she will have access to follow-up. \ufffd Acute blood clot in deep veins of legs or lungs \ufffd Had breast cancer more than 5 years ago, and it has not returned \ufffd Severe cirrhosis or severe liver tumor \ufffd Systemic lupus erythematosus with positive (or unknown) antiphospholipid antibodies",
    "page_number": 56,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 465
  },
  {
    "id": "chunk_00466",
    "text": "positive (or unknown) antiphospholipid antibodies \ufffd Taking barbiturates, carbamazepine, oxcarbazepine, phenytoin, primidone, topiramate, rifampicin, or rifabutin. A backup contraceptive method should also be used because these medications reduce the effectiveness of POPs.",
    "page_number": 56,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 466
  },
  {
    "id": "chunk_00467",
    "text": "hese medications reduce the effectiveness of POPs. Progestin-Only Pills for Women With HIV \ufffd Women living with HIV or on antiretroviral therapy can safely use POPs. \ufffd Urge these women to use condoms along with POPs. Used consistently and correctly, condoms help prevent transmission of HIV",
    "page_number": 56,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 467
  },
  {
    "id": "chunk_00468",
    "text": "orrectly, condoms help prevent transmission of HIV and other STIs. \ufffd For appropriate breastfeeding practices for women with HIV, see Maternal and Newborn Health, Preventing Mother-to-Child Transmission of HIV, p. 378. 34 Family Planning: A Global Handbook for Providers",
    "page_number": 56,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 468
  },
  {
    "id": "chunk_00469",
    "text": "2 35 slliP ylnO-nitsegorP Providing Progestin-Only Pills When to Start IMPORTANT: A woman can start using POPs any time she wants if it is reasonably certain she is not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover). Also, a",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 469
  },
  {
    "id": "chunk_00470",
    "text": "egnancy Checklist (see inside back cover). Also, a woman can be given POPs at any time and told when to start taking them. Woman\u2019s situation When to start Fully or nearly fully breastfeeding Less than 6 \ufffd If her monthly bleeding has not returned, she",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 470
  },
  {
    "id": "chunk_00471",
    "text": "6 \ufffd If her monthly bleeding has not returned, she months after can start POPs any time between giving birth giving birth and 6 months. No need for a backup method. \ufffd If her monthly bleeding has returned, she can start POPs as advised for women having menstrual cycles (see next page).",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 471
  },
  {
    "id": "chunk_00472",
    "text": "for women having menstrual cycles (see next page). More than 6 \ufffd If her monthly bleeding has not returned, she can months after start POPs any time it is reasonably certain she giving birth is not pregnant. She will need a backup method* for the first 2 days of taking pills. (If you cannot",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 472
  },
  {
    "id": "chunk_00473",
    "text": "r the first 2 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If her monthly bleeding has returned, she can start POPs as advised for women having menstrual cycles (see next page). Partially breastfeeding",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 473
  },
  {
    "id": "chunk_00474",
    "text": "al cycles (see next page). Partially breastfeeding If her monthly \ufffd She can start POPs any time it is reasonably bleeding has certain she is not pregnant.\u2020 She will need a not returned backup method for the first 2 days of taking pills. (If you cannot be reasonably certain, see How",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 474
  },
  {
    "id": "chunk_00475",
    "text": "lls. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) If her monthly \ufffd She can start POPs as advised for women having bleeding has menstrual cycles (see next page). returned",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 475
  },
  {
    "id": "chunk_00476",
    "text": "ing has menstrual cycles (see next page). returned * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 476
  },
  {
    "id": "chunk_00477",
    "text": "traceptive methods. If possible, give her condoms. \u2020 Where a visit 6 weeks after childbirth is routinely recommended and other opportunities to obtain contraception are limited, some providers and programs may allow a woman to start",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 477
  },
  {
    "id": "chunk_00478",
    "text": "providers and programs may allow a woman to start POPs at the 6-week visit, without further evidence that the woman is not pregnant, if her monthly bleeding has not yet returned. Providing Progestin-Only Pills",
    "page_number": 57,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 478
  },
  {
    "id": "chunk_00479",
    "text": "Woman\u2019s situation When to start(continued) Not breastfeeding Less than 4 weeks \ufffd She can start POPs at any time. No need for a after giving birth backup method. More than 4 weeks \ufffd If her monthly bleeding has not returned, she can after giving birth start POPs any time it is reasonably certain she",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 479
  },
  {
    "id": "chunk_00480",
    "text": "h start POPs any time it is reasonably certain she is not pregnant.\u2020 She will need a backup method for the first 2 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If her monthly bleeding has returned, she",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 480
  },
  {
    "id": "chunk_00481",
    "text": "462.) \ufffd If her monthly bleeding has returned, she can start POPs as advised for women having menstrual cycles (see below). Switching from \ufffd Immediately, if she has been using the hormonal a hormonal method consistently and correctly or if it is",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 481
  },
  {
    "id": "chunk_00482",
    "text": "onal method consistently and correctly or if it is method otherwise reasonably certain she is not pregnant. No need to wait for her next monthly bleeding. No need for a backup method. \ufffd If she is switching from injectables, she can begin taking POPs when the repeat injection would",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 482
  },
  {
    "id": "chunk_00483",
    "text": "begin taking POPs when the repeat injection would have been given. No need for a backup method. Having menstrual Any time of the month cycles or \ufffd If she is starting within 5 days after the start switching from of her monthly bleeding, no need for a backup a nonhormonal method. method",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 483
  },
  {
    "id": "chunk_00484",
    "text": "no need for a backup a nonhormonal method. method \ufffd If it is more than 5 days after the start of her monthly bleeding, she can start POPs any time it is reasonably certain she is not pregnant. She will need a backup method for the first 2 days of taking pills. (If you cannot be reasonably certain,",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 484
  },
  {
    "id": "chunk_00485",
    "text": "aking pills. (If you cannot be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) \ufffd If she is switching from an IUD, she can start POPs immediately (see Switching From an IUD to Another Method, in Chapter 10 \u2013 Copper-Bearing",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 485
  },
  {
    "id": "chunk_00486",
    "text": "to Another Method, in Chapter 10 \u2013 Copper-Bearing Intrauterine Device, pp. 187\u2013188) \u2020 Where a visit 6 weeks after childbirth is routinely recommended and other opportunities to obtain contraception are limited, some providers and programs may allow a woman to start",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 486
  },
  {
    "id": "chunk_00487",
    "text": "providers and programs may allow a woman to start POPs at the 6-week visit, without further evidence that the woman is not pregnant, if her monthly bleeding has not yet returned. 36 Family Planning: A Global Handbook for Providers",
    "page_number": 58,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 487
  },
  {
    "id": "chunk_00488",
    "text": "2 37 slliP ylnO-nitsegorP Woman\u2019s situation When to start No monthly \ufffd She can start POPs any time it is reasonably bleeding (not certain she is not pregnant. She will need a related to childbirth backup method for the first 2 days of taking pills. or breastfeeding)",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 488
  },
  {
    "id": "chunk_00489",
    "text": "he first 2 days of taking pills. or breastfeeding) After \ufffd Immediately. If she is starting within 7 days after miscarriage or first- or second-trimester miscarriage or abortion, abortion no need for a backup method. \ufffd If it is more than 7 days after first- or second-",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 489
  },
  {
    "id": "chunk_00490",
    "text": "If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start POPs any time it is reasonably certain she is not pregnant. She will need a backup method for the first 2 days of taking pills. (If you cannot be reasonably certain, see How and When to Use the",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 490
  },
  {
    "id": "chunk_00491",
    "text": "be reasonably certain, see How and When to Use the Pregnancy Checklist and Pregnancy Tests, p. 462.) After taking After taking progestin-only or combined ECPs: emergency \ufffd She can start or restart POPs immediately after contraceptive she takes the ECPs. No need to wait for her next pills (ECPs)",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 491
  },
  {
    "id": "chunk_00492",
    "text": "he ECPs. No need to wait for her next pills (ECPs) monthly bleeding. \u2013 A continuing user who needed ECPs due to pill-taking errors can continue where she left off with her current pack. \ufffd If she does not start immediately, but returns for POPs, she can start at any time if it is reasonably",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 492
  },
  {
    "id": "chunk_00493",
    "text": "OPs, she can start at any time if it is reasonably certain she is not pregnant. \ufffd All women will need to use a backup method for the first 2 days of taking pills. After taking ulipristal acetate (UPA) ECPs: \ufffd She can start or restart POPs on the 6th day after",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 493
  },
  {
    "id": "chunk_00494",
    "text": "She can start or restart POPs on the 6th day after taking UPA-ECPs. No need to wait for her next monthly bleeding. POPs and UPA interact. If POPs are started sooner, and thus both are present in the body, one or both may be less effective. \ufffd Give her a supply of pills and tell her to start them",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 494
  },
  {
    "id": "chunk_00495",
    "text": "e her a supply of pills and tell her to start them on the 6th day after taking the UPA-ECPs. \ufffd She will need to use a backup method from the time she takes UPA-ECPs until she has been taking POPs for 2 days. \ufffd If she does not start on the 6th day but returns",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 495
  },
  {
    "id": "chunk_00496",
    "text": "\ufffd If she does not start on the 6th day but returns later for POPs, she may start at any time if it is reasonably certain she is not pregnant. Providing Progestin-Only Pills",
    "page_number": 59,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 496
  },
  {
    "id": "chunk_00497",
    "text": "Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes and other side effects is an important part of providing the method. Counseling about bleeding changes may be the most important help a woman needs to keep using the method without concern.",
    "page_number": 60,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 497
  },
  {
    "id": "chunk_00498",
    "text": "an needs to keep using the method without concern. Describe the \ufffd Breastfeeding women normally do not have most common monthly bleeding for several months after giving side effects birth. POPs lengthen this period of time. \ufffd Women who are not breastfeeding may have",
    "page_number": 60,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 498
  },
  {
    "id": "chunk_00499",
    "text": "f time. \ufffd Women who are not breastfeeding may have frequent or irregular bleeding for the first several months, followed by regular bleeding or continued irregular bleeding. \ufffd Headaches, dizziness, breast tenderness, and possibly other side effects.",
    "page_number": 60,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 499
  },
  {
    "id": "chunk_00500",
    "text": "reast tenderness, and possibly other side effects. Explain about \ufffd Side effects are not signs of illness. Lack of these side effects bleeding does not mean pregnancy. \ufffd Usually become less or stop within the first few months of using POPs. Bleeding changes, however, usually persist.",
    "page_number": 60,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 500
  },
  {
    "id": "chunk_00501",
    "text": "POPs. Bleeding changes, however, usually persist. \ufffd Common, but some women do not have them. Explain what \ufffd Keep taking POPs. Skipping pills risks pregnancy. to do in case \ufffd Try taking pills with food or at bedtime to help of side effects avoid nausea.",
    "page_number": 60,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 501
  },
  {
    "id": "chunk_00502",
    "text": "r at bedtime to help of side effects avoid nausea. \ufffd The client can come back for help if side effects bother her or if she has other concerns. 38 Family Planning: A Global Handbook for Providers",
    "page_number": 60,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 502
  },
  {
    "id": "chunk_00503",
    "text": "2 39 slliP ylnO-nitsegorP Explaining How to Use 1. Give pills \ufffd Give as many packs as possible\u2014even as much as a year\u2019s supply (11 packs of 35 pills each or 13 packs of 28 pills each). 2. Explain pill pack \ufffd Show which kind of pack\u201428 pills or 35 pills.",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 503
  },
  {
    "id": "chunk_00504",
    "text": "ck \ufffd Show which kind of pack\u201428 pills or 35 pills. \ufffd Explain that all pills in POP packs are the same color and all are active pills, containing a hormone that prevents pregnancy. \ufffd Show how to take the first pill from the pack and then how to follow the directions or",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 504
  },
  {
    "id": "chunk_00505",
    "text": "the pack and then how to follow the directions or arrows on the pack to take the rest of the pills. 3. Give key \ufffd Take one pill each day\u2014until the pack is instruction empty. \ufffd Women who are not breastfeeding should take a pill at the same time each day. Taking a pill more than",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 505
  },
  {
    "id": "chunk_00506",
    "text": "at the same time each day. Taking a pill more than 3 hours late makes it less effective. \ufffd Discuss cues for taking a pill every day. Linking pill-taking to a daily activity\u2014such as cleaning her teeth\u2014 may help her remember. 4. Explain starting \ufffd When she finishes one pack, she should take the",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 506
  },
  {
    "id": "chunk_00507",
    "text": "\ufffd When she finishes one pack, she should take the next pack first pill from the next pack on the very next day. \ufffd It is very important to start the next pack on time. Starting a pack late risks pregnancy. 5. Provide backup \ufffd Sometimes she may need to use a backup method,",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 507
  },
  {
    "id": "chunk_00508",
    "text": "p \ufffd Sometimes she may need to use a backup method, method and such as when she misses pills or is late taking a pill. explain use \ufffd Backup methods include abstinence, male or female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 508
  },
  {
    "id": "chunk_00509",
    "text": ". Tell her that spermicides and withdrawal are the least effective contraceptive methods. Give her condoms, if possible. 6. Explain that \ufffd Without the additional protection of breastfeeding effectiveness itself, POPs are not as effective as most other decreases when hormonal methods. breastfeeding",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 509
  },
  {
    "id": "chunk_00510",
    "text": "her decreases when hormonal methods. breastfeeding \ufffd When she stops breastfeeding, she can continue stops taking POPs if she is satisfied with the method, or she is welcome to come back for another method. Providing Progestin-Only Pills",
    "page_number": 61,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 510
  },
  {
    "id": "chunk_00511",
    "text": "Supporting New and Continuing Users Managing Missed Pills It is easy to forget a pill or to be late in taking it. Adolescents are more likely to forget pills and so may need extra support and guidance. POP users should know what to do if they forget to take pills. If a woman",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 511
  },
  {
    "id": "chunk_00512",
    "text": "hat to do if they forget to take pills. If a woman is 3 or more hours late taking a pill (12 or more hours late taking a POP containing desogestrel 75 mg), or if she misses a pill completely, she should follow the instructions below. For",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 512
  },
  {
    "id": "chunk_00513",
    "text": "ely, she should follow the instructions below. For breastfeeding women, whether missing a pill places her at risk of pregnancy depends on whether or not her monthly bleeding has returned. Making Up Missed Progestin-Only Pills Key message \ufffd Take a missed pill as soon as possible.",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 513
  },
  {
    "id": "chunk_00514",
    "text": "message \ufffd Take a missed pill as soon as possible. \ufffd Keep taking pills as usual, one each day. (She may take 2 pills at the same time or on the same day.) Do you have \ufffd If yes, she also should use a backup method for the monthly bleeding next 2 days. regularly?",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 514
  },
  {
    "id": "chunk_00515",
    "text": "d for the monthly bleeding next 2 days. regularly? \ufffd Also, if she had sex in the past 5 days, she can consider taking ECPs (see Chapter 3 \u2013 Emergency Contraceptive Pills). Severe vomiting \ufffd If she vomits within 2 hours after taking a pill, she",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 515
  },
  {
    "id": "chunk_00516",
    "text": "she vomits within 2 hours after taking a pill, she or diarrhea should take another pill from her pack as soon as possible, and keep taking pills as usual. How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 516
  },
  {
    "id": "chunk_00517",
    "text": "lcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: \ufffd Support a woman\u2019s choice of POPs \ufffd Help her to remember to take a pill at about the same time each day \ufffd Show understanding and support if she has side effects",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 517
  },
  {
    "id": "chunk_00518",
    "text": "understanding and support if she has side effects \ufffd Help her to make sure that she has a new pill pack on hand to start on time \ufffd Help to make sure she has ECPs on hand in case she misses pills or starts a new pill pack late \ufffd Use condoms consistently in addition to POPs if he has an STI/HIV or",
    "page_number": 62,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 518
  },
  {
    "id": "chunk_00519",
    "text": "2 41 slliP ylnO-nitsegorP \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she has a major change in health status; or she thinks she might be pregnant. Also if:",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 519
  },
  {
    "id": "chunk_00520",
    "text": "tus; or she thinks she might be pregnant. Also if: \ufffd She has stopped breastfeeding and wants to switch to another method. \ufffd For a woman who has monthly bleeding: If she took a pill more than 3 hours late or missed one completely, and also had sex during the last",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 520
  },
  {
    "id": "chunk_00521",
    "text": "d one completely, and also had sex during the last 5 days, she may wish to consider ECPs (see Chapter 3). General health advice: Anyone who suddenly feels that something is seriously wrong with her health should immediately seek medical care from a nurse",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 521
  },
  {
    "id": "chunk_00522",
    "text": "should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the nurse or doctor what method she is using. Planning the Next Visit 1. Encourage her to come back for more pills before she uses up her supply",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 522
  },
  {
    "id": "chunk_00523",
    "text": "back for more pills before she uses up her supply of pills. 2. Contacting women after the first 3 months of POP use is recommended. This offers an opportunity to answer any questions, help with any problems, and check on correct use. Repeat Visits",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 523
  },
  {
    "id": "chunk_00524",
    "text": "problems, and check on correct use. Repeat Visits 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss. 2. Ask especially if she is concerned about bleeding changes. Give her any",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 524
  },
  {
    "id": "chunk_00525",
    "text": "is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, p. 42). 3. Ask if she often has problems remembering to take a pill every day. If so, discuss ways to remember, making up for missed pills, and ECPs, or",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 525
  },
  {
    "id": "chunk_00526",
    "text": "remember, making up for missed pills, and ECPs, or choosing another method. Adolescents may need extra support. 4. Give her more pill packs\u2014as much as a full year\u2019s supply (11 or 13 packs), if possible. Plan her next resupply visit before she will need more pills.",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 526
  },
  {
    "id": "chunk_00527",
    "text": "xt resupply visit before she will need more pills. 5. Ask a long-term client if she has had any new health problems since her last visit. Address problems as appropriate. For new health problems that may require switching methods, see p. 45.",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 527
  },
  {
    "id": "chunk_00528",
    "text": "ems that may require switching methods, see p. 45. 6. Ask a long-term client about major life changes that may affect her needs\u2014 particularly plans for having children and STI/HIV risk. Follow up as needed. Supporting New and Continuing Users",
    "page_number": 63,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 528
  },
  {
    "id": "chunk_00529",
    "text": "Managing Any Problems Problems Reported as Side Effects or Problems With Use May or may not be due to the method. \ufffd Problems with side effects affect women\u2019s satisfaction and use of POPs. They deserve the provider\u2019s attention. If the client reports side effects",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 529
  },
  {
    "id": "chunk_00530",
    "text": "er\u2019s attention. If the client reports side effects or problems, listen to her concerns, give her advice and support, and, if appropriate, treat. Make sure she understands the advice and agrees. \ufffd Encourage her to keep taking a pill every day even if she has side effects.",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 530
  },
  {
    "id": "chunk_00531",
    "text": "ing a pill every day even if she has side effects. Missing pills can risk pregnancy. \ufffd Many side effects will subside after a few months of use. For a woman whose side effects persist, give her a different POP formulation, if available, for at least 3 months.",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 531
  },
  {
    "id": "chunk_00532",
    "text": "formulation, if available, for at least 3 months. \ufffd Offer to help the client choose another method\u2014now, if she wishes, or if problems cannot be overcome. No monthly bleeding \ufffd Breastfeeding women: \u2212 Reassure her that this is normal during breastfeeding. It is not harmful. \ufffd Women not breastfeeding:",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 532
  },
  {
    "id": "chunk_00533",
    "text": "ing. It is not harmful. \ufffd Women not breastfeeding: \u2212 Reassure her that some women using POPs stop having monthly bleeding, and this is not harmful. There is no need to lose blood every month. It is similar to not having monthly bleeding during pregnancy.",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 533
  },
  {
    "id": "chunk_00534",
    "text": "r to not having monthly bleeding during pregnancy. She is not pregnant or infertile. Blood is not building up inside her. (Some women are happy to be free from monthly bleeding.) Irregular bleeding (bleeding at unexpected times that bothers the client)",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 534
  },
  {
    "id": "chunk_00535",
    "text": "eding at unexpected times that bothers the client) \ufffd Reassure her that many women using POPs experience irregular bleeding\u2014whether breastfeeding or not. (Breastfeeding itself also can cause irregular bleeding.) It is not harmful and sometimes becomes less or",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 535
  },
  {
    "id": "chunk_00536",
    "text": ".) It is not harmful and sometimes becomes less or stops after the first several months of use. Some women have irregular bleeding the entire time they are taking POPs, however. \ufffd Other possible causes of irregular bleeding include: \u2212 Vomiting or diarrhea",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 536
  },
  {
    "id": "chunk_00537",
    "text": "irregular bleeding include: \u2212 Vomiting or diarrhea \u2212 Taking anticonvulsants or rifampicin (see\u201c Starting treatment with anticonvulsants, rifampicin, or rifabutin\u201d, p. 45) \ufffd To reduce irregular bleeding: \u2212 Teach her to make up for missed pills properly, including after vomiting",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 537
  },
  {
    "id": "chunk_00538",
    "text": "or missed pills properly, including after vomiting or diarrhea (see Managing Missed Pills, p. 40). \u2212 For modest short-term relief she can try 800 mg ibuprofen 3 times daily after meals for 5 days, or other nonsteroidal anti-inflammatory drug",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 538
  },
  {
    "id": "chunk_00539",
    "text": "days, or other nonsteroidal anti-inflammatory drug (NSAID), beginning when irregular bleeding starts. NSAIDs provide 42 Family Planning: A Global Handbook for Providers",
    "page_number": 64,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 539
  },
  {
    "id": "chunk_00540",
    "text": "2 43 slliP ylnO-nitsegorP some relief of irregular bleeding for implants, progestin-only injectables, and IUDs, and they may also help POP users. \u2212 If she has been taking the pills for more than a few months and NSAIDs do not help, give her a different POP formulation, if available. Ask her to",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 540
  },
  {
    "id": "chunk_00541",
    "text": "ifferent POP formulation, if available. Ask her to try the new pills for at least 3 months. \ufffd If irregular bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 541
  },
  {
    "id": "chunk_00542",
    "text": "ng, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, p. 45). Heavy or prolonged bleeding (twice as much as usual or longer than 8 days)",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 542
  },
  {
    "id": "chunk_00543",
    "text": "ing (twice as much as usual or longer than 8 days) \ufffd Reassure her that some women using POPs experience heavy or prolonged bleeding. It is generally not harmful and usually becomes less or stops after a few months. \ufffd For modest short-term relief she can try NSAIDs, beginning when heavy",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 543
  },
  {
    "id": "chunk_00544",
    "text": "rm relief she can try NSAIDs, beginning when heavy bleeding starts. Try the same treatments as for irregular bleeding (see previous page). \ufffd To help prevent anemia, suggest she take iron tablets and tell her it is important to eat foods containing iron, such as meat and poultry",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 544
  },
  {
    "id": "chunk_00545",
    "text": "at foods containing iron, such as meat and poultry (especially beef and chicken liver), fish, green leafy vegetables, and legumes (beans, bean curd, lentils, and peas). \ufffd If heavy or prolonged bleeding continues or starts after several months",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 545
  },
  {
    "id": "chunk_00546",
    "text": "bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, p. 45). Missed pills \ufffd See Managing Missed Pills, p. 40.",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 546
  },
  {
    "id": "chunk_00547",
    "text": ". Missed pills \ufffd See Managing Missed Pills, p. 40. Ordinary headaches (nonmigrainous) \ufffd Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. \ufffd Any headaches that get worse or occur more often during POP use should be evaluated.",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 547
  },
  {
    "id": "chunk_00548",
    "text": "cur more often during POP use should be evaluated. Mood changes or changes in sex drive \ufffd Ask about changes in her life that could affect her mood or sex drive, including changes in her relationship with her partner. Give her support as appropriate.",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 548
  },
  {
    "id": "chunk_00549",
    "text": "with her partner. Give her support as appropriate. \ufffd Some women experience depression in the year after giving birth. This is not related to POPs. Clients who have serious mood changes such as major depression should be referred for care. \ufffd Consider locally available remedies.",
    "page_number": 65,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 549
  },
  {
    "id": "chunk_00550",
    "text": "Breast tenderness \ufffd Breastfeeding women: \u2212 See Maternal and Newborn Health, Sore Breasts, p. 356. \ufffd Women not breastfeeding: \u2212 Recommend that she wear a supportive bra (including during strenuous activity and sleep). \u2212 Try hot or cold compresses.",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 550
  },
  {
    "id": "chunk_00551",
    "text": "activity and sleep). \u2212 Try hot or cold compresses. \u2212 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. \u2212 Consider locally available remedies. Severe pain in lower abdomen \ufffd Abdominal pain may be due to various problems, such as enlarged ovarian",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 551
  },
  {
    "id": "chunk_00552",
    "text": "due to various problems, such as enlarged ovarian follicles or cysts. \u2212 A woman can continue to use POPs during evaluation and treatment. \u2212 There is no need to treat enlarged ovarian follicles or cysts unless they grow abnormally large, twist, or burst. Reassure the client that they",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 552
  },
  {
    "id": "chunk_00553",
    "text": "ge, twist, or burst. Reassure the client that they usually disappear on their own. To be sure the problem is resolving, see the client again in 6 weeks, if possible. \ufffd With severe abdominal pain, be particularly alert for additional signs or",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 553
  },
  {
    "id": "chunk_00554",
    "text": "ain, be particularly alert for additional signs or symptoms of ectopic pregnancy, which is rare and not caused by POPs, but it can be life-threatening (see Question 13, p. 48). \ufffd In the early stages of ectopic pregnancy, symptoms may be absent or",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 554
  },
  {
    "id": "chunk_00555",
    "text": "es of ectopic pregnancy, symptoms may be absent or mild, but eventually they will become severe. A combination of these signs or symptoms should increase suspicion of ectopic pregnancy: \u2212 Unusual abdominal pain or tenderness \u2212 Abnormal vaginal bleeding or no monthly bleeding\u2014especially if this is a",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 555
  },
  {
    "id": "chunk_00556",
    "text": "ing or no monthly bleeding\u2014especially if this is a change from her usual bleeding pattern \u2212 Light-headedness or dizziness \u2212 Fainting \ufffd If ectopic pregnancy or other serious health condition is suspected, refer at once for immediate diagnosis and care (for more on ectopic",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 556
  },
  {
    "id": "chunk_00557",
    "text": "immediate diagnosis and care (for more on ectopic pregnancies, see Managing Ectopic Pregnancy in Chapter 12 \u2013 Female Sterilization, p. 237.) Nausea or dizziness \ufffd For nausea, suggest taking POPs at bedtime or with food. \ufffd If symptoms continue, consider locally available remedies.",
    "page_number": 66,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 557
  },
  {
    "id": "chunk_00558",
    "text": "2 45 slliP ylnO-nitsegorP New Problems That May Require Switching Methods May or may not be due to the method. Unexplained vaginal bleeding (that suggests a medical condition not related to the method) \ufffd Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate.",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 558
  },
  {
    "id": "chunk_00559",
    "text": "ic examination. Diagnose and treat as appropriate. \ufffd She can continue using POPs while her condition is being evaluated. \ufffd If bleeding is caused by a sexually transmitted infection or pelvic inflammatory disease, she can continue using POPs during treatment.",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 559
  },
  {
    "id": "chunk_00560",
    "text": "ase, she can continue using POPs during treatment. Starting treatment with anticonvulsants, rifampicin, or rifabutin \ufffd Barbiturates, carbamazepine, oxcarbazepine, phenytoin, primidone, topiramate, rifampicin, rifabutin, and ritonavir may make POPs less effective.",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 560
  },
  {
    "id": "chunk_00561",
    "text": "butin, and ritonavir may make POPs less effective. If using these medications long-term, she may want a different method, such as progestin-only injectables or a copper-bearing IUD or LNG-IUD. \ufffd If using these medications short-term, she can use a backup method along with POPs.",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 561
  },
  {
    "id": "chunk_00562",
    "text": "term, she can use a backup method along with POPs. Migraine headaches (see Identifying Migraine Headaches and Auras, p. 458) \ufffd A woman who has migraine headaches with or without aura can safely start POPs. \ufffd If she develops migraine headaches without aura while taking POPs, she can",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 562
  },
  {
    "id": "chunk_00563",
    "text": "headaches without aura while taking POPs, she can continue to use POPs if she wishes. \ufffd If she develops migraine aura while using POPs, stop POPs. Help her choose a method without hormones. Certain serious health conditions (suspected blood clots in",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 563
  },
  {
    "id": "chunk_00564",
    "text": "erious health conditions (suspected blood clots in deep veins of legs or lungs, liver disease, or breast cancer). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. \ufffd Tell her to stop taking POPs. \ufffd Give her a backup method to use until the condition is evaluated.",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 564
  },
  {
    "id": "chunk_00565",
    "text": "up method to use until the condition is evaluated. \ufffd Refer for diagnosis and care if not already under care. Heart disease due to blocked or narrowed arteries (ischemic heart disease) or stroke \ufffd A woman who has one of these conditions can safely start POPs. If,",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 565
  },
  {
    "id": "chunk_00566",
    "text": "one of these conditions can safely start POPs. If, however, the condition develops after she starts using POPs, she should stop. Help her choose a method without hormones. \ufffd Refer for diagnosis and care if not already under care. Suspected pregnancy",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 566
  },
  {
    "id": "chunk_00567",
    "text": "are if not already under care. Suspected pregnancy \ufffd Assess for pregnancy, including ectopic pregnancy. \ufffd Tell her to stop taking POPs if pregnancy is confirmed. \ufffd There are no known risks to a fetus conceived while a woman is taking POPs (see Question 4, p. 46). Supporting New and Continuing Users",
    "page_number": 67,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 567
  },
  {
    "id": "chunk_00568",
    "text": "Questions and Answers About Progestin-Only Pills 1. Can a woman who is breastfeeding safely use POPs? In 2016 WHO considered this question and updated its guidance to allow a woman to use progestin-only pills after childbirth regardless of how recently she gave birth. She does not need to wait until",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 568
  },
  {
    "id": "chunk_00569",
    "text": "ly she gave birth. She does not need to wait until 6 weeks postpartum. POPs are safe for both the mother and the baby and do not affect milk production. 2. What should a woman do when she stops breastfeeding her baby? Can she continue taking POPs?",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 569
  },
  {
    "id": "chunk_00570",
    "text": "astfeeding her baby? Can she continue taking POPs? A woman who is satisfied with using POPs can continue using them when she has stopped breastfeeding. She is less protected from pregnancy than when breastfeeding, however. She can switch to another method if she wishes.",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 570
  },
  {
    "id": "chunk_00571",
    "text": "r. She can switch to another method if she wishes. 3. Can a woman take POPs at any age? Yes. There is no minimum or maximum age for POP use. POPs can be an appropriate method for adolescents. Adolescents who are breastfeeding have the same need for an effective way to",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 571
  },
  {
    "id": "chunk_00572",
    "text": "feeding have the same need for an effective way to space births as older women. They may need extra support and encouragement to use POPs consistently and effectively. 4. Do POPs cause birth defects? Will the fetus be harmed if a woman accidentally takes POPs while she is pregnant?",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 572
  },
  {
    "id": "chunk_00573",
    "text": "man accidentally takes POPs while she is pregnant? No. Good evidence shows that POPs will not cause birth defects and will not otherwise harm the fetus if a woman becomes pregnant while taking POPs or accidentally takes POPs when she is already pregnant.",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 573
  },
  {
    "id": "chunk_00574",
    "text": "identally takes POPs when she is already pregnant. 5. How long does it take to become pregnant after stopping POPs? Women who stop using POPs can become pregnant as quickly as women who stop nonhormonal methods. POPs do not delay the return of a woman\u2019s fertility after she stops taking them. The",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 574
  },
  {
    "id": "chunk_00575",
    "text": "woman\u2019s fertility after she stops taking them. The bleeding pattern a woman had before she used POPs generally returns after she stops taking them. Some women may have to wait a few months before their usual bleeding pattern returns. 46 Family Planning: A Global Handbook for Providers",
    "page_number": 68,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 575
  },
  {
    "id": "chunk_00576",
    "text": "2 47 slliP ylnO-nitsegorP 6. If a woman does not have monthly bleeding while taking POPs, does this mean that she is pregnant? Probably not, especially if she is breastfeeding. If she has been taking her pills every day, she is probably not pregnant and can keep taking",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 576
  },
  {
    "id": "chunk_00577",
    "text": ", she is probably not pregnant and can keep taking her pills. If she is still worried after being reassured, she can be offered a pregnancy test, if available, or referred for one. If not having monthly bleeding bothers her, switching to another method may help\u2014but not",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 577
  },
  {
    "id": "chunk_00578",
    "text": "her, switching to another method may help\u2014but not to another progestin-only method. These methods sometimes stop monthly bleeding. 7. Must the POP be taken every day? Yes. All of the pills in the POP package contain the hormone that prevents pregnancy. If a woman does not take a pill every day\u2014",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 578
  },
  {
    "id": "chunk_00579",
    "text": "gnancy. If a woman does not take a pill every day\u2014 especially a woman who is not breastfeeding\u2014she could become pregnant. (In contrast, the last 7 pills in a 28-pill pack of combined oral contraceptives are not active. They contain no hormones.)",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 579
  },
  {
    "id": "chunk_00580",
    "text": "eptives are not active. They contain no hormones.) 8. Is it important for a woman to take her POPs at the same time each day? Yes, for 2 reasons. POPs contain very little hormone, and taking a pill more than 3 hours late (more than 12 hours late with POPs containing",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 580
  },
  {
    "id": "chunk_00581",
    "text": "late (more than 12 hours late with POPs containing desogestrel 75 mg) could reduce their effectiveness for women who are not breastfeeding. (Breastfeeding women have the additional protection from pregnancy that breastfeeding provides, and so taking pills late is not",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 581
  },
  {
    "id": "chunk_00582",
    "text": "tfeeding provides, and so taking pills late is not as risky.) Also, taking a pill at the same time each day can help women remember to take their pills more consistently. Linking pill taking with a daily activity also helps women remember to take their pills. 9. Do POPs cause cancer?",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 582
  },
  {
    "id": "chunk_00583",
    "text": "mber to take their pills. 9. Do POPs cause cancer? No. Few large studies exist on POPs and cancer, but smaller studies of POPs are reassuring. Larger studies of implants have not shown any increased risk of cancer. Implants contain hormones similar to those",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 583
  },
  {
    "id": "chunk_00584",
    "text": "cancer. Implants contain hormones similar to those used in POPs, and, during the first few years of implant use, at about twice the dosage. 10. Can POPs be used as emergency contraceptive pills (ECPs) after unprotected sex? Yes. As soon as possible, but no more than 5 days after unprotected sex,",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 584
  },
  {
    "id": "chunk_00585",
    "text": "le, but no more than 5 days after unprotected sex, a woman can take POPs as ECPs (see Pill Formulations and Dosing for Emergency Contraception in Chapter 3, p. 55). Depending on the type of POP, she will have to take 40 to 50 pills. This is many pills, but it is",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 585
  },
  {
    "id": "chunk_00586",
    "text": "take 40 to 50 pills. This is many pills, but it is safe because there is very little hormone in each pill. Questions and Answers About Progestin-Only Pills",
    "page_number": 69,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 586
  },
  {
    "id": "chunk_00587",
    "text": "11. Do POPs lower women\u2019s mood or sex drive? Generally, no. Some women using POPs report these complaints. The great majority of POP users do not report any such changes, however, and some report that both mood and sex drive improve. It is difficult",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 587
  },
  {
    "id": "chunk_00588",
    "text": "t both mood and sex drive improve. It is difficult to tell whether such changes are due to the POPs or to other reasons. Providers can help a client with these problems (see \u201cMood changes or changes in sex drive\u201d, p. 43). There is no evidence that POPs affect women\u2019s sexual behavior.",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 588
  },
  {
    "id": "chunk_00589",
    "text": "evidence that POPs affect women\u2019s sexual behavior. 12. What should be done if a POP user has an ovarian cyst? The great majority of cysts are not true cysts but actually fluid-filled structures in the ovary (follicles) that continue to grow beyond the usual",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 589
  },
  {
    "id": "chunk_00590",
    "text": "(follicles) that continue to grow beyond the usual size in a normal menstrual cycle. They may cause some mild abdominal pain, but they require treatment only if they grow abnormally large, twist, or burst. These follicles usually go away without treatment (see \u201cSevere pain in lower abdomen\u201d, p. 44).",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 590
  },
  {
    "id": "chunk_00591",
    "text": "tment (see \u201cSevere pain in lower abdomen\u201d, p. 44). 13. Do POPs increase the risk of ectopic pregnancy? No. On the contrary, POPs reduce the risk of ectopic pregnancy. Ectopic pregnancies are rare among POP users. The rate of ectopic pregnancy",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 591
  },
  {
    "id": "chunk_00592",
    "text": "are among POP users. The rate of ectopic pregnancy among women using POPs is 48 per 10,000 women per year. The rate of ectopic pregnancy among women in the United States using no contraceptive method is 65 per 10,000 women per year. On the uncommon occasions that POPs fail and pregnancy occurs,",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 592
  },
  {
    "id": "chunk_00593",
    "text": "mon occasions that POPs fail and pregnancy occurs, 5 to 10 of every 100 of these pregnancies are ectopic. Thus, the great majority of pregnancies after POPs fail are not ectopic. Still, ectopic pregnancy can be life-threatening, and so a provider should be aware",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 593
  },
  {
    "id": "chunk_00594",
    "text": "ife-threatening, and so a provider should be aware that ectopic pregnancy is possible if POPs fail. 48 Family Planning: A Global Handbook for Providers",
    "page_number": 70,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 594
  },
  {
    "id": "chunk_00595",
    "text": "3 49 slliP evitpecartnoC ycnegremE CHAPTER 3 Emergency Contraceptive Pills Key Points for Providers and Clients \u2022 Emergency contraceptive pills (ECPs) help a woman avoid pregnancy after she has sex without contraception. \u2022 ECPs help to prevent pregnancy when taken up to 5 days",
    "page_number": 71,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 595
  },
  {
    "id": "chunk_00596",
    "text": "help to prevent pregnancy when taken up to 5 days after unprotected sex. The sooner they are taken, the better. \u2022 Do not disrupt an existing pregnancy. \u2022 Safe for all women\u2014even women who cannot use ongoing hormonal contraceptive methods. \u2022 Provide an opportunity for women to start using an",
    "page_number": 71,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 596
  },
  {
    "id": "chunk_00597",
    "text": "Provide an opportunity for women to start using an ongoing family planning method. \u2022 Several options can be used as emergency contraceptive pills. Dedicated products, progestin-only pills, and combined oral contraceptives all can act as emergency contraceptives. What Are Emergency",
    "page_number": 71,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 597
  },
  {
    "id": "chunk_00598",
    "text": "ct as emergency contraceptives. What Are Emergency Contraceptive Pills? \u2022 ECPs are sometimes called \u201cmorning after\u201d pills or postcoital contraceptives. \u2022 Work by preventing or delaying the release of eggs from the ovaries (ovulation). They do not work if a woman is already pregnant.",
    "page_number": 71,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 598
  },
  {
    "id": "chunk_00599",
    "text": ". They do not work if a woman is already pregnant. (The copper-bearing IUD also can be used for emergency contraception. See Chapter 10 \u2013 Copper-Bearing IUD, p. 176.)",
    "page_number": 71,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 599
  },
  {
    "id": "chunk_00600",
    "text": "What Pills Can Be Used as Emergency Contraceptive Pills? \u2022 A special ECP product with levonorgestrel only, or ulipristal acetate (UPA) \u2022 Progestin-only pills with levonorgestrel or norgestrel \u2022 Combined oral contraceptives with estrogen and a progestin\u2014",
    "page_number": 72,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 600
  },
  {
    "id": "chunk_00601",
    "text": "oral contraceptives with estrogen and a progestin\u2014 levonorgestrel, norgestrel, or norethindrone (also called norethisterone) When to Take Them? \u2022 As soon as possible after unprotected sex. The sooner ECPs are taken after unprotected sex, the better they prevent pregnancy.",
    "page_number": 72,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 601
  },
  {
    "id": "chunk_00602",
    "text": "nprotected sex, the better they prevent pregnancy. \u2022 Can help to prevent pregnancy when taken any time up to 5 days after unprotected sex. How Effective? \u2022 If 100 women each had sex once during the second or third week of the menstrual cycle without using contraception, 8 women would likely",
    "page_number": 72,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 602
  },
  {
    "id": "chunk_00603",
    "text": "without using contraception, 8 women would likely become pregnant. \u2022 If all 100 women used ulipristal acetate ECPs, fewer than 1 woman would likely become pregnant. \u2022 If all 100 women used progestin-only ECPs, 1 woman would likely become pregnant.",
    "page_number": 72,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 603
  },
  {
    "id": "chunk_00604",
    "text": "n-only ECPs, 1 woman would likely become pregnant. \u2022 If all 100 women used combined estrogen and progestin ECPs, 2 women would likely become pregnant. Effectiveness of Emergency Contraceptive Pills (ECPs) 8 pregnancies No ECPs <1 pregnancy Ulipristal acetate Progestin- 1 pregnancy",
    "page_number": 72,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 604
  },
  {
    "id": "chunk_00605",
    "text": "regnancy Ulipristal acetate Progestin- 1 pregnancy If 100 women each had only unprotected sex once ECPs during the second or third Combined 2 pregnancies week of the menstrual estrogen- cycle... progestin ECPs 50 Family Planning: A Global Handbook for Providers",
    "page_number": 72,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 605
  },
  {
    "id": "chunk_00606",
    "text": "3 51 slliP evitpecartnoC ycnegremE Return of fertility after taking ECPs: No delay. A woman can become pregnant immediately after taking ECPs. Taking ECPs prevents pregnancy only from acts of sex that took place in the 5 days before. They will",
    "page_number": 73,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 606
  },
  {
    "id": "chunk_00607",
    "text": "ex that took place in the 5 days before. They will not protect a woman from pregnancy from acts of sex more than 24 hours after she takes ECPs. To stay protected from pregnancy, women must begin to use another contraceptive method (see Planning Ongoing Contraception, p. 61).",
    "page_number": 73,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 607
  },
  {
    "id": "chunk_00608",
    "text": "ethod (see Planning Ongoing Contraception, p. 61). Protection against sexually transmitted infections (STIs): None Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 61) Some users report the following: \u2022 Changes in bleeding patterns, including:",
    "page_number": 73,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 608
  },
  {
    "id": "chunk_00609",
    "text": "lowing: \u2022 Changes in bleeding patterns, including: \u2013 Slight irregular bleeding for 1\u20132 days after taking ECPs \u2013 Monthly bleeding that starts earlier or later than expected In the first several days after taking ECPs: \u2022 Nausea\u2021 \u2022 Abdominal pain \u2022 Fatigue \u2022 Headaches \u2022 Breast tenderness \u2022 Dizziness",
    "page_number": 73,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 609
  },
  {
    "id": "chunk_00610",
    "text": "atigue \u2022 Headaches \u2022 Breast tenderness \u2022 Dizziness \u2022 Vomiting\u2021 Known Health Benefits Known Health Risks Help protect against: None \u2022 Risks of pregnancy \u2021 Women using progestin-only or ulipristal acetate ECP formulations are much less likely to",
    "page_number": 73,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 610
  },
  {
    "id": "chunk_00611",
    "text": "l acetate ECP formulations are much less likely to experience nausea and vomiting than women using estrogen and progestin ECP formulations. Side Effects, Health Benefits and Health Risks",
    "page_number": 73,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 611
  },
  {
    "id": "chunk_00612",
    "text": "Correcting Misunderstandings (see also Questions and Answers, p. 62) Emergency contraceptive pills: \u2022 Can be used by women of any age, including adolescents \u2022 Do not cause abortion \u2022 Do not prevent or affect implantation \u2022 Do not cause birth defects if pregnancy occurs",
    "page_number": 74,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 612
  },
  {
    "id": "chunk_00613",
    "text": "n \u2022 Do not cause birth defects if pregnancy occurs \u2022 Are not dangerous to a woman\u2019s health \u2022 Do not increase risky sexual behavior \u2022 Do not make women infertile \u2022 Can be used more than once in a woman\u2019s cycle Avoid Unnecessary Procedures",
    "page_number": 74,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 613
  },
  {
    "id": "chunk_00614",
    "text": "ce in a woman\u2019s cycle Avoid Unnecessary Procedures \u2022 A woman can take ECPs when needed without first seeing a health care provider. \u2022 No procedures or tests are needed before takings ECPs. The exception is that a woman who missed her last menses should have a pregnancy test before taking UPA-ECPs.",
    "page_number": 74,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 614
  },
  {
    "id": "chunk_00615",
    "text": "ould have a pregnancy test before taking UPA-ECPs. Why Some Women Say They Like Emergency Contraceptive Pills \u2022 Can be used as needed \u2022 Offer a second chance at preventing unwanted pregnancy \u2022 Enable a woman to avoid pregnancy if sex was forced or she was prevented from using contraception",
    "page_number": 74,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 615
  },
  {
    "id": "chunk_00616",
    "text": "rced or she was prevented from using contraception \u2022 Are controlled by the woman \u2022 Reduce the need for abortion in the case of contraceptive errors or if contraception is not used \u2022 Can have on hand in case the need arises 52 Family Planning: A Global Handbook for Providers",
    "page_number": 74,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 616
  },
  {
    "id": "chunk_00617",
    "text": "3 53 slliP evitpecartnoC ycnegremE Who Can Use Emergency Contraceptive Pills Safe and Suitable for All Women Tests and examinations are not necessary for using ECPs. Medical Eligibility Criteria for Emergency Contraceptive Pills All women can use ECPs safely and effectively, including",
    "page_number": 75,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 617
  },
  {
    "id": "chunk_00618",
    "text": "men can use ECPs safely and effectively, including women who cannot use ongoing hormonal contraceptive methods. Because of the short-term nature of their use, there are no medical conditions that make ECPs unsafe for any woman. Providing Emergency Contraceptive Pills",
    "page_number": 75,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 618
  },
  {
    "id": "chunk_00619",
    "text": "any woman. Providing Emergency Contraceptive Pills ECPs may be needed in many different situations. Many women do not know about them, however. Women who use contraceptive methods that depend on the user, such as pills and condoms, particularly benefit from learning about ECPs.",
    "page_number": 75,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 619
  },
  {
    "id": "chunk_00620",
    "text": "ms, particularly benefit from learning about ECPs. If possible, give all women who may need ECPs a supply in advance. If giving an advance supply is not possible, an advance prescription may be given in some settings or a woman can be told where to obtain them locally.",
    "page_number": 75,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 620
  },
  {
    "id": "chunk_00621",
    "text": "a woman can be told where to obtain them locally. An advance supply is helpful because a woman can keep them in case she needs them. Women are more likely to use ECPs if they already have them when needed. Also, having them on hand enables women to take them as",
    "page_number": 75,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 621
  },
  {
    "id": "chunk_00622",
    "text": "having them on hand enables women to take them as soon as possible after unprotected sex, when they will be most effective. Providing Emergency Contraceptive Pills",
    "page_number": 75,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 622
  },
  {
    "id": "chunk_00623",
    "text": "When to Use \u2022 Any time within 5 days after unprotected sex. The sooner after unprotected sex that ECPs are taken, the more effective they are. ECPs Appropriate in Many Situations ECPs can be used any time a woman is worried that she might become pregnant. For example, after: \u2022 Sexual assault",
    "page_number": 76,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 623
  },
  {
    "id": "chunk_00624",
    "text": "ome pregnant. For example, after: \u2022 Sexual assault \u2022 Any unprotected sex \u2022 Mistakes using contraception, such as: \u2013 Condom was used incorrectly, slipped, or broke \u2013 Couple incorrectly used a fertility awareness method (for example, failed to abstain or to use another method during the fertile days)",
    "page_number": 76,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 624
  },
  {
    "id": "chunk_00625",
    "text": "or to use another method during the fertile days) \u2013 Man failed to withdraw, as intended, before he ejaculated \u2013 Woman has had unprotected sex after she has missed 3 or more combined oral contraceptive pills or has started a new pack 3 or more days late \u2013 IUD has come out of place",
    "page_number": 76,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 625
  },
  {
    "id": "chunk_00626",
    "text": "ck 3 or more days late \u2013 IUD has come out of place \u2013 Woman has had unprotected sex when she is more than 4 weeks late for her repeat injection of DMPA, more than 2 weeks late for her repeat injection of NET-EN, or more than 7 days late for her repeat monthly injection",
    "page_number": 76,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 626
  },
  {
    "id": "chunk_00627",
    "text": "3 55 slliP evitpecartnoC ycnegremE Pill Formulations and Dosing for Emergency Contraception Pills to Take At 12 Hours Pill Type and Hormone Formulation First Later Dedicated ECP Products Progestin-only 1.5 mg LNG 1 0 0.75 mg LNG 2 0 Ulipristal acetate 30 mg ulipristal acetate 1 0",
    "page_number": 77,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 627
  },
  {
    "id": "chunk_00628",
    "text": "0 Ulipristal acetate 30 mg ulipristal acetate 1 0 Oral Contraceptive Pills Used for Emergency Contraception Combined 0.02 mg EE + 5 5 (estrogen-progestin) 0.1 mg LNG oral contraceptives 0.03 mg EE + 4 4 0.15 mg LNG 0.03 mg EE + 4 4 0.15 mg LNG 0.03 mg EE + 4 4 0.125 mg LNG 0.05 mg EE + 2 2",
    "page_number": 77,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 628
  },
  {
    "id": "chunk_00629",
    "text": "LNG 0.03 mg EE + 4 4 0.125 mg LNG 0.05 mg EE + 2 2 0.25 mg LNG 0.03 mg EE + 4 4 0.3 mg norgestrel 0.05 mg EE + 2 2 0.5 mg norgestrel Progestin-only pills 0.03 mg LNG 50* 0 0.0375 mg LNG 40* 0 0.075 mg norgestrel 40* 0 * Many pills, but safe. See Question 8, p. 63. LNG = levonorgestrel",
    "page_number": 77,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 629
  },
  {
    "id": "chunk_00630",
    "text": "safe. See Question 8, p. 63. LNG = levonorgestrel EE = ethinyl estradiol For information on brands of ECPs and oral contraceptive pills, see the International Consortium for Emergency Contraception (http://www.cecinfo.org). Providing Emergency Contraceptive Pills",
    "page_number": 77,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 630
  },
  {
    "id": "chunk_00631",
    "text": "Giving Emergency Contraceptive Pills 1. Give pill \u2022 She can take the pill or pills immediately. (or pills) \u2022 If she is using a 2-dose regimen, tell her to take the next dose in 12 hours. 2. Describe the \u2022 Nausea, abdominal pain, possibly others. most common",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 631
  },
  {
    "id": "chunk_00632",
    "text": "usea, abdominal pain, possibly others. most common \u2022 Slight bleeding or change in timing of monthly side effects bleeding. \u2022 Side effects are not signs of illness and they do not last long. Most women have no side effects. 3. Explain what \u2022 Nausea: to do about",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 632
  },
  {
    "id": "chunk_00633",
    "text": "ide effects. 3. Explain what \u2022 Nausea: to do about \u2013 Routine use of anti-nausea medications is side effects not recommended. \u2013 Women who have had nausea with previous ECP use or with the first dose of a 2-dose regimen can take anti-nausea medication such as 25\u201350 mg meclizine hydrochloride (such as",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 633
  },
  {
    "id": "chunk_00634",
    "text": "such as 25\u201350 mg meclizine hydrochloride (such as Agyrax, Antivert, Bonine, Postafene) one-half to one hour before taking ECPs. \u2022 Vomiting: \u2013 If the woman vomits within 2 hours after taking progestin-only or combined ECPs, she should take another dose. If she vomits within",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 634
  },
  {
    "id": "chunk_00635",
    "text": "she should take another dose. If she vomits within 3 hours of taking ulipristal acetate ECPs, she should take another dose. (She can use anti- nausea medication with this repeat dose, as above.) If vomiting continues, she can take a repeat dose of progestin-only or combined",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 635
  },
  {
    "id": "chunk_00636",
    "text": "n take a repeat dose of progestin-only or combined ECPs by placing the pills high in her vagina. If vomiting occurs more than 2 hours after taking progestin-only or combined ECPs, or 3 hours after taking UPA-ECPs, then she does not need to take any extra pills.",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 636
  },
  {
    "id": "chunk_00637",
    "text": "s, then she does not need to take any extra pills. 4. Give more ECPs \u2022 If possible, give her more ECPs to take home in and help her case she needs them in the future. start an ongoing \u2022 See Planning Ongoing Contraception, p. 61. method 5. Follow-up \u2022 Encourage her to return for an early pregnancy",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 637
  },
  {
    "id": "chunk_00638",
    "text": "p \u2022 Encourage her to return for an early pregnancy test if her monthly bleeding is more than 7 days late. 56 Family Planning: A Global Handbook for Providers",
    "page_number": 78,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 638
  },
  {
    "id": "chunk_00639",
    "text": "3 57 slliP evitpecartnoC ycnegremE Supporting Users \u201cCome Back Any Time\u201d: Reasons to Return No routine return visit is required. Assure every client that she is welcome to come back any time, however, and also if: \u2022 She thinks she might be pregnant, especially if she has no monthly bleeding",
    "page_number": 79,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 639
  },
  {
    "id": "chunk_00640",
    "text": "regnant, especially if she has no monthly bleeding or her next monthly bleeding is delayed by more than 7 days. \u2022 She did not start a continuing method immediately and now wants one. How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn",
    "page_number": 79,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 640
  },
  {
    "id": "chunk_00641",
    "text": "is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: \u2022 Support a woman\u2019s decision to use ECPs \u2022 Understand and support her need to choose and use a continuing method",
    "page_number": 79,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 641
  },
  {
    "id": "chunk_00642",
    "text": "ort her need to choose and use a continuing method \u2022 Help to make sure she has ECPs on hand in case she needs them again \u2022 If she needed ECPs because of a mistake with a method, understand and support correct use of the method or discuss using a different method Supporting Users",
    "page_number": 79,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 642
  },
  {
    "id": "chunk_00643",
    "text": "When to Start or Restart Contraception After ECP Use Method When to start or restart Hormonal methods After taking progestin-only or combined (combined oral ECPs: contraceptives, \u2022 Can start or restart any method immediately progestin-only pills, after she takes the ECPs. No need to wait for her",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 643
  },
  {
    "id": "chunk_00644",
    "text": "after she takes the ECPs. No need to wait for her progestin-only next monthly bleeding. injectables, monthly injectables, implants, \u2013 The continuing user of oral contraceptive pills combined patch, who needed ECPs due to error can resume",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 644
  },
  {
    "id": "chunk_00645",
    "text": "ned patch, who needed ECPs due to error can resume combined vaginal ring) use as before. She does not need to start a new pack. \u2013 Patch users should begin a new patch. \u2013 Ring users should follow the instructions for late replacement or removal on page 126.",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 645
  },
  {
    "id": "chunk_00646",
    "text": "tions for late replacement or removal on page 126. \u2022 All women need to abstain from sex or use a backup method* for the first 7 days of using their method. \u2022 If she does not start immediately, but instead returns for a method, she can start any method",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 646
  },
  {
    "id": "chunk_00647",
    "text": "ead returns for a method, she can start any method at any time if it is reasonably certain she is not pregnant. After taking ulipristal acetate (UPA) ECPs: \u2022 She can start or restart any method containing progestin on the 6th day after taking UPA-ECPs. No need to wait for her next monthly bleeding.",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 647
  },
  {
    "id": "chunk_00648",
    "text": "Ps. No need to wait for her next monthly bleeding. (If she starts a method containing progestin earlier, both the progestin and the UPA could be less effective.) \u2013 If she wants to use oral contraceptive pills, vaginal ring, or patch, give her a supply and tell her to start on the 6th day after taking",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 648
  },
  {
    "id": "chunk_00649",
    "text": "and tell her to start on the 6th day after taking UPA-ECPs. If she wants to use injectables or implants, give her an appointment to return for the method on the 6th day after taking UPA-ECPs or as soon as possible after that.",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 649
  },
  {
    "id": "chunk_00650",
    "text": "taking UPA-ECPs or as soon as possible after that. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 80,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 650
  },
  {
    "id": "chunk_00651",
    "text": "3 59 slliP evitpecartnoC ycnegremE Method When to start or restart \u2013 All women need to use a backup method from the time they take UPA-ECPs until they have been using a hormonal method for 7 days (or 2 days for progestin-only pills). \u2022 If she does not start on the 6th day, but instead",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 651
  },
  {
    "id": "chunk_00652",
    "text": "If she does not start on the 6th day, but instead returns later for a method, she may start any method at any time if it is reasonably certain she is not pregnant. Levonorgestrel After taking progestin-only or combined intrauterine device ECPs: \u2022 She can have the LNG-IUD inserted at any time",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 652
  },
  {
    "id": "chunk_00653",
    "text": "s: \u2022 She can have the LNG-IUD inserted at any time it can be determined that she is not pregnant (see Ruling Out Pregnancy, p. 461). \u2022 She should use a backup method* for the first 7 days after LNG-IUD insertion. After taking UPA-ECPs: \u2022 She can have the LNG-IUD inserted on the",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 653
  },
  {
    "id": "chunk_00654",
    "text": "A-ECPs: \u2022 She can have the LNG-IUD inserted on the 6th day after taking UPA-ECPs if it can be determined that she is not pregnant. \u2013 If she wants to use the LNG-IUD, give her an appointment to return to have it inserted on the 6th day after taking UPA-ECPs or as soon as possible after that.",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 654
  },
  {
    "id": "chunk_00655",
    "text": "taking UPA-ECPs or as soon as possible after that. \u2022 She will need to use a backup method from the time she takes UPA-ECPs until 7 days after the LNG-IUD is inserted. \u2022 If she does not have the LNG-IUD inserted on the 6th day, but instead returns later, she",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 655
  },
  {
    "id": "chunk_00656",
    "text": "ted on the 6th day, but instead returns later, she can have it inserted at any time if it can be determined she is not pregnant. Copper-bearing After taking progestin-only, combined, intrauterine device or UPA-ECPs: \u2022 If she decides to use a copper-bearing IUD after",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 656
  },
  {
    "id": "chunk_00657",
    "text": "\u2022 If she decides to use a copper-bearing IUD after taking ECPs, she can have it inserted on the same day she takes the ECPs. No need for a backup method. (Continued on next page) Supporting Users",
    "page_number": 81,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 657
  },
  {
    "id": "chunk_00658",
    "text": "Method When to start or restart (continued) Copper-bearing \u2022 If she does not have it inserted immediately, but intrauterine device instead returns for the method, she can have the (continued) copper-bearing IUD inserted any time if it can be determined that she is not pregnant.",
    "page_number": 82,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 658
  },
  {
    "id": "chunk_00659",
    "text": "if it can be determined that she is not pregnant. Note: The copper-bearing IUD can be used for emergency contraception. A woman who wants to use the IUD for regular contraception can have it inserted for emergency contraception within the first 5 days after unprotected sex and",
    "page_number": 82,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 659
  },
  {
    "id": "chunk_00660",
    "text": "within the first 5 days after unprotected sex and then continue using it (see Chapter 10 \u2013 Copper- Bearing IUD). Female sterilization After taking progestin-only, combined, or UPA-ECPs: \u2022 The sterilization procedure can be done within 7 days after the start of her next monthly",
    "page_number": 82,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 660
  },
  {
    "id": "chunk_00661",
    "text": "within 7 days after the start of her next monthly bleeding or any other time if it is reasonably certain she is not pregnant. Give her a backup method to use until she can have the procedure. Male and female After taking progestin-only, combined, condoms, or UPA-ECPs: spermicides, \u2022 Immediately.",
    "page_number": 82,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 661
  },
  {
    "id": "chunk_00662",
    "text": "condoms, or UPA-ECPs: spermicides, \u2022 Immediately. diaphragms, cervical caps, withdrawal Fertility After taking progestin-only, combined, awareness or UPA-ECPs: methods \u2022 Standard Days Method: With the start of her next monthly bleeding. \u2022 Symptoms-based methods: Once normal secretions have returned.",
    "page_number": 82,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 662
  },
  {
    "id": "chunk_00663",
    "text": "sed methods: Once normal secretions have returned. \u2022 Give her a backup method to use until she can begin the method of her choice. 60 Family Planning: A Global Handbook for Providers",
    "page_number": 82,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 663
  },
  {
    "id": "chunk_00664",
    "text": "3 61 slliP evitpecartnoC ycnegremE Planning Ongoing Contraception 1. Explain that ECPs will not protect her from pregnancy from acts of sex more than 24 hours after she takes them. Discuss the need for and choice of ongoing pregnancy prevention and, if at risk, protection from",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 664
  },
  {
    "id": "chunk_00665",
    "text": "gnancy prevention and, if at risk, protection from STIs including HIV (see Sexually Transmitted Infections, Including HIV, p. 339). 2. If she does not want to start a contraceptive method now, give her condoms or a cycle of oral contraceptives and ask her to use them if she",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 665
  },
  {
    "id": "chunk_00666",
    "text": "oral contraceptives and ask her to use them if she changes her mind. Give instructions on use. Invite her to come back any time if she wants another method or has any questions or problems. 3. If possible, give her more ECPs to use in the future in case of unprotected",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 666
  },
  {
    "id": "chunk_00667",
    "text": "e ECPs to use in the future in case of unprotected sex. She may need them if she has unprotected sex again as soon as 24 hours after taking the previous ECPs. Managing Any Problems Problems Reported as Side Effects May or may not be due to the method. Slight irregular bleeding",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 667
  },
  {
    "id": "chunk_00668",
    "text": "ot be due to the method. Slight irregular bleeding \u2022 Irregular bleeding due to ECPs will stop without treatment. \u2022 Assure the woman that this is not a sign of illness or pregnancy. Change in timing of next monthly bleeding or suspected pregnancy",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 668
  },
  {
    "id": "chunk_00669",
    "text": "ng of next monthly bleeding or suspected pregnancy \u2022 Monthly bleeding may start a few days earlier or later than expected. This is not a sign of illness or pregnancy. \u2022 If her next monthly bleeding is more than 7 days later than expected after",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 669
  },
  {
    "id": "chunk_00670",
    "text": "ding is more than 7 days later than expected after she takes ECPs, assess for pregnancy. There are no known risks to a fetus conceived if ECPs fail to prevent pregnancy (see Question 3, next page). Supporting Users",
    "page_number": 83,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 670
  },
  {
    "id": "chunk_00671",
    "text": "Questions and Answers About Emergency Contraceptive Pills 1. How do ECPs work? ECPs prevent the release of an egg from the ovary or delay its release by 5 to 7 days. By then, any sperm in the woman\u2019s reproductive tract will have died, since sperm can survive there for only about 5 days. If",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 671
  },
  {
    "id": "chunk_00672",
    "text": "sperm can survive there for only about 5 days. If ovulation has occurred and the egg was fertilized, ECPs do not prevent implantation or disrupt an already established pregnancy. 2. Do ECPs disrupt an existing pregnancy? No. ECPs do not work if a woman is already pregnant.",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 672
  },
  {
    "id": "chunk_00673",
    "text": ". ECPs do not work if a woman is already pregnant. 3. Will ECPs harm the fetus if a woman accidentally takes them while she is pregnant? No. Evidence does not show that ECPs will cause birth defects or otherwise harm the fetus if a woman is already pregnant when she takes",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 673
  },
  {
    "id": "chunk_00674",
    "text": "etus if a woman is already pregnant when she takes ECPs or if ECPs fail to prevent pregnancy. 4. How long do ECPs protect a woman from pregnancy? Women who take ECPs should understand that they could become pregnant the next time they have sex unless they begin to use another",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 674
  },
  {
    "id": "chunk_00675",
    "text": "ime they have sex unless they begin to use another method of contraception at once. Because ECPs delay ovulation in some women, she may be most fertile soon after taking ECPs. If she wants ongoing protection from pregnancy, she must start using another",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 675
  },
  {
    "id": "chunk_00676",
    "text": "ction from pregnancy, she must start using another contraceptive method by the next day, including a backup method if starting her continuing method requires it. In particular, a woman who has taken UPA-ECPs should wait until the 6th day to start a hormonal",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 676
  },
  {
    "id": "chunk_00677",
    "text": "should wait until the 6th day to start a hormonal contraceptive. She should use a backup method during this period. 5. Can ECPs be used more than once? Yes. If needed, ECPs can be taken again, even in the same cycle. A woman who needs ECPs often may want to consider a longer-acting and more",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 677
  },
  {
    "id": "chunk_00678",
    "text": "ften may want to consider a longer-acting and more effective family planning method. 6. Should women use ECPs as a continuing method of contraception? A woman can use ECPs whenever she needs them, even more than once in the same cycle. However, relying on ECPs as an ongoing",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 678
  },
  {
    "id": "chunk_00679",
    "text": "same cycle. However, relying on ECPs as an ongoing method should not be advised. It is not certain that ECPs, taken every time after sex, would be as effective as regular, continuing methods of contraception. Also, women who often take ECPs may have more side",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 679
  },
  {
    "id": "chunk_00680",
    "text": "Also, women who often take ECPs may have more side effects. Repeated use of ECPs poses no known health risks. It may be helpful, however, to screen women who take ECPs often for health conditions that can limit use of hormonal contraceptives. 62 Family Planning: A Global Handbook for Providers",
    "page_number": 84,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 680
  },
  {
    "id": "chunk_00681",
    "text": "3 63 slliP evitpecartnoC ycnegremE 7. What oral contraceptive pills can be used as ECPs? Many combined (estrogen-progestin) oral contraceptives and progestin- only pills can be used as ECPs. Any pills containing the hormones used for emergency contraception\u2014levonorgestrel, norgestrel, norethindrone,",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 681
  },
  {
    "id": "chunk_00682",
    "text": "ception\u2014levonorgestrel, norgestrel, norethindrone, and any of these progestins together with estrogen (ethinyl estradiol)\u2014 can be used. 8. Is it safe to take 40 or 50 progestin-only pills as ECPs? Yes. Progestin-only pills contain very small amounts of hormone. Thus,",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 682
  },
  {
    "id": "chunk_00683",
    "text": "pills contain very small amounts of hormone. Thus, it is necessary to take many pills in order to receive the total ECP dose needed. In contrast, the ECP dosage with combined (estrogen-progestin) oral contraceptives is generally only 2 to 5 pills in each of 2 doses 12",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 683
  },
  {
    "id": "chunk_00684",
    "text": "generally only 2 to 5 pills in each of 2 doses 12 hours apart. Women should not take 40 or 50 combined (estrogen- progestin) oral contraceptive pills as ECPs. For women who have been continuing users of POPs, this may be the method of emergency contraception most convenient for her, or the",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 684
  },
  {
    "id": "chunk_00685",
    "text": "ency contraception most convenient for her, or the only method available in time. 9. What is ulipristal acetate (UPA)? UPA is an anti-progestin\u2014that is, it modifies the activity of the natural hormone progesterone in a woman\u2019s monthly cycle. Thus, like other",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 685
  },
  {
    "id": "chunk_00686",
    "text": "erone in a woman\u2019s monthly cycle. Thus, like other ECPs, UPA-ECPs probably work by blocking or delaying release of an egg from the ovary (ovulation). All ECPs should be taken as soon as possible for greatest effectiveness. UPA-ECPs may be more effective",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 686
  },
  {
    "id": "chunk_00687",
    "text": "test effectiveness. UPA-ECPs may be more effective than other ECPs between 72 hours and 120 hours after unprotected sex. UPA-ECPs have been available in Europe since 2009 and received approval from the United States Food and Drug Administration in 2010",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 687
  },
  {
    "id": "chunk_00688",
    "text": "United States Food and Drug Administration in 2010 for use as an emergency contraceptive. They are now available in more than 50 countries. UPA-ECPs are not intended for use as a continuing oral contraceptive. 10. Are ECPs safe for women living with HIV? Can women on",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 688
  },
  {
    "id": "chunk_00689",
    "text": "ECPs safe for women living with HIV? Can women on antiretroviral therapy safely use ECPs? Yes. Women living with HIV and those on antiretroviral therapy can safely use ECPs. 11. Are ECPs appropriate for adolescents? Yes. A study of ECP use among girls 13 to 16 years old found it safe.",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 689
  },
  {
    "id": "chunk_00690",
    "text": "use among girls 13 to 16 years old found it safe. Furthermore, all of the study participants were able to use ECPs correctly. Also, access to ECPs does not influence sexual behavior. Adolescents might particularly need ECPs because of high rates of forced",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 690
  },
  {
    "id": "chunk_00691",
    "text": "icularly need ECPs because of high rates of forced sex, stigma about obtaining contraceptives, limited ability to plan for sex, and errors in using contraceptives. Questions and Answers About Emergency Contraceptive Pills",
    "page_number": 85,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 691
  },
  {
    "id": "chunk_00692",
    "text": "12. Can a woman who cannot use combined (estrogen-progestin) oral contraceptives or progestin-only pills as an ongoing method still safely use ECPs? Yes. This is because ECP treatment is very brief and the dose is small. 13. If ECPs failed to prevent pregnancy, does a woman have",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 692
  },
  {
    "id": "chunk_00693",
    "text": "CPs failed to prevent pregnancy, does a woman have a greater chance of that pregnancy being an ectopic pregnancy? No evidence suggests that ECPs increase the risk of ectopic pregnancy. Worldwide studies of progestin-only ECPs, including a US Food and Drug",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 693
  },
  {
    "id": "chunk_00694",
    "text": "progestin-only ECPs, including a US Food and Drug Administration review, have not found higher rates of ectopic pregnancy after ECPs failed than are found among pregnancies generally. 14. Why give women ECPs before they need them? Won\u2019t that discourage or otherwise affect contraceptive use?",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 694
  },
  {
    "id": "chunk_00695",
    "text": "discourage or otherwise affect contraceptive use? No. Studies of women given ECPs in advance report these findings: \u2022 Women who had ECPs on hand took them sooner after having unprotected sex than women who had to seek out ECPs. Progestin-only ECPs are more likely to be effective when taken sooner.",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 695
  },
  {
    "id": "chunk_00696",
    "text": "are more likely to be effective when taken sooner. \u2022 Women given ECPs ahead of time were more likely to use them when needed than women who had to go to a provider to get ECPs. \u2022 Women continued to use other contraceptive methods as they did before obtaining ECPs in advance.",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 696
  },
  {
    "id": "chunk_00697",
    "text": "hods as they did before obtaining ECPs in advance. \u2022 Women did not have unprotected sex more often. If ECPs require a prescription and cannot be given in advance, give a prescription that can be use as needed. 15. If a woman buys ECPs over the counter, can she use them correctly?",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 697
  },
  {
    "id": "chunk_00698",
    "text": "ECPs over the counter, can she use them correctly? Yes. Taking ECPs is simple, and medical supervision is not needed. Studies show that both young and adult women find the label and instructions easy to understand. In some countries ECPs are approved for over-the-",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 698
  },
  {
    "id": "chunk_00699",
    "text": "In some countries ECPs are approved for over-the- counter sales or nonprescription use. These countries include Canada, China, India, the United States, and many others around the world. 64 Family Planning: A Global Handbook for Providers",
    "page_number": 86,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 699
  },
  {
    "id": "chunk_00700",
    "text": "4 65 selbatcejnI ylnO-nitsegorP CHAPTER 4 Progestin-Only Injectables Key Points for Providers and Clients \u2022 Bleeding changes are common but not harmful. Typically there will be irregular bleeding for the first several months and then no monthly bleeding.",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 700
  },
  {
    "id": "chunk_00701",
    "text": "first several months and then no monthly bleeding. \u2022 Return for injections regularly. Coming back every 3 months (13 weeks) for DMPA or every 2 months (8 weeks) for NET-EN is important for greatest effectiveness. Subcutaneous DPMA can be self-injected.",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 701
  },
  {
    "id": "chunk_00702",
    "text": "ctiveness. Subcutaneous DPMA can be self-injected. \u2022 The next injection can be as much as 4 weeks late for DMPA or 2 weeks late for NET-EN. Even if it is later than this, the client may still be able to have the injection. \u2022 Gradual weight gain is common, averaging 1\u20132 kg per year.",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 702
  },
  {
    "id": "chunk_00703",
    "text": "weight gain is common, averaging 1\u20132 kg per year. \u2022 Return of fertility is often delayed. It takes several months longer on average to become pregnant after stopping progestin-only injectables than after stopping other methods. What Are Progestin-Only Injectables?",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 703
  },
  {
    "id": "chunk_00704",
    "text": "ther methods. What Are Progestin-Only Injectables? y The injectable contraceptives depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN) each contain a progestin like the natural hormone progesterone in a woman\u2019s body. (In contrast,",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 704
  },
  {
    "id": "chunk_00705",
    "text": "mone progesterone in a woman\u2019s body. (In contrast, combined injectable contraceptives contain both estrogen and progestin and must be given monthly, see Chapter 5 \u2013 Monthly Injectables). y They do not contain estrogen, and so can be used throughout",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 705
  },
  {
    "id": "chunk_00706",
    "text": "ot contain estrogen, and so can be used throughout breastfeeding, starting 6 weeks after giving birth, and by women who cannot use methods containing estrogen. y After injection, the hormone is released slowly into the bloodstream.",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 706
  },
  {
    "id": "chunk_00707",
    "text": "e hormone is released slowly into the bloodstream. y They are usually injected into the muscle (intramuscular injection). A newer formulation of DMPA can be injected just under the skin (subcutaneous injection). (See the box on DMPA for Subcutaneous Injection on p. 69).",
    "page_number": 87,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 707
  },
  {
    "id": "chunk_00708",
    "text": "y DMPA, the most widely used progestin-only injectable, is also known in its intramuscular form as \u201cthe shot\u201d, \u201cthe jab\u201d, the injection, Depo, Depo-Provera, and Petogen. The subcutaneous version (DMPA-SC) comes in two forms: the Uniject injection system currently marketed",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 708
  },
  {
    "id": "chunk_00709",
    "text": "s: the Uniject injection system currently marketed under the name Sayana Press; and the prefilled single-dose disposable hypodermic syringes marketed as Depo-SubQ Provera 104. The Uniject system allows DMPA-SC to be easily self-injected by clients who wish to do so.",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 709
  },
  {
    "id": "chunk_00710",
    "text": "easily self-injected by clients who wish to do so. y NET-EN is also known as Noristerat, Norigest, and Syngestal. (See the job aid entitled Comparing Injectables for differences between DMPA and NET-EN.) y Progestin-only injectables work primarily by preventing the release of eggs",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 710
  },
  {
    "id": "chunk_00711",
    "text": "s work primarily by preventing the release of eggs from the ovaries (ovulation). How Effective? Effectiveness depends on getting injections regularly: Risk of pregnancy is greatest when a woman misses an injection. y As commonly used, about 4 pregnancies would be expected per More",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 711
  },
  {
    "id": "chunk_00712",
    "text": "ed, about 4 pregnancies would be expected per More 100 women using progestin-only injectables over the first year. effective This means that 96 of every 100 women using injectables will not become pregnant. y When women have injections on time, less than 1 pregnancy",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 712
  },
  {
    "id": "chunk_00713",
    "text": "men have injections on time, less than 1 pregnancy would be expected per 100 women using progestin-only injectables over the first year (specifically, just 2 pregnancies would be expected per 1,000 women using this method). Return of fertility after injections are stopped: Fertility takes an",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 713
  },
  {
    "id": "chunk_00714",
    "text": "y after injections are stopped: Fertility takes an average of about 4 months longer to return for DMPA and 1 month longer for NET-EN compared with most other methods Less (see Question 8 at the end of this chapter). effective Protection against sexually transmitted infections (STIs): None.",
    "page_number": 88,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 714
  },
  {
    "id": "chunk_00715",
    "text": "4 67 selbatcejnI ylnO-nitsegorP Why Some Women Say They Like Progestin-Only Injectables \u2022 Requires action only every 2 or 3 months. No daily pill-taking. \u2022 Does not interfere with sex \u2022 Private: No one else can tell that a woman is using contraception \u2022 Stops monthly bleeding (for many women)",
    "page_number": 89,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 715
  },
  {
    "id": "chunk_00716",
    "text": "aception \u2022 Stops monthly bleeding (for many women) \u2022 May help women to gain weight Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 89) Most users report some changes in monthly bleeding.1 y With DMPA, these typically include: \u2013 First 3 months:",
    "page_number": 89,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 716
  },
  {
    "id": "chunk_00717",
    "text": "h DMPA, these typically include: \u2013 First 3 months: Bleeding changes are y Irregular bleeding normal and not harmful. y Prolonged bleeding If a woman finds them bothersome, counseling \u2013 At and after 1 year: and support can help. y No monthly bleeding y Infrequent bleeding y Irregular bleeding",
    "page_number": 89,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 717
  },
  {
    "id": "chunk_00718",
    "text": "leeding y Infrequent bleeding y Irregular bleeding y With NET-EN, bleeding patterns are less affected than with DMPA \u2013 First 6 months: y Fewer days of bleeding \u2013 After 1 year: y More likely to have monthly bleeding than DMPA users.",
    "page_number": 89,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 718
  },
  {
    "id": "chunk_00719",
    "text": "e likely to have monthly bleeding than DMPA users. 1 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. Side Effects, Health Benefits, and Health Risks",
    "page_number": 89,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 719
  },
  {
    "id": "chunk_00720",
    "text": "Some users report the following side effects: y Weight gain (see Question 5, p. 94) y Headaches y Dizziness y Abdominal bloating and discomfort y Mood changes Other possible physical changes: y Loss of bone density (largely reversible, see Question 11, p. 95) Health Benefits and Health Risks",
    "page_number": 90,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 720
  },
  {
    "id": "chunk_00721",
    "text": "estion 11, p. 95) Health Benefits and Health Risks Known Health Benefits Known Health Risks DMPA None Helps protect against: y Pregnancy and associated risks y Cancer of the lining of the uterus (endometrial cancer) y Uterine fibroids May help protect against: y Iron-deficiency anemia Reduces:",
    "page_number": 90,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 721
  },
  {
    "id": "chunk_00722",
    "text": "protect against: y Iron-deficiency anemia Reduces: y Sickle cell crises among women with sickle cell anemia y Symptoms of endometriosis (pelvic pain, irregular bleeding) NET-EN2 None Helps protect against: y Pregnancy and associated risks y Iron-deficiency anemia",
    "page_number": 90,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 722
  },
  {
    "id": "chunk_00723",
    "text": "ancy and associated risks y Iron-deficiency anemia 2 NET-EN may also offer many of the other health benefits that DMPA offers, but this list of benefits includes only those for which there is available research evidence. 68 Family Planning: A Global Handbook for Providers",
    "page_number": 90,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 723
  },
  {
    "id": "chunk_00724",
    "text": "4 69 selbatcejnI ylnO-nitsegorP DMPA for Subcutaneous Injection DMPA is now available in a special formulation, called DMPA-SC, intended only for subcutaneous (SC) injection (just under the skin) and not for injection into muscle. Subcutaneous injection is easier to learn than",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 724
  },
  {
    "id": "chunk_00725",
    "text": "le. Subcutaneous injection is easier to learn than intramuscular injection. DMPA-SC is available in 2 injection systems: in the Uniject device and in prefilled, single-dose, conventional syringes. Both have short needles meant for injection just below the skin.",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 725
  },
  {
    "id": "chunk_00726",
    "text": "t needles meant for injection just below the skin. With the Uniject system, the user squeezes a flexible reservoir that pushes the fluid through the needle. DMPA-SC in the Uniject system is marketed under the brand name Sayana Press. This product may be particularly useful",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 726
  },
  {
    "id": "chunk_00727",
    "text": "ana Press. This product may be particularly useful for community-based programs (see the box below, Delivering Injectable Contraception in the Community). Also, women can easily learn to self-inject DMPA-SC with this system (see the section in this chapter titled Self-Injection",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 727
  },
  {
    "id": "chunk_00728",
    "text": "the section in this chapter titled Self-Injection Can Be an Option, including the instructions for self-injection, pp. 83\u201386). Correcting Misunderstandings (see also Questions and Answers, at the end of this chapter) Progestin-only injectables:",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 728
  },
  {
    "id": "chunk_00729",
    "text": "e end of this chapter) Progestin-only injectables: y Can stop monthly bleeding, but this is not harmful and could help prevent anemia. It is similar to not having monthly bleeding during pregnancy; blood is not building up inside the woman. y Are highly effective regardless of the bleeding pattern.",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 729
  },
  {
    "id": "chunk_00730",
    "text": "ghly effective regardless of the bleeding pattern. y Do not disrupt an existing pregnancy. y Do not make women infertile. Delivering Injectable Contraception in the Community Injectable contraceptives are popular with many women. This method",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 730
  },
  {
    "id": "chunk_00731",
    "text": "aceptives are popular with many women. This method can be more widely available when it is offered in the community as well as in clinics. Lay health workers, auxiliary nurses, pharmacists, and other community- based providers of injectables should be trained and able to give",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 731
  },
  {
    "id": "chunk_00732",
    "text": "of injectables should be trained and able to give intramuscular injections safely. They should also be able to screen clients for pregnancy and for medical eligibility for different contraceptives. They can inform women about delayed return of fertility and common side",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 732
  },
  {
    "id": "chunk_00733",
    "text": "about delayed return of fertility and common side effects, including irregular bleeding, no monthly bleeding, and weight gain, and explain the importance of dual protection if a woman is at risk (Continued on next page) Side Effects, Health Benefits, and Health Risks",
    "page_number": 91,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 733
  },
  {
    "id": "chunk_00734",
    "text": "Delivering Injectable Contraception in the Community (continued) for STIs, including HIV. They also can inform women about the range of methods available, including methods only available at a clinic. All providers of injectables need specific competency-based training and",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 734
  },
  {
    "id": "chunk_00735",
    "text": "tables need specific competency-based training and supportive supervision to carry out these tasks. WHO recommends specific monitoring and evaluation of the provision of injectables by lay health workers (see Who Provides Family Planning?, p. 400 in Chapter 26).",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 735
  },
  {
    "id": "chunk_00736",
    "text": "Provides Family Planning?, p. 400 in Chapter 26). Prefilled syringes aid community-based programs Prefilled single-dose, single-use injection devices make community and home delivery easier and faster because providers do not have to",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 736
  },
  {
    "id": "chunk_00737",
    "text": "easier and faster because providers do not have to draw a measured dose into the syringe from a vial. Also, these devices cannot be reused, preventing the spread of infection. DMPA is available in a number of prefilled single-dose injection systems. DMPA for",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 737
  },
  {
    "id": "chunk_00738",
    "text": "prefilled single-dose injection systems. DMPA for intramuscular injection (DMPA-IM) is available in auto-disable syringes. The newer subcutaneous DMPA formulation (DMPA-SC), which is suitable only for injection just under the skin, comes in both the Uniject",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 738
  },
  {
    "id": "chunk_00739",
    "text": "ion just under the skin, comes in both the Uniject injection system (under the brand name Sayana Press) and the prefilled single-dose conventional disposable hypodermic syringes (marketed as Depo-SubQ Provera 104) (see the box on DMPA for Subcutaneous",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 739
  },
  {
    "id": "chunk_00740",
    "text": "Provera 104) (see the box on DMPA for Subcutaneous Injection, on the previous page). DMPA-SC, particularly in the Uniject system, is likely to make delivery of DMPA injection in the community and at home easier. In fact, women can learn to inject themselves with",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 740
  },
  {
    "id": "chunk_00741",
    "text": "In fact, women can learn to inject themselves with this formulation (see Teaching Clients How to Self-Inject, pp. 83\u201386). Working together, in communities and clinics For success, clinic-based providers and community-based providers need",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 741
  },
  {
    "id": "chunk_00742",
    "text": "based providers and community-based providers need to work together closely. Programs vary, but these are some ways that clinic-based providers can support community-based providers: \u2022 Managing side effects (see Managing Any Problems, pp. 89\u201392)",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 742
  },
  {
    "id": "chunk_00743",
    "text": "ide effects (see Managing Any Problems, pp. 89\u201392) \u2022 Using clinical judgment concerning medical eligibility in special cases (see Using Clinical Judgment in Special Cases, p. 74) \u2022 Ruling out pregnancy in women who are more than 4 weeks late for",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 743
  },
  {
    "id": "chunk_00744",
    "text": "gnancy in women who are more than 4 weeks late for a DMPA injection or more than 2 weeks late for a NET-EN injection (see Managing Late Injections, p. 88) \u2022 Responding to the concerns of clients referred by the community- based providers. The clinic can also serve as a \u201chome\u201d for the community-based",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 744
  },
  {
    "id": "chunk_00745",
    "text": "can also serve as a \u201chome\u201d for the community-based providers, where they can go for resupply, for supervision, training, and advice, and to turn in their records. 70 Family Planning: A Global Handbook for Providers",
    "page_number": 92,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 745
  },
  {
    "id": "chunk_00746",
    "text": "4 71 selbatcejnI ylnO-nitsegorP Who Can and Cannot Use Progestin-Only Injectables Safe and Suitable for Nearly All Women Nearly all women can use progestin-only injectables safely and effectively, including women who: y Have had children or have not had children y Are married or are not married",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 746
  },
  {
    "id": "chunk_00747",
    "text": "not had children y Are married or are not married y Are of any age, including adolescents and women over 40 years old y Have just had an abortion or miscarriage y Smoke cigarettes, regardless of age or the number of cigarettes smoked y Are breastfeeding, starting as soon as 6 weeks after childbirth",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 747
  },
  {
    "id": "chunk_00748",
    "text": "ding, starting as soon as 6 weeks after childbirth y Are living with HIV, whether or not they are on antiretroviral therapy (see the box on Progestin-Only Injectables for Women Living With HIV, p. 74) y Are at high risk of HIV, or other STIs. Avoid Unnecessary Procedures",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 748
  },
  {
    "id": "chunk_00749",
    "text": "f HIV, or other STIs. Avoid Unnecessary Procedures (see Importance of Selected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396) Women can begin using progestin-only injectables: y Without a pelvic examination y Without any blood tests or other routine laboratory tests",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 749
  },
  {
    "id": "chunk_00750",
    "text": "any blood tests or other routine laboratory tests y Without cervical cancer screening y Without a breast examination y Without a pregnancy test. A woman can begin using a progestin-only injectable at any time, even when she is not having monthly bleeding at",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 750
  },
  {
    "id": "chunk_00751",
    "text": "e, even when she is not having monthly bleeding at the time, if it is reasonably certain she is not pregnant (see Pregnancy Checklist, inside back cover). Blood pressure measurement is desirable before starting a hormonal method. However, where the risks of pregnancy are high and few methods",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 751
  },
  {
    "id": "chunk_00752",
    "text": "re the risks of pregnancy are high and few methods are available, a woman should not be denied a hormonal method simply because her blood pressure cannot be measured. If possible, she can have her blood pressure measured later, at a time and place convenient for her.",
    "page_number": 93,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 752
  },
  {
    "id": "chunk_00753",
    "text": "Medical Eligibility Criteria for Use of Progestin-Only Injectables Ask the client the questions below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions, then she can start progestin-only injectables if she wants.",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 753
  },
  {
    "id": "chunk_00754",
    "text": "can start progestin-only injectables if she wants. If she answers \u201cyes\u201d to a question, follow the instructions; in some cases she can still start progestin-only injectables. 1. Are you breastfeeding a baby less than 6 weeks old? \u274f \u274f No Yes The client can start using progestin-only injectables",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 754
  },
  {
    "id": "chunk_00755",
    "text": "client can start using progestin-only injectables as soon as 6 weeks after childbirth (see \u201cFully or nearly fully breastfeeding\u201d or \u201cPartially breastfeeding\u201d, in the section on When to Start, p. 76) 2. Do you have severe cirrhosis of the liver or severe liver tumor? \u274f \u274f",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 755
  },
  {
    "id": "chunk_00756",
    "text": "cirrhosis of the liver or severe liver tumor? \u274f \u274f No Yes If the client reports severe cirrhosis or severe liver tumor, such as liver cancer, do not provide progestin-only injectables. Help her choose a method without hormones. 3. Do you have high blood pressure? \u274f \u274f",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 756
  },
  {
    "id": "chunk_00757",
    "text": "hormones. 3. Do you have high blood pressure? \u274f \u274f No Yes Check her blood pressure if possible. y If the client is currently being treated for high blood pressure and it is adequately controlled, or her blood pressure is below 160/100 mmHg, provide progestin-only injectables.",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 757
  },
  {
    "id": "chunk_00758",
    "text": "160/100 mmHg, provide progestin-only injectables. y If systolic blood pressure is 160 mmHg or higher or diastolic blood pressure is 100 or higher, do not provide progestin- only injectables. Neither progestin-only injectables nor any methods containing estrogen are appropriate for the client;",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 758
  },
  {
    "id": "chunk_00759",
    "text": "ontaining estrogen are appropriate for the client; help her choose another method. y If the client reports having high blood pressure in the past, and you cannot check blood pressure, provide progestin- only injectables. 4. Have you had diabetes for more than 20 years or do you",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 759
  },
  {
    "id": "chunk_00760",
    "text": "you had diabetes for more than 20 years or do you have damage to your arteries, vision, kidneys, or nervous system caused by diabetes? \u274f \u274f No Yes Do not provide progestin-only injectables. Neither progestin-only injectables nor any methods containing",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 760
  },
  {
    "id": "chunk_00761",
    "text": "gestin-only injectables nor any methods containing estrogen are appropriate for the client; help her choose another method. 72 Family Planning: A Global Handbook for Providers",
    "page_number": 94,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 761
  },
  {
    "id": "chunk_00762",
    "text": "4 73 selbatcejnI ylnO-nitsegorP 5. Have you ever had a stroke, blood clot in your leg or lungs, heart attack, or other serious heart problems? \u274f \u274f No Yes If the client reports heart attack, heart disease due to blocked or narrowed arteries, or stroke, do not provide",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 762
  },
  {
    "id": "chunk_00763",
    "text": "ed or narrowed arteries, or stroke, do not provide progestin-only injectables. Help her choose a different method that does not contain estrogen. If she reports a current blood clot in one of her legs (affecting deep veins, not superficial",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 763
  },
  {
    "id": "chunk_00764",
    "text": "of her legs (affecting deep veins, not superficial veins) or in a lung and she is not on anticoagulant therapy, help her choose a method without hormones. 6. Are you having vaginal bleeding that is unusual for you? \u274f \u274f No Yes If the client has unexplained vaginal bleeding that",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 764
  },
  {
    "id": "chunk_00765",
    "text": "f the client has unexplained vaginal bleeding that suggests pregnancy or an underlying medical condition, progestin-only injectables could make diagnosis and monitoring of any treatment more difficult. Help her choose another method to use until she has been evaluated and",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 765
  },
  {
    "id": "chunk_00766",
    "text": "her method to use until she has been evaluated and treated, but not implants or a copper-bearing or hormonal IUD. After treatment, re-evaluate the client\u2019s eligibility for use of progestin-only injectables. 7. Do you have or have you ever had breast cancer? \u274f \u274f",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 766
  },
  {
    "id": "chunk_00767",
    "text": "o you have or have you ever had breast cancer? \u274f \u274f No Yes Do not provide progestin-only injectables. Help her choose a method without hormones. 8. Do you have several conditions that could increase your chances of heart disease (coronary artery disease) or",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 767
  },
  {
    "id": "chunk_00768",
    "text": "nces of heart disease (coronary artery disease) or stroke, such as high blood pressure and diabetes? \u274f \u274f No Yes Do not provide progestin-only injectables. Help the client choose a different method that does not contain estrogen. Also, a woman should not use progestin-only injectables if she reports",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 768
  },
  {
    "id": "chunk_00769",
    "text": "not use progestin-only injectables if she reports having lupus with positive (or unknown) antiphospholipid antibodies and is not on immunosuppressive treatment, or if she has severe thrombocytopenia. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use.",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 769
  },
  {
    "id": "chunk_00770",
    "text": "edical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits as well as the potential risks and side effects associated with the client\u2019s chosen method. Also, point out any conditions that would make the method inadvisable for use by that particular client.",
    "page_number": 95,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 770
  },
  {
    "id": "chunk_00771",
    "text": "Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not use progestin-only injectables. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her,",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 771
  },
  {
    "id": "chunk_00772",
    "text": "te methods are not available or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use progestin-only injectables. The provider needs to consider the severity of her condition and, for most",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 772
  },
  {
    "id": "chunk_00773",
    "text": "nsider the severity of her condition and, for most conditions, whether she will have access to follow-up care. y Breastfeeding and less than 6 weeks since giving birth (considering the risks of another pregnancy and that the woman may have limited further access to injectables)",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 773
  },
  {
    "id": "chunk_00774",
    "text": "an may have limited further access to injectables) y Severe high blood pressure (systolic 160 mm Hg or higher or diastolic 100 mm Hg or higher) y Acute blood clot in deep veins of legs or lungs y History of heart disease or current heart disease due to blocked or",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 774
  },
  {
    "id": "chunk_00775",
    "text": "disease or current heart disease due to blocked or narrowed arteries (ischemic heart disease) y History of stroke y Multiple risk factors for arterial cardiovascular disease such as diabetes and high blood pressure y Unexplained vaginal bleeding before evaluation for possible serious",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 775
  },
  {
    "id": "chunk_00776",
    "text": "al bleeding before evaluation for possible serious underlying condition y Had breast cancer more than 5 years ago, and it has not returned y Diabetes for more than 20 years, or damage to arteries, vision, kidneys, or nervous system caused by diabetes y Severe cirrhosis of the liver or liver tumor",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 776
  },
  {
    "id": "chunk_00777",
    "text": "tes y Severe cirrhosis of the liver or liver tumor y Systemic lupus erythematosus with positive (or unknown) antiphospholipid antibodies and not on immunosuppressive treatment, or severe thrombocytopenia Progestin-Only Injectables for Women Living With HIV",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 777
  },
  {
    "id": "chunk_00778",
    "text": "ogestin-Only Injectables for Women Living With HIV \u2022 Women who are living with HIV including those who are on antiretroviral therapy (ART) can safely use progestin-only injectables. \u2022 The time between injections does not need to be shortened for women on ART.",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 778
  },
  {
    "id": "chunk_00779",
    "text": "ns does not need to be shortened for women on ART. \u2022 Urge these women to use condoms as well. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. 74 Family Planning: A Global Handbook for Providers",
    "page_number": 96,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 779
  },
  {
    "id": "chunk_00780",
    "text": "4 75 selbatcejnI ylnO-nitsegorP Providing Progestin-Only Injectables When to Start IMPORTANT: A woman can start injectables any time she wants if it is reasonably certain she is not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover).",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 780
  },
  {
    "id": "chunk_00781",
    "text": "e the Pregnancy Checklist (see inside back cover). Woman\u2019s situation When to start Having Any time of the month menstrual y If it is within 7 days after the start of her monthly cycles bleeding, she can start immediately and there is no need for a backup method.",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 781
  },
  {
    "id": "chunk_00782",
    "text": "ediately and there is no need for a backup method. y If it is more than 7 days after the start of her monthly bleeding, she can start any time it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after the injection.",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 782
  },
  {
    "id": "chunk_00783",
    "text": "method* for the first 7 days after the injection. y If she is switching from an IUD, she can start immediately and there is no need for a backup method (see Switching From an IUD to Another Method, in Chapter 10 \u2013 Copper-Bearing Intrauterine Device, p. 182, and in Chapter 11 \u2013",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 783
  },
  {
    "id": "chunk_00784",
    "text": "g Intrauterine Device, p. 182, and in Chapter 11 \u2013 Levonorgestrel IUD, p. 211). Switching y If she has been using the other hormonal from another method consistently and correctly or if it hormonal is otherwise reasonably certain she is not method pregnant, she can start immediately (no need to",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 784
  },
  {
    "id": "chunk_00785",
    "text": "od pregnant, she can start immediately (no need to wait for her next monthly bleeding) and there is no need for a backup method. y If she is switching from another injectable, she can have the new injectable when the repeat injection would have been given. There is no need for a backup method.",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 785
  },
  {
    "id": "chunk_00786",
    "text": "been given. There is no need for a backup method. (Continued on next page) * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 97,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 786
  },
  {
    "id": "chunk_00787",
    "text": "Woman\u2019s situation When to start (continued) Fully or nearly fully breastfeeding Less than 6 y If she gave birth less than 6 weeks ago, delay months after her first injection until at least 6 weeks after giving birth giving birth. y If her monthly bleeding has not returned, she",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 787
  },
  {
    "id": "chunk_00788",
    "text": "h. y If her monthly bleeding has not returned, she can start injectables any time between 6 weeks and 6 months, if it is reasonably certain she is not pregnant. There is no need for a backup method. y If her monthly bleeding has returned, she can start injectables as advised for women having",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 788
  },
  {
    "id": "chunk_00789",
    "text": "can start injectables as advised for women having menstrual cycles (see the first row of this table). More than 6 y If her monthly bleeding has not returned, she months after can start injectables any time if it is reasonably giving birth certain she is not pregnant. She will need a",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 789
  },
  {
    "id": "chunk_00790",
    "text": "birth certain she is not pregnant. She will need a backup method* for the first 7 days after the injection. y If her monthly bleeding has returned, she can start injectables as advised for women having menstrual cycles (see the first row of this table). Partially breastfeeding",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 790
  },
  {
    "id": "chunk_00791",
    "text": "first row of this table). Partially breastfeeding Less than y Delay her first injection until at least 6 weeks 6 weeks after after giving birth. giving birth More than y If her monthly bleeding has not returned, she 6 weeks after can start injectables any time if it is reasonably",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 791
  },
  {
    "id": "chunk_00792",
    "text": "can start injectables any time if it is reasonably giving birth certain she is not pregnant.\u2021 She will need a backup method* for the first 7 days after the injection. y If her monthly bleeding has returned, she can start injectables as advised for women having",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 792
  },
  {
    "id": "chunk_00793",
    "text": "can start injectables as advised for women having menstrual cycles (see the first row of this table). * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 793
  },
  {
    "id": "chunk_00794",
    "text": "d withdrawal are the least effective contraceptive methods. If possible, give her condoms. \u2021 W here a visit 6 weeks after childbirth is routinely recommended and other opportunities to obtain contraception are limited, some providers and programs may give the first injection",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 794
  },
  {
    "id": "chunk_00795",
    "text": "roviders and programs may give the first injection at the 6-week visit, without further evidence that the woman is not pregnant, if her monthly bleeding has not yet returned. 76 Family Planning: A Global Handbook for Providers",
    "page_number": 98,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 795
  },
  {
    "id": "chunk_00796",
    "text": "4 77 selbatcejnI ylnO-nitsegorP Woman\u2019s situation When to start Not breastfeeding (after giving birth) Less than y She can start injectables at any time and there is 4 weeks after no need for a backup method. giving birth More than y If her monthly bleeding has not returned, she",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 796
  },
  {
    "id": "chunk_00797",
    "text": "an y If her monthly bleeding has not returned, she 4 weeks after can start injectables any time if it is reasonably giving birth certain she is not pregnant.\u2021 She will need a backup method* for the first 7 days after the injection. y If her monthly bleeding has returned, she can",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 797
  },
  {
    "id": "chunk_00798",
    "text": "n. y If her monthly bleeding has returned, she can start injectables as advised for women having menstrual cycles (see the first row of this table). No monthly y She can start injectables any time if it is bleeding (not reasonably certain she is not pregnant. She will",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 798
  },
  {
    "id": "chunk_00799",
    "text": "t reasonably certain she is not pregnant. She will related to childbirth need a backup method* for the first 7 days or breastfeeding) after the injection. After miscarriage y If she is starting within 7 days after first- or or abortion second-trimester miscarriage or abortion, she",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 799
  },
  {
    "id": "chunk_00800",
    "text": "tion second-trimester miscarriage or abortion, she can start immediately and there is no need for a backup method. y If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start injectables any time if it is reasonably certain",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 800
  },
  {
    "id": "chunk_00801",
    "text": "t injectables any time if it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after the injection. After taking After taking progestin-only or emergency combined ECPs: contraceptive y She can start or restart injectables on the same pills (ECPs)",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 801
  },
  {
    "id": "chunk_00802",
    "text": "rt or restart injectables on the same pills (ECPs) days as taking the ECPs. There is no need to wait for the next monthly bleeding to have the injection. She will need a backup method* for the first 7 days after the injection. y If she does not start immediately but returns",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 802
  },
  {
    "id": "chunk_00803",
    "text": "n. y If she does not start immediately but returns for injectables, she can start at any time if it is reasonably certain she is not pregnant. (Continued on next page) Providing Progestin-Only Injectables",
    "page_number": 99,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 803
  },
  {
    "id": "chunk_00804",
    "text": "Woman\u2019s situation When to start (continued) After taking ulipristal acetate (UPA) ECPs: y She can start or restart injectables on the 6th day after taking UPA-ECPs, so make an appointment for her to return for the injection on the 6th day or as soon as possible after that.",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 804
  },
  {
    "id": "chunk_00805",
    "text": "on the 6th day or as soon as possible after that. There is no need to wait for the next monthly bleeding to have the injection. The progestin in the injectables and UPA interact with each other. If the injectable is started sooner, and both are thus present in the body, one or both",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 805
  },
  {
    "id": "chunk_00806",
    "text": "and both are thus present in the body, one or both of the medications may be less effective. y She will need to use a backup method from the time she takes UPA-ECPs until 7 days after the injection. y If she does not start on the 6th day but returns later for injectables, she may start at any time if",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 806
  },
  {
    "id": "chunk_00807",
    "text": "ater for injectables, she may start at any time if it is reasonably certain she is not pregnant. Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes and other side effects must be provided before starting a woman on progestin-",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 807
  },
  {
    "id": "chunk_00808",
    "text": "be provided before starting a woman on progestin- only injectables. Counseling about bleeding changes may be the most important help a woman needs to enable her to keep using this method without concern. Describe the y For the first several months: most important",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 808
  },
  {
    "id": "chunk_00809",
    "text": "the y For the first several months: most important \u2013 irregular bleeding, prolonged bleeding, frequent common side bleeding effects y Later: \u2013 no monthly bleeding y Other common side effects include weight gain (about 1\u20132 kg per year), headaches, and dizziness, among others.",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 809
  },
  {
    "id": "chunk_00810",
    "text": "per year), headaches, and dizziness, among others. Explain about y Side effects are not signs of illness. these side y Common, but some women do not have them. effects y The client can come back for help if side effects bother her. 78 Family Planning: A Global Handbook for Providers",
    "page_number": 100,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 810
  },
  {
    "id": "chunk_00811",
    "text": "4 79 selbatcejnI ylnO-nitsegorP Giving Intramuscular Injection With a Conventional Syringe 1. Obtain 1 dose y DMPA: 150 mg of injectable y NET-EN: 200 mg contraception, a needle, and y For each injection, use a prefilled single-use syringe syringe and needle from a new, sealed package",
    "page_number": 101,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 811
  },
  {
    "id": "chunk_00812",
    "text": "inge syringe and needle from a new, sealed package (within expiration date and not damaged), if available. y If a prefilled single-use syringe is not available, use single-dose vials. Check the expiration date on the vial. If using an open multidose vial, check that the vial is not leaking.",
    "page_number": 101,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 812
  },
  {
    "id": "chunk_00813",
    "text": "ultidose vial, check that the vial is not leaking. \u2013 DMPA: Use a 2-ml syringe and a 21- to 23-gauge intramuscular needle. \u2013 NET-EN: Use a 2- or 5-ml syringe and a 19-gauge intramuscular needle. A narrower needle (21- to 23-gauge) can also be used.",
    "page_number": 101,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 813
  },
  {
    "id": "chunk_00814",
    "text": "arrower needle (21- to 23-gauge) can also be used. 2. Wash y Wash your hands with soap and water, if possible, and let them dry in the air. y If the injection site is dirty, wash it with soap and water. y There is no need to wipe the site with antiseptic. If using a prefilled syringe, skip to step 5",
    "page_number": 101,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 814
  },
  {
    "id": "chunk_00815",
    "text": "ptic. If using a prefilled syringe, skip to step 5 3. Prepare vial y DMPA: Gently shake the vial. y NET-EN: Shaking the vial is not necessary. y There is no need to wipe the top of the vial with antiseptic. y If the vial is cold, warm to skin temperature before giving the injection.",
    "page_number": 101,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 815
  },
  {
    "id": "chunk_00816",
    "text": "m to skin temperature before giving the injection. 4. Fill syringe y Pierce the top of the vial with a sterile needle and fill syringe with the proper dose. (Continued on next page) Providing Progestin-Only Injectables",
    "page_number": 101,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 816
  },
  {
    "id": "chunk_00817",
    "text": "Giving Intramuscular Injection With a Conventional Syringe (continued) 5. Inject formula y Insert the needle deep into the hip (ventrogluteal muscle), the upper arm (deltoid muscle), or the buttocks (gluteal muscle, upper outer portion), whichever the woman prefers. Inject the contents",
    "page_number": 102,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 817
  },
  {
    "id": "chunk_00818",
    "text": ", whichever the woman prefers. Inject the contents of the syringe. y Do not massage the injection site. 6. Dispose of y Do not recap, bend, or break needles before disposable disposal. syringes and y Place in a puncture-proof sharps container. needles safely",
    "page_number": 102,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 818
  },
  {
    "id": "chunk_00819",
    "text": "a puncture-proof sharps container. needles safely y Do no reuse disposable syringes and needles. They are meant to be destroyed after a single use. Because of their shape, they are very difficult to disinfect. Therefore, reuse might transmit diseases such as HIV and hepatitis.",
    "page_number": 102,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 819
  },
  {
    "id": "chunk_00820",
    "text": "might transmit diseases such as HIV and hepatitis. y If reusable syringes and needles are used, they must be sterilized again after each use (see Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404). 80 Family Planning: A Global Handbook for Providers",
    "page_number": 102,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 820
  },
  {
    "id": "chunk_00821",
    "text": "4 81 selbatcejnI ylnO-nitsegorP Giving the Injection With Subcutaneous DMPA in Uniject (Sayana Press) 1. Gather the Supplies include: supplies y Uniject prefilled injection device at room temperature that has not passed its expiration date y Soap and clean water",
    "page_number": 103,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 821
  },
  {
    "id": "chunk_00822",
    "text": "passed its expiration date y Soap and clean water y Cotton swabs or cotton balls, if available y Safe puncture-proof container for sharps disposal 2. Wash y Wash your hands with soap and water, if possible. y Let your hands dry in the air. y If the injection site is dirty, wash it with soap",
    "page_number": 103,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 822
  },
  {
    "id": "chunk_00823",
    "text": "If the injection site is dirty, wash it with soap and water. y There is no need to wipe the site with antiseptic. 3. Ask where the You can give the injection just under the skin: client wants the y In the back of the upper arm injection y In the abdomen (but not at the navel)",
    "page_number": 103,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 823
  },
  {
    "id": "chunk_00824",
    "text": "injection y In the abdomen (but not at the navel) y On the front of the thigh 4. Open the pouch y Open the foil pouch and remove the device. 5. Mix the solution y Hold the device by the port (see picture 1). y Shake it hard for Reservoir 30 seconds. Port y Check that the solution Needle",
    "page_number": 103,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 824
  },
  {
    "id": "chunk_00825",
    "text": "30 seconds. Port y Check that the solution Needle is mixed (granules Cap distributed throughout the solution) and there is no damage or leaking. 1. Parts of Uniject device (Continued on next page) Providing Progestin-Only Injectables",
    "page_number": 103,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 825
  },
  {
    "id": "chunk_00826",
    "text": "Giving the Injection With Subcutaneous DMPA in Uniject (Sayana Press) (continued) 6. Close the gap y Hold the device by the port. y Hold the device with the needle pointed upward to avoid spilling the drug. y Push the cap into the port (see part A of picture 2, below).",
    "page_number": 104,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 826
  },
  {
    "id": "chunk_00827",
    "text": "ap into the port (see part A of picture 2, below). y Continue to push firmly until the gap between the cap and port is closed (see part B of picture 2, below). y Take off the cap (see part C of picture 2, below). A B C 2. Close the gap and take off the cap",
    "page_number": 104,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 827
  },
  {
    "id": "chunk_00828",
    "text": "elow). A B C 2. Close the gap and take off the cap 7. Give the injection y Gently pinch the skin at the injection site (see picture 3). This helps to make sure that the drug is injected into fatty tissue just under the skin and not into muscle. y Holding the port, gently push the needle",
    "page_number": 104,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 828
  },
  {
    "id": "chunk_00829",
    "text": "muscle. y Holding the port, gently push the needle straight into the skin with the needle pointing down (never upward) until the port touches the skin. y Squeeze the reservoir slowly. Take 5\u20137 seconds. y Pull out the needle and then release the skin. 3. Pinch the skin and inject",
    "page_number": 104,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 829
  },
  {
    "id": "chunk_00830",
    "text": "hen release the skin. 3. Pinch the skin and inject y Do not clean or massage the site after injecting. 8. Discard the y Do not replace the cap. used device y Place the device in the sharps disposal container. 82 Family Planning: A Global Handbook for Providers",
    "page_number": 104,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 830
  },
  {
    "id": "chunk_00831",
    "text": "4 83 selbatcejnI ylnO-nitsegorP Advice for the Client After Providing Injection Give specific y Tell her not to massage the injection site. instructions y Tell the client the name of the injection. y Agree on a date for her next injection and give her a paper with the date written on it.",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 831
  },
  {
    "id": "chunk_00832",
    "text": "and give her a paper with the date written on it. Self-Injection Can Be an Option Women can learn to inject themselves with the subcutaneous formulation of DMPA (DMPA-SC). Some women like self-injection better than injections by health workers. Self-injection may save women time and money. WHO",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 832
  },
  {
    "id": "chunk_00833",
    "text": "Self-injection may save women time and money. WHO recommends making self-administration of injectable contraception available as an additional approach to deliver injectable contraception to individuals of reproductive age. Teaching Clients to Self-Inject",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 833
  },
  {
    "id": "chunk_00834",
    "text": "reproductive age. Teaching Clients to Self-Inject For clients who want to give themselves the injections, you can teach them how to do this. The following steps apply to self-injection with DMPA-SC in the Uniject device (marketed as Sayana Press). 1. Discuss the plan for storage and disposal.",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 834
  },
  {
    "id": "chunk_00835",
    "text": "ss). 1. Discuss the plan for storage and disposal. Storage. Discuss where the client can safely store the devices for many months. They should be kept out of the reach of children and animals and in moderate temperatures (not in direct sunlight or in a refrigerator).",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 835
  },
  {
    "id": "chunk_00836",
    "text": "res (not in direct sunlight or in a refrigerator). Disposal. Discuss how the client can dispose of the devices in a container that has a lid and cannot be punctured and which can be kept away from children. (Local programs should decide how to help women dispose of used needles.)",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 836
  },
  {
    "id": "chunk_00837",
    "text": "decide how to help women dispose of used needles.) 2. Explain and show the client how to self-inject. Show the client the device and describe its parts. (See pictures in the instructions, on the next pages.) Give her a copy of the instructions and pictures",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 837
  },
  {
    "id": "chunk_00838",
    "text": ") Give her a copy of the instructions and pictures provided below, a similar instruction sheet, or a booklet of more detailed Continued on p. 86 Note: The instructions How to Give Yourself an Injection with Sayana Press starting on the next page can be copied and given to the client.",
    "page_number": 105,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 838
  },
  {
    "id": "chunk_00839",
    "text": "How to Give Yourself an Injection with Sayana Press IImmppoorrttaanntt sstteeppss HHooww ttoo ddoo iitt 1. Choose a correct Choose either: the belly or The front of the thigh injection site (but not the navel) 1. Where to give yourself the injection",
    "page_number": 106,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 839
  },
  {
    "id": "chunk_00840",
    "text": "the navel) 1. Where to give yourself the injection 2. Hold the device y After washing hands, open the pouch and take out the and mix the injection device. solution y Hold the device by the port (not the cap) and shake it hard for about 30 seconds. Make sure the solution is Port completely mixed.",
    "page_number": 106,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 840
  },
  {
    "id": "chunk_00841",
    "text": ". Make sure the solution is Port completely mixed. 2. Mix the solution Parts of Uniject device 3. Push the cap and y Point the needle upward. the port together y Hold the cap with one hand and the port with the to close the gap other hand. y Press cap down firmly until the gap is closed.",
    "page_number": 106,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 841
  },
  {
    "id": "chunk_00842",
    "text": "4 85 selbatcejnI ylnO-nitsegorP IImmppoorrttaanntt sstteeppss HHooww ttoo ddoo iitt 4. Pinch your skin y Take the cap off the needle. Hold the device by into a \u201ctent\u201d the port. y With the other hand pinch about 4 cm (1\u00bd inches) of skin.",
    "page_number": 107,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 842
  },
  {
    "id": "chunk_00843",
    "text": "e other hand pinch about 4 cm (1\u00bd inches) of skin. 5. Put the needle y Press the needle straight into the skin with the needle into the skin, pointing downward. and squeeze the y Press the needle in until the port touches the skin reservoir slowly completely.",
    "page_number": 107,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 843
  },
  {
    "id": "chunk_00844",
    "text": "port touches the skin reservoir slowly completely. y Squeeze the reservoir slowly, for 5\u20137 seconds. 4&5. Pinch the skin and press the needle 6. Dispose of the y Pull the needle out and then let go of the skin. needle safely y Put the device in a disposal container that can be closed",
    "page_number": 107,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 844
  },
  {
    "id": "chunk_00845",
    "text": "device in a disposal container that can be closed and cannot be punctured. 7. Plan for your y Mark a calendar or other reminder for the same day next injection of the month, 3 months from today. y You can give yourself the next injection as early as",
    "page_number": 107,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 845
  },
  {
    "id": "chunk_00846",
    "text": "u can give yourself the next injection as early as 2 weeks before that date or as late as 4 weeks after. y If more than 4 weeks late, use another contraceptive method and see a health worker. y Make sure you have another device for the next injection and that it will not expire before then.",
    "page_number": 107,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 846
  },
  {
    "id": "chunk_00847",
    "text": "injection and that it will not expire before then. If you need help or more injection devices, contact: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd at \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd Self-Injection Can Be an Option",
    "page_number": 107,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 847
  },
  {
    "id": "chunk_00848",
    "text": "Teaching Clients To Self-Inject (continued from p. 83) instructions. Explain the important steps. Use a sample injection device and an injection model (instead of a human limb) to show the client how to do each step while helping the client follow along on the instruction",
    "page_number": 108,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 848
  },
  {
    "id": "chunk_00849",
    "text": "helping the client follow along on the instruction sheet. (If an injection model is not available, you can use a condom filled with salt or sugar. Alternatively, you can use fruit or bread.) 3. Ask the client to try it. After you have demonstrated the steps of",
    "page_number": 108,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 849
  },
  {
    "id": "chunk_00850",
    "text": "o try it. After you have demonstrated the steps of self-injection, ask the client to practice on the injection model with a Uniject device. Watch her and then discuss what went well and what did not. Answer her questions, and invite the client to keep practicing",
    "page_number": 108,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 850
  },
  {
    "id": "chunk_00851",
    "text": "uestions, and invite the client to keep practicing on the model until she can do all the steps correctly and feels ready to inject herself. 4. Ask the woman to inject herself while you are watching. When she has successfully done this, give her injection devices to take home so",
    "page_number": 108,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 851
  },
  {
    "id": "chunk_00852",
    "text": "e this, give her injection devices to take home so that she can inject herself every 3 months into the future. Make sure that she understands when her future injection dates are, and how to calculate those dates by noting the same day of the month every 3 months.",
    "page_number": 108,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 852
  },
  {
    "id": "chunk_00853",
    "text": "y noting the same day of the month every 3 months. 5. Tell the client where to get more injection devices. Invite her to contact you if she has any questions or problems with self-injection or with getting more injection devices. 86 Family Planning: A Global Handbook for Providers",
    "page_number": 108,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 853
  },
  {
    "id": "chunk_00854",
    "text": "4 87 selbatcejnI ylnO-nitsegorP Supporting New and Continuing Users How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can:",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 854
  },
  {
    "id": "chunk_00855",
    "text": "rt he can give to his partner. A male partner can: \u2022 Support his partner\u2019s choice of progestin-only injectables \u2022 Show understanding and support if she has side effects \u2022 Help her to remember to get her next injection on time \u2022 Help to make sure she has emergency contraceptive pills (ECPs) on hand",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 855
  },
  {
    "id": "chunk_00856",
    "text": "e has emergency contraceptive pills (ECPs) on hand in case she is late for an injection by more than 4 weeks for DMPA or more than 2 weeks for NET-EN \u2022 Use condoms consistently in addition to the progestin-only injectable if he has an STI/HIV or thinks he may be at risk of an STI/HIV.",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 856
  },
  {
    "id": "chunk_00857",
    "text": "STI/HIV or thinks he may be at risk of an STI/HIV. \u201cCome Back Anytime\u201d: Reasons to Return Before the Next Injection Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; if she has",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 857
  },
  {
    "id": "chunk_00858",
    "text": "ms, questions, or wants another method; if she has a major change in health status; or if she thinks she might be pregnant. General health advice Anyone who suddenly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 858
  },
  {
    "id": "chunk_00859",
    "text": "ould immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the health worker what method she is using. Planning the Next Injection 1. Agree on a date for the client\u2019s next injection in 3 months (13 weeks)",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 859
  },
  {
    "id": "chunk_00860",
    "text": "the client\u2019s next injection in 3 months (13 weeks) for DMPA, or in 2 months (8 weeks) for NET-EN. Give her a paper with the date written on it (or dates, if she is self-injecting and taking home more than 1 injection device). Discuss how to remember the",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 860
  },
  {
    "id": "chunk_00861",
    "text": "n 1 injection device). Discuss how to remember the date of her next injection, perhaps putting it on the same date as a holiday or other event, or circling the date on a calendar. Supporting New and Continuing Users",
    "page_number": 109,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 861
  },
  {
    "id": "chunk_00862",
    "text": "2. Ask her to try to come on the agreed date. With DMPA, she may come up to 4 weeks after the scheduled injection date and still get an injection. With NET-EN, she may come up to 2 weeks after the scheduled injection date and still get an injection. With either DMPA",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 862
  },
  {
    "id": "chunk_00863",
    "text": "date and still get an injection. With either DMPA or NET-EN, she can come up to 2 weeks before the scheduled injection date. 3. She should come back no matter how late she is for her next injection. See Managing Late Injections, below. Repeat Injection Visits",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 863
  },
  {
    "id": "chunk_00864",
    "text": "ng Late Injections, below. Repeat Injection Visits 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything she\u2019d like to discuss. 2. In particular, ask if she is concerned about bleeding changes. Give her",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 864
  },
  {
    "id": "chunk_00865",
    "text": "she is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, on the next page). 3. Give her the injection. Injection of DMPA can be given up to 4 weeks late. Injection of NET-EN can be given up to 2 weeks late. Either can be",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 865
  },
  {
    "id": "chunk_00866",
    "text": "-EN can be given up to 2 weeks late. Either can be given up to 2 weeks early (See Question 14, at the end of this chapter). 4. Plan for her next injection. Agree on a date for her next injection (in 3 months for DMPA, 2 months for NET-EN). Remind her that she should",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 866
  },
  {
    "id": "chunk_00867",
    "text": ", 2 months for NET-EN). Remind her that she should try to come on that date (at the scheduled appointment, if there is one), but tell her that she should come back no matter how late she is. (See Managing Late Injections, below). 5. Every year or so, check her blood pressure if possible (see Medical",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 867
  },
  {
    "id": "chunk_00868",
    "text": "check her blood pressure if possible (see Medical Eligibility Criteria for Use of Progestin-Only Injectables, Question 3, in this chapter, p. 72). 6. Ask long-term users of progestin-only injectables if they have had any new health problems. Address problems as appropriate. See New",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 868
  },
  {
    "id": "chunk_00869",
    "text": "problems. Address problems as appropriate. See New Problems That May Require Switching Methods, p. 91. 7. Ask long-term clients about any major life changes that may affect family planning needs \u2013 particularly plans for having children and STI/HIV risk. Follow up as needed. Managing Late Injections",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 869
  },
  {
    "id": "chunk_00870",
    "text": "isk. Follow up as needed. Managing Late Injections y If the client is up to 4 weeks late for a repeat injection of DMPA, or up to 2 weeks late for a repeat injection of NET-EN, she can receive her next injection. There is no need for tests, evaluation, or a backup method.",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 870
  },
  {
    "id": "chunk_00871",
    "text": "no need for tests, evaluation, or a backup method. y A client who is more than 4 weeks late for DMPA or more than 2 weeks late for NET-EN can receive her next injection, if: \u2013 she has not had sex since 2 weeks after the scheduled date of her injection, or",
    "page_number": 110,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 871
  },
  {
    "id": "chunk_00872",
    "text": "4 89 selbatcejnI ylnO-nitsegorP \u2013 she has used a backup method or has taken ECPs after any unprotected sex since 2 weeks after the scheduled date of her injection, or \u2013 she is fully or nearly fully breastfeeding and she gave birth less than 6 months ago.",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 872
  },
  {
    "id": "chunk_00873",
    "text": "feeding and she gave birth less than 6 months ago. However, in all three cases she will need a backup method for the first 7 days after the injection. y If the client is more than 4 weeks late for DMPA or more than 2 weeks late for NET-EN and she does not meet any of these three criteria,",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 873
  },
  {
    "id": "chunk_00874",
    "text": "and she does not meet any of these three criteria, additional steps can be taken to be reasonably certain she is not pregnant (see the job aid, Ruling Out Pregnancy). These steps are helpful because many women who have been using progestin-only injectables will have no",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 874
  },
  {
    "id": "chunk_00875",
    "text": "been using progestin-only injectables will have no monthly bleeding for at least a few months, even after discontinuation. Thus, asking her to come back during her next monthly bleeding means her next injection could be unnecessarily delayed and she may be left without contraceptive protection.",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 875
  },
  {
    "id": "chunk_00876",
    "text": "she may be left without contraceptive protection. y Discuss the client\u2019s reasons for being late for the repeat injection and explore solutions. Remind her that she should keep trying to come back every 3 months for DMPA, or every 2 months for NET-EN. If coming",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 876
  },
  {
    "id": "chunk_00877",
    "text": "for DMPA, or every 2 months for NET-EN. If coming back on time is often a problem, discuss the option of self-injection with DMPA-SC, and discuss using a backup method when she is late for her next injection, taking ECPs, or choosing another method, such as an implant or IUD. Managing Any Problems",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 877
  },
  {
    "id": "chunk_00878",
    "text": ", such as an implant or IUD. Managing Any Problems Problems Reported as Side Effects These problems may or may not be due to the progestin-only injectables but they affect women\u2019s satisfaction and use of this method and therefore",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 878
  },
  {
    "id": "chunk_00879",
    "text": "satisfaction and use of this method and therefore deserve the provider\u2019s attention. The following information advises how to address any reported side effects and specific conditions. Any reported side effects y Listen to the client\u2019s concerns, give her advice and support, and, if",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 879
  },
  {
    "id": "chunk_00880",
    "text": "t\u2019s concerns, give her advice and support, and, if appropriate, treat the condition. Make sure she understands the advice and agrees. y Offer to help her choose another method\u2014now, if she wishes, or if problems cannot be overcome. Supporting New and Continuing Users",
    "page_number": 111,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 880
  },
  {
    "id": "chunk_00881",
    "text": "No monthly bleeding y Reassure the client that most women using progestin-only injectables stop having monthly bleeding over time, and this is not harmful. There is no need to lose blood every month; blood is not building up inside her. It is similar to not having monthly bleeding during",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 881
  },
  {
    "id": "chunk_00882",
    "text": "t is similar to not having monthly bleeding during pregnancy. It does not mean she has become infertile. Some women are happy to be free from monthly bleeding, when they understand that it is not harmful. y If not having monthly bleeding bothers the woman, she may want to",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 882
  },
  {
    "id": "chunk_00883",
    "text": "onthly bleeding bothers the woman, she may want to switch to monthly (combined) injectables, if available (see Chapter 5). Irregular bleeding (bleeding at unexpected times) y Reassure her that many women using progestin-only injectables",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 883
  },
  {
    "id": "chunk_00884",
    "text": "r that many women using progestin-only injectables experience irregular bleeding. It is not harmful and usually becomes less or stops after the first few months of use. y For modest short-term relief, she can take 500 mg mefenamic acid",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 884
  },
  {
    "id": "chunk_00885",
    "text": "rt-term relief, she can take 500 mg mefenamic acid twice daily after meals for 5 days, or 40 mg of valdecoxib once daily for 5 days, beginning when irregular bleeding starts. y If irregular bleeding continues or starts after several months of normal",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 885
  },
  {
    "id": "chunk_00886",
    "text": "continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see the row on \u201cUnexplained vaginal bleeding\u201d, p. 92). Weight gain",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 886
  },
  {
    "id": "chunk_00887",
    "text": "Unexplained vaginal bleeding\u201d, p. 92). Weight gain y Review the client\u2019s diet with her and counsel as needed. Abdominal bloating and discomfort y Consider locally available remedies. Heavy or prolonged bleeding (twice as much as usual or longer than 8 days)",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 887
  },
  {
    "id": "chunk_00888",
    "text": "ing (twice as much as usual or longer than 8 days) y Reassure the client that some women using progestin-only injectables experience heavy or prolonged bleeding. It is not harmful and usually becomes less or stops after a few months.",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 888
  },
  {
    "id": "chunk_00889",
    "text": "usually becomes less or stops after a few months. y For modest short-term relief she can try (one at a time), beginning when heavy bleeding starts: \u2013 500 mg mefenamic acid twice daily after meals for 5 days \u2013 40 mg of valdecoxib daily for 5 days \u2013 50 \u00b5g ethinyl estradiol daily for 21 days",
    "page_number": 112,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 889
  },
  {
    "id": "chunk_00890",
    "text": "4 91 selbatcejnI ylnO-nitsegorP y If bleeding becomes a health threat or if the woman wants, help her choose a different method. In the meantime, she can use one of the treatments listed above to help reduce bleeding. y To help prevent anemia, suggest she take iron tablets and tell her it",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 890
  },
  {
    "id": "chunk_00891",
    "text": "mia, suggest she take iron tablets and tell her it is important to eat foods containing iron, such as meat and poultry (especially beef and chicken liver), fish, green leafy vegetables, and legumes (beans, bean curd, lentils, and peas).",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 891
  },
  {
    "id": "chunk_00892",
    "text": "and legumes (beans, bean curd, lentils, and peas). y If heavy or prolonged bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 892
  },
  {
    "id": "chunk_00893",
    "text": "ider underlying conditions unrelated to method use (see the row on the next page on \u201cUnexplained vaginal bleeding\u201d). Ordinary headaches (nonmigrainous) y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever.",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 893
  },
  {
    "id": "chunk_00894",
    "text": "aracetamol (325\u20131,000 mg), or other pain reliever. y Any headaches that get worse or occur more often during use of injectables should be evaluated. Mood changes or changes in sex drive y Ask the client about changes in her life that could affect her mood or sex",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 894
  },
  {
    "id": "chunk_00895",
    "text": "nges in her life that could affect her mood or sex drive, including changes in her relationship with her partner. Give support as appropriate. y Clients who have serious mood changes such as major depression should be referred for care. y Consider locally available remedies. Dizziness",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 895
  },
  {
    "id": "chunk_00896",
    "text": ". y Consider locally available remedies. Dizziness y Consider locally available remedies. New Problems That May Require Switching Methods These problems also may or may not be due to the use of progestin-only injectables. Migrainous headaches (see the job aid on Identifying Migraine",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 896
  },
  {
    "id": "chunk_00897",
    "text": "headaches (see the job aid on Identifying Migraine Headaches and Auras, pp. 458\u2013460) y If the client has migraine headaches without aura, she can continue to use the method if she wishes. y If she has a migraine aura, do not give the injection. Help her choose a method without hormones.",
    "page_number": 113,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 897
  },
  {
    "id": "chunk_00898",
    "text": "Unexplained vaginal bleeding (that suggests a medical condition not related to the method) y Refer or evaluate the client by history and pelvic examination. Diagnose and treat as appropriate. y If no cause of bleeding can be found, consider stopping progestin-only",
    "page_number": 114,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 898
  },
  {
    "id": "chunk_00899",
    "text": "ing can be found, consider stopping progestin-only injectables to make diagnosis easier. Provide another method of her choice (but not an implant or copper-bearing or hormonal IUD) to use until the condition is evaluated and treated.",
    "page_number": 114,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 899
  },
  {
    "id": "chunk_00900",
    "text": "use until the condition is evaluated and treated. y If bleeding is caused by an STI or pelvic inflammatory disease, she can continue using progestin-only injectables during treatment. Certain serious health conditions (suspected blocked or narrowed arteries, serious liver disease, severe high blood",
    "page_number": 114,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 900
  },
  {
    "id": "chunk_00901",
    "text": "arteries, serious liver disease, severe high blood pressure, blood clots in deep veins or legs or lungs, stroke, breast cancer, or damage to arteries, vision, kidneys, or nervous system caused by diabetes). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions.",
    "page_number": 114,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 901
  },
  {
    "id": "chunk_00902",
    "text": "\u2013 Signs and Symptoms of Serious Health Conditions. y Do not give the next injection. y Give the client a backup method to use until the condition is evaluated. y Refer the client for diagnosis and care if she is not already under care. Suspected pregnancy y Assess the client for pregnancy.",
    "page_number": 114,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 902
  },
  {
    "id": "chunk_00903",
    "text": "ected pregnancy y Assess the client for pregnancy. y Stop injections if pregnancy is confirmed. y There are no known risks to a fetus conceived while a woman is using injectables (see Question 12) or to a woman who receives an injection while pregnant.",
    "page_number": 114,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 903
  },
  {
    "id": "chunk_00904",
    "text": "4 93 selbatcejnI ylnO-nitsegorP Questions and Answers About Progestin-Only Injectables 1. Can women at risk for sexually transmitted infections (STIs) use progestin-only injectables? Yes. Women at risk for STIs can use progestin-only injectables. The few",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 904
  },
  {
    "id": "chunk_00905",
    "text": "r STIs can use progestin-only injectables. The few studies available have found that women using DMPA were more likely to acquire chlamydia than women not using hormonal contraception. The reason for this difference is not known. There are few studies",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 905
  },
  {
    "id": "chunk_00906",
    "text": "his difference is not known. There are few studies available on the use of NET-EN and STIs. Like anyone else at risk for STIs, a user of progestin-only injectables who may be at risk for STIs should be advised to use condoms correctly and consistently with every",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 906
  },
  {
    "id": "chunk_00907",
    "text": "use condoms correctly and consistently with every sex act\u2014this will reduce the risk of becoming infected with an STI. 2. Can women at high risk for HIV use progestin-only injectables? Yes. Except for using spermicides containing nonoxynol-9 (alone or with a",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 907
  },
  {
    "id": "chunk_00908",
    "text": "permicides containing nonoxynol-9 (alone or with a diaphragm), women at high risk of HIV infection can use any contraceptive method, including progestin-only injectables (see Chapter 16 \u2013 Spermicides and Diaphragms). More detailed information on the topic is",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 908
  },
  {
    "id": "chunk_00909",
    "text": "hragms). More detailed information on the topic is provided in Chapter 23 \u2013 Family Planning For Adolescents and Women at High Risk for HIV, including the importance of integrating HIV testing services into family planning care in settings where risk of HIV is high.",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 909
  },
  {
    "id": "chunk_00910",
    "text": "anning care in settings where risk of HIV is high. 3. I f a woman does not have monthly bleeding while using progestin-only injectables, does this mean that she is pregnant? Probably not, especially if she is breastfeeding. Eventually, most women",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 910
  },
  {
    "id": "chunk_00911",
    "text": "ly if she is breastfeeding. Eventually, most women using progestin-only injectables will not have monthly bleeding. If a woman has been getting her injections on time, she is probably not pregnant and can keep using injectables. If she is still worried after being",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 911
  },
  {
    "id": "chunk_00912",
    "text": "g injectables. If she is still worried after being reassured, she can be offered a pregnancy test, if available, or referred for one. If not having monthly bleeding bothers her, switching to a different method may help. 4. Can a woman who is breastfeeding safely use progestin-only injectables?",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 912
  },
  {
    "id": "chunk_00913",
    "text": "eastfeeding safely use progestin-only injectables? Yes. This is a good choice for a breastfeeding mother who wants a hormonal method. Progestin-only injectables are safe for both the mother and the baby starting as early as 6 weeks after childbirth. They do not affect milk production.",
    "page_number": 115,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 913
  },
  {
    "id": "chunk_00914",
    "text": "5. How much weight do women gain when they use progestin- only injectables? Women gain an average of 1\u20132 kg per year when using DMPA. Some of the weight increase may be the usual weight that people gain as they age. Some women, particularly overweight adolescents, have gained much",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 914
  },
  {
    "id": "chunk_00915",
    "text": "ticularly overweight adolescents, have gained much more than 1\u20132 kg per year. At the same time, some users of progestin- only injectables lose weight or have no significant change in weight. Asian women in particular do not tend to gain weight when using DMPA. 6. Do DMPA and NET-EN cause abortion?",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 915
  },
  {
    "id": "chunk_00916",
    "text": "using DMPA. 6. Do DMPA and NET-EN cause abortion? No. Research on progestin-only injectables finds that they do not disrupt an existing pregnancy. They should not be used to try to cause an abortion; they will not cause abortion. 7. Do progestin-only injectables make a woman infertile?",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 916
  },
  {
    "id": "chunk_00917",
    "text": "progestin-only injectables make a woman infertile? No. There may be a delay in regaining fertility after stopping progestin- only injectables, but in time the woman will be able to become pregnant as before, although fertility decreases as women get older. The bleeding",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 917
  },
  {
    "id": "chunk_00918",
    "text": "rtility decreases as women get older. The bleeding pattern a woman had before she used progestin-only injectables generally returns several months after the last injection even if she had no monthly bleeding while using injectables. 8. How long does it take to become pregnant after stopping",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 918
  },
  {
    "id": "chunk_00919",
    "text": "ong does it take to become pregnant after stopping DMPA or NET-EN? Women who stop using DMPA wait about 4 months longer on average to become pregnant than women who have used other methods. This means they become pregnant on average 10 months after their last",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 919
  },
  {
    "id": "chunk_00920",
    "text": "ome pregnant on average 10 months after their last injection. Women who stop using NET-EN wait about 1 month longer on average to become pregnant than women who have used other methods, or 6 months after their last injection. Since these are averages,",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 920
  },
  {
    "id": "chunk_00921",
    "text": "er their last injection. Since these are averages, a woman should not be worried if she has not become pregnant even as much as 12 months after stopping use. The length of time a woman has used injectables makes no difference to how quickly she becomes pregnant once she stops having injections.",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 921
  },
  {
    "id": "chunk_00922",
    "text": "becomes pregnant once she stops having injections. After stopping progestin-only injectables, a woman may ovulate before her monthly bleeding returns and thus can become pregnant. If she wants to continue avoiding pregnancy, she should start another method before monthly bleeding returns.",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 922
  },
  {
    "id": "chunk_00923",
    "text": "rt another method before monthly bleeding returns. 9. Does DMPA cause cancer? No. Many studies show that DMPA does not cause cancer. In fact, DMPA use helps protect against cancer of the lining of the uterus (endometrial cancer). Findings of a few studies on DMPA use and breast cancer are",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 923
  },
  {
    "id": "chunk_00924",
    "text": "of a few studies on DMPA use and breast cancer are similar to findings on the use of combined oral contraceptives (pills): women using DMPA were slightly more likely to be diagnosed with breast 94 Family Planning: A Global Handbook for Providers",
    "page_number": 116,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 924
  },
  {
    "id": "chunk_00925",
    "text": "4 95 selbatcejnI ylnO-nitsegorP cancer while using DMPA or within 10 years after they stopped. It is unclear whether these findings are explained by earlier detection of existing breast cancers among DMPA users (for example, due to more frequent contact",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 925
  },
  {
    "id": "chunk_00926",
    "text": "A users (for example, due to more frequent contact with health workers) or by a biologic effect of DMPA on breast cancer. A few studies on DMPA use and cervical cancer suggest that there may be a slightly increased risk of cervical cancer among women using",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 926
  },
  {
    "id": "chunk_00927",
    "text": "ncreased risk of cervical cancer among women using DMPA for 5 years or more. Cervical cancer cannot develop because of DMPA alone, however. It is caused by persistent infection with human papillomavirus (see the section on Cervical Cancer in Chapter 22,",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 927
  },
  {
    "id": "chunk_00928",
    "text": "(see the section on Cervical Cancer in Chapter 22, pp. 351\u2013354). Little information is available about NET-EN. It is considered to be as safe as DMPA and other contraceptive methods containing only a progestin, such as progestin-only pills and implants.",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 928
  },
  {
    "id": "chunk_00929",
    "text": "gestin, such as progestin-only pills and implants. 10. Can a woman switch from one progestin-only injectable to another? Switching injectables (from DMPA to NET-EN or vice versa) is safe, and it does not decrease effectiveness. If switching is necessary due to",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 929
  },
  {
    "id": "chunk_00930",
    "text": "se effectiveness. If switching is necessary due to shortages of supplies, the first injection of the new injectable should be given when the next injection of the old formulation would have been given. Clients need to be told that they are switching, the name of the",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 930
  },
  {
    "id": "chunk_00931",
    "text": "o be told that they are switching, the name of the new injectable, and its injection schedule. 11. How does DMPA affect bone density? During use, DMPA decreases bone mineral density slightly. This may increase the risk of developing osteoporosis and possibly also increase",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 931
  },
  {
    "id": "chunk_00932",
    "text": "developing osteoporosis and possibly also increase the risk of having bone fractures later, after menopause. WHO has concluded that this decrease in bone density does not place age or time limits on the use of DMPA. 12. Do progestin-only injectables cause birth defects? Will the",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 932
  },
  {
    "id": "chunk_00933",
    "text": "tin-only injectables cause birth defects? Will the fetus be harmed if a woman accidentally uses progestin-only injectables while she is pregnant? No. Good evidence shows that progestin-only injectables will not cause birth defects and will not otherwise harm the fetus if a woman becomes",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 933
  },
  {
    "id": "chunk_00934",
    "text": "ll not otherwise harm the fetus if a woman becomes pregnant while using progestin-only injectables or accidentally starts injectables when she is already pregnant. 13. D o progestin-only injectables lower women\u2019s mood or sex drive? Generally, no. Some women using injectables report these complaints,",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 934
  },
  {
    "id": "chunk_00935",
    "text": "e women using injectables report these complaints, but the great majority of users do not report any such changes. It is difficult to tell whether such changes are due to progestin-only injectables or to other reasons. Providers can help a client with these",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 935
  },
  {
    "id": "chunk_00936",
    "text": "er reasons. Providers can help a client with these problems (see \u201cMood changes or changes in sex drive\u201d, in the section of this chapter on Managing Any Problems, p. 91). There is no evidence that progestin-only injectables affect women\u2019s sexual behavior.",
    "page_number": 117,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 936
  },
  {
    "id": "chunk_00937",
    "text": "14. What if a woman returns for her next injection late? A woman can have her next DMPA injection even if she is up to 4 weeks late, without the need for further evidence that she is not pregnant. A woman can receive her next NET-EN injection if she is up to 2 weeks",
    "page_number": 118,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 937
  },
  {
    "id": "chunk_00938",
    "text": "her next NET-EN injection if she is up to 2 weeks late. Some women return even later for their repeat injection; in such cases providers can use the instructions on Ruling Out Pregnancy (p. 461), and if pregnancy can be ruled out then the injection can be",
    "page_number": 118,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 938
  },
  {
    "id": "chunk_00939",
    "text": "egnancy can be ruled out then the injection can be given and the woman should use a backup method for the next 7 days. Whether a woman is late for reinjection or not, her next injection of DMPA should be planned for 3 months (13 weeks) later, or her next",
    "page_number": 118,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 939
  },
  {
    "id": "chunk_00940",
    "text": "planned for 3 months (13 weeks) later, or her next injection of NET-EN should be planned for 2 months (8 weeks) later, as usual. When a Woman Can Have Her Next Injection of DMPA or NET-EN Up to 2 weeks BEFORE scheduled date DMPA MONTH 3 MONTH 4 25 Scheduled date Up to 4 weeks AFTER scheduled date",
    "page_number": 118,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 940
  },
  {
    "id": "chunk_00941",
    "text": "Scheduled date Up to 4 weeks AFTER scheduled date Up to 2 weeks BEFORE scheduled date NET-EN MONTH 2 MONTH 3 25 Scheduled date Up to 2 weeks AFTER scheduled date 96 Family Planning: A Global Handbook for Providers",
    "page_number": 118,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 941
  },
  {
    "id": "chunk_00942",
    "text": "5 97 selbatcejnI ylhtnoM CHAPTER 5 Monthly Injectables Key Points for Providers and Clients y Bleeding changes are common but not harmful. Typically, lighter monthly bleeding, fewer days of bleeding, or irregular or infrequent bleeding. y Return on time. Coming back every 4 weeks is important",
    "page_number": 119,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 942
  },
  {
    "id": "chunk_00943",
    "text": "rn on time. Coming back every 4 weeks is important for greatest effectiveness. y Injection can be as much as 7 days early or late. Even if later, she may still be able to have the injection. What Are Monthly Injectables? y Monthly injectables contain 2 hormones\u2014a progestin and an estrogen\u2014",
    "page_number": 119,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 943
  },
  {
    "id": "chunk_00944",
    "text": "es contain 2 hormones\u2014a progestin and an estrogen\u2014 like the natural hormones progesterone and estrogen in a woman\u2019s body. (Combined oral contraceptives also contain these 2 types of hormones.) y Also called combined injectable contraceptives, CICs, the injection.",
    "page_number": 119,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 944
  },
  {
    "id": "chunk_00945",
    "text": "ed injectable contraceptives, CICs, the injection. y Information in this chapter applies to medroxyprogesterone acetate (MPA)/estradiol cypionate and to norethisterone enanthate (NET-EN)/ estradiol valerate. The information may also apply to older formulations, about which less is known.",
    "page_number": 119,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 945
  },
  {
    "id": "chunk_00946",
    "text": "to older formulations, about which less is known. y MPA/estradiol cypionate is marketed under trade names such as Ciclofem, Ciclofemina, Cyclofem, Cyclo-Provera, Feminena, Lunella, Lunelle, and Novafem. NET-EN/estradiol valerate is marketed under trade names such as Mesigyna and Norigynon.",
    "page_number": 119,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 946
  },
  {
    "id": "chunk_00947",
    "text": "5 98 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM How Effective? More effective Effectiveness depends on returning on time: Risk of pregnancy is greatest when a woman is late for an injection or misses an injection. y As commonly used, about 3 pregnancies per 100 women using",
    "page_number": 120,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 947
  },
  {
    "id": "chunk_00948",
    "text": "only used, about 3 pregnancies per 100 women using monthly injectables over the first year. This means that 97 of every 100 women using injectables will not become pregnant. y When women have injections on time, less than 1 pregnancy per 100 women using monthly injectables over the first year",
    "page_number": 120,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 948
  },
  {
    "id": "chunk_00949",
    "text": "omen using monthly injectables over the first year (5 per 10,000 women). Less effective Return of fertility after injections are stopped: An average of about 5 months, one month longer than with most other methods (see Question 11, p. 103).",
    "page_number": 120,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 949
  },
  {
    "id": "chunk_00950",
    "text": "with most other methods (see Question 11, p. 103). Protection against sexually transmitted infections (STIs): None Why Some Women Say They Like Monthly Injectables y Do not require daily action y Are private: No one else can tell that a woman is using contraception y Can be stopped at any time",
    "page_number": 120,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 950
  },
  {
    "id": "chunk_00951",
    "text": "5 99 selbatcejnI ylhtnoM Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 112) Some users report the following: y Changes in bleeding patterns,\u2020 including: Bleeding changes are \u2013 Lighter bleeding and fewer days normal and not harmful.",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 951
  },
  {
    "id": "chunk_00952",
    "text": "er bleeding and fewer days normal and not harmful. of bleeding If a woman finds them bothersome, counseling \u2013 Irregular bleeding and support can help. \u2013 Infrequent bleeding \u2013 Prolonged bleeding \u2013 No monthly bleeding y Weight gain y Headaches y Dizziness y Breast tenderness",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 952
  },
  {
    "id": "chunk_00953",
    "text": "t gain y Headaches y Dizziness y Breast tenderness Known Health Benefits and Health Risks Long-term studies of monthly injectables are limited, but researchers expect that their health benefits and health risks are similar to those of combined",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 953
  },
  {
    "id": "chunk_00954",
    "text": "and health risks are similar to those of combined oral contraceptives (see Chapter 1 \u2013 Combined Oral Contraceptives, Health Benefits and Health Risks, p. 3). There may be some differences in the effects on the liver, however (see Question 2, p. 116).",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 954
  },
  {
    "id": "chunk_00955",
    "text": "ts on the liver, however (see Question 2, p. 116). Correcting Misunderstandings (see also Questions and Answers, p. 116) Monthly injectables: y Can stop monthly bleeding, but this is not harmful. It is similar to not having monthly bleeding during pregnancy. Blood is not building up inside the woman.",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 955
  },
  {
    "id": "chunk_00956",
    "text": "gnancy. Blood is not building up inside the woman. y Do not make women infertile. y Do not cause early menopause. y Do not cause birth defects or multiple births. y Do not cause itching. y Do not change women\u2019s sexual behavior.",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 956
  },
  {
    "id": "chunk_00957",
    "text": "itching. y Do not change women\u2019s sexual behavior. \u2020 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. Monthly Injectables",
    "page_number": 121,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 957
  },
  {
    "id": "chunk_00958",
    "text": "5 100 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Who Can and Cannot Use Monthly Injectables Safe and Suitable for Nearly All Women Nearly all women can use monthly injectables safely and effectively, including women who: y Have or have not had children",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 958
  },
  {
    "id": "chunk_00959",
    "text": "cluding women who: y Have or have not had children y Are married or are not married y Are of any age, including adolescents and women over 40 years old y Have just had an abortion or miscarriage y Smoke any number of cigarettes daily and are under 35 years old",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 959
  },
  {
    "id": "chunk_00960",
    "text": "ber of cigarettes daily and are under 35 years old y Smoke fewer than 15 cigarettes daily and are over 35 years old y Have anemia now or had anemia in the past y Have varicose veins y Are living with HIV, whether or not on antiretroviral therapy Avoid Unnecessary Procedures",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 960
  },
  {
    "id": "chunk_00961",
    "text": "ntiretroviral therapy Avoid Unnecessary Procedures Women can begin using monthly injectables: Blood pressure measurement is desirable before starting a y Without a pelvic examination hormonal method. However, y Without any blood tests or other where the risks of pregnancy",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 961
  },
  {
    "id": "chunk_00962",
    "text": "blood tests or other where the risks of pregnancy routine laboratory tests are high and few methods y Without cervical cancer screening are available, a woman should not be denied a hormonal y Without a breast examination method simply because her",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 962
  },
  {
    "id": "chunk_00963",
    "text": "out a breast examination method simply because her y Without a pregnancy test. A woman blood pressure cannot be can begin using monthly injectables measured. If possible, she even when she is not having monthly can have her blood pressure",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 963
  },
  {
    "id": "chunk_00964",
    "text": "is not having monthly can have her blood pressure bleeding at the time, if it is reasonably measured later at a time and certain she is not pregnant (see place convenient for her. Pregnancy Checklist, inside back cover). Monthly Injectables for Women With HIV",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 964
  },
  {
    "id": "chunk_00965",
    "text": "ack cover). Monthly Injectables for Women With HIV y Women living with HIV or on antiretroviral therapy can safely use monthly injectables. y Urge these women to use condoms along with monthly injectables. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs.",
    "page_number": 122,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 965
  },
  {
    "id": "chunk_00966",
    "text": "5 101 selbatcejnI ylhtnoM Medical Eligibility Criteria for Monthly Injectables Ask the client the questions below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions, then she can start monthly injectables if she wants. If she",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 966
  },
  {
    "id": "chunk_00967",
    "text": "can start monthly injectables if she wants. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases she can still start monthly injectables. 1. Are you breastfeeding a baby less than 6 months old? \u274f NO \u274f YES y If fully or nearly fully breastfeeding: She can start",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 967
  },
  {
    "id": "chunk_00968",
    "text": "fully or nearly fully breastfeeding: She can start 6 months after giving birth or when breast milk is no longer the baby\u2019s main food\u2014whichever comes first (see Fully or nearly fully breastfeeding, p. 105). y If partially breastfeeding: She can start monthly",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 968
  },
  {
    "id": "chunk_00969",
    "text": "If partially breastfeeding: She can start monthly injectables as soon as 6 weeks after giving birth (see Partially breastfeeding, p. 106). 2. Have you had a baby in the last 3 weeks and you are not breastfeeding? \u274f NO \u274f YES She can start monthly injectables as soon as",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 969
  },
  {
    "id": "chunk_00970",
    "text": "\u274f YES She can start monthly injectables as soon as 3 weeks after childbirth. (If there is an additional risk that she might develop a blood clot in a deep vein [deep vein thrombosis, or VTE], then she should not start monthly injectables at 3 weeks after childbirth, but can",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 970
  },
  {
    "id": "chunk_00971",
    "text": "y injectables at 3 weeks after childbirth, but can start at 6 weeks instead. These additional risk factors include previous VTE, thrombophilia, caesarean delivery, blood transfusion at delivery, postpartum hemorrhage, pre-eclampsia, obesity [\u226530 kg/m2], smoking, and being",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 971
  },
  {
    "id": "chunk_00972",
    "text": "eclampsia, obesity [\u226530 kg/m2], smoking, and being bedridden for a prolonged time.) 3. Do you smoke 15 or more cigarettes a day? \u274f NO \u274f YES If she is 35 years of age or older and smokes more than 15 cigarettes a day, do not provide monthly injectables.",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 972
  },
  {
    "id": "chunk_00973",
    "text": "arettes a day, do not provide monthly injectables. Urge her to stop smoking and help her choose another method. 4. Do you have severe liver disease\u2014active hepatitis, severe cirrhosis, or liver tumor? \u274f NO \u274f YES If she reports active hepatitis, severe cirrhosis,",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 973
  },
  {
    "id": "chunk_00974",
    "text": "If she reports active hepatitis, severe cirrhosis, or liver tumor, do not provide monthly injectables. Help her choose a method without hormones. (If she has mild cirrhosis or gallbladder disease, she can use monthly injectables.) (Continued on next page) Who Can and Cannot Use Monthly Injectables",
    "page_number": 123,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 974
  },
  {
    "id": "chunk_00975",
    "text": "5 102 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Medical Eligibility Criteria for Monthly Injectables (continued) 5. Do you have high blood pressure? \u274f NO \u274f YES If you cannot check blood pressure and she reports a history of high blood pressure, or if she is being treated",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 975
  },
  {
    "id": "chunk_00976",
    "text": "of high blood pressure, or if she is being treated for high blood pressure, do not provide monthly injectables. Refer her for a blood pressure check if possible or help her choose another method without estrogen. Check her blood pressure if possible: y If blood pressure is below 140/90 mm Hg, provide",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 976
  },
  {
    "id": "chunk_00977",
    "text": "y If blood pressure is below 140/90 mm Hg, provide monthly injectables. y If systolic blood pressure is 140 mm Hg or higher or diastolic blood pressure is 90 or higher, do not provide monthly injectables. Help her choose a method without estrogen, but not progestin-only injectables if systolic",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 977
  },
  {
    "id": "chunk_00978",
    "text": "en, but not progestin-only injectables if systolic blood pressure is 160 or higher or diastolic pressure is 100 or higher. (One blood pressure reading in the range of 140\u2013159/ 90\u201399 mm Hg is not enough to diagnose high blood pressure. Provide a backup method* to use until she can",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 978
  },
  {
    "id": "chunk_00979",
    "text": "ure. Provide a backup method* to use until she can return for another blood pressure check, or help her choose another method now if she prefers. If blood pressure at next check is below 140/90, she can use monthly injectables.)\u2020 6. Have you had diabetes for more than 20 years or",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 979
  },
  {
    "id": "chunk_00980",
    "text": "6. Have you had diabetes for more than 20 years or damage to your arteries, vision, kidneys, or nervous system caused by diabetes? \u274f NO \u274f YES Do not provide monthly injectables. Help her choose a method without estrogen but not progestin-only injectables.",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 980
  },
  {
    "id": "chunk_00981",
    "text": "thout estrogen but not progestin-only injectables. 7. Have you ever had a stroke, blood clot in your leg or lungs, heart attack, or other serious heart problems? \u274f NO \u274f YES If she reports heart attack, heart disease due to blocked or narrowed arteries, or stroke, do not provide",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 981
  },
  {
    "id": "chunk_00982",
    "text": "ed or narrowed arteries, or stroke, do not provide monthly injectables. Help her choose a method without estrogen but not progestin-only injectables. If she reports a current blood clot in the deep veins of the leg (not a superficial clot) or in the lungs, help her choose a method without hormones.",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 982
  },
  {
    "id": "chunk_00983",
    "text": "lungs, help her choose a method without hormones. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 124,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 983
  },
  {
    "id": "chunk_00984",
    "text": "5 103 selbatcejnI ylhtnoM 8. Do you have or have you ever had breast cancer? \u274f NO \u274f YES Do not provide monthly injectables. Help her choose a method without hormones. 9. Do you sometimes see a bright area of lost vision in the eye before a very bad headache (migraine aura)? Do",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 984
  },
  {
    "id": "chunk_00985",
    "text": "eye before a very bad headache (migraine aura)? Do you get throbbing, severe head pain, often on one side of the head, that can last from a few hours to several days and can cause nausea or vomiting (migraine headaches)? Such headaches are often made worse by light, noise, or moving about.",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 985
  },
  {
    "id": "chunk_00986",
    "text": "often made worse by light, noise, or moving about. \u274f NO \u274f YES If she has migraine aura at any age, do not provide monthly injectables. If she has migraine headaches without aura and is age 35 or older, do not provide monthly injectables. Help these women choose a method without",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 986
  },
  {
    "id": "chunk_00987",
    "text": "ectables. Help these women choose a method without estrogen. If she is under age 35 and has migraine headaches without aura, she can use monthly injectables (see Identifying Migraine Headaches and Auras, pp. 458\u2013460). 10. Are you planning major surgery that will keep you from",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 987
  },
  {
    "id": "chunk_00988",
    "text": "you planning major surgery that will keep you from walking for one week or more? \u274f NO \u274f YES If so, she can start monthly injectables 2 weeks after the surgery. Until she can start monthly injectables, she should use a backup method. 11. Do you have several conditions that could increase",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 988
  },
  {
    "id": "chunk_00989",
    "text": "Do you have several conditions that could increase your chances of heart disease (coronary artery disease) or stroke, such as older age, smoking, high blood pressure, or diabetes? \u274f NO \u274f YES Do not provide monthly injectables. Help her choose a",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 989
  },
  {
    "id": "chunk_00990",
    "text": "not provide monthly injectables. Help her choose a method without estrogen, but not progestin-only injectables. 12. Are you taking lamotrigine? \u274f NO \u274f YES Do not provide monthly injectables. Monthly injectables can make lamotrigine less effective. Help her choose a method without estrogen.",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 990
  },
  {
    "id": "chunk_00991",
    "text": "ective. Help her choose a method without estrogen. Also, women should not use monthly injectables if they report having thrombogenic mutations or lupus with positive (or unknown) anti- phospholipid antibodies. For complete classifications, see Appendix D",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 991
  },
  {
    "id": "chunk_00992",
    "text": "dies. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions that",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 992
  },
  {
    "id": "chunk_00993",
    "text": "ient will use. Also, point out any conditions that would make the method inadvisable, when relevant to the client. Who Can and Cannot Use Monthly Injectables",
    "page_number": 125,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 993
  },
  {
    "id": "chunk_00994",
    "text": "5 104 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not use monthly injectables. In special circumstances, however, when other,",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 994
  },
  {
    "id": "chunk_00995",
    "text": "es. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use monthly injectables. The",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 995
  },
  {
    "id": "chunk_00996",
    "text": "y decide that she can use monthly injectables. The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up. y Not breastfeeding and less than 3 weeks since giving birth, without",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 996
  },
  {
    "id": "chunk_00997",
    "text": "and less than 3 weeks since giving birth, without additional risk that she might develop a blood clot in a deep vein (VTE) y Not breastfeeding and between 3 and 6 weeks postpartum with additional risk that she might develop VTE y Primarily breastfeeding between 6 weeks and 6 months since",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 997
  },
  {
    "id": "chunk_00998",
    "text": "y breastfeeding between 6 weeks and 6 months since giving birth y Age 35 or older and smokes more than 15 cigarettes a day y High blood pressure (systolic blood pressure between 140 and 159 mm Hg or diastolic blood pressure between 90 and 99 mm Hg)",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 998
  },
  {
    "id": "chunk_00999",
    "text": "diastolic blood pressure between 90 and 99 mm Hg) y Controlled high blood pressure, where continuing evaluation is possible y History of high blood pressure, where blood pressure cannot be taken (including pregnancy-related high blood pressure) y Severe liver disease, infection, or tumor",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 999
  },
  {
    "id": "chunk_01000",
    "text": "ssure) y Severe liver disease, infection, or tumor y Age 35 or older and has migraine headaches without aura y Younger than age 35 and has migraine headaches that have developed or have gotten worse while using monthly injectables y Had breast cancer more than 5 years ago, and it has not returned",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1000
  },
  {
    "id": "chunk_01001",
    "text": "cer more than 5 years ago, and it has not returned y Diabetes for more than 20 years or damage to arteries, vision, kidneys, or nervous system caused by diabetes y Multiple risk factors for arterial cardiovascular disease, such as older age, smoking, diabetes, and high blood pressure",
    "page_number": 126,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1001
  },
  {
    "id": "chunk_01002",
    "text": "5 105 selbatcejnI ylhtnoM Providing Monthly Injectables When to Start IMPORTANT: A woman can start injectables any time she wants if it is reasonably certain she is not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover).",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1002
  },
  {
    "id": "chunk_01003",
    "text": "e the Pregnancy Checklist (see inside back cover). Woman\u2019s situation When to start Having menstrual Any time of the month cycles or y If she is starting within 7 days after the start of her switching from monthly bleeding, no need for a backup method. a nonhormonal",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1003
  },
  {
    "id": "chunk_01004",
    "text": "eeding, no need for a backup method. a nonhormonal y If it is more than 7 days after the start of her method monthly bleeding, she can start injectables any time if it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after the injection.",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1004
  },
  {
    "id": "chunk_01005",
    "text": "method* for the first 7 days after the injection. y If she is switching from an IUD, she can start injectables immediately (see Switching From an IUD to Another Method, in Chapter 10 \u2013 Copper-Bearing Intrauterine Device, pp. 187\u2013188). Switching from y Immediately, if she has been using the hormonal",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1005
  },
  {
    "id": "chunk_01006",
    "text": "y Immediately, if she has been using the hormonal a hormonal method consistently and correctly or if it is method otherwise reasonably certain she is not pregnant. No need to wait for her next monthly bleeding. No need for a backup method. y If she is switching from another injectable, she can",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1006
  },
  {
    "id": "chunk_01007",
    "text": "she is switching from another injectable, she can have the new injectable when the repeat injection would have been given. No need for a backup method. Fully or nearly fully breastfeeding Less than y Delay her first injection until 6 months after giving",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1007
  },
  {
    "id": "chunk_01008",
    "text": "ay her first injection until 6 months after giving 6 months after birth or when breast milk is no longer the baby\u2019s giving birth main food\u2014whichever comes first. More than y If her monthly bleeding has not returned, she can 6 months after start injectables any time if it is reasonably certain",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1008
  },
  {
    "id": "chunk_01009",
    "text": "t injectables any time if it is reasonably certain giving birth she is not pregnant. She will need a backup method* for the first 7 days after the injection. y If her monthly bleeding has returned, she can start injectables as advised for women having menstrual cycles (see above).",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1009
  },
  {
    "id": "chunk_01010",
    "text": "sed for women having menstrual cycles (see above). * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. Providing Monthly Injectables",
    "page_number": 127,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1010
  },
  {
    "id": "chunk_01011",
    "text": "5 106 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Woman\u2019s situation When to start (continued) Partially breastfeeding Less than 6 weeks y Delay her first injection until at least 6 weeks after giving birth after giving birth.",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1011
  },
  {
    "id": "chunk_01012",
    "text": "ast 6 weeks after giving birth after giving birth. More than 6 weeks y If her monthly bleeding has not returned, she can after giving birth start injectables any time if it is reasonably certain she is not pregnant.\u2020 She will need a backup method* for the first 7 days after the injection.",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1012
  },
  {
    "id": "chunk_01013",
    "text": "method* for the first 7 days after the injection. y If her monthly bleeding has returned, she can start injectables as advised for women having menstrual cycles (see p. 105). Not breastfeeding Less than 4 weeks y She can start injectables at any time on days",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1013
  },
  {
    "id": "chunk_01014",
    "text": "ks y She can start injectables at any time on days after giving birth 21\u201328 after giving birth. No need for a backup method. (If additional risk for VTE, wait until 6 weeks. See p. 101, Question 2.) More than 4 weeks y If her monthly bleeding has not returned, she can",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1014
  },
  {
    "id": "chunk_01015",
    "text": "If her monthly bleeding has not returned, she can after giving birth start injectables any time if it is reasonably certain she is not pregnant.\u2020 She will need a backup method* for the first 7 days after the injection. y If her monthly bleeding has returned, she can",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1015
  },
  {
    "id": "chunk_01016",
    "text": "n. y If her monthly bleeding has returned, she can start injectables as advised for women having menstrual cycles (see p. 105). No monthly y She can start injectables any time if it is bleeding (not reasonably certain she is not pregnant. She will",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1016
  },
  {
    "id": "chunk_01017",
    "text": "t reasonably certain she is not pregnant. She will related to childbirth need a backup method* for the first 7 days after or breastfeeding) the injection. * Backup methods include abstinence, male and female condoms, spermicides, and",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1017
  },
  {
    "id": "chunk_01018",
    "text": "tinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. \u2020 Where a visit 6 weeks after childbirth is routinely recommended and other opportunities to",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1018
  },
  {
    "id": "chunk_01019",
    "text": "s routinely recommended and other opportunities to obtain contraception are limited, some providers and programs may give the first injection at the 6-week visit, without further evidence that the woman is not pregnant, if her monthly bleeding has not yet returned.",
    "page_number": 128,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1019
  },
  {
    "id": "chunk_01020",
    "text": "5 107 selbatcejnI ylhtnoM Woman\u2019s situation When to start After y Immediately. If she is starting within 7 days after miscarriage or first- or second-trimester miscarriage or abortion abortion, no need for a backup method. y If it is more than 7 days after first- or second-",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1020
  },
  {
    "id": "chunk_01021",
    "text": "If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can start injectables any time if it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after the injection. After taking After taking progestin-only or",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1021
  },
  {
    "id": "chunk_01022",
    "text": "ction. After taking After taking progestin-only or emergency combined ECPs: contraceptive y She can start or restart injectables on the pills (ECPs) same day as taking the ECPs. There is no need to wait for her next monthly bleeding to have the injection.",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1022
  },
  {
    "id": "chunk_01023",
    "text": "r her next monthly bleeding to have the injection. y She will need a backup method* for the first 7 days after the injection. y If she does not start immediately, but returns for injectables, she can start at any time if it is reasonably certain she is not pregnant.",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1023
  },
  {
    "id": "chunk_01024",
    "text": "e if it is reasonably certain she is not pregnant. After taking ulipristal acetate (UPA) ECPs: y She can start or restart injectables on the 6th day after taking UPA-ECPs. No need to wait for her next monthly bleeding. Monthly injectables and UPA interact. If an injectable is started sooner,",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1024
  },
  {
    "id": "chunk_01025",
    "text": "UPA interact. If an injectable is started sooner, and thus both are present in the body, one or both may be less effective. y Make an appointment for her to return for the injection on the 6th day after taking UPA-ECPs, or as soon as possible after that. y She will need a backup method* from the",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1025
  },
  {
    "id": "chunk_01026",
    "text": "er that. y She will need a backup method* from the time she takes UPA-ECPs until 7 days after the injection. y If she does not start on the 6th day but returns later for injectables, she may start at any time if it is reasonably certain she is not pregnant.",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1026
  },
  {
    "id": "chunk_01027",
    "text": "e if it is reasonably certain she is not pregnant. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. Providing Monthly Injectables",
    "page_number": 129,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1027
  },
  {
    "id": "chunk_01028",
    "text": "5 108 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes and other side effects must come before giving the injection. Counseling about bleeding",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1028
  },
  {
    "id": "chunk_01029",
    "text": "re giving the injection. Counseling about bleeding changes may be the most important help a woman needs to keep using the method without concern. Describe the y Lighter bleeding and fewer days of bleeding, most common irregular bleeding, and infrequent bleeding. side effects",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1029
  },
  {
    "id": "chunk_01030",
    "text": "ar bleeding, and infrequent bleeding. side effects y Weight gain, headaches, dizziness, breast tenderness, and possibly other side effects. Explain about y Side effects are not signs of illness. Lack of these side effects bleeding does not mean pregnancy.",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1030
  },
  {
    "id": "chunk_01031",
    "text": "ese side effects bleeding does not mean pregnancy. y Usually become less or stop within the first few months after starting injections. y Common, but some women do not have them. y The client can come back for help if side effects bother her or if she has other concerns. Giving the Injection",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1031
  },
  {
    "id": "chunk_01032",
    "text": "or if she has other concerns. Giving the Injection 1. Obtain y 25 mg MPA/estradiol cypionate or 50 mg one dose of NET-EN/estradiol valerate, intramuscular injectable, injection needle, and 2 ml or 5 ml syringe. needle, and (NET-EN/estradiol valerate is sometimes",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1032
  },
  {
    "id": "chunk_01033",
    "text": "eedle, and (NET-EN/estradiol valerate is sometimes syringe available in prefilled syringes.) y For each injection use a disposable auto-disable syringe and needle from a new sealed package (within expiration date and not damaged), if available. 2. Wash y Wash hands with soap and water, if possible.",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1033
  },
  {
    "id": "chunk_01034",
    "text": "ash y Wash hands with soap and water, if possible. y If injection site is dirty, wash it with soap and water. y No need to wipe site with antiseptic. If using a prefilled syringe, skip to step 5.",
    "page_number": 130,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1034
  },
  {
    "id": "chunk_01035",
    "text": "5 109 selbatcejnI ylhtnoM 3. Prepare vial y MPA/estradiol cypionate: Gently shake the vial. y NET-EN/estradiol valerate: Shaking the vial is not necessary. y No need to wipe top of vial with antiseptic. y If vial is cold, warm to skin temperature before giving the injection.",
    "page_number": 131,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1035
  },
  {
    "id": "chunk_01036",
    "text": "m to skin temperature before giving the injection. 4. Fill syringe y Pierce top of vial with sterile needle and fill syringe with proper dose. 5. Inject formula y Insert sterile needle deep into the hip (ventrogluteal muscle), the upper arm (deltoid muscle), the buttocks (gluteal muscle, upper",
    "page_number": 131,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1036
  },
  {
    "id": "chunk_01037",
    "text": "ltoid muscle), the buttocks (gluteal muscle, upper outer portion), or outer (anterior) thigh, whichever the woman prefers. Inject the contents of the syringe. y Do not massage injection site. 6. Dispose of y Do not recap, bend, or break needles disposable before disposal. syringes and",
    "page_number": 131,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1037
  },
  {
    "id": "chunk_01038",
    "text": "k needles disposable before disposal. syringes and y Place in a puncture-proof sharps container. needles safely y Do not reuse disposable syringes and needles. They are meant to be destroyed after a single use. Because of their shape, they are very difficult to disinfect.",
    "page_number": 131,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1038
  },
  {
    "id": "chunk_01039",
    "text": "their shape, they are very difficult to disinfect. Therefore, reuse might transmit diseases such as HIV and hepatitis. y If reusable syringe and needle are used, they must be sterilized again after each use (see Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404).",
    "page_number": 131,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1039
  },
  {
    "id": "chunk_01040",
    "text": "5 110 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Supporting New and Continuing Users Give specific y Tell her not to massage the injection site. instructions y Tell the client the name of the injection and agree on a date for her next injection in about 4 weeks.",
    "page_number": 132,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1040
  },
  {
    "id": "chunk_01041",
    "text": "on a date for her next injection in about 4 weeks. How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: y Support a woman\u2019s choice of a monthly injectable",
    "page_number": 132,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1041
  },
  {
    "id": "chunk_01042",
    "text": "y Support a woman\u2019s choice of a monthly injectable y Show understanding and support if she has side effects y Help her to remember to get her next injection on time y Help to make sure she has ECPs on hand in case she is more than one week late for injection",
    "page_number": 132,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1042
  },
  {
    "id": "chunk_01043",
    "text": "case she is more than one week late for injection y Use condoms consistently in addition to monthly injectables if he has an STI/HIV or thinks he may be at risk of an STI/HIV \u201cCome Back Any Time\u201d: Reasons to Return Before the Next Injection",
    "page_number": 132,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1043
  },
  {
    "id": "chunk_01044",
    "text": "Time\u201d: Reasons to Return Before the Next Injection Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she has a major change in health status; or she thinks she might be pregnant. General health advice",
    "page_number": 132,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1044
  },
  {
    "id": "chunk_01045",
    "text": "hinks she might be pregnant. General health advice Anyone who suddenly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the",
    "page_number": 132,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1045
  },
  {
    "id": "chunk_01046",
    "text": "5 111 selbatcejnI ylhtnoM Planning the Next Injection Month 1. Agree on a date for her next injection in 4 weeks. 2. Ask her to try to come on time. She may come up to 7 days before the scheduled date or 7 days late and still get an injection. 3. She should come back no 4 weeks between",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1046
  },
  {
    "id": "chunk_01047",
    "text": "ection. 3. She should come back no 4 weeks between matter how late she is for her injections next injection. If more than 7 days late, she should abstain from sex or use condoms, spermicides, or withdrawal until she can get an injection.",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1047
  },
  {
    "id": "chunk_01048",
    "text": "des, or withdrawal until she can get an injection. She can also consider emergency contraceptive pills if she is more than 7 days late and she has had unprotected sex in the past 5 days (see Chapter 3 \u2013 Emergency Contraceptive Pills). Repeat Injection Visits",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1048
  },
  {
    "id": "chunk_01049",
    "text": "ency Contraceptive Pills). Repeat Injection Visits 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss. 2. Ask especially if she is concerned about bleeding changes. Give her",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1049
  },
  {
    "id": "chunk_01050",
    "text": "she is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, next page). 3. Give her the injection. Injection can be given up to 7 days early or late. 4. Plan for her next injection. Agree on a date for her next injection (in",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1050
  },
  {
    "id": "chunk_01051",
    "text": "ection. Agree on a date for her next injection (in 4 weeks). Remind her that she should try to come on time, but she should come back no matter how late she is. She may still be able to have her injection. 5. Every year or so, check her blood pressure if possible (see Medical",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1051
  },
  {
    "id": "chunk_01052",
    "text": "check her blood pressure if possible (see Medical Eligibility Criteria, Question 5, p. 102). 6. Ask a long-term client if she has had any new health problems. Address problems as appropriate. For new health problems that may require switching methods, see p. 114.",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1052
  },
  {
    "id": "chunk_01053",
    "text": "ms that may require switching methods, see p. 114. 7. Ask a long-term client about major life changes that may affect her needs\u2014particularly plans for having children and STI/HIV risk. Follow up as needed. Supporting New and Continuing Users",
    "page_number": 133,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1053
  },
  {
    "id": "chunk_01054",
    "text": "5 112 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Managing Late Injections y If the client is less than 7 days late for a repeat injection, she can receive her next injection. No need for tests, evaluation, or a backup method.",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1054
  },
  {
    "id": "chunk_01055",
    "text": "No need for tests, evaluation, or a backup method. y A client who is more than 7 days late can receive her next injection if: \u2013 She has not had sex since 7 days after the scheduled date of her injection, or \u2013 She has used a backup method When a Woman Can Have or has taken emergency",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1055
  },
  {
    "id": "chunk_01056",
    "text": "ethod When a Woman Can Have or has taken emergency contraceptive pills (ECPs) Her Next Injection of a after any unprotected Monthly Injectable sex since 7 days after the Up to 7 days scheduled date of her BEFORE injection. MONTH scheduled date \u2013 She will need a backup method",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1056
  },
  {
    "id": "chunk_01057",
    "text": "NTH scheduled date \u2013 She will need a backup method for the first 7 days after the injection. y If the client is more than 7 days late and does not meet these 18 criteria, additional steps can be taken to be reasonably certain she is not pregnant (see the job aid Ruling Out Pregnancy, p. 461).",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1057
  },
  {
    "id": "chunk_01058",
    "text": "nt (see the job aid Ruling Out Pregnancy, p. 461). y Discuss why the client was late Up to 7 days Scheduled date AFTER and solutions. If coming back on scheduled date time is often a problem, discuss using a backup method when she is late for her next injection, taking ECPs, or choosing another",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1058
  },
  {
    "id": "chunk_01059",
    "text": "r next injection, taking ECPs, or choosing another method. Managing Any Problems Problems Reported as Side Effects May or may not be due to the method. y Problems with side effects affect women\u2019s satisfaction and use of injectables. They deserve the provider\u2019s attention. If the client reports",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1059
  },
  {
    "id": "chunk_01060",
    "text": "ve the provider\u2019s attention. If the client reports side effects, listen to her concerns, give her advice and support, and, if appropriate, treat. Make sure she understands the advice and agrees. y Offer to help the client choose another method\u2014now, if she wishes, or if problems cannot be overcome.",
    "page_number": 134,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1060
  },
  {
    "id": "chunk_01061",
    "text": "5 113 selbatcejnI ylhtnoM Irregular bleeding (bleeding at unexpected times that bothers the client) y Reassure her that many women using monthly injectables experience irregular bleeding. It is not harmful and usually becomes less or stops after the first few months of use.",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1061
  },
  {
    "id": "chunk_01062",
    "text": "s less or stops after the first few months of use. y For modest short-term relief, she can try 800 mg ibuprofen 3 times daily after meals for 5 days, or other nonsteroidal anti-inflammatory drug (NSAID), beginning when irregular bleeding starts. NSAIDs provide",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1062
  },
  {
    "id": "chunk_01063",
    "text": "ing when irregular bleeding starts. NSAIDs provide some relief of irregular bleeding for implants, progestin-only injectables, and IUDs, and they may also help for monthly injectables. y If irregular bleeding continues or starts after several months of normal or",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1063
  },
  {
    "id": "chunk_01064",
    "text": "tinues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, next page).",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1064
  },
  {
    "id": "chunk_01065",
    "text": "e (see \u201cUnexplained vaginal bleeding\u201d, next page). Heavy or prolonged bleeding (twice as much as usual or longer than 8 days) y Reassure her that many women using monthly injectables experience heavy or prolonged bleeding. It is generally not harmful and usually",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1065
  },
  {
    "id": "chunk_01066",
    "text": "bleeding. It is generally not harmful and usually becomes less or stops after a few months. y For modest short-term relief, she can try 800 mg ibuprofen 3 times daily after meals for 5 days, or other NSAID, beginning when heavy bleeding",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1066
  },
  {
    "id": "chunk_01067",
    "text": "ays, or other NSAID, beginning when heavy bleeding starts. NSAIDs provide some relief of heavy bleeding for implants, progestin-only injectables, and IUDs, and they may also help for monthly injectables. y To help prevent anemia, suggest she take iron tablets and tell her it",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1067
  },
  {
    "id": "chunk_01068",
    "text": "mia, suggest she take iron tablets and tell her it is important to eat foods containing iron, such as meat and poultry (especially beef and chicken liver), fish, green leafy vegetables, and legumes (beans, bean curd, lentils, and peas).",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1068
  },
  {
    "id": "chunk_01069",
    "text": "and legumes (beans, bean curd, lentils, and peas). y If heavy or prolonged bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1069
  },
  {
    "id": "chunk_01070",
    "text": "asons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, next page). No monthly bleeding y Reassure her that some women using monthly injectables stop having monthly bleeding, and this not harmful. There is no need to lose blood",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1070
  },
  {
    "id": "chunk_01071",
    "text": "d this not harmful. There is no need to lose blood every month. It is similar to not having monthly bleeding during pregnancy. She is not pregnant or infertile. Blood is not building up inside her. (Some women are happy to be free from monthly bleeding.) Supporting New and Continuing Users",
    "page_number": 135,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1071
  },
  {
    "id": "chunk_01072",
    "text": "5 114 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Weight gain y Review diet and counsel as needed. Ordinary headaches (nonmigrainous) y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever.",
    "page_number": 136,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1072
  },
  {
    "id": "chunk_01073",
    "text": "aracetamol (325\u20131,000 mg), or other pain reliever. y Any headaches that get worse or occur more often during use of injectables should be evaluated. Breast tenderness y Recommend that she wear a supportive bra (including during strenuous activity and sleep). y Try hot or cold compresses.",
    "page_number": 136,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1073
  },
  {
    "id": "chunk_01074",
    "text": "activity and sleep). y Try hot or cold compresses. y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. y Consider locally available remedies. Dizziness y Consider locally available remedies. New Problems That May Require Switching Methods",
    "page_number": 136,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1074
  },
  {
    "id": "chunk_01075",
    "text": "s. New Problems That May Require Switching Methods May or may not be due to the method. Unexplained vaginal bleeding (that suggests a medical condition not related to the method) y Refer or evaluate by history and pelvic examination. Diagnose and treat as appropriate.",
    "page_number": 136,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1075
  },
  {
    "id": "chunk_01076",
    "text": "ic examination. Diagnose and treat as appropriate. y She can continue using monthly injectables while her condition is being evaluated. y If bleeding is caused by sexually transmitted infection or pelvic inflammatory disease, she can continue using monthly injectables during treatment.",
    "page_number": 136,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1076
  },
  {
    "id": "chunk_01077",
    "text": "ntinue using monthly injectables during treatment. Migraine headaches (see Identifying Migraine Headaches and Auras, p. 458) y Regardless of her age, a woman who develops migraine headaches, with or without aura, or whose migraine headaches become worse while using",
    "page_number": 136,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1077
  },
  {
    "id": "chunk_01078",
    "text": "5 115 selbatcejnI ylhtnoM Circumstances that will keep her from walking for 1 week or more y If she is having major surgery, or her leg is in a cast, or for other reasons she will be unable to move about for several weeks, she should: \u2013 Tell her doctors that she is using monthly injectables.",
    "page_number": 137,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1078
  },
  {
    "id": "chunk_01079",
    "text": "her doctors that she is using monthly injectables. \u2013 Stop injections one month before scheduled surgery, if possible, and use a backup method during this period. \u2013 Restart monthly injectables 2 weeks after she can move about again. Certain serious health conditions (suspected heart or liver",
    "page_number": 137,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1079
  },
  {
    "id": "chunk_01080",
    "text": "erious health conditions (suspected heart or liver disease, high blood pressure [systolic pressure of 140 mm Hg or higher or diastolic pressure of 90 mm Hg or higher], blood clots in deep veins of legs or lungs, stroke, breast cancer, or damage to arteries, vision, kidneys, or nervous system caused",
    "page_number": 137,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1080
  },
  {
    "id": "chunk_01081",
    "text": "rteries, vision, kidneys, or nervous system caused by diabetes). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. y Do not give the next injection. y Give her a backup method to use until the condition is evaluated. y Refer for diagnosis and care if not already under care.",
    "page_number": 137,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1081
  },
  {
    "id": "chunk_01082",
    "text": "for diagnosis and care if not already under care. Suspected pregnancy y Assess for pregnancy. y Stop injections if pregnancy is confirmed. y There are no known risks to a fetus conceived while a woman is using injectables (see Question 3, next page.) Starting treatment with lamotrigine",
    "page_number": 137,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1082
  },
  {
    "id": "chunk_01083",
    "text": "3, next page.) Starting treatment with lamotrigine y Combined hormonal methods, including monthly injectables, can make lamotrigine less effective. Unless she can use a different medication for seizures than lamotrigine, help her choose a method without estrogen. Supporting New and Continuing Users",
    "page_number": 137,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1083
  },
  {
    "id": "chunk_01084",
    "text": "5 116 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM Questions and Answers About Monthly Injectables 1. How are monthly injectables different from progestin-only injectables? The major difference between monthly injectables and the progestin-only",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1084
  },
  {
    "id": "chunk_01085",
    "text": "between monthly injectables and the progestin-only injectables DMPA or NET-EN is that the monthly injectables contain an estrogen as well as these progestins, making them a combined method. Also, monthly injectables contain less progestin. These differences",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1085
  },
  {
    "id": "chunk_01086",
    "text": "ectables contain less progestin. These differences result in more regular bleeding and fewer bleeding disturbances than with progestin-only injectables. Monthly injectables require a monthly injection, whereas NET-EN is injected every 2 months and DMPA, every",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1086
  },
  {
    "id": "chunk_01087",
    "text": "NET-EN is injected every 2 months and DMPA, every 3 months. (See the job aid Comparing Injectables.) 2. Do monthly injectables function like combined oral contraceptives? Largely, yes. Monthly injectables (also called combined injectable",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1087
  },
  {
    "id": "chunk_01088",
    "text": "nthly injectables (also called combined injectable contraceptives) are similar to combined oral contraceptives (COCs). There are few long-term studies done on monthly injectables, but researchers assume that most of the findings about COCs also apply",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1088
  },
  {
    "id": "chunk_01089",
    "text": "me that most of the findings about COCs also apply to monthly injectables. Monthly injectables, however, do not pass through the liver first because they are not taken by mouth like COCs. Short-term studies have shown that monthly injectables have less effect",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1089
  },
  {
    "id": "chunk_01090",
    "text": "ve shown that monthly injectables have less effect than COCs on blood pressure, blood clotting, the breakdown of fatty substances (lipid metabolism), and liver function. Long-term studies of the health risks and benefits of monthly injectables are under way.",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1090
  },
  {
    "id": "chunk_01091",
    "text": "and benefits of monthly injectables are under way. 3. Do monthly injectables cause birth defects? Will the fetus be harmed if a woman accidentally uses monthly injectables while she is pregnant? No. Good evidence from studies on other hormonal methods shows",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1091
  },
  {
    "id": "chunk_01092",
    "text": "dence from studies on other hormonal methods shows that hormonal contraception will not cause birth defects and will not otherwise harm the fetus if a woman becomes pregnant while using monthly injectables or accidentally starts injectables when she is already pregnant.",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1092
  },
  {
    "id": "chunk_01093",
    "text": "y starts injectables when she is already pregnant. 4. Do monthly injectables cause abortion? No. Research on combined contraceptives finds that they do not disrupt an existing pregnancy. They should not be used to try to cause an abortion. They will not do so.",
    "page_number": 138,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1093
  },
  {
    "id": "chunk_01094",
    "text": "5 117 selbatcejnI ylhtnoM 5. Should the dates for a woman\u2019s repeat injections be based on when monthly bleeding starts? No. Some providers think that the next injection should be given only when the next monthly bleeding begins. Bleeding episodes should not",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1094
  },
  {
    "id": "chunk_01095",
    "text": "thly bleeding begins. Bleeding episodes should not guide the injection schedule, however. A woman should receive the injection every 4 weeks. The timing of injections should not be based on her monthly bleeding. 6. Can monthly injectables be used to bring on monthly bleeding?",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1095
  },
  {
    "id": "chunk_01096",
    "text": "injectables be used to bring on monthly bleeding? No. A woman may experience some vaginal bleeding (a \u201cwithdrawal bleed\u201d) as a result of an injection, but there is no evidence that giving a woman who has irregular bleeding a single injection of a monthly",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1096
  },
  {
    "id": "chunk_01097",
    "text": "irregular bleeding a single injection of a monthly injectable will cause her monthly bleeding to begin properly about one month later. Also, giving a pregnant woman an injection will not cause an abortion. 7. Can women who smoke use monthly injectables safely?",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1097
  },
  {
    "id": "chunk_01098",
    "text": "an women who smoke use monthly injectables safely? Women younger than age 35 who smoke any number of cigarettes and women 35 and older who smoke fewer than 15 cigarettes a day can safely use monthly injectables. (In contrast, women 35 and older",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1098
  },
  {
    "id": "chunk_01099",
    "text": "thly injectables. (In contrast, women 35 and older who smoke any number of cigarettes should not use combined oral contraceptives.) Women age 35 and older who smoke more than 15 cigarettes a day should choose a method without estrogen such",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1099
  },
  {
    "id": "chunk_01100",
    "text": "a day should choose a method without estrogen such as progestin-only injectables, if available. All women who smoke should be urged to stop smoking. 8. Do monthly injectables lower women\u2019s mood or sex drive? Generally, no. Some women using monthly injectables report these",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1100
  },
  {
    "id": "chunk_01101",
    "text": "Some women using monthly injectables report these complaints. The great majority of injectables users do not report any such changes, however, and some report that both mood and sex drive improve. It is difficult to tell whether such changes are due to monthly",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1101
  },
  {
    "id": "chunk_01102",
    "text": "lt to tell whether such changes are due to monthly injectables or to other reasons. There is no evidence that monthly injectables affect women\u2019s sexual behavior. 9. Can women with varicose veins use monthly injectables? Yes. Monthly injectables are safe for women with varicose veins.",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1102
  },
  {
    "id": "chunk_01103",
    "text": "njectables are safe for women with varicose veins. Varicose veins are enlarged blood vessels close to the surface of the skin. They are not dangerous. They are not blood clots, nor are these veins the deep veins in the legs where a blood clot can be dangerous (deep",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1103
  },
  {
    "id": "chunk_01104",
    "text": "the legs where a blood clot can be dangerous (deep vein thrombosis). A woman who has or has had deep vein thrombosis should not use monthly injectables. Questions and Answers About Monthly Injectables",
    "page_number": 139,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1104
  },
  {
    "id": "chunk_01105",
    "text": "5 118 Family Planning: A Global Handbook for Providers selbatcejnI ylhtnoM 10. Do monthly injectables make a woman infertile? No. There may be a delay in regaining fertility after stopping monthly injectables, but in time the woman will be able to become pregnant as",
    "page_number": 140,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1105
  },
  {
    "id": "chunk_01106",
    "text": "time the woman will be able to become pregnant as before, although fertility decreases as women get older. The bleeding pattern a woman had before she used monthly injectables generally returns a few months after the last injection. 11. How long does it take to become pregnant after stopping",
    "page_number": 140,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1106
  },
  {
    "id": "chunk_01107",
    "text": "ong does it take to become pregnant after stopping monthly injectables? Women who stop using monthly injectables wait about one month longer on average to become pregnant than women who have used other methods. This means they become pregnant on average 5 months",
    "page_number": 140,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1107
  },
  {
    "id": "chunk_01108",
    "text": "his means they become pregnant on average 5 months after their last injection. These are averages. A woman should not be worried if she has not become pregnant even as much as 12 months after stopping use. After stopping monthly injectables, a woman may",
    "page_number": 140,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1108
  },
  {
    "id": "chunk_01109",
    "text": "e. After stopping monthly injectables, a woman may ovulate before her monthly bleeding returns\u2014and thus can become pregnant. If she wants to continue avoiding pregnancy, she should start another method before monthly bleeding returns.",
    "page_number": 140,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1109
  },
  {
    "id": "chunk_01110",
    "text": "CHAPTER 6 Combined Patch Key Points for Providers and Clients 6 y A woman wears a small adhesive patch on her body at all times, day and night. A new patch is put on each week for 3 weeks, and then no patch for the fourth week. y Replace each patch on time for greatest effectiveness.",
    "page_number": 141,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1110
  },
  {
    "id": "chunk_01111",
    "text": "ace each patch on time for greatest effectiveness. y Bleeding changes are common but not harmful. Typically, irregular bleeding for the first few months and then lighter and more regular bleeding. What Is the Combined Patch? y A small, thin, square of flexible plastic worn on the body.",
    "page_number": 141,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1111
  },
  {
    "id": "chunk_01112",
    "text": "thin, square of flexible plastic worn on the body. y Continuously releases 2 hormones\u2014a progestin and an estrogen, like the natural hormones progesterone and estrogen in a woman\u2019s body\u2014directly through the skin into the bloodstream. y The woman puts on a new patch every week for 3 weeks, then no",
    "page_number": 141,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1112
  },
  {
    "id": "chunk_01113",
    "text": "uts on a new patch every week for 3 weeks, then no patch for the fourth week. During this fourth week the woman will have monthly bleeding. y Also called Ortho Evra and Evra. y Works primarily by preventing the release of eggs from the ovaries (ovulation). How Effective? More effective",
    "page_number": 141,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1113
  },
  {
    "id": "chunk_01114",
    "text": "ovaries (ovulation). How Effective? More effective Effectiveness depends on the user: Risk of pregnancy is greatest when a woman is late to change the patch. y As commonly used, about 7 pregnancies per 100 women using the combined patch over the first year. This means that",
    "page_number": 141,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1114
  },
  {
    "id": "chunk_01115",
    "text": "ombined patch over the first year. This means that 93 of every 100 women using the combined patch will not become pregnant. y When no mistakes are made with use of the patch, less than Less 1 pregnancy per 100 women using a patch over the first year effective (3 per 1,000 women). 119 hctaP denibmoC",
    "page_number": 141,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1115
  },
  {
    "id": "chunk_01116",
    "text": "y Pregnancy rates may be slightly higher among women weighing 90 kg or more. Return of fertility after patch use is stopped: No delay Protection against sexually transmitted infections: None Side Effects, Health Benefits, and Health Risks Side Effects Some users report the following:",
    "page_number": 142,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1116
  },
  {
    "id": "chunk_01117",
    "text": "isks Side Effects Some users report the following: y Skin irritation or rash where the patch is applied y Changes in bleeding patterns\u2020: \u2013 Lighter bleeding and fewer days of bleeding \u2013 Irregular bleeding \u2013 Prolonged bleeding \u2013 No monthly bleeding Headaches y Nausea y Vomiting",
    "page_number": 142,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1117
  },
  {
    "id": "chunk_01118",
    "text": "No monthly bleeding Headaches y Nausea y Vomiting y Breast tenderness and pain y Abdominal pain y Flu symptoms/upper respiratory infection y Irritation, redness, or inflammation of the vagina (vaginitis) Known Health Benefits and Health Risks",
    "page_number": 142,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1118
  },
  {
    "id": "chunk_01119",
    "text": "(vaginitis) Known Health Benefits and Health Risks Long-term studies of the patch are limited, but researchers expect that its health benefits and risks are like those of combined oral contraceptives (see Chapter 1 \u2013 Combined Oral Contraceptives, section on Side Effects,",
    "page_number": 142,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1119
  },
  {
    "id": "chunk_01120",
    "text": "ined Oral Contraceptives, section on Side Effects, Health Benefits, and Health Risks, pp. 2\u20133). Medical eligibility criteria guidelines for when to start and helping continuing users for the combined patch are the same as for combined oral contraceptives and the combined vaginal ring. See Chapter 1 \u2013",
    "page_number": 142,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1120
  },
  {
    "id": "chunk_01121",
    "text": "ves and the combined vaginal ring. See Chapter 1 \u2013 Combined Oral Contraceptives, pp. 6, 11, and 19. \u2020 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in Glossary. 120 Family Planning: A Global Handbook for Providers",
    "page_number": 142,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1121
  },
  {
    "id": "chunk_01122",
    "text": "Providing the Combined Patch Explaining How to Use Explain how to y Explain to the user that she should tear the foil remove the patch pouch along the edge. from the pouch and y She should then pull out the patch and peel away remove backing the backing without touching the sticky surface. 6",
    "page_number": 143,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1122
  },
  {
    "id": "chunk_01123",
    "text": "the backing without touching the sticky surface. 6 Show her where y Explain that she can apply it on the upper outer and how to apply arm, back, stomach, abdomen, or buttocks, the patch wherever it is clean and dry, but not on the breasts. y She must press the sticky, medicated part against",
    "page_number": 143,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1123
  },
  {
    "id": "chunk_01124",
    "text": "She must press the sticky, medicated part against her skin for 10 seconds. She should run her finger along the edge to make sure it sticks. y The patch will stay on even during work, exercise, swimming, and bathing. She must change y She should apply each new patch on the same",
    "page_number": 143,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1124
  },
  {
    "id": "chunk_01125",
    "text": "ange y She should apply each new patch on the same the patch every day of each week\u2014the \u201cpatch-change day.\u201d For week for 3 weeks example, if she puts on her first patch on a in a row Sunday, all of her patches should be applied on a Sunday. y Explain that to avoid irritation, she should not",
    "page_number": 143,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1125
  },
  {
    "id": "chunk_01126",
    "text": "y Explain that to avoid irritation, she should not apply the new patch to the same place on the skin where the previous patch was. She should not y She will probably have monthly bleeding wear a patch on this week. the 4th week After the patch-free y She should never go without wearing a patch for",
    "page_number": 143,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1126
  },
  {
    "id": "chunk_01127",
    "text": "y She should never go without wearing a patch for week, she should more than 7 days. Doing so risks pregnancy. apply a new patch Providing the Combined Patch 121 hctaP denibmoC",
    "page_number": 143,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1127
  },
  {
    "id": "chunk_01128",
    "text": "Supporting New and Continuing Users Instructions for Late Replacement or Removal, or if the Patch Comes Off Forgot to apply a y Apply a new patch as soon as possible. new patch after y Keep the same patch-change day. the 7-day patch- y If late by only 1 or 2 days (48 hours or less), there is no",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1128
  },
  {
    "id": "chunk_01129",
    "text": "y only 1 or 2 days (48 hours or less), there is no free interval? need for a backup method. y If more than 2 days late (more than 48 hours) (that is, no patch was worn for 10 days or more in a row), use a backup method* for the first 7 days of patch use.",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1129
  },
  {
    "id": "chunk_01130",
    "text": "backup method* for the first 7 days of patch use. y Also, if more than 2 days late and unprotected sex occurred in the past 5 days, consider taking emergency contraceptive pills (ECPs) (see Chapter 3). Late changing the y If late by only 1 or 2 days (48 hours or less), apply a new",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1130
  },
  {
    "id": "chunk_01131",
    "text": "y only 1 or 2 days (48 hours or less), apply a new patch at the end of patch as soon as possible. Keep the same patch-change day. week 1 or 2? No need for a backup method. y If more than 2 days late (more than 48 hours), apply a new patch as soon as possible. This patch will begin a new",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1131
  },
  {
    "id": "chunk_01132",
    "text": "h as soon as possible. This patch will begin a new 4-week patch cycle, and this day of the week will become the new patch-change day. Also use a backup method* for the next 7 days. y Also, if more than 2 days late and unprotected sex occurred in the past 5 days, consider taking ECPs (see Chapter 3).",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1132
  },
  {
    "id": "chunk_01133",
    "text": "past 5 days, consider taking ECPs (see Chapter 3). Late taking off the y Remove the patch. patch at the end of y Start the next cycle on the usual patch-change day. week 3? y No need for a backup method. The patch came y Apply a new patch as soon as possible. (The same patch",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1133
  },
  {
    "id": "chunk_01134",
    "text": "y a new patch as soon as possible. (The same patch off and was off for can be re-used if it was off less than 24 hours.) less than 2 days y No need for a backup method. (48 hours or less)? y Keep the same patch change day. The patch came y Apply a new patch as soon as possible.",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1134
  },
  {
    "id": "chunk_01135",
    "text": "atch came y Apply a new patch as soon as possible. off and was off for y Use a backup method* for the next 7 days. more than 2 days y Keep the same patch-change day. (more than 48 hours)? y If during week 3, skip the patch-free week and start a new",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1135
  },
  {
    "id": "chunk_01136",
    "text": "g week 3, skip the patch-free week and start a new patch immediately after week 3. If a new patch cannot be started immediately, use a backup method* and keep using it through the first 7 days of patch use. y If during week one and unprotected sex occurred in the",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1136
  },
  {
    "id": "chunk_01137",
    "text": "uring week one and unprotected sex occurred in the past 5 days, consider taking ECPs (see Chapter 3). * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1137
  },
  {
    "id": "chunk_01138",
    "text": "ondoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. 122 Family Planning: A Global Handbook for Providers",
    "page_number": 144,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1138
  },
  {
    "id": "chunk_01139",
    "text": "CHAPTER 7 Combined Vaginal Ring 7 Key Points for Providers and Clients y A woman places a flexible ring in her vagina. She leaves it there at all times, every day and night for 3 weeks. Then, she removes the ring. Seven days later she inserts a new ring.",
    "page_number": 145,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1139
  },
  {
    "id": "chunk_01140",
    "text": "the ring. Seven days later she inserts a new ring. y Start each new ring on time for greatest effectiveness. y Bleeding changes are common but not harmful. Typically, irregular bleeding for the first few months and then lighter and more regular bleeding. What Is the Combined Vaginal Ring?",
    "page_number": 145,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1140
  },
  {
    "id": "chunk_01141",
    "text": "gular bleeding. What Is the Combined Vaginal Ring? y A flexible ring that a woman places in her vagina. y Continuously releases 2 hormones\u2014a progestin and an estrogen, like the natural hormones progesterone and estrogen in a woman\u2019s body\u2014from",
    "page_number": 145,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1141
  },
  {
    "id": "chunk_01142",
    "text": "s progesterone and estrogen in a woman\u2019s body\u2014from inside the ring. Hormones are absorbed through the wall of the vagina directly into the bloodstream. y She leaves the ring in place for 3 weeks, then removes it for the fourth week. During this fourth week the woman will have monthly bleeding.",
    "page_number": 145,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1142
  },
  {
    "id": "chunk_01143",
    "text": "fourth week the woman will have monthly bleeding. y Also called NuvaRing. y Works primarily by preventing the release of eggs from the ovaries (ovulation). 123 gniR lanigaV denibmoC",
    "page_number": 145,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1143
  },
  {
    "id": "chunk_01144",
    "text": "How Effective? More effective Effectiveness depends on the user: Risk of pregnancy is greatest when a woman is late to start a new ring. y As commonly used, about 7 pregnancies per 100 women using the combined vaginal ring over the first year. This means that 93 of every 100 women using the combined",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1144
  },
  {
    "id": "chunk_01145",
    "text": "eans that 93 of every 100 women using the combined vaginal ring will not become pregnant. y When no mistakes are made with use of the combined vaginal ring, less than 1 pregnancy per 100 women using the Less combined vaginal ring over the first year (3 per 1,000 women). effective",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1145
  },
  {
    "id": "chunk_01146",
    "text": "over the first year (3 per 1,000 women). effective Return of fertility after ring use is stopped: No delay Protection against sexually transmitted infections: None Side Effects, Health Benefits, and Health Risks Side Effects Some users report the following:",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1146
  },
  {
    "id": "chunk_01147",
    "text": "isks Side Effects Some users report the following: y Changes in bleeding patterns,\u2020 \u2013 Prolonged bleeding including: \u2013 No monthly bleeding \u2013 Lighter bleeding and fewer days of y Headaches bleeding y Irritation, redness, or inflammation \u2013 Irregular bleeding of the vagina (vaginitis)",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1147
  },
  {
    "id": "chunk_01148",
    "text": "ion \u2013 Irregular bleeding of the vagina (vaginitis) \u2013 Infrequent bleeding y White vaginal discharge Known Health Benefits and Health Risks Long-term studies of the vaginal ring are limited, but researchers expect that its health benefits and risks are like those of combined oral contraceptives",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1148
  },
  {
    "id": "chunk_01149",
    "text": "sks are like those of combined oral contraceptives (see Chapter 1 \u2013 Combined Oral Contraceptives, section on Side Effects, Health Benefits, and Health Risks, pp. 2\u20133). Evidence to date has not shown adverse effects. Medical eligibility criteria, guidelines for when to start, and helping",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1149
  },
  {
    "id": "chunk_01150",
    "text": "riteria, guidelines for when to start, and helping continuing users for the combined ring are the same as for combined oral contraceptives and the combined patch. See Chapter 1 \u2013 Combined Oral Contraceptives, pp. 6, 11, and 19.",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1150
  },
  {
    "id": "chunk_01151",
    "text": "\u2013 Combined Oral Contraceptives, pp. 6, 11, and 19. \u2020For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. 124 Family Planning: A Global Handbook for Providers",
    "page_number": 146,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1151
  },
  {
    "id": "chunk_01152",
    "text": "Providing the Combined Vaginal Ring Explaining How to Use Explain how to y The user can choose the position most comfortable insert the ring for her\u2014for example, standing with one leg up, squatting, or lying down. y She should press opposite sides of the ring 7",
    "page_number": 147,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1152
  },
  {
    "id": "chunk_01153",
    "text": "n. y She should press opposite sides of the ring 7 together and gently push the folded ring entirely inside the vagina. y The exact position is not important, but inserting it deeply helps it to stay in place, and she is less likely to feel it. The muscles of the vagina naturally keep",
    "page_number": 147,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1153
  },
  {
    "id": "chunk_01154",
    "text": "feel it. The muscles of the vagina naturally keep the ring in place. 1 2 3 Explain that the y She should leave the ring in place at all times, every ring must be left in day and night for 3 weeks. place for 3 weeks y She can take the ring out at the end of the third",
    "page_number": 147,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1154
  },
  {
    "id": "chunk_01155",
    "text": "She can take the ring out at the end of the third week and dispose of it in a waste receptacle. She should take y To remove the ring, she can hook her index finger out the ring for the inside it, or squeeze the ring between her index fourth week and middle fingers, and pull it out.",
    "page_number": 147,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1155
  },
  {
    "id": "chunk_01156",
    "text": "x fourth week and middle fingers, and pull it out. y She will probably have monthly bleeding this week. y If she forgets and leaves the ring in for as long as a fourth week, no special action is needed. Ring should never y The ring can be removed for sex, cleaning, or other",
    "page_number": 147,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1156
  },
  {
    "id": "chunk_01157",
    "text": "he ring can be removed for sex, cleaning, or other be left out for reasons, although removing it is not necessary and more than 48 is not recommended because some women forget hours until the to put it back within 48 hours. fourth week y If the ring slips out, she should rinse it in clean",
    "page_number": 147,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1157
  },
  {
    "id": "chunk_01158",
    "text": "Supporting New and Continuing Users Instructions for Late Replacement or Removal Left ring out y Put the ring back in as soon as possible. for 48 hours y No need for a backup method. or less during weeks 1 through 3? Left ring out y Put the ring back in as soon as possible.",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1158
  },
  {
    "id": "chunk_01159",
    "text": "ng out y Put the ring back in as soon as possible. for more y Use a backup method* for the next 7 days. than 48 hours y If the ring was left out for more than 48 hours in the during weeks first week and unprotected sex occurred in the previous 1 or 2?",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1159
  },
  {
    "id": "chunk_01160",
    "text": "d unprotected sex occurred in the previous 1 or 2? 5 days, consider taking emergency contraceptive pills (ECPs) (see Chapter 3). Left ring out y Put the ring back in as soon as possible. for more y Use a backup method* for the next 7 days. than 48 hours",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1160
  },
  {
    "id": "chunk_01161",
    "text": "backup method* for the next 7 days. than 48 hours y Start a new ring at the end of the third week and skip during the ring-free week. If unable to start the new ring at the week 3? end of the third week, use a backup method* and keep using it through the first 7 days after starting a new ring.",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1161
  },
  {
    "id": "chunk_01162",
    "text": "hrough the first 7 days after starting a new ring. Forgot to y Insert a new ring as soon as possible. If late by only insert a 1 or 2 days (48 hours or less)\u2014that is, the ring is left new ring at out no longer than 9 days in a row\u2014no need for a beginning of backup method.",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1162
  },
  {
    "id": "chunk_01163",
    "text": "in a row\u2014no need for a beginning of backup method. the cycle? y Keep the same ring removal day. y If the new ring is inserted more than 2 days (more than 48 hours) late\u2014that is, the ring is left out 10 days or more in a row\u2014use a backup method* for the first 7 days of ring use.",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1163
  },
  {
    "id": "chunk_01164",
    "text": "a backup method* for the first 7 days of ring use. y Also, if unprotected sex occurred in the past 5 days, consider taking ECPs (see Chapter 3). Kept ring in y If the same ring is used for up to 28 days (4 weeks), no longer than backup method is needed. She can take a ring-free week",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1164
  },
  {
    "id": "chunk_01165",
    "text": "up method is needed. She can take a ring-free week 3 weeks? or start a new ring immediately. y If the same ring is used for 28 to 35 days (more than 4 weeks but less than 5 weeks), insert a new ring and skip the ring-free week. No backup method is needed.",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1165
  },
  {
    "id": "chunk_01166",
    "text": "ip the ring-free week. No backup method is needed. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 148,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1166
  },
  {
    "id": "chunk_01167",
    "text": "CHAPTER 8 Progesterone- Releasing Vaginal Ring 8 Key Points for Providers and Clients y Suitable for postpartum women who are actively breastfeeding, at least 4 times per day. y A woman places a flexible ring in her vagina. She leaves it in",
    "page_number": 149,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1167
  },
  {
    "id": "chunk_01168",
    "text": "es a flexible ring in her vagina. She leaves it in place at all times, every day and night for 90 days. Four rings can be used, one after another, for approximately one year after giving birth. y Start each new ring immediately after removal of the previous ring for greatest effectiveness.",
    "page_number": 149,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1168
  },
  {
    "id": "chunk_01169",
    "text": "l of the previous ring for greatest effectiveness. y Easy for a woman to insert and remove from her vagina. If her reproductive plans change, she can take out the ring at any time without a provider\u2019s help. What Is the Progesterone- Releasing Vaginal Ring?",
    "page_number": 149,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1169
  },
  {
    "id": "chunk_01170",
    "text": "What Is the Progesterone- Releasing Vaginal Ring? y A smooth, soft, flexible silicone ring placed in the vagina to prolong lactational amenorrhea (postponing the return of monthly bleeding) and help breastfeeding women space pregnancies. y Continuously releases natural progesterone",
    "page_number": 149,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1170
  },
  {
    "id": "chunk_01171",
    "text": "cies. y Continuously releases natural progesterone hormone\u2014like that in a woman\u2019s body\u2014from inside the ring. The hormone passes through the wall of the vagina directly into the bloodstream. This ring does not contain estrogen. y Use of the ring starts 4 to 9 weeks after giving",
    "page_number": 149,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1171
  },
  {
    "id": "chunk_01172",
    "text": "y Use of the ring starts 4 to 9 weeks after giving birth. Each ring is kept in place for 90 days. The woman can then replace it with a new ring immediately. Up to 4 rings can be used, one after another, with no breaks. 127 gniR lanigaV gnisaeleR-enoretsegorP",
    "page_number": 149,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1172
  },
  {
    "id": "chunk_01173",
    "text": "y Works by preventing release of an egg from the ovaries (ovulation). Progesterone extends the postpartum amenorrhea of the breastfeeding woman. That is, it delays the return of monthly bleeding. y Safe and effective option for a woman: \u2212 Who has a baby at least 4 weeks old",
    "page_number": 150,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1173
  },
  {
    "id": "chunk_01174",
    "text": "for a woman: \u2212 Who has a baby at least 4 weeks old \u2212 Who is breastfeeding her baby at least 4 times per day More and plans to continue breastfeeding effective \u2212 Whose monthly bleeding has not returned How Effective? One or 2 pregnancies per 100 women using the progesterone-",
    "page_number": 150,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1174
  },
  {
    "id": "chunk_01175",
    "text": "pregnancies per 100 women using the progesterone- releasing vaginal ring for a year. Return of fertility after use is stopped: No delay Protection against sexually transmitted infections: None Less effective Side Effects, Health Benefits, and Health Risks Side Effects",
    "page_number": 150,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1175
  },
  {
    "id": "chunk_01176",
    "text": "ts, Health Benefits, and Health Risks Side Effects Some users report the following: y Spotting or irregular bleeding y Low abdominal pain y Breast pain y Vaginal discharge Known Health Benefits and Health Risks y No change in breast milk production or composition; the method",
    "page_number": 150,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1176
  },
  {
    "id": "chunk_01177",
    "text": "breast milk production or composition; the method supports continued breastfeeding and healthy infant nutrition. y Safe and effective, based on several 1-year studies. Its health risks may be like those of progestin-only pills (see Chapter 2 \u2212 Progestin-Only Pills,",
    "page_number": 150,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1177
  },
  {
    "id": "chunk_01178",
    "text": "-only pills (see Chapter 2 \u2212 Progestin-Only Pills, section on Side Effects, Health Benefits, and Health Risks, p. 31). y Women who are actively breastfeeding and are at least 4 weeks postpartum can safely use the progesterone-releasing vaginal ring (MEC Category 1).",
    "page_number": 150,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1178
  },
  {
    "id": "chunk_01179",
    "text": "Providing the Progesterone- Releasing Vaginal Ring Explain How to Use Explain how to y The user can choose the position most comfortable insert the ring for her\u2014for example, standing with one leg up, squatting, or lying down. y She should press opposite sides of the ring together",
    "page_number": 151,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1179
  },
  {
    "id": "chunk_01180",
    "text": "e should press opposite sides of the ring together and, with her index finger, gently push the ring entirely 8 inside the vagina as far as she can (see picture 1). It can help to push down with the muscles of the vagina while inserting the ring. 1 1 2",
    "page_number": 151,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1180
  },
  {
    "id": "chunk_01181",
    "text": "cles of the vagina while inserting the ring. 1 1 2 y The exact position of the ring in the vagina is not important, but inserting it deeply helps it to stay in place (see picture 2), and the user is less likely to feel it. The muscles of the vagina naturally keep the ring in place. 1 1 2",
    "page_number": 151,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1181
  },
  {
    "id": "chunk_01182",
    "text": "the vagina naturally keep the ring in place. 1 1 2 y She should not feel the ring after she places it into her vagina. If she feels the ring in her vagina, she has a sensation of it slipping, or it feels uncomfortable, she may not have pushed it back into her vagina far enough. Instruct her to use a",
    "page_number": 151,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1182
  },
  {
    "id": "chunk_01183",
    "text": "into her vagina far enough. Instruct her to use a clean finger to gently push the ring as far as she can into her vagina. There is no danger of the ring being pushed too far up in the vagina, breaking during insertion, or getting lost. (Continued on next page)",
    "page_number": 151,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1183
  },
  {
    "id": "chunk_01184",
    "text": "(continued) Explain that y She should keep the ring in place at all times to the ring must maintain effectiveness. be left in for y To continue avoiding pregnancy, the user can take 90 days the ring out at the end of the 90 days and replace it immediately with a new ring. She can use 4 rings, for",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1184
  },
  {
    "id": "chunk_01185",
    "text": "ediately with a new ring. She can use 4 rings, for up to one year of use in the postpartum period. y The ring can be disposed of in a waste receptacle. Disposing of the ring in a flush toilet is not recommended. The ring should y The ring should be left in place always. Some women",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1185
  },
  {
    "id": "chunk_01186",
    "text": "he ring should be left in place always. Some women never be left may remove the ring for sex or for cleaning, but this out for more is not necessary and not recommended because than 2 hours some women forget to put it back within 2 hours. y If the ring slips out completely, she should rinse it in",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1186
  },
  {
    "id": "chunk_01187",
    "text": "ring slips out completely, she should rinse it in clean water and immediately put it back in place. Explain that her y This generally does not interfere with sex or partner may decrease sexual pleasure. be able to feel the ring Supporting New and Continuing Users",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1187
  },
  {
    "id": "chunk_01188",
    "text": "feel the ring Supporting New and Continuing Users Instructions for Replacement or Switching Left the ring y Put the ring back in the vagina as soon as possible. out for more Contact your health care provider to discuss than 2 hours any concerns.",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1188
  },
  {
    "id": "chunk_01189",
    "text": "are provider to discuss than 2 hours any concerns. Left the ring y Put the ring back in as soon as possible. Use a out for more condom if you have sex in the next 48 hours. than 24 hours Contact your health care provider to discuss any concerns.",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1189
  },
  {
    "id": "chunk_01190",
    "text": "your health care provider to discuss any concerns. Feel the ring y Use a clean finger to push the ring up as far into slipping the vagina as possible. After 1 year y For longer birth spacing, she can plan ahead to of use or if switch to another family planning method. At least",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1190
  },
  {
    "id": "chunk_01191",
    "text": "switch to another family planning method. At least no longer 2 years between giving birth and the next pregnancy breastfeeding is healthy for both mother and child. at least 4 times per day 130 Family Planning: A Global Handbook for Providers",
    "page_number": 152,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1191
  },
  {
    "id": "chunk_01192",
    "text": "9 131 stnalpmI CHAPTER 9 Implants Key Points for Providers and Clients \u2022 Implants are small flexible rods that are placed just under the skin of the upper arm. \u2022 They provide long-term pregnancy protection. Implants are very effective for 3\u20135 years, depending on the type of implant, and they are",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1192
  },
  {
    "id": "chunk_01193",
    "text": "rs, depending on the type of implant, and they are immediately reversible. \u2022 They require a specifically trained provider to insert and remove them. A woman cannot start or stop implants on her own. \u2022 Little is required of the client once implants are in place.",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1193
  },
  {
    "id": "chunk_01194",
    "text": "required of the client once implants are in place. They avoid user errors and problems with resupply. \u2022 Bleeding changes are common but not harmful. Typically, there is prolonged irregular bleeding over the first year, and then lighter, more regular bleeding, infrequent bleeding, or no bleeding.",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1194
  },
  {
    "id": "chunk_01195",
    "text": "lar bleeding, infrequent bleeding, or no bleeding. What Are Implants? y Implants are small plastic rods, each about the size of a matchstick, that release a progestin like the natural hormone progesterone in a woman\u2019s body.",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1195
  },
  {
    "id": "chunk_01196",
    "text": "he natural hormone progesterone in a woman\u2019s body. y A specifically trained provider performs a minor surgical procedure to place 1 or 2 rods under the skin on the inside of a woman\u2019s upper arm. y They do not contain estrogen, and so can be used throughout breastfeeding",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1196
  },
  {
    "id": "chunk_01197",
    "text": "rogen, and so can be used throughout breastfeeding and by women who cannot use methods containing estrogen. y Types of implants: \u2013 Jadelle: 2 rods containing levonorgestrel (LNG), highly effective for 5 years \u2013 Implanon NXT (also known as Nexplanon; replaces Implanon): 1 rod",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1197
  },
  {
    "id": "chunk_01198",
    "text": "also known as Nexplanon; replaces Implanon): 1 rod containing etonogestrel (ETG), labeled for up to 3 years of use (a recent study shows it may be highly effective for 5 years). Implanon NXT can be seen on X-ray and has an improved insertion device.",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1198
  },
  {
    "id": "chunk_01199",
    "text": "een on X-ray and has an improved insertion device. \u2013 Levoplant (Sino-Implant (II)): 2 rods containing LNG, labeled for up to 3 years of use \u2013 Norplant: It consisted of 6 capsules and was effective for 5\u22127 years, but was discontinued in 2008 and is no longer available for insertion. A small",
    "page_number": 153,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1199
  },
  {
    "id": "chunk_01200",
    "text": "y Implants work primarily by: \u2013 Preventing the release of eggs from the ovaries (ovulation) \u2013 Thickening cervical mucus (this blocks sperm from reaching an egg) How Effective? Implants are one of the most effective and longest-lasting methods. y Far less than 1 pregnancy would be expected per 100",
    "page_number": 154,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1200
  },
  {
    "id": "chunk_01201",
    "text": "ar less than 1 pregnancy would be expected per 100 More women using implants over the first year. Specifically, effective just 1 pregnancy would be expected per 1,000 women using implants over the first year, which means that 999 of every 1,000 women using implants will not become",
    "page_number": 154,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1201
  },
  {
    "id": "chunk_01202",
    "text": "f every 1,000 women using implants will not become pregnant. Less than 1 pregnancy would be expected per 100 women over the duration of use of the implant. y A small risk of pregnancy remains beyond the first year of use and continues as long as the woman is using implants. Less",
    "page_number": 154,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1202
  },
  {
    "id": "chunk_01203",
    "text": "inues as long as the woman is using implants. Less y For heavier women, the effectiveness of Jadelle and effective Levoplant may decrease near the end of the duration of use stated on the label. These users may want to replace their implants sooner (see Question 9 at the end of this chapter, p. 162).",
    "page_number": 154,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1203
  },
  {
    "id": "chunk_01204",
    "text": "ee Question 9 at the end of this chapter, p. 162). Return of fertility after implants are removed: No delay Protection against sexually transmitted infections (STIs): None Why Some Women Say They Like Implants \u2022 Do not require the user to do anything once they are inserted",
    "page_number": 154,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1204
  },
  {
    "id": "chunk_01205",
    "text": "ire the user to do anything once they are inserted \u2022 Prevent pregnancy very effectively \u2022 Are both long-lasting and reversible \u2022 Do not interfere with sex 132 Family Planning: A Global Handbook for Providers",
    "page_number": 154,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1205
  },
  {
    "id": "chunk_01206",
    "text": "9 133 stnalpmI Side Effects, Health Benefits, Health Risks, and Complications Side Effects (see also Managing Any Problems, later in this chapter, p. 151) Some users report the following: y Changes in bleeding patterns.1 \u2013 First several months to 1 year: Bleeding changes are",
    "page_number": 155,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1206
  },
  {
    "id": "chunk_01207",
    "text": "rst several months to 1 year: Bleeding changes are y Lighter bleeding and fewer normal and not harmful. days of bleeding If a woman finds them bothersome, counseling y Prolonged bleeding and support can help. y Irregular bleeding y Infrequent bleeding y No monthly bleeding \u2013 After about 1 year:",
    "page_number": 155,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1207
  },
  {
    "id": "chunk_01208",
    "text": "eeding y No monthly bleeding \u2013 After about 1 year: y Lighter bleeding and fewer days of bleeding y Irregular bleeding y Infrequent bleeding y No monthly bleeding y Users of Implanon and Implanon y Acne (can improve or worsen) NXT are more likely to have y Weight change infrequent bleeding, prolonged",
    "page_number": 155,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1208
  },
  {
    "id": "chunk_01209",
    "text": "ave y Weight change infrequent bleeding, prolonged bleeding, or no monthly bleeding y Breast tenderness than irregular bleeding. y Dizziness y Headaches y Mood changes y Abdominal pain y Nausea Other possible physical changes: y Enlarged ovarian follicles",
    "page_number": 155,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1209
  },
  {
    "id": "chunk_01210",
    "text": "ble physical changes: y Enlarged ovarian follicles 1 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. Side Effects, Health Benefits, Health Risks, and Complications",
    "page_number": 155,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1210
  },
  {
    "id": "chunk_01211",
    "text": "Health Benefits and Health Risks Known Health Benefits Known Health Risks Help protect against: None y Pregnancy and associated risks, including ectopic pregnancy May help protect against: y Iron-deficiency anemia Reduces: y Risk of ectopic pregnancy Complications Uncommon:",
    "page_number": 156,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1211
  },
  {
    "id": "chunk_01212",
    "text": "Risk of ectopic pregnancy Complications Uncommon: y Infection at insertion site (most infections occur within the first 2 months after insertion) y Difficult removal (rare if properly inserted and the provider is skilled at removal) Rare:",
    "page_number": 156,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1212
  },
  {
    "id": "chunk_01213",
    "text": "rted and the provider is skilled at removal) Rare: y Expulsion of implant (most expulsions occur within the first 4 months after insertion) Extremely rare: y Migration of implant. There have been a few reports of implants found in another place in the body due to improper insertion (for example, in a",
    "page_number": 156,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1213
  },
  {
    "id": "chunk_01214",
    "text": "body due to improper insertion (for example, in a blood vessel). Correcting Misunderstandings (see also Questions and Answers, at the end of this chapter) Implants: y Do not work once they are removed. Their hormones do not remain in a woman\u2019s body.",
    "page_number": 156,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1214
  },
  {
    "id": "chunk_01215",
    "text": "d. Their hormones do not remain in a woman\u2019s body. y Do not cause any harm if they stop monthly bleeding. It is similar to not having monthly bleeding during pregnancy; blood is not building up inside the woman. y Do not make women infertile.",
    "page_number": 156,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1215
  },
  {
    "id": "chunk_01216",
    "text": "p inside the woman. y Do not make women infertile. y Do not increase the risk of ectopic pregnancy (see Question 7, p. 162). 134 Family Planning: A Global Handbook for Providers",
    "page_number": 156,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1216
  },
  {
    "id": "chunk_01217",
    "text": "9 135 stnalpmI Who Can and Cannot Use Implants Safe and Suitable for Nearly All Women Nearly all women can use implants safely and effectively, including women who: y Have had children or have not had children y Are married or are not married",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1217
  },
  {
    "id": "chunk_01218",
    "text": "not had children y Are married or are not married y Are of any age, including adolescents and women over 40 years old (see Question 13, at the end of this chapter) y Have just had an abortion, miscarriage, or ectopic pregnancy y Smoke cigarettes, regardless of age or the number of cigarettes smoked",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1218
  },
  {
    "id": "chunk_01219",
    "text": "gardless of age or the number of cigarettes smoked y Are breastfeeding y Have anemia now or in the past y Have varicose veins y Are living with HIV, whether or not they are on antiretroviral therapy (see the box titled: Implants for Women With HIV, p. 137) Avoid Unnecessary Procedures",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1219
  },
  {
    "id": "chunk_01220",
    "text": "men With HIV, p. 137) Avoid Unnecessary Procedures (see Importance of Selected Procedures for Providing Family Planning Methods, at the start of Chapter 26) Women can begin using implants: y Without a pelvic examination y Without any blood tests or other routine laboratory tests",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1220
  },
  {
    "id": "chunk_01221",
    "text": "any blood tests or other routine laboratory tests y Without cervical cancer screening y Without a breast examination y Without a pregnancy test \u2013 A woman can have implants inserted at any time, even when she is not having monthly bleeding at the time, if it is reasonably certain she is",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1221
  },
  {
    "id": "chunk_01222",
    "text": "ng at the time, if it is reasonably certain she is not pregnant (see Pregnancy Checklist, inside back cover). Blood pressure measurement is desirable before starting a hormonal method. However, where the risks of pregnancy are high and few",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1222
  },
  {
    "id": "chunk_01223",
    "text": "ver, where the risks of pregnancy are high and few methods are available, a woman should not be denied a hormonal method simply because her blood pressure cannot be measured. If possible, she can have her blood pressure measured later, at a time and place convenient for her.",
    "page_number": 157,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1223
  },
  {
    "id": "chunk_01224",
    "text": "Medical Eligibility Criteria for Use of Implants Ask the client the questions below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions, then she can have implants inserted if she wants. If she",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1224
  },
  {
    "id": "chunk_01225",
    "text": "he can have implants inserted if she wants. If she answers \u201cyes\u201d to a question, follow the instructions; in some cases she can still start using implants. 1. Do you have severe cirrhosis of the liver or a severe liver tumor? No Yes I f the client reports severe cirrhosis or severe liver",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1225
  },
  {
    "id": "chunk_01226",
    "text": "he client reports severe cirrhosis or severe liver tumor, such as liver cancer, do not provide implants. Help her choose a method without hormones. 2. Do you have a serious problem now with a blood clot in your leg or lungs? No Yes I f the client reports a current blood clot in one of her",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1226
  },
  {
    "id": "chunk_01227",
    "text": "client reports a current blood clot in one of her legs (affecting deep veins, not superficial veins) or in a lung and she is not on anticoagulant therapy, do not provide implants. Help her choose a method without hormones. 3. Are you having vaginal bleeding that is unusual for you?",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1227
  },
  {
    "id": "chunk_01228",
    "text": "u having vaginal bleeding that is unusual for you? No Yes I f the client has unexplained vaginal bleeding that suggests pregnancy or an underlying medical condition, implants could make diagnosis and monitoring of any treatment more difficult. Help her choose another method to use until the condition",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1228
  },
  {
    "id": "chunk_01229",
    "text": "r choose another method to use until the condition has been evaluated and treated, but not progestin- only injectables or a copper-bearing or hormonal IUD. After treatment, reconsider the use of implants. 4. Do you have or have you ever had breast cancer?",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1229
  },
  {
    "id": "chunk_01230",
    "text": "4. Do you have or have you ever had breast cancer? No Yes I f yes, do not provide implants. Help her choose a method without hormones. Also, a woman should not use implants if she reports having lupus with positive (or unknown) antiphospholipid antibodies and is not",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1230
  },
  {
    "id": "chunk_01231",
    "text": "or unknown) antiphospholipid antibodies and is not on immunosuppressive treatment. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits as well as the potential risks and",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1231
  },
  {
    "id": "chunk_01232",
    "text": "health benefits as well as the potential risks and side effects associated with the client\u2019s chosen method. Also, point out any conditions that would make the method inadvisable for use by that particular client. 136 Family Planning: A Global Handbook for Providers",
    "page_number": 158,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1232
  },
  {
    "id": "chunk_01233",
    "text": "9 137 stnalpmI Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not use implants. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her, a qualified",
    "page_number": 159,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1233
  },
  {
    "id": "chunk_01234",
    "text": "re not available or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use implants. The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up care.",
    "page_number": 159,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1234
  },
  {
    "id": "chunk_01235",
    "text": "s, whether she will have access to follow-up care. y Acute blood clot in deep veins of legs or lungs y Unexplained vaginal bleeding before evaluation for possible serious underlying condition y Had breast cancer more than 5 years ago, and it has not returned",
    "page_number": 159,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1235
  },
  {
    "id": "chunk_01236",
    "text": "cer more than 5 years ago, and it has not returned y Severe cirrhosis of the liver or liver tumor y Systemic lupus erythematosus with positive (or unknown) antiphospholipid antibodies, and not on immunosuppressive treatment Implants for Women With HIV",
    "page_number": 159,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1236
  },
  {
    "id": "chunk_01237",
    "text": "osuppressive treatment Implants for Women With HIV \u2022 Women who are living with HIV including those who are on antiretroviral therapy (ART) can safely use implants. \u2022 Efavirenz may reduce the effectiveness of implants. Women taking this",
    "page_number": 159,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1237
  },
  {
    "id": "chunk_01238",
    "text": "e the effectiveness of implants. Women taking this antiretroviral drug need to use condoms along with implants to provide better protection from pregnancy. (See Question 14, at the end of this chapter.) Who Can and Cannot Use Implants",
    "page_number": 159,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1238
  },
  {
    "id": "chunk_01239",
    "text": "Providing Implants When to Start IMPORTANT: A woman can start using implants any time she wants if it is reasonably certain she is not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover of this",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1239
  },
  {
    "id": "chunk_01240",
    "text": "Pregnancy Checklist (see inside back cover of this Handbook). No tests or examinations are necessary before starting implants, although blood pressure measurement is desirable. Woman\u2019s situation When to start Having menstrual Any time of the month cycles or",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1240
  },
  {
    "id": "chunk_01241",
    "text": "t Having menstrual Any time of the month cycles or y If it is within 7 days after the start of her monthly switching from bleeding, she can have implants inserted a nonhormonal immediately and there is no need for a method backup method. y If it is more than 7 days after the start of her",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1241
  },
  {
    "id": "chunk_01242",
    "text": "y If it is more than 7 days after the start of her monthly bleeding, she can have implants inserted any time if it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after insertion. y If she is switching from an IUD, see Switching",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1242
  },
  {
    "id": "chunk_01243",
    "text": ". y If she is switching from an IUD, see Switching From an IUD to Another Method, in Chapter 10 \u2013 Copper-Bearing Intrauterine Device, pp. 187\u2013188. Switching from y If she has been using the hormonal method another hormonal consistently and correctly or if it is otherwise",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1243
  },
  {
    "id": "chunk_01244",
    "text": "l consistently and correctly or if it is otherwise method reasonably certain she is not pregnant, she can have implants inserted immediately (no need to wait for her next monthly bleeding) and there is no need for a backup method. y If she is switching from a progestin-only or",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1244
  },
  {
    "id": "chunk_01245",
    "text": "od. y If she is switching from a progestin-only or combined monthly injectable, she can have implants inserted when the repeat injection would have been given. There is no need for a backup method. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal; the client",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1245
  },
  {
    "id": "chunk_01246",
    "text": "e condoms, spermicides, and withdrawal; the client should be informed that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. 138 Family Planning: A Global Handbook for Providers",
    "page_number": 160,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1246
  },
  {
    "id": "chunk_01247",
    "text": "9 139 stnalpmI Woman\u2019s situation When to start Fully or nearly fully breastfeeding Less than 6 y If her monthly bleeding has not returned, she can months after have implants inserted any time between giving giving birth birth and 6 months. There is no need for a backup method.",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1247
  },
  {
    "id": "chunk_01248",
    "text": "nd 6 months. There is no need for a backup method. y If her monthly bleeding has returned, she can have implants inserted as advised for women having menstrual cycles (see the first row of this table). More than 6 y If her monthly bleeding has not returned, she can",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1248
  },
  {
    "id": "chunk_01249",
    "text": "If her monthly bleeding has not returned, she can months after have implants inserted any time if it is reasonably giving birth certain she is not pregnant. She will need a backup method* for the first 7 days after insertion. y If her monthly bleeding has returned, she can have",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1249
  },
  {
    "id": "chunk_01250",
    "text": "If her monthly bleeding has returned, she can have implants inserted as advised for women having menstrual cycles (see the first row of this table). Partially y If her monthly bleeding has not returned, she can breastfeeding have implants inserted any time if it is reasonably",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1250
  },
  {
    "id": "chunk_01251",
    "text": "ave implants inserted any time if it is reasonably certain she is not pregnant.\u2020 She will need a backup method* for the first 7 days after insertion. y If her monthly bleeding has returned, she can have implants inserted as advised for women having menstrual cycles (see the first row of this table).",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1251
  },
  {
    "id": "chunk_01252",
    "text": "enstrual cycles (see the first row of this table). Not breastfeeding (after giving birth) Less than 4 weeks y She can have implants inserted at any time and after giving birth there is no need for a backup method. More than 4 y If her monthly bleeding has not returned, she can",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1252
  },
  {
    "id": "chunk_01253",
    "text": "If her monthly bleeding has not returned, she can weeks after giving have implants inserted any time if it is reasonably birth certain she is not pregnant.\u2020 She will need a backup method* for the first 7 days after insertion. y If her monthly bleeding has returned, she can have",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1253
  },
  {
    "id": "chunk_01254",
    "text": "If her monthly bleeding has returned, she can have implants inserted as advised for women having menstrual cycles (see the first row of this table). No monthly y She can have implants inserted any time if it bleeding (not is reasonably certain she is not pregnant. She",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1254
  },
  {
    "id": "chunk_01255",
    "text": "not is reasonably certain she is not pregnant. She related to childbirth will need a backup method* for the first 7 days or breastfeeding) after insertion. (Continued on next page) \u2020 Where a visit 6 weeks after childbirth is routinely recommended and other opportunities to obtain",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1255
  },
  {
    "id": "chunk_01256",
    "text": "nely recommended and other opportunities to obtain contraception are limited, some providers and programs may insert implants at the 6-week visit, without further evidence that the woman is not pregnant, if her monthly bleeding has not yet returned. Providing Implants",
    "page_number": 161,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1256
  },
  {
    "id": "chunk_01257",
    "text": "Woman\u2019s situation When to start (continued) After miscarriage y If it is within 7 days after first- or second- or abortion trimester miscarriage or abortion, she can have implants inserted immediately and there is no need for a backup method. y If it is more than 7 days after first- or second-",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1257
  },
  {
    "id": "chunk_01258",
    "text": "If it is more than 7 days after first- or second- trimester miscarriage or abortion, she can have implants inserted any time if it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after insertion. After taking After taking progestin-only or",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1258
  },
  {
    "id": "chunk_01259",
    "text": "rtion. After taking After taking progestin-only or emergency combined ECPs contraceptive pills y Implants can be inserted on the same day as (ECPs) taking the ECPs. There is no need to wait for the next monthly bleeding. She will need a backup method* for the first 7 days after insertion.",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1259
  },
  {
    "id": "chunk_01260",
    "text": "ckup method* for the first 7 days after insertion. y If she does not start immediately but returns for an implant, she can start at any time if it is reasonably certain she is not pregnant. After taking ulipristal acetate (UPA) ECPs y Implants can be inserted on the 6th day after",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1260
  },
  {
    "id": "chunk_01261",
    "text": "Ps y Implants can be inserted on the 6th day after taking UPA-ECPs, so make an appointment for her to return to have the implant inserted on the 6th day after taking UPA-ECPs or as soon as possible after that. There is no need to wait for the next monthly bleeding. Implants and UPA",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1261
  },
  {
    "id": "chunk_01262",
    "text": "it for the next monthly bleeding. Implants and UPA interact. The progestin in the implant and the UPA interact with each other. If an implant is inserted sooner, and both are thus present in the body, one or both of the medicines may be less effective. y She will need a backup method* from the",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1262
  },
  {
    "id": "chunk_01263",
    "text": "fective. y She will need a backup method* from the time she takes UPA-ECPs until 7 days after the implant is inserted. y If she does not start on the 6th day but returns later for implants, she can start at any time if it is reasonably certain she is not pregnant.",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1263
  },
  {
    "id": "chunk_01264",
    "text": "e if it is reasonably certain she is not pregnant. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal; the client should be informed that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 162,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1264
  },
  {
    "id": "chunk_01265",
    "text": "9 141 stnalpmI Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes and other side effects must be provided before inserting implants. Counseling about bleeding changes may be the most important help a woman needs to enable her to keep using this method without concern.",
    "page_number": 163,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1265
  },
  {
    "id": "chunk_01266",
    "text": "ble her to keep using this method without concern. Describe the most y Changes in her bleeding pattern: common side effects \u2013 Over the first year: Irregular bleeding that lasts more than 8 days at a time \u2013 Later: Regular, infrequent, or no bleeding at all y Other common side effects include",
    "page_number": 163,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1266
  },
  {
    "id": "chunk_01267",
    "text": "leeding at all y Other common side effects include headaches, abdominal pain, and breast tenderness, among others. Explain about these y Side effects are not signs of illness. side effects y Lack of bleeding does not mean pregnancy. y Most side effects usually become less or stop",
    "page_number": 163,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1267
  },
  {
    "id": "chunk_01268",
    "text": "y. y Most side effects usually become less or stop within the first year. y Common, but some women do not have them. y Client can come back for help if side effects bother her or if she has other concerns. Providing Implants",
    "page_number": 163,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1268
  },
  {
    "id": "chunk_01269",
    "text": "Inserting Implants Explaining the Insertion Procedure to the Client A woman who has chosen implants needs to know what will happen during insertion. The following description can help explain the procedure to her. Learning to insert and remove implants requires training and practice under",
    "page_number": 164,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1269
  },
  {
    "id": "chunk_01270",
    "text": "move implants requires training and practice under direct supervision. Inserting implants usually takes only a few minutes but can sometimes take longer, depending on the skill of the provider. Related complications are rare and also depend on the skill of the provider.",
    "page_number": 164,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1270
  },
  {
    "id": "chunk_01271",
    "text": "rare and also depend on the skill of the provider. Insertion Procedure for 1-Rod Implants \u2013 Implanon NXT (Nexplanon) The provider should ensure that the essential equipment, supplies, and the implant itself are available (see below).",
    "page_number": 164,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1271
  },
  {
    "id": "chunk_01272",
    "text": "and the implant itself are available (see below). The provider should use proper infection-prevention practices throughout the procedure. Implant pre-loaded inside needle Antiseptic solution Sterile with bowl gauze Gloves Sterile skin closure Local anesthetic Sterile (1% concentration with or drape",
    "page_number": 164,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1272
  },
  {
    "id": "chunk_01273",
    "text": "9 143 stnalpmI Steps for the Insertion Procedure for 1-Rod Implants 1 Place a clean, dry cloth under the woman\u2019s arm and position the non-dominant arm with elbow flexed and hand behind ear. Mark position on arm for insertion of rod, 8\u201310 cm from the medial epicondyle and 3\u20135 cm below the sulcus.",
    "page_number": 165,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1273
  },
  {
    "id": "chunk_01274",
    "text": "the medial epicondyle and 3\u20135 cm below the sulcus. 2 Prep insertion site with antiseptic solution and drape. Inject 1\u20132 mL of 1% lidocaine just under the skin, raising a wheal at the insertion point and advancing up to 5 cm along the insertion track. 3 Using the no-touch technique, remove the",
    "page_number": 165,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1274
  },
  {
    "id": "chunk_01275",
    "text": "track. 3 Using the no-touch technique, remove the sterile disposable 1-rod applicator from blister pack. Hold it at the textured surface area. Visually verify presence of implant inside of needle. Remove needle shield. Providing Implants",
    "page_number": 165,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1275
  },
  {
    "id": "chunk_01276",
    "text": "Steps for the Insertion Procedure for 1-Rod Implants (continued) 4 Provider should Stretch skin be situated to near insertion visualize the site with thumb insertion and and index finger. ensure it is Puncture skin subcutaneous with applicator and parallel to Subcutaneous at a 30\u00ba angle",
    "page_number": 166,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1276
  },
  {
    "id": "chunk_01277",
    "text": "icator and parallel to Subcutaneous at a 30\u00ba angle the arm. tissue and insert only Fascia the bevel of the Triceps needle. 5 Visualizing the needle, lower the Insert entire length of the needle applicator until parallel with surface without using force. of skin and gently advance, while",
    "page_number": 166,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1277
  },
  {
    "id": "chunk_01278",
    "text": "out using force. of skin and gently advance, while Verify entire length of the needle lifting skin upwards to ensure has been inserted in the skin before superficial placement. the next step. 6 Hold the applicator in this position This action will retract the needle",
    "page_number": 166,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1278
  },
  {
    "id": "chunk_01279",
    "text": "this position This action will retract the needle and press the purple slider into the body of the applicator. downwards until it stops. 144 Family Planning: A Global Handbook for Providers",
    "page_number": 166,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1279
  },
  {
    "id": "chunk_01280",
    "text": "9\n145\nstnalpmI\nSteps for the Insertion Procedure for 1-Rod Implants (continued)\n7 Gently remove applicator,\nleaving the implant in place.\n8 Palpate to check the implant\nis in place. Ask the woman to\npalpate the implant to confirm\nits presence.\n9 Close the incision site with a\nsterile skin closure.\n10 Apply pressure bandage dressing\nto minimize bleeding and bruising.\nProviding Implants",
    "page_number": 167,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1280
  },
  {
    "id": "chunk_01281",
    "text": "Insertion Procedure for 2-Rod Implants \u2013 Jadelle and Levoplant The provider should ensure that the essential equipment, supplies, and the implant itself are available (see below). The provider should use proper infection-prevention practices throughout the procedure. Antiseptic Sterile solution gauze",
    "page_number": 168,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1281
  },
  {
    "id": "chunk_01282",
    "text": "t the procedure. Antiseptic Sterile solution gauze with bowl Sterile Sterile skin gloves closure Local anesthetic Sterile (1% concentration with or drape without epinephrine) Pressure Syringe bandage Steps for the Insertion Procedure for 2-Rod Implants 1 Place a clean, dry cloth under the woman\u2019s",
    "page_number": 168,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1282
  },
  {
    "id": "chunk_01283",
    "text": "lants 1 Place a clean, dry cloth under the woman\u2019s arm and position the non-dominant arm with elbow flexed and hand parallel to ear. Mark positions (A) and (B) on arm for insertion of rods, 6\u20138 cm above the medial epicondyle 146 Family Planning: A Global Handbook for Providers",
    "page_number": 168,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1283
  },
  {
    "id": "chunk_01284",
    "text": "9 147 stnalpmI Steps for the Insertion Procedure for 2-Rod Implants (continued) 2 Prep insertion site with antiseptic solution and drape. Inject 1\u20132 mL of 1% lidocaine just under the skin raising a wheal at the insertion point and advancing up to 5 cm along the insertion tracks (A&B).",
    "page_number": 169,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1284
  },
  {
    "id": "chunk_01285",
    "text": "ncing up to 5 cm along the insertion tracks (A&B). 3 Stretch skin near insertion site Puncture skin with trocar at a with thumb and index finger. 20\u00ba angle and insert only the bevel of the needle. 4 Lower the applicator until Advance trocar and plunger to mark",
    "page_number": 169,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1285
  },
  {
    "id": "chunk_01286",
    "text": "pplicator until Advance trocar and plunger to mark parallel with surface of the (1) nearest the hub of the trocar. skin and gently advance, while lifting skin upwards to ensure superficial placement. 5 Remove plunger while Load first rod (A) into trocar holding trocar in place. with tissue forceps.",
    "page_number": 169,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1286
  },
  {
    "id": "chunk_01287",
    "text": "Steps for the Insertion Procedure for 2-Rod Implants (continued) 6 Reinsert plunger, advancing until resistance is felt 7 Hold plunger firmly in place with Withdraw trocar and plunger together one hand, and slide the trocar out until mark (2) nearest the trocar tip",
    "page_number": 170,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1287
  },
  {
    "id": "chunk_01288",
    "text": "e trocar out until mark (2) nearest the trocar tip of the incision until it reaches the (do not remove the trocar from the plunger handle. incision). 8 At mark (2), redirect the trocar 9 Palpate to check the implants about 15\u00ba away from the first rod are in place. Ask the woman to",
    "page_number": 170,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1288
  },
  {
    "id": "chunk_01289",
    "text": "from the first rod are in place. Ask the woman to inserted (A). Advance trocar and palpate the implants to confirm plunger toward (B) up to mark (1) their presence. and insert second rod (B) using the same technique (repeat steps 5\u20137). 10 Close the incision site 11 Apply pressure bandage dressing to",
    "page_number": 170,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1289
  },
  {
    "id": "chunk_01290",
    "text": "ncision site 11 Apply pressure bandage dressing to with a sterile skin closure. minimize bleeding and bruising. 148 Family Planning: A Global Handbook for Providers",
    "page_number": 170,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1290
  },
  {
    "id": "chunk_01291",
    "text": "9 149 stnalpmI Advice for the Client After Inserting Implants Give specific instructions Keep arm dry y The user should keep the insertion area dry for 4 days. She can take off the gauze after 2 days and the adhesive bandage and surgical tape when the incision heals, usually after 3\u20135 days.",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1291
  },
  {
    "id": "chunk_01292",
    "text": "e when the incision heals, usually after 3\u20135 days. Expect soreness, y After the anesthetic wears off, her arm may be bruising sore for a few days. She also may have swelling and bruising at the insertion site. This is common and will go away without treatment.",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1292
  },
  {
    "id": "chunk_01293",
    "text": "This is common and will go away without treatment. Length of y Explain that it is important to have implants pregnancy removed before they start to lose effectiveness. protection At that time, she can have a new set of implants inserted if she wants. y Discuss how to remember the date to return for",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1293
  },
  {
    "id": "chunk_01294",
    "text": ". y Discuss how to remember the date to return for implant removal and possible replacement. y Give each woman the following information in writing on a reminder card, like the one shown below, if possible, and explain: \u2013 the type of implant she has and in which arm \u2013 the date of insertion",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1294
  },
  {
    "id": "chunk_01295",
    "text": "t she has and in which arm \u2013 the date of insertion \u2013 the month and year when implants will need to be removed or replaced \u2013 where to go if she has problems or questions about her implants. Implant Reminder Card Client\u2019s name: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1295
  },
  {
    "id": "chunk_01296",
    "text": "me: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd Type of implant: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd Arm: L \ufffd\ufffd\ufffd\ufffd\ufffd R \ufffd\ufffd\ufffd\ufffd\ufffd Date inserted: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd Remove or replace by: Month: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd Year: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd If you have any problems or questions, go to:",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1296
  },
  {
    "id": "chunk_01297",
    "text": "\ufffd\ufffd\ufffd\ufffd If you have any problems or questions, go to: \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd (name and location of facility) Providing Implants",
    "page_number": 171,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1297
  },
  {
    "id": "chunk_01298",
    "text": "Supporting New and Continuing Users How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: \u2022 Support his partner\u2019s choice of implants",
    "page_number": 172,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1298
  },
  {
    "id": "chunk_01299",
    "text": "er can: \u2022 Support his partner\u2019s choice of implants \u2022 Show understanding and support if she has side effects \u2022 Use condoms consistently in addition to the implant if he has an STI/HIV or thinks he may be at risk of an STI/HIV \u2022 Help to remember when the implant is due for removal.",
    "page_number": 172,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1299
  },
  {
    "id": "chunk_01300",
    "text": "p to remember when the implant is due for removal. \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; if she",
    "page_number": 172,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1300
  },
  {
    "id": "chunk_01301",
    "text": "oblems, questions, or wants another method; if she has a major change in health status; or if she thinks she might be pregnant. Also if: y She has pain, heat, pus, or redness at the insertion site that becomes worse or does not go away, or she sees a rod coming out.",
    "page_number": 172,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1301
  },
  {
    "id": "chunk_01302",
    "text": "or does not go away, or she sees a rod coming out. y She wants the implants taken out, for whatever reason. y It is time for the implants to be removed and, if she wishes, for new implants to be put in. General health advice Anyone who suddenly feels that something is seriously wrong with",
    "page_number": 172,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1302
  },
  {
    "id": "chunk_01303",
    "text": "denly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the health worker what method she is using.",
    "page_number": 172,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1303
  },
  {
    "id": "chunk_01304",
    "text": "9 151 stnalpmI Follow-up Visits With Implant Users IMPORTANT: No routine return visit is required until it is time to remove the implants (see Removing Implants, pp. 157\u2013160). However, the client should be invited to return any time she wishes. At any future visit:",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1304
  },
  {
    "id": "chunk_01305",
    "text": "o return any time she wishes. At any future visit: 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything she would like to discuss. 2. In particular, ask if she is concerned about bleeding changes. Give",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1305
  },
  {
    "id": "chunk_01306",
    "text": "k if she is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, below). 3. Ask long-term clients if they have had any new health problems since their last visit. Address problems as appropriate. For new problems",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1306
  },
  {
    "id": "chunk_01307",
    "text": "Address problems as appropriate. For new problems that may require switching methods, see the section with that title on pp. 155\u2013156. 4. Ask long-term clients about any major life changes that may affect family planning needs\u2014particularly plans for having children and",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1307
  },
  {
    "id": "chunk_01308",
    "text": "g needs\u2014particularly plans for having children and STI/HIV risk. Follow up as needed. 5. If she wants to keep using implants and no new medical condition prevents it, remind her how much longer her implants will protect her from pregnancy. Managing Any Problems",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1308
  },
  {
    "id": "chunk_01309",
    "text": "protect her from pregnancy. Managing Any Problems Problems Reported as Side Effects or Complications These problems may or may not be due to the use of implants, but they affect women\u2019s satisfaction and use of this method and therefore deserve",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1309
  },
  {
    "id": "chunk_01310",
    "text": "ction and use of this method and therefore deserve the provider\u2019s attention. The following information advises how to address any reported side effects or complications, and specific conditions. Any reported side effects or complications",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1310
  },
  {
    "id": "chunk_01311",
    "text": "itions. Any reported side effects or complications y Listen to the client\u2019s concerns, give her advice and support, and, if appropriate, treat the condition. Make sure she understands the advice and agrees. y Offer to help her choose another method\u2014now, if she wishes, or if",
    "page_number": 173,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1311
  },
  {
    "id": "chunk_01312",
    "text": "Irregular bleeding (bleeding at unexpected times) y Reassure her that many women using implants experience irregular bleeding. It is not harmful and usually becomes less or stops after the first year of use. y For modest short-term relief, she can take 800 mg ibuprofen or 500 mg",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1312
  },
  {
    "id": "chunk_01313",
    "text": "rm relief, she can take 800 mg ibuprofen or 500 mg mefenamic acid 3 times daily after meals for 5 days, beginning when irregular bleeding starts. y If these medicines do not help her, she can try one of the following, beginning when irregular bleeding starts:",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1313
  },
  {
    "id": "chunk_01314",
    "text": "llowing, beginning when irregular bleeding starts: \u2013 Combined oral contraceptives (COCs) containing the progestin levonorgestrel \u2013 1 pill daily for 21 days \u2013 COCs containing 50 \u00b5g ethinyl estradiol \u2013 1 pill daily for 21 days",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1314
  },
  {
    "id": "chunk_01315",
    "text": "50 \u00b5g ethinyl estradiol \u2013 1 pill daily for 21 days y If irregular bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1315
  },
  {
    "id": "chunk_01316",
    "text": "ider underlying conditions unrelated to method use (see the row on \u201cUnexplained vaginal bleeding\u201d, on p. 156). No monthly bleeding y If the client has no monthly bleeding soon after implant insertion, rule out pregnancy (see the job aid, Ruling Out Pregnancy). She might have been",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1316
  },
  {
    "id": "chunk_01317",
    "text": "ob aid, Ruling Out Pregnancy). She might have been pregnant at the time of insertion. If she is pregnant, remove the implant. y If she is not pregnant, reassure her that some women stop having monthly bleeding when using implants, and this is not harmful. There is no need",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1317
  },
  {
    "id": "chunk_01318",
    "text": "mplants, and this is not harmful. There is no need to lose blood every month; blood is not building up inside her. It is similar to not having monthly bleeding during pregnancy. It does not mean she has become infertile. Some women are happy to be free from monthly",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1318
  },
  {
    "id": "chunk_01319",
    "text": "tile. Some women are happy to be free from monthly bleeding, when they understand that it is not harmful. Also, not bleeding can have health benefits, for example, reducing the risk of anemia. Heavy or prolonged bleeding (twice as much as usual or longer than 8 days)",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1319
  },
  {
    "id": "chunk_01320",
    "text": "ing (twice as much as usual or longer than 8 days) y Reassure the client that some women using implants experience heavy or prolonged bleeding. It is generally not harmful and usually becomes less or stops after a few months. y For modest short-term relief, she can try any of the treatments for",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1320
  },
  {
    "id": "chunk_01321",
    "text": "term relief, she can try any of the treatments for irregular bleeding suggested above, beginning when heavy bleeding starts. COCs containing 50 \u00b5g of ethinyl estradiol may work better than lower-dose COCs. y To help prevent anemia, suggest she take iron tablets and tell her it",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1321
  },
  {
    "id": "chunk_01322",
    "text": "mia, suggest she take iron tablets and tell her it is important to eat foods containing iron, such as meat and poultry (especially beef and chicken liver), fish, green leafy vegetables, and legumes (beans, bean curd, lentils, and peas). 152 Family Planning: A Global Handbook for Providers",
    "page_number": 174,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1322
  },
  {
    "id": "chunk_01323",
    "text": "9 153 stnalpmI y If heavy or prolonged bleeding continues or starts after several months of normal or no monthly bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see the row on \u201cUnexplained vaginal bleeding\u201d, on p. 156).",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1323
  },
  {
    "id": "chunk_01324",
    "text": "row on \u201cUnexplained vaginal bleeding\u201d, on p. 156). Ordinary headaches (nonmigrainous) y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. y Any headaches that get worse or occur more often during use of implants should be evaluated.",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1324
  },
  {
    "id": "chunk_01325",
    "text": "often during use of implants should be evaluated. Mild abdominal pain y Suggest paracetamol (325\u20131,000 mg), aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), or other pain reliever. y Consider locally available remedies. Acne y Consider locally available remedies.",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1325
  },
  {
    "id": "chunk_01326",
    "text": "edies. Acne y Consider locally available remedies. y If the client wants to stop using implants because of acne, she can consider switching to COCs. Acne improves for many women with COC use. Weight change y Review the client\u2019s diet with her and counsel as needed. Breast tenderness",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1326
  },
  {
    "id": "chunk_01327",
    "text": "with her and counsel as needed. Breast tenderness y Recommend that she wear a supportive bra (including during strenuous activity and sleep). y Try hot or cold compresses. y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever.",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1327
  },
  {
    "id": "chunk_01328",
    "text": "aracetamol (325\u20131,000 mg), or other pain reliever. y Consider locally available remedies. Mood changes or changes in sex drive y Ask the client about changes in her life that could affect her mood or sex drive, including changes in her relationship with her partner. Give her support as appropriate.",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1328
  },
  {
    "id": "chunk_01329",
    "text": "with her partner. Give her support as appropriate. y Clients who have serious mood changes such as major depression should be referred for care. y Consider locally available remedies. Supporting New and Continuing Users",
    "page_number": 175,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1329
  },
  {
    "id": "chunk_01330",
    "text": "Nausea or dizziness y Consider locally available remedies. Pain after insertion or removal y For pain after insertion, check that the bandage or gauze on her arm is not too tight. y Put a new bandage on the arm and advise her to avoid pressing on the site for a few days.",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1330
  },
  {
    "id": "chunk_01331",
    "text": "her to avoid pressing on the site for a few days. y Give her aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. Infection at the insertion site (redness, heat, pain, pus) y Do not remove the implants.",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1331
  },
  {
    "id": "chunk_01332",
    "text": "ss, heat, pain, pus) y Do not remove the implants. y Clean the infected area with soap and water or antiseptic. y Give oral antibiotics for 7\u201310 days. y Ask the client to return after taking all antibiotics if the infection does not clear. If infection has not cleared, remove the implants or refer",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1332
  },
  {
    "id": "chunk_01333",
    "text": "tion has not cleared, remove the implants or refer for removal. y Expulsion or partial expulsion often follows infection. Ask the client to return if she notices an implant coming out. Abscess (pocket of pus under the skin due to infection) y Do not remove the implants.",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1333
  },
  {
    "id": "chunk_01334",
    "text": "in due to infection) y Do not remove the implants. y Clean the area with antiseptic. y Cut open (incise) and drain the abscess. y Treat the wound. y Give oral antibiotics for 7\u201310 days. y Ask the client to return after taking all antibiotics if she has heat,",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1334
  },
  {
    "id": "chunk_01335",
    "text": "turn after taking all antibiotics if she has heat, redness, pain, or drainage of the wound. If infection is present when she returns, remove the implants or refer for removal. Expulsion (when one or more implants begin to come out of the arm)",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1335
  },
  {
    "id": "chunk_01336",
    "text": "one or more implants begin to come out of the arm) y This is rare, but if it does occur it will usually be within a few months of insertion or with infection. y If no infection is present, after offering an explanation and counseling,",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1336
  },
  {
    "id": "chunk_01337",
    "text": "ent, after offering an explanation and counseling, replace the expelled rod or capsule through a new incision near the other rods or capsules, or refer for replacement. 154 Family Planning: A Global Handbook for Providers",
    "page_number": 176,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1337
  },
  {
    "id": "chunk_01338",
    "text": "9 155 stnalpmI Severe pain in lower abdomen y Abdominal pain may be due to various problems, such as enlarged ovarian follicles or cysts. \u2013 A woman can continue to use implants during evaluation. \u2013 There is no need to treat enlarged ovarian follicles or cysts unless",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1338
  },
  {
    "id": "chunk_01339",
    "text": "o treat enlarged ovarian follicles or cysts unless they grow abnormally large, twist, or burst. \u2013 Reassure the client that they usually disappear on their own. To be sure the problem is resolving, see the client again in 6 weeks, if possible.",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1339
  },
  {
    "id": "chunk_01340",
    "text": "ing, see the client again in 6 weeks, if possible. y With severe abdominal pain, be particularly alert for additional signs or symptoms of ectopic pregnancy. Ectopic pregnancy is rare and not caused by implants, but it can be life-threatening (see Question 7,",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1340
  },
  {
    "id": "chunk_01341",
    "text": "s, but it can be life-threatening (see Question 7, p. 162). In the early stages of ectopic pregnancy, symptoms may be absent or mild, but eventually they will become severe. A combination of these signs or symptoms should increase suspicion of ectopic pregnancy: \u2013 unusual abdominal pain or tenderness",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1341
  },
  {
    "id": "chunk_01342",
    "text": "pregnancy: \u2013 unusual abdominal pain or tenderness \u2013 abnormal vaginal bleeding or no monthly bleeding\u2014especially if this is a change from her usual bleeding pattern \u2013 light-headedness or dizziness \u2013 fainting. y If ectopic pregnancy or another serious health condition is suspected,",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1342
  },
  {
    "id": "chunk_01343",
    "text": "or another serious health condition is suspected, refer the client at once for immediate diagnosis and care. (See Chapter 12 \u2013 Female Sterilization, section on Managing Ectopic Pregnancy, p. 237, for more on ectopic pregnancies.) New Problems That May Require Switching Methods",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1343
  },
  {
    "id": "chunk_01344",
    "text": ".) New Problems That May Require Switching Methods These problems also may or may not be due to the use of implants. Migraine headaches (see the job aid on Identifying Migraine Headaches and Auras, pp. 458\u2013460) y If the client has migraine headaches without aura, she can continue",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1344
  },
  {
    "id": "chunk_01345",
    "text": "migraine headaches without aura, she can continue to use implants if she wishes. y If she has migraine aura, remove the implants. Help her choose a method without hormones. Supporting New and Continuing Users",
    "page_number": 177,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1345
  },
  {
    "id": "chunk_01346",
    "text": "Unexplained vaginal bleeding (that suggests a medical condition not related to the method) y Refer or evaluate the client by history and pelvic examination. Diagnose and treat as appropriate. y If no cause of bleeding can be found, consider stopping implants to make",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1346
  },
  {
    "id": "chunk_01347",
    "text": "g can be found, consider stopping implants to make diagnosis easier. Provide another method of her choice (but not progestin- only injectables, or a copper-bearing or hormonal IUD) to use until the condition is evaluated and treated.",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1347
  },
  {
    "id": "chunk_01348",
    "text": "use until the condition is evaluated and treated. y If bleeding is caused by an STI or pelvic inflammatory disease, she can continue using implants during treatment. Certain serious health conditions (suspected blood clots in deep veins of legs or lungs, serious liver disease, or breast",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1348
  },
  {
    "id": "chunk_01349",
    "text": "of legs or lungs, serious liver disease, or breast cancer). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. y Remove the implants or refer for removal. y Give the client a backup method to use until the condition is evaluated.",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1349
  },
  {
    "id": "chunk_01350",
    "text": "up method to use until the condition is evaluated. y Refer the client for diagnosis and care if she is not already under care. Heart disease due to blocked or narrowed arteries (ischemic heart disease) or stroke y A woman who has one of these conditions can safely start implants.",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1350
  },
  {
    "id": "chunk_01351",
    "text": "one of these conditions can safely start implants. If, however, the condition develops while she is using implants: \u2013 Remove the implants or refer for removal. \u2013 Help her choose a method without hormones. \u2013 Refer the client for diagnosis and care if she is not already under care. Suspected pregnancy",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1351
  },
  {
    "id": "chunk_01352",
    "text": "she is not already under care. Suspected pregnancy y Assess the client for pregnancy, including ectopic pregnancy (see \u201cSevere pain in lower abdomen\u201d, previous page). y Remove the implants or refer for removal if she will carry the pregnancy to term.",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1352
  },
  {
    "id": "chunk_01353",
    "text": "r removal if she will carry the pregnancy to term. y There are no known risks to a fetus conceived while a woman has implants in place (see Question 5, p. 161). 156 Family Planning: A Global Handbook for Providers",
    "page_number": 178,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1353
  },
  {
    "id": "chunk_01354",
    "text": "9 157 stnalpmI Removing Implants IMPORTANT: Providers must not refuse or delay when a woman asks to have her implants removed, whatever her reason\u2014whether it is personal or medical. All staff must understand and agree that she must not be pressured",
    "page_number": 179,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1354
  },
  {
    "id": "chunk_01355",
    "text": "nderstand and agree that she must not be pressured or forced to continue using implants. If the implants may be difficult to remove, a provider with the necessary skills should be available. Removals should be provided free of charge if possible. Explaining the Removal Procedure to the Client",
    "page_number": 179,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1355
  },
  {
    "id": "chunk_01356",
    "text": "le. Explaining the Removal Procedure to the Client A woman needs to know what will happen during removal. The following description can help explain the procedure to her. The same removal procedure is used for all types of implants.",
    "page_number": 179,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1356
  },
  {
    "id": "chunk_01357",
    "text": "moval procedure is used for all types of implants. The provider should ask whether the woman wants to continue preventing pregnancy and discuss her options. If she wants new implants, they should be placed above or below the site of the previous implants or in the other arm.",
    "page_number": 179,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1357
  },
  {
    "id": "chunk_01358",
    "text": "site of the previous implants or in the other arm. Removal Procedure for Implants The provider should ensure that the essential equipment, and supplies, are available (see below). The provider should use proper infection- prevention practices throughout the procedure. Scalpel Antiseptic solution",
    "page_number": 179,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1358
  },
  {
    "id": "chunk_01359",
    "text": "oughout the procedure. Scalpel Antiseptic solution with bowl Curved mosquito forceps Sterile gloves Straight mosquito forceps Sterile drape Sterile gauze Local anesthetic (1% concentration Steri-Strips with or without or sterile skin epinephrine) closure Pressure Syringe bandage Removing Implants",
    "page_number": 179,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1359
  },
  {
    "id": "chunk_01360",
    "text": "Steps for the Removal Procedure 1 Locate 1- or 2-rod If the implant implant by palpation cannot be and pressing down. located, check Refer for further both of the examination if possible insertion not located. sites (A and B), Determine location as well as both of the distal end arms. If it is not",
    "page_number": 180,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1360
  },
  {
    "id": "chunk_01361",
    "text": "well as both of the distal end arms. If it is not of the implant possible to find by palpation and the implant, mark this as the refer the woman incision site. for further examination. 2 Prep insertion site with antiseptic solution and drape. Inject 1\u20132 mL of 1% lidocaine just under",
    "page_number": 180,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1361
  },
  {
    "id": "chunk_01362",
    "text": "nd drape. Inject 1\u20132 mL of 1% lidocaine just under the implant so as not to obscure it. If this is a 2-rod system, inject between the 2 rods. 3 Make a small (2 mm) stab incision, at the tip(s) of and parallel to the implants. 158 Family Planning: A Global Handbook for Providers",
    "page_number": 180,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1362
  },
  {
    "id": "chunk_01363",
    "text": "9 159 stnalpmI Steps for the Removal Procedure (continued) 4 Push the implant(s) toward the incision until the tip is visible. If this a 2-rod system, remove them 1 at a time. 5 Grasp implant with a curved mosquito forceps and gently remove it. 6 If the tip of the implant does not become visible",
    "page_number": 181,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1363
  },
  {
    "id": "chunk_01364",
    "text": "If the tip of the implant does not become visible in the incision, insert a forceps tip into the incision, grasp the implant and remove fibrous tissue with back of scalpel blade and/or gauze. 7 After the implant is exposed, grasp with second pair of mosquito foceps and gently remove it.",
    "page_number": 181,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1364
  },
  {
    "id": "chunk_01365",
    "text": "Steps for the Removal Procedure (continued)\n8 Ensure that the complete\nrod has been removed;\nshow it to the client.\nIf this is a 2-rod system,\nrepeat steps 4\u20137 to\nremove the second rod.\n9 Close the\nincision site\nwith sterile\nskin closure.\n10 Apply pressure\nbandage dressing\nto minimize\nbleeding and\nbruising.\n160 Family Planning: A Global Handbook for Providers",
    "page_number": 182,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1365
  },
  {
    "id": "chunk_01366",
    "text": "9 161 stnalpmI Questions and Answers About Implants 1. Do users of implants require follow-up visits? No. Routine periodic visits are not necessary for implant users. Annual visits may be helpful for other preventive care, but they are not necessary or required. Of course, women are welcome to return",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1366
  },
  {
    "id": "chunk_01367",
    "text": "r required. Of course, women are welcome to return at any time with questions or to have implants removed. 2. Can implants be left in a woman\u2019s arm? Leaving the implants in place beyond their effective lifespan is generally not recommended if the woman continues to be at risk",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1367
  },
  {
    "id": "chunk_01368",
    "text": "t recommended if the woman continues to be at risk of pregnancy. The implants themselves are not dangerous, but as the hormone levels in the implants drop, they become less and less effective. After they lose effectiveness, they may still release a small",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1368
  },
  {
    "id": "chunk_01369",
    "text": "lose effectiveness, they may still release a small dose of hormone for several more years, which serves no purpose. If a woman wants to continue using implants, she may have a new implant inserted in the other arm even if the first implant is not",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1369
  },
  {
    "id": "chunk_01370",
    "text": "in the other arm even if the first implant is not removed at that time; for example, if removal services are not immediately available. 3. Do implants cause cancer? No. Studies have not found increased risk of any cancer with use of implants. 4. How long does it take to become pregnant after the",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1370
  },
  {
    "id": "chunk_01371",
    "text": "How long does it take to become pregnant after the implants are removed? Women who stop using implants can become pregnant as quickly as women who stop nonhormonal methods. Implants do not delay the return of a woman\u2019s fertility after they are removed. The bleeding",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1371
  },
  {
    "id": "chunk_01372",
    "text": "n\u2019s fertility after they are removed. The bleeding pattern a woman had before she used implants generally returns after they are removed. 5. Do implants cause birth defects? Will the fetus be harmed if a woman accidentally becomes pregnant with implants in place?",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1372
  },
  {
    "id": "chunk_01373",
    "text": "identally becomes pregnant with implants in place? No. Good evidence shows that implants will not cause birth defects and will not otherwise harm the fetus if a woman becomes pregnant while using implants or accidentally has implants inserted when she is already pregnant.",
    "page_number": 183,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1373
  },
  {
    "id": "chunk_01374",
    "text": "6. Can implants come out of a woman\u2019s arm? Rarely, a rod may start to come out, most often in the first 4 weeks after insertion. This usually happens because they were not inserted well or because of an infection where they were inserted. In these",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1374
  },
  {
    "id": "chunk_01375",
    "text": "of an infection where they were inserted. In these cases, the woman will see the implant(s) coming out. Some women may have a sudden change in bleeding pattern. If a woman notices a rod coming out, she should start using a backup method and return to the clinic at once.",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1375
  },
  {
    "id": "chunk_01376",
    "text": "a backup method and return to the clinic at once. 7. Do implants increase the risk of ectopic pregnancy? No. On the contrary, implants greatly reduce the risk of ectopic pregnancy. Ectopic pregnancies are extremely rare among implant users. The rate of ectopic pregnancy among women with implants is",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1376
  },
  {
    "id": "chunk_01377",
    "text": "of ectopic pregnancy among women with implants is 6 per 100,000 women per year. The rate of ectopic pregnancy among women in the United States using no contraceptive method is 650 per 100,000 women per year. On the very rare occasions that implants fail and pregnancy occurs,",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1377
  },
  {
    "id": "chunk_01378",
    "text": "occasions that implants fail and pregnancy occurs, 10\u201317 of every 100 of these pregnancies are ectopic. Thus, the great majority of pregnancies after implants fail are not ectopic. Still, ectopic pregnancy can be life-threatening, and so a provider should be",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1378
  },
  {
    "id": "chunk_01379",
    "text": "n be life-threatening, and so a provider should be aware that ectopic pregnancy is possible if implants fail. 8. When can a breastfeeding woman start implants? In 2015, WHO considered this question and updated its guidance to allow a woman to use progestin-only implants after childbirth",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1379
  },
  {
    "id": "chunk_01380",
    "text": "an to use progestin-only implants after childbirth regardless of how recently she gave birth. She does not need to wait until 6 weeks postpartum. This change in guidance also applies to progestin-only pills and the LNG-IUD. For details on when",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1380
  },
  {
    "id": "chunk_01381",
    "text": "in-only pills and the LNG-IUD. For details on when breastfeeding women can start implants, see the section on When to Start, earlier in this chapter, on p. 138. 9. Should heavy women avoid implants? No. Some but not all studies have found that Jadelle implants became",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1381
  },
  {
    "id": "chunk_01382",
    "text": "ll studies have found that Jadelle implants became slightly less effective for heavier women after 4 or more years of use. As a precaution, women weighing over 80 kg may want to have their implants replaced after 4 years for greatest effectiveness. Studies of",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1382
  },
  {
    "id": "chunk_01383",
    "text": "ter 4 years for greatest effectiveness. Studies of Implanon have not found that effectiveness decreases for heavier women within the lifespan approved for this type of implant. 162 Family Planning: A Global Handbook for Providers",
    "page_number": 184,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1383
  },
  {
    "id": "chunk_01384",
    "text": "9 163 stnalpmI 10. What should be done if an implant user has an ovarian cyst? The great majority of cysts are not true cysts but actually fluid-filled structures in the ovary (follicles) that continue to grow beyond the usual size in a normal menstrual cycle. They may cause some",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1384
  },
  {
    "id": "chunk_01385",
    "text": "e in a normal menstrual cycle. They may cause some mild abdominal pain, but they require treatment only if they grow abnormally large, twist, or burst. These follicles usually go away without treatment (see the row on \u201cSevere pain in lower abdomen\u201d",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1385
  },
  {
    "id": "chunk_01386",
    "text": "ent (see the row on \u201cSevere pain in lower abdomen\u201d in the section of this chapter on Managing Any Problems, p. 151). 11. Can a woman work soon after having implants inserted? Yes. A woman can do her usual work immediately after leaving the",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1386
  },
  {
    "id": "chunk_01387",
    "text": "an do her usual work immediately after leaving the clinic as long as she does not bump the insertion site or get it wet. 12. Must a woman have a pelvic examination before she can have implants inserted? No. Instead, asking the right questions can help the provider be",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1387
  },
  {
    "id": "chunk_01388",
    "text": "sking the right questions can help the provider be reasonably certain she is not pregnant (see Pregnancy Checklist, inside back cover). No condition that can be detected by a pelvic examination rules out the use of implants. 13. Can young women, including adolescents, use implants?",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1388
  },
  {
    "id": "chunk_01389",
    "text": "young women, including adolescents, use implants? Yes. If a young woman wants to use implants, she can. In fact, implants and IUDs can be good methods for young women who want to be sure to avoid pregnancy for a number of years. They are highly effective and long-lasting methods. According to WHO\u2019s",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1389
  },
  {
    "id": "chunk_01390",
    "text": "ctive and long-lasting methods. According to WHO\u2019s Medical Eligibility Criteria for Contraceptive Use, age is not relevant to implant use. Implant use will not affect a young woman\u2019s future fertility, whether or not she has already had children.",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1390
  },
  {
    "id": "chunk_01391",
    "text": "lity, whether or not she has already had children. All young women seeking contraception, whether married or not and whether or not they have had children, can safely choose from the full range of available contraceptive methods. This includes",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1391
  },
  {
    "id": "chunk_01392",
    "text": "of available contraceptive methods. This includes implants, copper-bearing IUDs, and LNG-IUDs. If women want to have children in the future, however, they should not choose female sterilization, which is a permanent method. Questions and Answers About Implants",
    "page_number": 185,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1392
  },
  {
    "id": "chunk_01393",
    "text": "14. Should women who are taking efavirenz be offered implants? Yes. Women taking the antiretroviral (ARV) drug efavirenz as HIV treatment should be offered implants along with the full range of contraceptive methods. However, it is important to tell women who are",
    "page_number": 186,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1393
  },
  {
    "id": "chunk_01394",
    "text": "ds. However, it is important to tell women who are taking efavirenz that this drug is likely to make the implants less effective. For women taking efavirenz, implants may be about as effective as combined oral contraceptives or male condoms as typically used.",
    "page_number": 186,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1394
  },
  {
    "id": "chunk_01395",
    "text": "contraceptives or male condoms as typically used. Women taking efavirenz who choose implants should be encouraged to use condoms in addition to implants to enhance protection from pregnancy. Alternatively, they can consider other effective contraceptive",
    "page_number": 186,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1395
  },
  {
    "id": "chunk_01396",
    "text": "y, they can consider other effective contraceptive methods that do not interact with efavirenz or other ARV drugs. These methods include progestin-only injectables, the copper-bearing IUD, and the LNG-IUD, or\u2014if they want no more children\u2014female sterilization or vasectomy for their partner.",
    "page_number": 186,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1396
  },
  {
    "id": "chunk_01397",
    "text": "male sterilization or vasectomy for their partner. A user of implants who is starting on efavirenz or already taking it should be told about this reduced effectiveness. A provider can then help her decide whether to keep using implants or switch to another,",
    "page_number": 186,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1397
  },
  {
    "id": "chunk_01398",
    "text": "ether to keep using implants or switch to another, more effective method. If she prefers another method, the provider can remove the implants and help her start the other method. 164 Family Planning: A Global Handbook for Providers",
    "page_number": 186,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1398
  },
  {
    "id": "chunk_01399",
    "text": "10 165 eciveD eniretuartnI gniraeB-reppoC CHAPTER 10 Copper-Bearing Intrauterine Device This chapter describes primarily the TCu-380A intrauterine device. (For the levonorgestrel intrauterine device, see Chapter 11.) Key Points for Providers and Clients",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1399
  },
  {
    "id": "chunk_01400",
    "text": "Chapter 11.) Key Points for Providers and Clients y Long-term pregnancy protection. Shown to be very effective for up to 12 years, immediately reversible. y Inserted into the uterus by a specifically trained provider. y Little required of the client once the IUD is in place.",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1400
  },
  {
    "id": "chunk_01401",
    "text": "e required of the client once the IUD is in place. y Bleeding changes are common. Typically, longer and heavier bleeding and more cramps or pain during monthly bleeding, especially in the first 3 to 6 months. What Is the Copper-Bearing Intrauterine Device?",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1401
  },
  {
    "id": "chunk_01402",
    "text": "s. What Is the Copper-Bearing Intrauterine Device? y The copper-bearing intrauterine device (IUD) is a small, flexible plastic frame with copper sleeves or wire around it. A specifically trained health care provider inserts it into a woman\u2019s uterus through her vagina and cervix.",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1402
  },
  {
    "id": "chunk_01403",
    "text": "to a woman\u2019s uterus through her vagina and cervix. y Almost all types of IUDs have one or two strings, or threads, tied to them. The strings hang through the cervix into the vagina. y Works by causing a chemical change that damages sperm More and egg before they can meet. effective How Effective?",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1403
  },
  {
    "id": "chunk_01404",
    "text": "egg before they can meet. effective How Effective? One of the most effective and long-lasting methods: y Less than 1 pregnancy per 100 women using an IUD over the first year (6 per 1,000 women who use the IUD perfectly, and 8 per 1,000 women as commonly used). This means that 992 to 994",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1404
  },
  {
    "id": "chunk_01405",
    "text": "omen as commonly used). This means that 992 to 994 of every 1,000 women using IUDs will not become pregnant. y A small risk of pregnancy remains beyond the first year of use Less effective and continues as long as the woman is using the IUD.",
    "page_number": 187,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1405
  },
  {
    "id": "chunk_01406",
    "text": "y Studies have found that the TCu-380A is effective for 12 years. The TCu-380A is labeled for up to 10 years of use, however. (Providers should follow national guidelines as to when the IUD should be removed.) Return of fertility after IUD is removed: No delay",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1406
  },
  {
    "id": "chunk_01407",
    "text": "Return of fertility after IUD is removed: No delay Protection against sexually transmitted infections (STIs): None Side Effects, Health Benefits, Health Risks, and Complications Side Effects (see also Managing Any Problems, p. 183) Some users report the following:",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1407
  },
  {
    "id": "chunk_01408",
    "text": "Problems, p. 183) Some users report the following: y Changes in bleeding patterns\u2020 (especially Bleeding changes are in the first 3 to 6 months), including: normal and not harmful. \u2013 Prolonged and heavy monthly bleeding If a woman finds them bothersome, counseling \u2013 Irregular bleeding",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1408
  },
  {
    "id": "chunk_01409",
    "text": "s them bothersome, counseling \u2013 Irregular bleeding and support can help. \u2013 More cramps and pain during monthly bleeding Known Health Benefits Known Health Risks Helps protect against: Uncommon: y Risks of pregnancy y May contribute to anemia if a woman already has low iron blood stores",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1409
  },
  {
    "id": "chunk_01410",
    "text": "nemia if a woman already has low iron blood stores May help protect against: before insertion and the IUD causes y Cancer of the lining of the heavier monthly bleeding uterus (endometrial cancer) Rare: y Cervical cancer y Pelvic inflammatory disease (PID) may occur if the woman has chlamydia or",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1410
  },
  {
    "id": "chunk_01411",
    "text": "ease (PID) may occur if the woman has chlamydia or Reduces: gonorrhea at the time of IUD insertion y Risk of ectopic pregnancy Complications Rare: y Puncturing (perforation) of the wall of the uterus by the IUD or an instrument used for insertion. Usually heals without treatment.",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1411
  },
  {
    "id": "chunk_01412",
    "text": "ed for insertion. Usually heals without treatment. y Miscarriage, preterm birth, or infection in the rare case that the woman becomes pregnant with the IUD in place. \u2020 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary. 166 Family Planning: A Global Handbook for Providers",
    "page_number": 188,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1412
  },
  {
    "id": "chunk_01413",
    "text": "10 167 eciveD eniretuartnI gniraeB-reppoC Correcting Misunderstandings (see also Questions and Answers, p.188) Intrauterine devices: y Can be used by women of any age, including adolescents. y Can be used by women who have had children and those who have not. y Rarely lead to PID.",
    "page_number": 189,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1413
  },
  {
    "id": "chunk_01414",
    "text": "dren and those who have not. y Rarely lead to PID. y Do not increase the risk of contracting STIs, including HIV. y Do not increase the risk of miscarriage when a woman becomes pregnant after the IUD is removed. y Do not make women infertile. y Do not cause birth defects. y Do not cause cancer.",
    "page_number": 189,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1414
  },
  {
    "id": "chunk_01415",
    "text": "Do not cause birth defects. y Do not cause cancer. y Do not move to the heart or brain. y Do not cause discomfort or pain for the woman or the man during sex. y Substantially reduce the risk of ectopic pregnancy. Why Some Women Say They Like the IUD y Prevents pregnancy very effectively",
    "page_number": 189,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1415
  },
  {
    "id": "chunk_01416",
    "text": "Like the IUD y Prevents pregnancy very effectively y Is long-lasting y Is private\u2014usually no one else can tell a woman is using contraception (sometimes a partner may feel the strings during sex) y Has no further costs for supplies after the IUD is inserted",
    "page_number": 189,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1416
  },
  {
    "id": "chunk_01417",
    "text": "rther costs for supplies after the IUD is inserted y Does not require the user to do anything once the IUD is inserted Side Effects, Health Benefits, Health Risks and Complications",
    "page_number": 189,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1417
  },
  {
    "id": "chunk_01418",
    "text": "Who Can and Cannot Use the Copper-Bearing IUD Safe and Suitable for Nearly All Women Most women can use IUDs safely and effectively, including women who: y Have or have not had children y Are married or are not married y Are of any age, including adolescents and women over 40 years old",
    "page_number": 190,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1418
  },
  {
    "id": "chunk_01419",
    "text": "including adolescents and women over 40 years old y Have just had an abortion or miscarriage (if no evidence of infection) y Are breastfeeding y Do hard physical work y Have had ectopic pregnancy y Have had pelvic inflammatory disease (PID) y Have vaginal infections y Have anemia",
    "page_number": 190,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1419
  },
  {
    "id": "chunk_01420",
    "text": "ease (PID) y Have vaginal infections y Have anemia y Have HIV clinical disease that is mild or with no symptoms whether or not they are on antiretroviral therapy (see IUDs for Women With HIV, p. 172) Avoid Unnecessary Procedures (see Importance of Selected Procedures in Chapter 26 \u2013 Family Planning",
    "page_number": 190,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1420
  },
  {
    "id": "chunk_01421",
    "text": "elected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396) Women can begin using IUDs: y Without cervical cancer screening y Without a breast examination y Without a blood pressure check A pelvic examination and an STI risk assessment are essential. When available, a hemoglobin",
    "page_number": 190,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1421
  },
  {
    "id": "chunk_01422",
    "text": "ssment are essential. When available, a hemoglobin test and laboratory tests for STIs including HIV can contribute to safe and effective use. 168 Family Planning: A Global Handbook for Providers",
    "page_number": 190,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1422
  },
  {
    "id": "chunk_01423",
    "text": "10 169 eciveD eniretuartnI gniraeB-reppoC Medical Eligibility Criteria for Copper -Bearing IUDs Ask the client the questions below about known medical conditions. If she answers \u201cno\u201d to all of the questions, then she can have an IUD",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1423
  },
  {
    "id": "chunk_01424",
    "text": "to all of the questions, then she can have an IUD inserted if she wants. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases she can still have an IUD inserted. 1. Did you give birth more than 48 hours ago but less than 4 weeks ago?",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1424
  },
  {
    "id": "chunk_01425",
    "text": "more than 48 hours ago but less than 4 weeks ago? \u274f NO \u274f YES Delay inserting an IUD until 4 or more weeks after childbirth (see Soon after childbirth, p. 174). 2. Do you have an infection following childbirth or abortion? \u274f NO \u274f YES If she currently has infection of the reproductive",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1425
  },
  {
    "id": "chunk_01426",
    "text": "If she currently has infection of the reproductive organs during the first 6 weeks after childbirth (puerperal sepsis) or she just had an abortion-related infection in the uterus (septic abortion), do not insert the IUD. Treat or refer if she is not already receiving care. Help her choose another",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1426
  },
  {
    "id": "chunk_01427",
    "text": "ot already receiving care. Help her choose another method or offer a backup method.* After treatment, re- evaluate for IUD use. 3. Are you having vaginal bleeding that is unusual for you? \u274f NO \u274f YES If she has unexplained vaginal bleeding that suggests",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1427
  },
  {
    "id": "chunk_01428",
    "text": "she has unexplained vaginal bleeding that suggests pregnancy or an underlying medical condition, use of an IUD could make diagnosis and monitoring of any treatment more difficult. Help her choose a method to use while being evaluated and treated (but not a hormonal IUD, progestin-",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1428
  },
  {
    "id": "chunk_01429",
    "text": "ed and treated (but not a hormonal IUD, progestin- only injectable, or implant). After treatment, re-evaluate for IUD use. 4. Do you have any female conditions or problems (gynecologic or obstetric conditions or problems), such as genital cancer or pelvic tuberculosis? If so, what problems?",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1429
  },
  {
    "id": "chunk_01430",
    "text": "ncer or pelvic tuberculosis? If so, what problems? \u274f NO \u274f YES Known current cervical, endometrial, or ovarian cancer; gestational trophoblast disease; pelvic tuberculosis: Do not insert an IUD. Treat or refer for care if she is not already receiving care. Help her choose another method. In case of",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1430
  },
  {
    "id": "chunk_01431",
    "text": "g care. Help her choose another method. In case of pelvic tuberculosis, re-evaluate for IUD use after treatment. (Continued on next page) * Backup methods include abstinence, male and female condoms, spermicides, and",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1431
  },
  {
    "id": "chunk_01432",
    "text": "tinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. Who Can and Cannot Use the Copper-Bearing Intrauterine Device",
    "page_number": 191,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1432
  },
  {
    "id": "chunk_01433",
    "text": "Medical Eligibility Criteria for Copper-Bearing IUDs (continued) 5. Do you have HIV or AIDS? Do you have any health conditions associated with HIV infection? \u274f NO \u274f YES If a woman has HIV infection with severe or advanced clinical disease, do not insert an IUD. In contrast, a woman",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1433
  },
  {
    "id": "chunk_01434",
    "text": "isease, do not insert an IUD. In contrast, a woman living with HIV who has mild clinical disease or no clinical disease can have an IUD inserted, whether or not she is on antretroviral therapy. See IUDs for Women With HIV, p. 172. 6. Assess whether she is at very high individual risk for STIs.",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1434
  },
  {
    "id": "chunk_01435",
    "text": "ther she is at very high individual risk for STIs. Women who have a very high individual likelihood of STI infection should not have an IUD inserted unless gonorrhea and chlamydia are ruled out by lab tests (see Assessing Women for Risk of Sexually Transmitted Infections, p. 172).",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1435
  },
  {
    "id": "chunk_01436",
    "text": "Risk of Sexually Transmitted Infections, p. 172). 7. Rule out pregnancy. Ask the client the questions in the Pregnancy Checklist (see inside back cover). If she answers \u201cyes\u201d to any of these questions, you can be reasonably certain that she is not pregnant, and she can have an IUD",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1436
  },
  {
    "id": "chunk_01437",
    "text": "that she is not pregnant, and she can have an IUD inserted. If the Pregnancy Checklist cannot rule out pregnancy, use the job aid Ruling Out Pregnancy before inserting an IUD. Also, women should not use the IUD if they report having systemic",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1437
  },
  {
    "id": "chunk_01438",
    "text": "uld not use the IUD if they report having systemic lupus erythematosus with severe thrombocytopenia. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1438
  },
  {
    "id": "chunk_01439",
    "text": "health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions that would make the method inadvisable, when relevant to the client. Using Clinical Judgment in Special Cases",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1439
  },
  {
    "id": "chunk_01440",
    "text": "e client. Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not have an IUD inserted. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her, a qualified provider who can",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1440
  },
  {
    "id": "chunk_01441",
    "text": "or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use an IUD. The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up.",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1441
  },
  {
    "id": "chunk_01442",
    "text": "itions, whether she will have access to follow-up. y Between 48 hours and 4 weeks since giving birth y Noncancerous (benign) gestational trophoblast disease y Current ovarian cancer y Is at very high individual risk for STIs at the time of insertion y Has severe or advanced HIV clinical disease",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1442
  },
  {
    "id": "chunk_01443",
    "text": "tion y Has severe or advanced HIV clinical disease y Has systemic lupus erythematosus with severe thrombocytopenia 170 Family Planning: A Global Handbook for Providers",
    "page_number": 192,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1443
  },
  {
    "id": "chunk_01444",
    "text": "10 171 eciveD eniretuartnI gniraeB-reppoC Screening Questions for Pelvic Examination Before IUD Insertion A pelvic examination and STI risk assessment should be done before IUD insertion. (For STI risk assessment, see next page.) When performing the",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1444
  },
  {
    "id": "chunk_01445",
    "text": "sk assessment, see next page.) When performing the pelvic examination, asking yourself the questions below helps you check for signs of conditions that would rule out IUD insertion. If the answer to all of the questions is \u201cno,\u201d then the client can have an IUD inserted. If the",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1445
  },
  {
    "id": "chunk_01446",
    "text": "\u201d then the client can have an IUD inserted. If the answer to any question is \u201cyes,\u201d do not insert an IUD. For questions 1 through 5, if the answer is \u201cyes,\u201d refer for diagnosis and treatment as appropriate. Help her choose another method and counsel",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1446
  },
  {
    "id": "chunk_01447",
    "text": "priate. Help her choose another method and counsel her about condom use if she faces any risk of sexually transmitted infections (STIs). Give her condoms, if possible. If an STI or pelvic inflammatory disease (PID) is confirmed and she still wants an IUD, it",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1447
  },
  {
    "id": "chunk_01448",
    "text": "(PID) is confirmed and she still wants an IUD, it may be inserted as soon as she finishes treatment, if she is not at risk for reinfection before insertion. 1. Is there any type of ulcer on the vulva, vagina, or cervix? \u274f NO \u274f YES Possible STI. 2. Does the client feel pain in her lower abdomen when",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1448
  },
  {
    "id": "chunk_01449",
    "text": "oes the client feel pain in her lower abdomen when you move the cervix? \u274f NO \u274f YES Possible PID. 3. Is there tenderness in the uterus, ovaries, or fallopian tubes (adnexal tenderness)? \u274f NO \u274f YES Possible PID. 4. Is there a purulent cervical discharge? \u274f NO \u274f YES Possible STI or PID.",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1449
  },
  {
    "id": "chunk_01450",
    "text": "ervical discharge? \u274f NO \u274f YES Possible STI or PID. 5. Does the cervix bleed easily when touched? \u274f NO \u274f YES Possible STI or cervical cancer. 6. Is there an anatomical abnormality of the uterine cavity that will prevent correct IUD placement?",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1450
  },
  {
    "id": "chunk_01451",
    "text": "ne cavity that will prevent correct IUD placement? \u274f NO \u274f YES If an anatomical abnormality distorts the uterine cavity, proper IUD placement may not be possible. Help her choose another method. 7. Were you unable to determine the size and/or position of the uterus?",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1451
  },
  {
    "id": "chunk_01452",
    "text": "determine the size and/or position of the uterus? \u274f NO \u274f YES Determining the size and position of the uterus before IUD insertion is essential to ensure high placement of the IUD and to minimize risk of perforation. If size and position cannot be determined, do not insert an IUD. Help",
    "page_number": 193,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1452
  },
  {
    "id": "chunk_01453",
    "text": "Intrauterine Devices for Women With HIV y Women living with HIV can safely have an IUD inserted if they have mild or no clinical disease, whether or not they are on antiretroviral therapy. y Women who have HIV infection with advanced or severe clinical disease should not have an IUD inserted.",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1453
  },
  {
    "id": "chunk_01454",
    "text": "clinical disease should not have an IUD inserted. y If a woman becomes infected with HIV while she has an IUD in place, it does not need to be removed. y An IUD user living with HIV who develops advanced or severe clinical disease can keep the IUD but should be closely monitored for pelvic",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1454
  },
  {
    "id": "chunk_01455",
    "text": "the IUD but should be closely monitored for pelvic inflammatory disease. y Urge women who have HIV or are at risk for HIV to use condoms along with the IUD. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs.",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1455
  },
  {
    "id": "chunk_01456",
    "text": "s help prevent transmission of HIV and other STIs. y Women who are at risk of HIV but not infected with HIV can have an IUD inserted. The IUD does not increase the risk of becoming infected with HIV. Assessing Women for Risk of Sexually Transmitted Infections",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1456
  },
  {
    "id": "chunk_01457",
    "text": "Women for Risk of Sexually Transmitted Infections A woman who has gonorrhea or chlamydia now should not have an IUD inserted. Having these sexually transmitted infections (STIs) at the time of insertion may increase the risk of pelvic inflammatory",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1457
  },
  {
    "id": "chunk_01458",
    "text": "rtion may increase the risk of pelvic inflammatory disease. These STIs may be difficult to diagnose clinically, however, and reliable laboratory tests are time-consuming, expensive, and sometimes unavailable. Without clinical signs or symptoms and without laboratory",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1458
  },
  {
    "id": "chunk_01459",
    "text": "clinical signs or symptoms and without laboratory testing, the only indication that a woman might already have an STI is whether her behavior or her situation places her at very high individual likelihood of infection. If this risk for the individual client is very high, she",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1459
  },
  {
    "id": "chunk_01460",
    "text": "s risk for the individual client is very high, she generally should not have an IUD inserted.\u2021 (Local STI prevalence rates are not a basis for judging individual risk.) There is no universal set of questions that will determine if a woman",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1460
  },
  {
    "id": "chunk_01461",
    "text": "al set of questions that will determine if a woman is at very high individual risk for STIs. Instead of asking questions, providers can discuss with the client the personal behaviors and the situations in their community that are most likely to expose women to STIs.",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1461
  },
  {
    "id": "chunk_01462",
    "text": "nity that are most likely to expose women to STIs. \u2021 In contrast, if a current IUD user\u2019s situation changes and she finds herself at very high individual risk for gonorrhea or chlamydia, she can keep using her IUD. 172 Family Planning: A Global Handbook for Providers",
    "page_number": 194,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1462
  },
  {
    "id": "chunk_01463",
    "text": "10 173 eciveD eniretuartnI gniraeB-reppoC Steps to take: 1. Tell the client that a woman who faces a very high individual risk of STIs usually should not have an IUD inserted. 2. Ask the woman to consider her own risk and to think about whether she",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1463
  },
  {
    "id": "chunk_01464",
    "text": "nsider her own risk and to think about whether she might have an STI. A woman is often the best judge of her own risk.\u00a7 She does not have to tell the provider about her behavior or her partner\u2019s behavior. Providers can explain possibly risky situations that may place a",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1464
  },
  {
    "id": "chunk_01465",
    "text": "explain possibly risky situations that may place a woman at very high individual risk. The client can think about whether such situations occurred recently (in the past 3 months or so). If so, she may have an STI now, whether or not she has noticed symptoms, and",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1465
  },
  {
    "id": "chunk_01466",
    "text": "now, whether or not she has noticed symptoms, and may want to choose a method other than the IUD. Possibly risky situations include: y A sexual partner has STI symptoms such as pus coming from his penis, pain or All of these burning during urination, or an open sore situations pose less",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1466
  },
  {
    "id": "chunk_01467",
    "text": "ng urination, or an open sore situations pose less in the genital area risk if a woman or her y She or a sexual partner was diagnosed partner uses condoms with an STI recently consistently and correctly. y She has had more than one sexual partner recently y She has a sexual partner who has had",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1467
  },
  {
    "id": "chunk_01468",
    "text": "er recently y She has a sexual partner who has had other partners recently Also, a provider can mention other high-risk situations that exist locally. 3. Ask if she thinks she is a good candidate for an IUD or would like to consider other contraceptive methods, including other long-acting",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1468
  },
  {
    "id": "chunk_01469",
    "text": "contraceptive methods, including other long-acting methods. If, after considering her individual risk, she thinks she is a good candidate, and she is eligible, provide her with an IUD. If she wants to consider other methods or if you have strong reason to",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1469
  },
  {
    "id": "chunk_01470",
    "text": "ider other methods or if you have strong reason to believe that the client is at very high individual risk of infection, help her choose another method. Note: If she still wants the IUD while at very high individual risk of STIs, and reliable laboratory",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1470
  },
  {
    "id": "chunk_01471",
    "text": "h individual risk of STIs, and reliable laboratory testing for gonorrhea and chlamydia is available, a woman who tests negative can have an IUD inserted. A woman who tests positive can have an IUD inserted as soon as she finishes treatment,",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1471
  },
  {
    "id": "chunk_01472",
    "text": "an IUD inserted as soon as she finishes treatment, if she is not at risk of reinfection by the time of insertion. In special circumstances, if other, more appropriate methods are not available or not acceptable, a",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1472
  },
  {
    "id": "chunk_01473",
    "text": "ate methods are not available or not acceptable, a health care provider who can carefully assess a specific woman\u2019s condition and situation may decide that a woman at very high individual risk can have the IUD inserted even if STI testing is not available.",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1473
  },
  {
    "id": "chunk_01474",
    "text": "IUD inserted even if STI testing is not available. (Depending on the circumstances, the provider may consider presumptively treating her with a full curative dose of antibiotics effective against both gonorrhea and chlamydia and inserting the IUD after",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1474
  },
  {
    "id": "chunk_01475",
    "text": "onorrhea and chlamydia and inserting the IUD after she finishes treatment.) Whether or not she receives presumptive treatment, the provider should be sure that the client can return for the follow-up visit, will be carefully checked for infection, and will",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1475
  },
  {
    "id": "chunk_01476",
    "text": "will be carefully checked for infection, and will be treated immediately if needed. She should be asked to return at once if she develops a fever and either lower abdominal pain or abnormal vaginal discharge or both. \u00a7 Any woman who thinks she might have an STI should seek care immediately.",
    "page_number": 195,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1476
  },
  {
    "id": "chunk_01477",
    "text": "Providing the Intrauterine Device When to Start IMPORTANT: In many cases a woman can start the IUD any time if it is reasonably certain she is not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover). Woman\u2019s situation When to start",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1477
  },
  {
    "id": "chunk_01478",
    "text": "nside back cover). Woman\u2019s situation When to start Having menstrual Any time of the month cycles y If she is starting within 12 days after the start of her monthly bleeding, no need for a backup method. y If it is more than 12 days after the start of her",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1478
  },
  {
    "id": "chunk_01479",
    "text": "If it is more than 12 days after the start of her monthly bleeding, she can have the IUD inserted any time if it is reasonably certain she is not pregnant. No need for a backup method. Switching from y Immediately, if she has been using the method",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1479
  },
  {
    "id": "chunk_01480",
    "text": "om y Immediately, if she has been using the method another method consistently and correctly or if it is otherwise reasonably certain she is not pregnant. No need to wait for her next monthly bleeding. No need for a backup method. y If she is switching from an injectable, she can",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1480
  },
  {
    "id": "chunk_01481",
    "text": "y If she is switching from an injectable, she can have the IUD inserted when the next injection would have been given. No need for a backup method. Soon after y Any time within 48 hours after giving birth, childbirth including by caesarean delivery. (Provider needs",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1481
  },
  {
    "id": "chunk_01482",
    "text": "h including by caesarean delivery. (Provider needs (regardless of specific training in postpartum insertion by hand breastfeeding status) or using a ring forceps.) y If it is more than 48 hours after giving birth, delay until 4 weeks or more after giving birth. Fully or nearly fully breastfeeding",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1482
  },
  {
    "id": "chunk_01483",
    "text": "giving birth. Fully or nearly fully breastfeeding Less than y If the IUD is not inserted within the first 6 months after 48 hours and her monthly bleeding has not giving birth returned, she can have the IUD inserted any time between 4 weeks and 6 months after giving",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1483
  },
  {
    "id": "chunk_01484",
    "text": "any time between 4 weeks and 6 months after giving birth. No need for a backup method. y If her monthly bleeding has returned, she can have the IUD inserted as advised for women having menstrual cycles (see above). 174 Family Planning: A Global Handbook for Providers",
    "page_number": 196,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1484
  },
  {
    "id": "chunk_01485",
    "text": "10 175 eciveD eniretuartnI gniraeB-reppoC Woman\u2019s situation When to start Fully or nearly fully breastfeeding (continued) More than y If her monthly bleeding has not returned, she can 6 months after have the IUD inserted any time it is reasonably",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1485
  },
  {
    "id": "chunk_01486",
    "text": "er have the IUD inserted any time it is reasonably giving birth certain she is not pregnant. No need for a backup method. y If her monthly bleeding has returned, she can have the IUD inserted as advised for women having menstrual cycles (see previous page).",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1486
  },
  {
    "id": "chunk_01487",
    "text": "women having menstrual cycles (see previous page). Partially breastfeeding or not breastfeeding More than 4 weeks y If her monthly bleeding has not returned, she can after giving birth have the IUD inserted if it can be determined that she is not pregnant (see Ruling Out Pregnancy,",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1487
  },
  {
    "id": "chunk_01488",
    "text": "hat she is not pregnant (see Ruling Out Pregnancy, p. 461). No need for a backup method. y If her monthly bleeding has returned, she can have the IUD inserted as advised for women having menstrual cycles (see previous page). No monthly y Any time if it can be determined that she is not",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1488
  },
  {
    "id": "chunk_01489",
    "text": "y Any time if it can be determined that she is not bleeding (not pregnant (see Ruling Out Pregnancy, p. 461). related to childbirth No need for a backup method. or breastfeeding) After miscarriage y Immediately, if the IUD is inserted within 12",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1489
  },
  {
    "id": "chunk_01490",
    "text": "ge y Immediately, if the IUD is inserted within 12 or abortion days after first- or second-trimester abortion or miscarriage and if no infection is present. No need for a backup method. y If it is more than 12 days after first- or second- trimester miscarriage or abortion and no",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1490
  },
  {
    "id": "chunk_01491",
    "text": "r second- trimester miscarriage or abortion and no infection is present, she can have the IUD inserted any time if it is reasonably certain she is not pregnant. No need for a backup method. y If infection is present, treat or refer, and help the client choose another method. If she still wants",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1491
  },
  {
    "id": "chunk_01492",
    "text": "e client choose another method. If she still wants the IUD, it can be inserted after the infection has completely cleared. y IUD insertion after second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least",
    "page_number": 197,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1492
  },
  {
    "id": "chunk_01493",
    "text": "Woman\u2019s situation When to start (continued) For emergency y Within 5 days after unprotected sex. contraception y When the time of ovulation can be estimated, she can have an IUD inserted up to 5 days after ovulation. Sometimes this may be more than 5 days after unprotected sex.",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1493
  },
  {
    "id": "chunk_01494",
    "text": "his may be more than 5 days after unprotected sex. After taking y The IUD can be inserted on the same day that emergency she takes the ECPs (progestin-only, combined, contraceptive or ulipristal acetate ECPs). No need for a backup pills (ECPs) method.",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1494
  },
  {
    "id": "chunk_01495",
    "text": "e ECPs). No need for a backup pills (ECPs) method. y If she does not have it inserted immediately, but returns for an IUD, she can have it inserted any time if it can be determined that she is not pregnant (see Ruling Out Pregnancy, p. 461). Preventing Infection at IUD Insertion",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1495
  },
  {
    "id": "chunk_01496",
    "text": "cy, p. 461). Preventing Infection at IUD Insertion Proper insertion technique can help prevent many problems, such as infection, expulsion, and perforation. y Follow proper infection-prevention procedures. y Use high-level disinfected or sterile instruments.",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1496
  },
  {
    "id": "chunk_01497",
    "text": "Use high-level disinfected or sterile instruments. High-level disinfect by boiling, steaming, or soaking them in disinfectant chemicals. y Use a new, presterilized IUD that is packaged with its inserter. y The \u201cno-touch\u201d insertion technique is safest. This",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1497
  },
  {
    "id": "chunk_01498",
    "text": "The \u201cno-touch\u201d insertion technique is safest. This includes not letting the loaded IUD or uterine sound touch any unsterile surfaces (for example, hands, speculum, vagina, table top). The no-touch technique involves: \u2013 Loading the IUD into the inserter while the IUD",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1498
  },
  {
    "id": "chunk_01499",
    "text": "\u2013 Loading the IUD into the inserter while the IUD is still in the sterile package, to avoid touching the IUD directly \u2013 Cleaning the cervix thoroughly with antiseptic before IUD insertion \u2013 Being careful not to touch the vaginal wall or speculum blades with the uterine sound or loaded IUD inserter",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1499
  },
  {
    "id": "chunk_01500",
    "text": "ades with the uterine sound or loaded IUD inserter \u2013 Passing both the uterine sound and the loaded IUD inserter only once each through the cervical canal y Giving antibiotics routinely is generally not recommended for women at low risk of STIs. 176 Family Planning: A Global Handbook for Providers",
    "page_number": 198,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1500
  },
  {
    "id": "chunk_01501",
    "text": "10 177 eciveD eniretuartnI gniraeB-reppoC Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes must come before IUD insertion. Counseling about bleeding changes may be the most important help a woman needs to keep using the method without concern.",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1501
  },
  {
    "id": "chunk_01502",
    "text": "an needs to keep using the method without concern. Describe the y Changes in her bleeding pattern: most common \u2212 Prolonged and heavy monthly bleeding side effects \u2212 Irregular bleeding \u2212 More cramps and pain during monthly bleeding Explain about y Bleeding changes are not signs of illness.",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1502
  },
  {
    "id": "chunk_01503",
    "text": "about y Bleeding changes are not signs of illness. these side effects y Usually become less after the first several months after insertion. y Client can come back for help if problems bother her or if she has other concerns. Inserting the IUD",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1503
  },
  {
    "id": "chunk_01504",
    "text": "er or if she has other concerns. Inserting the IUD Talk with the y Explain the insertion procedure (see next page). client before the y Show her the speculum, tenaculum, and the IUD procedure and inserter in the package. y Tell her that she will experience some discomfort",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1504
  },
  {
    "id": "chunk_01505",
    "text": "Tell her that she will experience some discomfort or cramping during the procedure, and that this is to be expected. y Ask her to tell you any time that she feels discomfort or pain. y Ibuprofen (200\u2013400 mg), paracetamol (325\u2013 1,000 mg), or other pain reliever may be given 30",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1505
  },
  {
    "id": "chunk_01506",
    "text": "1,000 mg), or other pain reliever may be given 30 minutes before insertion to help reduce cramping and pain. Do not give aspirin, which slows blood clotting. Talk with the y Tell her what is happening, step by step, and client during reassure her.",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1506
  },
  {
    "id": "chunk_01507",
    "text": "ing, step by step, and client during reassure her. the procedure y Alert her before a step that may cause pain or might startle her. y Ask from time to time if she is feeling pain. Talk with the y Ask her how she is doing. client after the y Tell her that the procedure was successful and",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1507
  },
  {
    "id": "chunk_01508",
    "text": "e y Tell her that the procedure was successful and procedure that the IUD is in place. y Tell her that she can rest for a while and then slowly sit up before getting up and dressing. y Remind her that the two of you will be discussing next steps and follow-up. Providing the Copper-Bearing IUD",
    "page_number": 199,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1508
  },
  {
    "id": "chunk_01509",
    "text": "Explaining the Insertion Procedure A woman who has chosen the IUD needs to know what will happen during insertion. The following description can help explain the procedure to her. Learning IUD insertion requires training and practice under direct",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1509
  },
  {
    "id": "chunk_01510",
    "text": "ertion requires training and practice under direct supervision. Therefore, this description is a summary and not detailed instructions. 1. The provider uses proper infection- prevention procedures. 2. The provider conducts a pelvic Speculum examination to determine the",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1510
  },
  {
    "id": "chunk_01511",
    "text": "cts a pelvic Speculum examination to determine the position of the uterus and assess eligibility (see Screening Questions for Pelvic Examination Before IUD Insertion, p. 171). The provider first does the bimanual examination and then inserts a speculum into the vagina to inspect the cervix.",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1511
  },
  {
    "id": "chunk_01512",
    "text": "a speculum into the vagina to inspect the cervix. 3. The provider cleans the cervix and vagina with appropriate antiseptic. Tenaculum 4. The provider slowly inserts the tenaculum through the speculum Flashlight Sound and closes the tenaculum just enough to gently hold the cervix and uterus steady.",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1512
  },
  {
    "id": "chunk_01513",
    "text": "nough to gently hold the cervix and uterus steady. 5. The provider slowly and gently passes the uterine sound through the cervix to measure the depth and position of the uterus. Scissors 6. The provider loads the IUD into the inserter while both are still in the unopened sterile package. Forceps",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1513
  },
  {
    "id": "chunk_01514",
    "text": "are still in the unopened sterile package. Forceps 7. The provider slowly and gently inserts the IUD into the uterus and removes the inserter. 8. The provider cuts the strings Bowl with Narrow cotton balls forceps on the IUD, leaving about 3 centimeters hanging out of the cervix.",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1514
  },
  {
    "id": "chunk_01515",
    "text": "ing about 3 centimeters hanging out of the cervix. 9. After the insertion, the woman rests. She remains on the examination table until she feels ready to get dressed. 178 Family Planning: A Global Handbook for Providers",
    "page_number": 200,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1515
  },
  {
    "id": "chunk_01516",
    "text": "10 179 eciveD eniretuartnI gniraeB-reppoC Supporting New and Continuing Users Giving Specific Instructions Expect cramping y She can expect some cramping and pain for a and pain few days after insertion. y Suggest ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever as needed.",
    "page_number": 201,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1516
  },
  {
    "id": "chunk_01517",
    "text": "(325\u20131,000 mg), or other pain reliever as needed. y Also, she can expect some bleeding or spotting immediately after insertion. Irregular spotting can continue during the first month after insertion. Length of y Discuss how to remember the date to return for pregnancy removal or replacement.",
    "page_number": 201,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1517
  },
  {
    "id": "chunk_01518",
    "text": "te to return for pregnancy removal or replacement. protection y Give each woman the following information in writing on a reminder card, like the one shown below, if possible, and explain: \u2013 The type of IUD she has \u2013 Date of IUD insertion \u2013 Month and year when IUD will need to be removed or replaced",
    "page_number": 201,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1518
  },
  {
    "id": "chunk_01519",
    "text": "year when IUD will need to be removed or replaced \u2013 Where to go if she has problems or questions about her IUD Follow-up visit y A follow-up visit after her first monthly bleeding or 3 to 6 weeks after IUD insertion is recommended. No woman should be denied",
    "page_number": 201,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1519
  },
  {
    "id": "chunk_01520",
    "text": "nsertion is recommended. No woman should be denied an IUD, however, because follow-up would be difficult or not possible. Supporting New and Continuing Users",
    "page_number": 201,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1520
  },
  {
    "id": "chunk_01521",
    "text": "How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: y Support a woman\u2019s choice of the IUD y Show understanding and support if she has side effects",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1521
  },
  {
    "id": "chunk_01522",
    "text": "understanding and support if she has side effects y Use condoms consistently in addition to the IUD if he has an STI/HIV or thinks he may be at risk of an STI/HIV y Help to remember when the IUD is due for removal \u201cCome Back Any Time\u201d: Reasons to Return",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1522
  },
  {
    "id": "chunk_01523",
    "text": "or removal \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; or she has a major change in health status. Also if:",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1523
  },
  {
    "id": "chunk_01524",
    "text": "she has a major change in health status. Also if: y The IUD was expelled or she thinks it may have been expelled from her uterus. y She has symptoms of pelvic inflammatory disease (increasing or severe pain in the lower abdomen, pain during sex, unusual vaginal discharge, fever, chills,",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1524
  },
  {
    "id": "chunk_01525",
    "text": "ing sex, unusual vaginal discharge, fever, chills, nausea, and/or vomiting), especially in the first 20 days after insertion. y She thinks she might be pregnant. y She wants the IUD removed, for whatever reason. General health advice",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1525
  },
  {
    "id": "chunk_01526",
    "text": "emoved, for whatever reason. General health advice Anyone who at any time feels that something is seriously wrong with her health should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1526
  },
  {
    "id": "chunk_01527",
    "text": "is most likely not the cause of the condition, but she should tell the health worker what method she is using. Post-Insertion Follow-Up Visit (3 to 6 Weeks) 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss.",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1527
  },
  {
    "id": "chunk_01528",
    "text": "k if she has any questions or anything to discuss. 2. Ask especially if she is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, p. 181). 3. Ask her if she has: y Increasing or severe abdominal pain or pain during sex or urination",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1528
  },
  {
    "id": "chunk_01529",
    "text": "ere abdominal pain or pain during sex or urination y Unusual vaginal discharge y Fever or chills y Signs or symptoms of pregnancy 180 Family Planning: A Global Handbook for Providers",
    "page_number": 202,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1529
  },
  {
    "id": "chunk_01530",
    "text": "10 181 eciveD eniretuartnI gniraeB-reppoC y Felt the hard plastic of an IUD that has partially come out y A routine pelvic examination at the follow-up visit is not required. It may be appropriate in some settings or for some clients, however. Conduct a",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1530
  },
  {
    "id": "chunk_01531",
    "text": "e settings or for some clients, however. Conduct a pelvic examination particularly if the client\u2019s answers lead you to suspect infection or that the IUD has partially or completely come out. Any Visit 1. Ask how the client is doing with the method and about bleeding changes",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1531
  },
  {
    "id": "chunk_01532",
    "text": "s doing with the method and about bleeding changes (see Post-Insertion Follow-Up Visit, Items 1 and 2, previous page). 2. Ask a long-term client if she has had any new health problems. Address problems as appropriate. For new health problems that may require switching methods, see p. 185.",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1532
  },
  {
    "id": "chunk_01533",
    "text": "ms that may require switching methods, see p. 185. 3. Ask a long-term client about major life changes that may affect her needs\u2014 particularly plans for having children and STI/HIV risk. Follow up as needed. 4. Remind her how much longer the IUD will protect her from pregnancy and",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1533
  },
  {
    "id": "chunk_01534",
    "text": "longer the IUD will protect her from pregnancy and when she will need to have the IUD removed or replaced. Managing Any Problems Problems Reported As Side Effects or Complications May or may not be due to the method. y Problems with side effects or complications affect women\u2019s satisfaction",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1534
  },
  {
    "id": "chunk_01535",
    "text": "fects or complications affect women\u2019s satisfaction and use of IUDs. They deserve the provider\u2019s attention. If the client reports any side effects or complications, listen to her concerns, give her advice and support, and, if appropriate, treat. Make sure she understands the advice and agrees.",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1535
  },
  {
    "id": "chunk_01536",
    "text": ". Make sure she understands the advice and agrees. y Offer to help her choose another method\u2014now, if she wishes, or if problems cannot be overcome. Heavy or prolonged bleeding (twice as much as usual or longer than 8 days) y Reassure her that many women using IUDs experience heavy or",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1536
  },
  {
    "id": "chunk_01537",
    "text": "her that many women using IUDs experience heavy or prolonged bleeding. It is generally not harmful and usually becomes less or stops after the first several months of use. y For modest short-term relief she can try (one at a time): \u2013 Tranexamic acid (1,500 mg) 3 times daily for 3 days, then 1,000 mg",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1537
  },
  {
    "id": "chunk_01538",
    "text": "(1,500 mg) 3 times daily for 3 days, then 1,000 mg once daily for 2 days, beginning when heavy bleeding starts. \u2013 Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (400 mg) or indomethacin (25 mg) 2 times daily after meals for 5 days, beginning when heavy bleeding starts. Other NSAIDs\u2014",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1538
  },
  {
    "id": "chunk_01539",
    "text": "eginning when heavy bleeding starts. Other NSAIDs\u2014 except aspirin\u2014also may provide some relief of heavy or prolonged bleeding. Aspirin could increase bleeding. Supporting New and Continuing Users",
    "page_number": 203,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1539
  },
  {
    "id": "chunk_01540",
    "text": "y Provide iron tablets if possible and tell her it is important for her to eat foods containing iron (see \u201cPossible anemia\u201d, next page). y If heavy or prolonged bleeding continues or starts after several months of normal bleeding or long after the IUD was inserted, or if you suspect that",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1540
  },
  {
    "id": "chunk_01541",
    "text": "after the IUD was inserted, or if you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, p. 186). Irregular bleeding (bleeding at unexpected times that bothers the client)",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1541
  },
  {
    "id": "chunk_01542",
    "text": "eding at unexpected times that bothers the client) y Reassure her that many women using IUDs experience irregular bleeding. It is not harmful and usually becomes less or stops after the first several months of use. y For modest short-term relief she can try NSAIDs such as ibuprofen",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1542
  },
  {
    "id": "chunk_01543",
    "text": "t-term relief she can try NSAIDs such as ibuprofen (400 mg) or indomethacin (25 mg) 2 times daily after meals for 5 days, beginning when irregular bleeding starts. y If irregular bleeding continues or starts after several months of normal bleeding, or you suspect that something may be wrong for other",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1543
  },
  {
    "id": "chunk_01544",
    "text": "you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, p. 186). Cramping and pain y She can expect some cramping and pain for the first day or two after IUD insertion.",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1544
  },
  {
    "id": "chunk_01545",
    "text": "pain for the first day or two after IUD insertion. y Explain that some cramping also is common in the first 3 to 6 months of IUD use, particularly during monthly bleeding. Generally, this is not harmful and usually decreases over time.",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1545
  },
  {
    "id": "chunk_01546",
    "text": "is is not harmful and usually decreases over time. \u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. If she also has heavy or prolonged bleeding, aspirin should not be used because it may increase bleeding.",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1546
  },
  {
    "id": "chunk_01547",
    "text": "ould not be used because it may increase bleeding. y If severe cramping continues beyond the first 2 days after insertion, evaluate for partial expulsion or perforation. Possible anemia y The copper-bearing IUD may contribute to anemia if a woman already",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1547
  },
  {
    "id": "chunk_01548",
    "text": "ng IUD may contribute to anemia if a woman already has low iron blood stores before insertion and the IUD causes heavier monthly bleeding. y Pay special attention to IUD users with any of the following signs and symptoms: \u2013 Inside of eyelids or underneath fingernails looks pale, pale skin, fatigue",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1548
  },
  {
    "id": "chunk_01549",
    "text": "erneath fingernails looks pale, pale skin, fatigue or weakness, dizziness, irritability, headache, ringing in the ears, sore tongue, and brittle nails. \u2013 If blood testing is available, hemoglobin less than 9 g/dl or hematocrit less than 30. y Provide iron tablets if possible.",
    "page_number": 204,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1549
  },
  {
    "id": "chunk_01550",
    "text": "10 183 eciveD eniretuartnI gniraeB-reppoC y Tell her it is important to eat foods containing iron, such as meat and poultry (especially beef and chicken liver), fish, green leafy vegetables, and legumes (beans, bean curd, lentils, and peas). Partner can feel IUD strings during sex",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1550
  },
  {
    "id": "chunk_01551",
    "text": "and peas). Partner can feel IUD strings during sex y Explain that this happens sometimes when strings are cut too short. y If her partner finds the strings bothersome, describe and discuss this option: \u2013 Strings can be cut even shorter so they are not coming out of the cervical",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1551
  },
  {
    "id": "chunk_01552",
    "text": "shorter so they are not coming out of the cervical canal. Her partner will not feel the strings, but it will make the removal procedure somewhat more difficult (may require a specially trained provider). Severe pain in lower abdomen (suspected pelvic inflammatory disease [PID])",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1552
  },
  {
    "id": "chunk_01553",
    "text": "omen (suspected pelvic inflammatory disease [PID]) y Some common signs and symptoms of PID often also occur with other abdominal conditions, such as ectopic pregnancy. If ectopic pregnancy is ruled out, assess for PID. y If possible, do abdominal and pelvic examinations (see Appendix B \u2013 Signs",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1553
  },
  {
    "id": "chunk_01554",
    "text": "al and pelvic examinations (see Appendix B \u2013 Signs and Symptoms of Serious Health Conditions for signs from the pelvic examination that would indicate PID). y If a pelvic examination is not possible, and she has a combination of the following",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1554
  },
  {
    "id": "chunk_01555",
    "text": "ssible, and she has a combination of the following signs and symptoms in addition to lower abdominal pain, suspect PID: \u2013 Unusual vaginal discharge \u2013 Fever or chills \u2013 Pain during sex or urination \u2013 Bleeding after sex or between monthly bleeding \u2013 Nausea and vomiting \u2013 A tender pelvic mass",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1555
  },
  {
    "id": "chunk_01556",
    "text": "eding \u2013 Nausea and vomiting \u2013 A tender pelvic mass \u2013 Pain when the abdomen is gently pressed (direct abdominal tenderness) or when gently pressed and then suddenly released (rebound abdominal tenderness) y Treat PID or immediately refer for treatment:",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1556
  },
  {
    "id": "chunk_01557",
    "text": "s) y Treat PID or immediately refer for treatment: \u2013 Because of the serious consequences of PID, health care providers should treat all suspected cases, based on the signs and symptoms above. Treatment should be started as soon as possible. Treatment is",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1557
  },
  {
    "id": "chunk_01558",
    "text": "hould be started as soon as possible. Treatment is more effective at preventing long-term complications when appropriate antibiotics are given immediately. \u2013 Treat for gonorrhea, chlamydia, and anaerobic bacterial infections. Counsel the client about prevention and treatment of STIs and about",
    "page_number": 205,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1558
  },
  {
    "id": "chunk_01559",
    "text": "\u2013 There is no need to remove the IUD if she wants to continue using it. If she wants it removed, take it out after starting antibiotic treatment. (If the IUD is removed, consider emergency contraceptive pills and discuss choosing another method. See Switching from an IUD to Another Method, p. 187.)",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1559
  },
  {
    "id": "chunk_01560",
    "text": "Switching from an IUD to Another Method, p. 187.) \u2013 If the infection does not improve, consider removing the IUD while continuing antibiotics. If the IUD is not removed, antibiotics should still be continued. In both cases the woman\u2019s health should be closely monitored.",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1560
  },
  {
    "id": "chunk_01561",
    "text": "es the woman\u2019s health should be closely monitored. Severe pain in lower abdomen (suspected ectopic pregnancy) y Many conditions can cause severe abdominal pain. Be particularly alert for additional signs or symptoms of ectopic pregnancy, which is rare but can",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1561
  },
  {
    "id": "chunk_01562",
    "text": "mptoms of ectopic pregnancy, which is rare but can be life-threatening. While the IUD reduces risk of ectopic pregnancy, it does not eliminate it (see Question 10, p. 190). y In the early stages of ectopic pregnancy, symptoms may be absent or mild,",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1562
  },
  {
    "id": "chunk_01563",
    "text": "ectopic pregnancy, symptoms may be absent or mild, but eventually they will become severe. A combination of these signs or symptoms should increase suspicion of ectopic pregnancy: \u2212 Unusual abdominal pain or tenderness \u2212 Abnormal vaginal bleeding or no monthly bleeding\u2014especially if this is",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1563
  },
  {
    "id": "chunk_01564",
    "text": "eding or no monthly bleeding\u2014especially if this is a change from her usual bleeding pattern \u2212 Light-headedness or dizziness \u2212 Fainting y If ectopic pregnancy or other serious health condition is suspected, refer at once for immediate diagnosis and care. (See Chapter 12 \u2212 Female Sterilization,",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1564
  },
  {
    "id": "chunk_01565",
    "text": "and care. (See Chapter 12 \u2212 Female Sterilization, Managing Ectopic Pregnancy, p. 237, for more on ectopic pregnancies.) y If the client does not have these additional symptoms or signs, assess for pelvic inflammatory disease (see \u201cSevere pain in lower abdomen\u201d, p. 183).",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1565
  },
  {
    "id": "chunk_01566",
    "text": "ease (see \u201cSevere pain in lower abdomen\u201d, p. 183). Suspected uterine puncturing (perforation) y If puncturing is suspected at the time of insertion or sounding of the uterus, stop the procedure immediately (and remove the IUD if inserted). Observe the client in the clinic carefully:",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1566
  },
  {
    "id": "chunk_01567",
    "text": "rted). Observe the client in the clinic carefully: \u2013 For the first hour, keep the woman at bed rest and check her vital signs (blood pressure, pulse, respiration, and temperature) every 5 to 10 minutes. \u2013 If the woman remains stable after one hour, check for signs of",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1567
  },
  {
    "id": "chunk_01568",
    "text": "remains stable after one hour, check for signs of intra-abdominal bleeding, such as low hematocrit or hemoglobin or rebound on abdominal examination, if possible, and her vital signs. Observe for several more hours. If she has no signs or symptoms, she",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1568
  },
  {
    "id": "chunk_01569",
    "text": "l more hours. If she has no signs or symptoms, she can be sent home, but she should avoid sex for 2 weeks. Help her choose another method. \u2013 If she has a rapid pulse and falling blood pressure, or new pain or increasing pain around the uterus, refer her to a higher level of care.",
    "page_number": 206,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1569
  },
  {
    "id": "chunk_01570",
    "text": "10 185 eciveD eniretuartnI gniraeB-reppoC \u2013 If uterine perforation is suspected within 6 weeks or more after insertion based on clinical symptoms, refer the client for evaluation to a clinician experienced at removing such IUDs (see Question 6, p. 189). IUD partially comes out (partial expulsion)",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1570
  },
  {
    "id": "chunk_01571",
    "text": "189). IUD partially comes out (partial expulsion) y If the IUD partially comes out, remove the IUD. Discuss with the client whether she wants another IUD or a different method. If she wants another IUD, she can have one inserted right away if it is reasonably certain she is",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1571
  },
  {
    "id": "chunk_01572",
    "text": "rted right away if it is reasonably certain she is not pregnant. If the client does not want to continue using an IUD, help her choose another method. IUD completely comes out (complete expulsion) y If the client reports that the IUD came out, discuss with her whether she",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1572
  },
  {
    "id": "chunk_01573",
    "text": "hat the IUD came out, discuss with her whether she wants another IUD or a different method. If she wants another IUD, she can have one inserted at any time it is reasonably certain she is not pregnant. y If complete expulsion is suspected (for example, strings cannot be found",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1573
  },
  {
    "id": "chunk_01574",
    "text": "is suspected (for example, strings cannot be found on pelvic exam) and the client does not know whether the IUD came out, refer for ultrasound (or x-ray, if pregnancy can be ruled out) to assess whether the IUD might have moved to the abdominal cavity. Give her a backup method to use in the meantime.",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1574
  },
  {
    "id": "chunk_01575",
    "text": ". Give her a backup method to use in the meantime. Missing strings (suggesting possible pregnancy, uterine perforation, or expulsion) y Ask the client: \u2013 Whether and when she saw the IUD come out \u2013 When she had her last monthly bleeding \u2013 If she has any symptoms of pregnancy",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1575
  },
  {
    "id": "chunk_01576",
    "text": "ly bleeding \u2013 If she has any symptoms of pregnancy \u2013 If she has used a backup method since she noticed that the IUD came out y Always start with minor and safe procedures and be gentle. Check for the strings in the folds of the cervical canal with forceps. About half of missing",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1576
  },
  {
    "id": "chunk_01577",
    "text": "cervical canal with forceps. About half of missing IUD strings can be found in the cervical canal. y If strings cannot be located in the cervical canal, either they have gone up into the uterus or the IUD has been expelled unnoticed. Refer for",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1577
  },
  {
    "id": "chunk_01578",
    "text": "or the IUD has been expelled unnoticed. Refer for ultrasound (or x-ray, if pregnancy can be ruled out). Give her a backup method to use in the meantime, in case the IUD came out. Supporting New and Continuing Users",
    "page_number": 207,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1578
  },
  {
    "id": "chunk_01579",
    "text": "New Problems That May Require Switching Methods May or may not be due to the method. Unexplained vaginal bleeding (that suggests a medical condition not related to the method) y Refer or evaluate by history or pelvic examination. Diagnose and treat as appropriate.",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1579
  },
  {
    "id": "chunk_01580",
    "text": "ic examination. Diagnose and treat as appropriate. y She can continue using the IUD while her condition is being evaluated. y If bleeding is caused by sexually transmitted infection or pelvic inflammatory disease, she can continue using the IUD during treatment. Suspected Pregnancy",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1580
  },
  {
    "id": "chunk_01581",
    "text": "sing the IUD during treatment. Suspected Pregnancy y Assess for pregnancy, including ectopic pregnancy. y Explain that an IUD in the uterus during pregnancy increases the risk of preterm delivery or miscarriage, including infected (septic) miscarriage",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1581
  },
  {
    "id": "chunk_01582",
    "text": "scarriage, including infected (septic) miscarriage during the first or second trimester, which can be life-threatening. y If the woman does not want to continue the pregnancy, counsel her according to program guidelines. y If she continues the pregnancy:",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1582
  },
  {
    "id": "chunk_01583",
    "text": "gram guidelines. y If she continues the pregnancy: \u2013 Advise her that it is best to remove the IUD. \u2013 Explain the risks of pregnancy with an IUD in place. Early removal of the IUD reduces these risks, although the removal procedure itself involves a small risk of miscarriage.",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1583
  },
  {
    "id": "chunk_01584",
    "text": "edure itself involves a small risk of miscarriage. \u2013 If she agrees to removal, gently remove the IUD or refer for removal. \u2013 Explain that she should return at once if she develops any signs of miscarriage or septic miscarriage (vaginal bleeding, cramping, pain, abnormal vaginal discharge, or fever).",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1584
  },
  {
    "id": "chunk_01585",
    "text": "ping, pain, abnormal vaginal discharge, or fever). \u2013 If she chooses to keep the IUD, a nurse or doctor should follow her pregnancy closely. She should see a nurse or doctor at once if she develops any signs of septic miscarriage.",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1585
  },
  {
    "id": "chunk_01586",
    "text": "e if she develops any signs of septic miscarriage. y If the IUD strings are not visible and cannot be found in the cervical canal, the IUD cannot be safely retrieved. Refer for ultrasound, if possible, to determine whether the IUD is still in the uterus. If it is, or if ultrasound is",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1586
  },
  {
    "id": "chunk_01587",
    "text": "still in the uterus. If it is, or if ultrasound is not available, her pregnancy should be followed closely. She should seek care at once if she develops any signs of septic miscarriage. 186 Family Planning: A Global Handbook for Providers",
    "page_number": 208,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1587
  },
  {
    "id": "chunk_01588",
    "text": "10 187 eciveD eniretuartnI gniraeB-reppoC Removing the IUD and Switching Method IMPORTANT: Providers must not refuse or delay when a woman asks to have her IUD removed, whatever her reason, whether it is personal or medical. All staff must understand and agree that she must",
    "page_number": 209,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1588
  },
  {
    "id": "chunk_01589",
    "text": "All staff must understand and agree that she must not be pressured or forced to continue using the IUD. If a woman is finding side effects difficult to tolerate, first discuss the problems she is having (see Managing Any Problems, p. 181). Ask if she",
    "page_number": 209,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1589
  },
  {
    "id": "chunk_01590",
    "text": "ng (see Managing Any Problems, p. 181). Ask if she would rather try to manage the problem or to have the IUD removed immediately. Removing an IUD is usually simple. It can be done any time of the month. Removal may be easier during monthly bleeding, when the",
    "page_number": 209,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1590
  },
  {
    "id": "chunk_01591",
    "text": "al may be easier during monthly bleeding, when the cervix is naturally softened. In cases of uterine perforation or if removal is not easy (for example, when IUD strings are missing), refer the woman to an experienced clinician who can use an appropriate removal technique.",
    "page_number": 209,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1591
  },
  {
    "id": "chunk_01592",
    "text": "cian who can use an appropriate removal technique. Explaining the Removal Procedure Before removing the IUD, explain what will happen during removal: 1. The provider inserts a speculum to see the cervix and IUD strings and carefully cleans the cervix and vagina with an antiseptic solution",
    "page_number": 209,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1592
  },
  {
    "id": "chunk_01593",
    "text": "the cervix and vagina with an antiseptic solution such as iodine. 2. The provider asks the woman to take slow, deep breaths and to relax. The woman should say if she feels pain during the procedure. 3. Using narrow forceps, the provider pulls the IUD strings slowly and",
    "page_number": 209,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1593
  },
  {
    "id": "chunk_01594",
    "text": "Switching From an IUD to Another Method These guidelines ensure that the client is protected from pregnancy without interruption when switching from a copper-bearing IUD or a hormonal IUD to another method. See also When to Start for each method. Switching to When to start",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1594
  },
  {
    "id": "chunk_01595",
    "text": "Start for each method. Switching to When to start A hormonal y If starting during the first 7 days of monthly bleeding method: combined (first 5 days for COCs and POPs), start the hormonal oral contraceptives method now and remove the IUD. No need for a (COCs), progestin- backup method.",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1595
  },
  {
    "id": "chunk_01596",
    "text": "D. No need for a (COCs), progestin- backup method. only pills (POPs), y If starting after the first 7 days of monthly bleeding progestin-only (after the first 5 days for COCs and POPs) and she injectables, monthly has had sex since her last monthly bleeding, start the injectables,",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1596
  },
  {
    "id": "chunk_01597",
    "text": "her last monthly bleeding, start the injectables, hormonal method now. It is recommended that the combined patch, IUD be left in place until her next monthly bleeding. combined vaginal ring, or implants y If starting after the first 7 days of monthly bleeding (after",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1597
  },
  {
    "id": "chunk_01598",
    "text": "after the first 7 days of monthly bleeding (after the first 5 days for COCs and POPs) and she has not had sex since her last monthly bleeding, the IUD can stay in place and be removed during her next monthly bleeding, or the IUD can be removed and she can use a backup",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1598
  },
  {
    "id": "chunk_01599",
    "text": "or the IUD can be removed and she can use a backup method* for the next 7 days (2 days for POPs). Male or female y The next time she has sex after the IUD condoms, is removed. spermicides, diaphragms, cervical caps, or withdrawal Fertility awareness y In the same cycle that the IUD is removed.",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1599
  },
  {
    "id": "chunk_01600",
    "text": "eness y In the same cycle that the IUD is removed. methods Female sterilization y If during the first 7 days of monthly bleeding, remove the IUD and perform the female sterilization procedure. No need for a backup method. y If after the first 7 days of monthly bleeding, perform the",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1600
  },
  {
    "id": "chunk_01601",
    "text": "the first 7 days of monthly bleeding, perform the sterilization procedure. Ideally, the IUD should stay in place until her follow-up visit or her next monthly bleeding. If a follow-up visit is not possible, remove the IUD at the time of sterilization. No need for a backup method.",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1601
  },
  {
    "id": "chunk_01602",
    "text": "ime of sterilization. No need for a backup method. Vasectomy y Any time y The woman can keep the IUD until a test of her partner\u2019s semen shows that the vasectomy is working, or for 3 months, when the vasectomy will be fully effective.",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1602
  },
  {
    "id": "chunk_01603",
    "text": "onths, when the vasectomy will be fully effective. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms.",
    "page_number": 210,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1603
  },
  {
    "id": "chunk_01604",
    "text": "10 189 eciveD eniretuartnI gniraeB-reppoC Questions and Answers About the Copper-Bearing IUD 1. Does the IUD cause pelvic inflammatory disease (PID)? By itself, the IUD does not cause PID. Gonorrhea and chlamydia are the primary direct causes of PID. IUD insertion when a woman has",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1604
  },
  {
    "id": "chunk_01605",
    "text": "rect causes of PID. IUD insertion when a woman has gonorrhea or chlamydia may lead to PID, however. This does not happen often. When it does, it is most likely to occur in the first 20 days after IUD insertion. It has been estimated that, in a group of clients where",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1605
  },
  {
    "id": "chunk_01606",
    "text": "s been estimated that, in a group of clients where STIs are common and screening questions identify half the STI cases, there might be 1 case of PID in every 666 IUD insertions (or less than 2 per 1,000) (see Assessing Women for Risk of Sexually Transmitted Infections, p. 172).",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1606
  },
  {
    "id": "chunk_01607",
    "text": "Risk of Sexually Transmitted Infections, p. 172). 2. Can young women and older women use IUDs? Yes. There is no minimum or maximum age limit. An IUD should be removed after menopause has occurred\u2014within 12 months after her last monthly bleeding (see Women Near Menopause, in Chapter 21 \u2013 Serving",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1607
  },
  {
    "id": "chunk_01608",
    "text": "(see Women Near Menopause, in Chapter 21 \u2013 Serving Diverse Groups, p. 335). 3. If a current IUD user has a sexually transmitted infection (STI) or has become at very high individual risk of infection with an STI, should her IUD be removed?",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1608
  },
  {
    "id": "chunk_01609",
    "text": "infection with an STI, should her IUD be removed? No. If a woman develops a new STI after her IUD has been inserted, she is not especially at risk of developing PID because of the IUD. She can continue to use the IUD while she is being treated for the STI. Removing",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1609
  },
  {
    "id": "chunk_01610",
    "text": "D while she is being treated for the STI. Removing the IUD has no benefit and may leave her at risk of unwanted pregnancy. Counsel her on condom use and other strategies to avoid STIs in the future. 4. Does the IUD make a woman infertile? No. A woman can become pregnant once the IUD is removed just",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1610
  },
  {
    "id": "chunk_01611",
    "text": "n can become pregnant once the IUD is removed just as quickly as a woman who has never used an IUD, although fertility decreases as women get older. Good studies find no increased risk of infertility among women who have used IUDs, including young women",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1611
  },
  {
    "id": "chunk_01612",
    "text": "ng women who have used IUDs, including young women and women with no children. Whether or not a woman has an IUD, however, if she develops PID and it is not treated, there is some chance that she will become infertile. 5. Can a woman who has never had a baby use an IUD?",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1612
  },
  {
    "id": "chunk_01613",
    "text": ". Can a woman who has never had a baby use an IUD? Yes. A woman who has not had children generally can use an IUD, but she should understand that the IUD is more likely to come out because her uterus may be smaller than the uterus of a woman who has given birth.",
    "page_number": 211,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1613
  },
  {
    "id": "chunk_01614",
    "text": "6. Can the IUD travel from the woman\u2019s uterus to other parts of her body, such as her heart or her brain? The IUD never travels to the heart, brain, or any other part of the body outside the abdomen. The IUD normally stays within the uterus like a",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1614
  },
  {
    "id": "chunk_01615",
    "text": "n. The IUD normally stays within the uterus like a seed within a shell. Rarely, the IUD may come through the wall of the uterus into the abdominal cavity. This is most often due to a mistake during insertion. If it is discovered within 6 weeks or so after insertion or",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1615
  },
  {
    "id": "chunk_01616",
    "text": "discovered within 6 weeks or so after insertion or if it is causing symptoms at any time, the IUD will need to be removed by laparoscopic or laparotomic surgery. Usually, however, the out-of-place IUD causes no problems and should be left where it is. The woman will need another contraceptive method.",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1616
  },
  {
    "id": "chunk_01617",
    "text": "The woman will need another contraceptive method. 7. Should a woman have a \u201crest period\u201d after using her IUD for several years or after the IUD reaches its recommended time for removal? No. This is not necessary, and it could be harmful. Removing the old IUD",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1617
  },
  {
    "id": "chunk_01618",
    "text": "ary, and it could be harmful. Removing the old IUD and immediately inserting a new IUD poses less risk of infection than 2 separate procedures. Also, a woman could become pregnant during a \u201crest period\u201d before her new IUD is inserted. 8. Should antibiotics be routinely given before IUD insertion?",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1618
  },
  {
    "id": "chunk_01619",
    "text": "tibiotics be routinely given before IUD insertion? No, usually not. Most recent research done where STIs are not common suggests that PID risk is low with or without antibiotics. When appropriate questions to screen for STI risk are used and IUD insertion is done with",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1619
  },
  {
    "id": "chunk_01620",
    "text": "r STI risk are used and IUD insertion is done with proper infection-prevention procedures (including the no-touch insertion technique), there is little risk of infection. Antibiotics may be considered, however, in areas where STIs are common and STI screening is limited.",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1620
  },
  {
    "id": "chunk_01621",
    "text": "here STIs are common and STI screening is limited. 9. Must an IUD be inserted only during a woman\u2019s monthly bleeding? No. For a woman having menstrual cycles, an IUD can be inserted at any time during her menstrual cycle if it is reasonably certain that she is not",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1621
  },
  {
    "id": "chunk_01622",
    "text": "cycle if it is reasonably certain that she is not pregnant. Inserting the IUD during her monthly bleeding may be a good time because she is not likely to be pregnant, and insertion may be easier. It is not as easy to see signs of infection during monthly bleeding,however.",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1622
  },
  {
    "id": "chunk_01623",
    "text": "igns of infection during monthly bleeding,however. 10. Do IUDs increase the risk of ectopic pregnancy? No. On the contrary, IUDs greatly reduce the risk of ectopic pregnancy. Ectopic pregnancies are rare among IUD users. The rate of ectopic",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1623
  },
  {
    "id": "chunk_01624",
    "text": "cies are rare among IUD users. The rate of ectopic pregnancy among women with IUDs is 12 per 10,000 women per year. The rate of ectopic pregnancy among women in the United States using no contraceptive method is 65 per 10,000 women per year.",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1624
  },
  {
    "id": "chunk_01625",
    "text": "traceptive method is 65 per 10,000 women per year. On the rare occasions that the IUD fails and pregnancy occurs, 6 to 8 of every 100 of these pregnancies are ectopic. Thus, the great majority of pregnancies after IUD failure are not ectopic. Still, ectopic pregnancy",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1625
  },
  {
    "id": "chunk_01626",
    "text": "failure are not ectopic. Still, ectopic pregnancy can be life-threatening, and so a provider should be aware that ectopic pregnancy is possible if the IUD fails. 190 Family Planning: A Global Handbook for Providers",
    "page_number": 212,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1626
  },
  {
    "id": "chunk_01627",
    "text": "11 191 eciveD eniretuartnI lertsegronoveL CHAPTER 11 Levonorgestrel Intrauterine Device Key Points for Providers and Clients y Long-term pregnancy protection. Very effective for up to 7 years, depending on the type of LNG-IUD. Immediately reversible.",
    "page_number": 213,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1627
  },
  {
    "id": "chunk_01628",
    "text": "ng on the type of LNG-IUD. Immediately reversible. y Inserted into the uterus by a specifically trained provider. y Little required of the client once the LNG-IUD is in place. y Bleeding changes are common but not harmful. Typically, lighter and fewer days of bleeding, or infrequent or",
    "page_number": 213,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1628
  },
  {
    "id": "chunk_01629",
    "text": "ghter and fewer days of bleeding, or infrequent or irregular bleeding. What Is the Levonorgestrel Intrauterine Device? y The levonorgestrel intrauterine device (LNG-IUD) is a T-shaped plastic device that steadily releases a small amount of levonorgestrel each day.",
    "page_number": 213,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1629
  },
  {
    "id": "chunk_01630",
    "text": "eleases a small amount of levonorgestrel each day. (Levonorgestrel is a progestin hormone also used in some contraceptive implants and oral contraceptive pills.) y A specifically trained health care provider inserts it into a woman\u2019s uterus through her vagina and cervix.",
    "page_number": 213,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1630
  },
  {
    "id": "chunk_01631",
    "text": "to a woman\u2019s uterus through her vagina and cervix. y Also called the levonorgestrel-releasing intrauterine system, LNG-IUS, or hormonal IUD. y Marketed under such brand names as Mirena, Liletta, Levosert, Kyleena, Skyla, and Jaydess. The Kyleena, Skyla, and Jaydess IUDs and their inserters",
    "page_number": 213,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1631
  },
  {
    "id": "chunk_01632",
    "text": "leena, Skyla, and Jaydess IUDs and their inserters are slightly smaller than the Mirena, Liletta, and Levosert. y Works by preventing sperm from fertilizing an egg.",
    "page_number": 213,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1632
  },
  {
    "id": "chunk_01633",
    "text": "How Effective? One of the most effective and long-lasting methods: More effective y Less than 1 pregnancy per 100 women using an LNG-IUD over the first year (2 per 1,000 women). This means that 998 of every 1,000 women using LNG-IUDs will not become pregnant.",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1633
  },
  {
    "id": "chunk_01634",
    "text": "000 women using LNG-IUDs will not become pregnant. y A small risk of pregnancy remains beyond the first year of use and continues as long as the woman is using the LNG-IUD. \u2013 Over 5 years of use of the Mirena LNG-IUD: Less than 1 pregnancy per 100 women (5 to 8 per 1,000 women).",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1634
  },
  {
    "id": "chunk_01635",
    "text": "pregnancy per 100 women (5 to 8 per 1,000 women). y Mirena and Kyleena are approved for up to 5 years of use. Research shows that Mirena remains highly effective for 7 years. Less Levosert and Liletta are approved for up to 4 years of use. effective",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1635
  },
  {
    "id": "chunk_01636",
    "text": "a are approved for up to 4 years of use. effective Research supports up to 5 years of use of Levosert and Liletta. Skyla and Jaydess are approved for up to 3 years of use. Return of fertility after LNG-IUD is removed: No delay Protection against sexually transmitted infections (STIs): None",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1636
  },
  {
    "id": "chunk_01637",
    "text": "ainst sexually transmitted infections (STIs): None Side Effects, Health Benefits, Health Risks, and Complications Side Effects (see also Managing Any Problems, p. 212) Some users report the following: y Most commonly, changes in bleeding patterns,\u2020 including:",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1637
  },
  {
    "id": "chunk_01638",
    "text": "ommonly, changes in bleeding patterns,\u2020 including: \u2013 Lighter bleeding and fewer days of bleeding \u2013 Infrequent bleeding \u2013 Irregular bleeding Bleeding changes are normal and \u2013 No monthly bleeding not harmful. If a woman finds \u2013 Prolonged bleeding them bothersome, counseling y Acne and support can help.",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1638
  },
  {
    "id": "chunk_01639",
    "text": "othersome, counseling y Acne and support can help. y Headaches y Breast tenderness or pain y Nausea Other possible physical changes: y Weight gain y Ovarian cysts y Dizziness y Mood changes \u2020 For definitions of bleeding patterns, see \u201cvaginal bleeding\u201d in the Glossary.",
    "page_number": 214,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1639
  },
  {
    "id": "chunk_01640",
    "text": "11 193 eciveD eniretuartnI lertsegronoveL Known Health Benefits Known Health Risks Helps protect against: Rare: y In the short term, PID may y Risks of pregnancy occur if the woman has y Iron-deficiency anemia gonorrhea or chlamydia at the time of insertion. May help protect against:",
    "page_number": 215,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1640
  },
  {
    "id": "chunk_01641",
    "text": "t the time of insertion. May help protect against: y Endometrial cancer y Cervical cancer Reduces: y Menstrual cramps y Heavy monthly bleeding y Symptoms of endometriosis (pelvic pain, irregular bleeding) y Risk of ectopic pregnancy Complications Rare:",
    "page_number": 215,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1641
  },
  {
    "id": "chunk_01642",
    "text": "g) y Risk of ectopic pregnancy Complications Rare: y Puncturing (perforation) of the wall of the uterus by the LNG-IUD or an instrument used for insertion. Usually heals without treatment. Very rare: y Miscarriage, preterm birth, or infection in the very rare case that the",
    "page_number": 215,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1642
  },
  {
    "id": "chunk_01643",
    "text": "birth, or infection in the very rare case that the woman becomes pregnant with the LNG-IUD in place. Correcting Misunderstandings LNG-IUDs: y Can be used by women of any age, including adolescents. y Can be used by women who have had children and those who have not.",
    "page_number": 215,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1643
  },
  {
    "id": "chunk_01644",
    "text": "omen who have had children and those who have not. y Do not increase the risk of contracting STIs, including HIV. y Do not increase the risk of miscarriage when a woman becomes pregnant after the IUD is removed. y Do not make women infertile. y Do not cause birth defects. y Do not cause cancer.",
    "page_number": 215,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1644
  },
  {
    "id": "chunk_01645",
    "text": "Do not cause birth defects. y Do not cause cancer. y Do not move to the heart or brain. y Do not cause discomfort or pain for the woman or the man during sex. Levonorgestrel Intrauterine Device",
    "page_number": 215,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1645
  },
  {
    "id": "chunk_01646",
    "text": "Why Some Women Say They Like the LNG-IUD y Prevents pregnancy very effectively y Makes bleeding lighter and can prevent monthly bleeding for many months (amenorrhea) y Is long-lasting y Is private\u2014usually no one else can tell a woman is using contraception",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1646
  },
  {
    "id": "chunk_01647",
    "text": "o one else can tell a woman is using contraception (sometimes a partner may feel the strings during sex) y Has no further costs for supplies after the IUD is inserted y Does not require the user to do anything once the IUD is inserted Who Can and Cannot Use Levonorgestrel IUDs",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1647
  },
  {
    "id": "chunk_01648",
    "text": "nserted Who Can and Cannot Use Levonorgestrel IUDs Nearly All Women Can Use LNG-IUDs LNG-IUDs are safe and effective for nearly all women, including women who: y Have or have not had children y Are married or are not married y Are of any age, including adolescents and women over 40 years old",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1648
  },
  {
    "id": "chunk_01649",
    "text": "including adolescents and women over 40 years old y Have just had an abortion or miscarriage (if no evidence of infection) y Are breastfeeding y Do hard physical work y Have had ectopic pregnancy y Have had pelvic inflammatory disease (PID) y Have vaginal infections y Have anemia",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1649
  },
  {
    "id": "chunk_01650",
    "text": "ease (PID) y Have vaginal infections y Have anemia y Have HIV clinical disease that is mild or with no symptoms, whether or not they are on antiretroviral therapy (see LNG-IUD for Women With HIV, p. 199) Avoid Unnecessary Procedures",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1650
  },
  {
    "id": "chunk_01651",
    "text": "men With HIV, p. 199) Avoid Unnecessary Procedures (see Importance of Selected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396) A pelvic examination and an STI Women can begin using IUDs: risk assessment are essential. When y Without cervical cancer screening",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1651
  },
  {
    "id": "chunk_01652",
    "text": "ssential. When y Without cervical cancer screening available, a hemoglobin test and y Without a breast examination laboratory tests for STIs including HIV y Without a blood pressure check can contribute to safe and effective use. 194 Family Planning: A Global Handbook for Providers",
    "page_number": 216,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1652
  },
  {
    "id": "chunk_01653",
    "text": "11 195 eciveD eniretuartnI lertsegronoveL Medical Eligibility Criteria for Levonorgestrel IUDs Ask the client the questions below about known medical conditions. If she answers \u201cno\u201d to all of the questions (and no contraindications are found on pelvic exam; see p. 198), then she can have an LNG-IUD",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1653
  },
  {
    "id": "chunk_01654",
    "text": "ic exam; see p. 198), then she can have an LNG-IUD inserted. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases she can still have an LNG-IUD inserted. 1. Did you give birth more than 48 hours ago but less than 4 weeks ago?",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1654
  },
  {
    "id": "chunk_01655",
    "text": "more than 48 hours ago but less than 4 weeks ago? \u274f NO \u274f YES Delay inserting an LNG-IUD until 4 or more weeks after childbirth (see Soon after childbirth, p. 203). 2. Do you have an infection following childbirth or abortion? \u274f NO \u274f YES If she currently has infection of the reproductive",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1655
  },
  {
    "id": "chunk_01656",
    "text": "If she currently has infection of the reproductive organs during the first 6 weeks after childbirth (puerperal sepsis) or she just had an abortion-related infection in the uterus (septic abortion), do not insert the LNG-IUD. Treat or refer if she is not already receiving care. Help her choose",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1656
  },
  {
    "id": "chunk_01657",
    "text": "she is not already receiving care. Help her choose another method or offer a backup method.* After treatment, re-evaluate for LNG-IUD use. 3. Do you now have a blood clot in the deep veins of your leg or lungs? \u274f NO \u274f YES If she was recently diagnosed with a blood clot in",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1657
  },
  {
    "id": "chunk_01658",
    "text": "If she was recently diagnosed with a blood clot in legs (affecting deep veins, not superficial veins) or in a lung, and she is not on anticoagulant therapy, help her choose a method without hormones. 4. Do you have severe cirrhosis or severe liver tumor?",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1658
  },
  {
    "id": "chunk_01659",
    "text": "o you have severe cirrhosis or severe liver tumor? \u274f NO \u274f YES If she reports severe cirrhosis or severe liver tumor such as liver cancer, do not provide the LNG-IUD. Help her choose a method without hormones. 5. Do you have or have you ever had breast cancer?",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1659
  },
  {
    "id": "chunk_01660",
    "text": "5. Do you have or have you ever had breast cancer? \u274f NO \u274f YES Do not insert the LNG-IUD. Help her choose a method without hormones. (Continued on next page) * Backup methods include abstinence, male and female condoms, spermicides,",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1660
  },
  {
    "id": "chunk_01661",
    "text": "abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. Who Can and Cannot Use Levonorgestrel IUDs",
    "page_number": 217,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1661
  },
  {
    "id": "chunk_01662",
    "text": "6. Are you having vaginal bleeding that is unusual for you? \u274f NO \u274f YES If she has unexplained vaginal bleeding that suggests pregnancy or an underlying medical condition, use of an LNG-IUD could make diagnosis and monitoring of any treatment more difficult. Help her choose a method to",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1662
  },
  {
    "id": "chunk_01663",
    "text": "atment more difficult. Help her choose a method to use while being evaluated (but not a copper-bearing IUD, progestin-only injectable, or implant) and, if indicated, treated. After diagnosis/treatment, re-evaluate for IUD use. 7. Do you have any female conditions or problems",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1663
  },
  {
    "id": "chunk_01664",
    "text": ". 7. Do you have any female conditions or problems (gynecologic or obstetric conditions or problems), such as genital cancer, pelvic tuberculosis, or gestational trophoblastic disease? \u274f NO \u274f YES If she has current cervical, endometrial, or ovarian",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1664
  },
  {
    "id": "chunk_01665",
    "text": "she has current cervical, endometrial, or ovarian cancer; pelvic tuberculosis; or gestational trophoblastic disease, do not insert an LNG-IUD. Treat or refer for care if she is not already receiving care. Help her choose another method. In case of pelvic tuberculosis, re-evaluate for",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1665
  },
  {
    "id": "chunk_01666",
    "text": "d. In case of pelvic tuberculosis, re-evaluate for LNG-IUD use after treatment. 8. Do you have HIV or AIDS? Do you have any health conditions associated with HIV infection? \u274f NO \u274f YES If a woman has HIV infection with severe or advanced clinical disease, do not insert an LNG-IUD. In contrast, a",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1666
  },
  {
    "id": "chunk_01667",
    "text": "disease, do not insert an LNG-IUD. In contrast, a woman living with HIV who has mild clinical disease or no clinical disease can have an IUD inserted, whether or not she is on antretroviral therapy. (See LNG-IUD for Women With HIV, p. 199.)",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1667
  },
  {
    "id": "chunk_01668",
    "text": "therapy. (See LNG-IUD for Women With HIV, p. 199.) 9. Assess whether she is at very high individual risk for STIs. Women who have a very high individual likelihood of STIs should not have an LNG-IUD inserted unless gonorrhea and chlamydia are ruled",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1668
  },
  {
    "id": "chunk_01669",
    "text": "inserted unless gonorrhea and chlamydia are ruled out by lab tests (see Assessing Women for Risk of Sexually Transmitted Infections, p. 200). 10. Rule out pregnancy. Ask the client the questions in the Pregnancy Checklist (see inside",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1669
  },
  {
    "id": "chunk_01670",
    "text": "e questions in the Pregnancy Checklist (see inside back cover). If she answers \u201cyes\u201d to any of these questions, you can be reasonably certain that she is not pregnant and she can have an LNG- IUD inserted. If the Pregnancy Checklist cannot rule out pregnancy, use the job aid",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1670
  },
  {
    "id": "chunk_01671",
    "text": "ecklist cannot rule out pregnancy, use the job aid Ruling Out Pregnancy before inserting an LNG-IUD. 196 Family Planning: A Global Handbook for Providers",
    "page_number": 218,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1671
  },
  {
    "id": "chunk_01672",
    "text": "11 197 eciveD eniretuartnI lertsegronoveL Also, women should not use LNG-IUDs if they report having systemic lupus erythematosus with positive (or unknown) antiphospholipid antibodies, but are not receiving immunosuppressive treatment. For complete classifications, see Appendix D \u2013 Medical",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1672
  },
  {
    "id": "chunk_01673",
    "text": "complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1673
  },
  {
    "id": "chunk_01674",
    "text": "he client will use. Also, point out any conditions that would make the method inadvisable, when relevant to the client. Using Clinical Judgment in Special Cases Usually, a woman with any of the conditions listed below should not use an LNG-IUD. In special circumstances, however, when",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1674
  },
  {
    "id": "chunk_01675",
    "text": "n LNG-IUD. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use an LNG-IUD.",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1675
  },
  {
    "id": "chunk_01676",
    "text": "situation may decide that she can use an LNG-IUD. The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up. y Between 48 hours and 4 weeks since giving birth y Acute blood clot in deep veins of legs or lungs",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1676
  },
  {
    "id": "chunk_01677",
    "text": "y Acute blood clot in deep veins of legs or lungs y Had breast cancer more than 5 years ago, and it has not returned y Severe cirrhosis or severe liver tumor y Noncancerous (benign) gestational trophoblast disease y Has current ovarian cancer",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1677
  },
  {
    "id": "chunk_01678",
    "text": "l trophoblast disease y Has current ovarian cancer y Is at very high individual risk for STIs at the time of insertion y Has severe or advanced HIV clinical disease y Has systemic lupus erythematosus with positive (or unknown) antiphospholipid antibodies and is not receiving",
    "page_number": 219,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1678
  },
  {
    "id": "chunk_01679",
    "text": "Screening Questions for Pelvic Examination Before IUD Insertion A pelvic examination and STI risk assessment should be done before IUD insertion. (For STI risk assessment, see next page.) When performing the pelvic examination, asking yourself the questions below helps you check",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1679
  },
  {
    "id": "chunk_01680",
    "text": "sking yourself the questions below helps you check for signs of conditions that would rule out IUD insertion. If the answer to all of the questions is \u201cno,\u201d then the client can have an IUD inserted. If the answer to any question is \u201cyes,\u201d do not insert an IUD.",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1680
  },
  {
    "id": "chunk_01681",
    "text": "er to any question is \u201cyes,\u201d do not insert an IUD. For questions 1 through 5, if the answer is \u201cyes,\u201d refer for diagnosis and treatment as appropriate. Help her choose another method and counsel her about condom use if she faces any risk of sexually transmitted",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1681
  },
  {
    "id": "chunk_01682",
    "text": "use if she faces any risk of sexually transmitted infections (STIs). Give her condoms, if possible. If an STI or pelvic inflammatory disease (PID) is confirmed and she still wants an IUD, it may be inserted as soon as she finishes treatment, if she is not at risk for reinfection before insertion.",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1682
  },
  {
    "id": "chunk_01683",
    "text": "e is not at risk for reinfection before insertion. 1. Is there any type of ulcer on the vulva, vagina, or cervix? \u274f NO \u274f YES Possible STI. 2. Does the client feel pain in her lower abdomen when you move the cervix? \u274f NO \u274f YES Possible PID. 3. Is there tenderness in the uterus, ovaries, or fallopian",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1683
  },
  {
    "id": "chunk_01684",
    "text": "re tenderness in the uterus, ovaries, or fallopian tubes (adnexal tenderness)? \u274f NO \u274f YES Possible PID. 4. Is there a purulent cervical discharge? \u274f NO \u274f YES Possible STI or PID. 5. Does the cervix bleed easily when touched? \u274f NO \u274f YES Possible STI or cervical cancer.",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1684
  },
  {
    "id": "chunk_01685",
    "text": "uched? \u274f NO \u274f YES Possible STI or cervical cancer. 6. Is there an anatomical abnormality of the uterine cavity that will prevent correct IUD placement? \u274f NO \u274f YES If an anatomical abnormality distorts the uterine cavity, proper IUD placement may not be possible. Help her choose another method.",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1685
  },
  {
    "id": "chunk_01686",
    "text": "y not be possible. Help her choose another method. 7. Were you unable to determine the size and/or position of the uterus? \u274f NO \u274f YES Determining the size and position of the uterus before IUD insertion is essential to ensure high placement of the IUD and to minimize risk of perforation. If size and",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1686
  },
  {
    "id": "chunk_01687",
    "text": "D and to minimize risk of perforation. If size and position cannot be determined, do not insert an IUD. Help her choose another method. 198 Family Planning: A Global Handbook for Providers",
    "page_number": 220,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1687
  },
  {
    "id": "chunk_01688",
    "text": "11 199 eciveD eniretuartnI lertsegronoveL LNG-IUD for Women With HIV y Women living with HIV can safely have an LNG-IUD inserted if they have mild or no clinical disease, whether or not they are on antiretroviral therapy. y Women who have HIV infection with advanced or severe clinical",
    "page_number": 221,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1688
  },
  {
    "id": "chunk_01689",
    "text": "ave HIV infection with advanced or severe clinical disease should not have an IUD inserted. y If a woman becomes infected with HIV while she has an IUD in place, it does not need to be removed. y An IUD user living with HIV who develops advanced or severe clinical",
    "page_number": 221,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1689
  },
  {
    "id": "chunk_01690",
    "text": "with HIV who develops advanced or severe clinical disease can keep the IUD but should be closely monitored for pelvic inflammatory disease. y Urge women who have HIV or are at risk for HIV to use condoms along with the IUD. Used consistently and correctly, condoms help",
    "page_number": 221,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1690
  },
  {
    "id": "chunk_01691",
    "text": "IUD. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. y Women who are at risk of HIV but not infected with HIV can have an IUD inserted. The IUD does not increase the risk of becoming infected with HIV. Who Can and Cannot Use Levonorgestrel IUDs",
    "page_number": 221,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1691
  },
  {
    "id": "chunk_01692",
    "text": "Assessing Women for Risk of Sexually Transmitted Infections A woman who has gonorrhea or chlamydia now should not have an IUD inserted. Having these sexually transmitted infections (STIs) at the time of insertion may increase the risk of pelvic inflammatory",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1692
  },
  {
    "id": "chunk_01693",
    "text": "rtion may increase the risk of pelvic inflammatory disease. These STIs may be difficult to diagnose clinically, however, and reliable laboratory tests are time-consuming, expensive, and sometimes unavailable. Without clinical signs or symptoms and",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1693
  },
  {
    "id": "chunk_01694",
    "text": "navailable. Without clinical signs or symptoms and without laboratory testing, the only indication that a woman might already have an STI is whether her behavior or her situation places her at very high individual risk of infection. If this risk for the individual",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1694
  },
  {
    "id": "chunk_01695",
    "text": "risk of infection. If this risk for the individual client is very high, she generally should not have an IUD inserted.\u2021 (Local STI prevalence rates are not a basis for judging individual risk.) There is no universal set of questions that will determine if a woman",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1695
  },
  {
    "id": "chunk_01696",
    "text": "al set of questions that will determine if a woman is at very high individual risk for STIs. Instead of asking questions, providers can discuss with the client the personal behaviors and the situations in their community that are most likely to expose women to STIs. Steps to take:",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1696
  },
  {
    "id": "chunk_01697",
    "text": "ost likely to expose women to STIs. Steps to take: 1. Tell the client that a woman who faces a very high individual risk of STIs usually should not have an IUD inserted. 2. Ask the woman to consider her own risk and to think about whether she might have an STI. A woman is often the best judge",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1697
  },
  {
    "id": "chunk_01698",
    "text": "might have an STI. A woman is often the best judge of her own risk.\u00a7 She does not have to tell the provider about her behavior or her partner\u2019s behavior. Providers can explain possibly risky situations that may place a woman at very high individual",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1698
  },
  {
    "id": "chunk_01699",
    "text": "ons that may place a woman at very high individual risk. The client can think about whether such situations occurred recently (in the past 3 months or so). If so, she may have an STI now, whether or not she has noticed symptoms, and may want to choose a method other than the IUD.",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1699
  },
  {
    "id": "chunk_01700",
    "text": "nd may want to choose a method other than the IUD. 3. Ask if she thinks she is a good candidate for an IUD or would like to consider other contraceptive methods, including other long- acting methods. If, after considering her individual risk, she thinks",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1700
  },
  {
    "id": "chunk_01701",
    "text": "after considering her individual risk, she thinks she is a good candidate, and she is eligible, provide her with an IUD. If she wants to consider other methods or if you have strong reason to believe that the client is at very high individual risk of infection, help her choose another method.",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1701
  },
  {
    "id": "chunk_01702",
    "text": "risk of infection, help her choose another method. \u2021 In contrast, if a current IUD user\u2019s situation changes and she finds herself at very high individual risk for gonorrhea or chlamydia, she can keep using her IUD. \u00a7 Any woman who thinks she might have an STI should seek care immediately.",
    "page_number": 222,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1702
  },
  {
    "id": "chunk_01703",
    "text": "11 201 eciveD eniretuartnI lertsegronoveL Possibly risky situations include: y A sexual partner has STI symptoms such as pus coming from his penis, pain or burning during urination, or an open sore in the genital area y She or a sexual partner was diagnosed with an STI recently All of these",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1703
  },
  {
    "id": "chunk_01704",
    "text": "er was diagnosed with an STI recently All of these y She has had more than one sexual situations pose less partner recently risk if a woman or her y She has a sexual partner who has partner uses condoms had other partners recently consistently and correctly. Also, a provider can mention other",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1704
  },
  {
    "id": "chunk_01705",
    "text": "and correctly. Also, a provider can mention other high-risk situations that exist locally. Note: If she still wants the IUD while at very high individual risk of STIs, and reliable laboratory testing for gonorrhea and chlamydia is available,",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1705
  },
  {
    "id": "chunk_01706",
    "text": "testing for gonorrhea and chlamydia is available, a woman who tests negative can have an IUD inserted. A woman who tests positive can have an IUD inserted as soon as she finishes treatment, if she is not at risk of reinfection by the time of insertion.",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1706
  },
  {
    "id": "chunk_01707",
    "text": "t at risk of reinfection by the time of insertion. In special circumstances, if other, more appropriate methods are not available or not acceptable, a health care provider who can carefully assess a specific woman\u2019s condition and situation may decide that a",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1707
  },
  {
    "id": "chunk_01708",
    "text": "woman\u2019s condition and situation may decide that a woman at very high individual risk can have the IUD inserted even if STI testing is not available. (Depending on the circumstances, the provider may consider presumptively treating her with a full curative dose of",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1708
  },
  {
    "id": "chunk_01709",
    "text": "mptively treating her with a full curative dose of antibiotics effective against both gonorrhea and chlamydia and inserting the IUD after she finishes treatment.) Whether or not she receives presumptive treatment, the provider should be sure that the client can",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1709
  },
  {
    "id": "chunk_01710",
    "text": "t, the provider should be sure that the client can return for the follow-up visit, will be carefully checked for infection, and will be treated immediately if needed. She should be asked to return at once if she develops a fever and either lower abdominal pain or abnormal vaginal discharge or both.",
    "page_number": 223,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1710
  },
  {
    "id": "chunk_01711",
    "text": "Providing the Levonorgestrel Intrauterine Device When to Start IMPORTANT: In many cases a woman can start the LNG-IUD any time if it is reasonably certain she is not pregnant. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover).",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1711
  },
  {
    "id": "chunk_01712",
    "text": "e the Pregnancy Checklist (see inside back cover). Woman\u2019s situation When to start Having menstrual Any time of the month cycles or y If she is starting within 7 days after the start switching from of her monthly bleeding, no need for a backup a nonhormonal method. method",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1712
  },
  {
    "id": "chunk_01713",
    "text": "no need for a backup a nonhormonal method. method y If it is more than 7 days after the start of her monthly bleeding, she can have the LNG-IUD inserted any time if it is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after insertion.",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1713
  },
  {
    "id": "chunk_01714",
    "text": "ckup method* for the first 7 days after insertion. Switching from y Immediately, if she has been using the method a hormonal consistently and correctly or if it is otherwise method reasonably certain she is not pregnant. No need to wait for her next monthly bleeding.",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1714
  },
  {
    "id": "chunk_01715",
    "text": "nt. No need to wait for her next monthly bleeding. y If she is starting within 7 days after the start of her monthly bleeding, no need for a backup method. y If it is more than 7 days after the start of her monthly bleeding, she will need a backup method* for the first 7 days after insertion.",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1715
  },
  {
    "id": "chunk_01716",
    "text": "ckup method* for the first 7 days after insertion. y If she is switching from an injectable, she can have the LNG-IUD inserted when the repeat injection would have been given. No need for a backup method. * Backup methods include abstinence, male and female condoms, spermicides, and",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1716
  },
  {
    "id": "chunk_01717",
    "text": "tinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. 202 Family Planning: A Global Handbook for Providers",
    "page_number": 224,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1717
  },
  {
    "id": "chunk_01718",
    "text": "11 203 eciveD eniretuartnI lertsegronoveL Woman\u2019s situation When to start Soon after y Any time within 48 hours after giving birth childbirth (requires a provider with specific training (regardless of in postpartum insertion by hand or using a breastfeeding status) ring forceps).",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1718
  },
  {
    "id": "chunk_01719",
    "text": "nd or using a breastfeeding status) ring forceps). y After 48 hours, delay until at least 4 weeks. Fully or nearly fully breastfeeding Less than y If the LNG-IUD is not inserted within the first 48 6 months after hours and her monthly bleeding has not returned,",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1719
  },
  {
    "id": "chunk_01720",
    "text": "r hours and her monthly bleeding has not returned, giving birth she can have the LNG-IUD inserted any time between 4 weeks and 6 months. No need for a backup method. y If her monthly bleeding has returned, she can have the LNG-IUD inserted as advised for women",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1720
  },
  {
    "id": "chunk_01721",
    "text": "can have the LNG-IUD inserted as advised for women having menstrual cycles (see previous page). More than y If her monthly bleeding has not returned, she 6 months since can have the LNG-IUD inserted any time if it giving birth is reasonably certain she is not pregnant. She",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1721
  },
  {
    "id": "chunk_01722",
    "text": "rth is reasonably certain she is not pregnant. She will need a backup method* for the first 7 days after insertion. y If her monthly bleeding has returned, she can have the LNG-IUD inserted as advised for women having menstrual cycles (see previous page). Partially breastfeeding or not breastfeeding",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1722
  },
  {
    "id": "chunk_01723",
    "text": "age). Partially breastfeeding or not breastfeeding Less than 4 weeks y If the LNG-IUD is not inserted within the first 48 after giving birth hours, delay insertion until at least 4 weeks after giving birth. More than 4 weeks y If her monthly bleeding has not returned, she",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1723
  },
  {
    "id": "chunk_01724",
    "text": "ks y If her monthly bleeding has not returned, she after giving birth can have the LNG-IUD inserted any time if it can be determined that she is not pregnant (see Ruling Out Pregnancy, p. 461). She will need a backup method* for the first 7 days after insertion.",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1724
  },
  {
    "id": "chunk_01725",
    "text": "ckup method* for the first 7 days after insertion. y If her monthly bleeding has returned, she can have the LNG-IUD inserted as advised for women having menstrual cycles (see previous page). (Continued on next page) Providing the Levonorgestrel Intrauterine Device",
    "page_number": 225,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1725
  },
  {
    "id": "chunk_01726",
    "text": "Woman\u2019s situation When to start (continued) No monthly y Any time if it can be determined that she is not bleeding (not pregnant (see Ruling Out Pregnancy, p. 461). She related to childbirth will need a backup method* for the first 7 days or breastfeeding) after insertion.",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1726
  },
  {
    "id": "chunk_01727",
    "text": "he first 7 days or breastfeeding) after insertion. After y Immediately, if the LNG-IUD is inserted within miscarriage or 7 days after first- or second-trimester abortion abortion or miscarriage and if no infection is present. No need for a backup method.",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1727
  },
  {
    "id": "chunk_01728",
    "text": "infection is present. No need for a backup method. y If it is more than 7 days after first- or second- trimester miscarriage or abortion and no infection is present, she can have the LNG-IUD inserted any time if it is reasonably certain she is not pregnant. She will need a backup method*",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1728
  },
  {
    "id": "chunk_01729",
    "text": "he is not pregnant. She will need a backup method* for the first 7 days after insertion. y If infection is present, treat or refer and help the client choose another method. If she still wants the LNG-IUD, it can be inserted after the infection has completely cleared.",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1729
  },
  {
    "id": "chunk_01730",
    "text": "serted after the infection has completely cleared. y LNG-IUD insertion after second-trimester abortion or miscarriage requires specific training. If not specifically trained, delay insertion until at least 4 weeks after miscarriage or abortion. After taking y She can have the LNG IUD inserted when it",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1730
  },
  {
    "id": "chunk_01731",
    "text": "taking y She can have the LNG IUD inserted when it progestin-only, can be determined that she is not pregnant, for combined, or example, after the start of her next monthly ulipristal acetate bleeding (see Ruling Out Pregnancy, p. 461). Give",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1731
  },
  {
    "id": "chunk_01732",
    "text": "bleeding (see Ruling Out Pregnancy, p. 461). Give (UPA) emergency her a backup method* or oral contraceptive pills contraceptive pills to use until she can have the IUD inserted. (ECPs) y She should not have the LNG-IUD inserted in the first 6 days after taking UPA-ECPs.",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1732
  },
  {
    "id": "chunk_01733",
    "text": "nserted in the first 6 days after taking UPA-ECPs. These drugs interact. If the LNG-IUD is inserted sooner, and thus both LNG and UPA are present in the body, one or both may be less effective. * Backup methods include abstinence, male and female condoms, spermicides, and",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1733
  },
  {
    "id": "chunk_01734",
    "text": "tinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. 204 Family Planning: A Global Handbook for Providers",
    "page_number": 226,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1734
  },
  {
    "id": "chunk_01735",
    "text": "11 205 eciveD eniretuartnI lertsegronoveL Preventing Infection at LNG-IUD Insertion Proper insertion technique can help prevent many problems, such as infection, expulsion, and perforation. y Follow proper infection-prevention procedures.",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1735
  },
  {
    "id": "chunk_01736",
    "text": ". y Follow proper infection-prevention procedures. y Use high-level disinfected or sterile instruments. High-level disinfect by boiling, steaming, or soaking instruments in disinfectant chemicals. y Use a new, presterilized LNG-IUD that is packaged with its inserter.",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1736
  },
  {
    "id": "chunk_01737",
    "text": "ilized LNG-IUD that is packaged with its inserter. y The \u201cno-touch\u201d insertion technique is safest. This includes not letting the loaded IUD or uterine sound touch any unsterile surfaces (for example, hands, speculum, vagina, table top). The no-touch technique involves:",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1737
  },
  {
    "id": "chunk_01738",
    "text": "gina, table top). The no-touch technique involves: \u2013 Cleaning the cervix thoroughly with antiseptic before IUD insertion \u2013 Being careful not to touch the vaginal wall or speculum blades with the uterine sound or loaded IUD inserter \u2013 Passing both the uterine sound and the loaded IUD inserter only",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1738
  },
  {
    "id": "chunk_01739",
    "text": "the uterine sound and the loaded IUD inserter only once each through the cervical canal y Giving antibiotics routinely is generally not recommended for women at low risk of STIs. Giving Advice on Side Effects IMPORTANT: Thorough counseling about bleeding changes must come",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1739
  },
  {
    "id": "chunk_01740",
    "text": "orough counseling about bleeding changes must come before IUD insertion. Counseling about bleeding changes may be the most important help a woman needs to keep using the method without concern. Describe the y Changes in bleeding patterns: most common \u2212 Irregular bleeding followed by lighter bleeding,",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1740
  },
  {
    "id": "chunk_01741",
    "text": "\u2212 Irregular bleeding followed by lighter bleeding, side effects fewer days of bleeding, infrequent bleeding, and then no monthly bleeding. y Acne, headaches, breast tenderness and pain, and possibly other side effects. Explain about y Bleeding changes usually are not signs of illness.",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1741
  },
  {
    "id": "chunk_01742",
    "text": "Bleeding changes usually are not signs of illness. these side effects Lack of bleeding does not mean pregnancy. y Bleeding irregularities usually become less within 3 to 6 months after insertion. Many women have no bleeding at all after using the LNG-IUD for a",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1742
  },
  {
    "id": "chunk_01743",
    "text": "e no bleeding at all after using the LNG-IUD for a year or two. Other side effects also become less after the first several months following insertion. y The client can come back for help if side effects bother her or if she has other concerns. Providing the Levonorgestrel Intrauterine Device",
    "page_number": 227,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1743
  },
  {
    "id": "chunk_01744",
    "text": "Inserting the LNG-IUD Talk with the y Explain the insertion procedure (see next page). client before the y Show her the speculum, tenaculum, and the IUD procedure and inserter in the package. y Tell her that she will experience some discomfort or cramping during the procedure, and that this",
    "page_number": 228,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1744
  },
  {
    "id": "chunk_01745",
    "text": "rt or cramping during the procedure, and that this is to be expected. y Ask her to tell you any time that she feels discomfort or pain. y Ibuprofen (200\u2013400 mg), paracetamol (325\u2013 1,000 mg), or other pain reliever may be given 30 minutes before insertion to help reduce",
    "page_number": 228,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1745
  },
  {
    "id": "chunk_01746",
    "text": "e given 30 minutes before insertion to help reduce cramping and pain. Do not give aspirin, which slows blood clotting. Talk with the y Tell her what is happening, step by step, and client during the reassure her. procedure y Alert her before a step that may cause pain or might startle her.",
    "page_number": 228,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1746
  },
  {
    "id": "chunk_01747",
    "text": "e a step that may cause pain or might startle her. y Ask from time to time if she is feeling pain. Talk with the y Ask her how she is doing. client after the y Tell her that the procedure was successful and procedure that the IUD is in place. y Tell her that she can rest for a while and then",
    "page_number": 228,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1747
  },
  {
    "id": "chunk_01748",
    "text": "y Tell her that she can rest for a while and then slowly sit up before getting up and dressing. y Remind her that the two of you will be discussing next steps and follow-up. 206 Family Planning: A Global Handbook for Providers",
    "page_number": 228,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1748
  },
  {
    "id": "chunk_01749",
    "text": "11 207 eciveD eniretuartnI lertsegronoveL Explaining the Insertion Procedure A woman who has chosen the LNG-IUD needs to know what will happen during insertion. The following description can help explain the procedure to her. Learning LNG-IUD insertion requires training and practice under",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1749
  },
  {
    "id": "chunk_01750",
    "text": "IUD insertion requires training and practice under direct supervision. Therefore, this description is a summary and not detailed instructions. 1. The provider uses proper infection- prevention procedures. Speculum 2. The provider conducts a pelvic examination to determine the position",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1750
  },
  {
    "id": "chunk_01751",
    "text": "cts a pelvic examination to determine the position of the uterus and assess eligibility (see Screening Questions for Pelvic Examination Before IUD Insertion, p. 198). The provider first does the bimanual examination and then inserts a speculum into the vagina to inspect the cervix. Tenaculum",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1751
  },
  {
    "id": "chunk_01752",
    "text": "m into the vagina to inspect the cervix. Tenaculum 3. The provider cleans the cervix and vagina with appropriate antiseptic. Flashlight Sound 4. The provider slowly inserts the tenaculum through the speculum and closes the tenaculum just enough to gently hold the cervix and uterus steady.",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1752
  },
  {
    "id": "chunk_01753",
    "text": "nough to gently hold the cervix and uterus steady. 5. The provider slowly and gently passes Scissors the uterine sound through the cervix to measure the depth of the uterus. Forceps 6. The provider slowly and gently passes the inserter through the cervix, releases the LNG-IUD inside",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1753
  },
  {
    "id": "chunk_01754",
    "text": "er through the cervix, releases the LNG-IUD inside the uterine cavity, and removes the Bowl with Narrow cotton balls forceps inserter. 7. The provider cuts the strings on the IUD, leaving about 3 centimeters hanging out of the cervix.",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1754
  },
  {
    "id": "chunk_01755",
    "text": "ing about 3 centimeters hanging out of the cervix. 8. After the insertion, the woman rests. She remains on the examination table until she feels ready to get dressed. Providing the Levonorgestrel Intrauterine Device",
    "page_number": 229,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1755
  },
  {
    "id": "chunk_01756",
    "text": "Supporting New and Continuing Users Giving Specific Instructions Expect cramping y She can expect some cramping and pain for a and pain few days after insertion. y Suggest ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever as needed.",
    "page_number": 230,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1756
  },
  {
    "id": "chunk_01757",
    "text": "(325\u20131,000 mg), or other pain reliever as needed. y Also, she can expect some bleeding or spotting immediately after insertion. Length of y Discuss how to remember the date to return for pregnancy removal or replacement. protection y Give each woman the following information in",
    "page_number": 230,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1757
  },
  {
    "id": "chunk_01758",
    "text": "ion y Give each woman the following information in writing on a reminder card, like the one shown below, if possible, and explain: \u2013 The type of IUD she has \u2013 Date of IUD insertion \u2013 Month and year when IUD will need to be removed or replaced. \u2013 Where to go if she has problems or questions",
    "page_number": 230,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1758
  },
  {
    "id": "chunk_01759",
    "text": "ed. \u2013 Where to go if she has problems or questions about her IUD. Follow-up visit y A follow-up visit after her first monthly bleeding or 3 to 6 weeks after IUD insertion is recommended. No woman should be denied an IUD, however, because follow-up would be difficult or not possible.",
    "page_number": 230,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1759
  },
  {
    "id": "chunk_01760",
    "text": "11 209 eciveD eniretuartnI lertsegronoveL How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: y Support a woman\u2019s choice of the LNG-IUD",
    "page_number": 231,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1760
  },
  {
    "id": "chunk_01761",
    "text": "ner can: y Support a woman\u2019s choice of the LNG-IUD y Show understanding and support if she has side effects y Use condoms consistently in addition to the IUD if he has an STI/HIV or thinks he may be at risk of an STI/HIV y Help to remember when the IUD is due for removal",
    "page_number": 231,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1761
  },
  {
    "id": "chunk_01762",
    "text": "y Help to remember when the IUD is due for removal \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; or she has a major change in health status. Also if:",
    "page_number": 231,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1762
  },
  {
    "id": "chunk_01763",
    "text": "she has a major change in health status. Also if: y The IUD was expelled or she thinks it may have been expelled from her uterus. y She has symptoms of pelvic inflammatory disease (increasing or severe pain in the lower abdomen, pain during sex, unusual vaginal discharge, fever, chills,",
    "page_number": 231,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1763
  },
  {
    "id": "chunk_01764",
    "text": "ing sex, unusual vaginal discharge, fever, chills, nausea, and/or vomiting), especially in the first 20 days after insertion. y She thinks she might be pregnant. y She wants the IUD removed, whatever the reason. General health advice: Anyone who suddenly feels that something is seriously",
    "page_number": 231,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1764
  },
  {
    "id": "chunk_01765",
    "text": "one who suddenly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the nurse or doctor what method she is using.",
    "page_number": 231,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1765
  },
  {
    "id": "chunk_01766",
    "text": "Post-Insertion Follow-Up Visit (3 to 6 Weeks) 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss. 2. Ask especially if she is concerned about bleeding changes. Give her any",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1766
  },
  {
    "id": "chunk_01767",
    "text": "is concerned about bleeding changes. Give her any information or help that she needs (see Managing Any Problems, below). 3. Ask her if she has: y Increasing or severe abdominal pain or pain during sex or urination y Unusual vaginal discharge y Fever or chills y Signs or symptoms of pregnancy",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1767
  },
  {
    "id": "chunk_01768",
    "text": "y Fever or chills y Signs or symptoms of pregnancy y Felt the hard plastic of an IUD that has partially come out A routine pelvic examination at the follow-up visit is not required. It may be appropriate in some settings or for some clients, however. Conduct a pelvic",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1768
  },
  {
    "id": "chunk_01769",
    "text": "ngs or for some clients, however. Conduct a pelvic examination particularly if the client\u2019s answers lead you to suspect infection or that the IUD has partially or completely come out. Any Visit 1. Ask how the client is doing with the method and about bleeding changes.",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1769
  },
  {
    "id": "chunk_01770",
    "text": "doing with the method and about bleeding changes. 2. Ask a long-term client if she has had any new health problems. Address problems as appropriate. For new health problems that may require switching methods, see p. 216. 3. Ask a long-term client about major life changes that may affect her needs\u2014",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1770
  },
  {
    "id": "chunk_01771",
    "text": "bout major life changes that may affect her needs\u2014 particularly plans for having children and STI/HIV risk. Follow up as needed. 4. Remind her how much longer the IUD will protect her from pregnancy. Managing Any Problems Problems Reported As Side Effects or Complications",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1771
  },
  {
    "id": "chunk_01772",
    "text": "Problems Reported As Side Effects or Complications May or may not be due to the method. y Problems with side effects or complications affect women\u2019s satisfaction and use of IUDs. They deserve the provider\u2019s attention. If the client reports",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1772
  },
  {
    "id": "chunk_01773",
    "text": "ve the provider\u2019s attention. If the client reports any side effects or complications, listen to her concerns, give her advice and support, and, if appropriate, treat. Make sure she understands the advice and agrees. y Offer to help her choose another method\u2014now, if she wishes, or if",
    "page_number": 232,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1773
  },
  {
    "id": "chunk_01774",
    "text": "11 211 eciveD eniretuartnI lertsegronoveL Irregular bleeding or spotting (bleeding at unexpected times that bothers the client) y Reassure her that some women using LNG-IUDs experience irregular bleeding. It is not harmful and usually becomes less or stops after the first several months of use.",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1774
  },
  {
    "id": "chunk_01775",
    "text": "ss or stops after the first several months of use. y If irregular bleeding starts after several months of no bleeding, or you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, p. 216). No monthly bleeding",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1775
  },
  {
    "id": "chunk_01776",
    "text": "ed vaginal bleeding\u201d, p. 216). No monthly bleeding y Reassure her that many women eventually stop having monthly bleeding when using the LNG-IUD, and this is not harmful. There is no need to lose blood every month. It is similar to not having monthly bleeding during",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1776
  },
  {
    "id": "chunk_01777",
    "text": "t is similar to not having monthly bleeding during pregnancy. She is not pregnant or infertile. Blood is not building up inside her. (Some women are happy to be free from monthly bleeding.) y If monthly bleeding stops very soon after insertion of the LNG-IUD, assess",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1777
  },
  {
    "id": "chunk_01778",
    "text": "s very soon after insertion of the LNG-IUD, assess for pregnancy or other underlying condition. Heavier or prolonged bleeding (longer than 8 days) y Reassure her that some women using LNG-IUDs experience heavier or prolonged bleeding. It is generally not harmful and usually becomes less or",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1778
  },
  {
    "id": "chunk_01779",
    "text": "generally not harmful and usually becomes less or stops after the first several months of use. y Provide iron tablets if possible and tell her it is important for her to eat foods containing iron. y If heavier or prolonged bleeding continues or starts after several months of",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1779
  },
  {
    "id": "chunk_01780",
    "text": "eeding continues or starts after several months of no bleeding, or if you suspect that something may be wrong for other reasons, consider underlying conditions unrelated to method use (see \u201cUnexplained vaginal bleeding\u201d, p. 216). Cramping and pain",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1780
  },
  {
    "id": "chunk_01781",
    "text": "ined vaginal bleeding\u201d, p. 216). Cramping and pain y She can expect some cramping and pain for the first day or 2 after IUD insertion. \u2013 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. If she also has heavy or prolonged",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1781
  },
  {
    "id": "chunk_01782",
    "text": "pain reliever. If she also has heavy or prolonged bleeding, aspirin should not be used because it may increase bleeding. y If cramping continues beyond the first 2 days, evaluate for partial expulsion or perforation. Supporting New and Continuing Users",
    "page_number": 233,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1782
  },
  {
    "id": "chunk_01783",
    "text": "Acne y If the client wants to stop using the LNG-IUD because of acne, she can consider switching to COCs. Many women\u2019s acne improves with COC use. y Consider locally available remedies. Ordinary headaches (nonmigrainous) y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol",
    "page_number": 234,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1783
  },
  {
    "id": "chunk_01784",
    "text": "(325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. y Any headaches that get worse or occur more often during LNG-IUD use should be evaluated. Breast tenderness y Recommend that she wear a supportive bra (including during strenuous activity and sleep).",
    "page_number": 234,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1784
  },
  {
    "id": "chunk_01785",
    "text": "a (including during strenuous activity and sleep). y Try hot or cold compresses. y Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever. y Consider locally available remedies. Weight change y Review diet and counsel as needed. Nausea or dizziness",
    "page_number": 234,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1785
  },
  {
    "id": "chunk_01786",
    "text": "ew diet and counsel as needed. Nausea or dizziness y Consider locally available remedies. Mood changes y Clients who have serious mood changes such as major depression should be referred for care. y Consider locally available remedies. Partner can feel IUD strings during sex",
    "page_number": 234,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1786
  },
  {
    "id": "chunk_01787",
    "text": "remedies. Partner can feel IUD strings during sex y Explain that this happens sometimes when strings are cut too short. y If her partner finds the strings bothersome, describe and discuss this option: \u2013 Strings can be cut even shorter so they are not coming out of the",
    "page_number": 234,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1787
  },
  {
    "id": "chunk_01788",
    "text": "cut even shorter so they are not coming out of the cervical canal. Her partner will not feel the strings, but it will make the removal procedure somewhat more difficult (may require a specially trained provider). 212 Family Planning: A Global Handbook for Providers",
    "page_number": 234,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1788
  },
  {
    "id": "chunk_01789",
    "text": "11 213 eciveD eniretuartnI lertsegronoveL Severe pain in lower abdomen (suspected pelvic inflammatory disease [PID]) y Some common signs and symptoms of PID often also occur with other abdominal conditions, such as ectopic pregnancy. If ectopic pregnancy is ruled out, assess for PID.",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1789
  },
  {
    "id": "chunk_01790",
    "text": "If ectopic pregnancy is ruled out, assess for PID. y If possible, do abdominal and pelvic examinations (see Appendix B \u2013 Signs and Symptoms of Serious Health Conditions for signs from the pelvic examination that would indicate PID).",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1790
  },
  {
    "id": "chunk_01791",
    "text": "m the pelvic examination that would indicate PID). y If a pelvic examination is not possible, and she has a combination of the following signs and symptoms in addition to lower abdominal pain, suspect PID: \u2013 Unusual vaginal discharge \u2013 Fever or chills \u2013 Pain during sex or urination",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1791
  },
  {
    "id": "chunk_01792",
    "text": "e \u2013 Fever or chills \u2013 Pain during sex or urination \u2013 Bleeding after sex or between monthly bleeding \u2013 Nausea and vomiting \u2013 A tender pelvic mass \u2013 Pain when the abdomen is gently pressed (direct abdominal tenderness) or when gently pressed and then suddenly released (rebound abdominal tenderness)",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1792
  },
  {
    "id": "chunk_01793",
    "text": "n suddenly released (rebound abdominal tenderness) y Treat PID or immediately refer for treatment: \u2013 Because of the serious consequences of PID, health care providers should treat all suspected cases, based on the signs and symptoms above. Treatment should be started as soon as possible. Treatment is",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1793
  },
  {
    "id": "chunk_01794",
    "text": "hould be started as soon as possible. Treatment is more effective at preventing long-term complications when appropriate antibiotics are given immediately. \u2013 Treat for gonorrhea, chlamydia, and anaerobic bacterial infections. Counsel the client about prevention and treatment of STIs and about",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1794
  },
  {
    "id": "chunk_01795",
    "text": "t about prevention and treatment of STIs and about condom use. If possible, give her condoms. \u2013 There is no need to remove the IUD if she wants to continue using it. If she wants it removed, take it out after starting antibiotic treatment.",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1795
  },
  {
    "id": "chunk_01796",
    "text": ", take it out after starting antibiotic treatment. (If the IUD is removed, consider emergency contraceptive pills and discuss choosing another method. See Switching From the LNG-IUD to Another Method, p. 218.) y If the infection does not improve, consider removing the IUD while",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1796
  },
  {
    "id": "chunk_01797",
    "text": "does not improve, consider removing the IUD while continuing antibiotics. If the IUD is not removed, antibiotics should still be continued. In both cases the woman\u2019s health should be closely monitored. Supporting New and Continuing Users",
    "page_number": 235,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1797
  },
  {
    "id": "chunk_01798",
    "text": "Severe pain in lower abdomen (suspected ovarian cyst) y Abdominal pain may be due to various problems, such as enlarged ovarian follicles or cysts. \u2212 A woman can continue to use the LNG-IUD during evaluation and treatment. \u2212 There is no need to treat enlarged ovarian follicles or cysts unless they",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1798
  },
  {
    "id": "chunk_01799",
    "text": "at enlarged ovarian follicles or cysts unless they grow abnormally large, twist, or burst. Reassure the client that they usually disappear on their own. To be sure the problem is resolving, see the client again in 6 weeks, if possible. Severe pain in lower abdomen (suspected ectopic pregnancy)",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1799
  },
  {
    "id": "chunk_01800",
    "text": "ain in lower abdomen (suspected ectopic pregnancy) y Many conditions can cause severe abdominal pain. Be particularly alert for additional signs or symptoms of ectopic pregnancy, which is rare but can be life-threatening. The LNG-IUD reduces the risk of ectopic",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1800
  },
  {
    "id": "chunk_01801",
    "text": "reatening. The LNG-IUD reduces the risk of ectopic pregnancy, but it does not eliminate the risk altogether (see Question 10 in Chapter 10, p. 190). y In the early stages of ectopic pregnancy, symptoms may be absent or mild, but eventually they will become severe. A combination of these signs or",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1801
  },
  {
    "id": "chunk_01802",
    "text": "ill become severe. A combination of these signs or symptoms should increase suspicion of ectopic pregnancy: \u2212 Unusual abdominal pain or tenderness \u2212 Abnormal vaginal bleeding or no monthly bleeding\u2014especially if this is a change from her current bleeding pattern \u2212 Light-headedness or dizziness",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1802
  },
  {
    "id": "chunk_01803",
    "text": "t bleeding pattern \u2212 Light-headedness or dizziness \u2212 Fainting y If ectopic pregnancy or other serious health condition is suspected, refer at once for immediate diagnosis and care. (See Managing Ectopic Pregnancy, p. 237, in Chapter 12 \u2013 Female Sterilization, for more on ectopic pregnancies.)",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1803
  },
  {
    "id": "chunk_01804",
    "text": "e Sterilization, for more on ectopic pregnancies.) y If the client does not have these additional symptoms or signs, assess for pelvic inflammatory disease (see Severe pain in lower abdomen, previous page). Suspected uterine puncturing (perforation)",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1804
  },
  {
    "id": "chunk_01805",
    "text": "page). Suspected uterine puncturing (perforation) y If puncturing is suspected at the time of insertion or sounding of the uterus, stop the procedure immediately (and remove the IUD if inserted). Observe the client in the clinic carefully:",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1805
  },
  {
    "id": "chunk_01806",
    "text": "rted). Observe the client in the clinic carefully: \u2013 For the first hour, keep the woman at bed rest and check her vital signs (blood pressure, pulse, respiration, and temperature) every 5 to 10 minutes. \u2013 If the woman remains stable after one hour, check for signs of intra-",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1806
  },
  {
    "id": "chunk_01807",
    "text": "s stable after one hour, check for signs of intra- abdominal bleeding, such as low hematocrit or hemoglobin or rebound 214 Family Planning: A Global Handbook for Providers",
    "page_number": 236,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1807
  },
  {
    "id": "chunk_01808",
    "text": "11 215 eciveD eniretuartnI lertsegronoveL on abdominal examination, if possible, and her vital signs. Observe for several more hours. If she has no signs or symptoms, she can be sent home, but she should avoid sex for 2 weeks. Help her choose another method.",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1808
  },
  {
    "id": "chunk_01809",
    "text": "d sex for 2 weeks. Help her choose another method. \u2013 If she has a rapid pulse and falling blood pressure, or new pain or increasing pain around the uterus, refer her to a higher level of care. \u2013 If uterine perforation is suspected, based on clinical symptoms, within",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1809
  },
  {
    "id": "chunk_01810",
    "text": "n is suspected, based on clinical symptoms, within 6 weeks or more after insertion, refer the client for evaluation to a clinician experienced at removing such IUDs (see Question 6 in Chapter 10, p. 189). IUD partially comes out (partial expulsion)",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1810
  },
  {
    "id": "chunk_01811",
    "text": "189). IUD partially comes out (partial expulsion) y If the IUD partially comes out, remove the IUD. Discuss with the client whether she wants another IUD or a different method. If she wants another IUD, she can have one inserted immediately if it is reasonably",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1811
  },
  {
    "id": "chunk_01812",
    "text": "have one inserted immediately if it is reasonably certain she is not pregnant. If the client does not want to continue using an IUD, help her choose another method. IUD completely comes out (complete expulsion) y If the client reports that the IUD came out, discuss with her whether she",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1812
  },
  {
    "id": "chunk_01813",
    "text": "hat the IUD came out, discuss with her whether she wants another IUD or a different method. If she wants another IUD, she can have one inserted at any time if it is reasonably certain she is not pregnant. y If complete expulsion is suspected (for example, if strings are not found",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1813
  },
  {
    "id": "chunk_01814",
    "text": "s suspected (for example, if strings are not found on pelvic exam) and the client does not know whether the IUD came out, refer for ultrasound (or x-ray, if pregnancy can be ruled out) to assess whether the IUD might have moved to the abdominal cavity. Give her a backup method to use in the meantime.",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1814
  },
  {
    "id": "chunk_01815",
    "text": ". Give her a backup method to use in the meantime. Missing strings (suggesting possible pregnancy, uterine perforation, or expulsion) y Ask the client: \u2013 Whether and when she saw the IUD come out \u2013 When she had her last monthly bleeding \u2013 If she has any symptoms of pregnancy",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1815
  },
  {
    "id": "chunk_01816",
    "text": "ly bleeding \u2013 If she has any symptoms of pregnancy \u2013 If she has used a backup method since she noticed that the IUD came out y Always start with minor and safe procedures and be gentle. Check for the strings in the folds of the cervical canal with forceps. About half of missing",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1816
  },
  {
    "id": "chunk_01817",
    "text": "cervical canal with forceps. About half of missing IUD strings can be found in the cervical canal. y If strings cannot be located in the cervical canal, either they have gone up into the uterus or the IUD has been expelled unnoticed. Refer for",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1817
  },
  {
    "id": "chunk_01818",
    "text": "or the IUD has been expelled unnoticed. Refer for ultrasound (or x-ray, if pregnancy can be ruled out). Give her a backup method to use in the meantime, in case the IUD came out. Supporting New and Continuing Users",
    "page_number": 237,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1818
  },
  {
    "id": "chunk_01819",
    "text": "New Problems That May Require Switching Methods May or may not be due to the method. Unexplained vaginal bleeding (that suggests a medical condition not related to the method) y Refer or evaluate by history or pelvic examination. Diagnose and treat as appropriate.",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1819
  },
  {
    "id": "chunk_01820",
    "text": "ic examination. Diagnose and treat as appropriate. y She can continue using the IUD while her condition is being evaluated. y If bleeding is caused by sexually transmitted infection or pelvic inflammatory disease, she can continue using the IUD during treatment.",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1820
  },
  {
    "id": "chunk_01821",
    "text": ", she can continue using the IUD during treatment. Heart disease due to blocked or narrowed arteries (ischemic heart disease) y A woman who has this condition can safely start the LNG-IUD. If, however, the condition develops while she is using the LNG-IUD: \u2212 Remove the IUD or refer for removal.",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1821
  },
  {
    "id": "chunk_01822",
    "text": "he LNG-IUD: \u2212 Remove the IUD or refer for removal. \u2212 Help her choose a method without hormones. \u2212 Refer for diagnosis and care if not already under care. Migraine headaches (see Identifying Migraine Headaches and Auras, pp. 458\u2013460)",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1822
  },
  {
    "id": "chunk_01823",
    "text": "tifying Migraine Headaches and Auras, pp. 458\u2013460) y If she has migraine headaches without aura, she can continue to use the LNG-IUD if she wishes. y If she develops migraine with aura, remove the LNG-IUD. Help her choose a method without hormones.",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1823
  },
  {
    "id": "chunk_01824",
    "text": "NG-IUD. Help her choose a method without hormones. Certain serious health conditions (blood clots in deep veins of legs or lungs, breast cancer, gestational trophoblast disease, or pelvic tuberculosis). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions.",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1824
  },
  {
    "id": "chunk_01825",
    "text": "\u2013 Signs and Symptoms of Serious Health Conditions. y Remove the IUD or refer for removal. y Give her a backup method to use until the condition is evaluated. y Refer for diagnosis and care if not already under care. Suspected pregnancy y Assess for pregnancy, including ectopic pregnancy.",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1825
  },
  {
    "id": "chunk_01826",
    "text": "Assess for pregnancy, including ectopic pregnancy. y Explain that exposure of the fetus to an LNG-IUD does not increase the risk of birth defects. However, an IUD in the uterus during pregnancy increases the risk of preterm delivery or miscarriage, including infected",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1826
  },
  {
    "id": "chunk_01827",
    "text": "reterm delivery or miscarriage, including infected (septic) miscarriage during the first or second trimester, which can be life-threatening. 216 Family Planning: A Global Handbook for Providers",
    "page_number": 238,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1827
  },
  {
    "id": "chunk_01828",
    "text": "11 217 eciveD eniretuartnI lertsegronoveL y If the woman does not want to continue the pregnancy, counsel her according to program guidelines. y If she continues the pregnancy: \u2013 Advise her that it is best to remove the IUD. \u2013 Explain the risks of pregnancy with an IUD in place. Early removal",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1828
  },
  {
    "id": "chunk_01829",
    "text": "s of pregnancy with an IUD in place. Early removal of the IUD reduces these risks, although the removal procedure itself involves a small risk of miscarriage. \u2013 If she agrees to removal, gently remove the IUD or refer for removal. \u2013 Explain that she should return at once if she develops any signs of",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1829
  },
  {
    "id": "chunk_01830",
    "text": "should return at once if she develops any signs of miscarriage or septic miscarriage (vaginal bleeding, cramping, pain, abnormal vaginal discharge, or fever). \u2013 If she chooses to keep the IUD, a nurse or doctor should follow her pregnancy closely. She should see a nurse or doctor at once if",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1830
  },
  {
    "id": "chunk_01831",
    "text": "osely. She should see a nurse or doctor at once if she develops any signs of septic miscarriage. y If the IUD strings are not visible and cannot be found in the cervical canal, the IUD cannot be safely retrieved. Refer for ultrasound, if",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1831
  },
  {
    "id": "chunk_01832",
    "text": "nnot be safely retrieved. Refer for ultrasound, if possible, to determine whether the IUD is still in the uterus. If it is, or if ultrasound is not available, her pregnancy should be followed closely. She should seek care at once if she develops any signs of septic miscarriage. Removing the",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1832
  },
  {
    "id": "chunk_01833",
    "text": "lops any signs of septic miscarriage. Removing the Intrauterine Device IMPORTANT: Providers must not refuse or delay when a woman asks to have her IUD removed, whatever her reason, whether it is personal or medical. All staff must understand and agree that she must not be",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1833
  },
  {
    "id": "chunk_01834",
    "text": "aff must understand and agree that she must not be pressured or forced to continue using the IUD. If a woman is finding side effects difficult to tolerate, first discuss the problems she is having (see Managing Any Problems, p. 210). Ask if",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1834
  },
  {
    "id": "chunk_01835",
    "text": "having (see Managing Any Problems, p. 210). Ask if she would rather try to manage the problem or to have the IUD removed immediately. Removing an IUD is usually simple. It can be done any time of the month. Removal may be easier during monthly bleeding, when the cervix is",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1835
  },
  {
    "id": "chunk_01836",
    "text": "easier during monthly bleeding, when the cervix is naturally softened. In cases of uterine perforation or if removal is not easy (for example, when IUD strings are missing), refer the woman to an experienced clinician who can use an appropriate removal technique. Removing the IUD",
    "page_number": 239,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1836
  },
  {
    "id": "chunk_01837",
    "text": "Explaining the Removal Procedure Before removing the IUD, explain to the client what will happen during removal: 1. The provider inserts a speculum to see the cervix and IUD strings and carefully cleans the cervix and vagina with an antiseptic solution, such as iodine.",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1837
  },
  {
    "id": "chunk_01838",
    "text": "agina with an antiseptic solution, such as iodine. 2. The provider asks the woman to take slow, deep breaths and to relax. The woman should say if she feels pain during the procedure. 3. Using narrow forceps, the provider pulls the IUD strings slowly and",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1838
  },
  {
    "id": "chunk_01839",
    "text": "eps, the provider pulls the IUD strings slowly and gently until the IUD comes completely out of the cervix. Switching From the LNG-IUD to Another Method These guidelines ensure that the client is protected from pregnancy without interruption when switching from the LNG-IUD to another method. See also",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1839
  },
  {
    "id": "chunk_01840",
    "text": "ching from the LNG-IUD to another method. See also When to Start for each method. Switching to When to start Hormonal y If starting during the first 7 days of monthly methods: bleeding (first 5 days for COCs and POPs), start combined oral the hormonal method now and remove the IUD.",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1840
  },
  {
    "id": "chunk_01841",
    "text": "d oral the hormonal method now and remove the IUD. contraceptives No need for a backup method. (COCs), progestin- y If starting after the first 7 days of monthly only pills (POPs), bleeding (after the first 5 days for COCs and progestin-only POPs) and she has had sex since her last monthly",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1841
  },
  {
    "id": "chunk_01842",
    "text": "y POPs) and she has had sex since her last monthly injectables, bleeding, start the hormonal method now. It is monthly recommended that the IUD stay in place until injectables, her next monthly bleeding. combined patch, combined vaginal y If starting after the first 7 days of monthly",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1842
  },
  {
    "id": "chunk_01843",
    "text": "al y If starting after the first 7 days of monthly ring, or implants bleeding (after the first 5 days for COCs and POPs) and she has not had sex since her last monthly bleeding, the IUD can stay in place and be removed during her next monthly bleeding, or the IUD can be removed and she can use",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1843
  },
  {
    "id": "chunk_01844",
    "text": "leeding, or the IUD can be removed and she can use a backup method* for the next 7 days (2 days for POPs). (Continued on next page) * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive",
    "page_number": 240,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1844
  },
  {
    "id": "chunk_01845",
    "text": "11 219 eciveD eniretuartnI lertsegronoveL Switching to When to start (continued) Male or female y The next time she has sex after the IUD is condoms, removed. spermicides, diaphragms, cervical caps, or withdrawal Fertility awareness y In the cycle that the IUD is removed. methods",
    "page_number": 241,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1845
  },
  {
    "id": "chunk_01846",
    "text": "ss y In the cycle that the IUD is removed. methods Female y If during the first 7 days of monthly bleeding, sterilization remove the IUD and perform the female sterilization procedure. No need for a backup method. y If after the first 7 days of monthly bleeding,",
    "page_number": 241,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1846
  },
  {
    "id": "chunk_01847",
    "text": ". y If after the first 7 days of monthly bleeding, perform the sterilization procedure. Ideally, the IUD should stay in place until her follow-up visit or her next monthly bleeding. If a follow-up visit is not possible, remove the IUD at the time of sterilization. No need for a backup method.",
    "page_number": 241,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1847
  },
  {
    "id": "chunk_01848",
    "text": "ime of sterilization. No need for a backup method. Vasectomy y Any time y The woman can keep the IUD until a test of her partner\u2019s semen shows that the vasectomy is working, or for 3 months, when the vasectomy will be fully effective. Removing the IUD",
    "page_number": 241,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1848
  },
  {
    "id": "chunk_01849",
    "text": "Questions and Answers About the LNG-IUD See also Questions and Answers About the Copper-Bearing IUD in Chapter 10, pp. 188\u2013190. 1. How is the LNG-IUD different from the copper-bearing IUD? The LNG-IUD and the copper-bearing IUD are very similar, but they",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1849
  },
  {
    "id": "chunk_01850",
    "text": "the copper-bearing IUD are very similar, but they have important differences. Both the LNG-IUD and the copper-bearing IUD are very effective, but the LNG-IUD is slightly more effective. The LNG-IUD has different side effects from those of the copper-bearing",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1850
  },
  {
    "id": "chunk_01851",
    "text": "rent side effects from those of the copper-bearing IUD. LNG-IUD users usually experience lighter bleeding (regular or irregular) or no bleeding at all, while copper-bearing IUD users usually have regular but sometimes heavier or longer bleeding. In addition,",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1851
  },
  {
    "id": "chunk_01852",
    "text": "sometimes heavier or longer bleeding. In addition, LNG-IUD users may experience hormonal side effects (for example, headaches), which are not side effects of copper-bearing IUDs. The duration of use is shorter\u20143 or 5 years for the LNG-IUD, depending on",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1852
  },
  {
    "id": "chunk_01853",
    "text": "shorter\u20143 or 5 years for the LNG-IUD, depending on brand, versus 12 years for the copper-bearing IUD. Also, the LNG-IUD costs more than the copper-bearing IUD. (See the job aid, Comparing IUDs, p. 452.) 2. How is the LNG-IUD different from other hormonal methods?",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1853
  },
  {
    "id": "chunk_01854",
    "text": "the LNG-IUD different from other hormonal methods? The LNG-IUD continuously releases a small amount of hormone into the uterus. Because the hormone is released directly into the uterus, the amount in the bloodstream is lower than with other hormonal",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1854
  },
  {
    "id": "chunk_01855",
    "text": "the bloodstream is lower than with other hormonal methods. Thus, women experience fewer side effects. The LNG-IUD requires no action by the woman once it is inserted, unlike pills that a woman must take every day or injections that a woman must have every",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1855
  },
  {
    "id": "chunk_01856",
    "text": "ery day or injections that a woman must have every 1 to 3 months. The LNG-IUD must be inserted into the uterus, while most other hormonal methods come in the form of pills, injections, or implants under the skin. 3. What are the other benefits of the LNG-IUD, besides contraception?",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1856
  },
  {
    "id": "chunk_01857",
    "text": "er benefits of the LNG-IUD, besides contraception? The LNG-IUD is an effective treatment for heavy monthly blood loss. It is the most effective nonsurgical approach for this condition. Also, the LNG-IUD decreases bleeding for women with fibroids. Reduced blood",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1857
  },
  {
    "id": "chunk_01858",
    "text": "es bleeding for women with fibroids. Reduced blood loss can help women with anemia as well. Additionally, the LNG-IUD may help to treat endometriosis, endometrial hyperplasia, endometrial cancer, and perimenopausal menstrual disturbances. 220 Family Planning: A Global Handbook for Providers",
    "page_number": 242,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1858
  },
  {
    "id": "chunk_01859",
    "text": "12 221 noitaziliretS elameF CHAPTER 12 Female Sterilization Key Points for Providers and Clients \u2022 Permanent. Intended to provide life-long, permanent, and very effective protection against pregnancy. Reversal is usually not possible. \u2022 Involves a physical examination and surgery. The",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1859
  },
  {
    "id": "chunk_01860",
    "text": "\u2022 Involves a physical examination and surgery. The procedure is done by a specifically trained provider. \u2022 No long-term side effects. What Is Female Sterilization? \u2022 Permanent surgical contraception for women who will not want more children. \u2022 The 2 surgical approaches most often used:",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1860
  },
  {
    "id": "chunk_01861",
    "text": "dren. \u2022 The 2 surgical approaches most often used: \u2212 Minilaparotomy involves making a small incision in the abdomen. The fallopian tubes are brought to the incision to be cut or blocked. \u2212 Laparoscopy involves inserting a long, thin tube containing lenses into",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1861
  },
  {
    "id": "chunk_01862",
    "text": "inserting a long, thin tube containing lenses into the abdomen through a small incision. This laparoscope enables the doctor to reach and block or cut the fallopian tubes in the abdomen. \u2022 Also called tubal sterilization, tubal ligation, voluntary surgical",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1862
  },
  {
    "id": "chunk_01863",
    "text": "sterilization, tubal ligation, voluntary surgical contraception, tubectomy, bi-tubal ligation, tying the tubes, minilap, and \u201cthe operation.\u201d \u2022 Works because the fallopian tubes are blocked or cut. More Eggs released from the ovaries cannot move down the effective",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1863
  },
  {
    "id": "chunk_01864",
    "text": "ed from the ovaries cannot move down the effective tubes, and so they do not meet sperm. How Effective? One of the most effective contraceptive methods but carries a small risk of failure: \u2022 Less than 1 pregnancy per 100 women over the first year after",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1864
  },
  {
    "id": "chunk_01865",
    "text": "pregnancy per 100 women over the first year after having the sterilization procedure (5 per 1,000). This means that 995 of every 1,000 women relying on female sterilization will not Less become pregnant. effective Female Sterilization",
    "page_number": 243,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1865
  },
  {
    "id": "chunk_01866",
    "text": "\u2022 A small risk of pregnancy remains beyond the first year after the procedure and until the woman reaches menopause. \u2013 Over 10 years of use: About 2 pregnancies per 100 women (18 to 19 per 1,000 women). \u2022 Effectiveness varies slightly depending on how the",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1866
  },
  {
    "id": "chunk_01867",
    "text": "Effectiveness varies slightly depending on how the tubes are blocked, but pregnancy rates are low with all techniques. One of the most effective techniques is cutting and tying the cut ends of the fallopian tubes after childbirth (postpartum female sterilization).",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1867
  },
  {
    "id": "chunk_01868",
    "text": "fter childbirth (postpartum female sterilization). Fertility does not return because sterilization generally cannot be reversed. The procedure is intended to be permanent. Reversal surgery is difficult, expensive, and not available in most areas. When performed, reversal surgery often does",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1868
  },
  {
    "id": "chunk_01869",
    "text": "areas. When performed, reversal surgery often does not lead to pregnancy (see Question 7, p. 239). Protection against sexually transmitted infections (STIs): None Side Effects, Health Benefits, Health Risks, and Complications Side Effects None Known Health Benefits Known Health Risks",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1869
  },
  {
    "id": "chunk_01870",
    "text": "ects None Known Health Benefits Known Health Risks Helps protect against: Uncommon to extremely rare: \u2022 Risks of pregnancy \u2022 Complications of surgery \u2022 Pelvic inflammatory disease (PID) and anesthesia (see below) May help protect against: \u2022 Ovarian cancer Reduces: \u2022 Risk of ectopic pregnancy",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1870
  },
  {
    "id": "chunk_01871",
    "text": "varian cancer Reduces: \u2022 Risk of ectopic pregnancy Complications of Surgery (see also Managing Any Problems, p. 236) Uncommon to extremely rare: \u2022 Female sterilization is a safe method of contraception. It requires surgery and",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1871
  },
  {
    "id": "chunk_01872",
    "text": "e method of contraception. It requires surgery and anesthesia, however. Like other minor surgeries, female sterilization carries some risks, such as infection or abscess of the wound. Serious complications are uncommon. Death, due to the procedure or anesthesia, is extremely rare.",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1872
  },
  {
    "id": "chunk_01873",
    "text": "to the procedure or anesthesia, is extremely rare. \u2022 The risk of complications with local anesthesia, with or without sedation and analgesia, is significantly lower than with general anesthesia. Complications can be kept to a minimum if appropriate techniques are used and if the",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1873
  },
  {
    "id": "chunk_01874",
    "text": "imum if appropriate techniques are used and if the procedure is performed in an appropriate setting by a skilled provider. 222 Family Planning: A Global Handbook for Providers",
    "page_number": 244,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1874
  },
  {
    "id": "chunk_01875",
    "text": "12 223 noitaziliretS elameF Correcting Misunderstandings (see also Questions and Answers, p. 238) Female sterilization: \u2022 Does not make women weak. \u2022 Does not cause lasting pain in back, uterus, or abdomen. \u2022 Does not remove a woman\u2019s uterus or lead to a need to have it removed.",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1875
  },
  {
    "id": "chunk_01876",
    "text": "man\u2019s uterus or lead to a need to have it removed. \u2022 Does not cause hormonal imbalances. \u2022 Does not cause heavier bleeding or irregular bleeding or otherwise change women\u2019s menstrual cycles. \u2022 Does not cause any changes in weight, appetite, or appearance.",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1876
  },
  {
    "id": "chunk_01877",
    "text": "se any changes in weight, appetite, or appearance. \u2022 Does not change women\u2019s sexual behavior or sex drive. \u2022 Does not cause ectopic pregnancy. Instead, it substantially reduces the risk of ectopic pregnancy (see Question 11, page 240). Why Some Women Say They Like Female Sterilization",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1877
  },
  {
    "id": "chunk_01878",
    "text": "Why Some Women Say They Like Female Sterilization \u2022 Has no side effects \u2022 No need to worry about getting pregnant or about contraception again \u2022 Nothing to do or remember after the procedure Who Can Have Female Sterilization Safe for All Women",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1878
  },
  {
    "id": "chunk_01879",
    "text": "o Can Have Female Sterilization Safe for All Women With proper counseling and informed consent, any woman can have female sterilization safely, including women who: \u2022 Have no children or few children \u2022 Are married or are not married \u2022 Do not have husband\u2019s permission \u2022 Are young",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1879
  },
  {
    "id": "chunk_01880",
    "text": "ied \u2022 Do not have husband\u2019s permission \u2022 Are young \u2022 Just gave birth (within the last 7 days) \u2022 Are breastfeeding \u2022 Are living with HIV, whether or not on antiretroviral therapy (see Female Sterilization for Women With HIV, p. 227)",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1880
  },
  {
    "id": "chunk_01881",
    "text": "e Female Sterilization for Women With HIV, p. 227) In some of these situations, especially careful counseling is important to make sure the woman will not regret her decision (see Because Sterilization Is Permanent, p. 230). Who Can Have Female Sterilization",
    "page_number": 245,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1881
  },
  {
    "id": "chunk_01882",
    "text": "Avoid Unnecessary Procedures (See Importance of Selected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396) Women can have female sterilization: \u2022 Without any blood tests or routine laboratory tests \u2022 Without cervical cancer screening",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1882
  },
  {
    "id": "chunk_01883",
    "text": "boratory tests \u2022 Without cervical cancer screening \u2022 Without a pregnancy test. A woman can have female sterilization even when she is not having monthly bleeding at the time, if it is reasonably certain she is not pregnant (see Pregnancy Checklist, inside back cover).",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1883
  },
  {
    "id": "chunk_01884",
    "text": "nant (see Pregnancy Checklist, inside back cover). For female sterilization a pelvic examination and blood pressure screening are essential. When available, a hemoglobin test can contribute to safe and effective use. (See The Importance of Clinical Assessment, p. 228.)",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1884
  },
  {
    "id": "chunk_01885",
    "text": "ee The Importance of Clinical Assessment, p. 228.) Medical Eligibility Criteria for Female Sterilization All women can have female sterilization. No medical conditions prevent a woman from using female sterilization. This checklist asks the",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1885
  },
  {
    "id": "chunk_01886",
    "text": "sing female sterilization. This checklist asks the client about known medical conditions that may limit when, where, or how the female sterilization procedure should be performed. Ask the client the questions below. If she answers \u201cno\u201d to all of the questions,",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1886
  },
  {
    "id": "chunk_01887",
    "text": "elow. If she answers \u201cno\u201d to all of the questions, then the female sterilization procedure can be performed in a routine setting without delay. If she answers \u201cyes\u201d to a question, follow the instructions, which recommend caution, delay, or special arrangements. In the checklist below:",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1887
  },
  {
    "id": "chunk_01888",
    "text": ", or special arrangements. In the checklist below: \u2022 Caution means the procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition. \u2022 Delay means postpone female sterilization. These conditions must",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1888
  },
  {
    "id": "chunk_01889",
    "text": "stpone female sterilization. These conditions must be treated and resolved before female sterilization can be performed. Help the client choose another method to use until the procedure can be performed. \u2022 Special means special arrangements should be made to perform",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1889
  },
  {
    "id": "chunk_01890",
    "text": "ans special arrangements should be made to perform the procedure in a setting with an experienced surgeon and staff, equipment to provide general anesthesia, and other backup medical support. For these conditions, the capacity to decide on the most",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1890
  },
  {
    "id": "chunk_01891",
    "text": "ese conditions, the capacity to decide on the most appropriate procedure and anesthesia regimen also is needed. Help the client choose another method to use until the procedure can be performed. 224 Family Planning: A Global Handbook for Providers",
    "page_number": 246,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1891
  },
  {
    "id": "chunk_01892",
    "text": "12 225 noitaziliretS elameF 1. Do you have or have you ever had any female conditions or problems, such as infection or cancer? If so, what problems? \u274f NO \u274f YES If she has any of the following, use caution: \u2022 Previous abdominal or pelvic surgery \u2022 Past pelvic inflammatory disease since last pregnancy",
    "page_number": 247,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1892
  },
  {
    "id": "chunk_01893",
    "text": "t pelvic inflammatory disease since last pregnancy \u2022 Uterine fibroids \u2022 Breast cancer u If she has any of the following, delay female sterilization: Related to pregnancy \u2022 Current pregnancy \u2022 7\u201342 days postpartum \u2022 Postpartum after a pregnancy with severe pre-eclampsia or eclampsia",
    "page_number": 247,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1893
  },
  {
    "id": "chunk_01894",
    "text": "a pregnancy with severe pre-eclampsia or eclampsia \u2022 Serious postpartum or postabortion complications (such as infection, hemorrhage, or trauma) except uterine rupture or perforation (special; see below) \u2022 Hematometra (a large collection of blood in the uterus) Unrelated to pregnancy",
    "page_number": 247,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1894
  },
  {
    "id": "chunk_01895",
    "text": "ion of blood in the uterus) Unrelated to pregnancy \u2022 Unexplained vaginal bleeding that suggests an underlying medical condition \u2022 Purulent cervicitis, chlamydia, or gonorrhea \u2022 Pelvic inflammatory disease \u2022 Pelvic cancers (treatment may make her sterile in any case) \u2022 Malignant trophoblast disease",
    "page_number": 247,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1895
  },
  {
    "id": "chunk_01896",
    "text": "erile in any case) \u2022 Malignant trophoblast disease u If she has any of the following, make special arrangements: \u2022 Fixed uterus due to previous surgery or infection \u2022 Endometriosis \u2022 Hernia (abdominal wall or umbilical) \u2022 Postpartum or postabortion uterine rupture or perforation",
    "page_number": 247,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1896
  },
  {
    "id": "chunk_01897",
    "text": "Medical Eligibility Criteria for Female Sterilization (continued) 2. Do you have any heart problems, stroke, high blood pressure, diabetes, or complications of diabetes? If so, what? \u274f NO \u274f YES If she has any of the following, use caution: \u2022 Controlled high blood pressure",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1897
  },
  {
    "id": "chunk_01898",
    "text": "ing, use caution: \u2022 Controlled high blood pressure \u2022 Mild high blood pressure (140/90 to 159/99 mm Hg) \u2022 Past stroke or heart disease without complications \u2022 Diabetes without damage to arteries, vision, kidneys, or nervous system u If she has any of the following, delay female sterilization:",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1898
  },
  {
    "id": "chunk_01899",
    "text": "any of the following, delay female sterilization: \u2022 Heart disease due to blocked or narrowed arteries \u2022 Blood clots in deep veins of legs or lungs u If she has any of the following, make special arrangements: \u2022 Several conditions together that increase chances of heart",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1899
  },
  {
    "id": "chunk_01900",
    "text": "conditions together that increase chances of heart disease or stroke, such as older age, smoking, high blood pressure, or diabetes \u2022 Moderately high or severely high blood pressure (160/100 mm Hg or higher) \u2022 Diabetes for more than 20 years or damage to arteries,",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1900
  },
  {
    "id": "chunk_01901",
    "text": "etes for more than 20 years or damage to arteries, vision, kidneys, or nervous system caused by diabetes \u2022 Complicated valvular heart disease 3. Do you have any lingering, long-term diseases or any other conditions? If so, what? \u274f NO \u274f YES If she has any of the following, use caution:",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1901
  },
  {
    "id": "chunk_01902",
    "text": "YES If she has any of the following, use caution: \u2022 Moderate iron-deficiency anemia (hemoglobin 7\u201310 g/dl) \u2022 Severe lack of nutrition (Is she extremely thin?) \u2022 Sickle cell disease \u2022 Inherited anemia (thalassemia) \u2022 Diaphragmatic hernia \u2022 Epilepsy \u2022 Hypothyroidism",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1902
  },
  {
    "id": "chunk_01903",
    "text": "\u2022 Diaphragmatic hernia \u2022 Epilepsy \u2022 Hypothyroidism \u2022 Mild cirrhosis of the liver, liver tumors, or schistosomiasis with liver fibrosis \u2022 Kidney disease 226 Family Planning: A Global Handbook for Providers",
    "page_number": 248,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1903
  },
  {
    "id": "chunk_01904",
    "text": "12 227 noitaziliretS elameF \u2022 Obesity (Is she extremely overweight?) \u2022 Elective abdominal surgery at time sterilization is desired \u2022 Depression \u2022 Young age \u2022 Uncomplicated lupus with negative antiphospholipid antibodies u If she has any of the following, delay female sterilization:",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1904
  },
  {
    "id": "chunk_01905",
    "text": "any of the following, delay female sterilization: \u2022 Gallbladder disease with symptoms \u2022 Active viral hepatitis \u2022 Severe iron-deficiency anemia (hemoglobin less than 7 g/dl) \u2022 Lung disease (bronchitis or pneumonia) \u2022 Systemic infection or significant gastroenteritis \u2022 Abdominal skin infection",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1905
  },
  {
    "id": "chunk_01906",
    "text": "ificant gastroenteritis \u2022 Abdominal skin infection \u2022 Undergoing abdominal surgery for emergency or infection, or major surgery with prolonged immobilization u If she has any of the following, make special arrangements: \u2022 Severe cirrhosis of the liver \u2022 Hyperthyroidism",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1906
  },
  {
    "id": "chunk_01907",
    "text": "\u2022 Severe cirrhosis of the liver \u2022 Hyperthyroidism \u2022 Coagulation disorders (blood does not clot) \u2022 Chronic lung disease (asthma, bronchitis, emphysema, lung infection) \u2022 Pelvic tuberculosis \u2022 HIV with advanced or severe clinical disease (see Female Sterilization for Women With HIV, below)",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1907
  },
  {
    "id": "chunk_01908",
    "text": "ee Female Sterilization for Women With HIV, below) \u2022 Lupus with positive (or unknown) antiphospholipid antibodies, with severe thrombocytopenia, or on immunosuppressive treatment Female Sterilization for Women With HIV \u2022 Women who are living with HIV or are on antiretroviral therapy",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1908
  },
  {
    "id": "chunk_01909",
    "text": "e living with HIV or are on antiretroviral therapy (ART) can safely undergo female sterilization. Special arrangements are needed to perform female sterilization on a woman with advanced or severe clinical disease. The procedure may need to be delayed if she has an HIV-related illness.",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1909
  },
  {
    "id": "chunk_01910",
    "text": "d to be delayed if she has an HIV-related illness. \u2022 Urge these women to use condoms in addition to female sterilization. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. \u2022 No one should be coerced or pressured into having female sterilization, and",
    "page_number": 249,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1910
  },
  {
    "id": "chunk_01911",
    "text": "The Importance of Clinical Assessment Because female sterilization involves a surgical procedure and the administration of local anesthesia (with or without mild sedation and analgesia), the client must undergo a careful, comprehensive yet focused",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1911
  },
  {
    "id": "chunk_01912",
    "text": "must undergo a careful, comprehensive yet focused clinical assessment. This assessment is important in every case, but it is even more important when the procedure is performed in hard-to-reach areas, in an outreach service, or in facilities far from supporting higher-level health services.",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1912
  },
  {
    "id": "chunk_01913",
    "text": "far from supporting higher-level health services. The assessment must include review of the Medical Eligibility Criteria (pp. 224\u2013227) and a pelvic/genital examination. See Importance of Selected Procedures for Providing Family Planning Methods in Chapter 26, p. 396. Providing Female Sterilization",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1913
  },
  {
    "id": "chunk_01914",
    "text": "Chapter 26, p. 396. Providing Female Sterilization When to Perform the Procedure IMPORTANT: If there is no medical reason to delay, a woman can have the female sterilization procedure any time she wants if it is reasonably certain",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1914
  },
  {
    "id": "chunk_01915",
    "text": "ure any time she wants if it is reasonably certain she is not pregnant and there are no medical conditions that limit when, where, or how the female sterilization procedure should be performed. To be reasonably certain she is not pregnant, use the Pregnancy Checklist (see inside back cover).",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1915
  },
  {
    "id": "chunk_01916",
    "text": "e the Pregnancy Checklist (see inside back cover). Woman\u2019s situation When to perform Having menstrual Any time of the month cycles or \u2022 Any time within 7 days after the start of her switching from monthly bleeding. No need to use another method another method before the procedure.",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1916
  },
  {
    "id": "chunk_01917",
    "text": "nother method another method before the procedure. \u2022 If it is more than 7 days after the start of her monthly bleeding, she can have the procedure any time it is reasonably certain she is not pregnant. \u2022 If she is switching from oral contraceptives, she can",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1917
  },
  {
    "id": "chunk_01918",
    "text": "she is switching from oral contraceptives, she can continue taking pills until she has finished the pill pack to maintain her regular cycle. \u2022 If she is switching from an IUD, she can have the procedure immediately (see Switching From an IUD to Another Method, in Chapter 10 \u2013 Copper-",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1918
  },
  {
    "id": "chunk_01919",
    "text": "an IUD to Another Method, in Chapter 10 \u2013 Copper- Bearing IUD, pp. 187\u2013188). No monthly \u2022 Any time if it is reasonably certain she is not bleeding pregnant. 228 Family Planning: A Global Handbook for Providers",
    "page_number": 250,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1919
  },
  {
    "id": "chunk_01920",
    "text": "12 229 noitaziliretS elameF After childbirth \u2022 Immediately or within 7 days after giving birth, if she has made a voluntary, informed choice in advance. \u2022 Any time 6 weeks or more after childbirth if it is reasonably certain she is not pregnant.",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1920
  },
  {
    "id": "chunk_01921",
    "text": "h if it is reasonably certain she is not pregnant. After miscarriage \u2022 Within 48 hours after uncomplicated abortion, if she or abortion has made a voluntary, informed choice in advance. After using \u2022 The sterilization procedure can be done within",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1921
  },
  {
    "id": "chunk_01922",
    "text": "g \u2022 The sterilization procedure can be done within emergency 7 days after the start of her next monthly bleeding contraceptive or any other time if it is reasonably certain she is pills (ECPs) not pregnant. Give her a backup method or oral contraceptives to start the day after she finishes taking",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1922
  },
  {
    "id": "chunk_01923",
    "text": "eptives to start the day after she finishes taking the ECPs, to use until she can have the procedure. Ensuring Informed Choice IMPORTANT: A friendly counselor who listens to a woman\u2019s concerns, answers her questions, and gives adequate, clear, and practical information",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1923
  },
  {
    "id": "chunk_01924",
    "text": "d gives adequate, clear, and practical information about the procedure\u2014especially its permanence\u2014will help a woman make an informed choice and be a successful and satisfied user, without later regret (see Because Sterilization Is Permanent, next page). Involving her partner in",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1924
  },
  {
    "id": "chunk_01925",
    "text": "Is Permanent, next page). Involving her partner in counseling can be helpful but is not necessary or required. The 7 Points of Informed Consent Counseling must cover all 7 points of informed consent. In some programs the client and the counselor also sign an informed consent",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1925
  },
  {
    "id": "chunk_01926",
    "text": "nt and the counselor also sign an informed consent form. To give informed consent to sterilization, the client must understand the following points: 1. Temporary contraceptives also are available to the client, including long-acting reversible contraceptives.",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1926
  },
  {
    "id": "chunk_01927",
    "text": ", including long-acting reversible contraceptives. 2. Voluntary sterilization is a surgical procedure. 3. There are certain risks of the procedure as well as benefits. (Both risks and benefits must be explained in a way that the client can understand.)",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1927
  },
  {
    "id": "chunk_01928",
    "text": "xplained in a way that the client can understand.) 4. If successful, the procedure will prevent the client from ever having any more children. 5. The procedure is considered permanent and probably cannot be reversed. 6. The client can decide against the procedure at any time before it",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1928
  },
  {
    "id": "chunk_01929",
    "text": "decide against the procedure at any time before it takes place (without losing rights to other medical, health, or other services or benefits). 7. The procedure does not protect against sexually transmitted infections, including HIV. Providing Female Sterilization",
    "page_number": 251,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1929
  },
  {
    "id": "chunk_01930",
    "text": "Because Sterilization Is Permanent A woman or man considering sterilization should think carefully: \u201cCould I want more children in the future?\u201d Health care providers can help the client think about this question and make an informed choice.",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1930
  },
  {
    "id": "chunk_01931",
    "text": "k about this question and make an informed choice. If the client is considering having more children, another family planning method would be a better choice. Asking questions can help. The provider might ask: \u2022 \u201cDo you want to have any more children in the future?\u201d",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1931
  },
  {
    "id": "chunk_01932",
    "text": "you want to have any more children in the future?\u201d \u2022 \u201cIf not, do you think your mind could change later? What might change your mind? For example, suppose one of your children died?\u201d \u2022 \u201cSuppose you lost your spouse, and you married again?\u201d \u2022 \u201cDoes your partner want more children in the future?\u201d",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1932
  },
  {
    "id": "chunk_01933",
    "text": "es your partner want more children in the future?\u201d Clients who cannot answer these questions may need encouragement to think further about their decisions about sterilization. In general, people most likely to regret sterilization: \u2022 Are young \u2022 Have few or no children None of these",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1933
  },
  {
    "id": "chunk_01934",
    "text": "Are young \u2022 Have few or no children None of these characteristics rules \u2022 Have just lost a child out sterilization, but health care providers should make \u2022 Are not married especially sure that people \u2022 Are having marital problems with these characteristics make informed, \u2022 Have a partner who opposes",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1934
  },
  {
    "id": "chunk_01935",
    "text": "istics make informed, \u2022 Have a partner who opposes thoughtful sterilization choices. Also, for a woman, just after delivery or abortion is a convenient and safe time for voluntary sterilization, but women sterilized at this time may be more likely to regret it later. Thorough",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1935
  },
  {
    "id": "chunk_01936",
    "text": "me may be more likely to regret it later. Thorough counseling during pregnancy and a decision made before labor and delivery or before abortion care help to avoid regrets. The Decision About Sterilization Belongs to the Client Alone A man or woman may consult a partner and others about the decision",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1936
  },
  {
    "id": "chunk_01937",
    "text": "ay consult a partner and others about the decision to have sterilization and may consider their views, but the decision cannot be made for that person by a partner, another family member, a health care provider, a community leader, or anyone else. Family",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1937
  },
  {
    "id": "chunk_01938",
    "text": "ovider, a community leader, or anyone else. Family planning providers have a duty to make sure that the decision for or against sterilization is made by the client and is not pressured or forced by anyone. 230 Family Planning: A Global Handbook for Providers",
    "page_number": 252,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1938
  },
  {
    "id": "chunk_01939",
    "text": "12 231 noitaziliretS elameF Performing the Sterilization Procedure Explaining the Procedure A woman who has chosen female sterilization needs to know what will happen during the procedure. The following description can help to explain the procedure to her. Learning to perform female sterilization",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1939
  },
  {
    "id": "chunk_01940",
    "text": "e to her. Learning to perform female sterilization takes training and practice under direct supervision. Therefore, this description is a summary and not detailed instructions. (The description below is for procedures done more than 6 weeks after",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1940
  },
  {
    "id": "chunk_01941",
    "text": "low is for procedures done more than 6 weeks after childbirth. The procedure used up to 7 days after childbirth is slightly different.) The Minilaparotomy Procedure 1. The provider uses proper infection-prevention procedures at all times",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1941
  },
  {
    "id": "chunk_01942",
    "text": "roper infection-prevention procedures at all times (see Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404). 2. The provider performs a physical examination and a pelvic examination. The pelvic examination is to assess the condition and mobility of the uterus.",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1942
  },
  {
    "id": "chunk_01943",
    "text": "o assess the condition and mobility of the uterus. 3. The provider inserts a special instrument (uterine elevator) into the vagina, through the cervix, and into the uterus to raise each of the 2 fallopian tubes so they are closer to the incision. This may cause discomfort.",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1943
  },
  {
    "id": "chunk_01944",
    "text": "closer to the incision. This may cause discomfort. 4. The woman usually receives light sedation and analgesia to relax her. She stays awake. Local anesthetic is injected above the pubic hair line. She will not experience serious pain.",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1944
  },
  {
    "id": "chunk_01945",
    "text": "c hair line. She will not experience serious pain. 5. The provider makes a small horizontal incision (2\u20135 centimeters) in the anesthetized area. This usually causes little pain. (For women who have just given birth, the incision is made at the lower edge of the navel.)",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1945
  },
  {
    "id": "chunk_01946",
    "text": "incision is made at the lower edge of the navel.) 6. Each tube is tied and cut or else closed with a clip or ring. 7. The provider closes the incision with stitches and covers it with an adhesive bandage. 8. The woman receives instructions on what to do after she leaves the clinic",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1946
  },
  {
    "id": "chunk_01947",
    "text": "ructions on what to do after she leaves the clinic or hospital (see Explaining Self-Care for Female Sterilization, p. 234). She usually can leave in a few hours. Providing Female Sterilization",
    "page_number": 253,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1947
  },
  {
    "id": "chunk_01948",
    "text": "The Laparoscopy Procedure 1. The provider uses proper infection-prevention procedures at all times (see Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404). 2. The provider performs a physical examination and a pelvic examination.",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1948
  },
  {
    "id": "chunk_01949",
    "text": "s a physical examination and a pelvic examination. The pelvic examination is to assess condition and mobility of the uterus. 3. The woman usually receives light sedation and analgesia to relax her. She stays awake. Local anesthetic is injected under her navel. She will not experience serious pain.",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1949
  },
  {
    "id": "chunk_01950",
    "text": "r her navel. She will not experience serious pain. 4. The provider places a special needle into the woman\u2019s abdomen and, through the needle, inflates (insufflates) the abdomen with gas or air. This raises the wall of the abdomen away from the pelvic organs.",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1950
  },
  {
    "id": "chunk_01951",
    "text": "e wall of the abdomen away from the pelvic organs. 5. The provider makes a small incision (about one centimeter) in the anesthetized area and inserts a laparoscope. A laparoscope is a long, thin tube containing lenses. Through the lenses the provider can see inside",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1951
  },
  {
    "id": "chunk_01952",
    "text": "es. Through the lenses the provider can see inside the body and find the 2 fallopian tubes. 6. The provider inserts an instrument through the laparoscope (or, sometimes, through a second incision) to close off the fallopian tubes.",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1952
  },
  {
    "id": "chunk_01953",
    "text": "second incision) to close off the fallopian tubes. 7. Each tube is closed with a clip or a ring, or by electric current applied to block the tube (electrocoagulation). 8. The provider then removes the instrument and laparoscope. The gas or",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1953
  },
  {
    "id": "chunk_01954",
    "text": "removes the instrument and laparoscope. The gas or air is let out of the woman\u2019s abdomen. The provider closes the incision with stitches and covers it with an adhesive bandage. 9. The woman receives instructions on what to do after she leaves the clinic",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1954
  },
  {
    "id": "chunk_01955",
    "text": "ructions on what to do after she leaves the clinic or hospital (see Explaining Self-Care for Female Sterilization, p. 234). She usually can leave in a few hours. 232 Family Planning: A Global Handbook for Providers",
    "page_number": 254,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1955
  },
  {
    "id": "chunk_01956",
    "text": "12 233 noitaziliretS elameF Local Anesthesia Is Best for Female Sterilization Local anesthesia, used with or without mild sedation and analgesia, is preferable to general anesthesia. Local anesthesia with sedation and analgesia: \u2022 Is safer than general, spinal, or epidural anesthesia",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1956
  },
  {
    "id": "chunk_01957",
    "text": "safer than general, spinal, or epidural anesthesia \u2022 Lets the woman leave the clinic or hospital sooner \u2022 Allows faster recovery \u2022 Makes it possible to perform female sterilization in more facilities Sterilization under local anesthesia, with or without mild sedation",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1957
  },
  {
    "id": "chunk_01958",
    "text": "er local anesthesia, with or without mild sedation and analgesia, can be done when a member of the surgical team has been trained to provide sedation and analgesia and the surgeon has been trained to provide local anesthesia. The surgical team should",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1958
  },
  {
    "id": "chunk_01959",
    "text": "provide local anesthesia. The surgical team should be trained to manage emergencies, and the facility should have the basic equipment and medicines to manage any emergencies. Health care providers should explain to a woman ahead of time",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1959
  },
  {
    "id": "chunk_01960",
    "text": "providers should explain to a woman ahead of time that being awake during the procedure is safer for her. During the procedure providers should talk with the woman and help to reassure her if needed. The most common anesthetic used is lidocaine (lignocaine). Many",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1960
  },
  {
    "id": "chunk_01961",
    "text": "on anesthetic used is lidocaine (lignocaine). Many different sedatives and analgesics may be used. The dosage of medicines must be adjusted to body weight. Oversedation should be avoided because it can reduce the client\u2019s ability to stay conscious and could slow or stop her breathing.",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1961
  },
  {
    "id": "chunk_01962",
    "text": "ay conscious and could slow or stop her breathing. In some cases, general anesthesia may be needed. See Medical Eligibility Criteria for Female Sterilization, p. 224, for medical conditions needing special arrangements, which may include general anesthesia. Providing Female Sterilization",
    "page_number": 255,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1962
  },
  {
    "id": "chunk_01963",
    "text": "Supporting the User Explaining Self-Care for Female Sterilization Before the \u2022 Use another contraceptive until the procedure. procedure the \u2022 Not eat anything for 8 hours before surgery. woman should She can drink clear liquids until 2 hours before surgery.",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1963
  },
  {
    "id": "chunk_01964",
    "text": "drink clear liquids until 2 hours before surgery. \u2022 Not take any medication for 24 hours before the surgery (unless she is told to do so). \u2022 Wear clean, loose-fitting clothing to the health facility if possible. \u2022 Not wear nail polish or jewelry. \u2022 If possible, bring her partner, a friend, or a",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1964
  },
  {
    "id": "chunk_01965",
    "text": ". \u2022 If possible, bring her partner, a friend, or a relative to help her go home afterwards. After the \u2022 Rest for 2 days and avoid vigorous work and procedure the heavy lifting for a week. woman should \u2022 Keep the incision clean and dry for 1 to 2 days. \u2022 Avoid rubbing the incision for 1 week.",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1965
  },
  {
    "id": "chunk_01966",
    "text": "o 2 days. \u2022 Avoid rubbing the incision for 1 week. \u2022 Not have sex for at least 1 week, and then only when she feels comfortable having sex. What to do \u2022 She may have some abdominal pain and swelling about the most after the procedure. It usually goes away within",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1966
  },
  {
    "id": "chunk_01967",
    "text": "t after the procedure. It usually goes away within common problems a few days. Suggest ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain re- liever. She should not take aspirin, which slows blood clotting. Stronger pain reliever is rarely needed. If she had laparoscopy, she may have",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1967
  },
  {
    "id": "chunk_01968",
    "text": "arely needed. If she had laparoscopy, she may have shoulder pain or feel bloated for a few days. Plan the follow-up \u2022 Following up within 7 days or at least within visit 2 weeks is strongly recommended. No woman should be denied sterilization, however, because",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1968
  },
  {
    "id": "chunk_01969",
    "text": "n should be denied sterilization, however, because follow-up would be difficult or not possible. \u2022 A health care provider checks the site of the incision, looks for any signs of infection, and removes any stitches. This can be done in the clinic, in the client\u2019s home (by a specifically",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1969
  },
  {
    "id": "chunk_01970",
    "text": "he clinic, in the client\u2019s home (by a specifically trained paramedical worker, for example), or at any other health center. 234 Family Planning: A Global Handbook for Providers",
    "page_number": 256,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1970
  },
  {
    "id": "chunk_01971",
    "text": "12 235 noitaziliretS elameF How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: \u2022 Understand that female sterilization is permanent",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1971
  },
  {
    "id": "chunk_01972",
    "text": "Understand that female sterilization is permanent \u2022 Discuss with his partner whether they will want more children \u2022 Support her decision to end her fertility if they will not want more children \u2022 Discuss the alternative of vasectomy \u2022 Show understanding and support her through the procedure and",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1972
  },
  {
    "id": "chunk_01973",
    "text": "standing and support her through the procedure and recovery \u2022 Use condoms consistently in addition to female sterilization if he has an STI/HIV or thinks he may be at risk of an STI/HIV \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1973
  },
  {
    "id": "chunk_01974",
    "text": "ient that she is welcome to come back any time\u2014for example, if she has problems or questions, or she thinks she might be pregnant. (A few sterilizations fail and the woman becomes pregnant.) Also if: \u2022 She has bleeding, pain, pus, heat, swelling, or redness of the wound that",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1974
  },
  {
    "id": "chunk_01975",
    "text": "pus, heat, swelling, or redness of the wound that becomes worse or does not go away. \u2022 She develops high fever (greater than 38\u00b0 C/101\u00b0 F). \u2022 She experiences fainting, persistent light-headedness, or extreme dizziness in the first 4 weeks and especially in the first week.",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1975
  },
  {
    "id": "chunk_01976",
    "text": "he first 4 weeks and especially in the first week. General health advice: Anyone who suddenly feels that something is seriously wrong with her health after the female sterilization procedure should immediately seek medical care from a nurse or doctor. After a surgical",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1976
  },
  {
    "id": "chunk_01977",
    "text": "ical care from a nurse or doctor. After a surgical procedure any health problem must be assessed carefully and considered to be related to the procedure until it is medically demonstrated that it is not. General health advice Anyone who suddenly feels that something is seriously wrong with",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1977
  },
  {
    "id": "chunk_01978",
    "text": "denly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the health worker what method she is using. Supporting the User",
    "page_number": 257,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1978
  },
  {
    "id": "chunk_01979",
    "text": "Managing Any Problems Problems Reported as Complications \u2022 Problems affect women\u2019s satisfaction with female sterilization. They deserve the provider\u2019s attention. If the client reports complications of female sterilization, listen to her concerns, give advice and support, and,",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1979
  },
  {
    "id": "chunk_01980",
    "text": "ten to her concerns, give advice and support, and, if appropriate, treat. Make sure she understands the advice and agrees. Infection at the incision site (redness, heat, pain, pus) \u2022 Clean the infected area with soap and water or antiseptic. \u2022 Give oral antibiotics for 7 to 10 days.",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1980
  },
  {
    "id": "chunk_01981",
    "text": "iseptic. \u2022 Give oral antibiotics for 7 to 10 days. \u2022 Ask the client to return after taking all antibiotics if the infection has not cleared. Abscess (a pocket of pus under the skin caused by infection) \u2022 Clean the area with antiseptic. \u2022 Cut open (incise) and drain the abscess. \u2022 Treat the wound.",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1981
  },
  {
    "id": "chunk_01982",
    "text": "(incise) and drain the abscess. \u2022 Treat the wound. \u2022 Give oral antibiotics for 7 to 10 days. \u2022 Ask the client to return after taking all antibiotics if she has heat, redness, pain, or drainage of the wound. Severe pain in lower abdomen",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1982
  },
  {
    "id": "chunk_01983",
    "text": "rainage of the wound. Severe pain in lower abdomen \u2022 If the surgical procedure was recently performed, assess for any other problem that may indicate that the condition is related to the surgery, such as bleeding, lack of appetite, lack of bowel transit, lack of urination, or",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1983
  },
  {
    "id": "chunk_01984",
    "text": "tite, lack of bowel transit, lack of urination, or fever. If any of these are present, rapidly refer the client to a higher- level facility with surgical capability. \u2022 If the surgery took place some months or years ago, suspect an ectopic pregnancy. \u2022 See also Managing Ectopic Pregnancy, next page.",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1984
  },
  {
    "id": "chunk_01985",
    "text": "\u2022 See also Managing Ectopic Pregnancy, next page. Suspected pregnancy \u2022 Assess for pregnancy, including ectopic pregnancy. 236 Family Planning: A Global Handbook for Providers",
    "page_number": 258,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1985
  },
  {
    "id": "chunk_01986",
    "text": "12 237 noitaziliretS elameF Managing Ectopic Pregnancy \u2022 Ectopic pregnancy is any pregnancy that occurs outside the uterine cavity. Early diagnosis is important. Ectopic pregnancy is rare but could be life-threatening (see Question 11, p. 240). \u2022 In the early stages of ectopic pregnancy, symptoms may",
    "page_number": 259,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1986
  },
  {
    "id": "chunk_01987",
    "text": "he early stages of ectopic pregnancy, symptoms may be absent or mild, but eventually they will become severe. A combination of these signs or symptoms should increase suspicion of ectopic pregnancy: \u2013 Unusual abdominal pain or tenderness \u2013 Abnormal vaginal bleeding or no monthly bleeding\u2014especially",
    "page_number": 259,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1987
  },
  {
    "id": "chunk_01988",
    "text": "vaginal bleeding or no monthly bleeding\u2014especially if this is a change from a woman\u2019s usual bleeding pattern \u2013 Light-headedness or dizziness \u2013 Fainting \u2022 Ruptured ectopic pregnancy: Sudden sharp or stabbing lower abdominal pain, sometimes on one side and sometimes",
    "page_number": 259,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1988
  },
  {
    "id": "chunk_01989",
    "text": "bdominal pain, sometimes on one side and sometimes throughout the body, suggests a ruptured ectopic pregnancy (when the fallopian tube breaks due to the pregnancy). Right shoulder pain may develop due to blood from a ruptured ectopic pregnancy pressing on the diaphragm. Usually, within",
    "page_number": 259,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1989
  },
  {
    "id": "chunk_01990",
    "text": "egnancy pressing on the diaphragm. Usually, within a few hours the abdomen becomes rigid and the woman goes into shock. \u2022 Care: Ectopic pregnancy is a life-threatening, emergency condition requiring immediate surgery. If ectopic pregnancy is suspected, perform a pelvic examination only if facilities",
    "page_number": 259,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1990
  },
  {
    "id": "chunk_01991",
    "text": "d, perform a pelvic examination only if facilities for immediate surgery are available. Otherwise, immediately refer and/or transport the woman to a facility where definitive diagnosis and surgical care can be provided. Supporting the User",
    "page_number": 259,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1991
  },
  {
    "id": "chunk_01992",
    "text": "Questions and Answers About Female Sterilization 1. Will sterilization change a woman\u2019s monthly bleeding or make monthly bleeding stop? No. Most research finds no major changes in bleeding patterns after female sterilization. If a woman was using a hormonal method or IUD",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1992
  },
  {
    "id": "chunk_01993",
    "text": "ion. If a woman was using a hormonal method or IUD before sterilization, her bleeding pattern will return to the way it was before she used these methods. For example, women switching from combined oral contraceptives to female sterilization may notice heavier",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1993
  },
  {
    "id": "chunk_01994",
    "text": "eptives to female sterilization may notice heavier bleeding as their monthly bleeding returns to usual patterns. Note, however, that a woman\u2019s monthly bleeding usually becomes less regular as she approaches menopause. 2. Will sterilization make a woman lose her sexual desire? Will it make her fat?",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1994
  },
  {
    "id": "chunk_01995",
    "text": "oman lose her sexual desire? Will it make her fat? No. After sterilization a woman will look and feel the same as before. She can have sex the same as before. She may find that she enjoys sex more because she does not have to worry about getting pregnant. She",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1995
  },
  {
    "id": "chunk_01996",
    "text": "does not have to worry about getting pregnant. She will not gain weight because of the sterilization procedure. 3. Should sterilization be offered only to women who have had a certain number of children, who have reached a certain age, or who are married?",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1996
  },
  {
    "id": "chunk_01997",
    "text": "ho have reached a certain age, or who are married? No. There is no justification for denying sterilization to a woman just because of her age, the number or sex of her living children, or her marital status. Health care providers must not impose rigid rules about",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1997
  },
  {
    "id": "chunk_01998",
    "text": "h care providers must not impose rigid rules about age, number of children, age of last child, or marital status. Each woman must be allowed to decide for herself whether or not she will want more children and whether or not to have sterilization.",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1998
  },
  {
    "id": "chunk_01999",
    "text": "children and whether or not to have sterilization. 4. Is it not easier for the woman and the health care provider to use general anesthesia? Why use local anesthesia? Local anesthesia is safer. General anesthesia is more risky than the",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 1999
  },
  {
    "id": "chunk_02000",
    "text": "s safer. General anesthesia is more risky than the sterilization procedure itself. Correct use of local anesthesia removes the single greatest source of risk in female sterilization procedures\u2014general anesthesia. Also, after general anesthesia, women usually feel nauseous.",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2000
  },
  {
    "id": "chunk_02001",
    "text": "r general anesthesia, women usually feel nauseous. This does not happen as often after local anesthesia. When using local anesthesia with sedation and analgesia, however, providers must take care not to overdose the woman with the sedative.",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2001
  },
  {
    "id": "chunk_02002",
    "text": "care not to overdose the woman with the sedative. They also must handle the woman gently and talk with her throughout the procedure. This helps her to stay calm. With many clients, sedatives can be avoided, especially with good counseling and a skilled provider.",
    "page_number": 260,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2002
  },
  {
    "id": "chunk_02003",
    "text": "12 239 noitaziliretS elameF 5. Does a woman who has had a sterilization procedure ever have to worry about getting pregnant again? Generally, no. Female sterilization is very effective at preventing pregnancy and is intended to be permanent. It is not 100% effective,",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2003
  },
  {
    "id": "chunk_02004",
    "text": "ntended to be permanent. It is not 100% effective, however. Women who have been sterilized have a slight risk of becoming pregnant: About 5 of every 1,000 women become pregnant within a year after the procedure. The small risk of pregnancy remains beyond the first",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2004
  },
  {
    "id": "chunk_02005",
    "text": "e small risk of pregnancy remains beyond the first year and until the woman reaches menopause. 6. Pregnancy after female sterilization is rare, but why does it happen at all? Most often it is because the woman was already pregnant at the time",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2005
  },
  {
    "id": "chunk_02006",
    "text": "because the woman was already pregnant at the time of sterilization. In some cases an opening in the fallopian tube develops. Pregnancy also can occur if the provider makes a cut in the wrong place instead of the fallopian tubes. 7. Can sterilization be reversed if the woman decides she wants",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2006
  },
  {
    "id": "chunk_02007",
    "text": "ization be reversed if the woman decides she wants another child? Generally, no. Sterilization is intended to be permanent. People who may want more children should choose a different family planning method. Surgery to reverse sterilization is possible for only some women\u2014",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2007
  },
  {
    "id": "chunk_02008",
    "text": "rse sterilization is possible for only some women\u2014 those who have enough fallopian tube left. Even among these women, reversal often does not lead to pregnancy. The procedure is difficult and expensive, and providers who are able to perform such surgery are hard",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2008
  },
  {
    "id": "chunk_02009",
    "text": "ders who are able to perform such surgery are hard to find. When pregnancy does occur after reversal, the risk that the pregnancy will be ectopic is greater than usual. Thus, sterilization should be considered irreversible. 8. Is it better for the woman to have female sterilization or for",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2009
  },
  {
    "id": "chunk_02010",
    "text": "for the woman to have female sterilization or for the man to have a vasectomy? Each couple must decide for themselves which method is best for them. Both are very effective, safe, permanent methods for couples who know that they will not want more children. Ideally, a couple should consider",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2010
  },
  {
    "id": "chunk_02011",
    "text": "t more children. Ideally, a couple should consider both methods. If both are acceptable to the couple, vasectomy would be preferable because it is simpler, safer, easier, and less expensive than female sterilization. 9. Will the female sterilization procedure hurt?",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2011
  },
  {
    "id": "chunk_02012",
    "text": ". 9. Will the female sterilization procedure hurt? Yes, a little. Women receive local anesthetic to stop pain, and, except in special cases, they remain awake. A woman can feel the health care provider moving her uterus and fallopian tubes. This can be uncomfortable. If a trained",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2012
  },
  {
    "id": "chunk_02013",
    "text": "ian tubes. This can be uncomfortable. If a trained anesthetist or anesthesiologist and suitable equipment are available, general anesthesia may be chosen for women who are very frightened of pain. A woman may feel sore and weak for several days or even a few weeks after",
    "page_number": 261,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2013
  },
  {
    "id": "chunk_02014",
    "text": "10. How can health care providers help a woman decide about female sterilization? Provide clear, balanced information about female sterilization and other family planning methods, and help a woman think through her decision fully. Thoroughly discuss her feelings about having children and ending her",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2014
  },
  {
    "id": "chunk_02015",
    "text": "her feelings about having children and ending her fertility. For example, a provider can help a woman think how she would feel about possible life changes such as a change of partner or a child\u2019s death. Review The 7 Points of Informed Consent to be sure the woman",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2015
  },
  {
    "id": "chunk_02016",
    "text": "7 Points of Informed Consent to be sure the woman understands the sterilization procedure (see p. 229). 11. Does female sterilization increase the risk of ectopic pregnancy? No. On the contrary, female sterilization greatly reduces the risk of",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2016
  },
  {
    "id": "chunk_02017",
    "text": ", female sterilization greatly reduces the risk of ectopic pregnancy. Ectopic pregnancies are very rare among women who have had a sterilization procedure. The rate of ectopic pregnancy among women after female sterilization is 6 per 10,000 women per year. The",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2017
  },
  {
    "id": "chunk_02018",
    "text": "sterilization is 6 per 10,000 women per year. The rate of ectopic pregnancy among women in the United States using no contraceptive method is 65 per 10,000 women per year. On the rare occasions that sterilization fails and pregnancy occurs, 33",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2018
  },
  {
    "id": "chunk_02019",
    "text": "that sterilization fails and pregnancy occurs, 33 of every 100 (1 of every 3) of these pregnancies are ectopic. Thus, most pregnancies after sterilization failure are not ectopic. Still, ectopic pregnancy can be life-threatening, so a provider should be aware that",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2019
  },
  {
    "id": "chunk_02020",
    "text": "fe-threatening, so a provider should be aware that ectopic pregnancy is possible if sterilization fails. 12. Where can female sterilization be performed? If no pre-existing medical conditions require special arrangements: \u2022 Minilaparotomy can be provided in maternity centers and basic health",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2020
  },
  {
    "id": "chunk_02021",
    "text": "be provided in maternity centers and basic health facilities where surgery can be done. These include both permanent and temporary facilities that can refer the woman to a higher level of care in case of emergency. \u2022 Laparoscopy requires a better-equipped center, where the procedure",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2021
  },
  {
    "id": "chunk_02022",
    "text": "ires a better-equipped center, where the procedure is performed regularly and an anesthetist is available. 240 Family Planning: A Global Handbook for Providers",
    "page_number": 262,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2022
  },
  {
    "id": "chunk_02023",
    "text": "13 241 ymotcesaV CHAPTER 13 Vasectomy Key Points for Providers and Clients \u2022 Permanent. Intended to provide life-long, permanent, and very effective protection against pregnancy. Reversal is usually not possible. \u2022 Involves a safe, simple surgical procedure.",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2023
  },
  {
    "id": "chunk_02024",
    "text": "ble. \u2022 Involves a safe, simple surgical procedure. \u2022 3-month delay in taking effect. The man or couple must use condoms or another contraceptive method for 3 months after the vasectomy. \u2022 Does not affect male sexual performance. What Is Vasectomy?",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2024
  },
  {
    "id": "chunk_02025",
    "text": "affect male sexual performance. What Is Vasectomy? \u2022 Permanent contraception for men who will not want more children. \u2022 Through a puncture or small incision in the scrotum, the provider locates each of the 2 tubes that carries sperm to the penis (vas deferens) and cuts",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2025
  },
  {
    "id": "chunk_02026",
    "text": "carries sperm to the penis (vas deferens) and cuts or blocks them by cutting and tying them closed or by applying heat or electricity (cautery). \u2022 Also called male sterilization and male surgical contraception. \u2022 Works by closing off each vas deferens, keeping sperm out of semen.",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2026
  },
  {
    "id": "chunk_02027",
    "text": "off each vas deferens, keeping sperm out of semen. Semen is ejaculated, but it cannot cause pregnancy. How Effective? More effective One of the most effective methods but carries a small risk of failure: \u2022 Among the partners of men who have vasectomies, far less than",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2027
  },
  {
    "id": "chunk_02028",
    "text": "artners of men who have vasectomies, far less than 1 in every 100 will become pregnant in the first year of use of the method. In fact, less than 2 women in every 1,000 will become pregnant. This means that 998 or 999 of 1,000 women whose partners have had vasectomy will not become pregnant.",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2028
  },
  {
    "id": "chunk_02029",
    "text": "tners have had vasectomy will not become pregnant. \u2022 Sometimes men can have their semen examined at 3 months after the procedure to see if it still contains sperm. If no sperm is found, 1 woman in every 1,000 of these men\u2019s partners will Less effective become pregnant in the first year.",
    "page_number": 263,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2029
  },
  {
    "id": "chunk_02030",
    "text": "\u2022 Among partners of men who do not have their semen examined, pregnancies are slightly more common, but still less than 2 per 1,000 women. \u2022 Vasectomy is not fully effective for 3 months after the procedure. \u2212 Some pregnancies occur within the first year because the couple",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2030
  },
  {
    "id": "chunk_02031",
    "text": "ies occur within the first year because the couple does not use condoms or another effective method consistently and correctly in the first 3 months, before the vasectomy is fully effective. \u2022 A small risk of pregnancy remains beyond the first year after the",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2031
  },
  {
    "id": "chunk_02032",
    "text": "pregnancy remains beyond the first year after the vasectomy and until the man\u2019s partner reaches menopause. \u2212 Over 3 years of use: About 4 pregnancies per 1,000 women \u2022 If the partner of a man who has had a vasectomy becomes pregnant, it may be because:",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2032
  },
  {
    "id": "chunk_02033",
    "text": "d a vasectomy becomes pregnant, it may be because: \u2212 The couple did not always use another method during the first 3 months after the procedure \u2212 The provider made a mistake \u2212 The cut ends of the vas deferens grew back together",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2033
  },
  {
    "id": "chunk_02034",
    "text": "he cut ends of the vas deferens grew back together Fertility does not return because vasectomy generally cannot be stopped or reversed. The procedure is intended to be permanent. Reversal surgery is difficult, expensive, and not available in most areas. When performed,",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2034
  },
  {
    "id": "chunk_02035",
    "text": ", and not available in most areas. When performed, reversal surgery often does not lead to pregnancy (see Question 7, p. 244). Protection against sexually transmitted infections (STIs): None Why Some Men Say They Like Vasectomy \u2022 Is safe, permanent, and convenient",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2035
  },
  {
    "id": "chunk_02036",
    "text": "ike Vasectomy \u2022 Is safe, permanent, and convenient \u2022 Has fewer side effects and complications than many methods for women \u2022 The man takes responsibility for contraception\u2014takes burden off the woman \u2022 Increases enjoyment and frequency of sex 242 Family Planning: A Global Handbook for Providers",
    "page_number": 264,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2036
  },
  {
    "id": "chunk_02037",
    "text": "13 243 ymotcesaV Side Effects, Health Benefits, Health Risks, and Complications Known Health Benefits Known Health Risks \u2022 Helps protect against risks None of pregnancy in a partner Side Effects None Complications (see also Managing Any Problems, p. 252) Uncommon to rare:",
    "page_number": 265,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2037
  },
  {
    "id": "chunk_02038",
    "text": "o Managing Any Problems, p. 252) Uncommon to rare: \u2022 Severe scrotal or testicular pain that lasts for months or years (see Question 2, p. 253). Uncommon to very rare: \u2022 Infection at the incision site or inside the incision (uncommon with",
    "page_number": 265,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2038
  },
  {
    "id": "chunk_02039",
    "text": "ncision site or inside the incision (uncommon with conventional incision technique; very rare with no-scalpel technique; see Vasectomy Techniques, p. 248). Rare: \u2022 Bleeding under the skin that may cause swelling or bruising (hematoma).",
    "page_number": 265,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2039
  },
  {
    "id": "chunk_02040",
    "text": "in that may cause swelling or bruising (hematoma). Correcting Misunderstandings (see also Questions and Answers, p. 253) Vasectomy: \u2022 Does not remove the testicles. In vasectomy the tubes carrying sperm from the testicles are blocked. The testicles remain in place. \u2022 Does not decrease sex drive.",
    "page_number": 265,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2040
  },
  {
    "id": "chunk_02041",
    "text": "es remain in place. \u2022 Does not decrease sex drive. \u2022 Does not affect sexual function. A man\u2019s erection is as hard, it lasts as long, and he ejaculates the same as before. \u2022 Does not cause a man to grow fat or become weak, less masculine, or less productive.",
    "page_number": 265,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2041
  },
  {
    "id": "chunk_02042",
    "text": "r become weak, less masculine, or less productive. \u2022 Does not cause any diseases later in life. \u2022 Does not prevent transmission of STIs, including HIV. Side Effects, Health Benefits, Health Risks, and Complications",
    "page_number": 265,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2042
  },
  {
    "id": "chunk_02043",
    "text": "Who Can Have a Vasectomy Safe for All Men With proper counseling and informed consent, any man can have a vasectomy safely, including men who: \u2022 Have no children or few children \u2022 Are married or are not married \u2022 Do not have wife\u2019s permission \u2022 Are young \u2022 Have sickle cell disease",
    "page_number": 266,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2043
  },
  {
    "id": "chunk_02044",
    "text": "permission \u2022 Are young \u2022 Have sickle cell disease \u2022 Are at high risk of infection with HIV or another STI \u2022 Are living with HIV, whether or not on antiretroviral therapy (see Vasectomy for Men with HIV, p. 246). In some of these situations, especially careful counseling is important to",
    "page_number": 266,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2044
  },
  {
    "id": "chunk_02045",
    "text": "ons, especially careful counseling is important to make sure the man will not regret his decision (see Chapter 12 \u2013 Female Sterilization, section on Because Sterilization Is Permanent, p. 230). Avoid Unnecessary Procedures (see Importance of Selected Procedures in Chapter 26 \u2013",
    "page_number": 266,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2045
  },
  {
    "id": "chunk_02046",
    "text": "Importance of Selected Procedures in Chapter 26 \u2013 Family Planning Provision, p. 396) Men can have vasectomy: \u2022 Without any blood tests or routine A genital examination laboratory tests should be conducted before performing \u2022 Without a blood pressure check vasectomy. \u2022 Without a hemoglobin test",
    "page_number": 266,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2046
  },
  {
    "id": "chunk_02047",
    "text": "ssure check vasectomy. \u2022 Without a hemoglobin test \u2022 Without a cholesterol or liver function check \u2022 Even if the semen cannot be examined by microscope later to see if it still contains sperm. 244 Family Planning: A Global Handbook for Providers",
    "page_number": 266,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2047
  },
  {
    "id": "chunk_02048",
    "text": "13 245 ymotcesaV Medical Eligibility Criteria for Vasectomy All men can have vasectomy. No medical conditions prevent a man from using vasectomy. This checklist asks the client about known medical conditions that may limit when, where, or how the vasectomy",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2048
  },
  {
    "id": "chunk_02049",
    "text": "s that may limit when, where, or how the vasectomy procedure should be performed. Ask the client the questions below. If he answers \u201cno\u201d to all of the questions, then the vasectomy procedure can be performed in a routine setting without delay. If he answers",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2049
  },
  {
    "id": "chunk_02050",
    "text": "in a routine setting without delay. If he answers \u201cyes\u201d to a question below, follow the instructions, which recommend caution, delay, or special arrangements. In the checklist below: \u2022 Caution means the procedure can be performed in a routine",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2050
  },
  {
    "id": "chunk_02051",
    "text": "means the procedure can be performed in a routine setting but with extra preparation and precautions, depending on the condition. \u2022 Delay means postpone vasectomy. These conditions must be treated and resolved before vasectomy can be performed. Give",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2051
  },
  {
    "id": "chunk_02052",
    "text": "d resolved before vasectomy can be performed. Give the client another method to use until the procedure can be performed. \u2022 Special means special arrangements should be made to perform the procedure in a setting with an experienced surgeon and staff,",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2052
  },
  {
    "id": "chunk_02053",
    "text": "n a setting with an experienced surgeon and staff, equipment to provide general anesthesia, and other backup medical support. For these conditions, the capacity to decide on the most appropriate procedure and anesthesia regimen also is needed. Help",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2053
  },
  {
    "id": "chunk_02054",
    "text": "cedure and anesthesia regimen also is needed. Help the client choose another method* to use until the procedure can be performed. 1. Do you have any problems with your genitals, such as infections, swelling, injuries, or lumps on your penis or scrotum? If so, what problems?",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2054
  },
  {
    "id": "chunk_02055",
    "text": "ps on your penis or scrotum? If so, what problems? \u274f NO \u274f YES If he has any of the following, use caution: \u2022 Previous scrotal injury \u2022 Swollen scrotum due to swollen veins or membranes in the spermatic cord or testes (large varicocele or hydrocele) \u2022 Undescended testicle\u2014one side only. (Vasectomy is",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2055
  },
  {
    "id": "chunk_02056",
    "text": "Undescended testicle\u2014one side only. (Vasectomy is performed only on the normal side. Then, if any sperm are present in a semen sample after 3 months, the other side must be done, too.) (Continued on next page) * Backup methods include abstinence, male and female condoms, spermicides, and",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2056
  },
  {
    "id": "chunk_02057",
    "text": "tinence, male and female condoms, spermicides, and withdrawal. Tell him that spermicides and withdrawal are the least effective contraceptive methods. If possible, give him condoms. Who Can Have a Vasectomy",
    "page_number": 267,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2057
  },
  {
    "id": "chunk_02058",
    "text": "Medical Eligibility Criteria for Vasectomy (continued) u If he has any of the following, delay vasectomy: \u2022 Active sexually transmitted infection \u2022 Swollen, tender (inflamed) tip of the penis, sperm ducts (epididymis), or testicles \u2022 Scrotal skin infection or a mass in the scrotum",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2058
  },
  {
    "id": "chunk_02059",
    "text": "\u2022 Scrotal skin infection or a mass in the scrotum u If he has any of the following, make special arrangements: \u2022 Hernia in the groin. (If able, the provider can perform the vasectomy at the same time as repairing the hernia. If this is not possible, the hernia should be repaired first.)",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2059
  },
  {
    "id": "chunk_02060",
    "text": "ot possible, the hernia should be repaired first.) \u2022 Undescended testicles\u2014both sides 2. Do you have any other conditions or infections? If so, what? \u274f NO \u274f YES If he has the following, use caution: \u2022 Diabetes \u2022 Depression \u2022 Young age \u2022 Lupus with positive (or unknown) antiphospholipid",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2060
  },
  {
    "id": "chunk_02061",
    "text": "Lupus with positive (or unknown) antiphospholipid antibodies or on immunosuppressive treatment u If he has any of the following, delay vasectomy: \u2022 Systemic infection or gastroenteritis \u2022 Filariasis or elephantiasis u If he has any of the following, make special arrangements:",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2061
  },
  {
    "id": "chunk_02062",
    "text": "s any of the following, make special arrangements: \u2022 HIV with advanced or severe clinical disease (see Vasectomy for Men With HIV, below) \u2022 Blood fails to clot (coagulation disorders) \u2022 Lupus with severe thrombocytopenia Vasectomy for Men With HIV",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2062
  },
  {
    "id": "chunk_02063",
    "text": "severe thrombocytopenia Vasectomy for Men With HIV \u2022 Men who are living with HIV or are on antiretroviral therapy (ART) can safely have a vasectomy. Special arrangements are needed to perform vasectomy on a man who has advanced or severe clinical disease.",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2063
  },
  {
    "id": "chunk_02064",
    "text": "a man who has advanced or severe clinical disease. \u2022 Vasectomy does not prevent transmission of HIV. \u2022 Urge these men to use condoms in addition to vasectomy. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs.",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2064
  },
  {
    "id": "chunk_02065",
    "text": "s help prevent transmission of HIV and other STIs. \u2022 No one should be coerced or pressured into getting a vasectomy, and that includes men with HIV. 246 Family Planning: A Global Handbook for Providers",
    "page_number": 268,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2065
  },
  {
    "id": "chunk_02066",
    "text": "13 247 ymotcesaV Providing Vasectomy When to Perform the Procedure \u2022 Any time a man requests it (if there is no medical reason to delay). Ensuring Informed Choice IMPORTANT: A friendly counselor who listens to a man\u2019s concerns, answers his questions, and gives adequate, clear and practical",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2066
  },
  {
    "id": "chunk_02067",
    "text": "questions, and gives adequate, clear and practical information about the procedure\u2014especially its permanence\u2014will help a man make an informed choice and be a successful and satisfied user, without later regret (see Because Sterilization is Permanent, in Chapter 12, p. 230). Involving his",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2067
  },
  {
    "id": "chunk_02068",
    "text": "s Permanent, in Chapter 12, p. 230). Involving his partner in counseling can be helpful but is not necessary or required. The 7 Points of Informed Consent Counseling must cover all 7 points of informed consent. In some programs the client and the counselor sign an informed consent form.",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2068
  },
  {
    "id": "chunk_02069",
    "text": "t and the counselor sign an informed consent form. To give informed consent to vasectomy, the client must understand the following points: 1. Temporary contraceptives also are available to the client. 2. Voluntary vasectomy is a surgical procedure.",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2069
  },
  {
    "id": "chunk_02070",
    "text": "t. 2. Voluntary vasectomy is a surgical procedure. 3. There are certain risks of the procedure as well as benefits. (Both risks and benefits must be explained in a way that the client can understand.) 4. If successful, the procedure will prevent the client from ever having any more children.",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2070
  },
  {
    "id": "chunk_02071",
    "text": "ent the client from ever having any more children. 5. The procedure is considered permanent and probably cannot be reversed. 6. The client can decide against the procedure at any time before it takes place (without losing rights to other medical, health, or other services or benefits).",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2071
  },
  {
    "id": "chunk_02072",
    "text": "r medical, health, or other services or benefits). 7. The procedure does not protect against sexually transmitted infections, including HIV. Providing Vasectomy",
    "page_number": 269,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2072
  },
  {
    "id": "chunk_02073",
    "text": "Vasectomy Techniques Reaching the Vas: No-Scalpel Vasectomy No-scalpel vasectomy is the recommended technique for reaching each of the 2 tubes in the scrotum (vas deferens) that carries sperm to the penis. It is becoming the standard around the world.",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2073
  },
  {
    "id": "chunk_02074",
    "text": "nis. It is becoming the standard around the world. Differences from conventional procedure using incisions: \u2022 Uses one small puncture instead of 1 or 2 incisions in the scrotum. \u2022 No stitches required to close the skin. \u2022 Special anesthesia technique needs only one needle puncture instead",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2074
  },
  {
    "id": "chunk_02075",
    "text": "a technique needs only one needle puncture instead of 2 or more. Advantages: \u2022 Less pain and bruising and quicker recovery. \u2022 Fewer infections and less collection of blood in the tissue (hematoma). \u2022 Total time for the vasectomy has been shorter when skilled providers use the no-scalpel approach.",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2075
  },
  {
    "id": "chunk_02076",
    "text": "hen skilled providers use the no-scalpel approach. Both no-scalpel and conventional incision procedures are quick, safe, and effective. Blocking the Vas For most vasectomies ligation and excision is used. This entails cutting and removing a short piece of each tube and then tying both remaining",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2076
  },
  {
    "id": "chunk_02077",
    "text": "t piece of each tube and then tying both remaining cut ends of the vas. This procedure has a low failure rate. Applying heat or electricity to the ends of each vas (cauterizing) has an even lower failure rate than ligation and excision. The chances that vasectomy",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2077
  },
  {
    "id": "chunk_02078",
    "text": "ligation and excision. The chances that vasectomy will fail can be reduced further by enclosing a cut end of the vas, after the ends have been tied or cauterized, in the thin layer of tissue that surrounds the vas (fascial interposition). If training and equipment",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2078
  },
  {
    "id": "chunk_02079",
    "text": "(fascial interposition). If training and equipment are available, cautery and/or fascial interposition are recommended. Blocking the vas with clips is not recommended because of higher pregnancy rates. 248 Family Planning: A Global Handbook for Providers",
    "page_number": 270,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2079
  },
  {
    "id": "chunk_02080",
    "text": "13 249 ymotcesaV Performing the Vasectomy Procedure Explaining the Procedure A man who has chosen a vasectomy needs to know what will happen during the procedure. The following description can help to explain the procedure to him. Learning to perform a vasectomy takes training and practice under",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2080
  },
  {
    "id": "chunk_02081",
    "text": "form a vasectomy takes training and practice under direct supervision. Therefore, this description is a summary and not detailed instructions. 1. The provider uses proper infection-prevention procedures at all times (see Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2081
  },
  {
    "id": "chunk_02082",
    "text": "ion in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404). 2. The man receives an injection of local anesthetic in his scrotum to prevent pain. He stays awake throughout the procedure. 3. The provider feels the skin of the scrotum to find each vas deferens\u2014the",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2082
  },
  {
    "id": "chunk_02083",
    "text": "skin of the scrotum to find each vas deferens\u2014the 2 tubes in the scrotum that carry sperm. 4. The provider makes a puncture or incision in the skin: \u2013 Using the no-scalpel vasectomy technique, the provider grasps the tube with specially designed forceps and makes a tiny puncture in the skin at the",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2083
  },
  {
    "id": "chunk_02084",
    "text": "rceps and makes a tiny puncture in the skin at the midline of the scrotum with a special sharp surgical instrument. \u2013 Using the conventional procedure, the provider makes 1 or 2 small incisions in the skin with a scalpel. 5. The provider lifts out a small loop of each vas from the puncture or",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2084
  },
  {
    "id": "chunk_02085",
    "text": "out a small loop of each vas from the puncture or incision. Most providers then cut each tube and tie one or both cut ends closed with thread. Some close off the tubes with heat or electricity. They may also enclose one end of the vas in the thin layer of tissue that",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2085
  },
  {
    "id": "chunk_02086",
    "text": "ne end of the vas in the thin layer of tissue that surrounds the vas (see Vasectomy Techniques, previous page). 6. The puncture is covered with an adhesive bandage, or the incision may be closed with stitches. 7. The man receives instructions on what to do after he leaves the clinic or",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2086
  },
  {
    "id": "chunk_02087",
    "text": "ctions on what to do after he leaves the clinic or hospital (see Explaining Self-Care for Vasectomy, next page). The man may feel faint briefly after the procedure. He should stand first with help, and he should rest for 15 to 30 minutes. He usually can leave within an hour. Providing Vasectomy",
    "page_number": 271,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2087
  },
  {
    "id": "chunk_02088",
    "text": "Supporting the User Explaining Self-Care for Vasectomy Before the \u2022 Wear clean, loose-fitting clothing to the health procedure the facility. man should After the \u2022 Rest for 2 days if possible. procedure the \u2022 If possible, put cold compresses on the scrotum man should",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2088
  },
  {
    "id": "chunk_02089",
    "text": "ble, put cold compresses on the scrotum man should for the first 4 hours, which may decrease pain and bleeding. He will have some discomfort, swelling, and bruising. These should go away within 2 to 3 days. \u2022 Wear snug underwear or pants for 2 to 3 days to",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2089
  },
  {
    "id": "chunk_02090",
    "text": "\u2022 Wear snug underwear or pants for 2 to 3 days to help support the scrotum. This will lessen swelling, bleeding, and pain. \u2022 Keep the puncture/incision site clean and dry for 2 to 3 days. He can use a towel to wipe his body clean but should not soak in water. \u2022 Not have sex for at least 2 to 3 days.",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2090
  },
  {
    "id": "chunk_02091",
    "text": "in water. \u2022 Not have sex for at least 2 to 3 days. \u2022 Use condoms or another effective family planning method for 3 months after the procedure. (The previously recommended alternative, to wait for 20 ejaculations, has proved less reliable than waiting 3 months and is no longer recommended.)",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2091
  },
  {
    "id": "chunk_02092",
    "text": "an waiting 3 months and is no longer recommended.) What to do \u2022 Discomfort in the scrotum usually lasts 2 to 3 days. about the Suggest ibuprofen (200\u2013400 mg), paracetamol most common (325\u20131,000 mg), or other pain reliever. He should problems not take aspirin, which slows blood clotting.",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2092
  },
  {
    "id": "chunk_02093",
    "text": "lems not take aspirin, which slows blood clotting. Plan the follow-up \u2022 Ask him to return in 3 months for semen analysis, visit if available (see Question 4, p. 254). \u2022 No man should be denied a vasectomy, however, because follow-up would be difficult or not possible. MONTH Use another MONTH",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2093
  },
  {
    "id": "chunk_02094",
    "text": "difficult or not possible. MONTH Use another MONTH effective family MONTH planning method for 3 months after the vasectomy procedure. 250 Family Planning: A Global Handbook for Providers",
    "page_number": 272,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2094
  },
  {
    "id": "chunk_02095",
    "text": "13 251 ymotcesaV How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support she can give to her partner. A female partner can: \u2022 Understand that vasectomy is permanent \u2022 Discuss as a couple whether they will want more children",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2095
  },
  {
    "id": "chunk_02096",
    "text": "s as a couple whether they will want more children \u2022 If they will not want more children, support his decision to end his fertility \u2022 Discuss the alternative of female sterilization \u2022 Discuss how they are going to prevent pregnancy during the first 3",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2096
  },
  {
    "id": "chunk_02097",
    "text": "are going to prevent pregnancy during the first 3 months after the procedure, while waiting for vasectomy to become effective\u2014either use condoms or another method during this time \u2022 Show understanding and support him through the procedure and recovery",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2097
  },
  {
    "id": "chunk_02098",
    "text": "and support him through the procedure and recovery \u2022 Use female condoms consistently or encourage him to use male condoms consistently in addition to vasectomy if either partner has an STI/HIV or may be at risk of an STI/HIV \u201cCome Back Any Time\u201d: Reasons to Return",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2098
  },
  {
    "id": "chunk_02099",
    "text": "an STI/HIV \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that he is welcome to come back any time\u2014for example, if he has problems or questions, or his partner thinks she might be pregnant. (A few vasectomies fail and the men\u2019s partners become pregnant.) Also if:",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2099
  },
  {
    "id": "chunk_02100",
    "text": "and the men\u2019s partners become pregnant.) Also if: \u2022 He has bleeding, pain, pus, heat, swelling, or redness in the genital area that becomes worse or does not go away. General health advice: Anyone who suddenly feels that something is seriously",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2100
  },
  {
    "id": "chunk_02101",
    "text": "one who suddenly feels that something is seriously wrong with his health after a vasectomy procedure should immediately seek medical care from a nurse or doctor. After a surgical procedure any health problem must be assessed carefully and considered to be related to the",
    "page_number": 273,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2101
  },
  {
    "id": "chunk_02102",
    "text": "Managing Any Problems Problems Reported as Complications \u2022 Problems affect men\u2019s satisfaction with vasectomy. They deserve the pro- vider\u2019s attention. If the client reports complications of vasectomy, listen to his concerns, give advice and support, and, if appropriate, treat. Make sure",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2102
  },
  {
    "id": "chunk_02103",
    "text": "and support, and, if appropriate, treat. Make sure he understands the advice and agrees. Bleeding or blood clots after the procedure \u2022 Reassure him that minor bleeding and small uninfected blood clots usually go away without treatment within a couple of weeks.",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2103
  },
  {
    "id": "chunk_02104",
    "text": "o away without treatment within a couple of weeks. \u2022 Large blood clots may need to be surgically drained. \u2022 Infected blood clots require antibiotics and hospitalization. Infection at the puncture or incision site (redness, heat, pain, pus) \u2022 Clean the infected area with soap and water or antiseptic.",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2104
  },
  {
    "id": "chunk_02105",
    "text": "e infected area with soap and water or antiseptic. \u2022 Give oral antibiotics for 7 to 10 days. \u2022 Ask the client to return after taking all antibiotics if the infection has not cleared. Abscess (a pocket of pus under the skin caused by infection) \u2022 Clean the area with antiseptic.",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2105
  },
  {
    "id": "chunk_02106",
    "text": "ed by infection) \u2022 Clean the area with antiseptic. \u2022 Cut open (incise) and drain the abscess. \u2022 Treat the wound. \u2022 Give oral antibiotics for 7 to 10 days. \u2022 Ask the client to return after taking all antibiotics if he has heat, redness, pain, or drainage of the wound. Pain lasting for months",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2106
  },
  {
    "id": "chunk_02107",
    "text": "or drainage of the wound. Pain lasting for months \u2022 Suggest elevating the scrotum with snug underwear or pants or an athletic supporter. \u2022 Suggest soaking in warm water. \u2022 Suggest aspirin (325\u2013650 mg), ibuprofen (200\u2013400 mg), paracetamol (325\u20131,000 mg), or other pain reliever.",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2107
  },
  {
    "id": "chunk_02108",
    "text": "aracetamol (325\u20131,000 mg), or other pain reliever. \u2022 Provide antibiotics if infection is suspected. \u2022 If pain persists and cannot be tolerated, refer for further care (see Question 2, next page). 252 Family Planning: A Global Handbook for Providers",
    "page_number": 274,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2108
  },
  {
    "id": "chunk_02109",
    "text": "13 253 ymotcesaV Questions and Answers About Vasectomy 1. Will vasectomy make a man lose his sexual ability? Will it make him weak or fat? No. After vasectomy, a man will look and feel the same as before. He can have sex the same as before. His erections will be as hard and last as long as",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2109
  },
  {
    "id": "chunk_02110",
    "text": "His erections will be as hard and last as long as before, and ejaculations of semen will be the same. He can work as hard as before, and he will not gain weight because of the vasectomy. 2. Will there be any long-lasting pain from vasectomy?",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2110
  },
  {
    "id": "chunk_02111",
    "text": "ill there be any long-lasting pain from vasectomy? Some men report having chronic pain or discomfort in the scrotum or testicles that can last from 1 to 5 years or more after a vasectomy. In the largest studies, involving several thousand men, less than 1%",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2111
  },
  {
    "id": "chunk_02112",
    "text": "dies, involving several thousand men, less than 1% reported pain in the scrotum or testicles that had to be treated with surgery. In smaller studies, of about 200 men, as many as 6% reported severe pain in the scrotum or testicles more than 3 years after the",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2112
  },
  {
    "id": "chunk_02113",
    "text": "e scrotum or testicles more than 3 years after the vasectomy. In a similar group of men who did not have vasectomies, however, 2% reported similar pain. Few men with severe pain say that they regret having the vasectomy. The cause of the pain is unknown.",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2113
  },
  {
    "id": "chunk_02114",
    "text": "g the vasectomy. The cause of the pain is unknown. It may result from pressure caused by the build-up of sperm that has leaked from an improperly sealed or tied vas deferens, or from nerve damage. Treatment includes elevating the scrotum and taking pain",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2114
  },
  {
    "id": "chunk_02115",
    "text": "ent includes elevating the scrotum and taking pain relievers. An anesthetic can be injected into the spermatic cord to numb the nerves to the testicles. Some providers report that surgery to remove the painful site or reversing the vasectomy relieves the pain.",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2115
  },
  {
    "id": "chunk_02116",
    "text": "site or reversing the vasectomy relieves the pain. Severe, long-lasting pain following vasectomy is uncommon, but all men considering a vasectomy should be told about this risk. 3. Does a man need to use another contraceptive method after a vasectomy?",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2116
  },
  {
    "id": "chunk_02117",
    "text": "se another contraceptive method after a vasectomy? Yes, for the first 3 months. If his partner has been using a contraceptive method, she can continue to use it during this time. Not using another method in the first 3 months is the main cause of pregnancies among couples relying on vasectomy.",
    "page_number": 275,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2117
  },
  {
    "id": "chunk_02118",
    "text": "4. Is it possible to check if a vasectomy is working? Yes. A provider can examine a semen sample under a microscope to see if it still contains sperm. If the provider sees no moving (motile) sperm, the vasectomy is working. A semen examination is recommended at any",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2118
  },
  {
    "id": "chunk_02119",
    "text": "working. A semen examination is recommended at any time after 3 months following the procedure, but it is not essential. If there is less than one nonmotile sperm per 10 high-power fields (less than 100,000 sperm per milliliter) in the fresh sample, then the",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2119
  },
  {
    "id": "chunk_02120",
    "text": "perm per milliliter) in the fresh sample, then the man can rely on his vasectomy and stop using a backup method for contraception. If his semen contains more moving sperm, the man should continue to use a backup method and return to the clinic",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2120
  },
  {
    "id": "chunk_02121",
    "text": "ue to use a backup method and return to the clinic monthly for semen analysis. If his semen continues to have moving sperm, he may need to have a repeat vasectomy. 5. What if a man\u2019s partner gets pregnant? Every man having a vasectomy should know that vasectomies sometimes",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2121
  },
  {
    "id": "chunk_02122",
    "text": "a vasectomy should know that vasectomies sometimes fail and his partner could become pregnant as a result. He should not make the assumption that his partner was unfaithful if she becomes pregnant. If a man\u2019s partner becomes pregnant during the first 3 months",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2122
  },
  {
    "id": "chunk_02123",
    "text": "partner becomes pregnant during the first 3 months after his vasectomy, remind the man that for the first 3 months they needed to use another contraceptive method. If possible, offer a semen analysis and, if sperm are found, a repeat vasectomy. 6. Will the vasectomy stop working after a time?",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2123
  },
  {
    "id": "chunk_02124",
    "text": ". 6. Will the vasectomy stop working after a time? Generally, no. Vasectomy is intended to be permanent. In rare cases, however, the tubes that carry sperm grow back together and the man will require a repeat vasectomy. 7. Can a man have his vasectomy reversed if he decides that he",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2124
  },
  {
    "id": "chunk_02125",
    "text": "have his vasectomy reversed if he decides that he wants another child? Generally, no. Vasectomy is intended to be permanent. People who may want more children should choose a different family planning method. Surgery to reverse vasectomy is possible for only some",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2125
  },
  {
    "id": "chunk_02126",
    "text": "ery to reverse vasectomy is possible for only some men, and reversal often does not lead to pregnancy. The procedure is difficult and expensive, and providers who are able to perform such surgery are hard to find. Thus, vasectomy should be considered irreversible.",
    "page_number": 276,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2126
  },
  {
    "id": "chunk_02127",
    "text": "13 255 ymotcesaV 8. Is it better for the man to have a vasectomy or for the woman to have female sterilization? Each couple must decide for themselves which method is best for them. Both are very effective, safe, permanent methods for couples who know",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2127
  },
  {
    "id": "chunk_02128",
    "text": "tive, safe, permanent methods for couples who know that they will not want more children. Ideally, a couple should consider both methods. If both are acceptable to the couple, vasectomy would be preferable because it is simpler, safer, easier, and less expensive than female sterilization.",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2128
  },
  {
    "id": "chunk_02129",
    "text": "ier, and less expensive than female sterilization. 9. How can health care providers help a man decide about vasectomy? Provide clear, balanced information about vasectomy and other family planning methods, and help a man think through his decision fully.",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2129
  },
  {
    "id": "chunk_02130",
    "text": ", and help a man think through his decision fully. Thoroughly discuss his feelings about having children and ending his fertility. For example, a provider can help a man think how he would feel about possible life changes such as a change of partner or a child\u2019s",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2130
  },
  {
    "id": "chunk_02131",
    "text": "e changes such as a change of partner or a child\u2019s death. Review The 7 Points of Informed Consent to be sure the man understands the vasectomy procedure (see p. 247). 10. Should vasectomy be offered only to men who have reached a certain age or have a certain number of children?",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2131
  },
  {
    "id": "chunk_02132",
    "text": "certain age or have a certain number of children? No. There is no justification for denying vasectomy to a man just because of his age, the number of his living children, or his marital status. Health care providers must not impose rigid rules about age, number of",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2132
  },
  {
    "id": "chunk_02133",
    "text": "s must not impose rigid rules about age, number of children, age of last child, or marital status. Each man must be allowed to decide for himself whether or not he will want more children and whether or not to have a vasectomy. Questions and Answers About Vasectomy",
    "page_number": 277,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2133
  },
  {
    "id": "chunk_02134",
    "text": "11. Does vasectomy increase a man\u2019s risk of cancer or heart disease later in life? No. Evidence from large, well-designed studies shows that vasectomy does not increase risks of cancer of the testicles (testicular cancer) or cancer of the prostate (prostate cancer) or heart disease.",
    "page_number": 278,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2134
  },
  {
    "id": "chunk_02135",
    "text": "f the prostate (prostate cancer) or heart disease. 12. Can a man who has a vasectomy transmit or become infected with sexually transmitted infections (STIs), including HIV? Yes. Vasectomies do not protect against STIs, including HIV. All",
    "page_number": 278,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2135
  },
  {
    "id": "chunk_02136",
    "text": "es do not protect against STIs, including HIV. All men at risk of STIs, including HIV, whether or not they have had vasectomies, need to use condoms to protect themselves and their partners from infection. 13. Where can vasectomies be performed?",
    "page_number": 278,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2136
  },
  {
    "id": "chunk_02137",
    "text": "infection. 13. Where can vasectomies be performed? If no pre-existing medical conditions require special arrangements, vasectomy can be performed in almost any health facility, including health care centers, family planning clinics, and the treatment",
    "page_number": 278,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2137
  },
  {
    "id": "chunk_02138",
    "text": "enters, family planning clinics, and the treatment rooms of private doctors. Where other vasectomy services are not available, mobile teams can perform vasectomies and any follow-up examinations in basic health facilities and specially equipped vehicles,",
    "page_number": 278,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2138
  },
  {
    "id": "chunk_02139",
    "text": "health facilities and specially equipped vehicles, so long as basic medications, supplies, instruments, and equipment can be made available. 256 Family Planning: A Global Handbook for Providers",
    "page_number": 278,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2139
  },
  {
    "id": "chunk_02140",
    "text": "14 257 smodnoC elaM CHAPTER 14 Male Condoms This chapter describes male latex condoms. Female condoms are inserted into a woman\u2019s vagina (see Chapter 15). For a comparison, see the job aid Comparing Condoms, pp. 450\u2013451. Key Points for Providers and Clients",
    "page_number": 279,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2140
  },
  {
    "id": "chunk_02141",
    "text": "pp. 450\u2013451. Key Points for Providers and Clients y Male condoms help protect against sexually transmitted infections, including HIV. Condoms are the only contraceptive method that can protect against both pregnancy and sexually transmitted infections.",
    "page_number": 279,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2141
  },
  {
    "id": "chunk_02142",
    "text": "oth pregnancy and sexually transmitted infections. y Require correct use with every act of sex for greatest effectiveness. y Require both male and female partner\u2019s cooperation. Talking about condom use before sex can improve the chances one will be used.",
    "page_number": 279,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2142
  },
  {
    "id": "chunk_02143",
    "text": "fore sex can improve the chances one will be used. y May dull the sensation of sex for some men. Discussion between partners sometimes can help overcome this objection. What Are Male Condoms? y Sheaths, or coverings, that fit over a man\u2019s erect penis.",
    "page_number": 279,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2143
  },
  {
    "id": "chunk_02144",
    "text": ", or coverings, that fit over a man\u2019s erect penis. y Also called rubbers, \u201craincoats,\u201d \u201cumbrellas,\u201d skins, prophylactics and preservativos; known by many different brand names. y Most are made of thin latex rubber. Male condoms also are made",
    "page_number": 279,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2144
  },
  {
    "id": "chunk_02145",
    "text": "e of thin latex rubber. Male condoms also are made from other materials, including polyurethane, polyisoprene, lambskin, and nitrile. y Work by forming a barrier that keeps sperm out of the vagina, preventing pregnancy. Also keep infections in semen, on the penis, or in the vagina",
    "page_number": 279,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2145
  },
  {
    "id": "chunk_02146",
    "text": "How Effective? More effective Effectiveness depends on the user: Risk of pregnancy or sexually transmitted infection (STI) is greatest when condoms are not used with every act of sex. Very few pregnancies or infections occur due to incorrect use, slips, or breaks. Protection against pregnancy:",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2146
  },
  {
    "id": "chunk_02147",
    "text": "e, slips, or breaks. Protection against pregnancy: y As commonly used, about 13 pregnancies per 100 women whose partners use male condoms over the first year. This means that 87 of every 100 women whose partners use male condoms will not become pregnant.",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2147
  },
  {
    "id": "chunk_02148",
    "text": "artners use male condoms will not become pregnant. y When used correctly with every act of sex, about 2 pregnancies per 100 women whose partners use male condoms over the first year. Less effective Return of fertility after use of condoms is stopped: No delay Protection against HIV and other STIs:",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2148
  },
  {
    "id": "chunk_02149",
    "text": "d: No delay Protection against HIV and other STIs: y Male condoms significantly reduce the risk of becoming infected with HIV when used correctly with every act of vaginal or anal sex. y When used consistently and correctly, condom use prevents 80% to 95% of HIV",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2149
  },
  {
    "id": "chunk_02150",
    "text": "d correctly, condom use prevents 80% to 95% of HIV transmission that would have occurred without condoms (see Question 2, p. 267). y Condoms reduce the risk of becoming infected with many STIs when used consistently and correctly during vaginal or anal sex.",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2150
  },
  {
    "id": "chunk_02151",
    "text": "istently and correctly during vaginal or anal sex. \u2013 Protect best against STIs spread by discharge, such as HIV, gonorrhea, and chlamydia. \u2013 Also protect against STIs spread by skin-to-skin contact, such as herpes and human papillomavirus. Side Effects, Health Benefits, and Health Risks Side Effects",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2151
  },
  {
    "id": "chunk_02152",
    "text": "ts, Health Benefits, and Health Risks Side Effects None Known Health Benefits Known Health Risks Help protect against: Extremely rare: y Risks of pregnancy y Severe allergic reaction (among y STIs, including HIV people with latex allergy) May help protect against: y Conditions caused by STIs:",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2152
  },
  {
    "id": "chunk_02153",
    "text": "help protect against: y Conditions caused by STIs: \u2212 Recurring pelvic inflammatory disease and chronic pelvic pain \u2212 Cervical cancer \u2212 Infertility (male and female) 258 Family Planning: A Global Handbook for Providers",
    "page_number": 280,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2153
  },
  {
    "id": "chunk_02154",
    "text": "14 259 smodnoC elaM Why Some Men and Women Say They Like Condoms y Have no hormonal side effects y Can be used as a regular, temporary or backup method y Can be used without seeing a health care provider y Are sold in many places and generally easy to obtain",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2154
  },
  {
    "id": "chunk_02155",
    "text": "e sold in many places and generally easy to obtain y Help protect against both pregnancy and STIs, including HIV y Can make sex last longer Bringing Up Condom Use Some women find it hard to discuss their desire to use condoms with their partners. Others have difficulty persuading their",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2155
  },
  {
    "id": "chunk_02156",
    "text": "partners. Others have difficulty persuading their partners to use condoms every time they have sex. Men give different reasons for not using condoms. Some do not like the way condoms can dull the sensation of sex. Sometimes men\u2019s reasons are based on rumors or",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2156
  },
  {
    "id": "chunk_02157",
    "text": "ex. Sometimes men\u2019s reasons are based on rumors or misunderstanding. Having the facts can help a woman respond to her partner\u2019s objections (see Correcting Misunderstandings, next page). Talking first can help. Woman who talk to their partners about using",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2157
  },
  {
    "id": "chunk_02158",
    "text": "help. Woman who talk to their partners about using condoms before they begin to have sex can improve the chances that condoms are used. Women can try the approaches they think are best, depending on the partner and the circumstances. Some points",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2158
  },
  {
    "id": "chunk_02159",
    "text": "on the partner and the circumstances. Some points that have been persuasive in different situations include: y Emphasizing use of condoms for pregnancy prevention rather than STI protection. y Appealing to concern for each other\u2014for example: \u201cMany people in",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2159
  },
  {
    "id": "chunk_02160",
    "text": "oncern for each other\u2014for example: \u201cMany people in the community have HIV infection, so we need to be careful.\u201d y Suggesting that condom use can make sex more pleasurable for both of you. y Taking an uncompromising stance\u2014for example: \u201cI cannot have sex with you unless you use a condom.\u201d",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2160
  },
  {
    "id": "chunk_02161",
    "text": "cannot have sex with you unless you use a condom.\u201d y Suggesting to try a female condom, if available. Some men prefer them to male condoms. y For pregnant women, discussing the risks that STIs pose to the health of the baby and stressing how condoms can help protect the baby.",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2161
  },
  {
    "id": "chunk_02162",
    "text": "d stressing how condoms can help protect the baby. Also, a woman can suggest that her partner or the couple together come to the clinic for counseling on the importance of condom use. Side Effects, Health Benefits, and Health Risks",
    "page_number": 281,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2162
  },
  {
    "id": "chunk_02163",
    "text": "Correcting Misunderstandings (see also Questions and Answers, p. 267) Male condoms: y Do not make men sterile, impotent, or weak. y Do not decrease men\u2019s sex drive. y Cannot get lost in the woman\u2019s body. y Do not have holes that HIV can pass through. y Are not laced with HIV.",
    "page_number": 282,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2163
  },
  {
    "id": "chunk_02164",
    "text": "at HIV can pass through. y Are not laced with HIV. y Do not cause illness in a woman. Exposure to semen or sperm is not needed for a woman\u2019s good health. y Do not cause illness in men by making sperm \u201cback up\u201d. y Not only for use outside marriage. They are also used by married couples.",
    "page_number": 282,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2164
  },
  {
    "id": "chunk_02165",
    "text": "e marriage. They are also used by married couples. y Do not cause cancer and do not contain cancer-causing chemicals. Who Can and Cannot Use Male Condoms Medical Eligibility Criteria for Male Condoms All men and women can safely use latex male condoms except those with:",
    "page_number": 282,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2165
  },
  {
    "id": "chunk_02166",
    "text": "n safely use latex male condoms except those with: y Severe allergic reaction to latex rubber In special circumstances, such as high risk of STIs or HIV, if non-latex condoms are not available, a qualified provider who can carefully assess the man\u2019s or woman\u2019s condition and situation may decide that",
    "page_number": 282,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2166
  },
  {
    "id": "chunk_02167",
    "text": "or woman\u2019s condition and situation may decide that he or she can use latex condoms. Male condoms made from materials other than latex do not cause allergic reactions. For more information on latex allergy, see Mild irritation in or around",
    "page_number": 282,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2167
  },
  {
    "id": "chunk_02168",
    "text": "on latex allergy, see Mild irritation in or around the vagina or penis or mild allergic reaction to condom, p. 266; Severe allergic reaction to condom, p. 266; and Question 11, p. 270. 260 Family Planning: A Global Handbook for Providers",
    "page_number": 282,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2168
  },
  {
    "id": "chunk_02169",
    "text": "14 261 smodnoC elaM Providing Male Condoms When to Start y Any time, whenever a man or a couple wants protection from pregnancy or STIs. Explaining How to Use IMPORTANT: Whenever possible, show clients how to put on a condom. Use a model of a penis, if available, or other item, like a banana, to",
    "page_number": 283,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2169
  },
  {
    "id": "chunk_02170",
    "text": "is, if available, or other item, like a banana, to demonstrate. Basic Steps Important Details 1. Use a new y Check the condom package. condom for Do not use if torn or damaged. each act of sex Avoid using a condom past the expiration date. Do so only if a newer condom is not available.",
    "page_number": 283,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2170
  },
  {
    "id": "chunk_02171",
    "text": "te. Do so only if a newer condom is not available. y Tear open the package carefully. Do not use fingernails, teeth, or anything that can damage the condom. 2. Before any y For the most protection, put physical contact, the condom on before the place the penis makes any genital, oral,",
    "page_number": 283,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2171
  },
  {
    "id": "chunk_02172",
    "text": "efore the place the penis makes any genital, oral, condom on the or anal contact. tip of the erect penis with the rolled side out 3. Unroll the y The condom should unroll condom all the easily. Forcing it on could cause way to the base it to break during use. of the erect",
    "page_number": 283,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2172
  },
  {
    "id": "chunk_02173",
    "text": "y to the base it to break during use. of the erect y If the condom does not unroll penis easily, it may be on backwards, damaged, or too old. Throw it away and use a new condom. y If the condom is on backwards and another one is not available, turn it over and unroll it onto the penis.",
    "page_number": 283,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2173
  },
  {
    "id": "chunk_02174",
    "text": "Basic Steps Important Details (continued) 4. Immediately y Withdraw the penis. after y Slide the condom off, avoiding ejaculation, hold spilling semen. the rim of the condom in place y If having sex again or switching and withdraw from one sex act to another, the penis while use a new condom.",
    "page_number": 284,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2174
  },
  {
    "id": "chunk_02175",
    "text": "act to another, the penis while use a new condom. it is still erect 5. Dispose of y Wrap the condom in its the used package and put it in the condom safely rubbish bin or latrine. Do not put the condom into a flush toilet, as it can cause problems with plumbing. What Condom Users Should Not Do",
    "page_number": 284,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2175
  },
  {
    "id": "chunk_02176",
    "text": "ems with plumbing. What Condom Users Should Not Do Some practices can increase the risk that the condom will break and should be avoided. y Do not unroll the condom first and then try to put it on the penis. y Do not use lubricants with an oil base. See box on the next page.",
    "page_number": 284,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2176
  },
  {
    "id": "chunk_02177",
    "text": "icants with an oil base. See box on the next page. y Do not use a condom if the color is uneven or changed. y Do not use a condom that feels brittle, dried out, or very sticky. y Do not reuse condoms. y Do not have dry sex. y Do not use more than one condom at the same time.",
    "page_number": 284,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2177
  },
  {
    "id": "chunk_02178",
    "text": "Do not use more than one condom at the same time. y Do not use a male and female condom at the same time. Also, do not use the same condom when switching between different penetrative sex acts, such as from anal to vaginal sex. This can transfer bacteria that can cause infection.",
    "page_number": 284,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2178
  },
  {
    "id": "chunk_02179",
    "text": "14 263 smodnoC elaM Lubricants for Latex Condoms Lubrication helps encourage condom use and avoid condom breakage. There are 3 ways to provide lubrication\u2014natural vaginal secretions, adding a lubricant safe for use with condoms, or using condoms packaged with lubricant on them.",
    "page_number": 285,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2179
  },
  {
    "id": "chunk_02180",
    "text": "or using condoms packaged with lubricant on them. Clean water and saliva can be used for lubrication. The lubricants packaged with condoms are usually made of silicone. Silicone lubricants are also packaged separately. Lubricants made with",
    "page_number": 285,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2180
  },
  {
    "id": "chunk_02181",
    "text": "are also packaged separately. Lubricants made with water or glycol are also available, safe to use, and may be cheaper. Lubricants should be applied on the outside of the condom, in the vagina, or in the anus (but not on the penis). A drop or two",
    "page_number": 285,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2181
  },
  {
    "id": "chunk_02182",
    "text": "in the anus (but not on the penis). A drop or two of lubricant on the inside of the tip of the condom before it is unrolled can help increase the sensation of sex for some men. Too much lubricant inside, however, can make the condom slip off.",
    "page_number": 285,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2182
  },
  {
    "id": "chunk_02183",
    "text": "ant inside, however, can make the condom slip off. Lubricants made with oil can damage latex, so do not use the following with latex condoms: y any oils (cooking, baby, coconut, mineral) or products made with oil y petroleum jelly y lotions y cold creams y cocoa butter y butter y margarine",
    "page_number": 285,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2183
  },
  {
    "id": "chunk_02184",
    "text": "Supporting New and Continuing Users Ensure client y Ask the client to explain the 5 basic steps of using understands a condom by putting it on a model or other object correct use and then taking it off. When counseling, you can show the pictures on p. 261.",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2184
  },
  {
    "id": "chunk_02185",
    "text": "n counseling, you can show the pictures on p. 261. Ask clients how y Give plenty of condoms and, if available, a water- many condoms or silicone-based lubricant. Oil-based lubricants they will need should not be used with latex condoms. See box until they can on previous page. return",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2185
  },
  {
    "id": "chunk_02186",
    "text": "s. See box until they can on previous page. return y Tell clients where they can buy condoms, if needed. Explain why using y Just one unprotected act of sex can lead to a condom with pregnancy or STI \u2014or both. every act of sex y If a condom is not used for one act of sex, try to is important",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2186
  },
  {
    "id": "chunk_02187",
    "text": "s not used for one act of sex, try to is important use one the next time. A mistake once or twice does not mean that it is pointless to use condoms in the future. Explain about y Explain ECP use in case of errors in condom use\u2014 emergency including not using a condom\u2014to help",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2187
  },
  {
    "id": "chunk_02188",
    "text": "se\u2014 emergency including not using a condom\u2014to help contraceptive prevent pregnancy (see Chapter 3 \u2013 Emergency pills (ECPs) Contraceptive Pills). Give ECPs, if available. Discuss ways to y Discuss skills and techniques for negotiating talk about using condom use with partners (see Bringing Up",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2188
  },
  {
    "id": "chunk_02189",
    "text": "ut using condom use with partners (see Bringing Up condoms Condom Use, p. 259). How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support she can give to her partner. A female partner can: y Support a man\u2019s choice of male condoms",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2189
  },
  {
    "id": "chunk_02190",
    "text": "tner can: y Support a man\u2019s choice of male condoms y Discuss and agree to use the male condom with a full understanding of how to use it y Help him remember to use a condom every time y Help him to use the condom correctly y Help to keep a supply on hand",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2190
  },
  {
    "id": "chunk_02191",
    "text": "e condom correctly y Help to keep a supply on hand y Make sure she has ECPs on hand in case the condom slips or breaks, or if they forget to use it 264 Family Planning: A Global Handbook for Providers",
    "page_number": 286,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2191
  },
  {
    "id": "chunk_02192",
    "text": "14 265 smodnoC elaM \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she or he is welcome to come back any time\u2014for example, if he or she has problems, questions, or wants another method or she thinks she might be pregnant. Also if:",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2192
  },
  {
    "id": "chunk_02193",
    "text": "thod or she thinks she might be pregnant. Also if: y Client has difficulty using condoms correctly or every time he or she has sex. y Client has signs or symptoms of severe allergic reaction to latex condom (see Severe allergic reaction to condom, p. 266).",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2193
  },
  {
    "id": "chunk_02194",
    "text": "(see Severe allergic reaction to condom, p. 266). y Woman recently had unprotected sex and wants to avoid pregnancy. She may be able to use ECPs (see Chapter 3 \u2013 Emergency Contraceptive Pills). Repeat Visits 1. Ask clients how they are doing with the method and whether they are",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2194
  },
  {
    "id": "chunk_02195",
    "text": "hey are doing with the method and whether they are satisfied. Ask if they have any questions or anything to discuss. 2. Ask especially if they are having any trouble using condoms correctly and every time they have sex. Give clients any information or help that they",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2195
  },
  {
    "id": "chunk_02196",
    "text": "ex. Give clients any information or help that they need (see Managing Any Problems, below). 3. Give clients more condoms and encourage them to come back for more before their supply runs out. Remind them where else they can obtain condoms.",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2196
  },
  {
    "id": "chunk_02197",
    "text": "t. Remind them where else they can obtain condoms. 4. Ask a long-term client about major life changes that may affect her or his needs\u2014particularly plans for having children and STI/HIV risk. Follow up as needed. Managing Any Problems Problems With Use May or may not be due to the method.",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2197
  },
  {
    "id": "chunk_02198",
    "text": "lems With Use May or may not be due to the method. y Problems with condoms affect clients\u2019 satisfaction and use of the method. They deserve the provider\u2019s attention. If the client reports any problems, listen to the client\u2019s concerns and give advice and support. Make sure he",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2198
  },
  {
    "id": "chunk_02199",
    "text": "concerns and give advice and support. Make sure he understands the advice and agrees. y Offer to help the client choose another method\u2014now, if he or she wishes, or if problems cannot be overcome\u2014unless condoms are needed for protection from STIs, including HIV.",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2199
  },
  {
    "id": "chunk_02200",
    "text": "re needed for protection from STIs, including HIV. Condom breaks, slips off the penis, or is not used y ECPs can help prevent pregnancy in such cases (see Chapter 3). If a man notices a break or slip, he should tell his partner so that she can use ECPs if she wants.",
    "page_number": 287,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2200
  },
  {
    "id": "chunk_02201",
    "text": "y If a client reports that a condom broke, slipped off, or was not used, refer for possible post-exposure prophylaxis against HIV and possible presumptive treatment against other STIs (see Question 7, p. 269). If the client has signs or symptoms of STIs after having unprotected sex, assess or refer.",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2201
  },
  {
    "id": "chunk_02202",
    "text": "TIs after having unprotected sex, assess or refer. y If a client reports breaks or slips: \u2212 Ask clients to show how they are opening the condom package and putting the condom on, using a model or other item. Correct any errors. \u2212 Ask if any lubricants are being used. The wrong lubricant or too little",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2202
  },
  {
    "id": "chunk_02203",
    "text": "are being used. The wrong lubricant or too little lubricant can increase breakage (see Lubricants for Latex Condoms, p. 262). Too much lubricant can cause the condom to slip off. \u2212 Ask when the man withdraws his penis. Waiting too long to withdraw,",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2203
  },
  {
    "id": "chunk_02204",
    "text": "withdraws his penis. Waiting too long to withdraw, when the erection begins to subside, can increase the chance of slips. Difficulty putting on the condom y Ask clients to show how they put the condom on, using a model or other item. Correct any errors.",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2204
  },
  {
    "id": "chunk_02205",
    "text": ", using a model or other item. Correct any errors. Difficulty persuading partner to use condoms or not able to use a condom every time y Discuss ways to talk about condoms with partner (see Bringing Up Condom Use, p. 259) and also dual protection rationales (see Choosing a",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2205
  },
  {
    "id": "chunk_02206",
    "text": "nd also dual protection rationales (see Choosing a Dual Protection Strategy, p. 347, in Chapter 22 \u2013 STIs, Including HIV). y Consider combining condoms with: \u2212 Another effective contraceptive method for better pregnancy protection.",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2206
  },
  {
    "id": "chunk_02207",
    "text": "traceptive method for better pregnancy protection. \u2212 If no risk of STIs, a fertility awareness method, and using condoms only during the fertile time (see Chapter 18 \u2013 Fertility Awareness Methods). y Especially if the client or partner is at risk for STIs, encourage continued",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2207
  },
  {
    "id": "chunk_02208",
    "text": "r partner is at risk for STIs, encourage continued condom use while working out problems. If neither partner has an infection, a mutually faithful sexual relationship provides STI protection without requiring condom use but does not protect against pregnancy.",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2208
  },
  {
    "id": "chunk_02209",
    "text": "condom use but does not protect against pregnancy. Mild irritation in or around the vagina or penis or mild allergic reaction to condom (itching, redness, rash, and/or swelling of genitals, groin, or thighs during or after condom use)",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2209
  },
  {
    "id": "chunk_02210",
    "text": "tals, groin, or thighs during or after condom use) y Suggest trying another brand of condoms. A person may be more sensitive to one brand of condoms than to others. y Suggest putting lubricant or water on the condom to reduce rubbing that may cause irritation.",
    "page_number": 288,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2210
  },
  {
    "id": "chunk_02211",
    "text": "14 267 smodnoC elaM y If symptoms persist, assess or refer for possible vaginal infection or STI as appropriate. \u2212 If there is no infection and irritation continues or recurs, the client may have an allergy to latex. \u2212 If not at risk of STIs, including HIV, help the client choose another method.",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2211
  },
  {
    "id": "chunk_02212",
    "text": "luding HIV, help the client choose another method. \u2212 If the client or partner is at risk for STIs, suggest using female condoms or plastic male condoms, if available. If not available, urge continued use of latex condoms. Tell the client to stop using latex",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2212
  },
  {
    "id": "chunk_02213",
    "text": "latex condoms. Tell the client to stop using latex condoms if symptoms become severe (see Severe allergic reaction to condom, below). \u2013 If neither partner has an infection, a mutually faithful sexual relationship provides STI protection without requiring condom use",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2213
  },
  {
    "id": "chunk_02214",
    "text": "ovides STI protection without requiring condom use but does not protect against pregnancy. New Problems That May Require Switching Methods May or may not be due to the method. Female partner is using miconazole or econazole (for treatment of vaginal infections)",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2214
  },
  {
    "id": "chunk_02215",
    "text": "or econazole (for treatment of vaginal infections) y A woman should not rely on latex condoms during vaginal use of miconazole or econazole. They can damage latex. (Oral treatment will not harm condoms.) y She should use female condoms or plastic male condoms, another",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2215
  },
  {
    "id": "chunk_02216",
    "text": "se female condoms or plastic male condoms, another contraceptive method, or abstain from sex until treatment is completed.. Severe allergic reaction to condom (hives or rash over much of body, dizziness, difficulty breathing, or loss of consciousness during or after",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2216
  },
  {
    "id": "chunk_02217",
    "text": "reathing, or loss of consciousness during or after condom use). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. y Tell the client to stop using latex condoms. y Refer for care, if necessary. Severe allergic reaction to latex could",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2217
  },
  {
    "id": "chunk_02218",
    "text": "necessary. Severe allergic reaction to latex could lead to life-threatening anaphylactic shock. Help the client choose another method. y If the client or partner cannot avoid risk of STIs, suggest they use female condoms or plastic male condoms, if available. If neither",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2218
  },
  {
    "id": "chunk_02219",
    "text": "or plastic male condoms, if available. If neither partner has an infection, a mutually faithful sexual relationship provides STI protection without requiring condom use but does not protect against pregnancy. Supporting New and Continuing Users",
    "page_number": 289,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2219
  },
  {
    "id": "chunk_02220",
    "text": "Questions and Answers About Male Condoms 1. Are condoms effective at preventing pregnancy? Yes, male condoms are effective, but only if used correctly with every act of sex. When used consistently and correctly, only 2 of every 100 women whose partners use condoms become pregnant over the first",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2220
  },
  {
    "id": "chunk_02221",
    "text": "artners use condoms become pregnant over the first year of use. Many people, however, do not use condoms every time they have sex or do not use them correctly. This reduces protection from pregnancy. 2. How well do condoms help protect against HIV infection?",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2221
  },
  {
    "id": "chunk_02222",
    "text": "ell do condoms help protect against HIV infection? On average, condoms are 80% to 95% effective in protecting people from HIV infection when used correctly with every act of sex. This means that condom use prevents 80% to 95% of HIV transmissions",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2222
  },
  {
    "id": "chunk_02223",
    "text": "ondom use prevents 80% to 95% of HIV transmissions that would have occurred without condoms. (It does not mean that 5% to 20% of condom users will become infected with HIV.) For example, among 10,000 uninfected women whose partners have HIV, if each",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2223
  },
  {
    "id": "chunk_02224",
    "text": "uninfected women whose partners have HIV, if each couple has vaginal sex just once and has no additional risk factors for infection, on average: y If all 10,000 did not use condoms, about 10 women would likely become infected with HIV.",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2224
  },
  {
    "id": "chunk_02225",
    "text": "ut 10 women would likely become infected with HIV. y If all 10,000 used condoms correctly, 1 or 2 women would likely become infected with HIV. The chances that a person who is exposed to HIV will become infected can vary greatly. These chances depend on the partner\u2019s stage of HIV",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2225
  },
  {
    "id": "chunk_02226",
    "text": "These chances depend on the partner\u2019s stage of HIV infection (early and late stages are more infectious), whether the person exposed has other STIs (increases susceptibility), male circumcision status (uncircumcised men are more likely to become infected with HIV), and",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2226
  },
  {
    "id": "chunk_02227",
    "text": "are more likely to become infected with HIV), and pregnancy (women who are pregnant may be at higher risk of infection), among other factors. On average, women face twice the risk of infection, if exposed, that men do. 3. Does using a condom only some of the time offer any",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2227
  },
  {
    "id": "chunk_02228",
    "text": "oes using a condom only some of the time offer any protection from STIs, including HIV? For best protection, a condom should be used with every act of sex. In some cases, however, occasional use can be protective. For example, if",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2228
  },
  {
    "id": "chunk_02229",
    "text": "occasional use can be protective. For example, if a person has a regular, faithful partner and has one act of sex outside of the relationship, using a condom for that one act can be very protective. For people who are exposed frequently to STIs, including HIV, however,",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2229
  },
  {
    "id": "chunk_02230",
    "text": "xposed frequently to STIs, including HIV, however, using a condom only some of the time will offer limited protection. 268 Family Planning: A Global Handbook for Providers",
    "page_number": 290,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2230
  },
  {
    "id": "chunk_02231",
    "text": "14 269 smodnoC elaM 4. Will using condoms reduce the risk of STI transmission during anal sex? Yes. STIs can be passed from one person to another during any sex act that inserts the penis into any part of another person\u2019s body (penetration). Some sex acts are riskier than others. For example, the",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2231
  },
  {
    "id": "chunk_02232",
    "text": "sex acts are riskier than others. For example, the risk of becoming infected with HIV is 5 times higher with unprotected receptive anal sex than with unprotected receptive vaginal sex. When using a latex condom for anal sex, a water- or silicone-based lubricant is",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2232
  },
  {
    "id": "chunk_02233",
    "text": "anal sex, a water- or silicone-based lubricant is essential to help keep the condom from breaking. 5. Are plastic (synthetic) condoms effective for preventing STIs, including HIV? Yes. Plastic condoms are expected to provide the same protection as",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2233
  },
  {
    "id": "chunk_02234",
    "text": "oms are expected to provide the same protection as latex condoms, but they have not been studied as thoroughly. Condoms made of animal membrane such as lambskin condoms (also called natural skin condoms) are not effective for preventing STIs, including HIV.",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2234
  },
  {
    "id": "chunk_02235",
    "text": "not effective for preventing STIs, including HIV. 6. Do condoms often break or slip off during sex? No. On average, about 2% of condoms break, tear, or slip off completely during sex, primarily because they are used incorrectly. Used properly, condoms seldom break. In some studies with higher",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2235
  },
  {
    "id": "chunk_02236",
    "text": "condoms seldom break. In some studies with higher breakage rates, often a few users experienced most of the breakage in the entire study. Other studies also suggest that, while most people use condoms correctly, there are a few who consistently misuse",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2236
  },
  {
    "id": "chunk_02237",
    "text": "correctly, there are a few who consistently misuse condoms, which leads to breaks or slips. Thus, it is important to teach people the right way to open, put on, and take off condoms (see p. 261) and also to avoid practices that increase the risk of breakage",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2237
  },
  {
    "id": "chunk_02238",
    "text": "avoid practices that increase the risk of breakage (see What Condom Users Should Not Do, p. 262). 7. What can men and women do to reduce the risk of pregnancy and STIs if a condom slips or breaks during sex? If a condom slips or breaks, taking emergency contraceptive pills can",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2238
  },
  {
    "id": "chunk_02239",
    "text": "r breaks, taking emergency contraceptive pills can reduce the risk that a woman will become pregnant (see Chapter 3 \u2013 Emergency Contraceptive Pills). If exposure to HIV is likely, treatment with antiretroviral medications (post-exposure prophylaxis), where",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2239
  },
  {
    "id": "chunk_02240",
    "text": "ral medications (post-exposure prophylaxis), where available, can help reduce HIV transmission. If exposure to other STIs is likely, a provider can treat presumptively for those STIs\u2014that is, treat the client as if he or she were infected.",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2240
  },
  {
    "id": "chunk_02241",
    "text": "s, treat the client as if he or she were infected. Washing the penis does not help prevent STIs. Vaginal douching is not very effective in preventing pregnancy, and it increases a woman\u2019s risk of acquiring STIs, including HIV, and pelvic inflammatory disease. Questions and Answers About Male Condoms",
    "page_number": 291,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2241
  },
  {
    "id": "chunk_02242",
    "text": "8. Can a man put 2 or 3 condoms on at once for more protection? There is little evidence for the benefits of using 2 or more condoms. It is generally not recommended because of concerns that friction between the condoms could increase the chance of breakage.",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2242
  },
  {
    "id": "chunk_02243",
    "text": "the condoms could increase the chance of breakage. 9. Will condoms make a man unable to have an erection (impotent)? No, not for most men. Impotence has many causes. Some causes are physical, some are emotional. Condoms themselves do not cause",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2243
  },
  {
    "id": "chunk_02244",
    "text": "ome are emotional. Condoms themselves do not cause impotence. A few men may have problems keeping an erection when using condoms, however. Other men\u2014especially older men\u2014may have difficulty keeping an erection because condoms can dull the sensation of",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2244
  },
  {
    "id": "chunk_02245",
    "text": "erection because condoms can dull the sensation of having sex. Using more lubrication may help increase sensation for men using condoms. 10. Aren\u2019t condoms used mainly in casual relationships or by people who have sex for money? No. While many casual partners rely on condoms for STI protection,",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2245
  },
  {
    "id": "chunk_02246",
    "text": "asual partners rely on condoms for STI protection, married couples all over the world use condoms for pregnancy protection, too. In Japan, for example, about 40% of married couples use condoms\u2014more than any other family planning method. 11. Is allergy to latex common?",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2246
  },
  {
    "id": "chunk_02247",
    "text": "y planning method. 11. Is allergy to latex common? No. Allergy to latex is uncommon in the general population, and reports of mild allergic reactions to condoms are very rare. Severe allergic reactions to condoms are extremely rare.",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2247
  },
  {
    "id": "chunk_02248",
    "text": "allergic reactions to condoms are extremely rare. People who have an allergic reaction to rubber gloves or balloons may have a similar reaction to latex condoms. A mild reaction involves redness, itching, rash, or swelling of the skin that comes in contact with",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2248
  },
  {
    "id": "chunk_02249",
    "text": "or swelling of the skin that comes in contact with latex rubber. A severe reaction involves hives or rash over much of the body, dizziness, difficulty breathing, or loss of consciousness after coming in contact with latex. Both men and women can be allergic to latex and latex condoms.",
    "page_number": 292,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2249
  },
  {
    "id": "chunk_02250",
    "text": "15 271 smodnoC elameF CHAPTER 15 Female Condoms Key Points for Providers and Clients y Female condoms help protect against sexually transmitted infections, including HIV. Condoms are the only contraceptive method that can protect against both pregnancy and sexually transmitted infections.",
    "page_number": 293,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2250
  },
  {
    "id": "chunk_02251",
    "text": "oth pregnancy and sexually transmitted infections. y Require correct use with every act of sex for greatest effectiveness. y A woman can initiate female condom use, but the method requires her partner\u2019s cooperation. y May require some practice. Inserting and removing the female",
    "page_number": 293,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2251
  },
  {
    "id": "chunk_02252",
    "text": "e some practice. Inserting and removing the female condom from the vagina becomes easier with experience. What Are Female Condoms? y Sheaths, or linings, that fit loosely inside a woman\u2019s vagina, made of thin, transparent, soft film. \u2013 Have flexible rings at both ends",
    "page_number": 293,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2252
  },
  {
    "id": "chunk_02253",
    "text": "ent, soft film. \u2013 Have flexible rings at both ends \u2013 One ring at the closed end helps to insert the condom \u2013 The ring at the open end holds part of the condom outside the vagina y Female condoms are made of various materials, such as latex, polyurethane, and nitrile.",
    "page_number": 293,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2253
  },
  {
    "id": "chunk_02254",
    "text": "terials, such as latex, polyurethane, and nitrile. y Work by forming a barrier that keeps sperm out of the vagina, preventing pregnancy. Also helps to keep infections in semen, on the penis, or in the vagina from infecting the other partner. Female Condoms",
    "page_number": 293,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2254
  },
  {
    "id": "chunk_02255",
    "text": "How Effective? Effectiveness depends on the user: Risk of pregnancy or sexually More transmitted infection (STI) is greatest when female condoms are effective not used with every act of sex. Few pregnancies or infections occur due to incorrect use, slips, or breaks. Protection against pregnancy:",
    "page_number": 294,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2255
  },
  {
    "id": "chunk_02256",
    "text": "e, slips, or breaks. Protection against pregnancy: y As commonly used, about 21 pregnancies per 100 women using female condoms over the first year. This means that 79 of every 100 women using female condoms will not become pregnant. y When used correctly with every act of sex, about 5 pregnancies",
    "page_number": 294,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2256
  },
  {
    "id": "chunk_02257",
    "text": "rrectly with every act of sex, about 5 pregnancies per 100 women using female condoms over the first year. Less Return of fertility after use of female condom is stopped: No delay effective Protection against HIV and other STIs: y Female condoms reduce the risk of infection with STIs,",
    "page_number": 294,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2257
  },
  {
    "id": "chunk_02258",
    "text": "le condoms reduce the risk of infection with STIs, including HIV, when used correctly with every act of sex. Why Some Women Say They Like Female Condoms y Women can initiate their use y Have a soft, moist texture that feels more natural than male latex condoms during sex",
    "page_number": 294,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2258
  },
  {
    "id": "chunk_02259",
    "text": "ls more natural than male latex condoms during sex y Help protect against both pregnancy and STIs, including HIV y Outer ring provides added sexual stimulation for some women y Can be used without seeing a health care provider Why Some Men Say They Like Female Condoms",
    "page_number": 294,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2259
  },
  {
    "id": "chunk_02260",
    "text": "provider Why Some Men Say They Like Female Condoms y Can be inserted ahead of time so do not interrupt sex y Are not tight or constricting like male condoms y Do not dull the sensation of sex like male condoms y Do not have to be removed immediately after ejaculation",
    "page_number": 294,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2260
  },
  {
    "id": "chunk_02261",
    "text": "15 273 smodnoC elameF Side Effects, Health Benefits, and Health Risks Side Effects None Known Health Benefits Known Health Risks Help protect against: None y Risks of pregnancy y STIs, including HIV Correcting Misunderstandings (see also Questions and Answers, p. 269) Female condoms:",
    "page_number": 295,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2261
  },
  {
    "id": "chunk_02262",
    "text": "lso Questions and Answers, p. 269) Female condoms: y Cannot get lost in the woman\u2019s body. y Are not difficult to use, but correct use needs to be learned. y Do not have holes that HIV can pass through. y Are used by married couples. They are not only for use outside marriage.",
    "page_number": 295,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2262
  },
  {
    "id": "chunk_02263",
    "text": "uples. They are not only for use outside marriage. y Do not cause illness in a woman because they prevent semen or sperm from entering her body. Who Can Use Female Condoms Medical Eligibility Criteria for Female Condoms All women and men can use female condoms, except those with",
    "page_number": 295,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2263
  },
  {
    "id": "chunk_02264",
    "text": "and men can use female condoms, except those with severe allergic reaction to latex should not use latex female condoms. In special circumstances, such as high risk of STIs or HIV, if non-latex condoms are not available, a qualified provider who can carefully assess",
    "page_number": 295,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2264
  },
  {
    "id": "chunk_02265",
    "text": "ble, a qualified provider who can carefully assess the woman\u2019s or man\u2019s condition and situation may decide that she or he can use latex condoms. Condoms made from materials other than latex do not cause allergic reactions. For information on managing clients with latex allergy, see Chapter 14",
    "page_number": 295,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2265
  },
  {
    "id": "chunk_02266",
    "text": "anaging clients with latex allergy, see Chapter 14 \u2013 Male Condoms, section on Managing Any Problems, \u201cMild irritation in or around the vagina and penis or mild allergic reaction to condom\u201d and \u201cSevere allergic reaction to condom\u201d, p. 266. Who Can Use Female Condoms",
    "page_number": 295,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2266
  },
  {
    "id": "chunk_02267",
    "text": "Providing Female Condoms When to Start y Any time, whenever a woman or a couple wants protection from pregnancy or STIs. Explaining How to Use IMPORTANT: Whenever possible, show the client how to insert the female condom. Use a model or picture, if available, or your hands to demonstrate.",
    "page_number": 296,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2267
  },
  {
    "id": "chunk_02268",
    "text": "cture, if available, or your hands to demonstrate. You can create an opening similar to a vagina with one hand and show how to insert the female condom with the other hand. Basic Steps Important Details 1. Use a new y Check the condom package. Do not use if torn",
    "page_number": 296,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2268
  },
  {
    "id": "chunk_02269",
    "text": "new y Check the condom package. Do not use if torn female condom or damaged. Avoid using a condom past its for each act expiration date. Do so only if newer condoms are of sex not available. y If possible, wash your hands with mild soap and clean water before inserting the condom.",
    "page_number": 296,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2269
  },
  {
    "id": "chunk_02270",
    "text": "soap and clean water before inserting the condom. 2. Before any y For the most protection, insert the physical condom before the penis comes in contact, insert contact with the vagina. Can be the condom inserted up to 8 hours before sex. into the vagina y Choose a position that is comfortable",
    "page_number": 296,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2270
  },
  {
    "id": "chunk_02271",
    "text": "the vagina y Choose a position that is comfortable for insertion\u2014squat, raise one leg, sit, or lie down. y Rub the sides of the female condom together to spread the lubricant evenly. y Grasp the ring at the closed end, and squeeze it so it becomes long and narrow. y With the other hand, separate the",
    "page_number": 296,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2271
  },
  {
    "id": "chunk_02272",
    "text": "ng and narrow. y With the other hand, separate the outer lips (labia) and locate the opening of the vagina. y Gently push the inner ring into the vagina as far up as it will go. Insert a finger into the condom to push it into place. About 2 to 3 centimeters of the condom and the",
    "page_number": 296,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2272
  },
  {
    "id": "chunk_02273",
    "text": "15 275 smodnoC elameF Basic Steps Important Details 3. Ensure that y The man or woman should carefully guide the the penis tip of his penis inside the condom\u2014not between enters the the condom and the wall of the vagina. If his penis condom and goes outside the condom, withdraw and try again.",
    "page_number": 297,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2273
  },
  {
    "id": "chunk_02274",
    "text": "d goes outside the condom, withdraw and try again. stays inside y If the condom is accidentally pulled out of the the condom vagina or the outer ring is pushed into it during sex, put the condom back in place. 4. After the man y The female condom does not need to be removed",
    "page_number": 297,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2274
  },
  {
    "id": "chunk_02275",
    "text": "an y The female condom does not need to be removed withdraws his immediately after sex. penis, hold the y Remove the condom outer ring of before standing up, to the condom, avoid spilling semen. twist to seal in fluids, and y If the couple has sex gently pull it again, they should use",
    "page_number": 297,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2275
  },
  {
    "id": "chunk_02276",
    "text": "uple has sex gently pull it again, they should use out of the a new condom. vagina y Reuse of female condoms is not recommended (see Question 5, p. 280). 5. Dispose of y Wrap the condom in its package and put it in the the used rubbish bin or latrine. Do not put the condom",
    "page_number": 297,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2276
  },
  {
    "id": "chunk_02277",
    "text": "used rubbish bin or latrine. Do not put the condom condom safely into a flush toilet, as it can cause problems with plumbing. Providing Female Condoms",
    "page_number": 297,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2277
  },
  {
    "id": "chunk_02278",
    "text": "Supporting New and Continuing Users Ensure client y Ask the client to explain the 5 basic steps understands of using the female condom while handling one. correct use y If a model is available, the client can practice inserting the condom in the model and then taking it out.",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2278
  },
  {
    "id": "chunk_02279",
    "text": "ng the condom in the model and then taking it out. Ask the client how y Give plenty of condoms and, if available, many condoms lubricant. she thinks she will y Tell the client where she can buy female need until she can condoms, if needed. return",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2279
  },
  {
    "id": "chunk_02280",
    "text": "male need until she can condoms, if needed. return Explain why using y Just one unprotected act of sex can lead to a condom with pregnancy or STI\u2014or both. every act of sex y If a condom is not used for one act of sex, try is important to use one the next time. A mistake once or",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2280
  },
  {
    "id": "chunk_02281",
    "text": "ortant to use one the next time. A mistake once or twice does not mean that it is pointless to use condoms in the future. Explain about y Explain ECP use in case of errors in condom emergency use\u2014including not using a condom\u2014to help contraceptive prevent pregnancy (see Chapter 3 \u2013 Emergency",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2281
  },
  {
    "id": "chunk_02282",
    "text": "ptive prevent pregnancy (see Chapter 3 \u2013 Emergency pills (ECPs) Contraceptive Pills). Give ECPs if available. Discuss ways y Discuss skills and techniques for negotiating to talk about condom use with partners (see Bringing Up using condoms Condom Use in Chapter 14 \u2013 Male Condoms).",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2282
  },
  {
    "id": "chunk_02283",
    "text": "condoms Condom Use in Chapter 14 \u2013 Male Condoms). Lubricants for Female Condoms Some female condoms come pre-lubricated, and others come with a separately packaged lubricant. If a client needs additional lubrication, she can also use clean water, saliva, or a lubricant made of water,",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2283
  },
  {
    "id": "chunk_02284",
    "text": "clean water, saliva, or a lubricant made of water, glycol, or silicone. She also can use oil-based products such as coconut oil or butter with nitrile or polyurethane female condoms, but not with latex female condoms. Oil damages latex. 276 Family Planning: A Global Handbook for Providers",
    "page_number": 298,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2284
  },
  {
    "id": "chunk_02285",
    "text": "15 277 smodnoC elameF Tips for New Users y Suggest to a new user that she practice putting in and taking out the condom before the next time she has sex. Reassure her that correct use becomes easier with practice. A woman may need to use the female",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2285
  },
  {
    "id": "chunk_02286",
    "text": "with practice. A woman may need to use the female condom several times before she is comfortable with it. y Suggest she try different positions to see which way insertion is easiest for her. y The female condom is slippery. Some women find insertion easier if they",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2286
  },
  {
    "id": "chunk_02287",
    "text": "slippery. Some women find insertion easier if they put it in slowly, especially the first few times. y If a client is switching from another method to the female condom, suggest that she continue with the previous method until she can use the female condom with confidence.",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2287
  },
  {
    "id": "chunk_02288",
    "text": "til she can use the female condom with confidence. \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2288
  },
  {
    "id": "chunk_02289",
    "text": "problems, questions, or wants another method; she has any major change in health status; or she thinks she might be pregnant. Also if: y She has difficulty using female condoms correctly or every time she has sex. y She recently had unprotected sex and wants to avoid pregnancy. She",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2289
  },
  {
    "id": "chunk_02290",
    "text": "unprotected sex and wants to avoid pregnancy. She may be able to use ECPs (see Chapter 3). How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can:",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2290
  },
  {
    "id": "chunk_02291",
    "text": "rt he can give to his partner. A male partner can: y Support a woman\u2019s choice of the female condom y Discuss and agree to use the female condom with a full understanding of how to use it y Ensure that they use it every time, and correctly (for example, making",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2291
  },
  {
    "id": "chunk_02292",
    "text": "it every time, and correctly (for example, making sure that he inserts penis inside the condom and not between the condom and vaginal wall) y Help to keep a supply on hand y Help to make sure she has ECPs on hand in case the condom is not used or is used incorrectly",
    "page_number": 299,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2292
  },
  {
    "id": "chunk_02293",
    "text": "Repeat Visits 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss. 2. Ask especially if she has any trouble using female condoms correctly and every time she has sex. Give her any information or help that she needs",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2293
  },
  {
    "id": "chunk_02294",
    "text": "x. Give her any information or help that she needs (see Managing Any Problems, below). 3. Give her more female condoms and encourage her to come back for more before her supply runs out. Remind her where else she can obtain female condoms.",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2294
  },
  {
    "id": "chunk_02295",
    "text": "mind her where else she can obtain female condoms. 4. Ask a long-term client about major life changes that may affect her needs\u2014 particularly plans for having children and STI/HIV risk. Follow up as needed. Managing Any Problems Problems With Use May or may not be due to the method.",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2295
  },
  {
    "id": "chunk_02296",
    "text": "lems With Use May or may not be due to the method. y Problems with condoms affect clients\u2019 satisfaction and use of the method. They deserve the provider\u2019s attention. If the client reports any problems, listen to her concerns and give advice and support. Make sure she",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2296
  },
  {
    "id": "chunk_02297",
    "text": "oncerns and give advice and support. Make sure she understands the advice and agrees. y Offer to help the client choose another method\u2014now, if she wishes, or if problems cannot be overcome\u2014unless condoms are needed for protection from STIs, including HIV. Difficulty inserting the female condom",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2297
  },
  {
    "id": "chunk_02298",
    "text": "luding HIV. Difficulty inserting the female condom y Ask the client how she inserts a female condom. If a model is available, ask her to demonstrate and let her practice with the model. If not, ask her to demonstrate using her hands. Correct any errors. Inner ring uncomfortable or painful",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2298
  },
  {
    "id": "chunk_02299",
    "text": "ct any errors. Inner ring uncomfortable or painful y Suggest that she reinsert or reposition the condom so that the inner ring is tucked back behind the pubic bone and out of the way. Condom squeaks or makes noise during sex y Suggest adding more lubricant to the inside of the condom or onto",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2299
  },
  {
    "id": "chunk_02300",
    "text": "more lubricant to the inside of the condom or onto the penis. Condom slips, is not used, or is used incorrectly y ECPs can help prevent pregnancy (see Chapter 3). y Refer for possible post-exposure prophylaxis against HIV and possible",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2300
  },
  {
    "id": "chunk_02301",
    "text": "post-exposure prophylaxis against HIV and possible presumptive treatment against other STIs (see Chapter 14 \u2013 Male Condoms, Question 7, p. 269). If the client has signs or symptoms of STIs after having unprotected sex, assess or refer. 278 Family Planning: A Global Handbook for Providers",
    "page_number": 300,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2301
  },
  {
    "id": "chunk_02302",
    "text": "15 279 smodnoC elameF y If a client reports slips, she may be inserting the female condom incorrectly. Ask her to show how she is inserting the condom, using a model or demonstrating with her hands. Correct any errors. Difficulty persuading partner to use condoms or not able to",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2302
  },
  {
    "id": "chunk_02303",
    "text": "y persuading partner to use condoms or not able to use a condom every time y Discuss ways to talk with her partner about the importance of condom use for protection from pregnancy and STIs. (see Chapter 14 \u2013 Male Condoms, Difficulty persuading partner to use condoms or not able to use a condom",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2303
  },
  {
    "id": "chunk_02304",
    "text": "partner to use condoms or not able to use a condom every time, p. 265.) Mild irritation in or around the vagina or penis (itching, redness, or rash) y Usually goes away on its own without treatment. y Suggest adding lubricant to the inside of the condom or onto the penis to",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2304
  },
  {
    "id": "chunk_02305",
    "text": "t to the inside of the condom or onto the penis to reduce rubbing that may cause irritation. y If symptoms persist, assess and treat for possible vaginal infection or STI, as appropriate. \u2013 If there is no infection, help the client choose another method unless the",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2305
  },
  {
    "id": "chunk_02306",
    "text": ", help the client choose another method unless the client is at risk for STIs, including HIV. \u2013 For clients at risk of STIs, including HIV, suggest using male condoms. If using male condoms is not possible, urge continued use of female condoms despite discomfort.",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2306
  },
  {
    "id": "chunk_02307",
    "text": "ontinued use of female condoms despite discomfort. \u2013 If neither partner has an infection, a mutually faithful sexual relationship provides STI protection without requiring condom use but does not protect against pregnancy. Suspected pregnancy y Assess for pregnancy.",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2307
  },
  {
    "id": "chunk_02308",
    "text": "nancy. Suspected pregnancy y Assess for pregnancy. y A woman can safely use female condoms during pregnancy for continued STI protection. New Problems That May Require Switching Methods Severe allergic reaction to condom (hives or rash over much of body,",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2308
  },
  {
    "id": "chunk_02309",
    "text": "action to condom (hives or rash over much of body, dizziness, difficulty breathing, or loss of consciousness during or after condom use). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. y Tell the client to stop using latex condoms. Non-latex female condoms may be available.",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2309
  },
  {
    "id": "chunk_02310",
    "text": "ondoms. Non-latex female condoms may be available. y Refer for care, if necessary. Severe allergic reaction to latex could lead to life- threatening anaphylactic shock. Help the client choose another method. y If the client or partner cannot avoid risk of STIs, suggest they use non-latex female",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2310
  },
  {
    "id": "chunk_02311",
    "text": "id risk of STIs, suggest they use non-latex female condoms or plastic male condoms, if available. If neither partner has an infection, a mutually faithful sexual relationship provides STI protection without requiring condom use but does not protect against pregnancy.",
    "page_number": 301,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2311
  },
  {
    "id": "chunk_02312",
    "text": "Questions and Answers About Female Condoms 1. Is the female condom difficult to use? No, but it does require practice and patience. See Tips for New Users, p. 277. 2. Can female condoms effectively prevent both pregnancy and STIs, including HIV?",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2312
  },
  {
    "id": "chunk_02313",
    "text": "ly prevent both pregnancy and STIs, including HIV? Yes. Female condoms offer dual protection, against both pregnancy and STIs, including HIV, if used consistently and correctly. Many people, however, do not use condoms every time they have sex, or do not use",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2313
  },
  {
    "id": "chunk_02314",
    "text": "se condoms every time they have sex, or do not use them correctly. This reduces protection from both pregnancy and STIs. 3. Can a female condom and a male condom be used at the same time? No. Male and female condoms should not be used together. This can",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2314
  },
  {
    "id": "chunk_02315",
    "text": "male condoms should not be used together. This can cause friction that may lead to slipping or tearing of the condoms. 4. What is the best way to make sure the penis goes into the condom and not outside the condom? To avoid incorrect use, the man or the woman should carefully guide his",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2315
  },
  {
    "id": "chunk_02316",
    "text": "e, the man or the woman should carefully guide his penis and place the tip inside the outer ring of the condom. If the penis goes between the wall of the vagina and the condom, the man should withdraw and try again. 5. Can the female condom be used more than once?",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2316
  },
  {
    "id": "chunk_02317",
    "text": ". 5. Can the female condom be used more than once? Reuse of the female condom is not recommended. Reuse of currently available female condoms has not been sufficiently tested. 6. Can the female condom be used while a woman is having her monthly bleeding?",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2317
  },
  {
    "id": "chunk_02318",
    "text": "used while a woman is having her monthly bleeding? Women can use the female condom during their monthly bleeding. The female condom cannot be used at the same time as a tampon, however. The tampon must be removed before inserting a female condom. 7. Isn\u2019t the female condom too big to be comfortable?",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2318
  },
  {
    "id": "chunk_02319",
    "text": "Isn\u2019t the female condom too big to be comfortable? No. Female condoms are the same length as male condoms, but wider. They are very flexible and fit to the shape of the vagina. Female condoms have been carefully designed and tested to fit any woman, whatever the",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2319
  },
  {
    "id": "chunk_02320",
    "text": "designed and tested to fit any woman, whatever the size of her vagina, and any man, whatever the size of his penis. 8. Can a female condom get lost inside a woman\u2019s body? No. The female condom remains in a woman\u2019s vagina until she takes",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2320
  },
  {
    "id": "chunk_02321",
    "text": "condom remains in a woman\u2019s vagina until she takes it out. It cannot go past a woman\u2019s cervix and into the womb (uterus) because it is too large for that. 9. Can the female condom be used in different sexual positions? Yes. The female condom can be used in any sexual position.",
    "page_number": 302,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2321
  },
  {
    "id": "chunk_02322",
    "text": "16 281 smgarhpaiD dna sedicimrepS CHAPTER 16 Spermicides and Diaphragms Spermicides Key Points for Providers and Clients y Spermicides are placed deep in the vagina shortly before sex. y Require correct use with every act of sex for greatest effectiveness.",
    "page_number": 303,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2322
  },
  {
    "id": "chunk_02323",
    "text": "with every act of sex for greatest effectiveness. y One of the least effective contraceptive methods. y Can be used as a primary method or as a backup method. What Are Spermicides? y Sperm-killing substances inserted deep in the vagina, near the cervix, before sex. \u2212 Nonoxynol-9 is most widely used.",
    "page_number": 303,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2323
  },
  {
    "id": "chunk_02324",
    "text": "ix, before sex. \u2212 Nonoxynol-9 is most widely used. \u2212 Others include benzalkonium chloride, chlorhexidine, menfegol, octoxynol-9, and sodium docusate. y Available in foaming tablets, melting or foaming suppositories, cans of pressurized foam, melting film, jelly, and cream.",
    "page_number": 303,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2324
  },
  {
    "id": "chunk_02325",
    "text": "pressurized foam, melting film, jelly, and cream. \u2212 Jellies, creams, and foam from cans can be used alone, with a diaphragm, or with condoms. \u2212 Films, suppositories, foaming tablets, or foaming suppositories can be used alone or with condoms.",
    "page_number": 303,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2325
  },
  {
    "id": "chunk_02326",
    "text": "g suppositories can be used alone or with condoms. y Work by causing the membrane of sperm cells to break, killing them or slowing their movement. This keeps sperm from meeting an egg.",
    "page_number": 303,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2326
  },
  {
    "id": "chunk_02327",
    "text": "How Effective? More Effectiveness depends on the user: Risk of pregnancy is greatest effective when spermicides are not used with every act of sex. y One of the least effective family planning methods. y As commonly used, about 21 pregnancies per 100 women using",
    "page_number": 304,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2327
  },
  {
    "id": "chunk_02328",
    "text": "nly used, about 21 pregnancies per 100 women using spermicides over the first year. This means that 79 of every 100 women using spermicides will not become pregnant. y When used correctly with every act of sex, about 16 pregnancies per 100 women using spermicides over the first year.",
    "page_number": 304,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2328
  },
  {
    "id": "chunk_02329",
    "text": "r 100 women using spermicides over the first year. Return of fertility after spermicides are stopped: No delay Less effective Protection against sexually transmitted infections (STIs): None. Frequent use of nonoxynol-9 may increase risk of HIV infection (see Question 3, p. 296).",
    "page_number": 304,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2329
  },
  {
    "id": "chunk_02330",
    "text": "se risk of HIV infection (see Question 3, p. 296). Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 293) Some users report the following: y Irritation in or around the vagina or penis Other possible physical changes: y Vaginal lesions",
    "page_number": 304,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2330
  },
  {
    "id": "chunk_02331",
    "text": "Other possible physical changes: y Vaginal lesions Known Health Benefits Known Health Risks Help protect against: Uncommon: y Risks of pregnancy y Urinary tract infection, especially when using spermicides 2 or more times a day Rare: y Frequent use of nonoxynol-9 may increase risk of HIV",
    "page_number": 304,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2331
  },
  {
    "id": "chunk_02332",
    "text": "16 283 smgarhpaiD dna sedicimrepS Correcting Misunderstandings (see also Questions and Answers, p. 286) Spermicides: y Do not reduce vaginal secretions or make women bleed during sex. y Do not cause cervical cancer or birth defects. y Do not protect against STIs.",
    "page_number": 305,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2332
  },
  {
    "id": "chunk_02333",
    "text": "r or birth defects. y Do not protect against STIs. y Do not change men\u2019s or women\u2019s sex drive or reduce sexual pleasure for most men. y Do not stop women\u2019s monthly bleeding. Why Some Women Say They Like Spermicides y Are controlled by the woman y Have no hormonal side effects",
    "page_number": 305,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2333
  },
  {
    "id": "chunk_02334",
    "text": "olled by the woman y Have no hormonal side effects y Increase vaginal lubrication y Can be used without seeing a health care provider y Can be inserted ahead of time and so do not interrupt sex Who Can and Cannot Use Spermicides Safe and Suitable for Nearly All Women Medical Eligibility Criteria for",
    "page_number": 305,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2334
  },
  {
    "id": "chunk_02335",
    "text": "Nearly All Women Medical Eligibility Criteria for Spermicides All women can safely use spermicides except those who: y Are at high risk for HIV infection y Have HIV infection Women who are at high risk for HIV infection or who have HIV should use another method. Who Can and Cannot Use Spermicides",
    "page_number": 305,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2335
  },
  {
    "id": "chunk_02336",
    "text": "Providing Spermicides When to Start y Any time the client wants. Explaining How to Use Spermicides Give spermicide y Give as much spermicide as possible\u2014even as much as a year\u2019s supply, if available. Explain how 1. Check the expiration date and avoid using",
    "page_number": 306,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2336
  },
  {
    "id": "chunk_02337",
    "text": "n how 1. Check the expiration date and avoid using to insert spermicide past its expiration date. spermicide into \u2013 Wash hands with mild soap and clean water, the vagina if possible. 2. Foam or cream: Shake cans of foam hard. Squeeze spermicide from the can or tube",
    "page_number": 306,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2337
  },
  {
    "id": "chunk_02338",
    "text": "foam hard. Squeeze spermicide from the can or tube into a plastic applicator. Insert the applicator deep into the vagina, near the cervix, and push the plunger. Tablets, suppositories, jellies: Insert the spermicide deep into the vagina, near the cervix, with an applicator or with fingers.",
    "page_number": 306,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2338
  },
  {
    "id": "chunk_02339",
    "text": "ar the cervix, with an applicator or with fingers. Film: Fold film in half and insert with fingers that are dry (or else the film will stick to the fingers and not the cervix). Explain when y Foam or cream: Any time less than one hour to insert before sex. spermicide into",
    "page_number": 306,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2339
  },
  {
    "id": "chunk_02340",
    "text": "han one hour to insert before sex. spermicide into y Tablets, suppositories, jellies, film: Between the vagina 10 minutes and one hour before sex, depending on type. Explain about y Insert additional spermicide before each act of multiple acts vaginal sex. of sex",
    "page_number": 306,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2340
  },
  {
    "id": "chunk_02341",
    "text": "fore each act of multiple acts vaginal sex. of sex Do not wash y Douching is not recommended because it will the vagina (douche) wash away the spermicide and also increase the after sex risk of sexually transmitted infections. y If you must douche, wait for at least 6 hours after sex before doing so.",
    "page_number": 306,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2341
  },
  {
    "id": "chunk_02342",
    "text": "16 285 smgarhpaiD dna sedicimrepS Supporting the Spermicide User Ensure client y Ask the client to repeat how and when to insert understands her spermicide. correct use Describe the y Itching and irritation in or around the vagina most common or penis. side effects",
    "page_number": 307,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2342
  },
  {
    "id": "chunk_02343",
    "text": "ound the vagina most common or penis. side effects Explain about y Explain ECP use in case the spermicide is not emergency used at all or is not used properly (see Chapter 3 contraceptive \u2013 Emergency Contraceptive Pills). Give her ECPs, pills (ECPs) if available.",
    "page_number": 307,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2343
  },
  {
    "id": "chunk_02344",
    "text": "Pills). Give her ECPs, pills (ECPs) if available. Explain about y Spermicides should be stored in a cool, dry place, storage if possible, out of the sun. Suppositories may melt in hot weather. If kept dry, foaming tablets are not as likely to melt in hot weather. How Can a Partner Help?",
    "page_number": 307,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2344
  },
  {
    "id": "chunk_02345",
    "text": "ly to melt in hot weather. How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: \u2022 Support a woman\u2019s choice of spermicides or diaphragm with spermicide",
    "page_number": 307,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2345
  },
  {
    "id": "chunk_02346",
    "text": "choice of spermicides or diaphragm with spermicide \u2022 Discuss and agree to use spermicides with a full understanding of how to use them \u2022 Help her to remember to use spermicides or diaphragm with spermicide every time \u2022 Help to keep a supply of spermicide on hand",
    "page_number": 307,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2346
  },
  {
    "id": "chunk_02347",
    "text": "time \u2022 Help to keep a supply of spermicide on hand \u2022 Help to make sure the woman has ECPs on hand in case the spermicide or the diaphragm is not used or the diaphragm got dislodged \u2022 Use condoms consistently in addition to spermicides or diaphragm with spermicide if he has an STI/HIV or thinks he may",
    "page_number": 307,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2347
  },
  {
    "id": "chunk_02348",
    "text": "Diaphragms Key Points for Providers and Clients y The diaphragm is placed deep in the vagina before sex. It covers the cervix. Spermicide provides additional contraceptive protection. y A pelvic examination may be needed before starting use. The provider must select a diaphragm that fits properly.",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2348
  },
  {
    "id": "chunk_02349",
    "text": "ovider must select a diaphragm that fits properly. y Require correct use with every act of sex for greatest effectiveness. What Is the Diaphragm? y A soft latex cup that covers the cervix. Plastic and silicone diaphragms may also be available.",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2349
  },
  {
    "id": "chunk_02350",
    "text": "tic and silicone diaphragms may also be available. y The rim contains a firm, flexible spring that keeps the diaphragm in place. y Used with spermicidal cream, jelly, or foam to improve effectiveness. y Most diaphragms come in different sizes and require fitting by a specifically",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2350
  },
  {
    "id": "chunk_02351",
    "text": "ferent sizes and require fitting by a specifically trained provider. A one-size-fits-all diaphragm is becoming available. It does not require seeing a provider for fitting. (See Question 9, p. 297.) y Works by blocking sperm from entering the cervix; spermicide kills or",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2351
  },
  {
    "id": "chunk_02352",
    "text": "perm from entering the cervix; spermicide kills or disables sperm. Both keep sperm from meeting an egg. How Effective? More effective Effectiveness depends on the user: Risk of pregnancy is greatest when the diaphragm with spermicide is not used with every act of sex.",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2352
  },
  {
    "id": "chunk_02353",
    "text": "with spermicide is not used with every act of sex. y As commonly used, about 17 pregnancies per 100 women using the diaphragm with spermicide over the first year. This means that 83 of every 100 women using the diaphragm will not become pregnant.",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2353
  },
  {
    "id": "chunk_02354",
    "text": "omen using the diaphragm will not become pregnant. y When used correctly with every act of sex, about 16 pregnancies per 100 women using the diaphragm with spermicide over the first year. Less effective Return of fertility after use of the diaphragm is stopped: No delay",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2354
  },
  {
    "id": "chunk_02355",
    "text": "ty after use of the diaphragm is stopped: No delay Protection against STIs: May provide some protection against certain STIs but should not be relied on for STI prevention (see Question 8, p. 297). 286 Family Planning: A Global Handbook for Providers",
    "page_number": 308,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2355
  },
  {
    "id": "chunk_02356",
    "text": "16 287 smgarhpaiD dna sedicimrepS Side Effects, Health Benefits, and Health Risks Side Effects (see also Managing Any Problems, p. 293) Some users report the following: y Irritation in or around the vagina or penis Other possible physical changes: y Vaginal lesions",
    "page_number": 309,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2356
  },
  {
    "id": "chunk_02357",
    "text": "Other possible physical changes: y Vaginal lesions Known Health Benefits Known Health Risks Help protect against: Common to uncommon: y Risks of pregnancy y Urinary tract infection May help protect against: Uncommon: y Certain STIs (chlamydia, y Bacterial vaginosis gonorrhea, pelvic inflammatory",
    "page_number": 309,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2357
  },
  {
    "id": "chunk_02358",
    "text": "Bacterial vaginosis gonorrhea, pelvic inflammatory y Candidiasis disease, trichomoniasis) Rare: y Cervical precancer and cancer y Frequent use of nonoxynol-9 may increase risk of HIV infection (see Question 3, p. 296) Extremely rare: y Toxic shock syndrome",
    "page_number": 309,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2358
  },
  {
    "id": "chunk_02359",
    "text": "3, p. 296) Extremely rare: y Toxic shock syndrome Correcting Misunderstandings (see also Questions and Answers, p. 296) Diaphragms: y Do not affect the feeling of sex. A few men report feeling the diaphragm during sex, but most do not.",
    "page_number": 309,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2359
  },
  {
    "id": "chunk_02360",
    "text": "feeling the diaphragm during sex, but most do not. y Cannot pass through the cervix. They cannot go into the uterus or otherwise get lost in the woman\u2019s body. y Do not cause cervical cancer. Why Some Women Say They Like the Diaphragm y Is controlled by the woman y Has no hormonal side effects",
    "page_number": 309,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2360
  },
  {
    "id": "chunk_02361",
    "text": "Who Can and Cannot Use Diaphragms Safe and Suitable for Nearly All Women Nearly all women can use the diaphragm safely and effectively. Medical Eligibility Criteria for Diaphragms Ask the client the questions below about known medical conditions.",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2361
  },
  {
    "id": "chunk_02362",
    "text": "he questions below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions, then she can start using the diaphragm if she wants. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2362
  },
  {
    "id": "chunk_02363",
    "text": "a question, follow the instructions. In some cases she can still start using the diaphragm. These questions also apply to the cervical cap (see p. 299). 1. Have you recently had a baby or second-trimester spontaneous or induced abortion? If so, when?",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2363
  },
  {
    "id": "chunk_02364",
    "text": "ster spontaneous or induced abortion? If so, when? \u274f NO \u274f YES The diaphragm should not be fitted until 6 weeks after childbirth or second-trimester abortion, when the uterus and cervix have returned to normal size. Give her a backup method* to use until then. 2. Are you allergic to latex rubber?",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2364
  },
  {
    "id": "chunk_02365",
    "text": "e until then. 2. Are you allergic to latex rubber? \u274f NO \u274f YES She should not use a latex diaphragm. She can use a diaphragm made of plastic. 3. Do you have HIV infection? Do you think you are at high risk of HIV infection? (Discuss what places a woman at high risk for HIV \u2014",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2365
  },
  {
    "id": "chunk_02366",
    "text": "Discuss what places a woman at high risk for HIV \u2014 for example, her partner has HIV. [See Who Is At Risk, in Chapter 22 \u2013 STIs, Including HIV, p. 340].) \u274f NO \u274f YES Do not provide a diaphragm. For HIV protection, recommend using condoms alone or with another method.",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2366
  },
  {
    "id": "chunk_02367",
    "text": "ommend using condoms alone or with another method. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions that",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2367
  },
  {
    "id": "chunk_02368",
    "text": "ient will use. Also, point out any conditions that would make the method inadvisable, when relevant to the client. 288 Family Planning: A Global Handbook for Providers",
    "page_number": 310,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2368
  },
  {
    "id": "chunk_02369",
    "text": "16 289 smgarhpaiD dna sedicimrepS Using Clinical Judgment in Special Cases of Diaphragm Use Usually, a woman with any of the conditions listed below should not use the diaphragm. In special circumstances, however, when other, more appropriate methods are not available or acceptable to her,",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2369
  },
  {
    "id": "chunk_02370",
    "text": "te methods are not available or acceptable to her, a qualified provider who can carefully assess a specific woman\u2019s condition and situation may decide that she can use the diaphragm with spermicide. The provider needs to consider the severity of her",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2370
  },
  {
    "id": "chunk_02371",
    "text": "The provider needs to consider the severity of her condition and, for most conditions, whether she will have access to follow-up. y History of toxic shock syndrome y Allergy to latex, especially if the allergic reaction is mild (see \u201cMild",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2371
  },
  {
    "id": "chunk_02372",
    "text": "cially if the allergic reaction is mild (see \u201cMild irritation in or around the vagina or penis or mild allergic reaction to condom\u201d, p. 266, in Chapter 14 \u2013 Male Condoms) y HIV infection Providing Diaphragms When to Start Woman\u2019s situation When to start Any time At any time",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2372
  },
  {
    "id": "chunk_02373",
    "text": "man\u2019s situation When to start Any time At any time y If she has had a full-term delivery or second- trimester spontaneous or induced abortion less than 6 weeks ago, give her a backup method* to use, if needed, until 6 weeks have passed.",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2373
  },
  {
    "id": "chunk_02374",
    "text": "hod* to use, if needed, until 6 weeks have passed. Special advice for y Suggest that she try the diaphragm for a time women switching while still using her other method. This way from another she can safely gain confidence that she can method use the diaphragm correctly.",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2374
  },
  {
    "id": "chunk_02375",
    "text": "e that she can method use the diaphragm correctly. * Backup methods include abstinence, male and female condoms, spermicides, and withdrawal. Tell her that spermicides and withdrawal are the least effective contraceptive methods. If possible, give her condoms. Providing Diaphragms",
    "page_number": 311,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2375
  },
  {
    "id": "chunk_02376",
    "text": "Explaining the Fitting Procedure Learning to fit women for a diaphragm requires training and practice. Therefore, this is a summary and not detailed instructions. 1. The provider uses proper infection-prevention procedures (see Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2376
  },
  {
    "id": "chunk_02377",
    "text": "ion in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404). 2. The woman lies down as for a pelvic examination. 3. The provider checks for conditions that may make it impossible to use the diaphragm, such as uterine prolapse.",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2377
  },
  {
    "id": "chunk_02378",
    "text": "le to use the diaphragm, such as uterine prolapse. 4. The provider inserts the index and middle fingers into the vagina to determine the correct diaphragm size. 5. The provider inserts a special fitting diaphragm into the client\u2019s vagina",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2378
  },
  {
    "id": "chunk_02379",
    "text": "special fitting diaphragm into the client\u2019s vagina so that it covers the cervix. The provider then checks the location of the cervix and makes sure that the diaphragm fits properly and does not come out easily. 6. The provider gives the woman a properly fitting diaphragm and plenty",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2379
  },
  {
    "id": "chunk_02380",
    "text": "the woman a properly fitting diaphragm and plenty of spermicide to use with it, and teaches her to use it properly (see Explaining How to Use the Diaphragm, below). With a properly fitted diaphragm in place, the client should not be able to",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2380
  },
  {
    "id": "chunk_02381",
    "text": "aphragm in place, the client should not be able to feel anything inside her vagina, even when she walks or during sex. Explaining How to Use the Diaphragm IMPORTANT: Whenever possible, show the woman the location of the pubic bone and cervix with a model or a picture. Explain that the diaphragm",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2381
  },
  {
    "id": "chunk_02382",
    "text": "h a model or a picture. Explain that the diaphragm is inserted behind the pubic bone and covers the cervix. Basic Steps Important Details 1. Squeeze a y Wash hands with mild soap and clean water, if spoonful of possible. spermicidal y Check the diaphragm for holes, cracks, or tears cream, jelly,",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2382
  },
  {
    "id": "chunk_02383",
    "text": "iaphragm for holes, cracks, or tears cream, jelly, by holding it up to the light. or foam into the diaphragm y Check the expiration date of the spermicide and and around avoid using any beyond its expiration date. the rim 2. Press the rim y Insert the diaphragm less than 6 hours before",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2383
  },
  {
    "id": "chunk_02384",
    "text": "im y Insert the diaphragm less than 6 hours before together; push having sex. into the vagina y Choose a position that is comfortable for as far as it goes insertion\u2014squatting, raising one leg, sitting, or lying down. 290 Family Planning: A Global Handbook for Providers",
    "page_number": 312,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2384
  },
  {
    "id": "chunk_02385",
    "text": "16 291 smgarhpaiD dna sedicimrepS Basic Steps Important Details 3. Feel diaphragm y Through the dome of the diaphragm, the cervix to make sure feels like the tip of the nose. it covers y If the diaphragm feels uncomfortable, take it out the cervix and insert it again.",
    "page_number": 313,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2385
  },
  {
    "id": "chunk_02386",
    "text": "table, take it out the cervix and insert it again. 4. Leave in y Leave the diaphragm in place at least 6 hours place for after having sex but no longer than 24 hours. at least y Leaving the diaphragm in place for more than one 6 hours day may increase the risk of toxic shock syndrome. after sex",
    "page_number": 313,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2386
  },
  {
    "id": "chunk_02387",
    "text": "crease the risk of toxic shock syndrome. after sex It can also cause a bad odor and vaginal discharge. (Odor and discharge go away on their own after the diaphragm is removed.) y For multiple acts of sex, make sure that the diaphragm is in the correct position and also",
    "page_number": 313,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2387
  },
  {
    "id": "chunk_02388",
    "text": "the diaphragm is in the correct position and also insert additional spermicide in front of the diaphragm before each act of sex. 5. To remove, y Wash hands with mild soap and clean water, if slide a finger possible. under the y Insert a finger into the vagina until the rim of the rim of the",
    "page_number": 313,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2388
  },
  {
    "id": "chunk_02389",
    "text": "er into the vagina until the rim of the rim of the diaphragm is felt. diaphragm and pull it down y Gently slide a finger under the rim and pull the and out diaphragm down and out. Use care not to tear the diaphragm with a fingernail. y Wash the diaphragm with mild soap and clean",
    "page_number": 313,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2389
  },
  {
    "id": "chunk_02390",
    "text": "Supporting the Diaphragm User Ensure client y Ask the client to repeat how and when to insert understands and remove the diaphragm. correct use Explain that use y Inserting and removing the diaphragm becomes becomes easier easier with practice. with time",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2390
  },
  {
    "id": "chunk_02391",
    "text": "mes becomes easier easier with practice. with time Describe the y Itching and irritation in or around the vagina most common or penis. side effects Explain about y Explain ECP use in case the diaphragm moves emergency out of place or is not used properly (see",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2391
  },
  {
    "id": "chunk_02392",
    "text": "mergency out of place or is not used properly (see contraceptive Emergency Contraceptive Pills, p. 49). Give her pills (ECPs) ECPs, if available. Explain about y When a diaphragm gets thin, develops holes, or replacement becomes stiff, it should not be used and needs to",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2392
  },
  {
    "id": "chunk_02393",
    "text": "becomes stiff, it should not be used and needs to be replaced. She should obtain a new diaphragm about every 2 years. Tips for Users of Spermicides or the Diaphragm With Spermicide y Spermicides should be stored in a cool, dry place, if possible, out of the",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2393
  },
  {
    "id": "chunk_02394",
    "text": "ored in a cool, dry place, if possible, out of the sun. Suppositories may melt in hot weather. If kept dry, foaming tablets are not as likely to melt in hot weather. y The diaphragm should be stored in a cool, dry place, if possible.",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2394
  },
  {
    "id": "chunk_02395",
    "text": "hould be stored in a cool, dry place, if possible. y She needs a new diaphragm fitted if she has had a baby or a second- trimester miscarriage or abortion. \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2395
  },
  {
    "id": "chunk_02396",
    "text": "ient that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she has any major change in health status; or she thinks she might be pregnant. General health advice: Anyone who suddenly feels that something is seriously",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2396
  },
  {
    "id": "chunk_02397",
    "text": "one who suddenly feels that something is seriously wrong with her health should immediately seek medical care from a nurse or doctor. Her contraceptive method is most likely not the cause of the condition, but she should tell the nurse or doctor what method she is using.",
    "page_number": 314,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2397
  },
  {
    "id": "chunk_02398",
    "text": "16 293 smgarhpaiD dna sedicimrepS Repeat Visits 1. Ask how the client is doing with the method and whether she is satisfied. Ask if she has any questions or anything to discuss. 2. Ask especially if she has any problems using the method correctly and",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2398
  },
  {
    "id": "chunk_02399",
    "text": "he has any problems using the method correctly and every time she has sex. Give her any information or help she needs (see Managing Any Problems, below). 3. Give her more supplies and encourage her to come back for more before she runs out. Remind her where else she can obtain more",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2399
  },
  {
    "id": "chunk_02400",
    "text": "uns out. Remind her where else she can obtain more spermicides when needed. 4. Ask a long-term client if she has had any new health problems since her last visit. Address problems as appropriate. For new health problems that may require switching methods, see p. 295.",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2400
  },
  {
    "id": "chunk_02401",
    "text": "ms that may require switching methods, see p. 295. 5. Ask a long-term client about major life changes that may affect her needs\u2014particularly plans for having children and STI/HIV risk. Follow up as needed. Managing Any Problems Problems Reported as Side Effects or Problems With Use",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2401
  },
  {
    "id": "chunk_02402",
    "text": "lems Reported as Side Effects or Problems With Use May or may not be due to the method. y Side effects or problems with spermicides or diaphragms affect women\u2019s satisfaction and use of the method. They deserve the provider\u2019s attention.",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2402
  },
  {
    "id": "chunk_02403",
    "text": "the method. They deserve the provider\u2019s attention. If the client reports side effects or problems, listen to her concerns, give her advice and support, and, if appropriate, treat. Make sure she understands the advice and agrees. y Offer to help the client choose another method\u2014now, if she wishes,",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2403
  },
  {
    "id": "chunk_02404",
    "text": "e client choose another method\u2014now, if she wishes, or if problems cannot be overcome. Difficulty inserting or removing diaphragm y Give advice on insertion and removal. Ask her to insert and remove the diaphragm in the clinic. Check its placement after she inserts it. Correct any errors.",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2404
  },
  {
    "id": "chunk_02405",
    "text": "lacement after she inserts it. Correct any errors. Discomfort or pain with diaphragm use y A diaphragm that is too large can cause discomfort. Check if it fits well. \u2212 Fit her with a smaller diaphragm if it is too large. \u2212 If fit appears proper and different kinds of diaphragms are available,",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2405
  },
  {
    "id": "chunk_02406",
    "text": "r and different kinds of diaphragms are available, try a different diaphragm. y Ask her to insert and remove the diaphragm in the clinic. Check the diaphragm\u2019s placement after she inserts it. Give further advice as needed. Supporting the Diaphragm User",
    "page_number": 315,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2406
  },
  {
    "id": "chunk_02407",
    "text": "y Check for vaginal lesions: \u2212 If vaginal lesions or sores exist, suggest she use another method temporarily (condoms or oral contraceptives) and give her supplies. Lesions will go away on their own if she switches to another method.",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2407
  },
  {
    "id": "chunk_02408",
    "text": "ay on their own if she switches to another method. \u2212 Assess for vaginal infection or sexually transmitted infection (STI). Treat or refer for treatment as appropriate. Irritation in or around the vagina or penis (she or her partner has itching, rash, or irritation that lasts for a day or more)",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2408
  },
  {
    "id": "chunk_02409",
    "text": "rash, or irritation that lasts for a day or more) y Check for vaginal infection or STI. Treat or refer for treatment as appropriate. y If no infection, suggest trying a different type or brand of spermicide. Urinary tract infection (burning or pain with urination, frequent",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2409
  },
  {
    "id": "chunk_02410",
    "text": "nfection (burning or pain with urination, frequent urination in small amounts, blood in the urine, back pain) y Treat with cotrimoxazole 240 mg orally once a day for 3 days, or trimethoprim 100 mg orally once a day for 3 days, or nitrofurantoin 50 mg orally twice a day for 3 days.",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2410
  },
  {
    "id": "chunk_02411",
    "text": "itrofurantoin 50 mg orally twice a day for 3 days. y If infection recurs, consider refitting the client with a smaller diaphragm. Bacterial vaginosis (abnormal white or gray vaginal discharge with unpleasant odor; may also have burning during urination and/or itching around the vagina)",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2411
  },
  {
    "id": "chunk_02412",
    "text": "during urination and/or itching around the vagina) y Treat with metronidazole 2 g orally in a single dose or metronidazole 400\u2013500 mg orally twice a day for 7 days. Candidiasis (abnormal white vaginal discharge that can be watery or",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2412
  },
  {
    "id": "chunk_02413",
    "text": "rmal white vaginal discharge that can be watery or thick and chunky; may also have burning during urination and/or redness and itching around the vagina) y Treat with fluconazole 150 mg orally in a single dose, miconazole 200 mg",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2413
  },
  {
    "id": "chunk_02414",
    "text": "150 mg orally in a single dose, miconazole 200 mg vaginal suppository once a day for 3 days, or clotrimazole 100 mg vaginal tablets twice a day for 3 days. y Miconazole suppositories are oil-based and can weaken a latex diaphragm. Women using miconazole vaginally should not use latex diaphragms or",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2414
  },
  {
    "id": "chunk_02415",
    "text": "azole vaginally should not use latex diaphragms or condoms during treatment. They can use a plastic female or male condom or another method until all medication is taken. (Oral treatment will not harm latex.) Suspected pregnancy y Assess for pregnancy.",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2415
  },
  {
    "id": "chunk_02416",
    "text": "atex.) Suspected pregnancy y Assess for pregnancy. y There are no known risks to a fetus conceived while a woman is using spermicides. 294 Family Planning: A Global Handbook for Providers",
    "page_number": 316,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2416
  },
  {
    "id": "chunk_02417",
    "text": "16 295 smgarhpaiD dna sedicimrepS New Problems That May Require Switching Methods May or may not be due to the method. Recurring urinary tract infections or vaginal infections (such as bacterial vaginosis or candidiasis) y Consider refitting the client with a smaller diaphragm.",
    "page_number": 317,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2417
  },
  {
    "id": "chunk_02418",
    "text": "der refitting the client with a smaller diaphragm. Latex allergy (redness, itching, rash, and/or swelling of genitals, groin, or thighs [mild reaction]; or hives or rash over much of the body, dizziness, difficulty breathing, loss of consciousness [severe reaction])",
    "page_number": 317,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2418
  },
  {
    "id": "chunk_02419",
    "text": "reathing, loss of consciousness [severe reaction]) y Tell the client to stop using a latex diaphragm. Give her a plastic diaphragm, if available, or help her choose another method, but not latex condoms. Toxic shock syndrome (sudden high fever, body rash, vomiting,",
    "page_number": 317,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2419
  },
  {
    "id": "chunk_02420",
    "text": "syndrome (sudden high fever, body rash, vomiting, diarrhea, dizziness, sore throat, and muscle aches). See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions. y Treat or refer for immediate diagnosis and care. Toxic shock syndrome can be life-threatening.",
    "page_number": 317,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2420
  },
  {
    "id": "chunk_02421",
    "text": "are. Toxic shock syndrome can be life-threatening. y Tell the client to stop using the diaphragm. Help her choose another method but not the cervical cap. Supporting the Diaphragm User",
    "page_number": 317,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2421
  },
  {
    "id": "chunk_02422",
    "text": "Questions and Answers About Spermicides and Diaphragms 1. Do spermicides cause birth defects? Will the fetus be harmed if a woman accidentally uses spermicides while she is pregnant? No. Good evidence shows that spermicides will not cause birth defects or otherwise harm the fetus if a woman",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2422
  },
  {
    "id": "chunk_02423",
    "text": "rth defects or otherwise harm the fetus if a woman becomes pregnant while using spermicides or accidentally uses spermicides when she is already pregnant. 2. Do spermicides cause cancer? No, spermicides do not cause cancer. 3. Do spermicides increase the risk of becoming infected with HIV?",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2423
  },
  {
    "id": "chunk_02424",
    "text": "s increase the risk of becoming infected with HIV? Women who use nonoxynol-9 several times a day may face an increased risk of infection with HIV. Spermicides can cause vaginal irritation, which may cause small lesions to form on the lining of the vagina or on the external genitals. These lesions",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2424
  },
  {
    "id": "chunk_02425",
    "text": "vagina or on the external genitals. These lesions may make it easier for a woman to become infected with HIV. Studies that suggest spermicide use increases HIV risk have involved women who used spermicides several times a day. Women who have multiple daily acts of sex should use",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2425
  },
  {
    "id": "chunk_02426",
    "text": "men who have multiple daily acts of sex should use another contraceptive method. A study among women using nonoxynol-9 an average of 3 times a week, however, found no increased risk of HIV infection for spermicide users compared with women not using spermicides. New spermicides that are",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2426
  },
  {
    "id": "chunk_02427",
    "text": "en not using spermicides. New spermicides that are less irritating may become available. 4. Is the diaphragm uncomfortable for the woman? No, not if it is fitted and inserted correctly. The woman and her partner usually cannot feel the diaphragm during sex. The",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2427
  },
  {
    "id": "chunk_02428",
    "text": "usually cannot feel the diaphragm during sex. The provider selects the properly sized diaphragm for each woman so that it fits her and does not hurt. If it is uncomfortable, she should come back to have the fit checked and to make sure that she is inserting and removing the diaphragm properly.",
    "page_number": 318,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2428
  },
  {
    "id": "chunk_02429",
    "text": "16 297 smgarhpaiD dna sedicimrepS 5. If a woman uses the diaphragm without spermicides, will it still prevent pregnancy? There is not enough evidence to be certain. A few studies find that diaphragm users have higher pregnancy rates when they do not use",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2429
  },
  {
    "id": "chunk_02430",
    "text": "s have higher pregnancy rates when they do not use a spermicide with the diaphragm. Thus, using a diaphragm without spermicide is not recommended. 6. Could a woman leave a diaphragm in all day? Yes, although doing so is usually not recommended. A woman could",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2430
  },
  {
    "id": "chunk_02431",
    "text": "doing so is usually not recommended. A woman could leave a diaphragm in all day if she cannot put it in shortly before having sex. She should not leave the diaphragm in for more than 24 hours, however. This can increase the risk of toxic shock syndrome. 7. Can a woman use lubricants with a diaphragm?",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2431
  },
  {
    "id": "chunk_02432",
    "text": "e. 7. Can a woman use lubricants with a diaphragm? Yes, but only water- or silicone-based lubricants if the diaphragm is made of latex. Products made with oil cannot be used as lubricants because they damage latex. Materials that should not be used with",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2432
  },
  {
    "id": "chunk_02433",
    "text": "mage latex. Materials that should not be used with latex diaphragms include any oils (cooking, baby, coconut, mineral), petroleum jelly, lotions, cold creams, butter, cocoa butter, and margarine. Oil-based lubricants will not harm a plastic diaphragm.",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2433
  },
  {
    "id": "chunk_02434",
    "text": "ased lubricants will not harm a plastic diaphragm. Spermicides usually provide enough lubrication for diaphragm users. 8. Do diaphragms help protect women from STIs, including HIV? Research suggests that the diaphragm may help protect somewhat",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2434
  },
  {
    "id": "chunk_02435",
    "text": "gests that the diaphragm may help protect somewhat against infections of the cervix such as gonorrhea and chlamydia. Some studies have also found that it also may help protect against pelvic inflammatory disease and trichomoniasis. Studies are underway",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2435
  },
  {
    "id": "chunk_02436",
    "text": "y disease and trichomoniasis. Studies are underway to assess whether incorporating a microbicide into the diaphragm would help to prevent HIV and other STIs. Currently, only male and female condoms are recommended for protection from HIV and other STIs.",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2436
  },
  {
    "id": "chunk_02437",
    "text": "ecommended for protection from HIV and other STIs. 9. Is there a new diaphragm that does not require fitting? Yes. The one-size SILCS diaphragm has been developed to fit most women without the need for a provider specifically trained to fit the diaphragm. Made of silicone, it can be easier to handle",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2437
  },
  {
    "id": "chunk_02438",
    "text": "ragm. Made of silicone, it can be easier to handle and more comfortable than conventional latex diaphragms. It is registered under the brand name Caya in 3 dozen countries. Used with a spermicidal gel, it offers similar protection to conventional diaphragms.",
    "page_number": 319,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2438
  },
  {
    "id": "chunk_02439",
    "text": "10. What is the vaginal sponge, and how effective is it? The vaginal sponge is made of plastic and contains spermicides. It is moistened with water and inserted into the vagina so that it rests against the cervix. Each sponge can be used only once. It is not widely available.",
    "page_number": 320,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2439
  },
  {
    "id": "chunk_02440",
    "text": "can be used only once. It is not widely available. Effectiveness depends on the user: Risk of pregnancy is greatest when a woman does not use the sponge with every act of sex. Women who have given birth: y One of the least effective methods, as commonly used.",
    "page_number": 320,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2440
  },
  {
    "id": "chunk_02441",
    "text": "of the least effective methods, as commonly used. y As commonly used, about 32 pregnancies per 100 women using the sponge over the first year. y When used correctly with every act of sex, about 20 pregnancies per 100 women over the first year. More effective among women who have not given birth:",
    "page_number": 320,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2441
  },
  {
    "id": "chunk_02442",
    "text": "re effective among women who have not given birth: y As commonly used, about 16 pregnancies per 100 women using the sponge over the first year. y When used correctly with every act of sex, about 9 pregnancies per 100 women over the first year. 298 Family Planning: A Global Handbook for Providers",
    "page_number": 320,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2442
  },
  {
    "id": "chunk_02443",
    "text": "17 299 spaC lacivreC CHAPTER 17 Cervical Caps Key Points for Providers and Clients y The cervical cap is placed deep in the vagina before sex. It covers the cervix. y Requires correct use with every act of sex for greatest effectiveness. y Used together with spermicide to improve effectiveness.",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2443
  },
  {
    "id": "chunk_02444",
    "text": "together with spermicide to improve effectiveness. What Is the Cervical Cap? y A soft, deep, latex or plastic rubber cup that snugly covers the cervix. y Comes in different sizes; requires fitting by a specifically trained provider. How Effective?",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2444
  },
  {
    "id": "chunk_02445",
    "text": "by a specifically trained provider. How Effective? Effectiveness depends on the user: Risk of pregnancy is greatest when the cervical cap with spermicide is not used with every act of sex. Women who have given birth: y One of the least effective methods, as commonly used. More effective",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2445
  },
  {
    "id": "chunk_02446",
    "text": "ffective methods, as commonly used. More effective y As commonly used, about 32 pregnancies per 100 women using the cervical cap with spermicide over the first year. This means that 68 of every 100 women using the cervical cap will not become pregnant.",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2446
  },
  {
    "id": "chunk_02447",
    "text": "n using the cervical cap will not become pregnant. y When used correctly with every act of sex, about 26 pregnancies Never per 100 women using the cervical cap over the first year. given birth More effective among women who have not given birth: y As commonly used, about 16 pregnancies per 100 women",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2447
  },
  {
    "id": "chunk_02448",
    "text": "commonly used, about 16 pregnancies per 100 women using the cervical cap with spermicide over the first year. This means that 84 of every 100 women using the cervical cap will not become pregnant. Have given y When used correctly with every act of sex, about 9 Less birth effective",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2448
  },
  {
    "id": "chunk_02449",
    "text": "ith every act of sex, about 9 Less birth effective pregnancies per 100 women using the cervical cap over the first year. Return of fertility after use of cervical cap is stopped: No delay Protection against sexually transmitted infections: None",
    "page_number": 321,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2449
  },
  {
    "id": "chunk_02450",
    "text": "Side Effects, Health Benefits, and Health Risks Same as for diaphragms (see Side Effects, Health Benefits, and Health Risks in Chapter 16 \u2013 Spermicides and Diaphragms, p. 287). Medical Eligibility Criteria for Cervical Caps Ask the client the Medical Eligibility Criteria questions for diaphragms (see",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2450
  },
  {
    "id": "chunk_02451",
    "text": "Eligibility Criteria questions for diaphragms (see p. 278). Also ask the question below about known medical conditions. Examinations and tests are not necessary. If she answers \u201cno\u201d to all of the questions here and for the diaphragm, then she can start the",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2451
  },
  {
    "id": "chunk_02452",
    "text": "here and for the diaphragm, then she can start the cervical cap if she wants. If she answers \u201cyes\u201d to a question, follow the instructions. In some cases she can still start the cervical cap. 1. Have you been treated or are you going to be treated",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2452
  },
  {
    "id": "chunk_02453",
    "text": "ve you been treated or are you going to be treated for cervical precancer (cervical intraepithelial neoplasia [CIN]) or cervical cancer? \u274f NO \u274f YES Do not provide the cervical cap. For complete classifications, see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use.",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2453
  },
  {
    "id": "chunk_02454",
    "text": "edical Eligibility Criteria for Contraceptive Use. Be sure to explain the health benefits and risks and the side effects of the method that the client will use. Also, point out any conditions that would make the method inadvisable, when relevant to the client. Providing Cervical Caps",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2454
  },
  {
    "id": "chunk_02455",
    "text": "en relevant to the client. Providing Cervical Caps Providing the cervical cap is similar to providing diaphragms (see p. 289) and helping diaphragm users (see p. 293). Differences include: Inserting y Fill one-third of the cap with spermicidal cream, jelly, or foam.",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2455
  },
  {
    "id": "chunk_02456",
    "text": "of the cap with spermicidal cream, jelly, or foam. y Press the rim of the cap around the cervix until it is completely covered, pressing gently on the dome to apply suction and seal the cap. y Insert the cervical cap any time up to 42 hours before having sex. Removing",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2456
  },
  {
    "id": "chunk_02457",
    "text": "ny time up to 42 hours before having sex. Removing y Leave the cervical cap in for at least 6 hours after her partner\u2019s last ejaculation, but not more than 48 hours from the time it was put in. y Leaving the cap in place for more than 48 hours may increase the risk of",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2457
  },
  {
    "id": "chunk_02458",
    "text": "ce for more than 48 hours may increase the risk of toxic shock syndrome and can cause a bad odor and vaginal discharge. y Tip the cap rim sideways to break the seal against the cervix, and then gently pull the cap down and out of the vagina. 300 Family Planning: A Global Handbook for Providers",
    "page_number": 322,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2458
  },
  {
    "id": "chunk_02459",
    "text": "18 301 sdohteM ssenerawA ytilitreF CHAPTER 18 Fertility Awareness Methods Key Points for Providers and Clients y Fertility awareness methods require partners\u2019 cooperation. Couple must be committed to abstaining or using another method on fertile days.",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2459
  },
  {
    "id": "chunk_02460",
    "text": "bstaining or using another method on fertile days. y Must stay aware of body changes or keep track of days, according to rules of the specific method. y No side effects or health risks. What Are Fertility Awareness Methods? y \u201cFertility awareness\u201d means that a woman knows how to tell when the",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2460
  },
  {
    "id": "chunk_02461",
    "text": "ess\u201d means that a woman knows how to tell when the fertile time of her menstrual cycle starts and ends. (The fertile time is when she can become pregnant.) y Sometimes called periodic abstinence or natural family planning. y A woman can use several ways, alone or in combination, to tell when her",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2461
  },
  {
    "id": "chunk_02462",
    "text": "al ways, alone or in combination, to tell when her fertile time begins and ends. y Calendar-based methods involve keeping track of days of the menstrual cycle to identify the start and end of the fertile time. \u2013 Examples: Standard Days Method, which avoids unprotected vaginal sex on",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2462
  },
  {
    "id": "chunk_02463",
    "text": "ys Method, which avoids unprotected vaginal sex on days 8 through 19 of the menstrual cycle, and calendar rhythm method. y Symptoms-based methods depend on observing signs of fertility. \u2013 Cervical secretions: When a woman sees or feels cervical secretions, she",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2463
  },
  {
    "id": "chunk_02464",
    "text": "hen a woman sees or feels cervical secretions, she may be fertile. She may feel just a little vaginal wetness. \u2013 Basal body temperature (BBT): A woman\u2019s resting body temperature goes up slightly after the release of an egg (ovulation). She is not likely to",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2464
  },
  {
    "id": "chunk_02465",
    "text": "elease of an egg (ovulation). She is not likely to become pregnant from 3 days after this temperature rise through the start of her next monthly bleeding. Her temperature stays higher until the beginning of her next monthly bleeding.",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2465
  },
  {
    "id": "chunk_02466",
    "text": "until the beginning of her next monthly bleeding. \u2013 Examples: TwoDay Method, BBT method, ovulation method (also known as Billings method or cervical mucus method), and symptothermal method.",
    "page_number": 323,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2466
  },
  {
    "id": "chunk_02467",
    "text": "y Work primarily by helping a woman know when she could become pregnant. The couple prevents pregnancy by avoiding unprotected vaginal sex during these fertile days\u2014usually by abstaining or by using condoms or a diaphragm. Some couples use spermicides or withdrawal, but",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2467
  },
  {
    "id": "chunk_02468",
    "text": "m. Some couples use spermicides or withdrawal, but these are among the least effective methods. How Effective? More Effectiveness depends on the user: Risk of pregnancy is greatest effective when couples have sex on the fertile days without using another method.",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2468
  },
  {
    "id": "chunk_02469",
    "text": "on the fertile days without using another method. y As commonly used, in the first year about 15 pregnancies per 100 women using periodic abstinence. This means that 85 of every 100 women relying on periodic abstinence will not become pregnant. Most of the couples in this study were",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2469
  },
  {
    "id": "chunk_02470",
    "text": "e pregnant. Most of the couples in this study were using the calendar rhythm method. y Pregnancy rates with consistent and correct use vary for different types of fertility awareness methods (see table below). Less These rates reflect the experience of couples who volunteered to effective",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2470
  },
  {
    "id": "chunk_02471",
    "text": "experience of couples who volunteered to effective use these methods in research projects (see Question 3, p. 316). Reliable effectiveness rates are not available for the calendar rhythm method or the basal body temperature method.",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2471
  },
  {
    "id": "chunk_02472",
    "text": "hythm method or the basal body temperature method. y In general, abstaining during fertile times is more effective than using another method during fertile times. Pregnancies per 100 Women Over the First Year of Use Consistent and As commonly Method correct use used Calendar-based methods",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2472
  },
  {
    "id": "chunk_02473",
    "text": "nly Method correct use used Calendar-based methods Standard Days Method 5 12 Symptoms-based methods TwoDay Method 4 14 Ovulation method 3 23 Symptothermal method <1 2 Return of fertility after fertility awareness methods are stopped: No delay",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2473
  },
  {
    "id": "chunk_02474",
    "text": "fertility awareness methods are stopped: No delay Protection against sexually transmitted infections (STIs): None 302 Family Planning: A Global Handbook for Providers",
    "page_number": 324,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2474
  },
  {
    "id": "chunk_02475",
    "text": "18 303 sdohteM ssenerawA ytilitreF Side Effects, Health Benefits, and Health Risks Side Effects None Known Health Benefits Known Health Risks Help protect against: None y Risks of pregnancy Why Some Women Say They Like Fertility Awareness Methods y Have no side effects",
    "page_number": 325,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2475
  },
  {
    "id": "chunk_02476",
    "text": "Fertility Awareness Methods y Have no side effects y Do not require procedures and usually do not require supplies y Help women learn about their bodies and fertility y Allow some couples to adhere to their religious or cultural norms about contraception",
    "page_number": 325,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2476
  },
  {
    "id": "chunk_02477",
    "text": "ir religious or cultural norms about contraception y Can be used to identify fertile days by both women who want to become pregnant and women who want to avoid pregnancy Correcting Misunderstandings (see also Questions and Answers, p. 315) Fertility awareness methods:",
    "page_number": 325,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2477
  },
  {
    "id": "chunk_02478",
    "text": "and Answers, p. 315) Fertility awareness methods: y Can be effective if used consistently and correctly. y Do not require literacy or advanced education. y Do not harm men who abstain from sex. y Do not work when a couple is mistaken about when the fertile time",
    "page_number": 325,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2478
  },
  {
    "id": "chunk_02479",
    "text": "n a couple is mistaken about when the fertile time occurs, such as thinking it occurs during monthly bleeding. Fertility Awareness Methods for Women With HIV y Women who are living with HIV or are on antiretroviral therapy (ART) can safely use fertility awareness methods.",
    "page_number": 325,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2479
  },
  {
    "id": "chunk_02480",
    "text": "(ART) can safely use fertility awareness methods. y Urge these women to use condoms along with fertility awareness methods. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. Side Effects, Health Benefits, and Health Risks",
    "page_number": 325,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2480
  },
  {
    "id": "chunk_02481",
    "text": "Who Can Use Calendar-Based Methods Medical Eligibility Criteria for Calendar -Based Methods All women can use calendar-based methods. No medical conditions prevent the use of these methods, but some conditions can make them harder to use effectively.",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2481
  },
  {
    "id": "chunk_02482",
    "text": "onditions can make them harder to use effectively. Caution means that additional or special counseling may be needed to ensure correct use of the method. Delay means that use of a particular fertility awareness method should be delayed until the condition is evaluated or corrected. Give",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2482
  },
  {
    "id": "chunk_02483",
    "text": "ntil the condition is evaluated or corrected. Give the client another method to use until she can start the calendar- based method. In the following situation, use caution with calendar-based methods: y Menstrual cycles are irregular. (For example, menstrual cycle",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2483
  },
  {
    "id": "chunk_02484",
    "text": "ycles are irregular. (For example, menstrual cycle irregularities are common in young women in the first several years after their first monthly bleeding and in older women who are approaching menopause. Identifying the fertile time may be difficult.)",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2484
  },
  {
    "id": "chunk_02485",
    "text": "e. Identifying the fertile time may be difficult.) In the following situations, delay starting calendar-based methods: y Recently gave birth or is breastfeeding, (Delay until she has had at least 3 menstrual cycles and her cycles are regular again. For several",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2485
  },
  {
    "id": "chunk_02486",
    "text": "cles and her cycles are regular again. For several months after regular cycles have returned, use with caution.) y Recently had an abortion or miscarriage (Delay until the start of her next monthly bleeding.) y Irregular vaginal bleeding (Delay until cycles have become more regular.)",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2486
  },
  {
    "id": "chunk_02487",
    "text": "ing (Delay until cycles have become more regular.) In the following situation, delay or use caution with calendar-based methods: y Taking medicines that can make the menstrual cycle irregular (for example, certain antidepressants, thyroid medications, long-term",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2487
  },
  {
    "id": "chunk_02488",
    "text": "in antidepressants, thyroid medications, long-term use of certain antibiotics, or long-term use of any nonsteroidal anti-inflammatory drug, such as aspirin or ibuprofen). 304 Family Planning: A Global Handbook for Providers",
    "page_number": 326,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2488
  },
  {
    "id": "chunk_02489",
    "text": "18 305 sdohteM ssenerawA ytilitreF Providing Calendar-Based Methods When to Start Once trained, a woman or couple usually can begin using calendar-based methods at any time. Give clients who cannot start immediately another method to use until they can start. Woman\u2019s situation When to start",
    "page_number": 327,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2489
  },
  {
    "id": "chunk_02490",
    "text": "il they can start. Woman\u2019s situation When to start Having regular Any time of the month menstrual cycles y No need to wait until the start of next monthly bleeding. No monthly y Delay calendar-based methods until monthly bleeding bleeding returns.",
    "page_number": 327,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2490
  },
  {
    "id": "chunk_02491",
    "text": "d methods until monthly bleeding bleeding returns. After childbirth y Delay the Standard Days Method until she has (whether had 4 menstrual cycles and the last one was breastfeeding 26\u201332 days long. or not) y Regular cycles will return later in breastfeeding women than in women who are not",
    "page_number": 327,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2491
  },
  {
    "id": "chunk_02492",
    "text": "r in breastfeeding women than in women who are not breastfeeding. After miscarriage y Delay the Standard Days Method until the start or abortion of her next monthly bleeding, when she can start if she has no bleeding due to injury to the genital tract.",
    "page_number": 327,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2492
  },
  {
    "id": "chunk_02493",
    "text": "as no bleeding due to injury to the genital tract. Switching from y Delay starting the Standard Days Method until a hormonal the start of her next monthly bleeding. method y If she is switching from injectables, delay the Standard Days Method at least until her repeat",
    "page_number": 327,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2493
  },
  {
    "id": "chunk_02494",
    "text": "the Standard Days Method at least until her repeat injection would have been given, and then start it at the beginning of her next monthly bleeding. After taking y Delay the Standard Days Method until the start emergency of her next monthly bleeding. contraceptive pills",
    "page_number": 327,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2494
  },
  {
    "id": "chunk_02495",
    "text": "Explaining How to Use Calendar -Based Methods Standard Days Method IMPORTANT: A woman can use the Standard Days Method if most of her menstrual cycles are 26 to 32 days long. If she has more than 2 longer or shorter cycles within a year, the Standard Days Method will be less",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2495
  },
  {
    "id": "chunk_02496",
    "text": "thin a year, the Standard Days Method will be less effective and she may want to choose another method. Keep track of y A woman keeps track of the days of her the days of the menstrual cycle, counting the first day of monthly menstrual cycle bleeding as day 1.",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2496
  },
  {
    "id": "chunk_02497",
    "text": "day of monthly menstrual cycle bleeding as day 1. Avoid unprotected y Days 8 through 19 of every cycle are considered sex on days 8\u201319 fertile days for all users of the Standard Days Method. y The couple avoids vaginal sex or uses condoms or a diaphragm during days 8 through 19. They",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2497
  },
  {
    "id": "chunk_02498",
    "text": "doms or a diaphragm during days 8 through 19. They can also use withdrawal or spermicides, but these are less effective. y The couple can have unprotected sex on all the other days of the cycle\u2014days 1 through 7 at the beginning of the cycle and from day 20 until her next monthly bleeding begins.",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2498
  },
  {
    "id": "chunk_02499",
    "text": "rom day 20 until her next monthly bleeding begins. Use memory aids y The couple can use CycleBeads, a color-coded if needed string of beads that indicates fertile and nonfertile days of a cycle (see diagram below), or they can mark a calendar or use some other memory aid.",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2499
  },
  {
    "id": "chunk_02500",
    "text": "can mark a calendar or use some other memory aid. If monthly bleeding 6 1 On day 1\u2014the first day of does not begin monthly bleeding\u2014move the before reaching the rubber ring to the red bead. last brown bead, her menstrual cycle 2 is longer than The next day move the 32 days. ring to the next bead.",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2500
  },
  {
    "id": "chunk_02501",
    "text": "next day move the 32 days. ring to the next bead. Each bead represents Do this every day, a day of the even bleeding days. 5 menstrual cycle. If monthly bleeding begins again before reaching the dark brown bead, her 3 White bead days menstrual cycle are days when is shorter than the woman can",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2501
  },
  {
    "id": "chunk_02502",
    "text": "cycle are days when is shorter than the woman can 26 days. 4 become pregnant. Brown bead days are days She should avoid when pregnancy is unlikely and unprotected sex. she can have unprotected sex. 306 Family Planning: A Global Handbook for Providers",
    "page_number": 328,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2502
  },
  {
    "id": "chunk_02503",
    "text": "18 307 sdohteM ssenerawA ytilitreF Calendar Rhythm Method Keep track of y Before relying on this method, a woman records the days of the the number of days in each menstrual cycle menstrual cycle for at least 6 months. The first day of monthly bleeding is always counted as day 1.",
    "page_number": 329,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2503
  },
  {
    "id": "chunk_02504",
    "text": "ay of monthly bleeding is always counted as day 1. Estimate the y The woman subtracts 18 from the length of fertile time her shortest recorded cycle. This tells her the estimated first day of her fertile time. Then she subtracts 11 days from the length of her longest",
    "page_number": 329,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2504
  },
  {
    "id": "chunk_02505",
    "text": "e subtracts 11 days from the length of her longest recorded cycle. This tells her the estimated last day of her fertile time. Avoid unprotected y The couple avoids vaginal sex, or uses condoms sex during fertile or a diaphragm, during the fertile time. They can",
    "page_number": 329,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2505
  },
  {
    "id": "chunk_02506",
    "text": "or a diaphragm, during the fertile time. They can time also use withdrawal or spermicides, but these are less effective. Update y She updates these calculations each month, calculations always using the 6 most recent cycles. monthly Example: \u2013 If the shortest of her last 6 cycles was",
    "page_number": 329,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2506
  },
  {
    "id": "chunk_02507",
    "text": "xample: \u2013 If the shortest of her last 6 cycles was 27 days, 27 \u2013 18 = 9. She starts avoiding unprotected sex on day 9. \u2013 If the longest of her last 6 cycles was 31 days, 31 \u2013 11 = 20. She can have unprotected sex again on day 21. \u2013 Thus, she must avoid unprotected sex from",
    "page_number": 329,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2507
  },
  {
    "id": "chunk_02508",
    "text": "Who Can Use Symptoms- Based Methods Medical Eligibility Criteria for Symptoms-Based Methods All women can use symptoms-based methods. No medical conditions prevent the use of these methods, but some conditions can make them harder to use effectively.",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2508
  },
  {
    "id": "chunk_02509",
    "text": "onditions can make them harder to use effectively. Caution means that additional or special counseling may be needed to ensure correct use of the method. Delay means that use of a particular fertility awareness method should be delayed until the condition is evaluated or corrected. Give the client",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2509
  },
  {
    "id": "chunk_02510",
    "text": "ndition is evaluated or corrected. Give the client another method to use until she can start the symptoms-based method. In the following situations, use caution with symptoms-based methods: y Recently had an abortion or miscarriage y Menstrual cycles have just started or have become less frequent or",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2510
  },
  {
    "id": "chunk_02511",
    "text": "have just started or have become less frequent or stopped due to older age. (Menstrual cycle irregularities are common in young women in the first several years after their first monthly bleeding and in older women who are approaching menopause. Identifying the fertile time may be difficult.)",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2511
  },
  {
    "id": "chunk_02512",
    "text": "e. Identifying the fertile time may be difficult.) y A chronic condition that raises her body temperature (for basal body temperature and symptothermal methods) In the following situations, delay starting symptoms-based methods:",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2512
  },
  {
    "id": "chunk_02513",
    "text": "situations, delay starting symptoms-based methods: y Recently gave birth or is breastfeeding. (Delay until normal secretions have returned\u2014usually at least 6 months after childbirth for breastfeeding women and at least 4 weeks after childbirth for women",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2513
  },
  {
    "id": "chunk_02514",
    "text": "en and at least 4 weeks after childbirth for women who are not breastfeeding. For several months after regular cycles have returned, use with caution.) y An acute condition that raises her body temperature (for basal body temperature and symptothermal methods) y Irregular vaginal bleeding",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2514
  },
  {
    "id": "chunk_02515",
    "text": "ymptothermal methods) y Irregular vaginal bleeding y Abnormal vaginal discharge In the following situation, delay or use caution with symptoms- based methods: y Taking any medicines that change cervical secretions, for example, antihistimines, or medicines that raise body temperature, for example,",
    "page_number": 330,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2515
  },
  {
    "id": "chunk_02516",
    "text": "18 309 sdohteM ssenerawA ytilitreF Providing Symptoms-Based Methods When to Start Once trained, a woman or couple usually can begin using symptoms-based methods at any time. Women not using a hormonal method can practice monitoring their fertility signs before they start using symptoms-based",
    "page_number": 331,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2516
  },
  {
    "id": "chunk_02517",
    "text": "ility signs before they start using symptoms-based methods. Give clients who cannot start immediately another method to use until they can start. Woman\u2019s situation When to start Having regular Any time of the month menstrual cycles y No need to wait until the start of next monthly bleeding.",
    "page_number": 331,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2517
  },
  {
    "id": "chunk_02518",
    "text": "to wait until the start of next monthly bleeding. No monthly y Delay symptoms-based methods until monthly bleeding bleeding returns. After childbirth y She can start symptoms-based methods once (whether normal secretions have returned. breastfeeding y Normal secretions will return later in or not)",
    "page_number": 331,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2518
  },
  {
    "id": "chunk_02519",
    "text": "g y Normal secretions will return later in or not) breastfeeding women than in women who are not breastfeeding. After miscarriage y She can start symptoms-based methods or abortion immediately with special counseling and support, if she has no infection-related secretions or",
    "page_number": 331,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2519
  },
  {
    "id": "chunk_02520",
    "text": "ort, if she has no infection-related secretions or bleeding due to injury to the genital tract. Switching from a y She can start symptoms-based methods in the hormonal method next menstrual cycle after stopping a hormonal method. After taking y She can start symptoms-based methods once",
    "page_number": 331,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2520
  },
  {
    "id": "chunk_02521",
    "text": "Explaining How to Use Symptoms-Based Methods TwoDay Method IMPORTANT: If a woman has a vaginal infection or another condition that changes cervical mucus, the TwoDay Method will be difficult to use. Check for y The woman checks for cervical secretions every",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2521
  },
  {
    "id": "chunk_02522",
    "text": "r y The woman checks for cervical secretions every secretions afternoon and/or evening, on fingers, underwear, or tissue paper or by sensation in or around the vagina. y As soon as she notices any secretions of any type, color, or consistency, she considers herself fertile",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2522
  },
  {
    "id": "chunk_02523",
    "text": "lor, or consistency, she considers herself fertile that day and the following day. Avoid sex or use y The couple avoids vaginal sex or uses condoms or another method a diaphragm on each day with secretions and on on fertile days each day following a day with secretions. They can",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2523
  },
  {
    "id": "chunk_02524",
    "text": "each day following a day with secretions. They can also use withdrawal or spermicides, but these are less effective. Resume y The couple can have unprotected sex again after unprotected sex the woman has had 2 dry days (days without after 2 dry days secretions of any type) in a row.",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2524
  },
  {
    "id": "chunk_02525",
    "text": "after 2 dry days secretions of any type) in a row. Basal Body Temperature (BBT) Method IMPORTANT: If a woman has a fever or other changes in body temperature, the BBT method will be difficult to use. Take body y The woman takes her body temperature at the",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2525
  },
  {
    "id": "chunk_02526",
    "text": "body y The woman takes her body temperature at the temperature daily same time each morning before she gets out of bed and before she eats anything. She records her temperature on a special graph. y She watches for her temperature to rise slightly\u20140.2\u00b0 to 0.5\u00b0C (0.4\u00b0 to 1.0\u00b0F)\u2014",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2526
  },
  {
    "id": "chunk_02527",
    "text": "re to rise slightly\u20140.2\u00b0 to 0.5\u00b0C (0.4\u00b0 to 1.0\u00b0F)\u2014 just after ovulation (usually about midway through the menstrual cycle). Avoid sex or use y The couple avoids vaginal sex, or uses condoms or another method a diaphragm from the first day of monthly bleeding",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2527
  },
  {
    "id": "chunk_02528",
    "text": "a diaphragm from the first day of monthly bleeding until 3 days after until 3 days after the woman\u2019s temperature has the temperature risen above her regular temperature. They can also rise use withdrawal or spermicides, but these are less effective.",
    "page_number": 332,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2528
  },
  {
    "id": "chunk_02529",
    "text": "18 311 sdohteM ssenerawA ytilitreF Resume y When the woman\u2019s temperature has risen above unprotected sex her regular temperature and stayed higher for 3 full until next monthly days, ovulation has occurred and the fertile period bleeding begins has passed.",
    "page_number": 333,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2529
  },
  {
    "id": "chunk_02530",
    "text": "and the fertile period bleeding begins has passed. y The couple can have unprotected sex on the 4th day and until her next monthly bleeding begins. Ovulation 37.0 36.5 36.0 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 Day Ovulation Method IMPORTANT: If a woman has a vaginal infection or another condition",
    "page_number": 333,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2530
  },
  {
    "id": "chunk_02531",
    "text": "woman has a vaginal infection or another condition that changes cervical mucus, this method may be difficult to use. Check cervical y The woman checks every day for any cervical secretions daily secretions on fingers, underwear, or tissue paper or by sensation in or around the vagina.",
    "page_number": 333,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2531
  },
  {
    "id": "chunk_02532",
    "text": "sue paper or by sensation in or around the vagina. Avoid unprotected y Ovulation might occur early in the cycle, during sex on days of the last days of monthly bleeding. Heavy bleeding heavy monthly could make mucus difficult to observe. bleeding",
    "page_number": 333,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2532
  },
  {
    "id": "chunk_02533",
    "text": "ly could make mucus difficult to observe. bleeding Resume y Between the end of monthly bleeding and the start unprotected sex of secretions, the couple can have unprotected until secretions sex, but not on 2 days in a row. (Avoiding sex on begin the second day allows time for semen to disappear",
    "page_number": 333,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2533
  },
  {
    "id": "chunk_02534",
    "text": "the second day allows time for semen to disappear and for cervical mucus to be observed.) y It is recommended that they have sex in the evenings, after the woman has been in an upright position for at least a few hours and has been able to check for cervical mucus. (Continued on next page)",
    "page_number": 333,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2534
  },
  {
    "id": "chunk_02535",
    "text": "Avoid unprotected y As soon as she notices any secretions, she sex when considers herself fertile and avoids unprotected secretions begin sex. and until 4 days y She continues to check her cervical secretions after \u201cpeak day\u201d each day. The secretions have a \u201cpeak day\u201d\u2014the",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2535
  },
  {
    "id": "chunk_02536",
    "text": "ay\u201d each day. The secretions have a \u201cpeak day\u201d\u2014the last day that they are clear, slippery, stretchy, and wet. She will know this has passed when, on the next day, her secretions are sticky or dry, or she has no secretions at all. She continues to consider herself fertile for 3 days after that peak",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2536
  },
  {
    "id": "chunk_02537",
    "text": "onsider herself fertile for 3 days after that peak day and avoids unprotected sex. Resume y The couple can have unprotected sex on the unprotected sex 4th day after her peak day and until her next monthly bleeding begins. Symptothermal Method (basal body temperature +",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2537
  },
  {
    "id": "chunk_02538",
    "text": "ns. Symptothermal Method (basal body temperature + cervical secretions + other fertility signs) Avoid unprotected y Users identify fertile and nonfertile days by sex on fertile days combining BBT and ovulation method instructions. y Women may also identify the fertile time by other",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2538
  },
  {
    "id": "chunk_02539",
    "text": "Women may also identify the fertile time by other signs such as breast tenderness and ovulatory pain (lower abdominal pain or cramping around the time of ovulation). y The couple avoids unprotected sex between the first day of monthly bleeding and either the",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2539
  },
  {
    "id": "chunk_02540",
    "text": "n the first day of monthly bleeding and either the fourth day after peak cervical secretions or the third full day after the rise in temperature (BBT), whichever happens later. y Some women who use this method have unprotected sex between the end of monthly",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2540
  },
  {
    "id": "chunk_02541",
    "text": "od have unprotected sex between the end of monthly bleeding and the beginning of secretions, but not on 2 days in a row. 312 Family Planning: A Global Handbook for Providers",
    "page_number": 334,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2541
  },
  {
    "id": "chunk_02542",
    "text": "18 313 sdohteM ssenerawA ytilitreF Supporting New and Continuing Users How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can:",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2542
  },
  {
    "id": "chunk_02543",
    "text": "rt he can give to his partner. A male partner can: y Support a woman\u2019s choice of a fertility awareness method y Discuss and agree to use a fertility awareness method with a full understanding of how to use it y Share responsibility for keeping track of cycles and knowing when is the fertile period",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2543
  },
  {
    "id": "chunk_02544",
    "text": "k of cycles and knowing when is the fertile period y Not insist on sex without contraception during the fertile period y Agree in advance how to avoid pregnancy if they are going to have sex in the fertile period (for example, use of another method)",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2544
  },
  {
    "id": "chunk_02545",
    "text": "ertile period (for example, use of another method) y Help to make sure she has ECPs on hand in case they have unprotected sex during the fertile period y Use condoms consistently in addition to a fertility awareness method if he has an STI/HIV or thinks he may be at risk of an STI/HIV",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2545
  },
  {
    "id": "chunk_02546",
    "text": "STI/HIV or thinks he may be at risk of an STI/HIV \u201cCome Back Any Time\u201d: Reasons to Return No routine return visit is required. Providers should invite a woman or couple to meet with them a few times during the first few cycles if they want more help. Assure every",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2546
  },
  {
    "id": "chunk_02547",
    "text": "st few cycles if they want more help. Assure every client that she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she has any major change in health status; or thinks she might be pregnant. Also if: y She is having difficulty identifying her",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2547
  },
  {
    "id": "chunk_02548",
    "text": "lso if: y She is having difficulty identifying her fertile days. y She is having trouble avoiding sex or using another method on the fertile days. For example, her partner does not cooperate. Supporting New and Continuing Users",
    "page_number": 335,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2548
  },
  {
    "id": "chunk_02549",
    "text": "Helping Clients at Any Visit 1. Ask clients how they are doing with the method and whether they are satisfied. Ask if they have any questions or anything to discuss. 2. Ask especially if they are having difficulty identifying her fertile days or trouble avoiding unprotected sex on the fertile days.",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2549
  },
  {
    "id": "chunk_02550",
    "text": "uble avoiding unprotected sex on the fertile days. 3. Check whether the couple is using the method correctly. Review observations or records of fertility signs. If needed, plan for another visit. 4. Ask a long-term client if she has had any new health problems since her",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2550
  },
  {
    "id": "chunk_02551",
    "text": "t if she has had any new health problems since her last visit. Address problems as appropriate. 5. Ask a long-term client about major life changes that may affect her needs\u2014particularly plans for having children and STI/HIV risk. Follow up as needed. Managing Any Problems Problems With Use",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2551
  },
  {
    "id": "chunk_02552",
    "text": "as needed. Managing Any Problems Problems With Use y Problems with fertility awareness methods affect women\u2019s satisfaction and use of the method. They deserve the provider\u2019s attention. If the client reports any problems, listen to her concerns and give her advice and",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2552
  },
  {
    "id": "chunk_02553",
    "text": "ms, listen to her concerns and give her advice and support. Make sure she understands the advice and agrees. y Offer to help the client choose another method\u2014now, if she wishes, or if problems cannot be overcome. Inability to abstain from sex during the fertile time",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2553
  },
  {
    "id": "chunk_02554",
    "text": "bility to abstain from sex during the fertile time y Discuss the problem openly with the couple and help them feel at ease, not embarrassed. y Discuss possible use of condoms, diaphragm, withdrawal, or spermicides or sexual contact without vaginal sex during the fertile time.",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2554
  },
  {
    "id": "chunk_02555",
    "text": "ntact without vaginal sex during the fertile time. y If she has had unprotected sex in the past 5 days, she can consider ECPs (see Chapter 3 \u2013 Emergency Contraceptive Pills). Calendar-Based Methods Cycles are outside the 26\u201332 day range for Standard Days Method",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2555
  },
  {
    "id": "chunk_02556",
    "text": "tside the 26\u201332 day range for Standard Days Method y If she has 2 or more cycles outside the 26\u201332 day range within any 12 months, suggest she use the calendar rhythm method or a symptoms-based method instead. Very irregular menstrual cycles among users of calendar- based methods",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2556
  },
  {
    "id": "chunk_02557",
    "text": "rual cycles among users of calendar- based methods y Suggest use of a symptoms-based method instead. 314 Family Planning: A Global Handbook for Providers",
    "page_number": 336,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2557
  },
  {
    "id": "chunk_02558",
    "text": "18 315 sdohteM ssenerawA ytilitreF Symptoms-Based Methods Difficulty recognizing different types of secretions for the ovulation method y Counsel the client and help her learn how to interpret cervical secretions. y Suggest she use the TwoDay Method, which does not require the user to",
    "page_number": 337,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2558
  },
  {
    "id": "chunk_02559",
    "text": "TwoDay Method, which does not require the user to tell the difference among types of secretions. Difficulty recognizing the presence of secretions for the ovulation method or the TwoDay Method y Provide additional guidance on how to recognize secretions.",
    "page_number": 337,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2559
  },
  {
    "id": "chunk_02560",
    "text": "dditional guidance on how to recognize secretions. y Suggest she use a calendar-based method instead. Questions and Answers About Fertility Awareness Methods 1. Can only well-educated couples use fertility awareness methods? No. Couples with little or no formal schooling can and do use fertility",
    "page_number": 337,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2560
  },
  {
    "id": "chunk_02561",
    "text": "le or no formal schooling can and do use fertility awareness methods effectively. Couples must be highly motivated, well-trained in their method, and committed to avoiding unprotected sex during the fertile time. 2. Are fertility awareness methods reliable?",
    "page_number": 337,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2561
  },
  {
    "id": "chunk_02562",
    "text": "time. 2. Are fertility awareness methods reliable? For many couples, these methods provide reliable information about the fertile days. If the couple avoids vaginal sex, or uses condoms or a diaphragm during the woman\u2019s fertile time, fertility awareness methods",
    "page_number": 337,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2562
  },
  {
    "id": "chunk_02563",
    "text": "woman\u2019s fertile time, fertility awareness methods can be effective. Using withdrawal or spermicides during the fertile time is less effective. Questions and Answers About Fertility Awareness Methods",
    "page_number": 337,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2563
  },
  {
    "id": "chunk_02564",
    "text": "3. What is different about the newer fertility awareness methods, the Standard Days Method and the TwoDay Method? These fertility awareness methods are easier to use correctly than some of the older ones. Thus, they could appeal to more couples and be more",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2564
  },
  {
    "id": "chunk_02565",
    "text": "hus, they could appeal to more couples and be more effective for some people. They are like older methods, however, in that they rely on the same ways of judging when a woman might be fertile\u2014 by keeping track of the days of the cycle for the Standard Days Method",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2565
  },
  {
    "id": "chunk_02566",
    "text": "the days of the cycle for the Standard Days Method and by cervical secretions for the TwoDay Method. So far, there are few studies of these methods. A clinical trial found that, as the Standard Days Method was commonly used by women who had most cycles between",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2566
  },
  {
    "id": "chunk_02567",
    "text": "commonly used by women who had most cycles between 26 and 32 days long, there were 12 pregnancies per 100 women over the first year of use. In a clinical trial of the TwoDay Method as it was commonly used, there were 14 pregnancies per 100 women over the",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2567
  },
  {
    "id": "chunk_02568",
    "text": ", there were 14 pregnancies per 100 women over the first year of use. This rate is based on those who remained in the study. Women who detected secretions on fewer than 5 days or more than 14 days in each cycle were excluded. 4. How likely is a woman to become pregnant if she has sex",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2568
  },
  {
    "id": "chunk_02569",
    "text": "ikely is a woman to become pregnant if she has sex during monthly bleeding? During monthly bleeding the chances of pregnancy are low but not zero. Bleeding itself does not prevent pregnancy, and it does not promote pregnancy, either. In the first several days of monthly bleeding, the",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2569
  },
  {
    "id": "chunk_02570",
    "text": "In the first several days of monthly bleeding, the chances of pregnancy are lowest. For example, on day 2 of the cycle (counting from the first day of bleeding as day 1), the chance of getting pregnant is extremely low (less than 1%). As the days pass, the chances",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2570
  },
  {
    "id": "chunk_02571",
    "text": "low (less than 1%). As the days pass, the chances of pregnancy increase, whether or not she is still bleeding. The risk of pregnancy rises until ovulation. The day after ovulation the chances of pregnancy begin to drop steadily. Some fertility awareness methods that",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2571
  },
  {
    "id": "chunk_02572",
    "text": "op steadily. Some fertility awareness methods that depend on cervical secretions advise avoiding unprotected sex during monthly bleeding because cervical secretions cannot be detected during bleeding and there is a small risk of ovulation at this time.",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2572
  },
  {
    "id": "chunk_02573",
    "text": "d there is a small risk of ovulation at this time. 5. How many days of abstinence or use of another method might be required for each of the fertility awareness methods? The number of days varies based on the woman\u2019s cycle length. The average number of days a woman would be considered fertile\u2014and",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2573
  },
  {
    "id": "chunk_02574",
    "text": "er of days a woman would be considered fertile\u2014and would need to abstain or use another method\u2014with each method is: Standard Days Method, 12 days; TwoDay Method, 13 days; symptothermal method, 17 days; ovulation method, 18 days. 316 Family Planning: A Global Handbook for Providers",
    "page_number": 338,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2574
  },
  {
    "id": "chunk_02575",
    "text": "19 317 lawardhtiW Only CHAPTER 19 theEssentials Withdrawal Key Points for Providers and Clients y One of the least effective contraceptive methods. Some men use this method effectively, however. Offers better pregnancy protection than no method at all.",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2575
  },
  {
    "id": "chunk_02576",
    "text": "better pregnancy protection than no method at all. y Always available in every situation. Can be used as a primary method or as a backup method. y Requires no supplies and no clinic or pharmacy visit. y Promotes male involvement and couple communication. What Is Withdrawal?",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2576
  },
  {
    "id": "chunk_02577",
    "text": "ment and couple communication. What Is Withdrawal? y Just before ejaculation, the man withdraws his penis from his partner\u2019s vagina and ejaculates outside the vagina, keeping his semen away from her external genitalia. y Also known as coitus interruptus and \u201cpulling out.\u201d",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2577
  },
  {
    "id": "chunk_02578",
    "text": "lso known as coitus interruptus and \u201cpulling out.\u201d y Works by keeping sperm out of the woman\u2019s body. How Effective? Effectiveness depends on the user: Risk of pregnancy is greatest when More the man does not withdraw his penis from the vagina before he effective ejaculates with every act of sex.",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2578
  },
  {
    "id": "chunk_02579",
    "text": "ore he effective ejaculates with every act of sex. y One of the least effective methods, as commonly used. y As commonly used, about 20 pregnancies per 100 women whose partners use withdrawal over the first year. This means that 80 of every 100 women whose partners use withdrawal",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2579
  },
  {
    "id": "chunk_02580",
    "text": "0 of every 100 women whose partners use withdrawal will not become pregnant. y When used correctly with every act of sex, about 4 pregnancies per 100 women whose partners use withdrawal over the first year. Return of fertility after use of withdrawal is stopped: No delay",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2580
  },
  {
    "id": "chunk_02581",
    "text": "ility after use of withdrawal is stopped: No delay Protection against sexually transmitted infections: None Less effective Side Effects, Health Benefits, and Health Risks None",
    "page_number": 339,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2581
  },
  {
    "id": "chunk_02582",
    "text": "Who Can and Cannot Use Withdrawal y All men can use withdrawal. No medical conditions prevent its use. y Withdrawal may be especially appropriate for couples who: \u2013 have no other method available at the time \u2013 are waiting to start another method \u2013 have sex infrequently",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2582
  },
  {
    "id": "chunk_02583",
    "text": "ng to start another method \u2013 have sex infrequently \u2013 have objections to using other methods Using Withdrawal y Can be used at any time. y Effectiveness depends on the willingness and ability of the couple to use withdrawal with every act of intercourse. Explaining How to Use",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2583
  },
  {
    "id": "chunk_02584",
    "text": "th every act of intercourse. Explaining How to Use When the man y He should withdraw his penis from the woman\u2019s feels close to vagina and ejaculate outside the vagina, keeping ejaculating his semen away from her external genitalia. If the man has y Before sex he should urinate and wipe the tip",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2584
  },
  {
    "id": "chunk_02585",
    "text": "as y Before sex he should urinate and wipe the tip ejaculated of his penis to remove any semen remaining. recently Giving Advice on Use Learning proper y Suggest the couple also use another method use can take time until the man feels that he can use withdrawal correctly with every act of sex.",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2585
  },
  {
    "id": "chunk_02586",
    "text": "an use withdrawal correctly with every act of sex. Greater protection y Suggest an additional or alternative family from pregnancy is planning method. (Couples who have been using available withdrawal effectively should not be discouraged from continuing.)",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2586
  },
  {
    "id": "chunk_02587",
    "text": "tively should not be discouraged from continuing.) Some men may y Men who cannot sense consistently when have difficulty ejaculation is about to occur. using withdrawal y Men who ejaculate prematurely. Can use y Explain ECP use in case a man ejaculates before",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2587
  },
  {
    "id": "chunk_02588",
    "text": "y Explain ECP use in case a man ejaculates before emergency withdrawing (see Chapter 3 \u2013 Emergency contraceptive Contraceptive Pills). Give ECPs if available. pills (ECPs) 318 Family Planning: A Global Handbook for Providers",
    "page_number": 340,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2588
  },
  {
    "id": "chunk_02589",
    "text": "20 319 dohteM aehrronemA lanoitatcaL CHAPTER 20 Lactational Amenorrhea Method Key Points for Providers and Clients y A family planning method based on breastfeeding. Provides contraception for the mother and best feeding for the baby. y Can be effective for up to 6 months after childbirth, as",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2589
  },
  {
    "id": "chunk_02590",
    "text": "effective for up to 6 months after childbirth, as long as monthly bleeding has not returned and the woman is fully or nearly fully breastfeeding. y Requires breastfeeding often, day and night. Almost all of the baby\u2019s feedings should be breast milk.",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2590
  },
  {
    "id": "chunk_02591",
    "text": "all of the baby\u2019s feedings should be breast milk. y Provides an opportunity to offer a woman an ongoing method that she can continue to use after 6 months. What Is the Lactational Amenorrhea Method? y A temporary family planning method based on the natural effect of",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2591
  },
  {
    "id": "chunk_02592",
    "text": "ily planning method based on the natural effect of breastfeeding on fertility. (\u201cLactational\u201d means related to breastfeeding. \u201cAmenorrhea\u201d means not having monthly bleeding.) y The lactational amenorrhea method (LAM) requires 3 conditions. All 3 must be met:",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2592
  },
  {
    "id": "chunk_02593",
    "text": "od (LAM) requires 3 conditions. All 3 must be met: 1. The mother\u2019s monthly bleeding has not returned. 2. The baby is fully or nearly fully breastfed and is fed often, day and night. 3. The baby is less than 6 months old. y \u201cFully breastfeeding\u201d includes both exclusive breastfeeding (the infant",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2593
  },
  {
    "id": "chunk_02594",
    "text": "includes both exclusive breastfeeding (the infant receives no other liquid or food, not even water, in addition to breast milk) and almost-exclusive breastfeeding (the infant receives vitamins, water, juice, or other nutrients once in a while in addition to breast milk).",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2594
  },
  {
    "id": "chunk_02595",
    "text": "ients once in a while in addition to breast milk). y \u201cNearly fully breastfeeding\u201d means that the infant receives some liquid or food in addition to breast milk, but the majority of feedings (more than three-fourths of all feeds) are breast milk.",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2595
  },
  {
    "id": "chunk_02596",
    "text": "than three-fourths of all feeds) are breast milk. y Works primarily by preventing the release of eggs from the ovaries (ovulation). Frequent breastfeeding temporarily prevents the release of the natural hormones that cause ovulation.",
    "page_number": 341,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2596
  },
  {
    "id": "chunk_02597",
    "text": "How Effective? More Effectiveness depends on the user: Risk of pregnancy is greatest when effective a woman cannot fully or nearly fully breastfeed her infant. y As commonly used, about 2 pregnancies per 100 women using LAM in the first 6 months after childbirth. This means that 98",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2597
  },
  {
    "id": "chunk_02598",
    "text": "irst 6 months after childbirth. This means that 98 of every 100 women relying on LAM will not become pregnant. y When used correctly, less than 1 pregnancy per 100 women using LAM in the first 6 months after childbirth. Return of fertility after LAM is stopped: Depends on how much the",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2598
  },
  {
    "id": "chunk_02599",
    "text": "lity after LAM is stopped: Depends on how much the woman continues to breastfeed Less Protection against sexually transmitted infections: None effective Side Effects, Health Benefits, and Health Risks Side Effects None. Any problems are the same as for other breastfeeding women.",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2599
  },
  {
    "id": "chunk_02600",
    "text": "ems are the same as for other breastfeeding women. Known Health Benefits Known Health Risks Helps protect against: None y Risks of pregnancy Encourages: y The best breastfeeding patterns, with health benefits for both mother and baby",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2600
  },
  {
    "id": "chunk_02601",
    "text": "rns, with health benefits for both mother and baby Correcting Misunderstandings (see also Questions and Answers, p. 328) The lactational amenorrhea method: y Is highly effective when a woman meets all 3 LAM criteria. y Is just as effective among fat or thin women.",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2601
  },
  {
    "id": "chunk_02602",
    "text": "a. y Is just as effective among fat or thin women. y Can be used by women with normal nutrition. No special foods are required. y Can be used for a full 6 months without the need for supplementary foods. Mother\u2019s milk alone can fully nourish a baby for the first 6 months",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2602
  },
  {
    "id": "chunk_02603",
    "text": "ne can fully nourish a baby for the first 6 months of life. In fact, it is the ideal food for this time in a baby\u2019s life. y Can be used for 6 months without worry that the woman will run out of milk. Milk will continue to be produced through 6 months and longer in",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2603
  },
  {
    "id": "chunk_02604",
    "text": "inue to be produced through 6 months and longer in response to the baby\u2019s suckling or the mother\u2019s expression of her milk. 320 Family Planning: A Global Handbook for Providers",
    "page_number": 342,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2604
  },
  {
    "id": "chunk_02605",
    "text": "20 321 dohteM aehrronemA lanoitatcaL Who Can Use the Lactational Amenorrhea Method Medical Eligibility Criteria for the Lactational Amenorrhea Method All breastfeeding women can safely use LAM, but a woman in the following circumstances may want to consider other contraceptive methods:",
    "page_number": 343,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2605
  },
  {
    "id": "chunk_02606",
    "text": "may want to consider other contraceptive methods: y Has HIV infection (see The Lactational Amenorrhea Method for Women With HIV, next page) y Is using certain medications during breastfeeding (including mood- altering drugs, reserpine, ergotamine, anti-metabolites, cyclosporine,",
    "page_number": 343,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2606
  },
  {
    "id": "chunk_02607",
    "text": "rpine, ergotamine, anti-metabolites, cyclosporine, high doses of corticosteroids, bromocriptine, radioactive drugs, lithium, and certain anticoagulants) y The newborn has a condition that makes it difficult to breastfeed (including being small-for-date or premature and needing intensive",
    "page_number": 343,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2607
  },
  {
    "id": "chunk_02608",
    "text": "small-for-date or premature and needing intensive neonatal care, unable to digest food normally, or having deformities of the mouth, jaw, or palate) Why Some Women Say They Like the Lactational Amenorrhea Method y It is a natural family planning method",
    "page_number": 343,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2608
  },
  {
    "id": "chunk_02609",
    "text": "ea Method y It is a natural family planning method y It supports optimal breastfeeding, providing health benefits for the baby and the mother y It has no direct cost for family planning or for feeding the baby Who Can Use the Lactational Amenorrhea Method",
    "page_number": 343,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2609
  },
  {
    "id": "chunk_02610",
    "text": "The Lactational Amenorrhea Method for Women With HIV y Women who are living with HIV can use LAM. Breastfeeding will not make their condition worse. There is a chance, however, that mothers living with HIV, if they are not taking antiretroviral therapy",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2610
  },
  {
    "id": "chunk_02611",
    "text": "HIV, if they are not taking antiretroviral therapy (ART), will transmit HIV to their infants through breastfeeding. y Women taking ART can use LAM. Giving ART to an HIV-infected mother or an HIV-exposed infant very significantly reduces the risk",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2611
  },
  {
    "id": "chunk_02612",
    "text": "exposed infant very significantly reduces the risk of HIV transmission through breastfeeding. Among women who are not taking ART, 14% of their babies will be infected after 2 years of breastfeeding. Among women taking ART, less than 1% of their babies will be infected.",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2612
  },
  {
    "id": "chunk_02613",
    "text": "RT, less than 1% of their babies will be infected. y Exclusive breastfeeding reduces the risk of death from common childhood illness and improves the health and development of the child and also the health of the mother. y If national policy supports breastfeeding by women with HIV,",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2613
  },
  {
    "id": "chunk_02614",
    "text": "l policy supports breastfeeding by women with HIV, they should receive the appropriate ART interventions and should exclusively breastfeed their infants for the first 6 months of life, introduce appropriate complementary foods at 6 months, and",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2614
  },
  {
    "id": "chunk_02615",
    "text": "e appropriate complementary foods at 6 months, and continue breastfeeding for the first 12 months. Breastfeeding should then stop only once a nutritionally adequate and safe diet without breast milk can be provided. y Urge women with HIV to use condoms along with LAM. Used",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2615
  },
  {
    "id": "chunk_02616",
    "text": "women with HIV to use condoms along with LAM. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. y At 6 months\u2014or earlier if her monthly bleeding has returned or she stops exclusive breastfeeding\u2014a woman should begin to use",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2616
  },
  {
    "id": "chunk_02617",
    "text": "xclusive breastfeeding\u2014a woman should begin to use another contraceptive method in place of LAM. (For further guidance on infant feeding for women with HIV, see Chapter 24, Maternal and Newborn Health, Preventing Mother-to- Child Transmission of HIV, p. 378.)",
    "page_number": 344,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2617
  },
  {
    "id": "chunk_02618",
    "text": "20 323 dohteM aehrronemA lanoitatcaL Providing the Lactational Amenorrhea Method When to Start Woman\u2019s situation When to start Within 6 months y Start breastfeeding immediately (within one after childbirth hour) or as soon as possible after the baby is",
    "page_number": 345,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2618
  },
  {
    "id": "chunk_02619",
    "text": "rth hour) or as soon as possible after the baby is born. In the first few days after childbirth, the yellowish fluid produced by the mother\u2019s breasts (colostrum) contains substances very important to the baby\u2019s health. y Any time, if she has been fully or nearly",
    "page_number": 345,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2619
  },
  {
    "id": "chunk_02620",
    "text": "ealth. y Any time, if she has been fully or nearly breastfeeding her baby since birth and her monthly bleeding has not returned. Providing the Lactational Amenorrhea Method",
    "page_number": 345,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2620
  },
  {
    "id": "chunk_02621",
    "text": "When Can a Woman Use LAM? A breastfeeding woman can use LAM to space her next birth and as a transition to another contraceptive method. She may start LAM at any time if she meets all 3 criteria required for using the method. Ask the mother these 3 questions: 2 Are you regularly giving the",
    "page_number": 346,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2621
  },
  {
    "id": "chunk_02622",
    "text": "these 3 questions: 2 Are you regularly giving the baby other food besides breast milk or allowing long periods without breastfeeding, either day or night? 1 Has your monthly bleeding returned? 3 Is your baby more than 6 months old? If the answer to all of But, when the answer to",
    "page_number": 346,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2622
  },
  {
    "id": "chunk_02623",
    "text": "d? If the answer to all of But, when the answer to these questions is no\u2026 any one of these questions is yes\u2026 \u2026she can use LAM. There is only a 2% change of pregnancy at this \u2026her chances of pregnancy time. A woman may choose another increase. Advise her to begin",
    "page_number": 346,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2623
  },
  {
    "id": "chunk_02624",
    "text": "n may choose another increase. Advise her to begin family planning method at any using another family planning time\u2014but preferably not a method method and to continue with estrogen while her baby is less breastfeeding for the child\u2019s than 6 months old. Methods with health.",
    "page_number": 346,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2624
  },
  {
    "id": "chunk_02625",
    "text": "he child\u2019s than 6 months old. Methods with health. estrogen include combined oral contraceptives, monthly injectables, the combined patch, and the combined vaginal ring. 324 Family Planning: A Global Handbook for Providers",
    "page_number": 346,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2625
  },
  {
    "id": "chunk_02626",
    "text": "20 325 dohteM aehrronemA lanoitatcaL Explaining How to Use Breastfeed often y An ideal pattern is feeding on demand (that is, whenever the baby wants to be fed) and at least 10 to 12 times a day in the first few weeks after childbirth and thereafter 8 to 10 times a day,",
    "page_number": 347,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2626
  },
  {
    "id": "chunk_02627",
    "text": "ter childbirth and thereafter 8 to 10 times a day, including at least once at night in the first months. y Daytime feedings should be no more than 4 hours apart, and night-time feedings no more than 6 hours apart. y Some babies may not want to breastfeed 8 to",
    "page_number": 347,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2627
  },
  {
    "id": "chunk_02628",
    "text": "art. y Some babies may not want to breastfeed 8 to 10 times a day and may want to sleep through the night. These babies may need gentle encouragement to breastfeed more often. Start other foods y She should start giving other foods in addition to",
    "page_number": 347,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2628
  },
  {
    "id": "chunk_02629",
    "text": "She should start giving other foods in addition to at 6 months breast milk when the baby is 6 months old. At this age, breast milk can no longer fully nourish a growing baby. Plan follow-up visit y Plan for the next visit while the LAM criteria still apply, so that she can choose another method",
    "page_number": 347,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2629
  },
  {
    "id": "chunk_02630",
    "text": "still apply, so that she can choose another method and continue to be protected from pregnancy. y If possible, give her condoms or progestin-only pills now. She can start to use them if the baby is no longer fully or nearly fully breastfeeding, if her monthly bleeding returns, or if the baby",
    "page_number": 347,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2630
  },
  {
    "id": "chunk_02631",
    "text": "g, if her monthly bleeding returns, or if the baby reaches 6 months of age before she can come back for another method. Plan for a follow-on method. Give her any supplies now. Providing the Lactational Amenorrhea Method",
    "page_number": 347,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2631
  },
  {
    "id": "chunk_02632",
    "text": "Supporting New and Continuing Users How Can a Partner Help? The client\u2019s partner is welcome to participate in counseling and learn about the method and what support he can give to his partner. A male partner can: y Support a woman\u2019s choice of LAM",
    "page_number": 348,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2632
  },
  {
    "id": "chunk_02633",
    "text": "ale partner can: y Support a woman\u2019s choice of LAM y Understand how LAM works and when it will no longer work y Encourage her to breastfeed often and without giving her baby any supplementary food for the first 6 months y Make sure that she has extra nutrition and fluids while breastfeeding",
    "page_number": 348,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2633
  },
  {
    "id": "chunk_02634",
    "text": "has extra nutrition and fluids while breastfeeding y Discuss and plan what method to use when one of the LAM conditions is no longer met \u2013 that is, her monthly bleeding returns, she introduces other foods, or the baby reaches 6 months old\u2014or sooner if she prefers",
    "page_number": 348,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2634
  },
  {
    "id": "chunk_02635",
    "text": "baby reaches 6 months old\u2014or sooner if she prefers y Start or remind her to start another family planning method as soon as one of the LAM criteria is no longer met y Help to make sure she has ECPs on hand in case one of the LAM conditions is no longer met and she has not yet started to use",
    "page_number": 348,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2635
  },
  {
    "id": "chunk_02636",
    "text": "s no longer met and she has not yet started to use another contraceptive y Use condoms consistently in addition to LAM if he has an STI/HIV or thinks he may be at risk of an STI/HIV \u201cCome Back Any Time\u201d: Reasons to Return Assure every client that she is welcome to come back any time\u2014for example,",
    "page_number": 348,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2636
  },
  {
    "id": "chunk_02637",
    "text": "she is welcome to come back any time\u2014for example, if she has problems, questions, or wants another method; she has a major change in health status; or she thinks she might be pregnant. Also, if: y She no longer meets one or more of the 3 LAM criteria and so cannot keep relying on LAM.",
    "page_number": 348,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2637
  },
  {
    "id": "chunk_02638",
    "text": "20 327 dohteM aehrronemA lanoitatcaL Helping Clients Switch to a Continuing Method 1. A woman can switch to another method any time she wants while using LAM. If she still meets all 3 LAM criteria, it is reasonably certain she is not pregnant. She can start a new method with no need for a pregnancy",
    "page_number": 349,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2638
  },
  {
    "id": "chunk_02639",
    "text": "an start a new method with no need for a pregnancy test, examinations, or evaluation. 2. To continue preventing pregnancy, a woman must switch to another method as soon as any one of the 3 LAM criteria no longer applies. 3. Help the woman choose a new method before she needs it. If she",
    "page_number": 349,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2639
  },
  {
    "id": "chunk_02640",
    "text": "an choose a new method before she needs it. If she will continue to breastfeed, she can choose from several hormonal or nonhormonal methods, depending on how much time has passed since childbirth (see Chapter 24 \u2013 Maternal and Newborn Health,",
    "page_number": 349,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2640
  },
  {
    "id": "chunk_02641",
    "text": "rth (see Chapter 24 \u2013 Maternal and Newborn Health, Earliest Time That a Woman Can Start a Family Planning Method After Childbirth, p. 377). After 6 months, if a woman wants to continue breastfeeding, she can consider the progesterone-releasing vaginal ring (see p. 127). Managing Any Problems",
    "page_number": 349,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2641
  },
  {
    "id": "chunk_02642",
    "text": "g vaginal ring (see p. 127). Managing Any Problems Problems With Use y Problems with breastfeeding or LAM affect women\u2019s satisfaction and use of the method. If the client reports any problems, listen to her concerns, give her advice and support, and, if appropriate, treat. Make sure she",
    "page_number": 349,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2642
  },
  {
    "id": "chunk_02643",
    "text": "support, and, if appropriate, treat. Make sure she understands the advice and agrees. y Offer to help the client choose another method\u2014now, if she wishes, or if problems cannot be overcome. y For problems with breastfeeding, see Chapter 24 \u2013 Maternal and",
    "page_number": 349,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2643
  },
  {
    "id": "chunk_02644",
    "text": "Questions and Answers About the Lactational Amenorrhea Method 1. Can LAM be an effective method of family planning? Yes. LAM is effective if the woman\u2019s monthly bleeding has not returned, she is fully or nearly fully breastfeeding, and her baby is less than 6 months old.",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2644
  },
  {
    "id": "chunk_02645",
    "text": "stfeeding, and her baby is less than 6 months old. 2. When should a mother start giving her baby other foods besides breast milk? Ideally, when the baby is 6 months old. Along with other foods, breast milk should be a major part of the child\u2019s diet through the child\u2019s second year or longer.",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2645
  },
  {
    "id": "chunk_02646",
    "text": "\u2019s diet through the child\u2019s second year or longer. 3. Can women use LAM if they work away from home? Yes. Women who are able to keep their infants with them at work or nearby and are able to breastfeed frequently can rely on LAM as long",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2646
  },
  {
    "id": "chunk_02647",
    "text": "e to breastfeed frequently can rely on LAM as long as they meet all 3 criteria for LAM. Women who are separated from their infants can use LAM if breastfeeds are less than 4 hours apart. Women can also express their breast milk at least every 4 hours, but",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2647
  },
  {
    "id": "chunk_02648",
    "text": "ress their breast milk at least every 4 hours, but pregnancy rates may be slightly higher for women who are separated from their infants. The one study that assessed use of LAM among working women estimated a pregnancy rate of 5 per 100 women during",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2648
  },
  {
    "id": "chunk_02649",
    "text": "timated a pregnancy rate of 5 per 100 women during the first 6 months after childbirth, compared with about 2 per 100 women as LAM is commonly used. 4. What if a woman learns that she has HIV while she is using LAM? Can she continue breastfeeding and using LAM?",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2649
  },
  {
    "id": "chunk_02650",
    "text": "LAM? Can she continue breastfeeding and using LAM? If a woman is newly infected with HIV, the risk of transmission through breastfeeding may be higher than if she was infected earlier, because there is more HIV in her body. The breastfeeding recommendation is the",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2650
  },
  {
    "id": "chunk_02651",
    "text": "her body. The breastfeeding recommendation is the same as for other HIV-infected women, however. HIV-infected mothers and their infants should receive the appropriate antiretroviral therapy (ART), and mothers should exclusively breastfeed their infants for the",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2651
  },
  {
    "id": "chunk_02652",
    "text": "hould exclusively breastfeed their infants for the first 6 months of life, and then introduce appropriate complementary foods and continue breastfeeding for the first 12 months of life. At 6 months\u2014or earlier if her monthly bleeding has returned or she stops",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2652
  },
  {
    "id": "chunk_02653",
    "text": "if her monthly bleeding has returned or she stops exclusive breastfeeding\u2014she should begin to use another contraceptive method in place of LAM and continue to use condoms. (See also Chapter 24 \u2013 Maternal and Newborn Health, Preventing Mother-to- Child Transmission of HIV, p. 378.)",
    "page_number": 350,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2653
  },
  {
    "id": "chunk_02654",
    "text": "21 329 spuorG esreviD gnivreS CHAPTER 21 Serving Diverse Groups Key Points for Providers and Clients Adolescents y All contraceptives are safe for young people. Unmarried and married youth may have different sexual and reproductive health needs. Men",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2654
  },
  {
    "id": "chunk_02655",
    "text": "ifferent sexual and reproductive health needs. Men y Correct information can help men make better decisions about their own health and their partner\u2019s health, too. When couples discuss contraception, they are more likely to make plans that they can carry out. Women Near Menopause",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2655
  },
  {
    "id": "chunk_02656",
    "text": "lans that they can carry out. Women Near Menopause y To be sure to avoid pregnancy, a woman should use contraception until she has had no monthly bleeding for 12 months in a row. Clients With Disabilities y People with disabilities deserve full and sometimes",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2656
  },
  {
    "id": "chunk_02657",
    "text": "eople with disabilities deserve full and sometimes adapted information and the same respectful and conscientious care as other clients. Adolescents Young people may come to a family planning provider not only for contraception",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2657
  },
  {
    "id": "chunk_02658",
    "text": "amily planning provider not only for contraception but also for advice about physical changes, sex, relationships, family, and problems of growing up. Their needs depend on their particular situations. Some are unmarried and sexually active, others are not sexually active, while",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2658
  },
  {
    "id": "chunk_02659",
    "text": "ally active, others are not sexually active, while still others are already married. Some already have children. Age itself makes a great difference, since young people mature quickly during the adolescent years. These differences make it important to learn about each client first, to",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2659
  },
  {
    "id": "chunk_02660",
    "text": "it important to learn about each client first, to understand why that client has come, and to tailor counseling and the offer of services accordingly.",
    "page_number": 351,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2660
  },
  {
    "id": "chunk_02661",
    "text": "Provide Services with Care and Respect Young people deserve reproductive health services that meet their needs and are nonjudgmental and respectful, no matter how young the person is. Criticism or unwelcoming attitudes will keep young people away from the",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2661
  },
  {
    "id": "chunk_02662",
    "text": "ing attitudes will keep young people away from the care they need. Counseling and services do not encourage young people to have sex. Instead, they help young people protect their health. Appropriate sexual and reproductive health services, including contraception,",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2662
  },
  {
    "id": "chunk_02663",
    "text": "oductive health services, including contraception, should be available and accessible to all adolescents without requiring authorization from a parent or guardian by law, policy, or practice. As much as possible, programs should avoid discouraging adolescents from seeking",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2663
  },
  {
    "id": "chunk_02664",
    "text": "should avoid discouraging adolescents from seeking services and avoid limiting their choice of contraceptives because of cost. To make services friendly to youth, you can: y Show young people that you enjoy working with them. y Offer services that are free or as low cost as possible.",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2664
  },
  {
    "id": "chunk_02665",
    "text": "services that are free or as low cost as possible. y Offer a wide range of contraceptive methods, including long-acting reversible methods. y Counsel in private areas where you and the client cannot be seen or overheard. Ensure confidentiality and assure the client of confidentiality.",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2665
  },
  {
    "id": "chunk_02666",
    "text": "ntiality and assure the client of confidentiality. y Listen carefully and ask open-ended questions such as \u201cHow can I help you?\u201d and \u201cWhat questions do you have?\u201d y Use simple language and avoid medical terms. y Use terms that suit young people. Avoid such terms as \u201cfamily planning,\u201d",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2666
  },
  {
    "id": "chunk_02667",
    "text": "ung people. Avoid such terms as \u201cfamily planning,\u201d which may seem irrelevant to those who are not married. y Welcome partners and include them in counseling, if the client desires. y Try to make sure that a young woman\u2019s choices are her own and are",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2667
  },
  {
    "id": "chunk_02668",
    "text": "e that a young woman\u2019s choices are her own and are not pressured by her partner or her family. In particular, if she is being pressured to have sex, help a young woman think about what she can say and do to resist and reduce that pressure. Practice with her the skills to negotiate condom use.",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2668
  },
  {
    "id": "chunk_02669",
    "text": "ctice with her the skills to negotiate condom use. y Speak without expressing judgment (for example, say \u201cYou can\u201d rather than \u201cYou should\u201d). Do not criticize even if you do not approve of what the young person is saying or doing. Help young clients make decisions that are in their best interest.",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2669
  },
  {
    "id": "chunk_02670",
    "text": "ts make decisions that are in their best interest. y Take time to fully address questions, fears, and misinformation about sex, sexually transmitted infections (STIs), and contraceptives. Many young people want reassurance that the changes in their bodies and their feelings",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2670
  },
  {
    "id": "chunk_02671",
    "text": "hat the changes in their bodies and their feelings are normal. Be prepared to answer common questions about puberty, monthly bleeding, masturbation, night-time ejaculation, and genital hygiene. 330 Family Planning: A Global Handbook for Providers",
    "page_number": 352,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2671
  },
  {
    "id": "chunk_02672",
    "text": "21 331 spuorG esreviD gnivreS y Be aware of young people\u2019s norms about gender and gently encourage positive, healthful norms. In particular you can help young women feel that they have the right and the power to make their own decisions",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2672
  },
  {
    "id": "chunk_02673",
    "text": "he right and the power to make their own decisions about sex and contraception. You can help young men to understand the consequences of their sexual behavior for themselves and for their partners. All Contraceptives Are Safe for Young People",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2673
  },
  {
    "id": "chunk_02674",
    "text": "ners. All Contraceptives Are Safe for Young People Young people can safely use any contraceptive method. Age is not a medical reason for denying any method to adolescents. y Young women are often less tolerant of side effects than older women.",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2674
  },
  {
    "id": "chunk_02675",
    "text": "en less tolerant of side effects than older women. With counseling, however, they will know what to expect and may be less likely to stop using their methods. y Unmarried young people may have more sex partners than older people and so may face a greater risk of STIs. It is important when counseling",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2675
  },
  {
    "id": "chunk_02676",
    "text": "ater risk of STIs. It is important when counseling young people to consider STI risk and how to reduce it. For some contraceptive methods there are specific considerations for young people (see contraceptive method chapters for complete guidance):",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2676
  },
  {
    "id": "chunk_02677",
    "text": "traceptive method chapters for complete guidance): Long-acting reversible contraceptives\u2014implants and IUDs y Implants, copper-bearing IUDs, and LNG-IUDs may be good choices for many young women because: \u2013 These methods are very effective\u2014fewer than 1 pregnancy per 100 women in the first year of use.",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2677
  },
  {
    "id": "chunk_02678",
    "text": "pregnancy per 100 women in the first year of use. \u2013 Once in place, these methods do not require any action by the user. She does not have to plan in advance for sex. \u2013 They work for a number of years. \u2013 They are quickly reversible. Once the implant or IUD is removed,",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2678
  },
  {
    "id": "chunk_02679",
    "text": "ly reversible. Once the implant or IUD is removed, a woman can again become pregnant. \u2013 It is not obvious that the woman is using a contraceptive method. y IUDs are more likely to come out among women who have not given birth because their uteruses are small. Injectable contraceptives",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2679
  },
  {
    "id": "chunk_02680",
    "text": "heir uteruses are small. Injectable contraceptives y Injectables can be used without others knowing. Oral contraceptives y Some young women find taking a pill every day particularly difficult. Adolescents",
    "page_number": 353,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2680
  },
  {
    "id": "chunk_02681",
    "text": "Emergency contraceptive pills (ECPs) y Young women may have less control than older women over having sex and using contraception. They may need ECPs more often. It is safe to use ECPs multiple times between monthly bleedings. Using combined",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2681
  },
  {
    "id": "chunk_02682",
    "text": "le times between monthly bleedings. Using combined oral contraceptives or a long-acting reversible method would be more effective in the long run. y Provide young women with ECPs in advance, for use when needed. ECPs can be used whenever she has any unprotected sex, including sex against",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2682
  },
  {
    "id": "chunk_02683",
    "text": "she has any unprotected sex, including sex against her will, or a mistake has occurred when using contraception. Female sterilization and vasectomy y Provide with great caution. Young people and people with few or no children are among those most likely to regret sterilization.",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2683
  },
  {
    "id": "chunk_02684",
    "text": "e among those most likely to regret sterilization. Male and female condoms y Protect against STIs as well as pregnancy. Many young people need protection against both. y Readily available, and they are affordable and convenient for occasional sex.",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2684
  },
  {
    "id": "chunk_02685",
    "text": "are affordable and convenient for occasional sex. y Young men may be less successful than older men at using condoms correctly. They may need practice putting condoms on. Diaphragms, spermicides, and cervical caps y Although among the least effective methods, young women can control",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2685
  },
  {
    "id": "chunk_02686",
    "text": "e least effective methods, young women can control use of these methods, and they can be used as needed. Fertility awareness methods y Until a young woman has regular menstrual cycles, fertility awareness methods should be used with caution.",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2686
  },
  {
    "id": "chunk_02687",
    "text": "ity awareness methods should be used with caution. y Need a backup method or ECPs on hand in case abstinence fails. Withdrawal y Requires the man to know when he is about to ejaculate so he can withdraw in time. This may be difficult for some young men.",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2687
  },
  {
    "id": "chunk_02688",
    "text": "in time. This may be difficult for some young men. y One of the least effective methods of pregnancy prevention, but it may be the only method available\u2014and always available\u2014for some young people. 332 Family Planning: A Global Handbook for Providers",
    "page_number": 354,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2688
  },
  {
    "id": "chunk_02689",
    "text": "21 333 spuorG esreviD gnivreS Men Important Supporters, Important Clients To health care providers, men are important for 2 reasons. First, they influence women. Many men care about their partner\u2019s reproductive health and support them. Others stand in their way or make decisions for them.",
    "page_number": 355,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2689
  },
  {
    "id": "chunk_02690",
    "text": "ers stand in their way or make decisions for them. Thus, men\u2019s attitudes can determine whether women can practice healthy behaviors. In some circumstances, such as avoiding HIV infection or getting help quickly in an obstetric emergency, a man\u2019s actions can determine whether a woman lives or dies.",
    "page_number": 355,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2690
  },
  {
    "id": "chunk_02691",
    "text": "tions can determine whether a woman lives or dies. Men are also important as clients. Important family planning methods\u2014male condoms and vasectomy\u2014are used by men. Men also have their own sexual and reproductive health needs and concerns\u2014in particular regarding sexually",
    "page_number": 355,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2691
  },
  {
    "id": "chunk_02692",
    "text": "eeds and concerns\u2014in particular regarding sexually transmitted infections (STIs)\u2014which deserve the attention of the health care system and providers. Many Ways to Help Men Providers can give support and services to men both as supporters of women and as clients. Encourage Couples to Talk",
    "page_number": 355,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2692
  },
  {
    "id": "chunk_02693",
    "text": "of women and as clients. Encourage Couples to Talk Couples who discuss family planning\u2014 with or without a provider\u2019s help\u2014are In this Handbook most more likely to make plans that they can chapters include a box, carry out. Providers can: How Can a Partner Help?.",
    "page_number": 355,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2693
  },
  {
    "id": "chunk_02694",
    "text": "carry out. Providers can: How Can a Partner Help?. y Coach men and women on how to The points in this box can talk with their partners about sex, be useful when counseling family planning, and STIs. couples or helping a client get her partner\u2019s support y Encourage joint decision-making about",
    "page_number": 355,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2694
  },
  {
    "id": "chunk_02695",
    "text": "y Invite and encourage women to bring their partners to the clinic for joint counseling, decision-making, and care. y Encourage the man to understand and support his partner to choose the contraceptive method she prefers. y Encourage the man to consider taking",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2695
  },
  {
    "id": "chunk_02696",
    "text": "he prefers. y Encourage the man to consider taking more responsibility for family planning\u2014for example, by using condoms or vasectomy. y Suggest to female clients that they tell their partners about health services for men. Give informational materials to take home, if available.",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2696
  },
  {
    "id": "chunk_02697",
    "text": "nformational materials to take home, if available. Provide Accurate Information To inform men\u2019s decisions and opinions, they need correct information and correction of misperceptions. Topics important to men include: y Family planning methods, both for men and",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2697
  },
  {
    "id": "chunk_02698",
    "text": "clude: y Family planning methods, both for men and for women, including safety and effectiveness y STIs including HIV\u2014how they are and are not transmitted, signs and symptoms, testing, and treatment y The benefits of waiting until the youngest child is 2 years old before",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2698
  },
  {
    "id": "chunk_02699",
    "text": "ing until the youngest child is 2 years old before a woman becomes pregnant again y Male and female sexual and reproductive anatomy and function y Safe pregnancy and delivery Offer Services or Refer Important services that many men want include: y Male condoms and vasectomy services",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2699
  },
  {
    "id": "chunk_02700",
    "text": "ant include: y Male condoms and vasectomy services y Information and counseling about other contraceptive methods, particularly methods that must have male cooperation, such as fertility awareness-based methods and female condoms y Counseling and help for sexual problems",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2700
  },
  {
    "id": "chunk_02701",
    "text": "condoms y Counseling and help for sexual problems y STI/HIV counseling, testing, and treatment y Infertility counseling (see Infertility, p. 392) y Screening for penile, testicular, and prostate cancer Like women, men of all ages, married or unmarried, have their own sexual",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2701
  },
  {
    "id": "chunk_02702",
    "text": "ages, married or unmarried, have their own sexual and reproductive health needs. They deserve good-quality services and respectful, supportive, and nonjudgmental counseling. 334 Family Planning: A Global Handbook for Providers",
    "page_number": 356,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2702
  },
  {
    "id": "chunk_02703",
    "text": "21 335 spuorG esreviD gnivreS Women Near Menopause A woman has reached menopause when her ovaries stop releasing eggs (ovulating). Because bleeding does not come every month as menopause approaches, a woman is considered no longer fertile once she has gone",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2703
  },
  {
    "id": "chunk_02704",
    "text": "is considered no longer fertile once she has gone 12 months in a row without having any bleeding. Menopause usually occurs between the ages of 45 and 55. About half of women reach menopause by age 50. By age 55 some 96% of women have reached menopause.",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2704
  },
  {
    "id": "chunk_02705",
    "text": "y age 55 some 96% of women have reached menopause. To prevent pregnancy until it is clear that she is no longer fertile, an older woman can use any method, if she has no medical condition that limits its use. By itself, age does not restrict a woman from using any contraceptive method.",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2705
  },
  {
    "id": "chunk_02706",
    "text": "trict a woman from using any contraceptive method. Special Considerations About Method Choice When helping women near menopause choose a method, consider: Combined hormonal methods (combined oral contraceptives [COCs], monthly injectables, combined patch, combined vaginal ring)",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2706
  },
  {
    "id": "chunk_02707",
    "text": "njectables, combined patch, combined vaginal ring) y Women age 35 and older who smoke\u2014regardless of how much\u2014should not use COCs, the patch, or the \u2014combined vaginal ring. y Women age 35 and older who smoke 15 or more cigarettes a day should not use monthly injectables.",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2707
  },
  {
    "id": "chunk_02708",
    "text": "garettes a day should not use monthly injectables. y Women age 35 or older should not use COCs, monthly injectables, the patch, or the combined vaginal ring if they have migraine headaches (whether with migraine aura or not). Progestin-only methods (progestin-only pills, progestin-only",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2708
  },
  {
    "id": "chunk_02709",
    "text": "only methods (progestin-only pills, progestin-only injectables, implants) y A good choice for women who cannot use methods with estrogen. y During use, DMPA decreases bone mineral density slightly. This may increase the risk of developing osteoporosis and possibly having",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2709
  },
  {
    "id": "chunk_02710",
    "text": "isk of developing osteoporosis and possibly having bone fractures later, after menopause. WHO has concluded that this decrease in bone mineral density does not place age or time limits on use of DMPA. Emergency contraceptive pills y Can be used by women of any age, including those who cannot use",
    "page_number": 357,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2710
  },
  {
    "id": "chunk_02711",
    "text": "Female sterilization and vasectomy y May be a good choice for older women and their partners who know they will not want more children. y Older women are more likely to have conditions that require delay, referral, or caution for female sterilization.",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2711
  },
  {
    "id": "chunk_02712",
    "text": "ay, referral, or caution for female sterilization. Male and female condoms, diaphragms, spermicides, cervical caps, and withdrawal y Protect older women well because of women\u2019s reduced fertility in the years before menopause. y Affordable and convenient for women who may not have sex often.",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2712
  },
  {
    "id": "chunk_02713",
    "text": "d convenient for women who may not have sex often. Intrauterine device (copper-bearing IUDs and LNG-IUDs) y Expulsion rates fall as women grow older and are lowest in women over 40 years of age. y Insertion may be more difficult due to tightening of the cervical canal. Fertility awareness methods",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2713
  },
  {
    "id": "chunk_02714",
    "text": "of the cervical canal. Fertility awareness methods y Lack of regular cycles before menopause makes it more difficult to use these methods reliably. When a Woman Can Stop Using Family Planning Because bleeding does not come every month in the time before menopause,",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2714
  },
  {
    "id": "chunk_02715",
    "text": "not come every month in the time before menopause, it is difficult for a woman whose bleeding seems to have stopped to know when to stop using contraception. Thus, it is recommended to continue using a family planning method until 12 months with no bleeding have passed.",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2715
  },
  {
    "id": "chunk_02716",
    "text": "thod until 12 months with no bleeding have passed. Hormonal methods affect bleeding, and so it may be difficult to know if a woman using them has reached menopause. She can switch to a nonhormonal method. She no longer needs contraception once she has had no bleeding for 12 months in a row.",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2716
  },
  {
    "id": "chunk_02717",
    "text": "ce she has had no bleeding for 12 months in a row. Copper-bearing IUDs can be left in place until after menopause. The IUD should be removed 12 months after a woman\u2019s last monthly bleeding. 336 Family Planning: A Global Handbook for Providers",
    "page_number": 358,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2717
  },
  {
    "id": "chunk_02718",
    "text": "21 337 spuorG esreviD gnivreS Relieving Symptoms of Menopause Women experience physical effects before, during, and after menopause: hot flashes, excess sweating, difficulty holding urine, vaginal dryness that can make sex painful, and difficulty sleeping.",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2718
  },
  {
    "id": "chunk_02719",
    "text": "hat can make sex painful, and difficulty sleeping. Providers can suggest ways to reduce some of these symptoms: y Deep breathing from the diaphragm may make a hot flash go away faster. A woman can also try eating foods containing soy or taking 800 international units per day of vitamin E.",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2719
  },
  {
    "id": "chunk_02720",
    "text": "king 800 international units per day of vitamin E. y Eat foods rich in calcium (such as dairy products, beans, fish) and engage in moderate physical activity to help slow the loss of bone density that comes with menopause. y Vaginal lubricants or moisturizers can be used if vaginal dryness persists",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2720
  },
  {
    "id": "chunk_02721",
    "text": "isturizers can be used if vaginal dryness persists and causes irritation. During sex, use a commercially available vaginal lubricant, water, or saliva as a lubricant if vaginal dryness is a problem. Clients with Disabilities Health care providers should treat people with disabilities in the same",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2721
  },
  {
    "id": "chunk_02722",
    "text": "should treat people with disabilities in the same way that they should treat people without disabilities: with respect. People with disabilities have the same sexual and reproductive health needs and rights as people without disabilities, but often they are not",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2722
  },
  {
    "id": "chunk_02723",
    "text": "eople without disabilities, but often they are not given information about reproductive and sexual health or adequate care. People with disabilities are more vulnerable to abuse than non-disabled people. They are at increased risk of being infected with HIV and other",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2723
  },
  {
    "id": "chunk_02724",
    "text": "ncreased risk of being infected with HIV and other STIs. Many have been sterilized against their will, forced to have abortions, or forced into unwanted marriages, and many have experienced gender- based violence. Health care programs, including family planning programs,",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2724
  },
  {
    "id": "chunk_02725",
    "text": "care programs, including family planning programs, need to follow the relevant articles of the UN Convention on the Rights of Persons with Disabilities, especially the articles that address health, family life, and legal rights.",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2725
  },
  {
    "id": "chunk_02726",
    "text": "hat address health, family life, and legal rights. To counsel clients with disabilities, health care providers need to consider their preferences and the nature of their disability. For example, barrier methods may be difficult for some people with a physical disability, and",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2726
  },
  {
    "id": "chunk_02727",
    "text": "lt for some people with a physical disability, and women with an intellectual disability may have trouble remembering to take a pill each day or dealing with changes in monthly bleeding. Like all clients, people with disabilities need sexual and reproductive health",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2727
  },
  {
    "id": "chunk_02728",
    "text": "h disabilities need sexual and reproductive health education to make informed choices. People with intellectual disabilities have the same rights as other people to make their own decisions about contraception, including sterilization. They may need special support to do",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2728
  },
  {
    "id": "chunk_02729",
    "text": "sterilization. They may need special support to do so. For a client with an intellectual disability who is unable to communicate her or his preferences clearly, someone whom the client trusts should Clients with Disabilities",
    "page_number": 359,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2729
  },
  {
    "id": "chunk_02730",
    "text": "participate and help to make an informed choice that is as consistent What is supported as possible with the client\u2019s preference. decision-making? Especially for the choice of sterilization, In supported decision-making, health care systems should ensure supporters, advocates, or",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2730
  },
  {
    "id": "chunk_02731",
    "text": "re systems should ensure supporters, advocates, or that a process of supported decision- others help people with making is available. disabilities to make their To care for people with disabilities, own decisions, free of programs should make it known in conflict of interest or undue",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2731
  },
  {
    "id": "chunk_02732",
    "text": "uld make it known in conflict of interest or undue the community that they serve people influence, and without giving with disabilities without discrimination. decision-making power to Facilities should be made physically someone else. This process",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2732
  },
  {
    "id": "chunk_02733",
    "text": "ould be made physically someone else. This process accessible\u2014for example, with ramps may include documenting for wheelchairs and large bathrooms informed consent. (See with grab bars. Outreach programs Ensuring Informed Choice, should make a special effort to identify p. 229, in Chapter 12 \u2013 Female",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2733
  },
  {
    "id": "chunk_02734",
    "text": "effort to identify p. 229, in Chapter 12 \u2013 Female and reach people in the community Sterilization.) who have limited mobility. Print materials should have simple graphics, large print, and Braille, if possible, and information should be available in audio formats, such as CD or cassette",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2734
  },
  {
    "id": "chunk_02735",
    "text": "available in audio formats, such as CD or cassette tape, as well as in print. Providers may need especially to demonstrate actions as well as describing them, to speak slowly, and to pause often and check comprehension. Learning to respect the rights of people with disabilities and to care for them",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2735
  },
  {
    "id": "chunk_02736",
    "text": "s of people with disabilities and to care for them should be part of pre-service training for health care providers, and it should be reinforced with in-service training periodically. Moreover, meeting and talking with people with disabilities can give providers valuable information",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2736
  },
  {
    "id": "chunk_02737",
    "text": "sabilities can give providers valuable information about how to make services more respectful and accessible. Often, the changes needed are easy. 338 Family Planning: A Global Handbook for Providers",
    "page_number": 360,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2737
  },
  {
    "id": "chunk_02738",
    "text": "22 339 VIH gnidulcnI ,sITS CHAPTER 22 Sexually Transmitted Infections, Including HIV Key Points for Providers and Clients \u2022 People with sexually transmitted infections (STIs), including human immunodeficiency virus (HIV), can use most family planning methods safely and effectively.",
    "page_number": 361,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2738
  },
  {
    "id": "chunk_02739",
    "text": "st family planning methods safely and effectively. \u2022 Male and female condoms can prevent STIs, including HIV, when used consistently and correctly. \u2022 STIs often have no signs or symptoms, particularly in women. \u2022 People should seek health care if they think that they or",
    "page_number": 361,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2739
  },
  {
    "id": "chunk_02740",
    "text": "should seek health care if they think that they or their partners might have an STI. \u2022 Many STIs can be successfully treated. The sooner they are treated, the less likely they are to cause long-term health problems such as infertility or chronic pain, or to infect a sexual partner or a fetus.",
    "page_number": 361,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2740
  },
  {
    "id": "chunk_02741",
    "text": "ic pain, or to infect a sexual partner or a fetus. \u2022 Vaginal discharge can also be caused by infections that are not sexually transmitted. Sexually Transmitted Infections What Are Sexually Transmitted Infections? Sexually transmitted infections (STIs) are caused by bacteria, viruses, and",
    "page_number": 361,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2741
  },
  {
    "id": "chunk_02742",
    "text": "ctions (STIs) are caused by bacteria, viruses, and parasites that are spread through sexual contact. These organisms can be found in vaginal fluids and in semen, on the skin of the genitals and areas around them, and in the mouth, throat, and rectum. Most STIs cause no",
    "page_number": 361,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2742
  },
  {
    "id": "chunk_02743",
    "text": "the mouth, throat, and rectum. Most STIs cause no symptoms or cause symptoms that can easily go unnoticed. Others can cause pain and physical and psychological discomfort. If not treated, some STIs can cause pelvic inflammatory disease, chronic pelvic pain, infertility, and cervical",
    "page_number": 361,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2743
  },
  {
    "id": "chunk_02744",
    "text": "cancer in women, and some STIs can cause infertility, and anorectal and prostate cancer in men. Some STIs can also greatly increase the chance of becoming infected with HIV. Who Is at Risk for STIs? Some family planning clients may be at high risk of getting an STI. A person\u2019s",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2744
  },
  {
    "id": "chunk_02745",
    "text": "may be at high risk of getting an STI. A person\u2019s risk of getting an STI, including HIV, depends on: \u2022 specific higher-risk behaviors (see the box below) \u2022 how common these infections are in the community. Family planning providers can help their clients assess their risk of getting",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2745
  },
  {
    "id": "chunk_02746",
    "text": "an help their clients assess their risk of getting an STI if they know how common or prevalent these infections are locally. Limited access to good-quality health services results in more untreated infections, which increases spread in the community.",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2746
  },
  {
    "id": "chunk_02747",
    "text": "fections, which increases spread in the community. Understanding their own risk for HIV and other STIs helps people decide how to protect themselves and others. People are often the best judges of their own STI risk, especially when they are well informed about what",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2747
  },
  {
    "id": "chunk_02748",
    "text": "especially when they are well informed about what behaviors and situations can increase or decrease the risk of infection (see the box below and Avoiding STIs). Sexual Practices and Other Behaviors that Increase the Risk of Getting an STI, Including HIV",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2748
  },
  {
    "id": "chunk_02749",
    "text": "Increase the Risk of Getting an STI, Including HIV Sexual practices and behaviors that increase the client\u2019s risk of infection should be asked about respectfully during a private and confidential discussion: \u2022 Any type of sexual practice (oral, vaginal, or anal) with a partner who has",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2749
  },
  {
    "id": "chunk_02750",
    "text": "ce (oral, vaginal, or anal) with a partner who has STI symptoms, or who has been diagnosed or treated for an STI in the past 6 months \u2022 Any type of sexual practice (oral, vaginal, or anal) with more than 1 partner without condoms in the past 6 months\u2014the more partners, the greater the risk",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2750
  },
  {
    "id": "chunk_02751",
    "text": "t 6 months\u2014the more partners, the greater the risk \u2022 Exposure to contaminated needles from injection drug use or other (such as occupational) exposure 340 Family Planning: A Global Handbook for Providers",
    "page_number": 362,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2751
  },
  {
    "id": "chunk_02752",
    "text": "22 Sexually Transmitted Infections 341 VIH gnidulcnI ,sITS Some groups (known as \u201ckey populations\u201d) are at higher risk of HIV and other STIs, regardless of the prevalence in the general population. These include: \u2022 Adolescents \u2022 People who have sex for money, food, gifts, shelter, or favors",
    "page_number": 363,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2752
  },
  {
    "id": "chunk_02753",
    "text": "ave sex for money, food, gifts, shelter, or favors \u2022 Gay, bisexual, and other men who have sex with men \u2022 Transgender people \u2022 People who inject drugs \u2022 The sexual partners of these individuals. What Causes STIs? Several types of organisms cause STIs. Those caused by bacteria or parasites",
    "page_number": 363,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2753
  },
  {
    "id": "chunk_02754",
    "text": "cause STIs. Those caused by bacteria or parasites can generally be cured. STIs caused by viruses generally cannot be cured, although they can be treated to relieve or eliminate symptoms. Most STIs are spread by sexual activity, and much of this spread can be prevented by the",
    "page_number": 363,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2754
  },
  {
    "id": "chunk_02755",
    "text": "y, and much of this spread can be prevented by the correct and consistent use of condoms. Some people, however, can get an STI in other ways. Details are provided in the table below. STI Types, Causes, Cures, and How They Are Spread Sexual Nonsexual STI Type Curable spread spread",
    "page_number": 363,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2755
  },
  {
    "id": "chunk_02756",
    "text": "ad Sexual Nonsexual STI Type Curable spread spread Chancroid Bacterial Yes Vaginal, anal, None and oral sex Chlamydia Bacterial Yes Vaginal and anal From mother to child sex, or rarely, during delivery from genitals to mouth Gonorrhea Bacterial Yes Vaginal and anal From mother to child",
    "page_number": 363,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2756
  },
  {
    "id": "chunk_02757",
    "text": "acterial Yes Vaginal and anal From mother to child sex, or contact during delivery, or between mouth through breast milk and genitals Contaminated blood transfusion Hepatitis B Viral No Vaginal and anal From mother to child sex, or from during delivery, or penis to mouth through breast milk",
    "page_number": 363,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2757
  },
  {
    "id": "chunk_02758",
    "text": "STI Types, Causes, Cures and How They are Spread (continued) Sexual Nonsexual STI Type Curable spread spread Herpes Viral No Genital or oral From mother to child contact with an during pregnancy or ulcer, including delivery during vaginal and anal sex; also genital contact in area without ulcer",
    "page_number": 364,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2758
  },
  {
    "id": "chunk_02759",
    "text": "al sex; also genital contact in area without ulcer HIV Viral No Vaginal and anal From mother to child sex, or very during delivery, or rarely, oral sex through breast milk Injection drug use with nonsterile needles Contaminated blood transfusion Human Viral No Vaginal, anal, From mother to child",
    "page_number": 364,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2759
  },
  {
    "id": "chunk_02760",
    "text": "Human Viral No Vaginal, anal, From mother to child papilloma- and oral sex during delivery virus (HPV) Human Viral No Vaginal and From mother to child T-lympho- anal sex during pregnancy or tropic virus delivery, or through breast milk Contaminated blood transfusion",
    "page_number": 364,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2760
  },
  {
    "id": "chunk_02761",
    "text": "through breast milk Contaminated blood transfusion Syphilis Bacterial Yes Genital or oral From mother to child contact with an during pregnancy or ulcer, including delivery during vaginal and anal sex Contaminated blood transfusion Tricho- Parasitic Yes Vaginal, anal, From mother to child",
    "page_number": 364,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2761
  },
  {
    "id": "chunk_02762",
    "text": "22 Sexually Transmitted Infections 343 VIH gnidulcnI ,sITS STI Signs and Symptoms Common signs and symptoms which suggest an STI are listed in the table below, along with their possible causes. Symptoms Possible cause Discharge from the penis: pus, clear or Chlamydia, gonorrhea, trichomoniasis",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2762
  },
  {
    "id": "chunk_02763",
    "text": "pus, clear or Chlamydia, gonorrhea, trichomoniasis yellow-green drip Abnormal vaginal discharge Cervical STI: Chlamydia, gonorrhea Vaginal STI: Trichomoniasis Non-STI vaginal infection: Bacterial vaginosis, candidiasis (see Common Vaginal Infections That May Not Be Sexually Transmitted, next page)",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2763
  },
  {
    "id": "chunk_02764",
    "text": "s That May Not Be Sexually Transmitted, next page) Anorectal discharge Chlamydia, gonorrhea Lower abdominal pain (possible pelvic Chlamydia, gonorrhea, trichomoniasis inflammatory disease) Swollen and/or painful testicles Chlamydia, gonorrhea",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2764
  },
  {
    "id": "chunk_02765",
    "text": "llen and/or painful testicles Chlamydia, gonorrhea Warts on the genitals, anus, or HPV, especially types 6 and 11 surrounding areas Ulcers on the genitals, anus, or Genital herpes, syphilis, chancroid surrounding areas Early Identification of STIs",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2765
  },
  {
    "id": "chunk_02766",
    "text": "oid surrounding areas Early Identification of STIs Ideally, an STI would be identified (and treated) early, to avoid complications and stop the spread of infection. To help detect STIs early, for every client seeking family planning, a provider should:",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2766
  },
  {
    "id": "chunk_02767",
    "text": "client seeking family planning, a provider should: \u2022 Ask about the client\u2019s sexual history and assess their risk of getting an STI. \u2022 Ask whether the client or their partner(s) has symptoms of STIs, such as genital sores/pain/swelling, abnormal genital or anorectal discharge, or lower abdominal pain.",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2767
  },
  {
    "id": "chunk_02768",
    "text": "l or anorectal discharge, or lower abdominal pain. \u2022 Look for signs of STIs when doing a pelvic or genital examination. \u2022 For clients with signs and/or symptoms of STIs, promptly make a syndromic diagnosis and provide appropriate treatment, or in some",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2768
  },
  {
    "id": "chunk_02769",
    "text": "osis and provide appropriate treatment, or in some settings perform STI testing as needed (rapid or laboratory testing, depending on availability\u2014see next page) or refer the client to another facility for appropriate care. \u2022 For clients without STI signs or symptoms but who are at high risk for",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2769
  },
  {
    "id": "chunk_02770",
    "text": "STI signs or symptoms but who are at high risk for acquiring STIs, encourage them to get screened for syphilis and, when feasible, also for gonorrhea and chlamydia.",
    "page_number": 365,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2770
  },
  {
    "id": "chunk_02771",
    "text": "In addition, a family planning provider should: \u2022 Advise on condom and lubricant use, as appropriate to the client\u2019s needs. \u2022 Offer assistance with notifying sexual partners of all clients diagnosed with an STI and those who have symptoms and signs of an STI; this can be done",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2771
  },
  {
    "id": "chunk_02772",
    "text": "ave symptoms and signs of an STI; this can be done using different strategies based on the client\u2019s preferences for each partner. In settings where STI testing is available, providers should, where appropriate: \u2022 Offer hepatitis B testing, preferably using rapid screening tests that can",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2772
  },
  {
    "id": "chunk_02773",
    "text": "g, preferably using rapid screening tests that can be conducted during the same visit, and: if positive, the client should be referred for assessment of treatment eligibility; if negative, the client should consider hepatitis B vaccination when recommended and available (see",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2773
  },
  {
    "id": "chunk_02774",
    "text": "B vaccination when recommended and available (see the table on prevention measures in Avoiding STIs on the next page for recommended hepatitis B vaccination among adults). \u2022 Offer tests for gonorrhea and chlamydial infections, if available. Based on",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2774
  },
  {
    "id": "chunk_02775",
    "text": "and chlamydial infections, if available. Based on the history and risk, collect samples from the throat, vagina, and anus. If possible, offer the client the opportunity to collect samples themselves (self-collection), as some find this more acceptable.",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2775
  },
  {
    "id": "chunk_02776",
    "text": "lf-collection), as some find this more acceptable. \u2022 Inform clients at high risk of STI exposure that syphilis and HIV testing should be done regularly\u2014at least once a year. \u2022 Advise clients to look out for any genital sores, warts, or unusual discharge",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2776
  },
  {
    "id": "chunk_02777",
    "text": "for any genital sores, warts, or unusual discharge in themselves or their sexual partner(s) and, if present, seek health care as soon as possible. Common Vaginal Infections That May Not Be Sexually Transmitted Candidiasis (also called yeast infection or thrush) and bacterial vaginosis",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2777
  },
  {
    "id": "chunk_02778",
    "text": "yeast infection or thrush) and bacterial vaginosis are the most common vaginal infections and they are usually due to an overgrowth of organisms normally present in the vagina. They may or may not be sexually transmitted. Candidiasis (which can cause curd-like discharge",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2778
  },
  {
    "id": "chunk_02779",
    "text": ". Candidiasis (which can cause curd-like discharge and itchiness) is not usually sexually transmitted. Research links bacterial vaginosis with sexual behavior. Women with multiple partners are more likely to have bacterial vaginosis, but even a woman who has never had sex can,",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2779
  },
  {
    "id": "chunk_02780",
    "text": "nosis, but even a woman who has never had sex can, rarely, develop bacterial vaginosis. \u2022 In most settings these infections are much more common than STIs. Researchers estimate that between 5% and 25% of women have bacterial vaginosis, and between 5% and 15% have candidiasis, at any given time.",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2780
  },
  {
    "id": "chunk_02781",
    "text": "en 5% and 15% have candidiasis, at any given time. \u2022 Vaginal discharge due to these infections may be similar to discharge caused by some STIs; the discharge caused by bacterial vaginosis, for example, is similar to that caused by trichomoniasis. It is important to",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2781
  },
  {
    "id": "chunk_02782",
    "text": "that caused by trichomoniasis. It is important to explain to clients with vaginal discharge that they may not have an STI, particularly if they do not have any other symptoms and are at low risk of a STI. 344 Family Planning: A Global Handbook for Providers",
    "page_number": 366,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2782
  },
  {
    "id": "chunk_02783",
    "text": "22 345 VIH gnidulcnI ,sITS \u2022 Bacterial vaginosis can be cured with antibiotics, usually metronidazole. Candidiasis can be cured with antifungal medications such as fluconazole. Without treatment, bacterial vaginosis can sometimes lead to",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2783
  },
  {
    "id": "chunk_02784",
    "text": "eatment, bacterial vaginosis can sometimes lead to complications in pregnancy, and candidiasis can be spread to an infant during childbirth. Good hygiene may help some clients avoid vaginal infections. Washing the external genital area with unscented soap and clean water, and not using",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2784
  },
  {
    "id": "chunk_02785",
    "text": "with unscented soap and clean water, and not using douches, detergents, disinfectants, or vaginal cleaning or drying agents, are good hygiene practices. Avoiding STIs Family planning providers can help their clients in various ways to prevent STIs, including HIV. Prevention measure Notes",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2785
  },
  {
    "id": "chunk_02786",
    "text": "vent STIs, including HIV. Prevention measure Notes HPV vaccine See Vaccine Available for Prevention (in the section of this chapter on Cervical Cancer), p. 354. Hepatitis B vaccine Hepatitis B infection is prevented by vaccines, which are usually given to newborns and children.",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2786
  },
  {
    "id": "chunk_02787",
    "text": "which are usually given to newborns and children. Adolescents and adults at increased risk of infection (see the box in the section Who Is at Risk for STIs?, p. 360) are also recommended for vaccination, including people living with HIV, household and sexual",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2787
  },
  {
    "id": "chunk_02788",
    "text": "uding people living with HIV, household and sexual contacts of people with chronic hepatitis B virus infection, men who have sex with men, people with multiple sexual partners, persons in prisons, and persons who inject drugs. Condoms The correct and consistent use of male or female",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2788
  },
  {
    "id": "chunk_02789",
    "text": "s The correct and consistent use of male or female condoms offers effective protection against STIs, including HIV. See Chapters 14 and 15. Pre-Exposure PrEP can be an effective tool to prevent HIV when Prophylaxis (PrEP) taken as prescribed. See Chapter 23, section on",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2789
  },
  {
    "id": "chunk_02790",
    "text": "P) taken as prescribed. See Chapter 23, section on Preventing HIV Acquisition, p. 365. Post-Exposure PEP can be offered to prevent HIV infection after Prophylaxis (PEP) exposure, for emergency situations. It must be started within 72 hours after the possible exposure. See",
    "page_number": 367,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2790
  },
  {
    "id": "chunk_02791",
    "text": "STI prevention measures (continued) Prevention measure Notes Lubricant The use of lubricants is recommended for anal sex, and it can also help vaginal lubrication when needed or wanted. Lubricants prevent micro tears in the anorectal and vaginal mucosa, which can create entry",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2791
  },
  {
    "id": "chunk_02792",
    "text": "orectal and vaginal mucosa, which can create entry points for STIs. Water-based lubricants are recommended when used with condoms. Male Male circumcision can reduce men\u2019s risk of HIV circumcision infection by 50\u201360% when having vaginal sex with a female partner. Male circumcision can also reduce a",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2792
  },
  {
    "id": "chunk_02793",
    "text": "emale partner. Male circumcision can also reduce a female partner\u2019s risk of acquiring STIs. Preventing and Diagnosing and treating STIs helps prevent the client treating STIs from acquiring additional STIs; this is because sores or ulcers associated with existing STIs can make it easier",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2793
  },
  {
    "id": "chunk_02794",
    "text": "s associated with existing STIs can make it easier for other STIs (including HIV) to infect the person. For example, herpes simplex virus 2 (HSV-2) infection (genital herpes) increases the risk of acquiring HIV 3-fold, syphilis 2-fold, and trichomoniasis 1.5-fold.",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2794
  },
  {
    "id": "chunk_02795",
    "text": "old, syphilis 2-fold, and trichomoniasis 1.5-fold. A family planning provider should inform clients about practices or behaviors that increase someone\u2019s risk of getting a STI, including HIV (see Who Is At Risk for STIs?, p. 340). Clients can then think about their own circumstances",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2795
  },
  {
    "id": "chunk_02796",
    "text": "ients can then think about their own circumstances and practices to assess their risk of acquiring an STI. If a client seeks further advice or counseling, then depending on the needs of each client, providers should tailor their advice about effective strategies to reduce the risk of",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2796
  },
  {
    "id": "chunk_02797",
    "text": "e about effective strategies to reduce the risk of an STI, and should always do this in a private setting and with respect for confidentiality. The decision to use particular prevention measure(s) should be an informed choice, made voluntarily by the client. Providers should not allow their",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2797
  },
  {
    "id": "chunk_02798",
    "text": "ly by the client. Providers should not allow their personal views to influence clients\u2019 prevention choices. It is important to remember that clients might choose to use different strategies in different situations and with different partners, as well as at different times",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2798
  },
  {
    "id": "chunk_02799",
    "text": "different partners, as well as at different times in their lives. The best strategy is the one that a person can practice effectively. Family planning providers can help with HIV prevention, and its early diagnosis and treatment, particularly among people at higher risk of infection",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2799
  },
  {
    "id": "chunk_02800",
    "text": "ticularly among people at higher risk of infection and in countries where many people are living with HIV. See Chapter 23 \u2013 Family Planning for Adolescents and Women at High Risk for HIV. 346 Family Planning: A Global Handbook for Providers",
    "page_number": 368,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2800
  },
  {
    "id": "chunk_02801",
    "text": "22 347 VIH gnidulcnI ,sITS Safer Conception for HIV Serodiscordant Couples When a couple wants to have a child and one partner is living with HIV while the other is not (a serodiscordant couple), providers should: \u2022 Make sure that the partner living with HIV is receiving consistent and",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2801
  },
  {
    "id": "chunk_02802",
    "text": "artner living with HIV is receiving consistent and correct antiretroviral therapy (ART) and is regularly tested to monitor viral load (or CD4 cell count, if viral load testing is not available). Successful ART with viral suppression prevents HIV transmission to sexual partners: there is",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2802
  },
  {
    "id": "chunk_02803",
    "text": "ents HIV transmission to sexual partners: there is no transmission when viral load is undetectable or suppressed (less than or equal to 1,000 copies/mL). \u2022 Offer PrEP to the HIV-negative partner if the other partner, who is living with",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2803
  },
  {
    "id": "chunk_02804",
    "text": "e partner if the other partner, who is living with HIV, still has detectable viral load. PrEP should be used until the partner living with HIV has achieved viral suppression. Some HIV-negative partners may choose to continue with PrEP even after this point.",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2804
  },
  {
    "id": "chunk_02805",
    "text": "hoose to continue with PrEP even after this point. \u2022 Reassure the couple that this new approach means conception by artificial insemination is no longer necessary. \u2022 Inform the couple that both partners need to be screened and treated for any other STIs before trying for conception.",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2805
  },
  {
    "id": "chunk_02806",
    "text": "d for any other STIs before trying for conception. For information on family planning methods for people living with HIV, see Contraceptives for Clients With STIs, including HIV, p 349. Choosing a Dual Protection Strategy Family planning providers can talk to clients about how they can protect",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2806
  },
  {
    "id": "chunk_02807",
    "text": "ers can talk to clients about how they can protect themselves both from STIs, including HIV, and from pregnancy (known as \u201cdual protection\u201d). Strategy 1: Use male or female condoms consistently (with every sex act) and correctly \u2022 One method is used to help protect against both pregnancy and STIs.",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2807
  },
  {
    "id": "chunk_02808",
    "text": "d to help protect against both pregnancy and STIs. Strategy 2: Use male or female condoms consistently and correctly plus another family planning method \u2022 Using two methods provides extra protection from pregnancy in case the condom is not used, is used incorrectly, or breaks.",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2808
  },
  {
    "id": "chunk_02809",
    "text": "ondom is not used, is used incorrectly, or breaks. \u2022 This strategy may be a good choice for those who want to feel reassured about avoiding pregnancy if they cannot always be sure of consistent and correct condom use. Avoiding STIs",
    "page_number": 369,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2809
  },
  {
    "id": "chunk_02810",
    "text": "Strategy 3: If both partners know that they are not infected with any STIs, or if one partner is living with HIV but has achieved viral suppression through ART, then use any family planning method to prevent pregnancy and agree to stay in a mutually faithful relationship",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2810
  },
  {
    "id": "chunk_02811",
    "text": "agree to stay in a mutually faithful relationship \u2022 Many family planning clients believe they are in this group and thus feel protected from STIs, including HIV, without using condoms. \u2022 This strategy depends on good communication and trust between partners.",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2811
  },
  {
    "id": "chunk_02812",
    "text": "on good communication and trust between partners. Another dual protection strategy, which does not involve using condoms or any other contraceptives, is: Strategy 4: Engage only in sexual intimacy that avoids penetration or otherwise prevents semen and vaginal fluids from",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2812
  },
  {
    "id": "chunk_02813",
    "text": "r otherwise prevents semen and vaginal fluids from coming into contact with each other\u2019s genitals or mouths (for example, mutual masturbation) \u2022 This strategy may not prevent syphilis, genital herpes, genital warts, or other infection with HPV, depending on the type",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2813
  },
  {
    "id": "chunk_02814",
    "text": "or other infection with HPV, depending on the type of physical interaction that occurs. These STIs can be spread by skin-to-skin contact. \u2022 This strategy depends on good communication, trust, and self-control. \u2022 If this is the couple\u2019s first-choice strategy, it is best to have",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2814
  },
  {
    "id": "chunk_02815",
    "text": "couple\u2019s first-choice strategy, it is best to have condoms available in case penetrative sex occurs. Many clients will need help, support, and guidance to make their dual protection strategy succeed. For example, they may need help preparing",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2815
  },
  {
    "id": "chunk_02816",
    "text": "succeed. For example, they may need help preparing to talk with their partners about STI protection, learning how to use condoms and other methods of contraception, and handling practical matters such as where to get supplies and where to keep them. Providers",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2816
  },
  {
    "id": "chunk_02817",
    "text": "to get supplies and where to keep them. Providers unable to help with such matters should refer the client to someone who can provide more counseling or skills-building, such as role-playing to practice negotiating condom use. 348 Family Planning: A Global Handbook for Providers",
    "page_number": 370,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2817
  },
  {
    "id": "chunk_02818",
    "text": "22 349 VIH gnidulcnI ,sITS Contraceptives for Clients With STIs, Including HIV People with STIs and HIV (regardless of whether they are taking ART) can start and continue to use most contraceptive methods safely. There are a",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2818
  },
  {
    "id": "chunk_02819",
    "text": "use most contraceptive methods safely. There are a few limitations, however, as described in the table below. Each contraceptive method chapter in this Handbook (Chapters 1\u201320) also provides more information and considerations for clients with HIV, including those taking ART.",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2819
  },
  {
    "id": "chunk_02820",
    "text": "for clients with HIV, including those taking ART. Special Family Planning Considerations for Clients with STIs, including HIV Method Has STIs Has HIV Intrauterine \u2022 Do not insert an IUD \u2022 A client living with HIV device (IUD): in a client who is at clinical disease that is mild",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2820
  },
  {
    "id": "chunk_02821",
    "text": "n a client who is at clinical disease that is mild copper-bearing very high individual or with no symptoms IUD (Cu-IUD) or risk for gonorrhea (WHO Stages 1 or 2), levonorgestrel- and chlamydia, or including a client on containing IUD who currently has antiretroviral therapy",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2821
  },
  {
    "id": "chunk_02822",
    "text": "ining IUD who currently has antiretroviral therapy (LNG-IUD) gonorrhea, chlamydia, (ART), can have an IUD purulent cervicitis, or inserted. pelvic inflammatory \u2022 Generally, a client should disease (PID). not have an IUD inserted However, a current if they have HIV clinical IUD user who",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2822
  },
  {
    "id": "chunk_02823",
    "text": ", a current if they have HIV clinical IUD user who disease that is severe or becomes infected advanced (WHO Stages with gonorrhea 3 or 4). or chlamydia or develops PID can \u2022 A current IUD user who safely continue using becomes infected with the IUD during and HIV or whose HIV clinical",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2823
  },
  {
    "id": "chunk_02824",
    "text": "with the IUD during and HIV or whose HIV clinical after treatment for disease becomes severe the infection. or advanced (WHO Stages 3 or 4) can safely continue using the IUD. \u2022 A client using an IUD can keep the IUD in place when they start ART. (Continued on next page)",
    "page_number": 371,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2824
  },
  {
    "id": "chunk_02825",
    "text": "Special Family Planning Considerations for Clients with STIs, including HIV (continued) Method Has STIs Has HIV Female \u2022 If the client has \u2022 Clients living with HIV, sterilization gonorrhea, chlamydia, including those on ART, purulent cervicitis, or can safely undergo female",
    "page_number": 372,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2825
  },
  {
    "id": "chunk_02826",
    "text": "purulent cervicitis, or can safely undergo female PID, delay sterilization sterilization. until the condition \u2022 The procedure may need has been treated. to be delayed in clients with severe or advanced HIV clinical disease (WHO Stages 3 or 4) if the client currently has an HIV-related illness.",
    "page_number": 372,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2826
  },
  {
    "id": "chunk_02827",
    "text": "f the client currently has an HIV-related illness. Vasectomy \u2022 If the client has \u2022 Clients living with HIV, scrotal skin infection, including those on ART, active STI, or swollen, can safely undergo tender tip of penis, vasectomy. sperm ducts, or \u2022 The procedure may need testicles, delay",
    "page_number": 372,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2827
  },
  {
    "id": "chunk_02828",
    "text": "ucts, or \u2022 The procedure may need testicles, delay to be delayed in clients vasectomy until the with severe or advanced condition has been HIV clinical disease treated. (WHO Stages 3 or 4) if the client currently has an HIV-related illness. Spermicides \u2022 Can be used. \u2022 Generally, clients living",
    "page_number": 372,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2828
  },
  {
    "id": "chunk_02829",
    "text": "micides \u2022 Can be used. \u2022 Generally, clients living with HIV should not use spermicides (the risks usually outweigh the advantages). All hormonal methods (except hormone-releasing IUDs) can be used by any client with STIs, including HIV. 350 Family Planning: A Global Handbook for Providers",
    "page_number": 372,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2829
  },
  {
    "id": "chunk_02830",
    "text": "22 351 VIH gnidulcnI ,sITS Cervical Cancer What Is Cervical Cancer? Cervical cancer results from uncontrolled, untreated growth of abnormal cells in the cervix. Human papillomavirus (HPV), an STI, can cause abnormal cells on the cervix to develop and grow.",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2830
  },
  {
    "id": "chunk_02831",
    "text": "abnormal cells on the cervix to develop and grow. HPV is found on skin in the genital area and also in the tissues of the vagina, cervix, and mouth. It is primarily transmitted through skin-to-skin contact. Vaginal, anal, and oral sex can also spread HPV, as can digital contact. Over",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2831
  },
  {
    "id": "chunk_02832",
    "text": "can also spread HPV, as can digital contact. Over 40 types of HPV can infect the cervix but only 14 of them (referred to as the oncogenic or high-risk HPV types) can cause pre-cancer changes to the cells on the cervix. Of these high-risk types, 2 types (HPV 16 and 18) cause",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2832
  },
  {
    "id": "chunk_02833",
    "text": "ese high-risk types, 2 types (HPV 16 and 18) cause more than 70% of cervical cancers, with five additional types of HPV (HPV 31, 33, 45, 52, and 58) causing an additional 20% of cervical cancers. Overall, more than 95% of all cervical cancers are due to HPV, while approximately",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2833
  },
  {
    "id": "chunk_02834",
    "text": "rvical cancers are due to HPV, while approximately 5% are attributable to HIV (women living with HIV are more likely to develop cervical cancer). Two other types of HPV (HPV 6 and 11) cause most cases of genital warts. Most sexually active women are infected with at least one type of HPV",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2834
  },
  {
    "id": "chunk_02835",
    "text": "e women are infected with at least one type of HPV during their lives. In most cases the HPV infection clears (goes away) on its own. In some clients, however, HPV persists and causes cervical pre-cancer lesions, which can develop into cancer. Overall, less than 5.5% of clients",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2835
  },
  {
    "id": "chunk_02836",
    "text": "op into cancer. Overall, less than 5.5% of clients 30\u201344 years of age with persistent HPV infection get cervical cancer. Cancer of the cervix usually takes at least 10 to 20 years to develop. This means there is a long period of opportunity to detect and treat early cervical",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2836
  },
  {
    "id": "chunk_02837",
    "text": "of opportunity to detect and treat early cervical cell changes before they become cancer. This is the goal of screening and treatment for cervical pre-cancer lesions. Who Is at Greatest Risk for Cervical Cancer? Some factors make clients more likely to be infected by HPV. Other factors",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2837
  },
  {
    "id": "chunk_02838",
    "text": "s more likely to be infected by HPV. Other factors enhance the persistence of high-risk types of HPV infection and progression to cervical cancer. Every client benefits from screening and treatment of cervical pre-cancer lesions, but the following factors and characteristics",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2838
  },
  {
    "id": "chunk_02839",
    "text": "ons, but the following factors and characteristics increase the risk of being infected with HPV, developing a persistent HPV infection, and developing cervical pre-cancer or cancer: \u2022 Having multiple sexual partners and/or having a partner who has multiple sexual partners",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2839
  },
  {
    "id": "chunk_02840",
    "text": "having a partner who has multiple sexual partners \u2022 Having had many sexual partners over the years, and/or having a sexual partner who has had many sexual partners over the years \u2022 Having a weakened immune system (including those living with HIV, who",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2840
  },
  {
    "id": "chunk_02841",
    "text": "mmune system (including those living with HIV, who have 6 times the risk of developing cervical cancer compared with those who don\u2019t have HIV) Cervical Cancer",
    "page_number": 373,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2841
  },
  {
    "id": "chunk_02842",
    "text": "\u2022 Having other STIs, such as genital herpes, chlamydia, or gonorrhea \u2022 Being young at the time of first intercourse/first birth \u2022 Being a tobacco smoker \u2022 Having a partner who is not circumcised. Screening and Treatment Screening for cervical pre-cancer lesions is simple, quick, and generally",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2842
  },
  {
    "id": "chunk_02843",
    "text": "pre-cancer lesions is simple, quick, and generally not painful. Cervical screening should start at age 30 years, or at age 25 for those who are living with HIV. The recommended frequency of screening depends on the screening test used and whether a client is",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2843
  },
  {
    "id": "chunk_02844",
    "text": "on the screening test used and whether a client is living with HIV. Any cervical pre-cancer lesions (cell changes) that are detected must be treated, whether immediately after a positive primary test, or only after a positive second \u201ctriage\u201d test. Further details on",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2844
  },
  {
    "id": "chunk_02845",
    "text": "positive second \u201ctriage\u201d test. Further details on screening tests, screening frequency, and treatment are provided below. Screening Tests There are 3 different screening tests that may be used, depending on the capacity and conditions in a region. If available, the recommended",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2845
  },
  {
    "id": "chunk_02846",
    "text": "ditions in a region. If available, the recommended primary screening test is an HPV nucleic acid amplification test (HPV NAAT). The other 2 types of screening tests are cytology and visual inspection with acetic acid (VIA). 1. H PV NAATs are available in 2 types: HPV DNA NAATs or HPV mRNA NAATs.",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2846
  },
  {
    "id": "chunk_02847",
    "text": "lable in 2 types: HPV DNA NAATs or HPV mRNA NAATs. \u2022 HPV DNA NAATs detect the presence of a virus by detecting the viral DNA. \u2022 HPV mRNA NAATs detect the proteins that cause the HPV- mediated pre-cancer changes of the epithelial cells. For clients living with HIV, only HPV DNA NAATs are recommended.",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2847
  },
  {
    "id": "chunk_02848",
    "text": "ving with HIV, only HPV DNA NAATs are recommended. For clients without HIV, both types of HPV NAATs can be used, but an HPV DNA NAAT is recommended as the preferred primary screening test. Only samples for HPV DNA NAATs may be self-collected.",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2848
  },
  {
    "id": "chunk_02849",
    "text": "y samples for HPV DNA NAATs may be self-collected. 2. C ytology (conventional Papanicolaou [Pap] smear or liquid-based cytology [LBC]) requires collecting a small amount of cells from the cervix. The sample is sent to a laboratory for analysis. Using cytology",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2849
  },
  {
    "id": "chunk_02850",
    "text": "sent to a laboratory for analysis. Using cytology requires a well-functioning lab that has quality assurance systems in place. 3. V IA involves looking at the cervix with the naked eye 1 minute after applying a weak vinegar (3\u20135% acetic acid) solution to it. Maintaining",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2850
  },
  {
    "id": "chunk_02851",
    "text": "gar (3\u20135% acetic acid) solution to it. Maintaining a well-functioning VIA screening program requires training and supervision of providers and ongoing quality control. 352 Family Planning: A Global Handbook for Providers",
    "page_number": 374,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2851
  },
  {
    "id": "chunk_02852",
    "text": "22 353 VIH gnidulcnI ,sITS Screening Approaches Two screening approaches can be considered: a. In a screen-and-treat approach, the decision to proceed with treatment is made without triage testing (no second screening test and no histopathological diagnosis). HPV NAATs are the recommended screening",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2852
  },
  {
    "id": "chunk_02853",
    "text": "iagnosis). HPV NAATs are the recommended screening test in this approach, but VIA can also be used in a screen-and-treat approach while transitioning to the use of HPV NAATs. b. In a screen, triage, and treat approach, when the primary screening",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2853
  },
  {
    "id": "chunk_02854",
    "text": "ge, and treat approach, when the primary screening test is positive, the decision to proceed with treatment is based on the result of a second/triage test. HPV NAATs are the recommended primary screening test in this approach, but cytology can also be used in a screen,",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2854
  },
  {
    "id": "chunk_02855",
    "text": "proach, but cytology can also be used in a screen, triage, and treat approach while transitioning to the use of HPV NAATs. i. If an HPV NAAT is used as the primary screening test, then triage tests can be HPV 16/18 genotyping, VIA, colposcopy, or cytology",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2855
  },
  {
    "id": "chunk_02856",
    "text": "HPV 16/18 genotyping, VIA, colposcopy, or cytology followed by colposcopy. After a positive primary screening result with an HPV NAAT but a negative triage test result, clients do not need treatment, but they do need appropriate follow-up evaluation, and this",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2856
  },
  {
    "id": "chunk_02857",
    "text": "do need appropriate follow-up evaluation, and this should be at 2 years for the general population of women, and at 1 year for those living with HIV. ii. If cytology is used as the primary screening test, then the triage test is colposcopy. Women who have screened positive on a cytology primary",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2857
  },
  {
    "id": "chunk_02858",
    "text": "n who have screened positive on a cytology primary screening test and then have normal results on colposcopy should be retested with HPV DNA NAATs at 12 months and, if negative, move to the recommended screening interval (see below).",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2858
  },
  {
    "id": "chunk_02859",
    "text": "to the recommended screening interval (see below). After a positive primary screening test result and a positive triage test result, clients should receive treatment immediately or be referred for treatment or further evaluation. Starting age and interval of screening",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2859
  },
  {
    "id": "chunk_02860",
    "text": "evaluation. Starting age and interval of screening \u2022 For the general population of women, starting at age 30, HPV DNA NAATs are the recommended screening test in a screen-and-treat approach and also the recommended primary screening test in a screen,",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2860
  },
  {
    "id": "chunk_02861",
    "text": "he recommended primary screening test in a screen, triage, and treat approach, with a screening interval of 5\u201310 years. HPV mRNA NAATs may also be used, with a screening interval of 5 years. \u2022 For the population of women living with HIV, starting at age 25, HPV",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2861
  },
  {
    "id": "chunk_02862",
    "text": "of women living with HIV, starting at age 25, HPV DNA NAATs are the recommended primary screening test and a screen, triage, and treat approach is suggested rather than in a screen-and-treat approach, with a screening interval of 3\u20135 years.",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2862
  },
  {
    "id": "chunk_02863",
    "text": "approach, with a screening interval of 3\u20135 years. \u2022 Where HPV testing is not yet operational, WHO suggests a regular screening interval of every 3 years when using VIA or cytology as the sole or primary screening test among both the general population of women and those living with HIV.",
    "page_number": 375,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2863
  },
  {
    "id": "chunk_02864",
    "text": "\u2022 While transitioning to a program with a recommended regular screening interval, screening even just twice in a lifetime is beneficial among both the general population of women and women living with HIV. Treatment Methods Screening without treatment does not prevent cervical cancer. If a",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2864
  },
  {
    "id": "chunk_02865",
    "text": "t treatment does not prevent cervical cancer. If a client screens positive, then treatment (immediately or after further evaluation) must be provided to prevent progression of pre-cancer to cancer. The areas of the cervix that have been identified as abnormal",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2865
  },
  {
    "id": "chunk_02866",
    "text": "f the cervix that have been identified as abnormal can be removed either by ablation or excision. Ablation is the destruction of the abnormal tissue by freezing with a probe (cryotherapy) or using heat (thermal ablation). Excision involves surgically removing the abnormal tissue",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2866
  },
  {
    "id": "chunk_02867",
    "text": "n involves surgically removing the abnormal tissue using large-loop excision of the transformation zone (LLETZ) or cold knife conization (CKC). Only excisional treatment will result in a tissue specimen for histological examination. Ablation is less effective for larger growths,",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2867
  },
  {
    "id": "chunk_02868",
    "text": "on. Ablation is less effective for larger growths, but excision requires more extensive training and use of local anesthesia on the cervix. No hospital stay is needed for either type of treatment. Both treatments are generally well-tolerated and effective, and every effort should",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2868
  },
  {
    "id": "chunk_02869",
    "text": "l-tolerated and effective, and every effort should be made to provide treatment at the same facility where screening occurs, and at the same visit when screening occurs. Before treatment, women who have not yet been screened with VIA should be visually inspected using acetic",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2869
  },
  {
    "id": "chunk_02870",
    "text": "with VIA should be visually inspected using acetic acid to determine transformation zone type, rule out suspected cervical cancer, and determine eligibility for ablation. After treatment, women need to be followed up at 1 year. Vaccine Available for Prevention",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2870
  },
  {
    "id": "chunk_02871",
    "text": "wed up at 1 year. Vaccine Available for Prevention In the mid-2000s, the European Union and the United States Food and Drug Administration approved 2 vaccines against cervical cancer, pre-cancer, and genital warts. Both of these vaccines protect against HPV types 16 and 18,",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2871
  },
  {
    "id": "chunk_02872",
    "text": "hese vaccines protect against HPV types 16 and 18, which cause over 70% of cervical cancers. Cervarix protects only against those 2 HPV types, while Gardasil also protects against infection by HPV types 6 and 11, which cause 90% of genital warts. Both vaccines are most",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2872
  },
  {
    "id": "chunk_02873",
    "text": "cause 90% of genital warts. Both vaccines are most effective when administered to clients before they become sexually active. In 2018, Gardasil-9 became available; this newer HPV vaccine protects against an additional 5 types of HPV types that cause another 20% of cervical",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2873
  },
  {
    "id": "chunk_02874",
    "text": "es of HPV types that cause another 20% of cervical cancers. Recently, Cecolin, an HPV vaccine manufactured in China, has also received WHO Prequalification. 354 Family Planning: A Global Handbook for Providers",
    "page_number": 376,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2874
  },
  {
    "id": "chunk_02875",
    "text": "22 355 VIH gnidulcnI ,sITS Questions and Answers About STIs, Including HIV 1. Does having another STI mean a person is at greater risk of HIV infection if they are exposed to HIV? Yes. In particular, infections that cause sores on the genitals, such as",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2875
  },
  {
    "id": "chunk_02876",
    "text": "fections that cause sores on the genitals, such as chancroid and syphilis, increase a person\u2019s risk of becoming infected if exposed to HIV. Other STIs also increase the risk of HIV infection. 2. Does using a condom only some of the time offer any protection from STIs, including HIV?",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2876
  },
  {
    "id": "chunk_02877",
    "text": "ime offer any protection from STIs, including HIV? For best protection, a condom should be used at every act of sex, and used correctly. In some cases, however, occasional use can offer some protection. This depends on the risk of STI that the person is exposed",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2877
  },
  {
    "id": "chunk_02878",
    "text": "ends on the risk of STI that the person is exposed to (which depends on the person\u2019s and their partner\u2019s sexual behavior, number of sexual partners, and the number of people infected in the same population group or geographic area). For people who are",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2878
  },
  {
    "id": "chunk_02879",
    "text": "tion group or geographic area). For people who are frequently exposed to STIs, including HIV, using a condom only some of the time will offer only limited protection. 3. Who is more at risk of becoming infected with an STI? If exposed to STIs, women are more likely to become infected than men",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2879
  },
  {
    "id": "chunk_02880",
    "text": "women are more likely to become infected than men due to biological factors, because they have a greater area of exposure (the cervix and the vagina), and small tears may occur in the vaginal tissue during sex, providing a pathway for infection. All people who have anal",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2880
  },
  {
    "id": "chunk_02881",
    "text": "a pathway for infection. All people who have anal sex are at greater risk of an STI for the same reasons. 4. Can STIs be transmitted through oral sex (mouth on penis or vagina)? Yes. Herpes, syphilis, hepatitis B, HPV, chlamydia, and gonorrhea can be transmitted through oral sex.",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2881
  },
  {
    "id": "chunk_02882",
    "text": "and gonorrhea can be transmitted through oral sex. 5. Can STIs be transmitted through anal sex (penis in anus)? Yes. STIs, including HIV, are commonly transmitted through anal sex. Unprotected anal sex carries the highest sexual risk of HIV transmission.",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2882
  },
  {
    "id": "chunk_02883",
    "text": "rries the highest sexual risk of HIV transmission. The use of condoms with lubricants is the best way to protect against STIs during anal sex. Questions and Answers About STIs, Including HIV",
    "page_number": 377,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2883
  },
  {
    "id": "chunk_02884",
    "text": "6. Will washing the penis or vagina after sex lower the risk of becoming infected with an STI? Genital hygiene is important and a good practice. There is no evidence, however, that washing the genitals prevents STI infection. In fact, vaginal douching increases the risk of acquiring STIs, including",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2884
  },
  {
    "id": "chunk_02885",
    "text": "ng increases the risk of acquiring STIs, including HIV, and pelvic inflammatory disease. If exposure to HIV is certain, the use of post-exposure prophylaxis (PEP) prevents HIV acquisition. If exposure to other STIs is certain, PEP for STIs should also be used.",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2885
  },
  {
    "id": "chunk_02886",
    "text": "STIs is certain, PEP for STIs should also be used. 7. How well do condoms help protect against HIV infection? On average, among heterosexual couples, when one partner is HIV- positive and the other is HIV-negative, condoms offer at least 80%",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2886
  },
  {
    "id": "chunk_02887",
    "text": "other is HIV-negative, condoms offer at least 80% protection against HIV when used at every act of sexual intercourse. For insertive anal sex, condoms offer at least 63% protection, and for receptive anal sex, the protection is at least 72%. However,",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2887
  },
  {
    "id": "chunk_02888",
    "text": "anal sex, the protection is at least 72%. However, these estimates are based on self-reported condom use. They may, therefore, overestimate the true level of protection. The likelihood that a person who is exposed to HIV will become infected can vary greatly. The chance of infection depends on",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2888
  },
  {
    "id": "chunk_02889",
    "text": "n vary greatly. The chance of infection depends on several factors: \u2022 Stage of HIV infection: The first weeks after a person becomes infected are when they are most infectious and it is likely their serostatus will not be known at this early stage of infection.",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2889
  },
  {
    "id": "chunk_02890",
    "text": "ill not be known at this early stage of infection. \u2022 Viral suppression by antiretroviral therapy (ART): There is no risk of HIV transmission if ART is taken properly and viral load has become undetectable. \u2022 Type of sex act: Receptive anal sex confers the highest risk,",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2890
  },
  {
    "id": "chunk_02891",
    "text": "act: Receptive anal sex confers the highest risk, followed by vaginal sex; transmission through oral sex is negligible. \u2022 Presence of other STIs: HSV-2 (genital herpes) increases the risk of HIV 3-fold, syphilis 2-fold and trichomoniasis 1.5-fold.",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2891
  },
  {
    "id": "chunk_02892",
    "text": "fold, syphilis 2-fold and trichomoniasis 1.5-fold. \u2022 Male circumcision status: Male circumcision can reduce the risk of HIV infection by 50\u201360% among those who have vaginal sex with a female partner. 356 Family Planning: A Global Handbook for Providers",
    "page_number": 378,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2892
  },
  {
    "id": "chunk_02893",
    "text": "23 357 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF CHAPTER 23 Family Planning for Adolescents and Women at High Risk for HIV Key Points for Providers and Clients y All family planning methods, with the exception of nonoxynol-9",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2893
  },
  {
    "id": "chunk_02894",
    "text": "lanning methods, with the exception of nonoxynol-9 spermicides,* are safe for all people at high risk for HIV, including both hormonal (either combined or progestin-only) and non-hormonal methods. y Adolescents and women should be offered or referred for an HIV test if needed.",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2894
  },
  {
    "id": "chunk_02895",
    "text": "be offered or referred for an HIV test if needed. \u2013 In high HIV burden settings (\u22655% HIV prevalence), adolescents and women should be offered or referred for an HIV test as a routine part of family planning services. \u2013 In low and medium HIV burden settings (<5% HIV prevalence),",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2895
  },
  {
    "id": "chunk_02896",
    "text": "d medium HIV burden settings (<5% HIV prevalence), family planning providers should give information to help adolescents and women determine if they are at high risk for HIV and therefore if they need an HIV test. y All adolescents and women at high risk for HIV should be counseled",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2896
  },
  {
    "id": "chunk_02897",
    "text": "and women at high risk for HIV should be counseled about how to prevent HIV and should be screened to see if they would benefit from pre-exposure prophylaxis (PrEP) for HIV prevention. y PrEP can be used safely with all family planning methods and while breastfeeding.",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2897
  },
  {
    "id": "chunk_02898",
    "text": "l family planning methods and while breastfeeding. y Male and female condoms are the only methods that can prevent both HIV and other sexually transmitted infections (STIs), as well as unintended pregnancy, when used consistently and correctly.",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2898
  },
  {
    "id": "chunk_02899",
    "text": "d pregnancy, when used consistently and correctly. y Testing male partners for HIV has many benefits for women and men. y Regardless of an individual\u2019s level of risk, it is possible to contract HIV after having unprotected sex even just once, even in low-risk settings.",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2899
  },
  {
    "id": "chunk_02900",
    "text": "ted sex even just once, even in low-risk settings. * Repeated and high-dose use of nonoxynol-9 spermicide has been found to be associated with increased risk of genital lesions, which may increase the risk of acquiring HIV (see Chapter 16 \u2013",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2900
  },
  {
    "id": "chunk_02901",
    "text": "crease the risk of acquiring HIV (see Chapter 16 \u2013 Spermicides and Diaphragms, Question 3, p. 296). For this reason, the MEC category for spermicides and diaphragms is Category 4 (i.e. \u201cMethod not to be used\u201d) for women who are at high risk of",
    "page_number": 379,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2901
  },
  {
    "id": "chunk_02902",
    "text": "Some adolescents and women are at high risk for acquiring HIV. Family planning providers must recognize this in order to provide high-quality family planning services. As shown in the map on the next page, the incidence of HIV infection is especially high among adolescents and young women in parts",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2902
  },
  {
    "id": "chunk_02903",
    "text": "ly high among adolescents and young women in parts of East and Southern Africa. Adolescents and women at high risk for HIV can safely use all family planning methods, with the exception of nonoxynol-9 spermicides. Family planning providers should also support adolescents and women to access HIV",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2903
  },
  {
    "id": "chunk_02904",
    "text": "d also support adolescents and women to access HIV testing (including HIV self-tests) for themselves and their partners, as well as prevention services and care when indicated. Adolescents and women who are at risk for HIV may also be at risk of gender-based violence, including",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2904
  },
  {
    "id": "chunk_02905",
    "text": "lso be at risk of gender-based violence, including sexual violence, force, or coercion. If a provider suspects this is the case, or if a client discloses this information, refer to the section on Violence Against Women in Chapter 25 \u2013 Reproductive Health Issues (pp. 383\u2013396)",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2905
  },
  {
    "id": "chunk_02906",
    "text": "pter 25 \u2013 Reproductive Health Issues (pp. 383\u2013396) for information on how to support and care for the client. The client may also be at increased risk of acquiring an STI, including human papillomavirus (HPV). For more detailed information on STIs, including HPV, please see",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2906
  },
  {
    "id": "chunk_02907",
    "text": "led information on STIs, including HPV, please see Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV (pp. 339\u2013356). Who Is at High Risk for Acquiring HIV? A client-centered approach is an important first step to providing USEFUL TERMS: safe and effective care and services.",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2907
  },
  {
    "id": "chunk_02908",
    "text": "SEFUL TERMS: safe and effective care and services. HIV prevalence refers to Some adolescents and women who the percentage of persons in are sexually active are at risk for HIV a specified population who simply because they live in a place are living with HIV at a given",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2908
  },
  {
    "id": "chunk_02909",
    "text": "hey live in a place are living with HIV at a given with a high HIV burden. In such places, point in time. all adolescents and women who are seeking family planning services should HIV incidence refers be considered at high risk for HIV. to the rate that new HIV",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2909
  },
  {
    "id": "chunk_02910",
    "text": "red at high risk for HIV. to the rate that new HIV Additionally, women and adolescents infections are occurring in a who have multiple sexual partners or specified population over a a partner living with HIV may be at particular period of time. high risk for HIV, regardless of the HIV",
    "page_number": 380,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2910
  },
  {
    "id": "chunk_02911",
    "text": "23 359 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF What Are High HIV Burden Settings? In some parts of East and Southern Africa, a large percentage of the population is living with HIV and many people are getting infected with HIV.",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2911
  },
  {
    "id": "chunk_02912",
    "text": "HIV and many people are getting infected with HIV. These areas are called high HIV burden settings because at least one out of every 20 persons is living with HIV. Another way of saying this is that the HIV prevalence is 5% or greater. Sometimes HIV prevalence among women",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2912
  },
  {
    "id": "chunk_02913",
    "text": "% or greater. Sometimes HIV prevalence among women is high throughout the country, and sometimes there are specific locations within a country with high HIV prevalence among women. In addition, the needs of individuals differ. Incidence (new infections per 1,000) in 2019 among females",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2913
  },
  {
    "id": "chunk_02914",
    "text": "e (new infections per 1,000) in 2019 among females aged 15\u201324 years at subnational levels in sub-Saharan Africa Incidence rate per 1,000 60 0 Source: UNAIDS epidemiological estimates, 2020. Note: HIV incidence is estimated as new HIV infections per 1,000 person-years at risk.",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2914
  },
  {
    "id": "chunk_02915",
    "text": "new HIV infections per 1,000 person-years at risk. Countries: Selected countries in sub-Saharan Africa for which the data required to produce subnational HIV estimates were available. HIV Risk in Low or Medium HIV Burden Settings",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2915
  },
  {
    "id": "chunk_02916",
    "text": "ble. HIV Risk in Low or Medium HIV Burden Settings Adolescents and women living in low or medium HIV burden settings (where HIV prevalence is less than 5%) may also be at high risk for HIV. Family planning providers can help adolescents and women determine if they are",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2916
  },
  {
    "id": "chunk_02917",
    "text": "n help adolescents and women determine if they are at high risk for HIV by engaging in a discussion about aspects of their life that may make them more vulnerable to HIV. Health care providers should recommend an HIV test to all clients who may be at high risk for HIV in all settings.",
    "page_number": 381,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2917
  },
  {
    "id": "chunk_02918",
    "text": "These discussions to support adolescents and women to determine if they are at high risk for HIV can begin with talking about a range of factors that may indicate they are at risk for HIV, as listed in the box below. When possible, providers should use their country\u2019s national HIV guidelines and",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2918
  },
  {
    "id": "chunk_02919",
    "text": "ld use their country\u2019s national HIV guidelines and tools to help clients determine if they are at high risk for HIV. In these discussions, the provider should use language that is easy to understand, and must avoid being critical or judgmental; adolescents and",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2919
  },
  {
    "id": "chunk_02920",
    "text": "void being critical or judgmental; adolescents and women should be able to freely answer questions and discuss their concerns without fear of repercussions or judgment. Refer to Chapter 26 \u2013 Family Planning Provision for more tips on how to talk about sensitive issues (see",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2920
  },
  {
    "id": "chunk_02921",
    "text": "re tips on how to talk about sensitive issues (see the section on Successful Counseling, p. 398\u2013400). Chapter 22 on STIs includes detailed information to assist with understanding behaviors that increase STI risk (see Who Is at Risk for STIs?, p. 340, and Early Identification of STIs, pp. 343\u2013344).",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2921
  },
  {
    "id": "chunk_02922",
    "text": "0, and Early Identification of STIs, pp. 343\u2013344). Factors that may indicate higher risk for HIV in any setting y Having multiple sexual partners in the last six months y Having sex without a condom with a partner who is living with HIV who is not virally suppressed",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2922
  },
  {
    "id": "chunk_02923",
    "text": "o is living with HIV who is not virally suppressed y Having sex without a condom with a partner whose HIV status is unknown y Having an STI now or in the last year y Having a partner who is at high risk for HIV y Engaging in unprotected sex in exchange for money or goods",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2923
  },
  {
    "id": "chunk_02924",
    "text": "in unprotected sex in exchange for money or goods y Injecting drugs, and sharing needles for injection y Experiencing gender-based violence 360 Family Planning: A Global Handbook for Providers",
    "page_number": 382,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2924
  },
  {
    "id": "chunk_02925",
    "text": "23 361 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF What Family Planning Methods Can Be Used by Adolescents and Women at High Risk for HIV? All forms of contraception can be safely used by adolescents and women",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2925
  },
  {
    "id": "chunk_02926",
    "text": "eption can be safely used by adolescents and women at high risk for HIV, in the absence of any other medical or physiological contraindications, with the exception of spermicides (see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use). Research has demonstrated",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2926
  },
  {
    "id": "chunk_02927",
    "text": "for Contraceptive Use). Research has demonstrated the efficacy and safety of hormonal (either combined or progestin-only) and non-hormonal methods for women at risk for HIV infection, indicating that these methods will not increase the likelihood that a woman will contract",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2927
  },
  {
    "id": "chunk_02928",
    "text": "increase the likelihood that a woman will contract HIV, with the exception of spermicides. Condoms (both male and female) are the only currently available dual protection method for preventing both STIs (including HIV) and unintended pregnancy. Additionally, counseling on the",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2928
  },
  {
    "id": "chunk_02929",
    "text": "ntended pregnancy. Additionally, counseling on the benefits of dual method use \u2013 condoms plus another form of contraception \u2013 helps clients make informed choices regarding the prevention of HIV, other STIs, and pregnancy (see Chapter 22 \u2013 Sexually Transmitted Infections,",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2929
  },
  {
    "id": "chunk_02930",
    "text": "(see Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, section on Choosing a Dual Protection Strategy, pp. 347\u2013348). Providing HIV Testing and Prevention Services Providers can break down barriers to accessing HIV testing and prevention",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2930
  },
  {
    "id": "chunk_02931",
    "text": "n barriers to accessing HIV testing and prevention interventions by offering these services when adolescents and women present for family planning. In high HIV burden settings, and when providing family planning services to those at high risk for HIV, this means providing:",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2931
  },
  {
    "id": "chunk_02932",
    "text": "those at high risk for HIV, this means providing: y Male and female condoms and lubricant y Information about HIV testing, and referral for or provision of HIV testing, if available (see the sections Talking about HIV Testing on p. 364, and HIV Testing Options on p. 365).",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2932
  },
  {
    "id": "chunk_02933",
    "text": "ing on p. 364, and HIV Testing Options on p. 365). y Information about all HIV prevention options and treatment y For women learning they are HIV-positive during the consultation: Post- test counseling, antiretroviral therapy (ART) or referral for immediate treatment, and supported linkage to care",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2933
  },
  {
    "id": "chunk_02934",
    "text": "immediate treatment, and supported linkage to care y For women testing negative during the consultation: HIV risk-reduction counseling, supported linkage to pre-exposure prophylaxis (PrEP) screening and provision (see the section, Preventing HIV Acquisition on pp. 365\u2013366).",
    "page_number": 383,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2934
  },
  {
    "id": "chunk_02935",
    "text": "y Partner testing or couples HIV testing and counseling, for women who are accompanied by their partners, and where both partners consent y Referral for partner testing for women not accompanied by their partners, with the woman\u2019s consent y Condom promotion for male partners.",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2935
  },
  {
    "id": "chunk_02936",
    "text": "an\u2019s consent y Condom promotion for male partners. The table on the next page outlines the distinction between how HIV testing and prevention services are offered to women living in high HIV burden settings versus in low- and medium-burden settings. In high",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2936
  },
  {
    "id": "chunk_02937",
    "text": "versus in low- and medium-burden settings. In high HIV burden settings, testing and prevention services are offered to all adolescents and women presenting for family planning services, whereas in low- and medium-burden settings, these services are not routinely",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2937
  },
  {
    "id": "chunk_02938",
    "text": "-burden settings, these services are not routinely offered and instead providers offer testing for those at high risk for HIV. Who Should Be Offered an HIV Test? HIV testing services should be offered to all family planning clients at",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2938
  },
  {
    "id": "chunk_02939",
    "text": "hould be offered to all family planning clients at high risk for HIV, either because they live in a high HIV burden region or because they are at high risk despite living in a low or medium HIV burden setting (see table on the next page). For these clients, HIV testing should",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2939
  },
  {
    "id": "chunk_02940",
    "text": "next page). For these clients, HIV testing should be routinely offered with all family planning services, because it is a critical first step in obtaining appropriate HIV care and treatment, risk-reduction counseling, and prevention services.",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2940
  },
  {
    "id": "chunk_02941",
    "text": "isk-reduction counseling, and prevention services. y In high HIV burden settings, all adolescents and women should be offered an HIV test (with full information and counseling) when they come for family planning services, or be referred for HIV testing elsewhere if it is not available on site.",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2941
  },
  {
    "id": "chunk_02942",
    "text": "testing elsewhere if it is not available on site. y In low and medium HIV burden settings, all adolescents and women who are at high risk for HIV after discussing their risk factors with a provider (see the box earlier in this chapter) should be offered an HIV",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2942
  },
  {
    "id": "chunk_02943",
    "text": "earlier in this chapter) should be offered an HIV test. This includes sex workers and women who inject drugs. If an HIV test is not available at the family planning center, they should be referred to another location for testing. How Often Should Women Retest for HIV?",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2943
  },
  {
    "id": "chunk_02944",
    "text": "or testing. How Often Should Women Retest for HIV? In all settings, regardless of HIV burden, adolescents and women can test every year if they have any of the risk factors described in the box earlier in this chapter on p. 360. They should also retest if they become",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2944
  },
  {
    "id": "chunk_02945",
    "text": "on p. 360. They should also retest if they become pregnant, as a routine service during antenatal care. For further information, please refer to the Questions and Answers section at the end of this chapter. 362 Family Planning: A Global Handbook for Providers",
    "page_number": 384,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2945
  },
  {
    "id": "chunk_02946",
    "text": "23 363 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF HIV testing and prevention services to be routinely offered to clients presenting for family planning (FP) services, by setting Low and medium HIV High HIV burden settings burden settings (HIV prevalence < 5%) (HIV prevalence \u2265 5%)",
    "page_number": 385,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2946
  },
  {
    "id": "chunk_02947",
    "text": "ttings (HIV prevalence < 5%) (HIV prevalence \u2265 5%) FP clients not FP clients at high risk at high risk HIV service for HIV for HIV All FP clients Male and female condoms Yes Yes Yes and lubricant Discussion to assess HIV risk before offering (or referring for) HIV testing Not mandatory\u2014",
    "page_number": 385,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2947
  },
  {
    "id": "chunk_02948",
    "text": "ring (or referring for) HIV testing Not mandatory\u2014 (see section above on Yes Yes HIV testing should who is at high risk, and be a routine offer the box listing potential risk factors) Offer or refer for HIV testing and provide Not a Yes Yes information about HIV routine offer testing",
    "page_number": 385,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2948
  },
  {
    "id": "chunk_02949",
    "text": "es Yes information about HIV routine offer testing For women testing positive during the FP consultation: post-test counseling, provision of or Yes Yes Yes referral for antiretroviral therapy (ART), and supported linkage to care For women testing negative during the FP consultation: HIV risk-",
    "page_number": 385,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2949
  },
  {
    "id": "chunk_02950",
    "text": "ing negative during the FP consultation: HIV risk- reduction counseling, Not a Yes Yes and supported linkage to routine offer pre-exposure prophylaxis (PrEP) screening and provision Partner testing (or Yes\u2014 Yes\u2014 partner referral) or Not a if both if both",
    "page_number": 385,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2950
  },
  {
    "id": "chunk_02951",
    "text": "s\u2014 Yes\u2014 partner referral) or Not a if both if both couples HIV testing and routine offer partners partners counseling consent consent Condom promotion for Yes Yes Yes male partners Providing HIV Testing and Prevention Services",
    "page_number": 385,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2951
  },
  {
    "id": "chunk_02952",
    "text": "Talking About HIV Testing Providers can help clients understand what it means to have an HIV test and how getting an HIV test and learning their status will benefit them. Clients should be fully informed and receive counseling. The following messages can",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2952
  },
  {
    "id": "chunk_02953",
    "text": "and receive counseling. The following messages can be provided using individual or group information sessions or through other means, such as posters, brochures, or videos. For information on other STIs, please refer to Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV (pp. 339\u2013356).",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2953
  },
  {
    "id": "chunk_02954",
    "text": "ansmitted Infections, Including HIV (pp. 339\u2013356). Key things to know about HIV testing, results, and follow-up before taking an HIV test: y Their testing situation, discussions, and HIV status will be kept confidential and will not be disclosed.",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2954
  },
  {
    "id": "chunk_02955",
    "text": "ll be kept confidential and will not be disclosed. y The HIV test results can be trusted, as long as national testing algorithms have been followed. y A negative test result means the client does not have HIV at that time (does not need any treatment).",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2955
  },
  {
    "id": "chunk_02956",
    "text": "ve HIV at that time (does not need any treatment). \u2013 A client who has tested negative will receive counseling on how to protect themself from HIV, and be screened for (or linked to) HIV prevention services to help them remain HIV-negative (including PrEP",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2956
  },
  {
    "id": "chunk_02957",
    "text": "s to help them remain HIV-negative (including PrEP and/or condom use), especially if they are at high risk for HIV (see Preventing HIV Acquisition, on the next page). y A positive test result means that HIV antibodies have been detected, and the person is living with HIV.",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2957
  },
  {
    "id": "chunk_02958",
    "text": "been detected, and the person is living with HIV. \u2013 Even if she feels well, a client who has tested positive should be provided with full information and referred/linked immediately to HIV services; it is a priority to start effective HIV treatment and to access",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2958
  },
  {
    "id": "chunk_02959",
    "text": "ity to start effective HIV treatment and to access appropriate care and support as soon as possible. y Options for partner testing or referral should be discussed. There are benefits to voluntarily informing male partners about both positive and",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2959
  },
  {
    "id": "chunk_02960",
    "text": "ly informing male partners about both positive and negative HIV test results and encouraging male partners to also get tested. Disclosure to anyone (male partners, husbands, and any family members) must always be voluntary. y HIV treatment (also called antiretroviral therapy or ART) is highly",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2960
  },
  {
    "id": "chunk_02961",
    "text": "so called antiretroviral therapy or ART) is highly effective, well tolerated, and works best when started early. \u2013 HIV treatment enables a person with HIV to stay healthy, and people who take ART consistently and correctly can become virally suppressed,",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2961
  },
  {
    "id": "chunk_02962",
    "text": "ently and correctly can become virally suppressed, at which stage they do not transmit HIV to others. \u2013 HIV treatment may be available in the same health care facility as the family planning clinic, or clients may need to access it via referral to another facility.",
    "page_number": 386,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2962
  },
  {
    "id": "chunk_02963",
    "text": "23 365 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF After providing this information about HIV testing individually or in a group, providers should give clients the opportunity to ask questions and to accept",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2963
  },
  {
    "id": "chunk_02964",
    "text": "nts the opportunity to ask questions and to accept or decline the test individually and in private. It is important that providers give clients the opportunity to ask questions both before and after having an HIV test. Some common questions and responses are included at the end of this chapter.",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2964
  },
  {
    "id": "chunk_02965",
    "text": "responses are included at the end of this chapter. HIV Testing Options Family planning providers should be comfortable discussing HIV risk behaviors and testing, as well as offering and conducting HIV tests, and post-test counselling and referrals, especially in high HIV burden settings. In family",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2965
  },
  {
    "id": "chunk_02966",
    "text": "especially in high HIV burden settings. In family planning settings, the most common HIV tests available will be the rapid HIV tests and HIV self-tests. Family planning providers should counsel on ALL available testing options and allow clients to choose the option they prefer.",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2966
  },
  {
    "id": "chunk_02967",
    "text": "nd allow clients to choose the option they prefer. Rapid HIV tests: Most clients will have a rapid test for HIV that uses a small amount of blood. If the test is negative, then the woman does not have HIV. If the test is positive, then the result must be confirmed with a different",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2967
  },
  {
    "id": "chunk_02968",
    "text": "then the result must be confirmed with a different rapid test. It is important to follow the national HIV testing algorithm which will include multiple tests to diagnose HIV. HIV self-testing (HIVST) kits: Some clients may prefer to test",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2968
  },
  {
    "id": "chunk_02969",
    "text": "ting (HIVST) kits: Some clients may prefer to test themselves using HIVST kits, either at the facility or at home. Some of these use blood and others use saliva. Since there may be false-positive test results with HIVST, all positive test results need to be confirmed at a clinic using",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2969
  },
  {
    "id": "chunk_02970",
    "text": "est results need to be confirmed at a clinic using rapid tests, according to the national HIV testing algorithm. Preventing HIV Acquisition Family planning providers can help adolescents and women who are at risk for HIV stay negative. They can do this by sharing accurate information about",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2970
  },
  {
    "id": "chunk_02971",
    "text": "can do this by sharing accurate information about HIV prevention measures, and by providing condoms, and access to pre- and post-exposure prophylaxis (PrEP and PEP) as needed. Ways for women to prevent HIV acquisition: y Use male or female condoms and lubricant correctly every time you have",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2971
  },
  {
    "id": "chunk_02972",
    "text": "ondoms and lubricant correctly every time you have sex; this will prevent HIV and other STIs. y Avoid unprotected sexual contact with partners who are living with HIV and those who do not know their HIV status; always use condoms and consider taking PrEP. y Encourage partners to test for HIV.",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2972
  },
  {
    "id": "chunk_02973",
    "text": "taking PrEP. y Encourage partners to test for HIV. y Know your partner\u2019s status and encourage them to start HIV treatment if they are HIV-positive. y Take PrEP as prescribed. Providing HIV Testing and Prevention Services",
    "page_number": 387,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2973
  },
  {
    "id": "chunk_02974",
    "text": "y Use sterile needles/syringes if injecting drugs. y Women who have experienced sexual violence or abuse should be offered post-exposure prophylaxis (PEP) and emergency contraceptive pills (ECPs) in a supportive and non-judgmental environment (for details, see",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2974
  },
  {
    "id": "chunk_02975",
    "text": "e and non-judgmental environment (for details, see Chapter 3 \u2013 Emergency Contraceptive Pills). Women who exchange unprotected sex for goods or money, have multiple sex partners, inject drugs, or have sex with men who inject drugs are at",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2975
  },
  {
    "id": "chunk_02976",
    "text": "rugs, or have sex with men who inject drugs are at especially high risk for acquiring HIV. They should also be provided condoms and lubricants, and be offered PrEP or PEP, depending on the situation. It is important to remember that all family planning methods are safe (with",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2976
  },
  {
    "id": "chunk_02977",
    "text": "er that all family planning methods are safe (with the exception of spermicides) and effective for these women and should be initiated as soon as possible, if desired. PrEP, or pre-exposure prophylaxis,1 is a pill that is taken every day",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2977
  },
  {
    "id": "chunk_02978",
    "text": "re prophylaxis,1 is a pill that is taken every day by a person who is HIV-negative to prevent that person from being infected with HIV if or when they are exposed to the virus. PrEP is a combination of HIV drugs, but it is not treatment for HIV. PrEP is safe and can be offered",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2978
  },
  {
    "id": "chunk_02979",
    "text": "treatment for HIV. PrEP is safe and can be offered to adolescents and women living in high HIV burden areas or at high risk for HIV for other reasons. PrEP can safely be used with all types of contraceptive methods, including hormonal methods, and is safe to use when breastfeeding.",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2979
  },
  {
    "id": "chunk_02980",
    "text": "al methods, and is safe to use when breastfeeding. Additional information about PrEP can be found in Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, section on Avoiding STIs (pp. 345\u2013346). PEP, or post-exposure prophylaxis, is an emergency method of",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2980
  },
  {
    "id": "chunk_02981",
    "text": "st-exposure prophylaxis, is an emergency method of preventing HIV infection. A person who is HIV-negative would need to take a 4-week course of antiretroviral drugs (ARVs) starting very soon after \u2013 and never later than 72 hours after \u2013 that person may have been exposed to HIV.",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2981
  },
  {
    "id": "chunk_02982",
    "text": "after \u2013 that person may have been exposed to HIV. It is an emergency measure, rather than a regular method of preventing HIV transmission. It is a valuable preventative treatment for those seeking family planning services after experiencing sexual violence, forced or coerced sex,",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2982
  },
  {
    "id": "chunk_02983",
    "text": "periencing sexual violence, forced or coerced sex, or after having unprotected sex (or condom failure) with someone living with HIV who is not virally suppressed through use of antiretroviral therapy (ART), or with someone whose HIV status is unknown. Like PrEP, PEP can",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2983
  },
  {
    "id": "chunk_02984",
    "text": "ne whose HIV status is unknown. Like PrEP, PEP can safely be taken with all types of contraceptive methods, including hormonal methods, and is safe to use when breastfeeding. 1 Currently there are several new long-acting HIV prevention options (including the dapivirine vaginal ring",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2984
  },
  {
    "id": "chunk_02985",
    "text": "ion options (including the dapivirine vaginal ring and the cabotegravir long-acting injectable) and combination HIV prevention and contraceptive products which have either recently been shown to be effective or are under development. In the future, providing",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2985
  },
  {
    "id": "chunk_02986",
    "text": "or are under development. In the future, providing these options in contraception services could be acceptable for women, and feasible. A program of operational research is planned to understand how these new options could be provided safely to enable the greatest impact.",
    "page_number": 388,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2986
  },
  {
    "id": "chunk_02987",
    "text": "23 367 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF Male Partner HIV Testing and Prevention Messages It is important for all sexually active people to get tested for HIV and to learn the HIV status of their sexual partner(s). As a family planning provider, your",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2987
  },
  {
    "id": "chunk_02988",
    "text": "al partner(s). As a family planning provider, your clients are likely to be mainly or exclusively women. But a woman\u2019s sexual partners can transmit HIV to her, and she can transmit HIV to her sexual partner(s). Partner testing benefits the male partner because he will learn his",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2988
  },
  {
    "id": "chunk_02989",
    "text": "enefits the male partner because he will learn his own HIV status. If he is found to be living with HIV, he can be referred for immediate HIV care and treatment. If he tests negative, he can take measures to remain negative. Referrals for the following services should be routinely offered:",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2989
  },
  {
    "id": "chunk_02990",
    "text": "he following services should be routinely offered: Partner services: If an adolescent girl or a woman tests positive, and she chooses to disclose her status to her partner, the provider can link couples to HIV services and counseling. This must be done confidentially and must",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2990
  },
  {
    "id": "chunk_02991",
    "text": "nseling. This must be done confidentially and must be entirely voluntary. If the client does not wish to disclose her status to her partner, the provider can refer the case to trained HIV testing service personnel to help ensure confidential partner management services, which",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2991
  },
  {
    "id": "chunk_02992",
    "text": "re confidential partner management services, which includes informing her sexual partners that they may have been exposed to HIV and offering them a test without disclosing the woman\u2019s identity. There are benefits to informing male partners about test results and encouraging them to",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2992
  },
  {
    "id": "chunk_02993",
    "text": "artners about test results and encouraging them to get tested; however, this must always be voluntary. HIV self-testing (HIVST): Male partners can also learn their status by using an HIVST kit. Some family planning clinics may provide HIVST kits for women to take to their partners.",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2993
  },
  {
    "id": "chunk_02994",
    "text": "de HIVST kits for women to take to their partners. Couple testing: One way of encouraging male partner testing is by offering couples testing, in which both members of the couple are counseled and tested at the same time, which may make it easier for them to decide to share their",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2994
  },
  {
    "id": "chunk_02995",
    "text": "y make it easier for them to decide to share their results with each other. Both members must agree to learn their own HIV status and also to have their HIV status disclosed to the other member. Other important messages about men and HIV transmission:",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2995
  },
  {
    "id": "chunk_02996",
    "text": "important messages about men and HIV transmission: y If an adolescent boy or a man is HIV-negative, he can stay HIV-negative by using condoms and lubricant consistently and correctly or by taking PrEP. His risk of HIV will be reduced if he has only one sexual partner and, if",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2996
  },
  {
    "id": "chunk_02997",
    "text": "reduced if he has only one sexual partner and, if uncircumcised, he accesses voluntary medical male circumcision (VMMC). y If an adolescent boy or a man is living with HIV and taking ART, he will not transmit HIV to his HIV-negative partner as long as his HIV viral load is",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2997
  },
  {
    "id": "chunk_02998",
    "text": "-negative partner as long as his HIV viral load is suppressed. The same is true if an adolescent girl or a woman is living with HIV and taking ART, and her partner is HIV-negative. y ART does not protect against other STIs. To reduce the risk of other STIs, couples should use condoms with lubricant.",
    "page_number": 389,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2998
  },
  {
    "id": "chunk_02999",
    "text": "Questions and Answers about Family Planning for Adolescents and Women at High Risk for HIV 1. Is it safe for women at high risk for HIV to use hormonal contraceptives? Yes, all family planning methods, including hormonal methods, are considered safe to use for all women regardless of HIV risk, in the",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 2999
  },
  {
    "id": "chunk_03000",
    "text": "o use for all women regardless of HIV risk, in the absence of any other medical or physiological contraindications. The only exception is the spermicide nonoxynol-9, which should not be used by women at high risk for HIV.2 2. What does a reactive (\u201cpositive\u201d) HIV self-test result mean?",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3000
  },
  {
    "id": "chunk_03001",
    "text": "a reactive (\u201cpositive\u201d) HIV self-test result mean? The HIV self-test (HIVST) is for screening only and does not provide a definitive HIV-positive diagnosis. An HIVST shows either reactive (\u201cpositive\u201d) or nonreactive (\u201cnegative\u201d) results. A reactive (\u201cpositive\u201d)",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3001
  },
  {
    "id": "chunk_03002",
    "text": "tive (\u201cnegative\u201d) results. A reactive (\u201cpositive\u201d) HIVST result is not a positive HIV diagnosis. Everyone with a reactive (\u201cpositive\u201d) HIVST result needs additional testing by a trained provider in order to diagnose HIV, starting with the first test in the",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3002
  },
  {
    "id": "chunk_03003",
    "text": "diagnose HIV, starting with the first test in the national testing algorithm. An invalid HIVST result means that the test needs to be repeated with another new HIVST kit. Any person uncertain about their HIVST result should be encouraged to seek testing from a trained provider.",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3003
  },
  {
    "id": "chunk_03004",
    "text": "ncouraged to seek testing from a trained provider. 3. What does a non-reactive (\u201cnegative\u201d) HIV self-test result mean? A non-reactive (\u201cnegative\u201d) HIV self-test (HIVST) result can be considered to be a correct negative result. There is no need for",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3004
  },
  {
    "id": "chunk_03005",
    "text": "be a correct negative result. There is no need for immediate follow-up or further HIV testing (except for those taking pre-exposure prophylaxis [PrEP]). If the client is at high risk of acquiring HIV, they can take measures to remain HIV-negative (such",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3005
  },
  {
    "id": "chunk_03006",
    "text": "hey can take measures to remain HIV-negative (such as HIV risk-reduction counseling, PrEP screening, or taking PrEP). An invalid HIVST result means that the test needs to be repeated with another new HIVST kit. Any person uncertain about their",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3006
  },
  {
    "id": "chunk_03007",
    "text": "er new HIVST kit. Any person uncertain about their 2 Repeated and high-dose use of nonoxynol-9 spermicide has been found to be associated with increased risk of genital lesions, which may increase the risk of acquiring HIV (see Chapter 16 \u2013 Spermicides and",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3007
  },
  {
    "id": "chunk_03008",
    "text": "of acquiring HIV (see Chapter 16 \u2013 Spermicides and Diaphragms, Question 3, p. 286). For this reason, the MEC category for spermicides and diaphragms is Category 4 (i.e. \u201cMethod not to be used\u201d) for women who are at high risk of acquiring HIV",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3008
  },
  {
    "id": "chunk_03009",
    "text": "\u201d) for women who are at high risk of acquiring HIV (see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use). 368 Family Planning: A Global Handbook for Providers",
    "page_number": 390,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3009
  },
  {
    "id": "chunk_03010",
    "text": "23 369 VIH rof ksiR hgiH ta nemoW dna stnecselodA rof gninnalP ylimaF HIVST result should be encouraged to seek testing from a trained provider. 4. Why are HIV self-tests useful? Despite not giving a definitive positive diagnosis, HIV self-testing (HIVST)",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3010
  },
  {
    "id": "chunk_03011",
    "text": "itive positive diagnosis, HIV self-testing (HIVST) is an important screening tool and a good option for many people as it provides a convenient and confidential method of HIV testing. HIVST is an effective way to reach people who may not otherwise get tested for",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3011
  },
  {
    "id": "chunk_03012",
    "text": "reach people who may not otherwise get tested for HIV, including adolescents and key populations.3 5. Is it safe to become pregnant on PrEP? Yes. PrEP is a safe and effective way to prevent HIV when trying to conceive. Many HIV serodiscordant couples (where one partner is",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3012
  },
  {
    "id": "chunk_03013",
    "text": "y HIV serodiscordant couples (where one partner is HIV-positive and virally suppressed on antiretroviral therapy, and the other is HIV-negative) desire pregnancy, and use of PrEP can be considered as a strategy for safer conception. Thus, women at high",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3013
  },
  {
    "id": "chunk_03014",
    "text": "strategy for safer conception. Thus, women at high risk of HIV acquisition who are trying to conceive should be offered PrEP for as long as needed, in order to prevent HIV infection. PrEP does not prevent pregnancy or other STIs. (See Chapter 22 \u2013 Sexually",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3014
  },
  {
    "id": "chunk_03015",
    "text": "regnancy or other STIs. (See Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, section on Safer Conception for HIV Serodiscordant Couples, p. 347). 6. Is it safe to take PrEP when pregnant or breastfeeding? Yes. Taking PrEP is safe for women who are pregnant or breastfeeding.",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3015
  },
  {
    "id": "chunk_03016",
    "text": "safe for women who are pregnant or breastfeeding. PrEP is a combination of antiretroviral drugs that may be taken by pregnant and breastfeeding women without any problems for the woman or her baby. In sub-Saharan Africa, HIV infection can occur at high rates during",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3016
  },
  {
    "id": "chunk_03017",
    "text": "rica, HIV infection can occur at high rates during pregnancy, and the risk of passing HIV on to a baby is higher if the mother contracts HIV while she is pregnant. PrEP is a safe and important option for preventing HIV among pregnant women and their babies. 7. How long can a woman take PrEP?",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3017
  },
  {
    "id": "chunk_03018",
    "text": "d their babies. 7. How long can a woman take PrEP? Adolescents and women can safely take PrEP for as long as they are at risk for HIV. They should be tested for HIV every 3 months to make sure they are still HIV-negative while taking PrEP. If a person tests HIV-positive",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3018
  },
  {
    "id": "chunk_03019",
    "text": "while taking PrEP. If a person tests HIV-positive while taking PrEP, they should be referred to antiretroviral therapy (ART) services immediately. 3 Key populations are \u201cdefined groups who, due to specific higher-risk behaviours, are at increased risk of",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3019
  },
  {
    "id": "chunk_03020",
    "text": "c higher-risk behaviours, are at increased risk of HIV irrespective of the epidemic type or local context\u201d. For a more complete definition, see: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations \u2013 2016 update. Geneva:",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3020
  },
  {
    "id": "chunk_03021",
    "text": "nd care for key populations \u2013 2016 update. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/handle/10665/246200). Questions and Answers about Family Planning for Women at High Risk for HIV",
    "page_number": 391,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3021
  },
  {
    "id": "chunk_03022",
    "text": "8. Does PrEP reduce the effectiveness of hormonal contraceptives? No. PrEP does not affect the effectiveness of hormonal contraceptives, and hormonal contraceptives do not affect the effectiveness of PrEP. This is because the medicines in PrEP do not change levels of hormonal",
    "page_number": 392,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3022
  },
  {
    "id": "chunk_03023",
    "text": "medicines in PrEP do not change levels of hormonal contraceptives in the body. PrEP is safe to take with any method of contraception, and any method of contraception is safe to use with PrEP. 9. What does it mean to be in the \u201cwindow period\u201d?",
    "page_number": 392,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3023
  },
  {
    "id": "chunk_03024",
    "text": "9. What does it mean to be in the \u201cwindow period\u201d? The \u201cwindow period\u201d is a short period of time (usually less than 3 weeks) when a person has contracted HIV but has not yet developed an immune response (anti-HIV antibodies) to the virus. Since HIV tests detect anti-",
    "page_number": 392,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3024
  },
  {
    "id": "chunk_03025",
    "text": "bodies) to the virus. Since HIV tests detect anti- HIV antibodies, a standard HIV testing algorithm could indicate that a woman is negative during the \u201cwindow period\u201d when she is actually HIV- positive (she does have HIV in her body). If a woman has had a recent",
    "page_number": 392,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3025
  },
  {
    "id": "chunk_03026",
    "text": "have HIV in her body). If a woman has had a recent HIV exposure and she tests negative for HIV, she should get another test in 2 weeks to confirm her HIV status. 370 Family Planning: A Global Handbook for Providers",
    "page_number": 392,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3026
  },
  {
    "id": "chunk_03027",
    "text": "24 371 htlaeH nrobweN dna lanretaM CHAPTER 24 Maternal and Newborn Health Key Points for Providers and Clients y Wait until the youngest child is at least 2 years old before trying to become pregnant again. Spacing births is good for the mother\u2019s and the baby\u2019s health.",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3027
  },
  {
    "id": "chunk_03028",
    "text": "hs is good for the mother\u2019s and the baby\u2019s health. y Make the first antenatal care contact within the first 12 weeks of pregnancy and schedule at least 8 contacts during the pregnancy. y Plan ahead for family planning after delivery. y Prepare for childbirth. Have a plan for normal delivery and an",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3028
  },
  {
    "id": "chunk_03029",
    "text": "childbirth. Have a plan for normal delivery and an emergency plan, too. y Breastfeed for a healthier baby. Health care providers see many women who want to become pregnant, who are pregnant, or who have recently given birth. They also see",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3029
  },
  {
    "id": "chunk_03030",
    "text": "t, or who have recently given birth. They also see adolescent girls who are pregnant. Providers can help women plan pregnancies, plan for contraception after delivery, prepare for childbirth, and care for their babies. Attentive care can help women see pregnancy as a positive experience.",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3030
  },
  {
    "id": "chunk_03031",
    "text": "help women see pregnancy as a positive experience. Planning Pregnancy A woman who wants to have a child can use advice about preparing for safe pregnancy and delivery and having a healthy child: y It is best to wait at least 2 years after giving birth before stopping",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3031
  },
  {
    "id": "chunk_03032",
    "text": "t least 2 years after giving birth before stopping contraception to become pregnant again. y At least 3 months before stopping contraception to get pregnant, a woman should begin to eat a healthy, balanced diet, and she should continue doing so throughout pregnancy. A healthy diet includes adequate",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3032
  },
  {
    "id": "chunk_03033",
    "text": "ughout pregnancy. A healthy diet includes adequate energy, protein, vitamins, and minerals from green and orange vegetables, meat, fish, beans, nuts, whole grains, and fruit. Folic acid and iron are particularly important.",
    "page_number": 393,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3033
  },
  {
    "id": "chunk_03034",
    "text": "\u2013 Folic acid is found in such foods as legumes (beans, bean curd, lentils, and peas), citrus fruits, whole grains, and green leafy vegetables. Folic acid tablets are recommended. \u2013 Iron is found in such foods as meat and poultry, fish, green leafy",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3034
  },
  {
    "id": "chunk_03035",
    "text": "such foods as meat and poultry, fish, green leafy vegetables, and legumes. Iron tablets are recommended. y If a woman has a sexually transmitted infection (STI) or may have been exposed to an STI, including HIV, treatment can reduce the chances that her child will be born with the",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3035
  },
  {
    "id": "chunk_03036",
    "text": "e the chances that her child will be born with the infection. If a woman thinks she has been exposed or might be infected, she should seek testing, if available (see also Safer Conception for HIV Serodiscordant Couples, p. 347). During Pregnancy",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3036
  },
  {
    "id": "chunk_03037",
    "text": "Serodiscordant Couples, p. 347). During Pregnancy The first antenatal care contact should come early in pregnancy, ideally before week 12. For most women, 8 contacts with a health care provider during pregnancy are appropriate. Women with certain health conditions or",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3037
  },
  {
    "id": "chunk_03038",
    "text": "propriate. Women with certain health conditions or complications of pregnancy may need more contacts. Health Promotion and Disease Prevention y Counsel women about good nutrition. Pregnant women should eat foods that contain iron, folate, vitamin A, calcium, and iodine. They should",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3038
  },
  {
    "id": "chunk_03039",
    "text": "olate, vitamin A, calcium, and iodine. They should avoid using tobacco and breathing second-hand smoke, drinking alcohol, and taking drugs (except medications recommended by a health care provider). Pregnant women should take daily oral iron and folic acid supplements if available.",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3039
  },
  {
    "id": "chunk_03040",
    "text": "oral iron and folic acid supplements if available. y Encourage women to stay active. Physical activity is healthy for a pregnant woman and helps her avoid gaining too much weight. y If a woman has had hyperglycemia (high blood sugar) first diagnosed",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3040
  },
  {
    "id": "chunk_03041",
    "text": "d hyperglycemia (high blood sugar) first diagnosed during a pregnancy, it should be classified as either gestational diabetes mellitus, which will resolve for most women after pregnancy, or diabetes mellitus in pregnancy, which will require continuing treatment after",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3041
  },
  {
    "id": "chunk_03042",
    "text": "ncy, which will require continuing treatment after pregnancy. High blood sugar increases the chances of adverse outcomes of pregnancy. y Assess gestational age with an ultrasound scan, if available, before 24 weeks\u2019 gestation. y Help pregnant women protect themselves from infections and to get",
    "page_number": 394,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3042
  },
  {
    "id": "chunk_03043",
    "text": "24 373 htlaeH nrobweN dna lanretaM \u2013 If she is at risk for STIs, discuss condom use or abstinence during pregnancy (see Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV). \u2013 Ensure that pregnant women are immunized against tetanus.",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3043
  },
  {
    "id": "chunk_03044",
    "text": "that pregnant women are immunized against tetanus. \u2013 To prevent or treat anemia where hookworm infection is common, provide treatment (antihelminthic therapy) after the first trimester. \u2013 Screen pregnant women for bacteriuria (bacteria in the urine)according",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3044
  },
  {
    "id": "chunk_03045",
    "text": "n for bacteriuria (bacteria in the urine)according to program guidelines. Cases with symptoms and cases without symptoms should be treated with antibiotics. Bacteriuria without symptoms increases the chances of preterm birth and low birth weight.",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3045
  },
  {
    "id": "chunk_03046",
    "text": "the chances of preterm birth and low birth weight. y Help pregnant women protect their babies from infections. \u2013 Test for syphilis as early in pregnancy as possible, and treat as needed. \u2013 Offer HIV testing and counseling. \u2013 Pregnant women are particularly likely to get malaria. Provide",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3046
  },
  {
    "id": "chunk_03047",
    "text": "en are particularly likely to get malaria. Provide insecticide-treated bed nets for malaria prevention and effective malaria treatment to every pregnant woman in areas where malaria is widespread, whether or not malaria is diagnosed (presumptive",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3047
  },
  {
    "id": "chunk_03048",
    "text": ", whether or not malaria is diagnosed (presumptive treatment). Monitor pregnant women for malaria and provide immediate treatment if diagnosed. y For common symptoms during pregnancy, these treatments may help: \u2013 Nausea in early pregnancy: ginger, chamomile, vitamin B6, acupuncture",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3048
  },
  {
    "id": "chunk_03049",
    "text": "gnancy: ginger, chamomile, vitamin B6, acupuncture \u2013 Heartburn: avoid large, fatty meals and alcohol; stop smoking; take antacids (at least 2 hours before or after taking iron and folic acid supplements) \u2013 Leg cramps: magnesium, calcium",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3049
  },
  {
    "id": "chunk_03050",
    "text": "acid supplements) \u2013 Leg cramps: magnesium, calcium \u2013 Low back pain and pelvic pain: regular exercise, physiotherapy, support belts, acupuncture \u2013 Constipation: wheat bran or other fiber supplements \u2013 Varicose veins and edema: compression stockings, leg elevation, soaking in water",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3050
  },
  {
    "id": "chunk_03051",
    "text": "ression stockings, leg elevation, soaking in water y To improve continuity and quality of care, each pregnant woman should be given her clinic case notes or records about her pregnancy and asked to take them to any health facility that she visits. During Pregnancy",
    "page_number": 395,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3051
  },
  {
    "id": "chunk_03052",
    "text": "Planning for Family Planning After Delivery Help pregnant women and new mothers decide how they will avoid pregnancy after childbirth. Ideally, family planning counseling should start during antenatal care. y Waiting until her baby is at least 2 years old before a woman tries to",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3052
  },
  {
    "id": "chunk_03053",
    "text": "by is at least 2 years old before a woman tries to become pregnant again is best for the baby and good for the mother, too. y A woman who is not fully or nearly fully breastfeeding is able to become pregnant as soon as 4 to 6 weeks after childbirth.",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3053
  },
  {
    "id": "chunk_03054",
    "text": "pregnant as soon as 4 to 6 weeks after childbirth. y A woman who is fully or nearly fully breastfeeding is able to become pregnant as soon as 6 months postpartum (see Chapter 20 \u2013 Lactational Amenorrhea Method). y For maximum protection, a woman should not wait until the return of",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3054
  },
  {
    "id": "chunk_03055",
    "text": "ction, a woman should not wait until the return of monthly bleeding to start a contraceptive method. Instead, she should start as soon as guidance allows (see Earliest Time That a Woman Can Start a Family Planning Method After Childbirth, p. 377). Preparing for Childbirth and Complications",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3055
  },
  {
    "id": "chunk_03056",
    "text": ". 377). Preparing for Childbirth and Complications Potentially life-threatening complications develop in about 15% of pregnancies, and all of these women need immediate care. Over 70% of maternal deaths are due to complications of pregnancy and childbirth, such as hemorrhage,",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3056
  },
  {
    "id": "chunk_03057",
    "text": "s of pregnancy and childbirth, such as hemorrhage, hypertension, infection, and abortion. Most complications cannot be predicted, but providers can help women and their families be prepared for them in case they happen. y Help women arrange for skilled attendance at birth, and ensure that they",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3057
  },
  {
    "id": "chunk_03058",
    "text": "skilled attendance at birth, and ensure that they know how to contact the skilled birth attendant at the first signs of labor. y Explain danger signs during pregnancy and childbirth to women and their families (see next page). y Help the woman and her family plan how she will reach emergency care if",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3058
  },
  {
    "id": "chunk_03059",
    "text": "r family plan how she will reach emergency care if complications arise: Where will she go? Who will take her there? What transport will they use? How will she pay for medical help? Are there people ready to donate blood? Health facilities caring for pregnant women should have providers who are",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3059
  },
  {
    "id": "chunk_03060",
    "text": "g for pregnant women should have providers who are trained to: y Monitor labor y Care for the newborn at birth and during the first week 374 Family Planning: A Global Handbook for Providers",
    "page_number": 396,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3060
  },
  {
    "id": "chunk_03061",
    "text": "24 375 htlaeH nrobweN dna lanretaM y Manage pre-eclampsia and eclampsia and their complications y Manage difficult labor y Manage postpartum hemorrhage, the leading cause of preventable maternal mortality y Perform newborn resuscitation y Manage preterm labor and care for preterm and small babies",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3061
  },
  {
    "id": "chunk_03062",
    "text": "reterm labor and care for preterm and small babies y Manage maternal and newborn infections y Communicate effectively. Providers need to be supportive, respectful, and sensitive to the needs of the pregnant woman and her family. Women",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3062
  },
  {
    "id": "chunk_03063",
    "text": "needs of the pregnant woman and her family. Women should feel involved and informed so that they can make informed choices about their care. Facilities must have a referral system in place for complications that need to be handled at a higher-level facility.",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3063
  },
  {
    "id": "chunk_03064",
    "text": "hat need to be handled at a higher-level facility. Danger Signs During Pregnancy and Childbirth If any of these signs appears, the family should follow their emergency plan and get the woman to emergency care immediately. y Fever (38\u00b0C/101\u00b0F or higher) y High blood pressure",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3064
  },
  {
    "id": "chunk_03065",
    "text": "Fever (38\u00b0C/101\u00b0F or higher) y High blood pressure y Foul-smelling discharge from vagina y Vaginal bleeding y Severe headache/blurred vision y Difficulty breathing y Decreased or no fetal movements y Convulsions, fainting y Green or brown fluid leaking from vagina y Severe abdominal pain",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3065
  },
  {
    "id": "chunk_03066",
    "text": "fluid leaking from vagina y Severe abdominal pain After Childbirth y Mothers and newborns should receive routine postnatal care. Four routine postpartum contacts are recommended: 1. In the facility for the first 24 hours or at home within the first 24 hours 2. On day 3 3. In days 7 through 14",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3066
  },
  {
    "id": "chunk_03067",
    "text": "first 24 hours 2. On day 3 3. In days 7 through 14 4. At 6 weeks y Coordinate family planning visits with an infant\u2019s immunization schedule. y Optimal breastfeeding offers triple value: important improvements in child survival and health, better health for mothers, and temporary contraception",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3067
  },
  {
    "id": "chunk_03068",
    "text": "er health for mothers, and temporary contraception (see Lactational Amenorrhea Method, p. 319). Still, any breastfeeding is better than none (except if a woman has HIV; see Preventing Mother-to- Child Transmission of HIV, p. 378). After Childbirth",
    "page_number": 397,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3068
  },
  {
    "id": "chunk_03069",
    "text": "Guidelines for Best Breastfeeding 1. Begin breastfeeding the newborn as soon as possible\u2014 within 1 hour after delivery y This stimulates uterine contractions that may help prevent heavy bleeding. y It helps the infant to establish suckling early, which stimulates milk production.",
    "page_number": 398,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3069
  },
  {
    "id": "chunk_03070",
    "text": "suckling early, which stimulates milk production. y Colostrum, the yellowish milk produced in the first days after childbirth, provides important nutrients for the child and transfers immunities from mother to child. 2. Fully or nearly fully breastfeed for 6 months",
    "page_number": 398,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3070
  },
  {
    "id": "chunk_03071",
    "text": ". 2. Fully or nearly fully breastfeed for 6 months y Mother\u2019s milk alone can fully nourish a baby for the first 6 months of life. y Avoids the risks of feeding the baby contaminated liquids or foods. y Full breastfeeding provides contraceptive benefits for the first",
    "page_number": 398,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3071
  },
  {
    "id": "chunk_03072",
    "text": "ding provides contraceptive benefits for the first 6 months as long as monthly bleeding has not returned (see Chapter 20 \u2013 Lactational Amenorrhea Method). 3. At 6 months, add other foods to breastfeeding y After 6 months babies need a variety of foods in addition to breast milk.",
    "page_number": 398,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3072
  },
  {
    "id": "chunk_03073",
    "text": "eed a variety of foods in addition to breast milk. y At each feeding breastfeed before giving other foods. y Breastfeeding can and should continue through the child\u2019s second year or longer. 376 Family Planning: A Global Handbook for Providers",
    "page_number": 398,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3073
  },
  {
    "id": "chunk_03074",
    "text": "24 377 htlaeH nrobweN dna lanretaM Earliest Time That a Woman Can Start a Family Planning Method After Childbirth Fully or Partially Family Planning Nearly Fully Breastfeeding or Method Breastfeeding Not Breastfeeding Lactational Immediately (Not applicable) Amenorrhea Method",
    "page_number": 399,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3074
  },
  {
    "id": "chunk_03075",
    "text": "nal Immediately (Not applicable) Amenorrhea Method Vasectomy Immediately or during partner\u2019s pregnancy\u2021 Male or female Immediately condoms Spermicides Progestin-only pills Immediately Implants Copper-bearing IUD Within 48 hours. Otherwise wait 4 weeks. Levonorgestrel IUD",
    "page_number": 399,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3075
  },
  {
    "id": "chunk_03076",
    "text": "hours. Otherwise wait 4 weeks. Levonorgestrel IUD Female sterilization Within 7 days. Otherwise wait 6 weeks. Progesterone- 4\u20139 weeks If breastfeeding at least releasing vaginal ring postpartum 4 times a day, start at 4\u20139 weeks postpartum Not breastfeeding: Does not apply",
    "page_number": 399,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3076
  },
  {
    "id": "chunk_03077",
    "text": "weeks postpartum Not breastfeeding: Does not apply Diaphragm Can be fitted 6 weeks after childbirth Fertility awareness Start when normal secretions have returned methods (for symptoms-based methods) or she has had 3 regular menstrual cycles (for calendar-based",
    "page_number": 399,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3077
  },
  {
    "id": "chunk_03078",
    "text": "had 3 regular menstrual cycles (for calendar-based methods). This will be later for breastfeeding women than for women who are not breastfeeding. (Continued on next page) \u2021 If a man has a vasectomy during the first 6 months of his partner\u2019s pregnancy, it will be",
    "page_number": 399,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3078
  },
  {
    "id": "chunk_03079",
    "text": "Fully or Partially Family Planning Nearly Fully Breastfeeding or Method Breastfeeding Not Breastfeeding Progestin-only 6 weeks after Immediately if not injectables childbirth\u00a7 breastfeeding\u00a7 6 weeks after childbirth if partially breastfeeding\u00a7 Combined oral 6 months after 21 days after childbirth if",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3079
  },
  {
    "id": "chunk_03080",
    "text": "ed oral 6 months after 21 days after childbirth if contraceptives childbirth\u00a7 not breastfeeding\u00a7 Monthly injectables 6 weeks after childbirth if Combined patch partially breastfeeding\u00a7 Combined vaginal ring \u00a7 Earlier use is not usually recommended unless other, more appropriate methods are not",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3080
  },
  {
    "id": "chunk_03081",
    "text": "ded unless other, more appropriate methods are not available or not acceptable. Preventing Mother-to-Child Transmission of HIV A woman living with HIV can pass HIV to her child during pregnancy, delivery, or breastfeeding. Treatment can greatly reduce the chances of this.",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3081
  },
  {
    "id": "chunk_03082",
    "text": "Treatment can greatly reduce the chances of this. Lifelong antiretroviral therapy (ART) is recommended for all adults and children from the time their HIV-positive status is known. A woman who started ART before pregnancy or when tested during pregnancy greatly",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3082
  },
  {
    "id": "chunk_03083",
    "text": "pregnancy or when tested during pregnancy greatly reduces the chances that her baby will be infected in the uterus or during delivery. ART for the mother also greatly reduces the chances of passing HIV to her infant through breast milk. Also, the newborns of mothers living with HIV should receive 2",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3083
  },
  {
    "id": "chunk_03084",
    "text": "wborns of mothers living with HIV should receive 2 antiretroviral drugs (ARVs) for the first 6 weeks of life. This further reduces the chances of HIV passing from mother to child in the period around birth. How can family planning providers help prevent mother-to-child transmission of HIV?",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3084
  },
  {
    "id": "chunk_03085",
    "text": "help prevent mother-to-child transmission of HIV? y Help women\u2014and men\u2014avoid HIV infection (see Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, Avoiding STIs, p. 345). Women and men at high risk of HIV infection can take PrEP, pre- exposure prophylaxis, a daily oral treatment with ARVs.",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3085
  },
  {
    "id": "chunk_03086",
    "text": "ure prophylaxis, a daily oral treatment with ARVs. y Prevent unintended pregnancies: Help women who do not want a child to choose a contraceptive method that they can use effectively. 378 Family Planning: A Global Handbook for Providers",
    "page_number": 400,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3086
  },
  {
    "id": "chunk_03087",
    "text": "24 379 htlaeH nrobweN dna lanretaM y Offer HIV counseling and testing: In all settings offer counseling and testing in family planning facilities to all pregnant women and to the partners of women with HIV. Where HIV is common, offer testing",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3087
  },
  {
    "id": "chunk_03088",
    "text": "women with HIV. Where HIV is common, offer testing to all women. Testing in family planning facilities can be helpful because a woman\u2019s HIV status might affect her choice of a family planning method. If testing in family planning facilities is not possible,",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3088
  },
  {
    "id": "chunk_03089",
    "text": "ing in family planning facilities is not possible, refer clients to an HIV testing service or offer self-testing so that they can learn their HIV status. y Refer for prevention of HIV transmission: Refer women with HIV who are pregnant, or who want to become pregnant, to services for",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3089
  },
  {
    "id": "chunk_03090",
    "text": "t, or who want to become pregnant, to services for prevention of mother-to-child transmission, if available. If a couple wants to have a child, and one partner has HIV while the other does not, they can take steps to reduce the chances of passing HIV",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3090
  },
  {
    "id": "chunk_03091",
    "text": "an take steps to reduce the chances of passing HIV while trying for conception (see Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, Safer Conception for HIV Serodiscordant Couples, p. 347). y Promote and support appropriate infant feeding: In each country",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3091
  },
  {
    "id": "chunk_03092",
    "text": "upport appropriate infant feeding: In each country national authorities decide which of 2 infant feeding practices should be promoted to pregnant women and mothers living with HIV and that all health facilities should support. The 2 practices are either",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3092
  },
  {
    "id": "chunk_03093",
    "text": "ilities should support. The 2 practices are either (1) breastfeeding while mothers receive ART or (2) avoiding all breastfeeding (while mothers still receive ART). Countries decide which practice will lead to more children surviving free of HIV, depending on conditions in the country.",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3093
  },
  {
    "id": "chunk_03094",
    "text": "ee of HIV, depending on conditions in the country. Where national authorities have decided to promote and support breastfeeding and ART for mothers with HIV: \u2013 Counsel all women, including women with HIV, that breastfeeding, and especially early and exclusive breastfeeding, is the best way to",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3094
  },
  {
    "id": "chunk_03095",
    "text": "ly and exclusive breastfeeding, is the best way to promote the child\u2019s survival. \u2013 Mothers living with HIV and their infants should receive appropriate ART, and mothers should exclusively breastfeed their infants for the first 6 months of life, then introduce appropriate",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3095
  },
  {
    "id": "chunk_03096",
    "text": "first 6 months of life, then introduce appropriate complementary foods and continue breastfeeding. All children need complementary foods from 6 months of age. \u2013 Mothers living with HIV should breastfeed for at least 12 months and may continue breastfeeding for up to 24 months or more (like",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3096
  },
  {
    "id": "chunk_03097",
    "text": "ue breastfeeding for up to 24 months or more (like other women) while being fully supported to keep taking ART. \u2013 Breastfeeding should stop only when a nutritionally adequate and safe diet without breast milk can be provided. (Continued on next page) After Childbirth",
    "page_number": 401,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3097
  },
  {
    "id": "chunk_03098",
    "text": "Preventing Mother-to-Child Transmission of HIV (continued) \u2013 When mothers decide to stop breastfeeding, they should stop gradually within one month, and infants should be given safe and adequate replacement feeds to enable normal growth and development. Stopping breastfeeding abruptly is not advised.",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3098
  },
  {
    "id": "chunk_03099",
    "text": "t. Stopping breastfeeding abruptly is not advised. \u2013 Even when ART is not available, breastfeeding (exclusive breastfeeding in the first 6 months of life and continued breastfeeding for the first 12 months of life) may still give infants born to mothers living with HIV a greater chance of survival",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3099
  },
  {
    "id": "chunk_03100",
    "text": "thers living with HIV a greater chance of survival while avoiding HIV infection than not breastfeeding at all. \u2013 If a woman is temporarily unable to breastfeed\u2014for example, she or the infant is sick, she is weaning, or her supply of ARVs has run",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3100
  },
  {
    "id": "chunk_03101",
    "text": "ick, she is weaning, or her supply of ARVs has run out\u2014she may express and heat-treat breast milk to destroy the HIV before feeding it to the infant. Milk should be heated to the boiling point in a small pot and then cooled by letting the milk stand or by",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3101
  },
  {
    "id": "chunk_03102",
    "text": "ot and then cooled by letting the milk stand or by placing the pot in a container of cool water. This approach should be used only short-term, not throughout breastfeeding. \u2013 Women with HIV who are breastfeeding need support to maintain their own nutritional status and keep their breasts",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3102
  },
  {
    "id": "chunk_03103",
    "text": "heir own nutritional status and keep their breasts healthy. Infection of the milk ducts in the breast (mastitis), a pocket of pus under the skin (breast abscess), and cracked nipples increase the risk of HIV transmission. If a problem does occur,",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3103
  },
  {
    "id": "chunk_03104",
    "text": "risk of HIV transmission. If a problem does occur, prompt and appropriate care is important (see \u201cSore or cracked nipples\u201d, p. 382). Where national authorities have decided to recommend that mothers living with HIV should avoid all breastfeeding even where ART is provided:",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3104
  },
  {
    "id": "chunk_03105",
    "text": "void all breastfeeding even where ART is provided: y Mothers living with HIV should receive skilled counseling to ensure that they provide a replacement food that is safe and adequate and is safely prepared, stored, and given to their infant.",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3105
  },
  {
    "id": "chunk_03106",
    "text": "afely prepared, stored, and given to their infant. \u2013 For infants less than 6 months of age, the recommended alternative to breastfeeding is commercial infant formula, as long as home conditions outlined below are met. Home-modified animal milk is not",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3106
  },
  {
    "id": "chunk_03107",
    "text": "ed below are met. Home-modified animal milk is not recommended as a replacement food in the first 6 months of life. \u2013 For infants more than 6 months of age, alternatives to breastfeeding include: \u25a1 Commercial infant formula milk, as long as home conditions outlined on the next page are met",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3107
  },
  {
    "id": "chunk_03108",
    "text": "home conditions outlined on the next page are met \u25a1 Animal milk (boiled for infants under 12 months), as part of a diet providing adequate micronutrients. Children should be fed meals, including milk-only feeds, other foods, and combination of milk feeds and other foods, 4 or 5 times per day.",
    "page_number": 402,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3108
  },
  {
    "id": "chunk_03109",
    "text": "24 381 htlaeH nrobweN dna lanretaM y All children need complementary foods from 6 months of age. y Mothers living with HIV should consider replacement feeding only if all the following conditions are met: \u2013 safe water and sanitation are ensured in the household and community; and",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3109
  },
  {
    "id": "chunk_03110",
    "text": "on are ensured in the household and community; and \u2013 the mother or caregiver can reliably provide sufficient infant formula to support the infant\u2019s normal growth and development; and \u2013 the mother or caregiver can prepare it cleanly and frequently",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3110
  },
  {
    "id": "chunk_03111",
    "text": "or caregiver can prepare it cleanly and frequently enough so that it is safe enough and carries a low risk of diarrhea and malnutrition; and \u2013 the mother or caregiver can give the replacement feeding exclusively in the first 6 months; and \u2013 the family supports this practice; and",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3111
  },
  {
    "id": "chunk_03112",
    "text": "nths; and \u2013 the family supports this practice; and \u2013 the mother or caregiver can obtain comprehensive child health services. y If infants and young children are known to be living with HIV, mothers should be strongly encouraged to exclusively breastfeed for the first",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3112
  },
  {
    "id": "chunk_03113",
    "text": "encouraged to exclusively breastfeed for the first 6 months of life and continue breastfeeding up to 2 years or beyond. Managing Any Breastfeeding Problems If a client reports any of these common problems, listen to her concerns and",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3113
  },
  {
    "id": "chunk_03114",
    "text": "these common problems, listen to her concerns and give advice and support. Make sure she understands the advice and agrees. Baby is not getting enough milk y Reassure the woman that most women can produce enough breast milk to feed their babies.",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3114
  },
  {
    "id": "chunk_03115",
    "text": "n produce enough breast milk to feed their babies. y If the newborn is gaining more than 500 grams a month, weighs more than birth weight at 2 weeks, or urinates at least 6 times a day, reassure her that her baby is getting enough breast milk.",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3115
  },
  {
    "id": "chunk_03116",
    "text": "e her that her baby is getting enough breast milk. y Tell her to breastfeed her newborn about every 2 hours to increase milk supply. y Recommend that she reduce any supplemental foods and/or liquids if the baby is less than 6 months of age. Sore breasts",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3116
  },
  {
    "id": "chunk_03117",
    "text": "he baby is less than 6 months of age. Sore breasts y If her breasts are full, tight, and painful, then she may have engorged breasts. If one breast has tender lumps, then she may have blocked ducts. Engorged breasts or blocked ducts may progress to red and tender After Childbirth",
    "page_number": 403,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3117
  },
  {
    "id": "chunk_03118",
    "text": "infected breasts. Treat breast infection with antibiotics according to clinic guidelines. To aid healing, advise her to: \u2013 Continue to breastfeed often \u2013 Massage her breasts before and during breastfeeding \u2013 Apply heat or a warm compress to breasts \u2013 Try different breastfeeding positions",
    "page_number": 404,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3118
  },
  {
    "id": "chunk_03119",
    "text": "to breasts \u2013 Try different breastfeeding positions \u2013 Ensure that the infant attaches properly to the breast \u2013 Express some milk before breastfeeding Sore or cracked nipples y If her nipples are cracked, she can continue breastfeeding. Assure her that they will heal with time.",
    "page_number": 404,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3119
  },
  {
    "id": "chunk_03120",
    "text": "feeding. Assure her that they will heal with time. y To aid healing, advise her to: \u2013 Apply drops of breast milk to the nipples after breastfeeding and allow to air-dry. \u2013 After feeding, use a finger to break suction first before removing the baby from the breast.",
    "page_number": 404,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3120
  },
  {
    "id": "chunk_03121",
    "text": "on first before removing the baby from the breast. \u2013 Do not wait until the breast is full to breastfeed. If full, express some milk first. y Teach her about proper attachment and how to check for signs that the baby is not attaching properly.",
    "page_number": 404,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3121
  },
  {
    "id": "chunk_03122",
    "text": "for signs that the baby is not attaching properly. y Tell her to clean her nipples with only water only once a day and to avoid soaps and alcohol-based solutions. y Examine her nipples and the baby\u2019s mouth and buttocks for signs of fungal infection (thrush).",
    "page_number": 404,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3122
  },
  {
    "id": "chunk_03123",
    "text": "25 383 seussI htlaeH evitcudorpeR CHAPTER 25 Reproductive Health Issues Key Points for Clients and Providers Postabortion Care \u2022 Fertility returns quickly, as early as 8\u201310 days and usually within 1 month after spontaneous or induced abortion. Women and couples need to start using a",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3123
  },
  {
    "id": "chunk_03124",
    "text": "abortion. Women and couples need to start using a family planning method almost immediately to avoid unplanned pregnancy. \u2022 Information provision and counseling (where desired to support decision-making) regarding the return of ovulation within 2 weeks,",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3124
  },
  {
    "id": "chunk_03125",
    "text": "regarding the return of ovulation within 2 weeks, contraceptive methods, and self-care at home are essential components of postabortion care. Violence Against Women \u2022 Violence is not the woman\u2019s fault. It is very common. All health care providers can do something to help. Infertility",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3125
  },
  {
    "id": "chunk_03126",
    "text": "re providers can do something to help. Infertility \u2022 Infertility can often be prevented. Avoiding sexually transmitted infections and receiving prompt treatment for these and other reproductive tract infections can reduce a client\u2019s risk of infertility. Family Planning in Postabortion Care",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3126
  },
  {
    "id": "chunk_03127",
    "text": "infertility. Family Planning in Postabortion Care Postabortion care includes any or all of the following, as needed or desired: an optional postabortion follow-up visit 7\u201314 days after the procedure, management of residual side effects or complications, and contraceptive",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3127
  },
  {
    "id": "chunk_03128",
    "text": "l side effects or complications, and contraceptive services. Immediately after an abortion, before the client leaves the facility, it is important to provide family planning information and also to offer counseling and methods of contraception. Many different health workers",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3128
  },
  {
    "id": "chunk_03129",
    "text": "ds of contraception. Many different health workers can offer family planning services, including those who provide abortion and postabortion care. When such services are integrated with postabortion care and are offered immediately after an abortion, women are more likely to use",
    "page_number": 405,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3129
  },
  {
    "id": "chunk_03130",
    "text": "Help Women Obtain Family Planning Provide Important Information A woman has important choices and opportunities, before, during, and after abortion care. To make decisions about her health and fertility, she needs to know the following.",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3130
  },
  {
    "id": "chunk_03131",
    "text": "th and fertility, she needs to know the following. \u2022 Fertility returns quickly. Following an induced or spontaneous abortion, ovulation can return as early as 8\u201310 days later and usually within 1 month. Hence, initiating a family planning method immediately",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3131
  },
  {
    "id": "chunk_03132",
    "text": "e, initiating a family planning method immediately after abortion if possible, or as soon as possible within the first month, is important for women who desire to delay or prevent a future pregnancy. \u2022 All contraceptive options may be considered after an abortion. The",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3132
  },
  {
    "id": "chunk_03133",
    "text": "e options may be considered after an abortion. The client\u2019s wishes and her future plans for childbearing are paramount and the woman should be empowered to make an informed choice. Information provided about the different methods should include failure",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3133
  },
  {
    "id": "chunk_03134",
    "text": "about the different methods should include failure rates since some women may have sought an abortion due to the failure of the contraceptive method they were using. Ultimately, the choice must be made by the woman but her choice should be an informed one.",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3134
  },
  {
    "id": "chunk_03135",
    "text": "he woman but her choice should be an informed one. \u2022 If the woman decides to wait before choosing a contraceptive method for ongoing use, she should consider using a backup method in the meantime if she has sex. Backup methods include abstinence, male",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3135
  },
  {
    "id": "chunk_03136",
    "text": "e has sex. Backup methods include abstinence, male or female condoms, spermicides,1 and withdrawal; the client should be informed that spermicides and withdrawal are the least effective contraceptive methods, and if possible, she should be given condoms and emergency contraceptive pills.",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3136
  },
  {
    "id": "chunk_03137",
    "text": "e given condoms and emergency contraceptive pills. \u2022 If the woman decides not to use contraception at this time, providers can offer information on her fertility condition, the most appropriate available methods, and where to obtain them. Providers can also offer",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3137
  },
  {
    "id": "chunk_03138",
    "text": "and where to obtain them. Providers can also offer condoms, oral contraceptives, and emergency contraceptive pills for women to take home and use later. \u2022 If being treated for infection or vaginal or cervical injury, the woman should wait until she has completed treatment/management of the",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3138
  },
  {
    "id": "chunk_03139",
    "text": "ntil she has completed treatment/management of the infection/injury before having sex again. \u2022 If a woman who has suffered a miscarriage wants to become pregnant again soon, the provider should encourage her to wait at least 6 months as this may reduce the risks of low birth weight, premature birth,",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3139
  },
  {
    "id": "chunk_03140",
    "text": "ce the risks of low birth weight, premature birth, maternal anemia, and a repeat miscarriage. \u2022 A woman receiving postabortion care may need other reproductive health services. In particular, a provider can help her consider if she",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3140
  },
  {
    "id": "chunk_03141",
    "text": "articular, a provider can help her consider if she 1 A client can use spermicides if they have no vaginal or cervical injury. 384 Family Planning: A Global Handbook for Providers",
    "page_number": 406,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3141
  },
  {
    "id": "chunk_03142",
    "text": "25 385 seussI htlaeH evitcudorpeR might have been exposed to sexually transmitted infections, and may need to ask whether she has experienced sexual violence (see section on Violence Against Women, pp. 388\u2013392). Counsel With Compassion",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3142
  },
  {
    "id": "chunk_03143",
    "text": "ainst Women, pp. 388\u2013392). Counsel With Compassion Counseling is more than information provision. It is a focused, interactive process to provide support, information, and non-directive guidance from a trained and skilled person, in an environment where a person can openly",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3143
  },
  {
    "id": "chunk_03144",
    "text": "erson, in an environment where a person can openly share their thoughts, feelings, perceptions, and personal experiences. The process should support final decision-making by the client about the topic being discussed. Before or after an abortion, some clients may wish to receive counseling.",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3144
  },
  {
    "id": "chunk_03145",
    "text": "tion, some clients may wish to receive counseling. In particular, a woman who has had postabortion complications may need additional support. A woman who has faced the double risk of unplanned pregnancy and unsafe induced abortion especially needs help and support,",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3145
  },
  {
    "id": "chunk_03146",
    "text": "nduced abortion especially needs help and support, including psychological services. The counseling should be client-centered. When offering and providing counseling, it is essential to apply the following guiding principles. \u2022 Ensure that the person agrees to receive counseling and has had the",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3146
  },
  {
    "id": "chunk_03147",
    "text": "erson agrees to receive counseling and has had the opportunity to choose not to receive counseling. \u2022 Ask the client to explain what she wants or needs and any concerns she may have, including her wishes regarding pregnancy, and consideration",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3147
  },
  {
    "id": "chunk_03148",
    "text": "her wishes regarding pregnancy, and consideration of the pros and cons of different methods such as the likely impact on menstrual bleeding, pain, and acne. \u2022 Give her the time she needs, and actively listen to her expressed values,",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3148
  },
  {
    "id": "chunk_03149",
    "text": "eeds, and actively listen to her expressed values, needs, and preferences (including if she wants someone she trusts to be present during counseling). \u2022 Treat the client with respect and avoid making any judgment or criticism. \u2022 Ensure privacy and confidentiality.",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3149
  },
  {
    "id": "chunk_03150",
    "text": "r criticism. \u2022 Ensure privacy and confidentiality. \u2022 Communicate information in a manner and language that is understandable to the individual. \u2022 Present all suitable options tailored to the person\u2019s medical eligibility, expressed needs and preferences, while avoiding imposing one\u2019s personal",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3150
  },
  {
    "id": "chunk_03151",
    "text": "references, while avoiding imposing one\u2019s personal values and beliefs onto them. \u2022 Make it clear to the client that she will be the one to decide her family planning method. Family Planning in Postabortion Care",
    "page_number": 407,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3151
  },
  {
    "id": "chunk_03152",
    "text": "When to Start Contraceptive Methods After ruling out the presence of any medical conditions that may affect medical eligibility (see Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use), the following methods may be started immediately. First- Second- trimester trimester medical/ medical/",
    "page_number": 408,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3152
  },
  {
    "id": "chunk_03153",
    "text": "rst- Second- trimester trimester medical/ medical/ Contraceptive surgical surgical Special method abortion abortion considerations Reversible methods (in order of effectiveness) Intrauterine Can insert at Can insert at Avoid after device (IUD) the time success the time success septic abortion",
    "page_number": 408,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3153
  },
  {
    "id": "chunk_03154",
    "text": "the time success the time success septic abortion of abortion is of abortion is determined determined, but insertion must be done by a specially trained person Implant Can start immediately Self-administration after abortion; in the case of injectable can Progestin-only",
    "page_number": 408,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3154
  },
  {
    "id": "chunk_03155",
    "text": "tion; in the case of injectable can Progestin-only of medical abortion, can be considered injectables start immediately after Combined the first pill of the medical injectable abortion regimen contraceptives (monthly) Combined patch Combined ring Combined oral contraceptives Progestin-only pills",
    "page_number": 408,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3155
  },
  {
    "id": "chunk_03156",
    "text": "Combined oral contraceptives Progestin-only pills Diaphragm Can start Wait for and cap immediately after 6 weeks abortion Fertility Can start when regular Special counseling awareness-based menstrual cycles return may be needed methods (FABs) to ensure correct use of FABs",
    "page_number": 408,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3156
  },
  {
    "id": "chunk_03157",
    "text": "eeded methods (FABs) to ensure correct use of FABs Irreversible (permanent) methods Female Can have this surgery The decision to sterilization immediately after abortion have this surgery must be made in advance of the abortion 386 Family Planning: A Global Handbook for Providers",
    "page_number": 408,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3157
  },
  {
    "id": "chunk_03158",
    "text": "25 387 seussI htlaeH evitcudorpeR Additional considerations: \u2022 IUD insertion immediately after a second-trimester abortion is associated with a higher risk for expulsion, which the woman should be informed about, and the insertion requires a specially trained provider.",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3158
  },
  {
    "id": "chunk_03159",
    "text": "e insertion requires a specially trained provider. \u2022 The option of self-administration of injectable contraception in the post- abortion period should be offered to women as an alternative to provider- administered injections (see Teaching Clients to Self-inject, in Chapter 4",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3159
  },
  {
    "id": "chunk_03160",
    "text": "(see Teaching Clients to Self-inject, in Chapter 4 \u2013 Progestin-Only Injectables, p. 83\u201386). \u2022 If pills are the chosen method, provide up to 1 year\u2019s supply of pills, depending on the woman\u2019s preference and anticipated usage. \u2022 Sterilization is permanent and must be decided upon in advance of the",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3160
  },
  {
    "id": "chunk_03161",
    "text": "rmanent and must be decided upon in advance of the abortion, and not while a woman is sedated, under stress, or in pain. Counsel carefully and be sure that the client understands they have the option to choose a reversible method (see Because Sterilization Is",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3161
  },
  {
    "id": "chunk_03162",
    "text": "a reversible method (see Because Sterilization Is Permanent, in Chapter 12 \u2013 Female Sterilization, p. 230). \u2022 Clients who choose to initiate the contraceptive ring should be instructed to check for expulsion in the event of residual or heavy bleeding during/ after the medical abortion process.",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3162
  },
  {
    "id": "chunk_03163",
    "text": "eeding during/ after the medical abortion process. \u2022 The diaphragm must be refitted after uncomplicated first-trimester miscarriage or abortion. After uncomplicated second-trimester miscarriage or abortion, refitting of the diaphragm should be delayed 6 weeks to allow",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3163
  },
  {
    "id": "chunk_03164",
    "text": "f the diaphragm should be delayed 6 weeks to allow the uterus to return to normal size. \u2022 Fertility awareness-based methods (FABs): A woman can start symptoms- based methods once she has no infection-related secretions or bleeding",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3164
  },
  {
    "id": "chunk_03165",
    "text": "he has no infection-related secretions or bleeding due to injury to the genital tract. She can start calendar-based methods with her next monthly bleeding, if she is not having bleeding due to injury to the genital tract (see Chapter 18 \u2013 Fertility Awareness Methods,",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3165
  },
  {
    "id": "chunk_03166",
    "text": "act (see Chapter 18 \u2013 Fertility Awareness Methods, in particular the sections on Providing Calendar-Based Methods and Providing Symptoms-Based Methods). Family Planning in Postabortion Care",
    "page_number": 409,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3166
  },
  {
    "id": "chunk_03167",
    "text": "Violence Against Women Every family planning provider probably sees many women who have experienced violence. Physical violence includes acts such as hitting, slapping, kicking, punching, beating, and using a weapon. Sexual violence",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3167
  },
  {
    "id": "chunk_03168",
    "text": "hing, beating, and using a weapon. Sexual violence includes unwanted sexual contact or attention, coercive sex, and forced sex (rape). Violence against women can be psychological, too, such as insults, intimidation, threats to hurt someone she loves, humiliation,",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3168
  },
  {
    "id": "chunk_03169",
    "text": "n, threats to hurt someone she loves, humiliation, isolating a woman from family and friends, and restricting her access to resources. Women experiencing violence have special health needs, many of them sexual and reproductive health needs. Providers of reproductive",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3169
  },
  {
    "id": "chunk_03170",
    "text": "productive health needs. Providers of reproductive health care are in a good position to identify women who experience violence and to attend to their physical health needs as well as provide psychosocial support and referrals. Women who experience violence often seek health services, although",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3170
  },
  {
    "id": "chunk_03171",
    "text": "ence violence often seek health services, although many will not mention the violence. Violence can lead to a range of health problems, including injuries, unwanted pregnancy, sexually transmitted infections (STIs) including HIV, decreased sexual desire, pain during sex,",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3171
  },
  {
    "id": "chunk_03172",
    "text": "ing HIV, decreased sexual desire, pain during sex, and chronic pelvic pain. Violence may start or become worse during a pregnancy, placing the fetus at risk as well. A man\u2019s violence or the threat of violence can deprive a woman of her right to make her own choice",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3172
  },
  {
    "id": "chunk_03173",
    "text": "eprive a woman of her right to make her own choice about whether to use family planning or what method to use. What Can Family Planning Providers Do? 1. Help women feel welcome, safe, and free to talk. Help women feel comfortable to speak freely about any personal issue,",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3173
  },
  {
    "id": "chunk_03174",
    "text": "fortable to speak freely about any personal issue, including violence. Assure every woman that what she discloses will be kept confidential. Give a woman opportunities to discuss issues that concern her\u2014for example, her partner\u2019s attitudes toward her use of family planning",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3174
  },
  {
    "id": "chunk_03175",
    "text": "tner\u2019s attitudes toward her use of family planning or any possible problems with using family planning\u2014or you can ask simply if there is anything she would like to discuss. Most women will not bring up that they are being abused, but some may disclose it if",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3175
  },
  {
    "id": "chunk_03176",
    "text": "they are being abused, but some may disclose it if asked. Be alert to symptoms, injuries, or signs that suggest violence. Violence at home may lead a woman to refuse family planning or to insist on a specific method, to resist family planning counseling,",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3176
  },
  {
    "id": "chunk_03177",
    "text": "ific method, to resist family planning counseling, or to insist on reversal of female sterilization. Many pregnancies close together or requests for pregnancy termination may also be an indication of violence at home. (Of course, there could be many other reasons for these preferences and behaviors.)",
    "page_number": 410,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3177
  },
  {
    "id": "chunk_03178",
    "text": "25 389 seussI htlaeH evitcudorpeR 2. If you suspect violence, ask about it. \u201cShould I ask all my clients Some tips for bringing up the about violence?\u201d topic of violence: Health care providers should \u2022 To increase trust, explain why routinely ask all clients about you are asking\u2014because you",
    "page_number": 411,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3178
  },
  {
    "id": "chunk_03179",
    "text": "y ask all clients about you are asking\u2014because you violence only if they are trained want to help. in asking about violence and \u2022 Use language that is comfortable offering first-line support, if for you and best fits your own privacy and confidentiality style. can be ensured, and if referral",
    "page_number": 411,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3179
  },
  {
    "id": "chunk_03180",
    "text": "identiality style. can be ensured, and if referral linkages to other support \u2022 Do not ask such questions when services are in place. a woman\u2019s partner or anyone else is present or when privacy cannot be ensured. To explore whether a client is experiencing partner violence and to support",
    "page_number": 411,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3180
  },
  {
    "id": "chunk_03181",
    "text": "nt is experiencing partner violence and to support her disclosure of violence, you can first approach the topic indirectly. You can say, for example: \u2013 \u201cMany women experience problems with their husband or partner or someone else they live with.\u201d",
    "page_number": 411,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3181
  },
  {
    "id": "chunk_03182",
    "text": "usband or partner or someone else they live with.\u201d \u2013 \u201cI have seen women with problems like yours who have been having trouble at home.\u201d Violence Against Women",
    "page_number": 411,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3182
  },
  {
    "id": "chunk_03183",
    "text": "You can follow it up with more direct questions, such as these: \u2013 \u201cAre you afraid of your husband (or partner)?\u201d \u2013 \u201cHas your husband (or partner) or someone else at home ever threatened to hurt you or physically harm you in some way? If so, when has this happened?\u201d",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3183
  },
  {
    "id": "chunk_03184",
    "text": "m you in some way? If so, when has this happened?\u201d \u2013 \u201cDoes your husband (or partner) or someone at home bully you or insult you or try to control you?\u201d \u2013 \u201cHas your husband (or partner) forced you into sex or forced you to have any sexual contact you did not want?\u201d",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3184
  },
  {
    "id": "chunk_03185",
    "text": "you to have any sexual contact you did not want?\u201d To explore further how violence affects a woman\u2019s reproductive and sexual life, you can ask these 4 questions: \u2013 \u201cHas your partner ever told you not to use contraception, blocked you from getting a method, or hidden or taken away your contraception?\u201d",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3185
  },
  {
    "id": "chunk_03186",
    "text": "thod, or hidden or taken away your contraception?\u201d \u2013 \u201cHas your partner ever tried to force you or pressure you to become pregnant?\u201d \u2013 \u201cHas your partner ever refused to use a condom?\u201d \u2013 \u201cHas your partner ever made you have sex without using contraception so that you would become pregnant?\u201d",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3186
  },
  {
    "id": "chunk_03187",
    "text": "contraception so that you would become pregnant?\u201d 3. Offer first-line support. In response to a disclosure of violence, you should offer first- line support. First-line support provides practical care and responds to a woman\u2019s emotional, physical, safety, and support needs,",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3187
  },
  {
    "id": "chunk_03188",
    "text": "\u2019s emotional, physical, safety, and support needs, without intruding on her privacy. First-line support is the most important care that you can provide. Even if this is all you can do, you will have greatly helped your client. First-line support involves 5 simple tasks. The",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3188
  },
  {
    "id": "chunk_03189",
    "text": "t. First-line support involves 5 simple tasks. The letters in the word \u201cLIVES\u201d can remind you of these 5 tasks that protect women\u2019s lives\u2014Listen, Inquire about needs and concerns, Validate, Enhance safety, Support. 390 Family Planning: A Global Handbook for Providers Violence Against Women",
    "page_number": 412,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3189
  },
  {
    "id": "chunk_03190",
    "text": "25 391 seussI htlaeH evitcudorpeR L Listen to the woman closely, with empathy, and without ISTEN judging. Give her a chance to say what she wants to say in a safe and private place to a caring person who wants to help. Listening is the most important part of good",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3190
  },
  {
    "id": "chunk_03191",
    "text": "help. Listening is the most important part of good communication and the basis of first-line support. If she does not want to talk about violence, assure her that you are available whenever she needs you, and that anything she discloses will be kept confidential.",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3191
  },
  {
    "id": "chunk_03192",
    "text": "anything she discloses will be kept confidential. I Assess and respond to her various needs and concerns. As NQUIRE you listen to the woman\u2019s story, pay particular attention to ABOUT what she says about her needs and concerns\u2014and what she NEEDS AND",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3192
  },
  {
    "id": "chunk_03193",
    "text": "bout her needs and concerns\u2014and what she NEEDS AND does not say but implies with words or body language. She CONCERNS may let you know about physical needs, emotional needs, or economic needs, her safety concerns, or social support that she needs. Respect her ability and her right to make her own",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3193
  },
  {
    "id": "chunk_03194",
    "text": "Respect her ability and her right to make her own choices about her life. V Show her that you understand and believe her. ALIDATE Validating another person\u2019s experience means letting the person know that you are listening closely, that you understand what she is saying, and that you believe what she",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3194
  },
  {
    "id": "chunk_03195",
    "text": "what she is saying, and that you believe what she says without judgment or conditions. Some important things that you can say: \u2013 \u201cIt\u2019s not your fault. You are not to blame.\u201d \u2013 \u201cThis happens to many women.\u201d \u2013 \u201cYou are not alone, and help is available.\u201d",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3195
  },
  {
    "id": "chunk_03196",
    "text": "en.\u201d \u2013 \u201cYou are not alone, and help is available.\u201d E Discuss a plan to protect herself from further harm if NHANCE violence occurs again. Explain that partner violence is not SAFETY likely to stop on its own. It tends to continue and may become worse and happen more often. You can ask:",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3196
  },
  {
    "id": "chunk_03197",
    "text": "y become worse and happen more often. You can ask: \u2013 \u201cAre you or your children in danger now?\u201d \u2013 \u201cDo you feel safe to go home?\u201d \u2013 \u201cIs there a friend or relative who can help you with the situation at home?\u201d If the woman faces immediate danger, help her",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3197
  },
  {
    "id": "chunk_03198",
    "text": "me?\u201d If the woman faces immediate danger, help her consider various courses of action. If not in immediate danger, help her make a longer-term plan. S Support her by helping her connect to information, UPPORT services, and social support. Women\u2019s needs generally",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3198
  },
  {
    "id": "chunk_03199",
    "text": "vices, and social support. Women\u2019s needs generally go beyond what you can provide in the clinic. You can help by discussing the woman\u2019s needs with her; telling her about other sources of help, such as shelter, social services, child protection, police, legal aid, financial aid, peer support; and",
    "page_number": 413,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3199
  },
  {
    "id": "chunk_03200",
    "text": "4. Provide appropriate care. Tailor your care and counseling to a woman\u2019s circumstances. \u2022 Treat any injuries or see that she gets treatment. \u2022 Discuss with her how she can make the best choices for family planning in her circumstances.",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3200
  },
  {
    "id": "chunk_03201",
    "text": "choices for family planning in her circumstances. \u2013 If your client wants a method that would be hard for her partner to detect or to interfere with, an injectable may be her best choice. You might also discuss IUDs and implants. Be sure to point out that even these methods can sometimes be detected.",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3201
  },
  {
    "id": "chunk_03202",
    "text": "that even these methods can sometimes be detected. \u2013 Make clear that these methods do not protect her against STIs including HIV. Condoms are the only family planning method that protects against STIs as well as pregnancy. Give information",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3202
  },
  {
    "id": "chunk_03203",
    "text": "gainst STIs as well as pregnancy. Give information and offer referral to support services, if available, for women\u2019s empowerment and skills building on condom use negotiation and safer sexual practices. \u2013 Provide emergency contraceptive pills if appropriate and wanted.",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3203
  },
  {
    "id": "chunk_03204",
    "text": "ncy contraceptive pills if appropriate and wanted. 5. Document the abuse experienced by the woman. Carefully and confidentially document the woman\u2019s history of abuse along with symptoms or injuries and the cause of the injuries if relevant. Record the relationship of the perpetrator to the woman.",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3204
  },
  {
    "id": "chunk_03205",
    "text": "the relationship of the perpetrator to the woman. Infertility What Is Infertility? Involuntary infertility is a disease of the reproductive system: the inability to become pregnant when desired. Involuntary childlessness is the inability to",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3205
  },
  {
    "id": "chunk_03206",
    "text": "red. Involuntary childlessness is the inability to give birth to desired children, whether due to inability to achieve pregnancy or due to stillbirth or miscarriage. These conditions occur in couples who have never had children (primary infertility) and, more often, in couples",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3206
  },
  {
    "id": "chunk_03207",
    "text": "(primary infertility) and, more often, in couples who have had children previously (secondary infertility). Infertility is defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. (On average, 85% of women would be pregnant by then.)",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3207
  },
  {
    "id": "chunk_03208",
    "text": "average, 85% of women would be pregnant by then.) Worldwide, infertility affects about 12% of couples who are seeking to have a child\u2014about 2% who have never had children and about 10% who have had children previously. There are differences among regions.",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3208
  },
  {
    "id": "chunk_03209",
    "text": "n previously. There are differences among regions. In some countries or communities, infertility or childlessness can have drastic consequences, especially for women but also with significant impact on men. These consequences can include economic deprivation, divorce, stigma and",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3209
  },
  {
    "id": "chunk_03210",
    "text": "include economic deprivation, divorce, stigma and discrimination, isolation, intimate partner violence, murder, mental health disorders, and suicide. 392 Family Planning: A Global Handbook for Providers",
    "page_number": 414,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3210
  },
  {
    "id": "chunk_03211",
    "text": "25 393 seussI htlaeH evitcudorpeR What Causes Infertility? Globally, infertility has many causes, which vary depending on the setting. Although often the woman is blamed, the cause of infertility can be in either the man or the woman or in both.",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3211
  },
  {
    "id": "chunk_03212",
    "text": "can be in either the man or the woman or in both. Medically, causes of infertility range from the effects of STIs in one or both partners to hormonal imbalances and defects of the uterus in women and low sperm count, low sperm motility, and malformed sperm in men.",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3212
  },
  {
    "id": "chunk_03213",
    "text": "t, low sperm motility, and malformed sperm in men. Lifestyle factors include smoking, alcohol, and drug abuse as well as obesity and nutritional deficiencies. Exposures to chemicals in the environment that disrupt the endocrine system as well as other environmental and stress-",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3213
  },
  {
    "id": "chunk_03214",
    "text": "system as well as other environmental and stress- related factors are suspected as well. A large WHO study in the late 1970s found that STIs were a major cause of infertility in developing countries. It is not known how much STIs contribute to infertility now.",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3214
  },
  {
    "id": "chunk_03215",
    "text": "known how much STIs contribute to infertility now. However, the evidence is clear that, if left untreated, gonorrhea and chlamydia can infect the fallopian tubes, the uterus, and the ovaries in women. This is known as pelvic inflammatory disease (PID). Clinical PID is",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3215
  },
  {
    "id": "chunk_03216",
    "text": "pelvic inflammatory disease (PID). Clinical PID is painful, but sometimes PID has no symptoms and goes unnoticed (silent PID). Gonorrhea and chlamydia can scar women\u2019s fallopian tubes, blocking eggs from traveling down the tubes to meet sperm. Similarly, untreated",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3216
  },
  {
    "id": "chunk_03217",
    "text": "down the tubes to meet sperm. Similarly, untreated gonorrhea and chlamydia in men can cause scarring and blockage in the sperm duct (epididymis) and urethra (see the job aids: Female Anatomy and Male Anatomy). Other factors or conditions that can reduce fertility or cause infertility include:",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3217
  },
  {
    "id": "chunk_03218",
    "text": "can reduce fertility or cause infertility include: \u2022 Other reproductive tract infections, including genital tuberculosis (TB) in both men and women \u2022 HIV \u2022 Medical procedures that introduce infection into a woman\u2019s upper reproductive tract or uterus, including postpartum and postabortion infections",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3218
  },
  {
    "id": "chunk_03219",
    "text": ", including postpartum and postabortion infections \u2022 Mumps that develop after puberty in men \u2022 Certain disorders of the reproductive tract, such as endometriosis, polycystic ovaries, and fibroids (myomas) \u2022 Anatomical, endocrine, genetic, or immune system problems in both men and women",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3219
  },
  {
    "id": "chunk_03220",
    "text": "c, or immune system problems in both men and women \u2022 Surgical interventions that adversely affect reproductive tissues or organs \u2022 Cancer treatments that affect reproductive health and the capacity to reproduce \u2022 Aging in both women and men. Infertility",
    "page_number": 415,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3220
  },
  {
    "id": "chunk_03221",
    "text": "Preventing Involuntary Infertility Involuntary infertility often can be prevented. Providers can: \u2022 Counsel clients about STI prevention (see the section on Avoiding STIs, in Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, p. 345).",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3221
  },
  {
    "id": "chunk_03222",
    "text": "ly Transmitted Infections, Including HIV, p. 345). Encourage clients to seek treatment as soon as they think they might have an STI or might have been exposed. \u2022 Treat or refer clients with signs and symptoms of STIs and clinical PID",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3222
  },
  {
    "id": "chunk_03223",
    "text": "s with signs and symptoms of STIs and clinical PID (see the section on Signs and Symptoms of STIs, in Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, p. 343). Treating these infections can help to prevent infertility.",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3223
  },
  {
    "id": "chunk_03224",
    "text": "these infections can help to prevent infertility. \u2022 Avoid causing infection by following proper infection-prevention practices when performing medical procedures that pass instruments from the vagina into the uterus, such as IUD insertion (see the section on Infection",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3224
  },
  {
    "id": "chunk_03225",
    "text": "uch as IUD insertion (see the section on Infection Prevention in the Clinic, in Chapter 26 \u2013 Family Planning Provision, p. 404). \u2022 Treat or refer clients with signs or symptoms of infection postpartum or postabortion. \u2022 Help clients with fertility problems become aware of risks to fertility\u2014",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3225
  },
  {
    "id": "chunk_03226",
    "text": "ility problems become aware of risks to fertility\u2014 not only infections but also lifestyle and environmental factors. \u2022 Counsel clients about available options for their future childbearing\u2014that is, fertility preservation techniques such as sperm freezing for men and in",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3226
  },
  {
    "id": "chunk_03227",
    "text": "n techniques such as sperm freezing for men and in vitro fertilization or freezing eggs\u2014if they are being treated or are having surgery for cancer or other diseases that may affect reproductive tissues or organs. Counseling Clients With Fertility Problems",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3227
  },
  {
    "id": "chunk_03228",
    "text": "organs. Counseling Clients With Fertility Problems \u2022 Counsel both partners together, if possible. A man may blame his partner for infertility if he doesn\u2019t understand that the problem could be on his side or may lie with both partners.",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3228
  },
  {
    "id": "chunk_03229",
    "text": "ould be on his side or may lie with both partners. \u2022 Explain that a man is just as likely to have fertility problems as a woman. In more than 40% of couples with fertility problems, it is because of semen or sperm abnormalities, or other health problems of the male",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3229
  },
  {
    "id": "chunk_03230",
    "text": "bnormalities, or other health problems of the male partner. In 20% of couples with fertility problems, both male and female factors reduce fertility. Sometimes it is not possible to find the cause of the problem. \u2022 Recommend that the couple attempt pregnancy with unprotected sex",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3230
  },
  {
    "id": "chunk_03231",
    "text": "the couple attempt pregnancy with unprotected sex for at least 12 months before they suspect infertility. Provide educational materials and guidance on risks to fertility. (See the section on Safer Conception for HIV Serodiscordant Couples, in Chapter 22 \u2013 Sexually",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3231
  },
  {
    "id": "chunk_03232",
    "text": "V Serodiscordant Couples, in Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV, p. 347.) 394 Family Planning: A Global Handbook for Providers",
    "page_number": 416,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3232
  },
  {
    "id": "chunk_03233",
    "text": "25 395 seussI htlaeH evitcudorpeR \u2022 The most fertile time of a woman\u2019s cycle is several days before and at the time of ovulation (when an ovary releases an egg) (see the job aid in this Handbook, The Menstrual Cycle). Fertility awareness methods can",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3233
  },
  {
    "id": "chunk_03234",
    "text": "Menstrual Cycle). Fertility awareness methods can help couples identify the most fertile time of each cycle (see Chapter 18 \u2013 Fertility Awareness Methods). Provide educational material about these methods and/or refer the couple to a fertility care provider or specialist.",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3234
  },
  {
    "id": "chunk_03235",
    "text": "couple to a fertility care provider or specialist. \u2022 If, after 1 year, following the suggestions above has not resulted in a pregnancy or live birth, refer both partners to a qualified fertility care provider for evaluation and assessment, if available. Referral to a fertility",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3235
  },
  {
    "id": "chunk_03236",
    "text": "assessment, if available. Referral to a fertility care provider or specialist may be particularly helpful in the following situations: the couple is affected by HIV or suspected genital TB; the woman is age 35 or older; she has polycystic ovary syndrome or has been",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3236
  },
  {
    "id": "chunk_03237",
    "text": "der; she has polycystic ovary syndrome or has been diagnosed with endometriosis; the woman or the man suspects they had an STI and it was not treated; either had been treated for a cancer or had surgery that may have affected the reproductive tissues or organs.",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3237
  },
  {
    "id": "chunk_03238",
    "text": "have affected the reproductive tissues or organs. \u2022 The couple also may want to consider adoption or other alternatives to having children or more children of their own, such as taking in nieces and nephews. Contraceptives Do Not Cause Infertility",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3238
  },
  {
    "id": "chunk_03239",
    "text": "d nephews. Contraceptives Do Not Cause Infertility \u2022 With most modern contraceptive methods, there is no significant delay in the time to desired pregnancy after contraception is stopped. On average, pregnancy occurs after 3 to 6 months of unprotected sex. There is great",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3239
  },
  {
    "id": "chunk_03240",
    "text": "r 3 to 6 months of unprotected sex. There is great variation around this average, however, related to the age and the health status of the individuals in the couple. When counseling couples who stop contraception and want to have a child, aging and other factors affecting",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3240
  },
  {
    "id": "chunk_03241",
    "text": "to have a child, aging and other factors affecting the fertility of the woman and the man need to be considered. \u2022 The return of fertility after injectable contraceptives are stopped usually takes longer than with most other methods (see Chapter 4 \u2013 Progestin-",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3241
  },
  {
    "id": "chunk_03242",
    "text": "ith most other methods (see Chapter 4 \u2013 Progestin- Only Injectables, Questions 7 and 8, pp. 93\u201394, and Chapter 5 \u2013 Monthly Injectables, Questions 10 and 11, p. 118). In time, however, a woman will be as fertile as before using the method, taking aging into account.",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3242
  },
  {
    "id": "chunk_03243",
    "text": "efore using the method, taking aging into account. \u2022 Among women with current gonorrhea or chlamydia, IUD insertion slightly increases the risk of pelvic inflammatory disease in the first 20 days after insertion. However, research has not found that former IUD",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3243
  },
  {
    "id": "chunk_03244",
    "text": "n. However, research has not found that former IUD users are more likely to be infertile than other women (see Chapter 10 \u2013 Copper-Bearing Intrauterine Device, Question 4, p. 189). Infertility",
    "page_number": 417,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3244
  },
  {
    "id": "chunk_03245",
    "text": "CHAPTER 26 Family Planning Provision Importance of Selected Procedures for Providing Family Planning Methods The table on the next page shows how important various examinations and tests are when providing specific family planning methods.",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3245
  },
  {
    "id": "chunk_03246",
    "text": "e when providing specific family planning methods. Most methods do not require any of these exams or tests (Class C). However, these exams and tests may be useful as part of a general health check-up or for the diagnosis or monitoring of other health conditions. Key to the chart:",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3246
  },
  {
    "id": "chunk_03247",
    "text": "ring of other health conditions. Key to the chart: Class A: Essential and mandatory in all circumstances for safe and effective use of the contraceptive method. A pelvic or genital examination is essential for IUD insertion, most diaphragms,",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3247
  },
  {
    "id": "chunk_03248",
    "text": "n is essential for IUD insertion, most diaphragms, female sterilization, and vasectomy. STI risk assessment also is essential before IUD insertion. Blood pressure screening is essential before female sterilization. Class B: Contributes substantially to safe and effective use.",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3248
  },
  {
    "id": "chunk_03249",
    "text": "ntributes substantially to safe and effective use. If the test or examination cannot be done, however, the risk of not performing it should be weighed against the benefits of making the contraceptive method available. Laboratory screening for STIs and a hemoglobin test would contribute to the safety",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3249
  },
  {
    "id": "chunk_03250",
    "text": "d a hemoglobin test would contribute to the safety of IUD insertion. A hemoglobin test also would contribute to the safety of female sterilization. Class C: Does not contribute substantially to safe and effective use of the contraceptive method. These tests and",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3250
  },
  {
    "id": "chunk_03251",
    "text": "e use of the contraceptive method. These tests and exams are not required or helpful for hormonal contraceptive methods, male or female condoms, or spermicides. These classifications apply to people who are presumed to be healthy. For a",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3251
  },
  {
    "id": "chunk_03252",
    "text": "ly to people who are presumed to be healthy. For a person with a known medical condition or other special condition, refer to Appendix D \u2013 Medical Eligibility Criteria for Contraceptive Use. For information on ruling out pregnancy, see the job aid on p. 461. Ruling",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3252
  },
  {
    "id": "chunk_03253",
    "text": "g out pregnancy, see the job aid on p. 461. Ruling out pregnancy is essential for IUD insertion and helpful for deciding when to start hormonal methods. 396 Family Planning: A Global Handbook for Providers",
    "page_number": 418,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3253
  },
  {
    "id": "chunk_03254",
    "text": "26 397 noisivorP gninnalP ylimaF Specific situation laro denibmoC *sevitpecartnoc selbatcejni ylhtnoM sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI sDUI-GNL dna -uC elamef dna elaM smodnoc dna smgarhpaiD spac lacivrec sedicimrepS elameF noitazilirets ymotcesaV Breast examination",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3254
  },
  {
    "id": "chunk_03255",
    "text": "elameF noitazilirets ymotcesaV Breast examination C C C C C C C C C C NA by provider Pelvic/genital C C C C C A C A C A A examination Cervical cancer C C C C C C C C C C NA screening Routine laboratory C C C C C C C C C C C tests Hemoglobin test C C C C C B C C C B C STI risk assessment:",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3255
  },
  {
    "id": "chunk_03256",
    "text": "in test C C C C C B C C C B C STI risk assessment: medical history and C C C C C A** C C\u2020 C\u2020 C C physical examination STI/HIV screening: C C C C C B** C C\u2020 C\u2020 C C laboratory tests Blood pressure \u2021 \u2021 \u2021 \u2021 \u2021 C C C C A C\u00a7 screening",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3256
  },
  {
    "id": "chunk_03257",
    "text": "ts Blood pressure \u2021 \u2021 \u2021 \u2021 \u2021 C C C C A C\u00a7 screening Note: No tests or examinations are needed before using fertility awareness-based methods, lactational amenorrhea method, or emergency contraceptive pills. NA = Not applicable * Includes patch and combined vaginal ring.",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3257
  },
  {
    "id": "chunk_03258",
    "text": "icable * Includes patch and combined vaginal ring. ** If a woman has a very high individual likelihood of exposure to STIs, she generally should not have an IUD inserted unless other methods are not available or not acceptable. If she has current purulent",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3258
  },
  {
    "id": "chunk_03259",
    "text": "ble or not acceptable. If she has current purulent cervicitis, gonorrhea, or chlamydia, she should not have an IUD inserted until these conditions are resolved and she is otherwise medically eligible. \u2020 Women at high risk of HIV infection should not use spermicides. Using spermicides alone or",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3259
  },
  {
    "id": "chunk_03260",
    "text": "ld not use spermicides. Using spermicides alone or diaphragms or cervical caps with spermicides is not usually recommended for women with HIV infection unless other, more appropriate methods are not available or acceptable.",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3260
  },
  {
    "id": "chunk_03261",
    "text": "propriate methods are not available or acceptable. \u2021 Desirable, but in settings where the risks of pregnancy are high, and hormonal methods are among the few methods widely available, women should not be denied use of hormonal methods solely because their blood pressure cannot be measured.",
    "page_number": 419,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3261
  },
  {
    "id": "chunk_03262",
    "text": "Successful Counseling Good counseling helps clients choose and use family planning methods that suit them. Clients differ, their situations differ, and they need different kinds of help. The best counseling is tailored to the individual client. Client Type Usual Counseling Tasks",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3262
  },
  {
    "id": "chunk_03263",
    "text": "ividual client. Client Type Usual Counseling Tasks Returning y Provide more supplies or routine follow-up clients with y Ask a friendly question about how the client is doing no problems with the method Returning y Understand the problem and help resolve it\u2014whether",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3263
  },
  {
    "id": "chunk_03264",
    "text": "Understand the problem and help resolve it\u2014whether clients with the problem is side effects, trouble using the method, problems an uncooperative partner, or another problem New clients y Check that the client\u2019s understanding is accurate",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3264
  },
  {
    "id": "chunk_03265",
    "text": "Check that the client\u2019s understanding is accurate with a y Support the client\u2019s choice, if client is medically eligible method y Discuss how to use method and how to cope with any in mind side effects New clients y Discuss the client\u2019s situation, plans, and what is",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3265
  },
  {
    "id": "chunk_03266",
    "text": "Discuss the client\u2019s situation, plans, and what is with no important to her or him about a method method y Help the client consider methods that might suit her in mind or him. If needed, help her or him reach a decision y Support the client\u2019s choice, give instructions on use,",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3266
  },
  {
    "id": "chunk_03267",
    "text": "ort the client\u2019s choice, give instructions on use, and discuss how to cope with any side effects Give time to clients who need it. Many clients are returning with no problems and need little counseling. Returning clients with problems and",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3267
  },
  {
    "id": "chunk_03268",
    "text": "le counseling. Returning clients with problems and new clients with no method in mind need the most time, but usually they are few. Tips for Successful Counseling y Show every client respect, and help each client feel at ease. y Encourage the client to explain needs, express concerns, ask questions.",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3268
  },
  {
    "id": "chunk_03269",
    "text": "to explain needs, express concerns, ask questions. y Let the client\u2019s wishes and needs guide the discussion. y Be alert to related needs such as protection from sexually transmitted infections including HIV, and support for condom use.",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3269
  },
  {
    "id": "chunk_03270",
    "text": "ections including HIV, and support for condom use. y Talk with the client in a private place, where no one else can hear. y Assure the client of confidentiality \u2014that you will not tell others about your conversation or the client\u2019s decisions.",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3270
  },
  {
    "id": "chunk_03271",
    "text": "about your conversation or the client\u2019s decisions. y Listen carefully. Listening is as important as giving correct information. 398 Family Planning: A Global Handbook for Providers",
    "page_number": 420,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3271
  },
  {
    "id": "chunk_03272",
    "text": "26 399 noisivorP gninnalP ylimaF y Give just key information and instructions. Use words the client knows. y Respect and support the client\u2019s informed decisions. y Bring up side effects, if any, and take the client\u2019s concerns seriously. y Check the client\u2019s understanding.",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3272
  },
  {
    "id": "chunk_03273",
    "text": "rns seriously. y Check the client\u2019s understanding. y Invite the client to come back any time for any reason. Counseling has succeeded when: y Clients feel they got the help they wanted y Clients know what to do and feel confident that they can do it y Clients feel respected and appreciated",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3273
  },
  {
    "id": "chunk_03274",
    "text": "can do it y Clients feel respected and appreciated y Clients come back when they need to y And, most important, clients use their methods effectively and with satisfaction. Counseling About Effectiveness The effectiveness of a family planning method is very important to most",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3274
  },
  {
    "id": "chunk_03275",
    "text": "a family planning method is very important to most clients. The effectiveness of family planning methods varies greatly (see Appendix A \u2013 Contraceptive Effectiveness). Describing and discussing effectiveness is an important part of counseling.",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3275
  },
  {
    "id": "chunk_03276",
    "text": "effectiveness is an important part of counseling. Describing effectiveness to clients takes thought and care. Instead of talking about pregnancy rates, which can be hard to understand, it may be more useful to compare the effectiveness of methods and to discuss whether the",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3276
  },
  {
    "id": "chunk_03277",
    "text": "ffectiveness of methods and to discuss whether the client feels able to use the method effectively. The chart on the back cover can help. The chart groups contraceptive methods according to their effectiveness as commonly used. Also, it points",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3277
  },
  {
    "id": "chunk_03278",
    "text": "ir effectiveness as commonly used. Also, it points out how the user can obtain the greatest possible effectiveness. y In general, methods that require little or no action by clients are the most effective. The 4 most effective methods\u2014implants,",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3278
  },
  {
    "id": "chunk_03279",
    "text": "effective. The 4 most effective methods\u2014implants, IUDs, female sterilization, and vasectomy\u2014are shown in the top row of the chart. All 4 methods need a health care provider\u2019s help to get started, but then they need little or no action by the user. These methods are",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3279
  },
  {
    "id": "chunk_03280",
    "text": "little or no action by the user. These methods are very effective for everyone who uses them\u2014less than one pregnancy in 100 women in 1 year of use. Moreover, implants and IUDs are highly effective for 4 to 5 years or more, and female sterilization and vasectomy are permanent.",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3280
  },
  {
    "id": "chunk_03281",
    "text": "female sterilization and vasectomy are permanent. y Methods in the second row can be highly effective when used correctly and consistently. They require some repeated action by the user, however\u2014some seldom, such as getting 4 injections a year, and some Successful Counseling",
    "page_number": 421,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3281
  },
  {
    "id": "chunk_03282",
    "text": "often, such as taking a pill every day, 365 days a year. As a result, they are less effective, on average, than methods in the top row, but still effective. Pregnancy rates for these methods range from 2 to 7 pregnancies in 100 women in a year.",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3282
  },
  {
    "id": "chunk_03283",
    "text": "ge from 2 to 7 pregnancies in 100 women in a year. y The methods in the lower rows of the chart usually have much higher pregnancy rates\u2014as high as 20 or more pregnancies in 100 women in 1 year of use for the least effective methods. The effectiveness of these",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3283
  },
  {
    "id": "chunk_03284",
    "text": "east effective methods. The effectiveness of these methods depends greatly on the user taking correct action repeatedly, such as using a condom with every act of sexual intercourse. Particularly for these methods, some highly motivated couples are much more",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3284
  },
  {
    "id": "chunk_03285",
    "text": "thods, some highly motivated couples are much more successful than average. Others make more mistakes and are more likely than average to get pregnant. Women tend to underestimate the effectiveness of the methods on the upper rows of the chart and overestimate the effectiveness of the methods",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3285
  },
  {
    "id": "chunk_03286",
    "text": "and overestimate the effectiveness of the methods on the lower rows. This may lead them to make misinformed decisions and to choose a contraceptive method that does not meet their needs. Counseling may need to gently correct these common misperceptions.",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3286
  },
  {
    "id": "chunk_03287",
    "text": "eed to gently correct these common misperceptions. In counseling it is not possible or necessary to provide complete information about every method. Clients do, however, benefit from key information, especially about the method that they want. The goal of counseling about",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3287
  },
  {
    "id": "chunk_03288",
    "text": "ethod that they want. The goal of counseling about method choice is to help the client find a method that she or he can use successfully and with satisfaction. Well-informed clients are more likely to be satisfied with their method and to use it longer. Clients need to understand",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3288
  },
  {
    "id": "chunk_03289",
    "text": "d and to use it longer. Clients need to understand how that method works, how effective it is, how to make the method most effective, what are the most likely side effects, and what to do if such side effects occur. With this knowledge and understanding, clients are better able",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3289
  },
  {
    "id": "chunk_03290",
    "text": "owledge and understanding, clients are better able to exercise their right to make a truly informed choice. Who Provides Family Planning? Many different people can learn to inform and advise people about family planning and to provide family planning methods. When more types of health",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3290
  },
  {
    "id": "chunk_03291",
    "text": "family planning methods. When more types of health workers are authorized and trained to provide family planning methods, more people have access to them. The types of health care providers who can and do provide family planning include the following:",
    "page_number": 422,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3291
  },
  {
    "id": "chunk_03292",
    "text": "26 401 noisivorP gninnalP ylimaF Type of Health Worker Examples Specialist doctor y Gynecologist, obstetrician Non-specialist y Family doctor, general practitioner doctor Advanced associate y Assistant medical officer, clinical officer, medical",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3292
  },
  {
    "id": "chunk_03293",
    "text": "sistant medical officer, clinical officer, medical and associate licentiate practitioner, health officer, physician clinician assistant, surgical technician, non-physician clinician, medical assistant, nurse practitioner Midwife y Registered midwife, midwife, community midwife, nurse-midwife",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3293
  },
  {
    "id": "chunk_03294",
    "text": "midwife, midwife, community midwife, nurse-midwife Nurse y Registered nurse, clinical nurse specialist, licensed nurse, BSc nurse Auxiliary y Auxiliary midwife nurse-midwife Auxiliary nurse y Auxiliary nurse, nurse assistant, enrolled nurse Pharmacist y Pharmacist, chemist, clinical pharmacist,",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3294
  },
  {
    "id": "chunk_03295",
    "text": "macist y Pharmacist, chemist, clinical pharmacist, community pharmacist Pharmacy worker y Pharmacy assistant, pharmacy technician dispenser, pharmacist aide Lay health worker y Community health worker (CHW), village health worker, community health volunteer User/self y Woman, man, client",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3295
  },
  {
    "id": "chunk_03296",
    "text": "ty health volunteer User/self y Woman, man, client In addition, some methods can be offered by health workers but do not require health workers. For example, condoms are sold in shops and by vendors and in vending machines. Also, lay health workers in the community",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3296
  },
  {
    "id": "chunk_03297",
    "text": "achines. Also, lay health workers in the community and experienced and successful users can teach others how to use their method\u2014for example, fertility awareness methods, male and female condoms, LAM, and withdrawal\u2014and they can support and advise new users",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3297
  },
  {
    "id": "chunk_03298",
    "text": "thdrawal\u2014and they can support and advise new users of many other methods. Users of injectables can learn to give themselves injections with a special formulation of DMPA in the Uniject delivery device (see Chapter 4 \u2013 Progestin-Only Injectables, Self-injection Can Be an Option,",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3298
  },
  {
    "id": "chunk_03299",
    "text": "Only Injectables, Self-injection Can Be an Option, pp. 83\u201386). Programs can support self-injection with information and training, strong referral links to health care providers, and monitoring and follow-up. Who Provides Family Planning?",
    "page_number": 423,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3299
  },
  {
    "id": "chunk_03300",
    "text": "Task-Sharing: WHO Recommendations Many countries and programs are changing their policies or regulations to allow more types of providers to offer contraceptive methods\u2014a change known as task-sharing. Task-sharing refers to expanding the levels of health",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3300
  },
  {
    "id": "chunk_03301",
    "text": "k-sharing refers to expanding the levels of health care providers who can appropriately deliver health services. Task-sharing helps to: y address shortages and uneven distribution of providers, particularly in rural and remote areas",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3301
  },
  {
    "id": "chunk_03302",
    "text": "providers, particularly in rural and remote areas y give higher-level clinicians more time to use their specialized skills y provide more family planning methods at the primary care level, and y overall, increase access to safe and timely care",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3302
  },
  {
    "id": "chunk_03303",
    "text": "y overall, increase access to safe and timely care To encourage and guide task-sharing, WHO has developed recommendations on which types of health workers can safely and effectively provide specific family planning methods. WHO based these recommendations",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3303
  },
  {
    "id": "chunk_03304",
    "text": "planning methods. WHO based these recommendations on evidence that a wide variety of providers can safely and effectively provide contraception. The table on the next page summarizes the WHO recommendations. Specific competency-based training and continued educational support",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3304
  },
  {
    "id": "chunk_03305",
    "text": "y-based training and continued educational support help all types of health care providers do a better job at providing family planning. They are particularly important when providers take on new tasks. Some tasks and some providers require more training and support than",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3305
  },
  {
    "id": "chunk_03306",
    "text": "e providers require more training and support than others. Training needs to cover skills in informing and counseling clients about choosing and using specific methods, including their side effects, as well as any specific technical skills such as how to give injections or insert",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3306
  },
  {
    "id": "chunk_03307",
    "text": "al skills such as how to give injections or insert and remove an IUD or an implant. Even specialist doctors need training in specific techniques\u2014for example, no-scalpel vasectomy and laparoscopic tubal sterilization. Checklists and other job aids can help a wide range of",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3307
  },
  {
    "id": "chunk_03308",
    "text": "klists and other job aids can help a wide range of providers and managers in various ways, such as screening clients for medical eligibility criteria, making sure all steps in a process are carried out (such as infection prevention), and ensuring good quality of services.",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3308
  },
  {
    "id": "chunk_03309",
    "text": "revention), and ensuring good quality of services. As programs plan for task-sharing and carrying it out, maintaining quality and safety are the top concerns. Successful task-sharing requires that a program pay attention to: y training and support y supplying the new providers with the method",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3309
  },
  {
    "id": "chunk_03310",
    "text": "port y supplying the new providers with the method y supervision y referral for managing any complications y changes to protocols, regulations, and training programs y salaries or payment that reflect the providers\u2019 scope of practice. 402 Family Planning: A Global Handbook for Providers",
    "page_number": 424,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3310
  },
  {
    "id": "chunk_03311",
    "text": "26 403 noisivorP gninnalP ylimaF Who Provides Family Planning? sredivorP ecivreS fo sepyT suoiraV yb dereffO yllacipyT secivreS dna sdohteM gninnalP ylimaF eht swohs woleb trahc ehT .secivres gninnalp ylimaf cfiiceps reffo nac sredivorp fo serdac hcihw yficeps senilediug yreviled ecivres dna seicilop",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3311
  },
  {
    "id": "chunk_03312",
    "text": "w yficeps senilediug yreviled ecivres dna seicilop lanoitaN .OHW morf snoitadnemmocer no desab sredivorp fo serdac eseht yb dereffo yllacipyt era taht sdohtem gninnalp ylimaf /etaicossA htlaeH yaL -noN decnavdA yrailixuA srekroW tsilaicepS tsilaiceps etaicossA -esruN yrailixuA ycamrahP sa hcuS(",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3312
  },
  {
    "id": "chunk_03313",
    "text": "iceps etaicossA -esruN yrailixuA ycamrahP sa hcuS( rotcoD rotcoD snaicinilC seviwdiM sesruN seviwdiM sesruN stsicamrahP srekroW )sWHC ECIVRES EVITPECARTNOC gnillesnuoc eciohc demrofnI \u2022 )sCOC( sevitpecartnoc laro denibmoC \u2022 )sPOP sevitpecartnoc laro ylno-nitsegorP \u2022 4 4 4 4 4 4 4 4 4 4 )sPCE(",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3313
  },
  {
    "id": "chunk_03314",
    "text": "c laro ylno-nitsegorP \u2022 4 4 4 4 4 4 4 4 4 4 )sPCE( sllip evitpecartnoc ycnegremE \u2022 dohteM yaDowT dna dohteM syaD dradnatS \u2022 )MAL( dohtem aehrronema lanoitatcaL \u2022 ,spac ,smgarhpaid ,)elamef & elam( smodnoC \u2022 sedicimreps 4 4 4 4 4 4 4 4 4 4 ,NE-TEN ,APMD( sevitpecartnoc elbatcejnI \u2022 )selbatcejni",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3314
  },
  {
    "id": "chunk_03315",
    "text": "EN ,APMD( sevitpecartnoc elbatcejnI \u2022 )selbatcejni ylhtnom denibmoc 4 4 4 4 4 4 4 6 6 4 lavomer dna noitresni tnalpmI \u2022 4 4 4 4 4 4 4 6 6 6 )DUI( secived eniretuartnI \u2022 4 4 4 4 4 4 4 6 6 6 )noitazilirets elam( ymotcesaV \u2022 4 4 4 4 4 6 6 6 6 6 )noitazilirets elamef( noitagil labuT \u2022 DNEGEL gnireffo ot",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3315
  },
  {
    "id": "chunk_03316",
    "text": "lirets elamef( noitagil labuT \u2022 DNEGEL gnireffo ot roirp gniniart cfiiceps-ksat eviecer lliw srekrow htlaeh dengissa eht taht emussa snoitadnemmocer eht fo llA dednemmoceR 4 .larrefer dna ,noisivrepus ,gnirotinom rof smsinahcem gninoitcnuf seriuqer osla gnirahs-ksat gnitpodA .secivres dessessa ton",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3316
  },
  {
    "id": "chunk_03317",
    "text": "osla gnirahs-ksat gnitpodA .secivres dessessa ton ecnedive ;ecitcarp fo epocs lacipyt nihtiw deredisnoC 4 htlaeh fo sepyt fo egnar a rof edivorp yehT .sgnittes ecruoser-wol dna -hgih htob ni elbacilppa era snoitadnemmocer ehT secnatsmucric cfiiceps ni dednemmoceR 4 rehtie ylpmi ton od dna evisulcni",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3317
  },
  {
    "id": "chunk_03318",
    "text": "ni dednemmoceR 4 rehtie ylpmi ton od dna evisulcni eb ot dednetni era snoitpo ehT .ylevitceffe dna ylefas ksat eht mrofrep nac ohw srekrow cfiiceps a rof rekrow htlaeh fo epyt eht fo eciohc ehT .redivorp fo epyt ralucitrap yna fo noisulcxe na ro rof ecnereferp a hcraeser suorogir fo txetnoc eht ni",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3318
  },
  {
    "id": "chunk_03319",
    "text": "f ecnereferp a hcraeser suorogir fo txetnoc eht ni dednemmoceR 4 .snoitidnoc dna sdeen lacol nopu dneped lliw ksat tsniaga dednemmoceR dessessa ton ecnedive ;ecitcarp fo epocs lacipyt eht edistuo deredisnoC 6 6",
    "page_number": 425,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3319
  },
  {
    "id": "chunk_03320",
    "text": "Infection Prevention in the Clinic Infection-prevention procedures are simple, effective, and inexpensive.Germs (infectious organisms) of concern in the clinic include bacteria (such as staphylococcus), viruses (particularly HIV and hepatitis B), fungi, and parasites.",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3320
  },
  {
    "id": "chunk_03321",
    "text": "ularly HIV and hepatitis B), fungi, and parasites. In the clinic infectious organisms can be found in blood, body fluids with visible blood, and tissue. (Feces, nasal secretions, saliva, sputum, sweat, tears, urine, and vomit are not considered potentially infectious unless they contain",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3321
  },
  {
    "id": "chunk_03322",
    "text": "sidered potentially infectious unless they contain blood.) The organisms can be passed through mucous membranes or broken skin, such as cuts and scratches, and by needle sticks with used needles and other puncture wounds. Infectious organisms can pass from clinics to",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3322
  },
  {
    "id": "chunk_03323",
    "text": "nds. Infectious organisms can pass from clinics to communities when waste disposal is not proper or staff members do not wash their hands properly before leaving the clinic. Basic Rules of Infection Prevention These rules apply the universal precautions for infection prevention to the family",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3323
  },
  {
    "id": "chunk_03324",
    "text": "precautions for infection prevention to the family planning clinic. Wash hands y Hand washing may be the single most important infection-prevention procedure. y Wash hands before and after examining or treating each client. (Hand washing is not necessary if clients",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3324
  },
  {
    "id": "chunk_03325",
    "text": "client. (Hand washing is not necessary if clients do not require an examination or treatment.) y Use clean water and plain soap, and rub hands for at least 10 to 15 seconds. Be sure to clean between the fingers and under fingernails. Wash hands after handling soiled instruments and other items or",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3325
  },
  {
    "id": "chunk_03326",
    "text": "ter handling soiled instruments and other items or touching mucous membranes, blood, or other body fluids. Wash hands before putting on gloves, after taking off gloves, and whenever hands get dirty. Wash hands when you arrive at work, after you use the",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3326
  },
  {
    "id": "chunk_03327",
    "text": "h hands when you arrive at work, after you use the toilet or latrine, and when you leave work. Dry hands with a paper towel or a clean, dry cloth towel that no one else uses, or air-dry. y If clean water and soap are not available, a hand sanitizer containing at least 60% alcohol can reduce",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3327
  },
  {
    "id": "chunk_03328",
    "text": "nitizer containing at least 60% alcohol can reduce the number of germs on the hands. Sanitizers do not eliminate all types of germs and might not remove harmful chemicals. Process y High-level disinfect or sterilize instruments that touch instruments intact mucous membranes or broken skin.",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3328
  },
  {
    "id": "chunk_03329",
    "text": "nstruments intact mucous membranes or broken skin. that will be y Sterilize instruments that touch tissue beneath reused the skin (see The 4 Steps of Processing Equipment, p. 407). 404 Family Planning: A Global Handbook for Providers",
    "page_number": 426,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3329
  },
  {
    "id": "chunk_03330",
    "text": "26 405 noisivorP gninnalP ylimaF Wear gloves y Wear gloves for any procedure that risks touching blood, other body fluids, mucous membranes, broken skin, soiled items, dirty surfaces, or waste. Wear surgical gloves for surgical procedures such as insertion of implants. Wear single-use examination",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3330
  },
  {
    "id": "chunk_03331",
    "text": "insertion of implants. Wear single-use examination gloves for procedures that touch intact mucous membranes or generally to avoid exposure to body fluids. Gloves are not necessary for giving injections. y Change gloves between procedures on the same client and between clients.",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3331
  },
  {
    "id": "chunk_03332",
    "text": "procedures on the same client and between clients. y Do not touch clean equipment or surfaces with dirty gloves or bare hands. y Wash hands before putting on gloves. Do not wash gloved hands instead of changing gloves. Gloves are not a substitute for hand washing.",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3332
  },
  {
    "id": "chunk_03333",
    "text": "ves. Gloves are not a substitute for hand washing. y Wear clean utility gloves when cleaning soiled instruments and equipment, handling waste, and cleaning blood or body fluid spills. Do pelvic y Pelvic examinations are not needed for most examinations family planning methods\u2014only for female",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3333
  },
  {
    "id": "chunk_03334",
    "text": "aminations family planning methods\u2014only for female only when sterilization, the IUD, diaphragm, and cervical needed cap (see Importance of Selected Procedures for Providing Family Planning Methods, p. 396). Pelvic examinations should be done only when there is a",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3334
  },
  {
    "id": "chunk_03335",
    "text": "c examinations should be done only when there is a reason\u2014such as suspicion of sexually transmitted infections, when the examination could help with diagnosis or treatment. For injections, y Auto-disable syringes and needles are safer and",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3335
  },
  {
    "id": "chunk_03336",
    "text": "y Auto-disable syringes and needles are safer and use new auto- more reliable than standard single-use disposable disable syringes syringes and needles, and any disposable syringes and needles and needles are safer than sterilizing reusable syringes and needles. Sterilizing and reusing",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3336
  },
  {
    "id": "chunk_03337",
    "text": "able syringes and needles. Sterilizing and reusing syringes and needles should be avoided. It might be considered only when single-use injection equipment is not available and the program can document the quality of sterilization. y Cleaning the client\u2019s skin before the injection is not",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3337
  },
  {
    "id": "chunk_03338",
    "text": "ning the client\u2019s skin before the injection is not needed unless the skin is dirty. If it is, wash with soap and water and dry with a clean towel. Wiping with an antiseptic has no added benefit. Wipe surfaces y Wipe examination tables, bench tops, and other",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3338
  },
  {
    "id": "chunk_03339",
    "text": "s y Wipe examination tables, bench tops, and other with chlorine surfaces that come in contact with unbroken skin solution with 0.5% chlorine solution after each client. Infection Prevention in the Clinic",
    "page_number": 427,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3339
  },
  {
    "id": "chunk_03340",
    "text": "Dispose of single- y Use personal protective equipment\u2014goggles, use equipment mask, apron, and closed protective shoes\u2014when and supplies handling wastes. properly and safely y Needles and syringes meant for single use must not be reused. Do not take apart the needle",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3340
  },
  {
    "id": "chunk_03341",
    "text": "e must not be reused. Do not take apart the needle and syringe. Used needles should not be broken, bent, or recapped. Put used needles and syringes immediately into a puncture-proof container for disposal. (If needles and syringes will not be incinerated, they should be decontaminated by",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3341
  },
  {
    "id": "chunk_03342",
    "text": "t be incinerated, they should be decontaminated by flushing with 0.5% chlorine solution before they are put into the puncture-proof container.) The puncture-proof sharps container should be sealed and either burned, incinerated, or deeply buried when three-fourths full.",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3342
  },
  {
    "id": "chunk_03343",
    "text": "nerated, or deeply buried when three-fourths full. y Dressings and other soiled solid waste should be collected in plastic bags and, within 2 days, burned and buried in a deep pit. Liquid wastes should be poured down a utility sink drain or a flushable toilet, or poured into a deep pit and buried.",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3343
  },
  {
    "id": "chunk_03344",
    "text": "able toilet, or poured into a deep pit and buried. y Clean waste containers with detergent and rinse with water. y Remove utility gloves and clean them whenever they are dirty and at least once every day. y Wash hands before and after disposing of soiled equipment and waste.",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3344
  },
  {
    "id": "chunk_03345",
    "text": "and after disposing of soiled equipment and waste. Wash linens y Wash linens (for example, bedding, caps, gowns, and surgical drapes) by hand or machine and line-dry or machine-dry. When handling soiled linens, wear gloves, hold linens away from your body, and do not shake them.",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3345
  },
  {
    "id": "chunk_03346",
    "text": "linens away from your body, and do not shake them. Little Risk of HIV Infection in the Clinic Health care providers may be exposed to HIV through needle sticks, mucous membranes, or broken skin, but the risk of infection is low: y Needle sticks or cuts cause most infections in health care settings.",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3346
  },
  {
    "id": "chunk_03347",
    "text": "uts cause most infections in health care settings. The average risk of HIV infection after a needle-stick exposure to HIV-infected blood is 3 infections per 1,000 needle sticks. y The risk after exposure of the eye, nose, or mouth to HIV-infected",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3347
  },
  {
    "id": "chunk_03348",
    "text": "xposure of the eye, nose, or mouth to HIV-infected blood is estimated to be about 1 infection per 1,000 exposures. Following universal precautions is the best way that providers can avoid workplace exposure to HIV and other fluid-borne infections. Post-exposure",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3348
  },
  {
    "id": "chunk_03349",
    "text": "IV and other fluid-borne infections. Post-exposure prophylaxis (PEP) with antiretroviral drugs will help to prevent HIV infection if a needle stick might have exposed a provider to HIV. 406 Family Planning: A Global Handbook for Providers",
    "page_number": 428,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3349
  },
  {
    "id": "chunk_03350",
    "text": "26 407 noisivorP gninnalP ylimaF Make Infection Prevention a Habit With each and every client, a health care provider should think, \u201cWhat infection prevention is needed?\u201d Any client or provider may have an infection without knowing it and without obvious symptoms. Infection prevention is a sign",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3350
  },
  {
    "id": "chunk_03351",
    "text": "t obvious symptoms. Infection prevention is a sign of good health care that can attract clients. For some clients cleanliness is one of the most important signs of quality. The 4 Steps of Processing Equipment 1. Decontaminate to kill infectious organisms such as HIV and hepatitis B",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3351
  },
  {
    "id": "chunk_03352",
    "text": "l infectious organisms such as HIV and hepatitis B and to make instruments, gloves, and other objects safer for people who clean them. Soak in 0.5% chlorine solution for 10 minutes. Rinse with clean cool water or clean immediately. 2. Clean to remove body fluids, tissue, and dirt. Wash or scrub with",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3352
  },
  {
    "id": "chunk_03353",
    "text": "body fluids, tissue, and dirt. Wash or scrub with a brush with liquid soap or detergent and water. Avoid bar soap or powdered soap, which can stay on the equipment. Rinse and dry. While cleaning, wear utility gloves and personal protective equipment\u2014goggles, mask, apron, and enclosed shoes.",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3353
  },
  {
    "id": "chunk_03354",
    "text": "quipment\u2014goggles, mask, apron, and enclosed shoes. 3. High-level disinfect or sterilize. y High-level disinfect to kill all infectious organisms except some bacterial endospores (a dormant, resistant form of bacteria) by boiling, by steaming, or with chemicals. High-level disinfect",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3354
  },
  {
    "id": "chunk_03355",
    "text": "steaming, or with chemicals. High-level disinfect instruments or supplies that touch intact mucous membranes or broken skin, such as vaginal specula, uterine sounds, and gloves for pelvic examinations. y Sterilize to kill all infectious organisms, including bacterial",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3355
  },
  {
    "id": "chunk_03356",
    "text": "kill all infectious organisms, including bacterial endospores, with a high-pressure steam autoclave, a dry-heat oven, chemicals, or radiation. Sterilize instruments such as scalpels and needles that touch tissue beneath the skin. If sterilization is not possible or practical (for example, for",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3356
  },
  {
    "id": "chunk_03357",
    "text": "ion is not possible or practical (for example, for laparoscopes), instruments must be high-level disinfected. 4. Store instruments and supplies to protect them from contamination. They should be stored in a high-level disinfected or sterilized",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3357
  },
  {
    "id": "chunk_03358",
    "text": "e stored in a high-level disinfected or sterilized container in a clean area away from clinic traffic. The equipment used to sterilize and high-level disinfect instruments and supplies also must be guarded against contamination. Infection Prevention in the Clinic",
    "page_number": 429,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3358
  },
  {
    "id": "chunk_03359",
    "text": "Managing Contraceptive Supplies Good-quality reproductive health care requires a continuous supply of contraceptives and other commodities. Family planning providers are the most important link in the contraceptive supply chain that moves commodities from the manufacturer to the client.",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3359
  },
  {
    "id": "chunk_03360",
    "text": "s commodities from the manufacturer to the client. Accurate and timely reports and orders from providers help supply chain managers determine what products are needed, how much to buy, and where to distribute them. Clinic staff members do their part when they",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3360
  },
  {
    "id": "chunk_03361",
    "text": "them. Clinic staff members do their part when they properly manage contraceptive inventory, accurately record and report what is provided to clients, and promptly order new supplies. In some facilities one staff member is assigned all the logistics duties. In other",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3361
  },
  {
    "id": "chunk_03362",
    "text": "ber is assigned all the logistics duties. In other facilities different staff members may help with logistics as needed. Clinic staff members need to be familiar with, and work within, whatever systems are in place to make certain that they have the supplies they need.",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3362
  },
  {
    "id": "chunk_03363",
    "text": "ake certain that they have the supplies they need. Logistics Responsibilities in the Clinic Each supply chain operates according to specific procedures that work in a specific setting, but typical contraceptive logistics responsibilities of clinic staff include these common activities: Daily",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3363
  },
  {
    "id": "chunk_03364",
    "text": "linic staff include these common activities: Daily y Track the number and types of contraceptives dispensed to clients using the appropriate recording form (typically called a \u201cdaily activity register\u201d). y Maintain proper storage conditions for all supplies: clean, dry storage,",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3364
  },
  {
    "id": "chunk_03365",
    "text": "e conditions for all supplies: clean, dry storage, away from direct sun and protected from extreme heat. y Provide contraceptives to clients by \u201cFirst Expiry, First Out\u201d management of the stock of supplies. \u201cFirst Expiry, First Out,\u201d or FEFO, sees to it that",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3365
  },
  {
    "id": "chunk_03366",
    "text": "First Expiry, First Out,\u201d or FEFO, sees to it that products with the earliest labeled expiry dates are the first products issued or dispensed. FEFO clears out older stock first to prevent waste due to expiry. Regularly (monthly or quarterly, depending on the logistics system)",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3366
  },
  {
    "id": "chunk_03367",
    "text": "y or quarterly, depending on the logistics system) y Count the amount of each method on hand in the clinic and determine the quantity of contraceptives to order (often done with a clinic pharmacist). This is a good time to inspect the supplies, looking for such",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3367
  },
  {
    "id": "chunk_03368",
    "text": "ood time to inspect the supplies, looking for such problems as products past their expiry date, damaged containers and packages, IUD or implant packaging that has come open, or discoloration of condoms. 408 Family Planning: A Global Handbook for Providers",
    "page_number": 430,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3368
  },
  {
    "id": "chunk_03369",
    "text": "26 409 noisivorP gninnalP ylimaF y Work with any community-based distribution agents supervised by clinic staff, reviewing their consumption records and helping them complete their order forms. Issue contraceptive supplies to community-based",
    "page_number": 431,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3369
  },
  {
    "id": "chunk_03370",
    "text": "s. Issue contraceptive supplies to community-based agents based on their orders. A record of the date of expiry of these supplies can help with retrieving supplies that have not been distributed and are out of date. y Report to and make requests of the family planning program coordinator",
    "page_number": 431,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3370
  },
  {
    "id": "chunk_03371",
    "text": "equests of the family planning program coordinator or health supplies officer (typically at the district level), using the appropriate reporting and ordering form or forms. The quantity that is ordered is the amount that will bring the stock up to the level that will",
    "page_number": 431,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3371
  },
  {
    "id": "chunk_03372",
    "text": "hat will bring the stock up to the level that will meet expected need until the next order is received. (A plan should be made in advance to place emergency orders or borrow supplies from neighboring facilities if there are sudden increases in demand, potential",
    "page_number": 431,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3372
  },
  {
    "id": "chunk_03373",
    "text": "if there are sudden increases in demand, potential for running out of inventory, or large losses, for example, if a warehouse is flooded.) y Receive the ordered contraceptive supplies from the clinic pharmacist or other appropriate person in the supply chain. Receipts should be checked",
    "page_number": 431,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3373
  },
  {
    "id": "chunk_03374",
    "text": "CHAPTER 27 Providing Family Planning Services During an Epidemic Key Points for Providers and Clients y Family planning services should be maintained throughout an epidemic. y Medical eligibility criteria for safe use of contraceptive methods do not change during an epidemic.",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3374
  },
  {
    "id": "chunk_03375",
    "text": "aceptive methods do not change during an epidemic. y Some contraceptive methods can be safely and effectively self-initiated and continued with or without support from health care providers. y More widespread use of digital health technologies and direct",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3375
  },
  {
    "id": "chunk_03376",
    "text": "read use of digital health technologies and direct pharmacy access may improve access during an epidemic. Introduction Epidemics of life-threatening infectious diseases are becoming more common, and cause significant disruptions to the health care system, affecting the",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3376
  },
  {
    "id": "chunk_03377",
    "text": "sruptions to the health care system, affecting the delivery of both routine and urgent health services and care. Family planning providers need to balance the demands of responding to outbreaks, while simultaneously maintaining family planning services in all three phases",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3377
  },
  {
    "id": "chunk_03378",
    "text": "ining family planning services in all three phases of an epidemic response: mitigation and preparedness, emergency, and post-emergency. In epidemics, large numbers of people may require medical attention, health care systems may be over-stretched, and public order may be threatened.",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3378
  },
  {
    "id": "chunk_03379",
    "text": "ver-stretched, and public order may be threatened. The impact of an epidemic on reproductive health can be a direct result of the infectious disease, or an indirect consequence of excessive pressures on the broader health care system, including limited resources, commodity",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3379
  },
  {
    "id": "chunk_03380",
    "text": "are system, including limited resources, commodity stock-outs, challenges in accessing the usual service-delivery sites, reduced availability of health care providers, fears of disease transmission and acquisition, and misconceptions about safety. 410 Family Planning: A Global Handbook for Providers",
    "page_number": 432,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3380
  },
  {
    "id": "chunk_03381",
    "text": "27 411 cimedipE na gniruD secivreS gninnalP ylimaF gnidivorP When health care systems are overwhelmed due to an outbreak, both direct mortality from the outbreak disease and indirect mortality from other preventable and treatable conditions are likely to increase. Family planning",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3381
  },
  {
    "id": "chunk_03382",
    "text": "conditions are likely to increase. Family planning promotes both physical and mental health, and reduces maternal and infant morbidity and mortality through the prevention of unintended pregnancy and unsafe abortion. Unintended pregnancy during an epidemic is associated with",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3382
  },
  {
    "id": "chunk_03383",
    "text": "ed pregnancy during an epidemic is associated with increased risks. Family planning is a lifesaving, essential service, and should be maintained throughout an epidemic. Maintaining Family Planning Services in an Epidemic Individuals\u2019 ability to access and effectively use family planning services is",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3383
  },
  {
    "id": "chunk_03384",
    "text": "ss and effectively use family planning services is time-sensitive, because incorrect or delayed contraceptive use greatly reduces effectiveness. In providing family planning services during an epidemic, providers should: y Screen clients for symptoms of the epidemic disease and\u2014if symptoms are",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3384
  },
  {
    "id": "chunk_03385",
    "text": "mptoms of the epidemic disease and\u2014if symptoms are present\u2014manage or refer the client in accordance with local protocols. y Protect their own and their client\u2019s safety during interactions by following rules of infection prevention appropriate to the type of epidemic,",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3385
  },
  {
    "id": "chunk_03386",
    "text": "on prevention appropriate to the type of epidemic, including sanitizing equipment and rooms using the correct protocols (see Chapter 26 \u2013 Family Planning Provision, section on Infection Prevention in the Clinic, pp. 404\u2013407). y Ensure that the client makes a voluntary and informed method choice, and",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3386
  },
  {
    "id": "chunk_03387",
    "text": "makes a voluntary and informed method choice, and that privacy and confidentiality are respected. y Provide the full range of methods when resources and circumstances permit, but be open about what is not available, and when additional",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3387
  },
  {
    "id": "chunk_03388",
    "text": "n about what is not available, and when additional methods may become available. Offer the client a \u201cbridging\u201d method if their method of choice is not available. y Provide multi-month supplies of oral contraceptives and subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection, and",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3388
  },
  {
    "id": "chunk_03389",
    "text": "esterone acetate (DMPA-SC) for self-injection, and multiple doses of emergency contraceptive pills (ECPs), as needed, to cover a longer duration of use. y Discuss and counsel on IUDs (see Chapters 10 and 11) and implants (see Chapter 9) that may be effective beyond the labelled duration of use.",
    "page_number": 433,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3389
  },
  {
    "id": "chunk_03390",
    "text": "Safe Use of Contraceptive Methods in an Epidemic The medical eligibility criteria (MEC) for contraceptive use do not change during an epidemic. To provide safe family planning care during an epidemic, providers should: y Share tasks with other cadres of health workers, when family planning",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3390
  },
  {
    "id": "chunk_03391",
    "text": "her cadres of health workers, when family planning services and methods can be safely provided, to allow more specialized clinicians to use their skills to provide specialized services. y Continue to use WHO\u2019s Medical Eligibility Criteria for Contraceptive",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3391
  },
  {
    "id": "chunk_03392",
    "text": "O\u2019s Medical Eligibility Criteria for Contraceptive Use (MEC) and the MEC wheel or app to evaluate the safety of contraceptive methods for each client (see Digital Health Tools at the end of this chapter). y Recognize health risks, including signs and symptoms of serious health",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3392
  },
  {
    "id": "chunk_03393",
    "text": "ks, including signs and symptoms of serious health conditions that may be more common during a protracted epidemic. If a client reports such signs or symptoms, refer them for care or manage the conditions. y Reassess the safety of contraceptive methods for clients who develop",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3393
  },
  {
    "id": "chunk_03394",
    "text": "y of contraceptive methods for clients who develop serious health conditions. (See Appendix B \u2013 Signs and Symptoms of Serious Health Conditions). Self-Care for Contraception Many contraceptive methods can be safely and effectively self-administered",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3394
  },
  {
    "id": "chunk_03395",
    "text": "ds can be safely and effectively self-administered without a physical exam. Combined oral contraceptives (COCs), progestin- only pills (POPs), emergency contraceptive pills (ECPs), spermicides, some diaphragms, male and female condoms, fertility awareness-based methods,",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3395
  },
  {
    "id": "chunk_03396",
    "text": "female condoms, fertility awareness-based methods, and lactational amenorrhea are all methods that clients can self-administer. Clients can initiate and continue these methods with or without the support of a health worker. Clients can also self-inject with DMPA-SC after training",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3396
  },
  {
    "id": "chunk_03397",
    "text": "s can also self-inject with DMPA-SC after training (see Chapter 4 \u2013 Progestin-Only Injectables, section on Self-Injection Can Be an Option, pp. 83\u201386). In providing family planning services during an epidemic, providers should: y Dispense DMPA-SC, COCs, POPs, ECPs, spermicides, flexible diaphragms,",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3397
  },
  {
    "id": "chunk_03398",
    "text": "OCs, POPs, ECPs, spermicides, flexible diaphragms, and male and female condoms in pharmacies or drug stores without a prescription, where allowed by national regulations. y Distribute these methods in community outreach programs without a prescription, where allowed by national regulations.",
    "page_number": 434,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3398
  },
  {
    "id": "chunk_03399",
    "text": "27 Providing Family Planning Services During an Epidemic 413 cimedipE na gniruD secivreS gninnalP ylimaF gnidivorP Use of Digital Health Technologies Digital health technologies can help health care providers maintain access to",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3399
  },
  {
    "id": "chunk_03400",
    "text": "can help health care providers maintain access to family planning for clients even during an epidemic. There are many formats and uses for digital health technologies, and they may be particularly valuable during an epidemic when clinic-based services are restricted.",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3400
  },
  {
    "id": "chunk_03401",
    "text": "pidemic when clinic-based services are restricted. Examples of some of the technologies used in a digital health framework to connect providers with clients include: SMS or text messaging, phone or video \u201cvisits\u201d, informative pod casts, mobile apps, and web-based tools",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3401
  },
  {
    "id": "chunk_03402",
    "text": "mative pod casts, mobile apps, and web-based tools such as email or open medical records (medical records that clients can directly review or access themselves). With the exception of IUDs, implants, some diaphragms, and permanent methods (male and female sterilization),",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3402
  },
  {
    "id": "chunk_03403",
    "text": "permanent methods (male and female sterilization), contraceptive methods do not require a physical exam prior to initiation. In providing family planning services during an epidemic, providers should: y Use digital health technologies to connect with clients, counsel them,",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3403
  },
  {
    "id": "chunk_03404",
    "text": "echnologies to connect with clients, counsel them, and prescribe methods that do not require physical examination. y Leverage digital health technologies to share important information on the safety of contraceptive methods, and how to access services and self- administer selected methods.",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3404
  },
  {
    "id": "chunk_03405",
    "text": "ss services and self- administer selected methods. Digital Health Tools Contraceptive delivery tool for humanitarian settings To access and install the Android or Apple App, follow this link for information: https://www.who.int/ news/item/07-12-2018-delivering-contraceptive-",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3405
  },
  {
    "id": "chunk_03406",
    "text": "nt/ news/item/07-12-2018-delivering-contraceptive- services-in-humanitarian-settings Medical eligibility criteria for contraceptive use app To access and install the Android or Apple App, follow this link for information: https://www.who.int/ news/item/29-08-2019-new-app-for-who-s-medical-",
    "page_number": 435,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3406
  },
  {
    "id": "chunk_03407",
    "text": "Wall Chart Available To Help Clients Choose Contraceptive Methods The wall chart \u201cDo you know your family planning choices?\u201d offers important points that a client can consider, and a provider can discuss, about many family planning methods. The wall chart includes the effectiveness chart",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3407
  },
  {
    "id": "chunk_03408",
    "text": "s. The wall chart includes the effectiveness chart shown on the back cover of this book and a summary of medical eligibility criteria for contraceptive use. Printed copies of the wall chart can be ordered online at: www.fphandbook.org/order-form. World HU ep ald ta ht Oed r gt ao n i in zc al tu iod",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3408
  },
  {
    "id": "chunk_03409",
    "text": "ld HU ep ald ta ht Oed r gt ao n i in zc al tu iod n e2021 guidance through \u2022 One or 2 small rods placed under the skin of \u2022 Small, flexible device made with either \u2022 Meant to be permanent. For women who \u2022 Meant to be permanent. For men",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3409
  },
  {
    "id": "chunk_03410",
    "text": "nt. For women who \u2022 Meant to be permanent. For men a woman's upper arm. copper or hormone, placed inside the are sure that they will not want more who are sure that they will not want",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3410
  },
  {
    "id": "chunk_03411",
    "text": "not want more who are sure that they will not want Little to do once implants are in place. womb. children. Think carefully before deciding. more children. Think carefully before",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3411
  },
  {
    "id": "chunk_03412",
    "text": "re deciding. more children. Think carefully before \u2022 Very effective for 3 to 5 years, depending on \u2022 Very effective, reversible, long-term copper \u2022 Very effective (but not I00% effective). deciding. \u2022 w wC oh ani mc h b a e nim u hp s ael sa dn h t aa. dt a cn hy il da rg ee n",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3412
  },
  {
    "id": "chunk_03413",
    "text": "u hp s ael sa dn h t aa. dt a cn hy il da rg ee n a .nd whether or not a T y 3e C ta ou r s- 6.3 H8 y0 eo aA r rm sI .U onD a lc La Nn Gbe - Iu Us Ded c a at n le ba es ut s1 e2 d for \u2022 s PIn u av r ino g el iv sre y bs . T lp ohh cey k",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3413
  },
  {
    "id": "chunk_03414",
    "text": "s PIn u av r ino g el iv sre y bs . T lp ohh cey k s ewi dc oa .ml e ax na m us ua an ld ly s sa tf ae y, ss i am wp al ke e . \u2022 \u2022 uU Vn es t re i yl a t en h fo fe et cvh tae is vr e e m c ate o ftt m eh ro y 3d s t mf ao r or t nst th t hoe s f w (ir bos ut r t k3 n. m oto In 0t 0h %s,",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3414
  },
  {
    "id": "chunk_03415",
    "text": "hoe s f w (ir bos ut r t k3 n. m oto In 0t 0h %s, \u2022 oA u w t to hm e a in m c pa lan n h tsa v ae t a a nt yr a ti in me ed . Tp hro ev ni d se hr e t ca ak ne \u2022 C wean ll ab se ain t s oe tr ht ee rd tr imigh et s .after childbirth, as \u2022 pP ra oin c ea dn ud r s ew . Se ell rin iog u c sa cn o l mas pt la ic afe tw io nd sa y as r ea f rt ae rr e . \u2022 e Saff fe ec , t si iv me) p. le, convenient surgery. Done in a",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3415
  },
  {
    "id": "chunk_03416",
    "text": ", t si iv me) p. le, convenient surgery. Done in a \u2022 \u2022 b o NU Sae cn o fc c ee to u x dr hm p , uaoee r rrc m ip n t mer gfue d o blg .nl rn i etga h ahn l stt y t b fw b el le ei et e dh ed i d nn i in gno .g g d o me rl aa s yy p . so tt oti pn . g may \u2022 \u2022 S SI l n aoU no eon e rDm g ih m oe e em ur i a a,p svo e a (i cn s e li on opt rh w e md bl cy u l pi be ar lb le ili o clln dye aog ie tna d idi t ogn i i nn fs rai oe srg n sr nd am tt ) r .i .ho ea Wy e n r l. p ab i tW rse h e p h . i L rt Pe Nh e ea vv lGc veio e in- cp r I t U p a De nr d \u2022 \u2022 s aN Ce sao x an u tl o a b oln e tag hdb- et oile ri nt r ty em i m o r is r egi sd hf .ee te ae li ff n tf ee g rsc .t cs h. iN ldo b ie rtff he , c at s o wn e ll \u2022 \u2022 f dP Ne aaw oyin s e,m . s f A fwi en ceu fe tlt l we i ons ng. m ,P so ea er ni xn ub hi ars au l v b i aesl b o i ln iac lg isk t t ye c i nad ogn. r p l fa a es i et n l. ia n gfe sw .",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3416
  },
  {
    "id": "chunk_03417",
    "text": "c i nad ogn. r p l fa a es i et n l. ia n gfe sw . infection occasionally occurs if a woman has certain sexually transmitted infections when the IUD is inserted. \u2022 Can come out on its own, especially \u2022 Effective and reversible without delay. \u2022 Good choice for breastfeeding mothers",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3417
  },
  {
    "id": "chunk_03418",
    "text": "out delay. \u2022 Good choice for breastfeeding mothers \u2022 Three types: DMPA\u2014injection every at first. \u2022 Take one pill every day and start new packs who want pills.",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3418
  },
  {
    "id": "chunk_03419",
    "text": "pill every day and start new packs who want pills. 3 months (13 weeks); NET EN\u2014injection \u2022 A woman can become pregnant with no on time for greatest effectiveness. \u2022 Very effective during breastfeeding and",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3419
  },
  {
    "id": "chunk_03420",
    "text": "iveness. \u2022 Very effective during breastfeeding and every 2 months; Cyclo-Fem and delay after the IUD is removed. \u2022 Unexpected bleeding or spotting may reversible without delay.",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3420
  },
  {
    "id": "chunk_03421",
    "text": "bleeding or spotting may reversible without delay. \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 \u2022 o l o y b c C c i c u f c p fC E P C D M W WMa n ero h o o ar s rf rt r et wa ja af M a a ne eh ui i e ue m ne i hqnv l yn n y1 ta g de ac tc P e a uh o m f h ms nlrb tr b bgts bo Aw t l ne t i ca yas i aet ie i moee ov f ur v nr cv\u2014 c i e ne i.l e a bn et n ra ne ue tl a oe uD teO hn e.b e,i jp r g bi k a s d ny t eh S a. wdn . l cM e tt yen le o mi t c gM pa ej oihl n .t hd he d va N atuP d o C te mg oio e lc t t i in oA r o yc nta ,s re oE nt c an se t e hsa ts nt .,i T g nh tie io tx Ahtf sf n n2 g s heao he c l i a i tn ae fl j g sg fE sn t la rd l e . r sw tt i i t i .i t gyn tN t e ee vi a c arn hnm i c oe h ien e s t n rv nj na ej l oe ae t p e n e o o dgao g jn D ey bc mk ,ecr . r D t wen oo rt 6 al us t cy e M,e i e t it ut M e t o a n o sh wsel w m ss ia r rn Ph eon a ,nl l a P -st Ay ol ed p md o xo ds n f Ae e e ey e m rv pr ,oin s liw ov on - e k n fif it et d sSs to ae i en-j u s th h cn ee e C nftun r rh mt i t. e h c da l h a r et e i lN ct e ot fi n.i aer i h lf t d nha n y a y e rj dDe ecE b e4 ge nj ber . bo t lT cul r M e e aw c ll gm t s ee s ks o t a ePE ie esei. n em b tr AoN e dd g lnu aen -k i i, nn Si .n s ot gC g . it t y . \u2022 \u2022 \u2022 \u2022 s iH- - - nB a mA Ao 6 e e o c eH M H e xr w em x lf lf b f u ut pe ea tn ooc or eo ah dm r r e e rne mn p l o in ea lp ta nb bi y, r t dl hr ats gy ba a e shl t l n ty b b h vb yos f rp H e ey y e r t asfl ba e u e h na I h ng if Vl cdn a sl tet o sel d a e sy /in me ul pn t n At a eri s d lb rg yn is d Im ni tec r Dlg sn w ti ah oe gt pi egnl tm St nia o k l dl hl d l a ,s d h ae o,me a wnt nb a a innft n no se a cnih hfgi r f r on g ye d 6 eo eent h d rh cn nrd o au s m ti . to na n h t,s u i ub n ooe a dg e srf sa ns o, n no ee es sb f d tt s toLoe doLr hhu Ad dr e (mA esr cS a M n ruo o oM To es epn r rt l I,d dw f s r et df e, ). ou h e ,r a cl de i n tl ny n ls d yk : \u2022 \u2022 \u2022 \u2022\u2022 \u2022 \u2022 \u2022 t e co M m c T c n b o W E U BS S C H i oh o xo a o l fmc t lh sea e foo ahfa ao rc m em t ue e n e dl ern rn m eu p cms a a de dep et rg f tr b e lb o ih i c, ep li l a e w nne yr vi c ewe tl r c rno r, ,e ay eg o fo s eau u w so of tg , n i p pt nt vb nm ii ip s au m r ofe ze i oe e ldel f o ns eal ee en a ua na mc n idee cen tr .e cn r si sttn eiga msl ta td e o a ey ool s a m ih ns dl ti o xah ni y fn t ae a dt r .a ge nsao a m g s c ve ea i Cv .w en n ( m a oer t ie lh ub ty s spov a ra r a se a ta f e h ny dym rwi a mr tdc cr . r e r i f g uh as wo de i hy a c oel c bat p,dw o m g ato. h rl lr e hl v ma o N eya i m che s t e rn lm o r d r hp e as e c o da e da d ar ie gao ovst n l m. e e n mi cd w e n mg i. n eh aria rpSth ia h o hp.a n mc yh ol set er l e n th ,se y fr i tm oet a n). he r i ih , ro mda n s ef e a nva tu , u .a e on arn awl vsf. g .d li d f yo r e i tn s ri itg a m .h e et a .ch \u2022 \u2022 \u2022 \u2022 \u2022 \u2022\u2022 \u2022 o v s U h d ce u N A D C R N CT If ua hf on ua f e sf a euo on g c ik we e rwh u q ln rr i ho t die c x ne a u ntp o i e t b t n bh ap a lr a i gho v mi l r iig l ev a y eb s y rne en m fe r sc ar ts et r o sc ee m en he m.t n iho v o cf ne xe pa , fe e p f n a eenld l os u ,s a e y ri lt tct dfl os rl r hal e hf l s. t. o s to ie rr l ire ig o wnoy dv re n mthv t de e m eid hs he c vt l rs se i i y e ar i e et '. l n b f s ec m gy o y wt fg l u f il ie c nee, bmd u a ht se os c a. ye ra s e ap d e o t el y el d t bl so i aip n a . nf eet a st co e g h fnt f tc o erf r hi fe o en oa ear c a g r ctg r t eu tf rhe er ite i dp do oa ie r e c v il c nn na t ne r t teo i .dt l ,o g l y ,e m e am a .. vs fue ttt m o s ei tm i eh ro d oe sn d.",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3421
  },
  {
    "id": "chunk_03422",
    "text": "am a .. vs fue ttt m o s ei tm i eh ro d oe sn d. every time. Emergency Contraceptive Pills \u2022 For protection from STIs/HIV, some Some Methods Are Not Advised If You Have Certain Health Conditions",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3422
  },
  {
    "id": "chunk_03423",
    "text": "Not Advised If You Have Certain Health Conditions \u2022 \u2022 w mH Saie i ft s el h tp ai f n k op e rr 5 e w adv le la i tyn whst o aap m fr ft ae ee mg nrn .iu la ynn ppc lry ao nw t neh ic ne t gn e d mt a s ek e te hxn o o dr . a \u2022 \u2022 c f E Eao a fm fsu eyip cl y tl te i o vps e l uau in ss fe e n u i w snc eo g i dt n hm d c e ao o tm rlh i rtos et ld cea tsl lo . p yn r eag vc w eti rci yt eh . t io mth ee . r C Smo on kd ei t cio ign ar ettes and also age 35 or older C mM o oe m nt th b ho i ln yd e is d n jN eo cro ta alt b c loA esnd .trv ais ce epd tive pills (COCs). If you smoke heavily,",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3423
  },
  {
    "id": "chunk_03424",
    "text": "is ce epd tive pills (COCs). If you smoke heavily, \u2022 tT hh ee by ad bo y n ifo at wdi os mru ap nt ip sr ae lg rn ea an dc yy p o rer gh na ar nm t. \u2022 O Sof mte en pn eo ot pu ls ee od b e jev ce tr y t ht aim t ce o, h no dw omev se ir n. terrupt",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3424
  },
  {
    "id": "chunk_03425",
    "text": "r y t ht aim t ce o, h no dw omev se ir n. terrupt Known high blood pressure C 2-O anC ds , 3m -mon ot nh tl hy ii nn jj ee cc tt aa bb ll ee ss .. If severe high blood pressure, also",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3425
  },
  {
    "id": "chunk_03426",
    "text": "bb ll ee ss .. If severe high blood pressure, also \u2022 aR re eg u mla or r efa em ffi ely c tp ivla en . n Pi ln eg a sm e e ct oh no sd ids er s the ex m, r .e Td au lkc ie n gs e wn is ta ht i po an r, to nr e re m cab na r hr ea lpss . F 6u mlly o no tr h n searly fully breastfeeding in first COCs, monthly injectables",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3426
  },
  {
    "id": "chunk_03427",
    "text": "y breastfeeding in first COCs, monthly injectables starting another method now. Breastfeeding in first 6 weeks 2- and 3-month injectables First 21 days after childbirth, COCs, monthly injectables. (COCs and monthly injectables not",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3427
  },
  {
    "id": "chunk_03428",
    "text": "hly injectables. (COCs and monthly injectables not Comparing Effectiveness of Family Planning Methods not breastfeeding a thd av ti s ye od u f o mr i gfi hr ts t d 6 e vw ele oe pk s b la oft oe dr cd le ol ti v ie nr ay dif e t eh pe r ve e ia nr e (V s Tp Ee )c . i Tal h r ee sa es o cln os t s",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3428
  },
  {
    "id": "chunk_03429",
    "text": "e (V s Tp Ee )c . i Tal h r ee sa es o cln os t s are more likely for several months following the birth of a child.) How to make your Wait until 6 weeks after childbirth to fit diaphragm correctly.",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3429
  },
  {
    "id": "chunk_03430",
    "text": "weeks after childbirth to fit diaphragm correctly. peL ir np e 1 rs oe 0s ng 0 t n e h wa ya n o en c am y1 r e n m IA om rft repe erl m t apn eh ro mto cs be, ed dI ruU rm eD, ,li o tftelr eme oa rle neof stf the einrc gi lt tiozi v adtoe i o: n: C h Mee ia gr r rt t aa , i i nbn el ou hon ec d ao dvm e as cm s heo eln ss , (s o ae r r t i ylo i pvu e es r , o d o fi rs s e eba vrs eee ras es to h f c e at ah n de c a e cr he) C p CrO OovC Cids se, , i mrn .j oe nc tt hab lyl e ins, j ep cr to ag be lest si .n A-o sn kl y y op uill rs , p i rm op vl ia dn et rs .. Ask your",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3430
  },
  {
    "id": "chunk_03431",
    "text": "op uill rs , p i rm op vl ia dn et rs .. Ask your Vfirasts e3 cmtoonmthys: Use another method for M spi ogr t a ii nn e o na eu r ea y e(s )o , am t e at nim y e ags e see a growing bright COCs, monthly injectables. Ask your provider.",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3431
  },
  {
    "id": "chunk_03432",
    "text": "time Gall bladder disease COCs. Ask your provider. L (a P Pfna aiod lc tlr sn ct :a 6i h g Tt h ,m a i t ro k ieon n n aa g tl :p h iA Klls e m e) ea: p ceB h inr n e d o pa ars ly atr cfhe eee , d ca ho aMf nte ge ent , ohd naoy d t im e C S o i une nre fx e tr v ru ct e eta a r aii l oyn l ty en hu dst irn ; g Aa pc hn e Io Ds i lm n vm Sidm ci it v ito nie dn fd u l a c a mio n l fn r me id sc ai kt tt i oi o oo rn fn y ss g deoo itf sf t eitf nhe ag sm e e ta c h (l e oe Pr s Ivo Deir x )g ; ans I I W t (U U Tre hoD D a im t. . s m U A e ines ns ce n k lw t u c ,y dio co t eh anu sn dr H to gp hIm eVr eno , s Ii ev n Ue ri cd av Dl le e u l yr n d f. o i ui n rf s g a e a l w s a wo no o ymu m s fe ai an n m ng w i l wa yin t ip tho hl t aA h n aIe cnDr tin u Sm g a a le mn At dh e ID o tt hhd Soo . ids fe t ho en y choose.",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3432
  },
  {
    "id": "chunk_03433",
    "text": "At dh e ID o tt hhd Soo . ids fe t ho en y choose. M coa rrl ee c tc lyo n evd eo rym tis m, ed yia op u h hr ava eg sm ex: Use s H inh vIe V o i ls i vn eo f e sn c p tt eir o re mna t icm ca idne en u st s . ean ad n yd o min eg t hw oe dl l e.) x W ceo pm t e mn e ta ht oh dig sh t hri as tk of",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3433
  },
  {
    "id": "chunk_03434",
    "text": "x W ceo pm t e mn e ta ht oh dig sh t hri as tk of FAebsrttaiilni toyr auwsea croenndeomsss mone ftehrtoilde sd:a ys. Known pregnancy No method needed. Standard Days Method and Two Day. pep rA r 1eb 0go 0n u a wt n oc2 i m0 es en",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3434
  },
  {
    "id": "chunk_03435",
    "text": "o Day. pep rA r 1eb 0go 0n u a wt n oc2 i m0 es en M F syopee uemt h rho a mavd l ee im c sc iea doy xe nb sde : oe Ua mss eie s c,r o wt ro ri etu chs te dly. r eavwerayl ,t ime FhMACao goanr er md nymb mlcao yo n u or dfnoek i 2 cr ia an 1In tn2f ido ot0 er n2m rm ,nU Po aa rrStoet Aii o goc; rn on e aammp la i De sab .iso el uo voetfr ldtt ohhepeirs mss @ew e naf ja tlhlm , uGccihl lcya op rp b.tol a af lrnr , go Gn . Tmi Hn hg /Ki Psm n Rcoe Hhtwah /rPloetE dduCsgp, ,e dh u aSe ntUa del eCt sh rCa c tnE ha dS er eSr te , epJpo rr lmohacnv seis d so He fp ro Crs e p oc vka oiionn pu s ec sroClayne t s pin vu ut elebt A rlF i sgafho rm eer ei dlCy m eoP edlma nitn tmi on 7iunn 2nsg 0.i : Tc 0Aa Ah tG iAisol o 1wnb 9 a aP Cllr l AHocg 0har 0n aard 0mtb 0 osw1 o . (ak RJsH e f moC vr ia sCP diorPeo n) v,p i \u00a91d oe1 sr1 2ss i 0. b M 2H le1ae r , bak Jol yet hhts n uPc spal apr Hce oe o rp, p tSr ko fu irniv oti semd Ce3 r t1 ehs n0 ec t, eaBUn ran l fotiotibmert doa irSnet a,t h tee s",
    "page_number": 436,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3435
  },
  {
    "id": "chunk_03436",
    "text": "APPENDIX A Contraceptive Effectiveness Rates of Unintended Pregnancies per 100 Women First-Year 12-Month Pregnancy Ratea Pregnancy Ratec (Trussell & Aikenb) (Polis et al.d) Consistent and As commonly As commonly Family planning method Key correct use used used Implants 0.1 0.1 0.6 0\u20130.9",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3436
  },
  {
    "id": "chunk_03437",
    "text": "y correct use used used Implants 0.1 0.1 0.6 0\u20130.9 Vasectomy 0.1 0.15 Very effective Female sterilization 0.5 0.5 Levonorgestrel IUD 0.5 0.7 1\u20139 Copper-bearing IUD 0.6 0.8 1.4 Effective LAM (for 6 months) 0.9e 2e Monthly injectable 0.05e 3e 10\u201319 Progestin-only injectable 0.2 4 1.7 Moder-",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3437
  },
  {
    "id": "chunk_03438",
    "text": "e 10\u201319 Progestin-only injectable 0.2 4 1.7 Moder- Combined oral contraceptives 0.3 7 5.5 ately effective Progestin-only pills 0.3 7 Combined patch 0.3 7 20+ Combined vaginal ring 0.3 7 Less effective Male condoms 2 13 5.4 Standard Days Method 5 12 TwoDay Method 4 14 Ovulation method 3 23",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3438
  },
  {
    "id": "chunk_03439",
    "text": "thod 5 12 TwoDay Method 4 14 Ovulation method 3 23 Other fertility awareness 15 methods Diaphragms with spermicide 16 17 Withdrawal 4 20 13.4 Female condoms 5 21 Spermicide 16 21 Cervical capf 26g, 9h 32g, 16h No method 85 85",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3439
  },
  {
    "id": "chunk_03440",
    "text": "21 Cervical capf 26g, 9h 32g, 16h No method 85 85 a Rates largely from the United States. Data from best available source as determined by authors. b Trussell J and Aiken ARA, Contraceptive efficacy. In: Hatcher RA et al. Contraceptive Technology, 21st revised edition. New York: Ardent Media, 2018.",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3440
  },
  {
    "id": "chunk_03441",
    "text": "1st revised edition. New York: Ardent Media, 2018. A c Rates from developing countries. Data from self-reports in population-based surveys. d Polis CB et al. Contraceptive failure rates in the developing world: an analysis of Demographic and Health",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3441
  },
  {
    "id": "chunk_03442",
    "text": "oping world: an analysis of Demographic and Health Survey data in 43 countries. New York: Guttmacher Institute, 2016. e Source: Hatcher R et al. Contraceptive technology. 20th ed. New York: Ardent Media, 2011.",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3442
  },
  {
    "id": "chunk_03443",
    "text": "technology. 20th ed. New York: Ardent Media, 2011. f Source: Trussell J. Contraceptive failure in the United States. Contraception. 2004:70(2): 89\u201396. g Pregnancy rate for women who have given birth h Pregnancy rate for women who have never given birth 415 ssenevitceffE evitpecartnoC",
    "page_number": 437,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3443
  },
  {
    "id": "chunk_03444",
    "text": "APPENDIX B Signs and Symptoms of Serious Health Conditions The table below lists signs and symptoms of some serious health conditions. These conditions are mentioned under Health Risks or Managing Any Problems in the chapters on contraceptive methods. These conditions occur rarely to",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3444
  },
  {
    "id": "chunk_03445",
    "text": "aceptive methods. These conditions occur rarely to extremely rarely among users of the method. They also occur rarely among people of reproductive age generally. Still, it is important to recognize possible signs of these conditions and to take action or refer for care if a client reports",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3445
  },
  {
    "id": "chunk_03446",
    "text": "take action or refer for care if a client reports them. In some cases clients who develop one of these conditions may need to choose another contraceptive method. Condition Description Signs and Symptoms Deep vein A blood clot that Persistent, severe pain in one leg,",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3446
  },
  {
    "id": "chunk_03447",
    "text": "lood clot that Persistent, severe pain in one leg, thrombosis develops in the deep sometimes with swelling or red skin. veins of the body, generally in the legs Ectopic Pregnancy in which the In the early stages of ectopic pregnancy, pregnancy fertilized egg implants symptoms may be absent or mild,",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3447
  },
  {
    "id": "chunk_03448",
    "text": "lized egg implants symptoms may be absent or mild, in tissue outside the but eventually they become severe. uterus, most commonly A combination of these signs and in a fallopian tube but symptoms should increase suspicion of sometimes in the cervix ectopic pregnancy:",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3448
  },
  {
    "id": "chunk_03449",
    "text": "cion of sometimes in the cervix ectopic pregnancy: or abdominal cavity \u2022 Unusual abdominal pain or tenderness \u2022 Abnormal vaginal bleeding or no monthly bleeding\u2014especially if a change from her usual bleeding pattern \u2022 Light-headedness or dizziness \u2022 Fainting",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3449
  },
  {
    "id": "chunk_03450",
    "text": "pattern \u2022 Light-headedness or dizziness \u2022 Fainting Heart attack Occurs when the blood Chest discomfort or supply to the heart is uncomfortable pressure; fullness, blocked, usually due to squeezing, or pain in the center a build-up of cholesterol of the chest that lasts longer than",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3450
  },
  {
    "id": "chunk_03451",
    "text": "of cholesterol of the chest that lasts longer than and other substances in a few minutes or that comes and the coronary arteries goes; spreading pain or numbness in one or both arms, back, jaw, or stomach; shortness of breath; cold sweats; nausea. 416 Family Planning: A Global Handbook for Providers",
    "page_number": 438,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3451
  },
  {
    "id": "chunk_03452",
    "text": "Condition Description Signs and Symptoms Liver Infection with hepatitis Yellow eyes or skin (jaundice) and disorders inflames the liver; abdominal swelling, tenderness, or pain, cirrhosis scars tissue, especially in the upper abdomen. which blocks blood flow through the liver",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3452
  },
  {
    "id": "chunk_03453",
    "text": "abdomen. which blocks blood flow through the liver Pelvic An infection of the Lower abdominal pain; pain during inflammatory upper genital tract, sex, pelvic examination, or urination; disease (PID) caused by various types abnormal vaginal bleeding or discharge;",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3453
  },
  {
    "id": "chunk_03454",
    "text": "ious types abnormal vaginal bleeding or discharge; of bacteria fever; cervix bleeds when touched. In a pelvic examination, signs of PID include tenderness in the ovaries or fallopian tubes, yellowish cervical discharge containing mucus and pus, bleeding easily when the cervix is touched",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3454
  },
  {
    "id": "chunk_03455",
    "text": "nd pus, bleeding easily when the cervix is touched with a swab, or a positive swab test, and tenderness or pain when moving the cervix and uterus during pelvic examination. Pulmonary A blood clot that Sudden shortness of breath, which may",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3455
  },
  {
    "id": "chunk_03456",
    "text": "od clot that Sudden shortness of breath, which may embolism travels through the worsen with a deep breath, cough that bloodstream to the may bring up blood, fast heart rate, and lungs a light-headed feeling. Ruptured When a fallopian Sudden sharp or stabbing pain in lower",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3456
  },
  {
    "id": "chunk_03457",
    "text": "a fallopian Sudden sharp or stabbing pain in lower ectopic preg- tube breaks due to an abdomen, sometimes on one side. nancy ectopic pregnancy Possible right shoulder pain. Usually, within hours the abdomen becomes rigid and the woman goes into shock.",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3457
  },
  {
    "id": "chunk_03458",
    "text": "domen becomes rigid and the woman goes into shock. Severe When a person\u2019s body Rash over much of the body, dizziness allergic has a strong reaction to brought on by a sudden drop in blood reaction contact with latex pressure, difficult breathing, loss of consciousness (anaphylactic shock). to latex",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3458
  },
  {
    "id": "chunk_03459",
    "text": "ss of consciousness (anaphylactic shock). to latex Stroke When arteries to the Numbness or weakness of the face, brain become blocked arm or leg, especially on one side of the or burst, preventing body; confusion or trouble speaking or normal blood flow and understanding; trouble seeing in one or",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3459
  },
  {
    "id": "chunk_03460",
    "text": "d flow and understanding; trouble seeing in one or leading to the death of both eyes; trouble walking, dizziness, brain tissue loss of balance or coordination; severe headache with no other known cause. Signs and symptoms develop suddenly.",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3460
  },
  {
    "id": "chunk_03461",
    "text": "known cause. Signs and symptoms develop suddenly. Toxic shock A severe reaction High fever, body rash, vomiting, syndrome throughout the body diarrhea, dizziness, muscle aches. Signs B to toxins released by and symptoms develop suddenly. bacteria Signs and Symptoms of Serious Health Conditions 417",
    "page_number": 439,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3461
  },
  {
    "id": "chunk_03462",
    "text": "APPENDIX C Medical Conditions That Make Pregnancy Especially Risky Some common medical conditions make pregnancy riskier to a woman\u2019s health. The effectiveness of her contraceptive method thus has special importance. For a comparison of the effectiveness of family planning",
    "page_number": 440,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3462
  },
  {
    "id": "chunk_03463",
    "text": "comparison of the effectiveness of family planning methods, see Contraceptive Effectiveness, p. 415. Some methods depend more on their users for effectiveness than do others. Mostly, the methods that require correct use with every act of",
    "page_number": 440,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3463
  },
  {
    "id": "chunk_03464",
    "text": "methods that require correct use with every act of sex or abstaining during fertile days are the less effective methods, as commonly used: \u2022 Spermicides \u2022 Withdrawal \u2022 Fertility awareness methods \u2022 Cervical caps \u2022 Diaphragms \u2022 Female condoms \u2022 Male condoms",
    "page_number": 440,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3464
  },
  {
    "id": "chunk_03465",
    "text": "caps \u2022 Diaphragms \u2022 Female condoms \u2022 Male condoms If a woman says that she has any of the common conditions listed below: \u2022 She should be told that pregnancy could be especially risky to her health and in some cases to the health of her baby.",
    "page_number": 440,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3465
  },
  {
    "id": "chunk_03466",
    "text": "ealth and in some cases to the health of her baby. \u2022 During counseling, focus special attention on the effectiveness of methods. Clients who are considering a method that requires correct use with every act of sex should think carefully whether they can use it effectively.",
    "page_number": 440,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3466
  },
  {
    "id": "chunk_03467",
    "text": "ink carefully whether they can use it effectively. Reproductive Tract Infections and Disorders \u2022 Breast cancer \u2022 Endometrial cancer \u2022 Ovarian cancer \u2022 Some sexually transmitted infections (gonorrhea, chlamydia) \u2022 Some vaginal infections (bacterial vaginosis)",
    "page_number": 440,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3467
  },
  {
    "id": "chunk_03468",
    "text": "Cardiovascular Disease \u2022 High blood pressure (systolic blood pressure higher than 160 mm Hg or diastolic blood pressure higher than 100 mm Hg) \u2022 Complicated valvular heart disease \u2022 Ischemic heart disease (heart disease due to narrowed arteries) \u2022 Stroke \u2022 Thrombogenic mutations Other Infections",
    "page_number": 441,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3468
  },
  {
    "id": "chunk_03469",
    "text": "\u2022 Stroke \u2022 Thrombogenic mutations Other Infections \u2022 HIV (see Chapter 22 \u2013 Sexually Transmitted Infections, Including HIV) \u2022 Tuberculosis \u2022 Schistosomiasis with fibrosis of the liver Endocrine Conditions \u2022 Diabetes if insulin dependent, with damage to arteries, kidneys, eyes, or",
    "page_number": 441,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3469
  },
  {
    "id": "chunk_03470",
    "text": "endent, with damage to arteries, kidneys, eyes, or nervous system (nephropathy, retinopathy, neuropathy), or of more than 20 years\u2019 duration Anemia \u2022 Sickle cell disease Gastrointestinal Conditions \u2022 Severe (decompensated) cirrhosis of the liver",
    "page_number": 441,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3470
  },
  {
    "id": "chunk_03471",
    "text": "ns \u2022 Severe (decompensated) cirrhosis of the liver \u2022 Malignant (cancerous) liver tumors (hepatoma) and hepatocellular carcinoma of the liver Neurologic Conditions \u2022 Epilepsy Rheumatic Conditions \u2022 Systemic lupus erythematosus C Medical Conditions That Make Pregnancy Especially Risky 419 yksiR",
    "page_number": 441,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3471
  },
  {
    "id": "chunk_03472",
    "text": "APPENDIX D Medical Eligibility Criteria for Contraceptive Use The table on the following pages summarizes the World Health Organization Medical Eligibility Criteria for Contraceptive Use, fifth edition (2015). These criteria",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3472
  },
  {
    "id": "chunk_03473",
    "text": "aceptive Use, fifth edition (2015). These criteria are the basis for the Medical Eligibility Criteria checklists in most chapters of this Handbook on family planning methods. These checklists are based on the 2-level system for providers with limited clinical judgment (see table below). The",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3473
  },
  {
    "id": "chunk_03474",
    "text": "h limited clinical judgment (see table below). The checklist questions address conditions in MEC categories 3 or 4 that the woman knows of. The boxes \u201cUsing Clinical Judgment in Special Cases\u201d list conditions that are in MEC category 3: The method can be provided if other, more",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3474
  },
  {
    "id": "chunk_03475",
    "text": "egory 3: The method can be provided if other, more appropriate methods are not available or acceptable to the client, and a qualified provider can carefully assess the specific woman\u2019s condition and situation. Categories for Temporary Methods",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3475
  },
  {
    "id": "chunk_03476",
    "text": "on and situation. Categories for Temporary Methods Category With Clinical Judgment With Limited Clinical Judgment 1 Use method in any circumstances Yes 2 Generally use method (Use the method) Use of method not usually recommended 3 unless other more appropriate methods No",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3476
  },
  {
    "id": "chunk_03477",
    "text": "mmended 3 unless other more appropriate methods No are not available or not acceptable (Do not use the method) 4 Method not to be used Note: In the table beginning on the next page, category 3 and 4 conditions are shaded",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3477
  },
  {
    "id": "chunk_03478",
    "text": "next page, category 3 and 4 conditions are shaded to indicate that the method should not be provided where clinical judgment is limited. Categories that are new or changed since the 2011 edition of this Handbook are shown in bold type.",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3478
  },
  {
    "id": "chunk_03479",
    "text": "1 edition of this Handbook are shown in bold type. For vasectomy, male and female condoms, spermicides, diaphragms, cervical caps, and the lactational amenorrhea method, see pp. 429\u2013431. For fertility awareness methods, see p. 431. Categories for Female Sterilization and Vasectomy",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3479
  },
  {
    "id": "chunk_03480",
    "text": "Categories for Female Sterilization and Vasectomy Accept (A) There is no medical reason to deny the method to a person with this condition or in this circumstance. Caution (C) The method is normally provided in a routine setting, but with extra preparation and precautions.",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3480
  },
  {
    "id": "chunk_03481",
    "text": "tting, but with extra preparation and precautions. Delay (D) Use of the method should be delayed until the condition is evaluated and/or corrected. Alternative, temporary methods of contraception should be provided. Special (S) The procedure should be undertaken in a setting with an experienced",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3481
  },
  {
    "id": "chunk_03482",
    "text": "uld be undertaken in a setting with an experienced surgeon and staff, equipment needed to provide general anesthesia, and other backup medical support. The capacity to decide on the most appropriate procedure and anesthesia support also is needed.",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3482
  },
  {
    "id": "chunk_03483",
    "text": "e procedure and anesthesia support also is needed. Alternative, temporary methods of contraception should be provided if referral is required or there is otherwise any delay. 420 Family Planning: A Global Handbook for Providers",
    "page_number": 442,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3483
  },
  {
    "id": "chunk_03484",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition Medical Eligibility Criteria for Contraceptive Use 421 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3484
  },
  {
    "id": "chunk_03485",
    "text": "1 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3485
  },
  {
    "id": "chunk_03486",
    "text": "gronoveL ecived eniretuartni *noitazilirets elameF PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY Pregnant NA NA NA NA NA NA NA 4 4 D Age Menarche to Menarche to Menarche to Young < 40 years < 18 years < 20 years age 1 1 1 1 2 1 \u2014 2 2 C _> 40 years 18 to 45 years _> 20 years 2 2 2 1 1 1 \u2014 1 1 > 45",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3486
  },
  {
    "id": "chunk_03487",
    "text": "18 to 45 years _> 20 years 2 2 2 1 1 1 \u2014 1 1 > 45 1 2 1 \u2014 Parity Nulliparous (has not given 1 1 1 1 1 1 \u2014 2 2 A birth) Parous (has given birth) 1 1 1 1 1 1 \u2014 1 1 A Breastfeeding < 6 weeks postpartum 4 4 4 2 3a 2 1 b b * UPA=2 _> 6 weeks to < 6 months 1 postpartum (primarily 3 3 3 1 1 1 b b A",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3487
  },
  {
    "id": "chunk_03488",
    "text": "6 months 1 postpartum (primarily 3 3 3 1 1 1 b b A UPA=2 breastfeeding) 1 _> 6 months postpartum 2 2 2 1 1 1 b b A UPA=2 Postpartum (not breastfeeding) < 21 days 3 3 3 1 1 1 \u2014 b b With other added VTE 4 4 4 * risk factors 21\u201342 days 2 2 2 1 1 1 \u2014 b b With other added VTE 3 3 3 risk factors",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3488
  },
  {
    "id": "chunk_03489",
    "text": "1 1 \u2014 b b With other added VTE 3 3 3 risk factors >42 days 1 1 1 1 1 1 \u2014 1 1 A Postabortion First trimester 1 1 1 1 1 1 \u2014 1 1 Second trimester 1 1 1 1 1 1 \u2014 2 2 * D Immediate post-septic abortion 1 1 1 1 1 1 \u2014 4 4",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3489
  },
  {
    "id": "chunk_03490",
    "text": "D Immediate post-septic abortion 1 1 1 1 1 1 \u2014 4 4 * For additional conditions relating to emergency contraceptive pills and female sterilization, see p. 429. (Continued) a In settings where pregnancy morbidity and mortality risks are high and this method is one of few widely available",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3490
  },
  {
    "id": "chunk_03491",
    "text": "igh and this method is one of few widely available contraceptives, it may be made accessible to breastfeeding women immediately postpartum. b Postpartum IUD use: For the copper-bearing IUD, insertion at <48 hours is category 1. For the LNG-IUD, insertion at",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3491
  },
  {
    "id": "chunk_03492",
    "text": "hours is category 1. For the LNG-IUD, insertion at <48 hours is category 2 for breastfeeding women and category 1 for women not breastfeeding. For all women and both IUD types, insertion from 48 hours to <4 weeks is category 3; \u22654 weeks, category 1; and puerperal sepsis, category 4. esU evitpecartnoC",
    "page_number": 443,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3492
  },
  {
    "id": "chunk_03493",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition 422 Family Planning: A Global Handbook for Providers laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3493
  },
  {
    "id": "chunk_03494",
    "text": "ro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3494
  },
  {
    "id": "chunk_03495",
    "text": "gronoveL ecived eniretuartni *noitazilirets elameF Past ectopic pregnancy 1 1 1 2 1 1 1 1 1 A History of pelvic surgery 1 1 1 1 1 1 \u2014 1 1 C* Smoking Age < 35 years 2 2 2 1 1 1 \u2014 1 1 A Age _> 35 years <15 cigarettes/day 3 2 3 1 1 1 \u2014 1 1 A _>15 cigarettes/day 4 3 4 1 1 1 \u2014 1 1 A Obesity",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3495
  },
  {
    "id": "chunk_03496",
    "text": "A _>15 cigarettes/day 4 3 4 1 1 1 \u2014 1 1 A Obesity _> 30 kg/m2 body mass index 2 2 2 1 1\u2020 1 1 1 1 C Blood pressure measurement NAc NAc NAc NAc NAc NAc \u2014 NA NA NA unavailable CARDIOVASCULAR DISEASE Multiple risk factors for arterial cardiovascular disease 3/4d 3/4d 3/4d 2 3 2 \u2014 1 2 S",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3496
  },
  {
    "id": "chunk_03497",
    "text": "ardiovascular disease 3/4d 3/4d 3/4d 2 3 2 \u2014 1 2 S (older age, smoking, diabetes, and hypertension) Hypertensione History of hypertension, where blood pressure CANNOT be evaluated 3 3 3 2c 2c 2c \u2014 1 2 NA (including hypertension in pregnancy) Adequately controlled",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3497
  },
  {
    "id": "chunk_03498",
    "text": "g hypertension in pregnancy) Adequately controlled hypertension, where blood 3 3 3 1 2 1 \u2014 1 1 C pressure CAN be evaluated Elevated blood pressure (properly measured) Systolic 140\u2013159 or 3 3 3 1 2 1 \u2014 1 1 Cf diastolic 90\u201399 Systolic _> 160 or 4 4 4 2 3 2 \u2014 1 2 Sf diastolic _> 100g",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3498
  },
  {
    "id": "chunk_03499",
    "text": "c _> 160 or 4 4 4 2 3 2 \u2014 1 2 Sf diastolic _> 100g \u2020 From menarche to age <18 years, _>30 kg/m2 body mass index is category 2 for DMPA, category 1 for NET-EN. c In settings where pregnancy morbidity and mortality risks are high and this method is one of few widely available",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3499
  },
  {
    "id": "chunk_03500",
    "text": "igh and this method is one of few widely available contraceptives, women should not be denied access simply because their blood pressure cannot be measured. d When multiple major risk factors exist, any of which alone would substantially increase the risk of cardiovascular disease,",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3500
  },
  {
    "id": "chunk_03501",
    "text": "ially increase the risk of cardiovascular disease, use of the method may increase her risk to an unacceptable level. However, a simple addition of categories for multiple risk factors is not intended. For example, a combination of factors assigned a category 2 may not necessarily warrant a",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3501
  },
  {
    "id": "chunk_03502",
    "text": "ssigned a category 2 may not necessarily warrant a higher category. e Assuming no other risk factors for cardiovascular disease exist. A single reading of blood pressure is not sufficient to classify a woman as hypertensive.",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3502
  },
  {
    "id": "chunk_03503",
    "text": "ot sufficient to classify a woman as hypertensive. f Elevated blood pressure should be controlled before the procedure and monitored during the procedure.",
    "page_number": 444,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3503
  },
  {
    "id": "chunk_03504",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition Medical Eligibility Criteria for Contraceptive Use 423 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3504
  },
  {
    "id": "chunk_03505",
    "text": "3 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3505
  },
  {
    "id": "chunk_03506",
    "text": "gronoveL ecived eniretuartni *noitazilirets elameF Vascular disease 4 4 4 2 3 2 \u2014 1 2 S History of high blood pressure during pregnancy (where 2 2 2 1 1 1 \u2014 1 1 A current blood pressure is measurable and normal) Deep venous thrombosis (DVT)/Pulmonary embolism (PE)",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3506
  },
  {
    "id": "chunk_03507",
    "text": "ep venous thrombosis (DVT)/Pulmonary embolism (PE) History of DVT/PE 4 4 4 2 2 2 * 1 2 A Acute DVT/PE 4 4 4 3 3 3 * 1 3 D DVT/PE and on 4 4 4 2 2 2 * 1 2 S anticoagulant therapy Family history of DVT/PE 2 2 2 1 1 1 * 1 1 A (first-degree relatives) Major surgery With prolonged 4 4 4 2 2 2 \u2014 1 2 D",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3507
  },
  {
    "id": "chunk_03508",
    "text": ") Major surgery With prolonged 4 4 4 2 2 2 \u2014 1 2 D immobilization Without prolonged 2 2 2 1 1 1 \u2014 1 1 A immobilization Minor surgery without 1 1 1 1 1 1 \u2014 1 1 A prolonged immobilization Known thrombogenic mutations (e.g., factor V Leiden, prothrombin mutation; 4 4 4 2 2 2 * 1 2 A",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3508
  },
  {
    "id": "chunk_03509",
    "text": "Leiden, prothrombin mutation; 4 4 4 2 2 2 * 1 2 A protein S, protein C, and antithrombin deficiencies)g Superficial venous disorders Varicose veins 1 1 1 1 1 1 \u2014 1 1 A Superficial venous thrombosis 2 2 2 1 1 1 \u2014 1 1 A Ischemic heart diseaseg I C I C I C Current D 4 4 4 2 3 3 2 3 * 1 2 3 History of C",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3509
  },
  {
    "id": "chunk_03510",
    "text": "I C Current D 4 4 4 2 3 3 2 3 * 1 2 3 History of C Stroke (history of cerebrovascular accident)g 4 4 4 2 3 3 2 3 * 1 2 C Known dyslipidemias without other known 2 2 2 2 2 2 \u2014 1 2 A cardiovascular D risk factorsh (Continued)",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3510
  },
  {
    "id": "chunk_03511",
    "text": "\u2014 1 2 A cardiovascular D risk factorsh (Continued) g This condition may make pregnancy an unacceptable health risk. Women should be advised that because of relatively higher pregnancy rates, as commonly used, spermicides, withdrawal, fertility awareness methods, cervical caps,",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3511
  },
  {
    "id": "chunk_03512",
    "text": "rawal, fertility awareness methods, cervical caps, diaphragms, or female or male condoms may not be the most appropriate choice. h Routine screening is not appropriate because of the rarity of the condition and the high cost of screening. esU evitpecartnoC rof airetirC ytilibigilE lacideM",
    "page_number": 445,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3512
  },
  {
    "id": "chunk_03513",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition 424 Family Planning: A Global Handbook for Providers laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3513
  },
  {
    "id": "chunk_03514",
    "text": "ro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF Valvular heart disease",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3514
  },
  {
    "id": "chunk_03515",
    "text": "artni *noitazilirets elameF Valvular heart disease Uncomplicated 2 2 2 1 1 1 \u2014 1 1 Ci Complicated \u2021, g 4 4 4 1 1 1 \u2014 2i 2i S* Systemic lupus erythematosus I C I C Positive (or unknown) 4 4 4 3 3 3 3 \u2014 1 1 3 S antiphospholipid antibodies Severe thrombocytopenia 2 2 2 2 3 2 2 \u2014 3 2 2 S",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3515
  },
  {
    "id": "chunk_03516",
    "text": "es Severe thrombocytopenia 2 2 2 2 3 2 2 \u2014 3 2 2 S Immunosuppresive treatment 2 2 2 2 2 2 2 \u2014 2 1 2 S None of the above 2 2 2 2 2 2 2 \u2014 1 1 2 C NEUROLOGICAL CONDITIONS Headachesj I C I C I C I C I C I C I C Nonmigrainous (mild or severe) 1 2 1 2 1 2 1 1 1 1 1 1 \u2014 1 1 1 A Migraine 2",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3516
  },
  {
    "id": "chunk_03517",
    "text": "vere) 1 2 1 2 1 2 1 1 1 1 1 1 \u2014 1 1 1 A Migraine 2 Without aura I C I C I C I C I C I C I C Age < 35 2 3 2 3 2 3 1 2 2 2 2 2 \u2014 1 2 2 A Age _> 35 3 4 3 4 3 4 1 2 2 2 2 2 \u2014 1 2 2 A With aura, at any age 4 4 4 4 4 4 2 3 2 3 2 3 \u2014 1 2 3 A Epilepsy 1k 1k 1k 1k 1k 1k \u2014 1 C DEPRESSIVE DISORDERS",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3517
  },
  {
    "id": "chunk_03518",
    "text": "lepsy 1k 1k 1k 1k 1k 1k \u2014 1 C DEPRESSIVE DISORDERS Depressive disorders 1l 1l 1l 1l 1l 1l \u2014 1 1l C REPRODUCTIVE TRACT INFECTIONS AND DISORDERS Vaginal bleeding patterns I C Irregular pattern without 1 1 1 2 2 2 \u2014 1 1 1 A heavy bleeding Heavy or prolonged",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3518
  },
  {
    "id": "chunk_03519",
    "text": "2 2 2 \u2014 1 1 1 A heavy bleeding Heavy or prolonged bleeding (including regular 1 1 1 2 2 2 \u2014 2 1 2 A and irregular patterns) Unexplained vaginal bleeding I C I C (suspicious for serious 2 2 2 2 3 3 \u2014 D condition), before evaluation 4 2 4 2 Endometriosis 1 1 1 1 1 1 \u2014 2 1 S Benign ovarian tumors",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3519
  },
  {
    "id": "chunk_03520",
    "text": "etriosis 1 1 1 1 1 1 \u2014 2 1 S Benign ovarian tumors 1 1 1 1 1 1 \u2014 1 1 A (including cysts) Severe dysmenorrhea 1 1 1 1 1 1 \u2014 2 1 A \u2021 Pulmonary hypertension, atrial fibrillation, history of subacute bacterial endocarditis. i Prophylactic antibiotics are advised before providing the method.",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3520
  },
  {
    "id": "chunk_03521",
    "text": "tibiotics are advised before providing the method. j Category is for women without any other risk factors for stroke. k If taking anticonvulsants, refer to section on drug interactions, p. 428. l Certain medications may interact with the method, making it less effective.",
    "page_number": 446,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3521
  },
  {
    "id": "chunk_03522",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition Medical Eligibility Criteria for Contraceptive Use 425 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3522
  },
  {
    "id": "chunk_03523",
    "text": "5 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3523
  },
  {
    "id": "chunk_03524",
    "text": "gronoveL ecived eniretuartni *noitazilirets elameF Gestational trophoblastic disease Decreasing or undetectable 1 1 1 1 1 1 \u2014 3 3 A \u00df-hCG levels Persistently elevated \u00df-hCG 1 1 1 1 1 1 \u2014 4 4 D levels or malignant diseaseg Cervical ectropion 1 1 1 1 1 1 \u2014 1 1 A Cervical intraepithelial",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3524
  },
  {
    "id": "chunk_03525",
    "text": "opion 1 1 1 1 1 1 \u2014 1 1 A Cervical intraepithelial 2 2 2 1 2 2 \u2014 1 2 A neoplasia (CIN) Cervical cancer I C I C 2 2 2 1 2 2 \u2014 D (awaiting treatment) 4 2 4 2 Breast disease Undiagnosed mass 2 2 2 2 2 2 \u2014 1 2 A Benign breast disease 1 1 1 1 1 1 \u2014 1 1 A Family history of cancer 1 1 1 1 1 1 \u2014 1 1 A",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3525
  },
  {
    "id": "chunk_03526",
    "text": "1 1 A Family history of cancer 1 1 1 1 1 1 \u2014 1 1 A Breast cancer Currentg 4 4 4 4 4 4 \u2014 1 4 C Past, no evidence of 3 3 3 3 3 3 \u2014 1 3 A disease for at least 5 years I C I C Endometrial cancerg 1 1 1 1 1 1 \u2014 D 4 2 4 2 Ovarian cancerg 1 1 1 1 1 1 \u2014 3 2 3 2 D Uterine fibroids Without distortion of the",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3526
  },
  {
    "id": "chunk_03527",
    "text": "2 3 2 D Uterine fibroids Without distortion of the 1 1 1 1 1 1 \u2014 1 1 C uterine cavity With distortion of the 1 1 1 1 1 1 \u2014 4 4 C uterine cavity Anatomical abnormalities Distorted uterine cavity \u2014 \u2014 \u2014 \u2014 \u2014 \u2014 \u2014 4 4 \u2014 Other abnormalities not distorting the uterine cavity",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3527
  },
  {
    "id": "chunk_03528",
    "text": "er abnormalities not distorting the uterine cavity or interfering with IUD \u2014 \u2014 \u2014 \u2014 \u2014 \u2014 \u2014 2 2 \u2014 insertion (including cervical stenosis or lacerations) Pelvic inflammatory disease (PID) D Past PID (assuming no current risk factors for STIs) I C I C With subsequent pregnancy 1 1 1 1 1 1 \u2014 1 1 1 1 A",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3528
  },
  {
    "id": "chunk_03529",
    "text": "With subsequent pregnancy 1 1 1 1 1 1 \u2014 1 1 1 1 A Without subsequent 1 1 1 1 1 1 \u2014 2 2 2 2 C pregnancy (Continued) esU evitpecartnoC rof airetirC ytilibigilE lacideM",
    "page_number": 447,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3529
  },
  {
    "id": "chunk_03530",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition 426 Family Planning: A Global Handbook for Providers laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3530
  },
  {
    "id": "chunk_03531",
    "text": "ro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3531
  },
  {
    "id": "chunk_03532",
    "text": "gronoveL ecived eniretuartni *noitazilirets elameF Current PID 1 1 1 1 1 1 \u2014 4 2m 4 2m D Sexually transmitted infections (STIs)g I C I C Current purulent cervicitis, 1 1 1 1 1 1 \u2014 4 2 4 2 D chlamydia, or gonorrhea Other STIs (excluding HIV 1 1 1 1 1 1 \u2014 2 2 2 2 A and hepatitis) Vaginitis (including",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3532
  },
  {
    "id": "chunk_03533",
    "text": "1 \u2014 2 2 2 2 A and hepatitis) Vaginitis (including trichomonas vaginalis and 1 1 1 1 1 1 \u2014 2 2 2 2 A bacterial vaginosis) 2 2 Increased risk of STIs 1 1 1 1 1 1 \u2014 3n 2 3n 2 A HIV/AIDSg I C I C High risk of HIV 1 1 1 1 1 1 \u2014 1 1 1 1 A Asymptomatic or mild HIV",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3533
  },
  {
    "id": "chunk_03534",
    "text": "V 1 1 1 1 1 1 \u2014 1 1 1 1 A Asymptomatic or mild HIV clinical disease (WHO stage 1 1 1 1 1 1 \u2014 2 2 2 2 A 1 or 2) Severe or advanced HIV clinical disease (WHO stage 1 1 1 1 1 1 \u2014 3 2 3 2 So 3 or 4) Antiretroviral therapy Treated with nucleoside 2 2 reverse transcriptase 1 1 1 1 1 1 \u2014 3p 2 3p 2 \u2014",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3534
  },
  {
    "id": "chunk_03535",
    "text": "2 reverse transcriptase 1 1 1 1 1 1 \u2014 3p 2 3p 2 \u2014 inhibitors (NRTIs)** Treated with non-nucleoside reverse transcriptase inhibitors (NNRTIs) DMPA Efavirenz (EFV) or 1 2 2 nevirapine (NVP) 2 2 2 2 NET-EN 2 \u2014 3p 2 3p 2 \u2014 2 Etravirine (ETR) or 2 2 rilpivirine (RPV) 1 1 1 1 1 1 \u2014 3p 2 3p 2 \u2014 DMPA",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3535
  },
  {
    "id": "chunk_03536",
    "text": "2 rilpivirine (RPV) 1 1 1 1 1 1 \u2014 3p 2 3p 2 \u2014 DMPA Treated with 1 2 2 protease inhibitors (Pls)\u2020\u2020 2 2 2 2 NET-EN 2 \u2014 3p 2 3p 2 \u2014 2 \u2020\u2020PIs include: ritonavir-boosted atazanavir (ATV/r), ritonavir-boosted lopinavir (LPV/r), ritonavir-boosted darunavir (DRV/r), ritonavir (RTV).",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3536
  },
  {
    "id": "chunk_03537",
    "text": "onavir-boosted darunavir (DRV/r), ritonavir (RTV). **NRTIs include: abacavir (ABC), tenofovir (TDF), zidovudine (AZT), lamivudine (3TC), didanosine (DDI), emtricitabine (FTC), stavudine (D4T).",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3537
  },
  {
    "id": "chunk_03538",
    "text": "osine (DDI), emtricitabine (FTC), stavudine (D4T). m Treat PID using appropriate antibiotics. There is usually no need to remove the IUD if the client wishes to continue use. n The condition is category 3 if a woman has a very high individual likelihood of STIs.",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3538
  },
  {
    "id": "chunk_03539",
    "text": "man has a very high individual likelihood of STIs. o Presence of an AIDS-related illness may require a delay in the procedure. p Condition is category 2 for IUD insertion for asymptomatic or mild HIV clinical disease (WHO stage 1 or 2),",
    "page_number": 448,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3539
  },
  {
    "id": "chunk_03540",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition 427 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3540
  },
  {
    "id": "chunk_03541",
    "text": "noM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF Treated with integrase 2 2",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3541
  },
  {
    "id": "chunk_03542",
    "text": "i *noitazilirets elameF Treated with integrase 2 2 inhibitors (raltegravir [RAL]) 1 1 1 1 1 1 \u2014 3p 2 3p 2 \u2014 OTHER INFECTIONS Schistosomiasis Uncomplicated 1 1 1 1 1 1 \u2014 1 1 A Fibrosis of liver (if severe, see cirrhosis, next page)g 1 1 1 1 1 1 \u2014 1 1 C Tuberculosisg I C I C",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3542
  },
  {
    "id": "chunk_03543",
    "text": "t page)g 1 1 1 1 1 1 \u2014 1 1 C Tuberculosisg I C I C Non-pelvic 1 1 1 1 1 1 \u2014 1 1 1 1 A Known pelvic 1 1 1 1 1 1 \u2014 4 3 4 3 S Malaria 1 1 1 1 1 1 \u2014 1 1 A ENDOCRINE CONDITIONS Diabetes History of gestational 1 1 1 1 1 1 \u2014 1 1 Aq diabetes Non-vascular diabetes Non-insulin dependent 2 2 2 2 2 2 \u2014 1 2 Ci,q",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3543
  },
  {
    "id": "chunk_03544",
    "text": "betes Non-insulin dependent 2 2 2 2 2 2 \u2014 1 2 Ci,q Insulin dependentg 2 2 2 2 2 2 \u2014 1 2 Ci,q With kidney, eye, or nerve damageg 3/4r 3/4r 3/4r 2 3 2 \u2014 1 2 S Other vascular disease or diabetes of >20 years\u2019 3/4r 3/4r 3/4r 2 3 2 \u2014 1 2 S durationg Thyroid disorders Simple goiter 1 1 1 1 1 1 \u2014 1 1 A",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3544
  },
  {
    "id": "chunk_03545",
    "text": "hyroid disorders Simple goiter 1 1 1 1 1 1 \u2014 1 1 A Hyperthyroid 1 1 1 1 1 1 \u2014 1 1 S Hypothyroid 1 1 1 1 1 1 \u2014 1 1 C GASTROINTESTINAL CONDITIONS Gallbladder disease Symptomatic Treated by 2 2 2 2 2 2 \u2014 1 2 A cholecystectomy D Medically treated 3 2 3 2 2 2 \u2014 1 2 A Current 3 2 3 2 2 2 \u2014 1 2 D",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3545
  },
  {
    "id": "chunk_03546",
    "text": "ed 3 2 3 2 2 2 \u2014 1 2 A Current 3 2 3 2 2 2 \u2014 1 2 D (Continued) q If blood glucose is not well controlled, referral to a higher-level facility is recommended. r Assess according to severity of condition. Medical Eligibility Criteria for Contraceptive Use esU evitpecartnoC rof airetirC ytilibigilE",
    "page_number": 449,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3546
  },
  {
    "id": "chunk_03547",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition 428 Family Planning: A Global Handbook for Providers laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3547
  },
  {
    "id": "chunk_03548",
    "text": "ro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF Asymptomatic 2 2 2 2 2 2 \u2014 1 2 A",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3548
  },
  {
    "id": "chunk_03549",
    "text": "tazilirets elameF Asymptomatic 2 2 2 2 2 2 \u2014 1 2 A History of cholestasis Pregnancy-related 2 2 2 1 1 1 \u2014 1 1 A Past combined oral 3 2 3 2 2 2 \u2014 1 2 A contraceptives-related Viral hepatitis I C I C I C 3 3 Acute or flare 4r 2 3 2 4r , s 2 1 1 1 2 1 1 D Carrier 1 1 1 1 1 1 \u2014 1 1 A",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3549
  },
  {
    "id": "chunk_03550",
    "text": "4r , s 2 1 1 1 2 1 1 D Carrier 1 1 1 1 1 1 \u2014 1 1 A Chronic 1 1 1 1 1 1 \u2014 1 1 A Cirrhosis Mild (compensated) 1 1 1 1 1 1 \u2014 1 1 A Severe (decompensated)g 4 3 4 3 3 3 \u2014 1 3 St Liver tumors Focal nodular hyperplasia 2 2 2 2 2 2 \u2014 1 2 A Hepatocellular adenoma 4 3 4 3 3 3 \u2014 1 3 Ct",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3550
  },
  {
    "id": "chunk_03551",
    "text": "1 2 A Hepatocellular adenoma 4 3 4 3 3 3 \u2014 1 3 Ct Malignant (hepatoma)g 4 3/4 4 3 3 3 \u2014 1 3 Ct ANEMIAS Thalassemia 1 1 1 1 1 1 \u2014 2 1 C Sickle cell diseaseg 2 2 2 1 1 1 \u2014 2 1 C Iron-deficiency anemia 1 1 1 1 1 1 \u2014 2 1 D/Cu DRUG INTERACTIONS (for antiretroviral drugs, see HIV/AIDS)",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3551
  },
  {
    "id": "chunk_03552",
    "text": "ERACTIONS (for antiretroviral drugs, see HIV/AIDS) Anticonvulsant therapy Certain anticonvulsants (barbiturates, DMPA 1 carbamazepine, 3l 2 3l 3l 2l \u2014 1 1 \u2014 NET-EN oxcarbazepine, phenytoin, 2 primidone, topiramate) Lamotrigine 3\u00a7 3\u00a7 3\u00a7 1 1 1 \u2014 1 1 \u2014 Antimicrobial therapy",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3552
  },
  {
    "id": "chunk_03553",
    "text": "igine 3\u00a7 3\u00a7 3\u00a7 1 1 1 \u2014 1 1 \u2014 Antimicrobial therapy Broad-spectrum antibiotics 1 1 1 1 1 1 \u2014 1 1 \u2014 s In women with symptomatic viral hepatitis, withhold these methods until liver function returns to normal or 3 months after she becomes asymptomatic, whichever is earlier.",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3553
  },
  {
    "id": "chunk_03554",
    "text": "er she becomes asymptomatic, whichever is earlier. t Liver function should be evaluated. u For hemoglobin <7 g/dl, delay. For hemoglobin _>7 to <10 g/dl, caution. \u00a7 Combined hormonal contraceptives may reduce the effectiveness of lamotrigine.",
    "page_number": 450,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3554
  },
  {
    "id": "chunk_03555",
    "text": "= Use the method = Do not use the method I = Initiation of the method C = Continuation of the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable Condition *Additional conditions relating to emergency contraceptive pills:",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3555
  },
  {
    "id": "chunk_03556",
    "text": "ditions relating to emergency contraceptive pills: Category 1: Repeated use; rape; CYP3A4 inducers (e.g., rifampicin, phenytoin, phenobarbital, carbamazepine, efavirenz, fosphenytoin, nevirapine, oxcarbazepine, primidone, rifabutin, St. John\u2019s wort/Hypericum perforatum).",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3556
  },
  {
    "id": "chunk_03557",
    "text": "rifabutin, St. John\u2019s wort/Hypericum perforatum). Category 2: History of severe cardiovascular complications (ischemic heart disease, cerebrovascular attack, or other thromboembolic conditions, and angina pectoralis). *Additional conditions relating to female sterilization:",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3557
  },
  {
    "id": "chunk_03558",
    "text": "ional conditions relating to female sterilization: Caution: Diaphragmatic hernia; kidney disease; severe nutritional deficiencies; previous abdominal or pelvic surgery; concurrent with elective surgery. Delay: Abdominal skin infection; acute respiratory disease (bronchitis, pneumonia);",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3558
  },
  {
    "id": "chunk_03559",
    "text": "acute respiratory disease (bronchitis, pneumonia); systemic infection or gastroenteritis; emergency surgery (without previous counseling); surgery for an infectious condition; certain postpartum conditions (7 to 41 days after childbirth); severe pre-eclampsia/eclampsia; prolonged rupture of membranes",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3559
  },
  {
    "id": "chunk_03560",
    "text": "clampsia/eclampsia; prolonged rupture of membranes (24 hours or more); fever during or immediately after delivery; sepsis after delivery; severe hemorrhage; severe trauma to the genital tract; cervical or vaginal tear at time",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3560
  },
  {
    "id": "chunk_03561",
    "text": "he genital tract; cervical or vaginal tear at time of delivery); certain postabortion conditions (sepsis, fever, or severe hemorrhage; severe trauma to the genital tract; cervical or vaginal tear at time of abortion; acute hematometra); subacute bacterial endocarditis; unmanaged atrial fibrillation.",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3561
  },
  {
    "id": "chunk_03562",
    "text": "erial endocarditis; unmanaged atrial fibrillation. Special arrangements: Coagulation disorders; chronic asthma, bronchitis, emphysema, or lung infection; fixed uterus due to previous surgery or infection; abdominal wall or umbilical hernia; postpartum uterine rupture or perforation; postabortion",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3562
  },
  {
    "id": "chunk_03563",
    "text": "artum uterine rupture or perforation; postabortion uterine perforation. Conditions relating to vasectomy: No special considerations: High risk of HIV, asymptomatic or mild HIV clinical disease, sickle cell disease. Caution: Young age; depressive disorders; diabetes; previous scrotal injury; large",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3563
  },
  {
    "id": "chunk_03564",
    "text": "isorders; diabetes; previous scrotal injury; large varicocele or hydrocele; cryptorchidism (may require referral); lupus with positive (or unknown) antiphospholipid antibodies; lupus and on immunosuppressive treatment.",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3564
  },
  {
    "id": "chunk_03565",
    "text": "ibodies; lupus and on immunosuppressive treatment. Delay: Active STIs (excluding HIV and hepatitis); scrotal skin infection; balanitis; epididymitis or orchitis; systemic infection or gastroenteritis; filariasis; elephantiasis; intrascrotal mass.",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3565
  },
  {
    "id": "chunk_03566",
    "text": "tis; filariasis; elephantiasis; intrascrotal mass. Special arrangements: Severe or advanced HIV clinical disease may require delay; coagulation disorders; inguinal hernia; lupus with severe thrombocytopenia. Medical Eligibility Criteria for Contraceptive Use 429 laro denibmoC sevitpecartnoc",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3566
  },
  {
    "id": "chunk_03567",
    "text": "Contraceptive Use 429 laro denibmoC sevitpecartnoc selbatcejni ylhtnoM dna hctap denibmoC gnir lanigav denibmoc sllip ylno-nitsegorP ylno-nitsegorP selbatcejni stnalpmI ycnegremE *sllip evitpecartnoc gniraeb-reppoC ecived eniretuartni lertsegronoveL ecived eniretuartni *noitazilirets elameF",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3567
  },
  {
    "id": "chunk_03568",
    "text": "gronoveL ecived eniretuartni *noitazilirets elameF Antifungals and antiparasitics 1 1 1 1 1 1 \u2014 1 1 \u2014 DMPA Rifampicin or rifabutin 1 3l 2 3l 3l 2 \u2014 1 1 \u2014 therapy NET-EN 2 D esU evitpecartnoC rof airetirC ytilibigilE lacideM",
    "page_number": 451,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3568
  },
  {
    "id": "chunk_03569",
    "text": "Condition v Wait to fit/use until uterine involution is complete. w Diaphragm cannot be used in certain cases of uterine prolapse. x Cap use is not appropriate for a client with severely distorted cervical anatomy.",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3569
  },
  {
    "id": "chunk_03570",
    "text": "a client with severely distorted cervical anatomy. y Caution: Women living with HIV should receive appropriate antiretroviral therapy (ART) and exclusively breastfeed for the first 6 months of a baby\u2019s life, introduce appropriate complementary foods at 6 months, and continue breastfeeding",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3570
  },
  {
    "id": "chunk_03571",
    "text": "tary foods at 6 months, and continue breastfeeding through 12 months. (See Chapter 24 \u2013 Maternal and Newborn Health, Preventing Mother-to-Child Transmission of HIV, p. 378.) z Does not apply to plastic condoms, diaphragms, and cervical caps.",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3571
  },
  {
    "id": "chunk_03572",
    "text": "to plastic condoms, diaphragms, and cervical caps. \u2021\u2021For additional conditions relating to the lactational amenorrhea method, see next page. 430 Family Planning: A Global Handbook for Providers dna elaM elamef smodnoc sedicimrepS smgarhpaiD spac lacivreC lanoitatcaL aehrronema \u2021\u2021dohtem",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3572
  },
  {
    "id": "chunk_03573",
    "text": "paiD spac lacivreC lanoitatcaL aehrronema \u2021\u2021dohtem Conditions relating to male and female condoms, spermicides, diaphragms, cervical caps, and the lactational amenorrhea method: All other conditions listed on the previous pages that do not appear here are a category 1 or",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3573
  },
  {
    "id": "chunk_03574",
    "text": "pages that do not appear here are a category 1 or NA for male and female condoms, spermicides, diaphragms, and cervical caps, and not listed in the Medical Eligibility Criteria for the lactational amenorrhea method. = Use the method = Do not use the method \u2014 = Condition not listed; does not",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3574
  },
  {
    "id": "chunk_03575",
    "text": "use the method \u2014 = Condition not listed; does not affect eligibility for method NA = Not applicable REPRODUCTIVE HISTORY Parity Nulliparous (has not given birth) 1 1 1 1 \u2014 Parous (has given birth) 1 1 2 2 \u2014 < 6 weeks postpartum 1 1 NAv NAv \u2014 CARDIOVASCULAR DISEASE Complicated valvular heart",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3575
  },
  {
    "id": "chunk_03576",
    "text": "CARDIOVASCULAR DISEASE Complicated valvular heart disease (pulmonary hypertension, 1 1 2 2 \u2014 risk of atrial fibrillation, history of subacute bacterial endocarditis)g REPRODUCTIVE TRACT INFECTIONS AND DISORDERS Cervical intraepithelial neoplasia 1 1 1 4 \u2014 Cervical cancer 1 2 1 4 \u2014",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3576
  },
  {
    "id": "chunk_03577",
    "text": "lial neoplasia 1 1 1 4 \u2014 Cervical cancer 1 2 1 4 \u2014 Anatomical abnormalities 1 1 NAw NAx \u2014 HIV/AIDSg High risk of HIV 1 4 4 4 \u2014 Asymptomatic or mild HIV clinical 1 3 3 3 Cy disease (WHO stage 1 or 2) Severe or advanced HIV clinical 1 3 3 3 Cy disease (WHO stage 3 or 4) OTHERS",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3577
  },
  {
    "id": "chunk_03578",
    "text": "nical 1 3 3 3 Cy disease (WHO stage 3 or 4) OTHERS History of toxic shock syndrome 1 1 3 3 \u2014 Urinary tract infection 1 1 2 2 \u2014 Allergy to latexz 3 1 3 3 \u2014",
    "page_number": 452,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3578
  },
  {
    "id": "chunk_03579",
    "text": "Additional conditions relating to the lactational amenorrhea method: Conditions affecting the newborn that may make breastfeeding difficult: Congenital deformities of the mouth, jaw, or palate; newborns who are small-for-date or",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3579
  },
  {
    "id": "chunk_03580",
    "text": "jaw, or palate; newborns who are small-for-date or premature and needing intensive neonatal care; and certain metabolic disorders. Medication used during breastfeeding: To protect infant health, breastfeeding is not recommended for women using such drugs as anti-metabolites, bromocriptine,",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3580
  },
  {
    "id": "chunk_03581",
    "text": "ing such drugs as anti-metabolites, bromocriptine, certain anticoagulants, corticosteroids (high doses), cyclosporine, ergotamine, lithium, mood-altering drugs, radioactive drugs, and reserpine. Conditions relating to fertility awareness methods:",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3581
  },
  {
    "id": "chunk_03582",
    "text": "onditions relating to fertility awareness methods: A = Accept C = Caution D = Delay Symptoms-based Calendar-based Condition methods methods Age: post menarche or perimenopause C C Breastfeeding <6 weeks postpartum D Daa Breastfeeding _>6 weeks postpartum Cbb Dbb Postpartum, not breastfeeding Dcc Daa",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3582
  },
  {
    "id": "chunk_03583",
    "text": "rtum Cbb Dbb Postpartum, not breastfeeding Dcc Daa Postabortion C Ddd Irregular vaginal bleeding D D Vaginal discharge D A Taking drugs that affect cycle regularity, D/Cee D/Cee hormones, and/or fertility signs Diseases that elevate body temperature Acute D A Chronic C A",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3583
  },
  {
    "id": "chunk_03584",
    "text": "hat elevate body temperature Acute D A Chronic C A aa Delay until she has had 3 regular menstrual cycles. bb Use caution after monthly bleeding or normal secretions return (usually at least 6 weeks after childbirth).",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3584
  },
  {
    "id": "chunk_03585",
    "text": "eturn (usually at least 6 weeks after childbirth). cc Delay until monthly bleeding or normal secretions return (usually <4 weeks postpartum). dd Delay until she has had one regular menstrual cycle. ee Delay until the drug\u2019s effect has been determined, then use caution.",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3585
  },
  {
    "id": "chunk_03586",
    "text": "ug\u2019s effect has been determined, then use caution. Conditions relating to the progesterone-releasing vaginal ring: Pregnancy N/A Breastfeeding _>4 weeks postpartum 1 D Medical Eligibility Criteria for Contraceptive Use 431 esU evitpecartnoC rof airetirC ytilibigilE lacideM",
    "page_number": 453,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3586
  },
  {
    "id": "chunk_03587",
    "text": "Glossary abscess A pocket of pus surrounded by inflammation, caused by a bacterial infection and marked by persistent pain. acquired immunodeficiency syndrome (AIDS) The condition, due to infection with human immunodeficiency virus (HIV), when the body\u2019s immune system breaks down",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3587
  },
  {
    "id": "chunk_03588",
    "text": "s (HIV), when the body\u2019s immune system breaks down and is unable to fight certain infections. AIDS See acquired immunodeficiency syndrome. amenorrhea See vaginal bleeding. anaphylactic shock See Severe allergic reaction to latex, Appendix B.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3588
  },
  {
    "id": "chunk_03589",
    "text": "See Severe allergic reaction to latex, Appendix B. anemia A condition in which the body lacks adequate hemoglobin, commonly due to iron deficiency or excessive blood loss. As a result, tissues do not receive adequate oxygen.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3589
  },
  {
    "id": "chunk_03590",
    "text": "a result, tissues do not receive adequate oxygen. antiretroviral (ARV) drugs A group of drugs used to treat HIV infection. There are several ARV classes, which work against HIV in different ways. Patients on antiretroviral therapy (ART) take a combination of several ARV drugs at once.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3590
  },
  {
    "id": "chunk_03591",
    "text": ") take a combination of several ARV drugs at once. atrial fibrillation A heart rhythm disorder in which the upper heart chambers contract in an abnormal or disorganized manner. aura See migraine aura. backup method A contraceptive method used when mistakes are made with using an ongoing",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3591
  },
  {
    "id": "chunk_03592",
    "text": "used when mistakes are made with using an ongoing method of contraception, or to help ensure that a woman does not become pregnant when she first starts to use a contraceptive method. Include abstinence, male or female condoms, spermicides, and withdrawal.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3592
  },
  {
    "id": "chunk_03593",
    "text": "le or female condoms, spermicides, and withdrawal. bacterial endocarditis Infection that occurs when bacteria from the bloodstream colonize damaged heart tissue or valves. bacterial vaginosis A common condition caused by overgrowth of bacteria normally found in the vagina.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3593
  },
  {
    "id": "chunk_03594",
    "text": "ergrowth of bacteria normally found in the vagina. balanitis Inflammation of the tip of the penis. benign breast disease Growth of abnormal but noncancerous breast tissue. benign ovarian tumor Noncancerous growth that develops on or in the ovary.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3594
  },
  {
    "id": "chunk_03595",
    "text": "cancerous growth that develops on or in the ovary. blood pressure The force of the blood against the walls of blood vessels. Generally, normal systolic (pumping) blood pressure is less than 140 mm Hg, and normal diastolic (resting) blood pressure is less than 90 mm Hg (see hypertension).",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3595
  },
  {
    "id": "chunk_03596",
    "text": "pressure is less than 90 mm Hg (see hypertension). bone density A measure of how dense and strong a bone is. When old bone breaks down faster than new bone tissue is formed, bones become less dense, increasing risk of fractures. breakthrough bleeding See vaginal bleeding.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3596
  },
  {
    "id": "chunk_03597",
    "text": "tures. breakthrough bleeding See vaginal bleeding. breast cancer Malignant (cancerous) growth that develops in breast tissue. breastfeeding Feeding an infant with milk produced by the breasts (see also Lactational Amenorrhea Method, p. 319). Breastfeeding patterns include:",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3597
  },
  {
    "id": "chunk_03598",
    "text": "a Method, p. 319). Breastfeeding patterns include: exclusive breastfeeding Giving the infant only breast milk with no supplementation of any type\u2014not even water \u2014except for perhaps vitamins, minerals, or medication.",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3598
  },
  {
    "id": "chunk_03599",
    "text": "ept for perhaps vitamins, minerals, or medication. fully breastfeeding Giving the infant breast milk almost exclusively but also water, juice, vitamins, or other nutrients infrequently. nearly fully breastfeeding Giving the infant some liquid or food in addition to breast milk,",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3599
  },
  {
    "id": "chunk_03600",
    "text": "nt some liquid or food in addition to breast milk, but more than three-fourths of feedings are breastfeeds. partially breastfeeding Any breastfeeding less than nearly fully breastfeeding, giving the infant more supplementation with other liquids or food. Less than three-fourths of feedings",
    "page_number": 454,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3600
  },
  {
    "id": "chunk_03601",
    "text": "G yrassolG candidiasis A common vaginal infection caused by a yeast-like fungus. Also known as yeast infection or thrush. Not usually sexually transmitted. cardiovascular disease Any disease of the heart, blood vessels, or blood circulation.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3601
  },
  {
    "id": "chunk_03602",
    "text": "of the heart, blood vessels, or blood circulation. cerebrovascular disease Any disease of the blood vessels of the brain. cervical cancer Malignant (cancerous) growth that occurs in the cervix, usually due to persistent infection with certain types of human papillomavirus.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3602
  },
  {
    "id": "chunk_03603",
    "text": "ection with certain types of human papillomavirus. cervical ectropion A nonserious condition in which the mucus-producing cells found in the cervical canal begin to grow on the area around the opening of the cervix.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3603
  },
  {
    "id": "chunk_03604",
    "text": "grow on the area around the opening of the cervix. cervical intraepithelial neoplasia (CIN) Abnormal, precancerous cells in the cervix. Mild forms may go away on their own, but more severe abnormalities may progress to cervical cancer if not treated. Also called cervical dysplasia or precancer.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3604
  },
  {
    "id": "chunk_03605",
    "text": "ated. Also called cervical dysplasia or precancer. cervical laceration See laceration. cervical mucus A thick fluid plugging the opening of the cervix. Most of the time it is thick enough to prevent sperm from entering the uterus. At the midpoint of the menstrual",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3605
  },
  {
    "id": "chunk_03606",
    "text": "ering the uterus. At the midpoint of the menstrual cycle, however, the mucus becomes thin and watery, and sperm can more easily pass through. cervical stenosis When the cervical opening is narrower than normal. cervicitis See purulent cervicitis.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3606
  },
  {
    "id": "chunk_03607",
    "text": "r than normal. cervicitis See purulent cervicitis. cervix The lower portion of the uterus extending into the upper vagina (see Female Anatomy, p. 454). chancroid A sexually transmitted infection caused by a bacterium, which causes an ulcer to grow on the genitals.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3607
  },
  {
    "id": "chunk_03608",
    "text": "um, which causes an ulcer to grow on the genitals. chlamydia A sexually transmitted infection caused by a bacterium. If left untreated, it can cause infertility. cholecystectomy Surgical removal of the gallbladder. cholestasis Reduced flow of bile secreted by the liver.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3608
  },
  {
    "id": "chunk_03609",
    "text": "stasis Reduced flow of bile secreted by the liver. cirrhosis (of the liver) See Liver disorders, Appendix B. cryptorchidism Failure of one or both testes to descend into the scrotum after birth. decontaminate (medical equipment) To remove infectious organisms in order to make",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3609
  },
  {
    "id": "chunk_03610",
    "text": "t) To remove infectious organisms in order to make instruments, gloves, and other objects safer for people who clean them. deep vein thrombosis See Deep vein thrombosis, Appendix B. depression A mental condition typically marked by dejection, despair, lack of hope, and",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3610
  },
  {
    "id": "chunk_03611",
    "text": "ly marked by dejection, despair, lack of hope, and sometimes either extreme tiredness or agitation. diabetes (diabetes mellitus) A chronic disorder that occurs when blood glucose levels become too high because the body does not produce enough insulin or cannot use the insulin properly.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3611
  },
  {
    "id": "chunk_03612",
    "text": "enough insulin or cannot use the insulin properly. disinfection See high-level disinfection. dual protection Avoiding both pregnancy and sexually transmitted infection. dysmenorrhea Pain during vaginal bleeding, commonly known as menstrual cramps.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3612
  },
  {
    "id": "chunk_03613",
    "text": "inal bleeding, commonly known as menstrual cramps. eclampsia A condition of late pregnancy, labor, and the period immediately after delivery characterized by convulsions. In serious cases, sometimes followed by coma and death. ectopic pregnancy See Ectopic pregnancy, Appendix B.",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3613
  },
  {
    "id": "chunk_03614",
    "text": "topic pregnancy See Ectopic pregnancy, Appendix B. ejaculation The release of semen from the penis at orgasm. elephantiasis A chronic and often extreme swelling and hardening of skin and tissue just beneath the skin, especially of the legs and scrotum, due to an obstruction in the lymphatic system",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3614
  },
  {
    "id": "chunk_03615",
    "text": "tum, due to an obstruction in the lymphatic system (see filariasis). embryo The product of fertilization of an egg (ovum) by a sperm during the first 8 weeks of development. Glossary 433",
    "page_number": 455,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3615
  },
  {
    "id": "chunk_03616",
    "text": "endometrial cancer Malignant (cancerous) growth in the lining of the uterus. endometriosis A condition in which tissue of the endometrium grows outside the uterus. Tissue may attach itself to the reproductive organs or to other organs in the abdominal cavity.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3616
  },
  {
    "id": "chunk_03617",
    "text": "organs or to other organs in the abdominal cavity. Can cause pelvic pain and impair fertility. endometrium The membrane that lines the inner surface of the uterus. It thickens and is then shed once a month, causing monthly bleeding. During pregnancy, this lining is not shed but",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3617
  },
  {
    "id": "chunk_03618",
    "text": "ing. During pregnancy, this lining is not shed but instead changes and produces hormones, helping to support the pregnancy (see Female Anatomy, p. 454). engorgement (breast engorgement) A condition during breastfeeding that occurs when",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3618
  },
  {
    "id": "chunk_03619",
    "text": "A condition during breastfeeding that occurs when more milk accumulates in the breasts than the infant consumes. May make breasts feel full, hard, tender, and warm. Can be prevented (or relieved) by breastfeeding often and on demand.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3619
  },
  {
    "id": "chunk_03620",
    "text": "or relieved) by breastfeeding often and on demand. epididymis A coiled tube (duct) attached to and lying on the testes. Developing sperm reach maturity and develop their swimming capabilities within this duct. The matured sperm leave the epididymis through the vas deferens (see Male Anatomy, p. 457).",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3620
  },
  {
    "id": "chunk_03621",
    "text": "rough the vas deferens (see Male Anatomy, p. 457). epididymitis Inflammation of the epididymis. epilepsy A chronic disorder caused by disturbed brain function. May involve convulsions. estrogen Hormone responsible for female sexual development. Natural estrogens, especially the",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3621
  },
  {
    "id": "chunk_03622",
    "text": "ual development. Natural estrogens, especially the hormone estradiol, are secreted by a mature ovarian follicle, which surrounds the egg (ovum). Also, a group of synthetic drugs that have effects similar to those of natural estrogen; some are used in some hormonal contraceptives.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3622
  },
  {
    "id": "chunk_03623",
    "text": "en; some are used in some hormonal contraceptives. expulsion When a contraceptive implant or intrauterine device fully or partially comes out of place. fallopian tube Either of a pair of slender ducts that connect the uterus to the region of each",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3623
  },
  {
    "id": "chunk_03624",
    "text": "ucts that connect the uterus to the region of each ovary. Fertilization of an egg (ovum) by sperm usually takes place in one of the fallopian tubes (see Female Anatomy, p. 454). fertilization Union of an ovum with a sperm.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3624
  },
  {
    "id": "chunk_03625",
    "text": "454). fertilization Union of an ovum with a sperm. fetus The product of fertilization from the end of the 8th week of pregnancy until birth (see embryo). fibroid See uterine fibroid. fibrosis The excess formation of fibrous tissue, as in reaction to organ damage.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3625
  },
  {
    "id": "chunk_03626",
    "text": "of fibrous tissue, as in reaction to organ damage. filariasis A chronic parasitic disease caused by filarial worms. May lead to inflammation and permanent clogging of channels in the lymphatic system and elephantiasis.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3626
  },
  {
    "id": "chunk_03627",
    "text": "hannels in the lymphatic system and elephantiasis. fixed uterus A uterus that cannot be moved out of place, often as a result of endometriosis, past surgery, or infection. follicle A small round structure in the ovary, each of which contains an egg (ovum).",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3627
  },
  {
    "id": "chunk_03628",
    "text": "n the ovary, each of which contains an egg (ovum). During ovulation a follicle on the surface of the ovary opens and releases a mature egg. foreskin Hood of skin covering the end of the penis (see Male Anatomy, p. 457). fully breastfeeding See breastfeeding.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3628
  },
  {
    "id": "chunk_03629",
    "text": "y, p. 457). fully breastfeeding See breastfeeding. gallbladder diseases Conditions that affect the gallbladder, a sac located under the liver that stores bile used in fat digestion. May include inflammation, infection, or obstruction, gallbladder",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3629
  },
  {
    "id": "chunk_03630",
    "text": "flammation, infection, or obstruction, gallbladder cancer, or gall stones (when the components of bile solidify within the organ). gastroenteritis Inflammation of the stomach and intestine. genital herpes A disease caused by a virus, spread by sexual contact.",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3630
  },
  {
    "id": "chunk_03631",
    "text": "sease caused by a virus, spread by sexual contact. genital warts Growths on the vulva, the vaginal wall, and the cervix in women, and on the penis in men. Caused by certain types of human papillomavirus. 434 Family Planning: A Global Handbook for Providers",
    "page_number": 456,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3631
  },
  {
    "id": "chunk_03632",
    "text": "G yrassolG gestational trophoblast disease Disease during pregnancy involving abnormal cell growth of the trophoblast, the outermost layer of cells of the developing embryo, which develops into the placenta. goiter A noncancerous enlargement of the thyroid.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3632
  },
  {
    "id": "chunk_03633",
    "text": "goiter A noncancerous enlargement of the thyroid. gonorrhea A sexually transmitted infection caused by a bacterium. If not treated, can cause infertility. heart attack See Heart attack, Appendix B. See also ischemic heart disease. heavy bleeding See vaginal bleeding.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3633
  },
  {
    "id": "chunk_03634",
    "text": "eart disease. heavy bleeding See vaginal bleeding. hematocrit The percentage of whole blood that is made up of red blood cells. Used as a measurement of anemia. hematoma A bruise or area of skin discoloration caused by broken blood vessels beneath the skin.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3634
  },
  {
    "id": "chunk_03635",
    "text": "n caused by broken blood vessels beneath the skin. hematometra An accumulation of blood in the uterus, which may occur following spontaneous or induced abortion. hemoglobin The iron-containing material in red blood cells that carries oxygen from the lungs to the tissues of the body.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3635
  },
  {
    "id": "chunk_03636",
    "text": "oxygen from the lungs to the tissues of the body. hepatitis See Liver disorders, Appendix B. hernia The projection of an organ, part of an organ, or any bodily structure through the wall that normally contains it. herpes See genital herpes.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3636
  },
  {
    "id": "chunk_03637",
    "text": "t normally contains it. herpes See genital herpes. high-level disinfection (medical instruments) To destroy all living microorganisms except some forms of bacteria. Compare with sterilize. HIV See human immunodeficiency virus.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3637
  },
  {
    "id": "chunk_03638",
    "text": "h sterilize. HIV See human immunodeficiency virus. hormone A chemical substance formed in one organ or part of the body and carried in the blood to another organ or part, where it works through chemical action. Also, manufactured chemical substances that function as hormones.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3638
  },
  {
    "id": "chunk_03639",
    "text": "red chemical substances that function as hormones. human immunodeficiency virus (HIV) The virus that causes acquired immunodeficiency syndrome (AIDS). human papillomavirus (HPV) A common, highly contagious virus spread by sexual activity and",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3639
  },
  {
    "id": "chunk_03640",
    "text": "hly contagious virus spread by sexual activity and skin-to-skin contact in the genital area. Certain subtypes of HPV are responsible for most cases of cervical cancer; others cause genital warts. hydrocele The collection of fluid in a body cavity, especially in the testes or along the spermatic cord.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3640
  },
  {
    "id": "chunk_03641",
    "text": "ecially in the testes or along the spermatic cord. hyperlipidemia High level of fats in the blood that increases the risk of heart disease. hypertension Higher blood pressure than normal; 140 mm Hg or higher (systolic) or 90 mm Hg or higher (diastolic).",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3641
  },
  {
    "id": "chunk_03642",
    "text": "gher (systolic) or 90 mm Hg or higher (diastolic). hyperthyroidism Too much production of thyroid hormones. hypothyroidism Not enough production of thyroid hormones. implantation The embedding of the embryo in the endometrium of the uterus, where it",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3642
  },
  {
    "id": "chunk_03643",
    "text": "embryo in the endometrium of the uterus, where it establishes contact with the woman\u2019s blood supply for nourishment. infertility The inability of a couple to produce living children. informed choice A freely made decision based on clear, accurate, and relevant information.",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3643
  },
  {
    "id": "chunk_03644",
    "text": "ased on clear, accurate, and relevant information. A goal of family planning counseling. infrequent bleeding See vaginal bleeding. inguinal hernia A hernia in the groin. intercourse See sex. Glossary 435",
    "page_number": 457,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3644
  },
  {
    "id": "chunk_03645",
    "text": "irregular bleeding See vaginal bleeding. ischemic heart disease, ischemia Ischemia is reduced blood flow to tissues of the body. When this reduced flow is in the arteries of the heart, it is called ischemic heart disease.",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3645
  },
  {
    "id": "chunk_03646",
    "text": "of the heart, it is called ischemic heart disease. jaundice Abnormal yellowing of the skin and eyes. Usually a symptom of liver disease. labia The inner and outer lips of the vagina, which protect the internal female organs (see Female Anatomy, p. 454).",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3646
  },
  {
    "id": "chunk_03647",
    "text": "ternal female organs (see Female Anatomy, p. 454). laceration A wound or irregular tear of the flesh anywhere on the body, including the cervix and vagina. laparoscope A device consisting of a tube with lenses for viewing the inside of an organ or body",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3647
  },
  {
    "id": "chunk_03648",
    "text": "lenses for viewing the inside of an organ or body cavity. Used in diagnosis and in some female sterilization procedures. laparoscopy A procedure performed with a laparoscope. latex allergy When a person\u2019s body has a reaction to contact with latex, including persistent or",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3648
  },
  {
    "id": "chunk_03649",
    "text": "ion to contact with latex, including persistent or recurring severe redness, itching, or swelling. In extreme cases, may lead to anaphylactic shock (see Severe allergic reaction to latex, Appendix B). lesion A disturbed or diseased area of skin or other body tissue.",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3649
  },
  {
    "id": "chunk_03650",
    "text": "bed or diseased area of skin or other body tissue. liver disease Includes tumors, hepatitis, and cirrhosis. mastitis An inflammation of breast tissue due to infection that may cause fever, redness, and pain. menarche The beginning of cycles of monthly bleeding. Occurs during puberty after girls start",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3650
  },
  {
    "id": "chunk_03651",
    "text": "bleeding. Occurs during puberty after girls start producing estrogen and progesterone. menopause The time in a woman\u2019s life when monthly bleeding stops permanently. Occurs when a woman\u2019s ovaries stop releasing eggs (ova). A woman is considered menopausal after she has had no bleeding for 12 months.",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3651
  },
  {
    "id": "chunk_03652",
    "text": "ausal after she has had no bleeding for 12 months. menorrhagia See vaginal bleeding. menses, menstrual period, menstruation See monthly bleeding. menstrual cycle A repeating series of changes in the ovaries and endometrium that includes",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3652
  },
  {
    "id": "chunk_03653",
    "text": "anges in the ovaries and endometrium that includes ovulation and monthly bleeding. Most women have cycles that each last between 24 and 35 days (see The Menstrual Cycle, p. 456). migraine aura A nervous system disturbance that affects sight and sometimes touch and speech",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3653
  },
  {
    "id": "chunk_03654",
    "text": "that affects sight and sometimes touch and speech (see Identifying Migraine Headaches and Auras, p. 458). migraine headache A type of severe, recurrent headache (see Identifying Migraine Headaches and Auras, p. 458).",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3654
  },
  {
    "id": "chunk_03655",
    "text": "Identifying Migraine Headaches and Auras, p. 458). minilaparotomy A female sterilization technique performed by bringing the fallopian tubes to a small incision in the abdomen and then usually tying and cutting them. miscarriage Natural loss of pregnancy during the first 20 weeks.",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3655
  },
  {
    "id": "chunk_03656",
    "text": "tural loss of pregnancy during the first 20 weeks. monthly bleeding Monthly flow of bloody fluid from the uterus through the vagina in adult women, which takes place between menarche and menopause. Also, the monthly vaginal",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3656
  },
  {
    "id": "chunk_03657",
    "text": "menarche and menopause. Also, the monthly vaginal flow of bloody fluid that women have while using combined hormonal contraceptives (a withdrawal bleed). mucous membrane Membrane lining passages and cavities of the body that come in contact with air. nearly fully breastfeeding See breastfeeding.",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3657
  },
  {
    "id": "chunk_03658",
    "text": "air. nearly fully breastfeeding See breastfeeding. nephropathy Kidney disease, including damage to the small blood vessels in the kidneys from long-standing diabetes. neuropathy Nervous system or nerve disease, including nerve degeneration due to damage to",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3658
  },
  {
    "id": "chunk_03659",
    "text": "ase, including nerve degeneration due to damage to the small blood vessels in the nervous system from long-standing diabetes. nonsteroidal anti-inflammatory drug (NSAID) A class of drugs used to reduce pain, fever, and swelling. 436 Family Planning: A Global Handbook for Providers",
    "page_number": 458,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3659
  },
  {
    "id": "chunk_03660",
    "text": "G yrassolG orchitis Inflammation of a testis (see Male Anatomy, p. 457). ovarian cyst Fluid-filled sac that develops in the ovary or on its surface. Usually disappears on its own but may rupture and cause pain and complications.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3660
  },
  {
    "id": "chunk_03661",
    "text": "but may rupture and cause pain and complications. ovaries A pair of female sex glands that store and release ova (see ovum) and produce the sex hormones estrogen and progesterone (see Female Anatomy, p. 454). ovulation The release of an ovum from an ovary.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3661
  },
  {
    "id": "chunk_03662",
    "text": "). ovulation The release of an ovum from an ovary. ovum Reproductive egg cell produced by the ovaries. partially breastfeeding See breastfeeding. pelvic inflammatory disease See Pelvic inflammatory disease, Appendix B.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3662
  },
  {
    "id": "chunk_03663",
    "text": "sease See Pelvic inflammatory disease, Appendix B. pelvic tuberculosis Infection of the pelvic organs by tuberculosis bacteria from the lungs. pelvis The skeletal structure located in the lower part of the human torso, resting on the legs",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3663
  },
  {
    "id": "chunk_03664",
    "text": "lower part of the human torso, resting on the legs and supporting the spine. In females, also refers to the hollow portion of the pelvic bone structure through which the fetus passes during birth. penis The male organ for urination and sexual intercourse (see Male Anatomy, p. 457).",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3664
  },
  {
    "id": "chunk_03665",
    "text": "and sexual intercourse (see Male Anatomy, p. 457). perforation A hole in the wall of an organ or the process of making the hole, as with a medical instrument. placenta The organ that nourishes a growing fetus. The placenta (afterbirth) is formed during",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3665
  },
  {
    "id": "chunk_03666",
    "text": "fetus. The placenta (afterbirth) is formed during pregnancy and comes out of the uterus within a few minutes after the birth of a baby. postpartum After childbirth; the first 6 weeks after childbirth. pre-eclampsia Hypertension with either excess protein in the urine, or local or generalized",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3666
  },
  {
    "id": "chunk_03667",
    "text": "cess protein in the urine, or local or generalized swelling, or both (but without convulsions) after 20 weeks of pregnancy. May progress to eclampsia. premature birth A birth that occurs before 37 weeks of pregnancy.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3667
  },
  {
    "id": "chunk_03668",
    "text": "A birth that occurs before 37 weeks of pregnancy. preventive measures Actions taken to prevent disease, such as washing hands or providing medicines or other therapy. progesterone A steroid hormone that is produced by the ovary after ovulation. Prepares",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3668
  },
  {
    "id": "chunk_03669",
    "text": "is produced by the ovary after ovulation. Prepares the endometrium for implantation of a fertilized egg (ovum), protects the embryo, enhances development of the placenta, and helps prepare the breasts for breastfeeding.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3669
  },
  {
    "id": "chunk_03670",
    "text": ", and helps prepare the breasts for breastfeeding. progestin (progestogen) Any of a large group of synthetic medicines that have effects similar to those of progesterone. Some are used in hormonal contraceptives. prolonged bleeding See vaginal bleeding.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3670
  },
  {
    "id": "chunk_03671",
    "text": "ceptives. prolonged bleeding See vaginal bleeding. prolonged rupture of membranes Occurs when the fluid-filled sac surrounding a pregnant woman\u2019s fetus breaks 24 hours or more before delivery of the infant. prophylaxis See preventive measures.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3671
  },
  {
    "id": "chunk_03672",
    "text": "f the infant. prophylaxis See preventive measures. prostate Male reproductive organ where some of the semen is produced (see Male Anatomy, p. 457). puerperal sepsis Infection of the reproductive organs during the first 42 days postpartum (puerperium).",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3672
  },
  {
    "id": "chunk_03673",
    "text": "during the first 42 days postpartum (puerperium). pulmonary embolism See Pulmonary embolism, Appendix B. pulmonary hypertension Continuous hypertension in the pulmonary artery, impeding blood flow from the heart to the lungs.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3673
  },
  {
    "id": "chunk_03674",
    "text": ", impeding blood flow from the heart to the lungs. purulent cervicitis Inflammation of the cervix accompanied by a pus-like discharge. Often indicates infection with gonorrhea or chlamydia. pus A yellowish-white fluid formed in infected tissue.",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3674
  },
  {
    "id": "chunk_03675",
    "text": "A yellowish-white fluid formed in infected tissue. retinopathy Disease of the retina (nerve tissue lining the back of the eye), including damage to the small blood vessels to the retina from long-standing diabetes. ruptured ectopic pregnancy See Ruptured ectopic pregnancy, Appendix B. Glossary 437",
    "page_number": 459,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3675
  },
  {
    "id": "chunk_03676",
    "text": "schistosomiasis A parasitic disease caused by a flatworm living in a snail host. People become infected while wading or bathing in water containing larvae of the infected snails. scrotum The pouch of skin behind the penis that contains the testes (see Male Anatomy, p. 457).",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3676
  },
  {
    "id": "chunk_03677",
    "text": "at contains the testes (see Male Anatomy, p. 457). semen The thick, white fluid produced by a man\u2019s reproductive organs and released through the penis during ejaculation. Contains sperm unless the man has had a vasectomy.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3677
  },
  {
    "id": "chunk_03678",
    "text": "Contains sperm unless the man has had a vasectomy. seminal vesicles Male organs where sperm mixes with semen (see Male Anatomy, p. 457). sepsis The presence of various pus-forming and disease-causing organisms, or poisonous substances that they produce, in the blood or body tissues.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3678
  },
  {
    "id": "chunk_03679",
    "text": "s that they produce, in the blood or body tissues. septic abortion Induced or spontaneous abortion involving infection. sex, sexual intercourse Sexual activity in which the penis is inserted into a body cavity. anal Sex involving the anus. oral Sex involving the mouth.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3679
  },
  {
    "id": "chunk_03680",
    "text": "involving the anus. oral Sex involving the mouth. vaginal Sex involving the vagina. sexually transmitted infection (STI) Any of a group of bacterial, fungal, and viral infections and parasites that are transmitted during sexual activity.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3680
  },
  {
    "id": "chunk_03681",
    "text": "sites that are transmitted during sexual activity. sickle cell anemia, sickle cell disease Hereditary, chronic form of anemia. Blood cells take on an abnormal sickle or crescent shape when deprived of oxygen. speculum A medical tool used to widen a body opening to better see inside. A speculum is",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3681
  },
  {
    "id": "chunk_03682",
    "text": "a body opening to better see inside. A speculum is inserted into the vagina to help see the cervix. sperm The male sex cell. Sperm are produced in the testes of an adult male, mixed with semen in the seminal vesicles, and released during ejaculation (see Male Anatomy, p. 457).",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3682
  },
  {
    "id": "chunk_03683",
    "text": "sed during ejaculation (see Male Anatomy, p. 457). spermatic cord A cord consisting of the vas deferens, arteries, veins, nerves, and lymphatic vessels that passes from the groin down to the back of each testis (see Male Anatomy, p. 457). spontaneous abortion See miscarriage.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3683
  },
  {
    "id": "chunk_03684",
    "text": "my, p. 457). spontaneous abortion See miscarriage. spotting See vaginal bleeding. sterilize (medical equipment) To destroy all microorganisms, including spores that are not killed by high-level disinfection. stroke See Stroke, Appendix B.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3684
  },
  {
    "id": "chunk_03685",
    "text": "level disinfection. stroke See Stroke, Appendix B. superficial thrombophlebitis Inflammation of a vein just beneath the skin due to a blood clot. syphilis A sexually transmitted infection caused by a bacterium. If untreated, may progress",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3685
  },
  {
    "id": "chunk_03686",
    "text": "caused by a bacterium. If untreated, may progress to systemic infection, causing general paralysis and dementia. May be transmitted to the fetus during pregnancy or childbirth. tampon A plug of cotton or other absorbent material used to absorb fluids, such as a plug",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3686
  },
  {
    "id": "chunk_03687",
    "text": "ent material used to absorb fluids, such as a plug inserted in the vagina to absorb bloody flow during monthly bleeding. testes, testicles The 2 male reproductive organs that produce sperm and the hormone testosterone. Located in the scrotum. (Testis if referring to one of the testes; see Male",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3687
  },
  {
    "id": "chunk_03688",
    "text": "Testis if referring to one of the testes; see Male Anatomy, p. 457). thalassemia An inherited type of anemia. thromboembolic disorder (or disease) Abnormal clotting of blood in the blood vessels. thrombogenic mutations Any of several genetic disorders that cause abnormal thickening or",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3688
  },
  {
    "id": "chunk_03689",
    "text": "enetic disorders that cause abnormal thickening or clotting of the blood. thrombophlebitis Inflammation of a vein due to the presence of a blood clot (see thrombosis). thrombosis Formation of a blood clot inside a blood vessel. thrush See candidiasis.",
    "page_number": 460,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3689
  },
  {
    "id": "chunk_03690",
    "text": "G yrassolG thyroid disease Any disease of the thyroid (see hyperthyroid, hypothyroid). toxic shock syndrome See Toxic shock syndrome, Appendix B. trichomoniasis A sexually transmitted infection caused by a protozoan. trophoblast disease See gestational trophoblastic disease.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3690
  },
  {
    "id": "chunk_03691",
    "text": "ast disease See gestational trophoblastic disease. tuberculosis A contagious disease caused by a bacterium. Most commonly infects the respiratory system; also infects the organs in a woman\u2019s pelvis, and then known as pelvic tuberculosis.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3691
  },
  {
    "id": "chunk_03692",
    "text": "n\u2019s pelvis, and then known as pelvic tuberculosis. urethra Tube through which urine is released from the body (see Female Anatomy, p. 454, and Male Anatomy, p. 457). In men semen also passes through the urethra. uterine fibroid Noncancerous tumor that grows in the muscle of the uterus.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3692
  },
  {
    "id": "chunk_03693",
    "text": "rous tumor that grows in the muscle of the uterus. uterine perforation Puncturing of the wall of the uterus, which may occur during an induced abortion or with insertion of an intrauterine device. uterine rupture A tear of the uterus, typically during labor or late pregnancy.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3693
  },
  {
    "id": "chunk_03694",
    "text": "uterus, typically during labor or late pregnancy. uterus The hollow, muscular organ that carries the fetus during pregnancy. Also called the womb (see Female Anatomy, p. 454). vagina The passage joining the outer sexual organs with the uterus in females (see Female Anatomy, p. 454).",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3694
  },
  {
    "id": "chunk_03695",
    "text": "he uterus in females (see Female Anatomy, p. 454). vaginal bleeding Any bloody vaginal discharge (pink, red, or brown) that requires the use of sanitary protection (pads, cloths, or tampons). Different vaginal bleeding patterns include: amenorrhea No bleeding at all at expected bleeding times.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3695
  },
  {
    "id": "chunk_03696",
    "text": "hea No bleeding at all at expected bleeding times. breakthrough bleeding Any bleeding outside of expected bleeding times (i.e., outside of regular monthly bleeding) that requires use of sanitary protection. heavy bleeding (menorrhagia) Bleeding that is twice as heavy as a woman\u2019s usual bleeding.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3696
  },
  {
    "id": "chunk_03697",
    "text": "hat is twice as heavy as a woman\u2019s usual bleeding. infrequent bleeding Fewer than 2 bleeding episodes over 3 months. irregular bleeding Spotting and/or breakthrough bleeding that occurs outside of expected bleeding times (i.e., outside of regular monthly bleeding).",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3697
  },
  {
    "id": "chunk_03698",
    "text": "times (i.e., outside of regular monthly bleeding). menstrual bleeding, monthly bleeding. Bleeding that takes place, on average, for 3\u20137 days about every 28 days. prolonged bleeding Bleeding that lasts longer than 8 days.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3698
  },
  {
    "id": "chunk_03699",
    "text": "d bleeding Bleeding that lasts longer than 8 days. spotting Any bloody vaginal discharge outside of expected bleeding times that requires no sanitary protection. vaginal mucus The fluid secreted by glands in the vagina.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3699
  },
  {
    "id": "chunk_03700",
    "text": "mucus The fluid secreted by glands in the vagina. vaginitis Inflammation of the vagina. May be due to infection by bacteria, viruses, or fungi, or to chemical irritation. Not a sexually transmitted infection. valvular heart disease Health problems due to improperly functioning heart valves.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3700
  },
  {
    "id": "chunk_03701",
    "text": "oblems due to improperly functioning heart valves. varicose veins Enlarged, twisted veins, most commonly seen in veins just beneath the skin of the legs. vas deferens (vas, vasa) Two muscular tubes that transport sperm from the testes to the",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3701
  },
  {
    "id": "chunk_03702",
    "text": "tubes that transport sperm from the testes to the seminal vesicles. These tubes are cut or blocked during a vasectomy (see Male Anatomy, p. 457). vascular disease Any disease of the blood vessels. vulva The exterior female genitals. warts See genital warts. withdrawal bleed See monthly bleeding.",
    "page_number": 461,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3702
  },
  {
    "id": "chunk_03703",
    "text": "Methodology The 2022 edition of Family Planning: A Global Handbook for Providers reflects the most up-to-date World Health Organization (WHO) recommendations issued since the publication of the 3rd edition in 2018. Of note, revisions to",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3703
  },
  {
    "id": "chunk_03704",
    "text": "of the 3rd edition in 2018. Of note, revisions to Chapters 4, 22, and 25 incorporate recommendations published by WHO that address medical eligibility for the use of progestin-only injectables among woman at high risk for HIV (1); syndromic management of sexually",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3704
  },
  {
    "id": "chunk_03705",
    "text": "risk for HIV (1); syndromic management of sexually transmitted infections (2); screening, prevention, and treatment of cervical cancer (3,4,5); and postabortion contraception (6). Expanded guidance on implant insertion and removal techniques in Chapter 9 was added based",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3705
  },
  {
    "id": "chunk_03706",
    "text": "nd removal techniques in Chapter 9 was added based upon new information provided by the product manufacturer to improve client care. The development of the new chapter titled Family Planning for Adolescents and Women at High Risk for HIV was informed by recommendations",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3706
  },
  {
    "id": "chunk_03707",
    "text": "High Risk for HIV was informed by recommendations issued by a WHO Guideline Development Group that met in July 2019 to review contraceptive eligibility for women at high risk of HIV (7), and also presented in a July 2020 policy brief by WHO and the Joint United Nations",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3707
  },
  {
    "id": "chunk_03708",
    "text": "0 policy brief by WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS) highlighting recommended actions for improved clinical and prevention services and choices (8). The new chapter titled Providing Family Planning Services During an Epidemic is based",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3708
  },
  {
    "id": "chunk_03709",
    "text": "mily Planning Services During an Epidemic is based on interim WHO operational guidance on maintaining essential services during an outbreak (published in March and updated in June 2020) (9) and a WHO Q&A web page responding to questions on COVID-19 and family planning (10).",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3709
  },
  {
    "id": "chunk_03710",
    "text": "to questions on COVID-19 and family planning (10). A multidisciplinary group of experts, including experts in family planning, sexually transmitted infections, abortion care, cervical cancer, and HIV, as well as representatives from affected populations, and clinicians, epidemiologists,",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3710
  },
  {
    "id": "chunk_03711",
    "text": "cted populations, and clinicians, epidemiologists, pharmacologists, program managers, and policy-makers, contributed to the development and review of the revised chapters and newly developed chapters (see Acknowledgements, pp. ix\u2013x). Definitions Used in This Handbook",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3711
  },
  {
    "id": "chunk_03712",
    "text": "ents, pp. ix\u2013x). Definitions Used in This Handbook Effectiveness: Rates are largely the percentages of US women estimated to have unintended pregnancies during the first year of use, unless noted otherwise. See Appendix A. Side effects: Conditions reported by at least 5% of users in selected studies,",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3712
  },
  {
    "id": "chunk_03713",
    "text": "orted by at least 5% of users in selected studies, regardless of evidence of causality or biological plausibility, listed in order of frequency with the most common at the top. 440 Family Planning: A Global Handbook for Providers",
    "page_number": 462,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3713
  },
  {
    "id": "chunk_03714",
    "text": "441 ygolodohteM Terms describing health risks (percentage of users experiencing a risk): Common: \u226515% and <45% Uncommon: \u22651% and <15% Rare: \u22650.1% and <1% (<1 per 100 and \u22651 per 1,000) Very rare: \u22650.01% and <0.1% (<1 per 1,000 and \u22651 per 10,000) Extremely rare: <0.01% (<1 per 10,000)",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3714
  },
  {
    "id": "chunk_03715",
    "text": "per 10,000) Extremely rare: <0.01% (<1 per 10,000) Reference List for the Methodology 1. Contraceptive eligibility for women at high risk of HIV: guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. Geneva:",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3715
  },
  {
    "id": "chunk_03716",
    "text": "methods used by women at high risk of HIV. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/handle/10665/326653). 2. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342523).",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3716
  },
  {
    "id": "chunk_03717",
    "text": "1 (https://apps.who.int/iris/handle/10665/342523). 3. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342365).",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3717
  },
  {
    "id": "chunk_03718",
    "text": "1 (https://apps.who.int/iris/handle/10665/342365). 4. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus. Geneva:",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3718
  },
  {
    "id": "chunk_03719",
    "text": "se of mRNA tests for human papillomavirus. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/350652). 5. Human papillomavirus ( HPV) nucleic acid amplification tests ( NAATs) to screen for",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3719
  },
  {
    "id": "chunk_03720",
    "text": "ic acid amplification tests ( NAATs) to screen for cervical pre-cancer lesions and prevent cervical cancer: policy brief. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/352495). 6. Abortion care guideline. Geneva: World Health Organization; 2022",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3720
  },
  {
    "id": "chunk_03721",
    "text": "guideline. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/349316). 7. Contraceptive eligibility for women at high risk of HIV: guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. Geneva:",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3721
  },
  {
    "id": "chunk_03722",
    "text": "methods used by women at high risk of HIV. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/handle/10665/326653). 8. Actions for improved clinical and prevention services and choices: preventing HIV and",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3722
  },
  {
    "id": "chunk_03723",
    "text": "revention services and choices: preventing HIV and other sexually transmitted infections among women and girls using contraceptive services in contexts with high HIV incidence. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332287).",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3723
  },
  {
    "id": "chunk_03724",
    "text": "0 (https://apps.who.int/iris/handle/10665/332287). 9. Maintaining essential health services: operational guidance for the COVID-19 context: interim guidance. 1 June 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332240).",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3724
  },
  {
    "id": "chunk_03725",
    "text": "0 (https://apps.who.int/iris/handle/10665/332240). 10. Coronavirus disease (COVID-19): contraception and family planning. Geneva: World Health Organization; 2020 (https://www.who.int/emergencies/diseases/novel- coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-",
    "page_number": 463,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3725
  },
  {
    "id": "chunk_03726",
    "text": "WHO Guidance Documents Used in Preparation of This Edition of the Handbook WHO\u2019s evidence-based cornerstones (guidance documents) for national family planning guidelines and programmes Medical eligibility criteria for contraceptive use, fifth edition. 2015.",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3726
  },
  {
    "id": "chunk_03727",
    "text": "iteria for contraceptive use, fifth edition. 2015. https://apps.who.int/iris/handle/10665/181468 Selected practice recommendations for contraceptive use, third edition. 2016. https://apps.who.int/iris/handle/10665/252267 WHO\u2019s mobile applications (apps) relevant to family planning",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3727
  },
  {
    "id": "chunk_03728",
    "text": "le applications (apps) relevant to family planning Contraceptive delivery tool for humanitarian settings To access and install the Android or Apple App, follow this link for information: https://www.who.int/news/item/07-12-2018-delivering- contraceptive-services-in-humanitarian-settings",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3728
  },
  {
    "id": "chunk_03729",
    "text": "g- contraceptive-services-in-humanitarian-settings Medical eligibility criteria for contraceptive use app To access and install the Android or Apple App, follow this link for information: https://www.who.int/news/item/29-08-2019-new-app-for- who-s-medical-eligibility-criteria-for-contraceptive-use",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3729
  },
  {
    "id": "chunk_03730",
    "text": "medical-eligibility-criteria-for-contraceptive-use Abortion care guideline. 2022. https://apps.who.int/iris/handle/10665/349316 (sections 3.5.4; 3.6.3). Actions for improved clinical and prevention services and choices: preventing",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3730
  },
  {
    "id": "chunk_03731",
    "text": "al and prevention services and choices: preventing HIV and other sexually transmitted infections among women and girls using contraceptive services in contexts with high HIV incidence. 2020. https:// apps.who.int/iris/handle/10665/332287",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3731
  },
  {
    "id": "chunk_03732",
    "text": "20. https:// apps.who.int/iris/handle/10665/332287 Brief sexuality-related communication: recommendations for a public health approach. 2015. https://apps.who.int/iris/handle/10665/170251 Cervical cancer: fact sheet. 2022. https://www.who.int/news-room/fact- sheets/detail/cervical-cancer",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3732
  },
  {
    "id": "chunk_03733",
    "text": ".int/news-room/fact- sheets/detail/cervical-cancer Comprehensive cervical cancer control: a guide to essential practice, second edition. 2014. https://apps.who.int/iris/handle/10665/144785 442 Family Planning: A Global Handbook for Providers",
    "page_number": 464,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3733
  },
  {
    "id": "chunk_03734",
    "text": "443 ygolodohteM WHO Guidance Documents stnemucoD ecnadiuG OHW Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. 2022. https://apps.who.int/iris/ handle/10665/360601",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3734
  },
  {
    "id": "chunk_03735",
    "text": "22. https://apps.who.int/iris/ handle/10665/360601 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, second edition. 2016. https://apps.who.int/iris/handle/10665/208825",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3735
  },
  {
    "id": "chunk_03736",
    "text": "016. https://apps.who.int/iris/handle/10665/208825 Contraceptive eligibility for women at high risk of HIV: guidance statement: recommendations on contraceptive methods used by women at high risk of HIV. 2019. https://apps.who.int/iris/handle/10665/326653",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3736
  },
  {
    "id": "chunk_03737",
    "text": "019. https://apps.who.int/iris/handle/10665/326653 Coronavirus disease (COVID-19): contraception and family planning. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question- and-answers-hub/q-a-detail/coronavirus-disease-covid-19-contraception-and- family-planning.",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3737
  },
  {
    "id": "chunk_03738",
    "text": "sease-covid-19-contraception-and- family-planning. Eliminating forced, coercive and otherwise involuntary sterilization: an interagency statement by OHCHR, UN Women, UNAIDS, UNDP, UNFPA, UNICEF and WHO. 2014. https://apps.who.int/iris/handle/10665/112848",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3738
  },
  {
    "id": "chunk_03739",
    "text": "014. https://apps.who.int/iris/handle/10665/112848 Ensuring human rights in the provision of contraceptive information and services: guidance and recommendations. 2014. https://apps.who.int/iris/ handle/10665/102539 Ensuring human rights within contraceptive service delivery: implementation",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3739
  },
  {
    "id": "chunk_03740",
    "text": "hin contraceptive service delivery: implementation guide. 2015. https://apps.who.int/iris/handle/10665/158866 Gender mainstreaming for health managers: a practical approach. 2011. https://apps.who.int/iris/handle/10665/44516 Guidelines for the management of symptomatic sexually transmitted",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3740
  },
  {
    "id": "chunk_03741",
    "text": "the management of symptomatic sexually transmitted infections. 2021. https://apps.who.int/iris/handle/10665/342523 Health care for women subjected to intimate partner violence or sexual violence: a clinical handbook. 2014. https://apps.who.int/iris/ handle/10665/136101",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3741
  },
  {
    "id": "chunk_03742",
    "text": "14. https://apps.who.int/iris/ handle/10665/136101 Human papillomavirus (HPV): fact sheet. 2017. https://www.who.int/europe/ news-room/fact-sheets/item/human-papillomavirus-%28hpv%29 Human papillomavirus ( HPV) nucleic acid amplification tests ( NAATs) to",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3742
  },
  {
    "id": "chunk_03743",
    "text": "HPV) nucleic acid amplification tests ( NAATs) to screen for cervical pre-cancer lesions and prevent cervical cancer: policy brief. 2022. https://apps.who.int/iris/handle/10665/352495. International Statistical Classification of Diseases and Related Health",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3743
  },
  {
    "id": "chunk_03744",
    "text": "ical Classification of Diseases and Related Health Problems, 11th edition (ICD-11) [website]. 2022. https://icd.who.int/en Maintaining essential health services: operational guidance for the COVID-19 context: interim guidance. 2020. https://apps.who.int/iris/ handle/10665/332240",
    "page_number": 465,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3744
  },
  {
    "id": "chunk_03745",
    "text": "Monitoring human rights in contraceptive services and programmes. 2017. https://apps.who.int/iris/handle/10665/259274 Preventing HIV and other STIs among women and girls using contraceptive services in contexts with high HIV incidence: actions for improved clinical and",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3745
  },
  {
    "id": "chunk_03746",
    "text": "h HIV incidence: actions for improved clinical and prevention services and choices: policy brief. 2020. https://apps.who.int/iris/ handle/10665/332287 Programming strategies for postpartum family planning. 2013. https://apps. who.int/iris/handle/10665/93680",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3746
  },
  {
    "id": "chunk_03747",
    "text": "013. https://apps. who.int/iris/handle/10665/93680 Promoting sexual and reproductive health for persons with disabilities: WHO/UNFPA guidance note. 2009. https://apps.who.int/iris/ handle/10665/44207 Responding to intimate partner violence and sexual violence against",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3747
  },
  {
    "id": "chunk_03748",
    "text": "imate partner violence and sexual violence against women: WHO clinical and policy guidelines. 2013. https://apps.who.int/iris/ handle/10665/85240 Technical consultation on the effects of hormonal contraception on bone health: summary report. 2005. https://apps.who.int/iris/handle/10665/69845",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3748
  },
  {
    "id": "chunk_03749",
    "text": "2005. https://apps.who.int/iris/handle/10665/69845 WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. 2021. https://apps.who.int/iris/handle/10665/342365 WHO guideline for screening and treatment of cervical pre-cancer lesions",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3749
  },
  {
    "id": "chunk_03750",
    "text": "ening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus ( HPV). 2021. https://apps.who.int/iris/handle/10665/350652 WHO guideline on self-care interventions for health and well-being: 2022",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3750
  },
  {
    "id": "chunk_03751",
    "text": "care interventions for health and well-being: 2022 revision. 2022. https://apps.who.int/iris/handle/10665/357828 WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. 2017. https://apps.who.int/iris/handle/10665/255890",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3751
  },
  {
    "id": "chunk_03752",
    "text": "017. https://apps.who.int/iris/handle/10665/255890 WHO recommendations on adolescent sexual and reproductive health and rights. 2018. https://apps.who.int/iris/handle/10665/275374 WHO recommendations on antenatal care for a positive pregnancy",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3752
  },
  {
    "id": "chunk_03753",
    "text": "dations on antenatal care for a positive pregnancy experience. 2016. https://apps.who.int/iris/handle/10665/250796 WHO recommendations on maternal and newborn care for a positive postnatal experience. 2022. https://apps.who.int/iris/handle/10665/352658",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3753
  },
  {
    "id": "chunk_03754",
    "text": "022. https://apps.who.int/iris/handle/10665/352658 WHO recommendations: optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting. 2012. https://apps.who.int/iris/handle/10665/77764",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3754
  },
  {
    "id": "chunk_03755",
    "text": "2012. https://apps.who.int/iris/handle/10665/77764 WHO technical brief: preventing HIV during pregnancy and breastfeeding in the context of PrEP: technical brief. 2017. https://apps.who.int/iris/ handle/10665/255866 444 Family Planning: A Global Handbook for Providers",
    "page_number": 466,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3755
  },
  {
    "id": "chunk_03756",
    "text": "445 ssenevisulcnI redneG dna ytilauqE redneG noitceS rof tsyiLg oelcondeorhetfeeMR Reference List for Section on Gender Equality and Gender Inclusiveness Please refer to pp. xv\u2013xvii. 1. The United Nations Fourth World Conference on Women, Beijing, China,",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3756
  },
  {
    "id": "chunk_03757",
    "text": "Fourth World Conference on Women, Beijing, China, Platform for Action, Section C: Women and Health. United Nations; 1995 (https://www.un.org/womenwatch/daw/beijing/platform/health.htm). 2. Gender mainstreaming for health managers: a practical approach.",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3757
  },
  {
    "id": "chunk_03758",
    "text": "reaming for health managers: a practical approach. Geneva: World Health Organization; 2011 (https://apps.who.int/iris/ handle/10665/44516). 3. Ayhan CHB, Bilgin H, Uluman OT, et al. A systematic review of the discrimination against sexual and gender minority in health care settings.",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3758
  },
  {
    "id": "chunk_03759",
    "text": "exual and gender minority in health care settings. Int J Health Serv. 2020;50(1):44\u201361. doi:10.1177/0020731419885093. 4. White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms,",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3759
  },
  {
    "id": "chunk_03760",
    "text": "ritical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222\u201331. doi:10.1016/j. socscimed.2015.11.010. 5. Drabish K, Theeke LA. Health impact of stigma, discrimination, prejudice, and bias experienced by transgender people: a systematic review of",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3760
  },
  {
    "id": "chunk_03761",
    "text": "nced by transgender people: a systematic review of quantitative studies. Issues Ment Health Nurs. 2022;43(2):111\u20138. doi:10.10 80/01612840.2021.1961330. 6. International Statistical Classification of Diseases and Related Health Problems, 11th edition (ICD-11) [website]. Geneva: World Health",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3761
  },
  {
    "id": "chunk_03762",
    "text": "h edition (ICD-11) [website]. Geneva: World Health Organization; 2022 (https://icd.who.int/en). 7. WHO guideline on self-care interventions for health and well-being: 2022 revision. Geneva: World Health Organization; 2022 (https://apps.who.int/ iris/handle/10665/357828).",
    "page_number": 467,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3762
  },
  {
    "id": "chunk_03763",
    "text": "Illustration and Photo Credits Illustrations by Greg Dayman, Rita Meyer, and Rafael Avila, unless otherwise noted below. Adaptations by Rafael Avila. Covers Mark Beisser, CCP, Tina Larson, Prographics p. 34 DELIVER p. 38 Cheikh Fall, CCP, courtesy of Photoshare p. 50 Francine Mueller, CCP",
    "page_number": 468,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3763
  },
  {
    "id": "chunk_03764",
    "text": "courtesy of Photoshare p. 50 Francine Mueller, CCP p. 66 David Alexander, CCP, courtesy of Photoshare p. 70 PATH/Will Boase pp. 81\u201382 PATH pp. 84\u201385 PATH p. 98 Schering AG p. 120 Ortho-McNeil Pharmaceutical p. 124 David Alexander, CCP, courtesy of Photoshare p. 127 Population Council",
    "page_number": 468,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3764
  },
  {
    "id": "chunk_03765",
    "text": ", courtesy of Photoshare p. 127 Population Council pp 142\u2013148 [Need] pp. 157\u2013159 [Need] p. 167 Jhpiego. Source: Bluestone B, Chase R, and Lu ER, editors. IUD guidelines for family planning service programs. 3rd ed. Baltimore: Jhpiego; 2006. (adapted)",
    "page_number": 468,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3765
  },
  {
    "id": "chunk_03766",
    "text": "grams. 3rd ed. Baltimore: Jhpiego; 2006. (adapted) p. 168 David Alexander, CCP, courtesy of Photoshare p. 176 David Alexander, CCP, courtesy of Photoshare pp. 178\u2013179 Jhpiego. Source: Bluestone B, Chase R, and Lu ER, editors. IUD guidelines for family planning service programs.",
    "page_number": 468,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3766
  },
  {
    "id": "chunk_03767",
    "text": "D guidelines for family planning service programs. 3rd ed. Baltimore: Jhpiego; 2006. (adapted) p. 199 David Alexander, CCP, courtesy of Photoshare 446 Family Planning: A Global Handbook for Providers",
    "page_number": 468,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3767
  },
  {
    "id": "chunk_03768",
    "text": "447 ygolodohteM Illustration and Photo Credits stiderC pp. 207\u2013208 Jhpiego. Source: Bluestone B, Chase R, and Lu ER, editors. IUD guidelines for family planning service programs. 3rd ed. Baltimore: Jhpiego; 2006. (adapted) p. 231 EngenderHealth (adapted) p. 249 EngenderHealth (adapted)",
    "page_number": 469,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3768
  },
  {
    "id": "chunk_03769",
    "text": "erHealth (adapted) p. 249 EngenderHealth (adapted) p. 272 David Alexander, CCP, courtesy of Photoshare p. 275 Female Health Foundation (adapted) p. 282 David Alexander, CCP, courtesy of Photoshare p. 300 Francine Mueller, CCP p. 296 Institute for Reproductive Health, Georgetown University (adapted)",
    "page_number": 469,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3769
  },
  {
    "id": "chunk_03770",
    "text": "productive Health, Georgetown University (adapted) p. 302 Institute for Reproductive Health, Georgetown University (adapted) p. 327 LINKAGES Project, Academy for Educational Development p. 333 Bangladesh Center for Communication Programs p. 372 Rick Maiman, David and Lucile Packard Foundation,",
    "page_number": 469,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3770
  },
  {
    "id": "chunk_03771",
    "text": "Rick Maiman, David and Lucile Packard Foundation, courtesy of Photoshare p. 374 CCP, courtesy of Photoshare p. 404 Lamia Jaroudi, CCP, courtesy of Photoshare p. 407 CCP, courtesy of Photoshare p. 474 FHI 360 Inside back cover FHI 360",
    "page_number": 469,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3771
  },
  {
    "id": "chunk_03772",
    "text": "JOB AID Comparing Contraceptives Comparing Combined Methods Charac- Combined Oral Monthly Combined Combined teristic Contraceptives Injectables Patch Vaginal Ring How it Pill taken orally. Intramuscular Patch worn on Ring inserted in is used injection. upper outer the vagina. arm, back, abdomen or",
    "page_number": 470,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3772
  },
  {
    "id": "chunk_03773",
    "text": "ion. upper outer the vagina. arm, back, abdomen or buttocks. Not on breasts. Frequency Daily. Monthly: Weekly: Patch Monthly: Ring of use Injection every is changed kept in place 4 weeks. every week for for 3 weeks and 3 weeks. No taken out during patch worn 4th week. 4th week.",
    "page_number": 470,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3773
  },
  {
    "id": "chunk_03774",
    "text": "No taken out during patch worn 4th week. 4th week. Effective- Depends on user\u2019s Least Requires Depends on ness ability to take a pill dependent on user\u2019s user keeping every day. the user. User attention once the ring in place, must obtain a week. not leaving it out injection every for more than",
    "page_number": 470,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3774
  },
  {
    "id": "chunk_03775",
    "text": ". not leaving it out injection every for more than 4 weeks (plus 48 hours or minus at a time. 7 days). Bleeding Typically, irregular Irregular Similar to Similar to COCs, patterns bleeding for the bleeding or COCs, but but irregular first few months no monthly irregular bleeding is less",
    "page_number": 470,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3775
  },
  {
    "id": "chunk_03776",
    "text": "t few months no monthly irregular bleeding is less and then lighter bleeding is more bleeding common than and more regular common than is more with COCs. bleeding. with COCs. common in Also, some the first few have prolonged cycles than bleeding in with COCs. the first few months.",
    "page_number": 470,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3776
  },
  {
    "id": "chunk_03777",
    "text": "than bleeding in with COCs. the first few months. Privacy No physical signs No physical Patch may be Partner may be of use but others signs of use. seen by partner able to feel the may find the pills. or others. ring. 448 Family Planning: A Global Handbook for Providers",
    "page_number": 470,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3777
  },
  {
    "id": "chunk_03778",
    "text": "449 ygolodohteM Comparing Injectables Charac- Monthly DMPA NET-EN teristic Injectables Time between 3 months. 2 months. 1 month. injections How early or 2 weeks before or 2 weeks before 7 days before or late a client 4 weeks after or after scheduled after scheduled",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3778
  },
  {
    "id": "chunk_03779",
    "text": "t 4 weeks after or after scheduled after scheduled can have the scheduled injection date. injection date. next injection injection date. Injection Deep intramuscular Deep intramuscular Deep intramuscular technique (IM) injection into the injection into the injection into the",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3779
  },
  {
    "id": "chunk_03780",
    "text": "ion into the injection into the injection into the hip, upper arm, or hip, upper arm, or hip, upper arm, buttock. buttock. May be buttock, or outer slightly more painful thigh. Subcutaneous injection than DMPA-IM. into back of upper arm, abdomen, or front of thigh.",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3780
  },
  {
    "id": "chunk_03781",
    "text": "nto back of upper arm, abdomen, or front of thigh. Typical Irregular and Irregular or Irregular, frequent, bleeding prolonged bleeding prolonged bleeding or prolonged patterns in at first, then no in first 6 months but bleeding in first 3",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3781
  },
  {
    "id": "chunk_03782",
    "text": "then no in first 6 months but bleeding in first 3 first year bleeding or infrequent shorter bleeding months. Mostly bleeding. About 40% episodes than with regular bleeding of users have no DMPA. After 6 patterns by 1 year. monthly bleeding after months bleeding About 2% of users",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3782
  },
  {
    "id": "chunk_03783",
    "text": "y bleeding after months bleeding About 2% of users 1 year. patterns are similar have no monthly to those with DMPA. bleeding after 30% of users have 1 year. no monthly bleeding after 1 year. Average 1\u20132 kg per year. 1\u20132 kg per year. 1 kg per year. weight gain",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3783
  },
  {
    "id": "chunk_03784",
    "text": "year. 1\u20132 kg per year. 1 kg per year. weight gain Pregnancy About 4 pregnancies Assumed to be About rate, as per 100 women in the similar to DMPA. 3 pregnancies per commonly first year. 100 women in used the first year. Average delay 4 months longer than 1 month longer 1 month longer",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3784
  },
  {
    "id": "chunk_03785",
    "text": "4 months longer than 1 month longer 1 month longer in time to for women who used than for women than for women pregnancy other methods. who used other who used other after stopping methods. methods. injections Comparing Injectables sdiA boJ",
    "page_number": 471,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3785
  },
  {
    "id": "chunk_03786",
    "text": "Comparing Implants Characteristic Jadelle Implanon NXT Levoplant Type of progestin Levonorgestrel Etonogestrel Levonorgestrel Number 2 rods 1 rod 2 rods Approved lifespan 5 years 3 years 4 years Comparing Condoms Characteristic Male Condoms Female Condoms",
    "page_number": 472,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3786
  },
  {
    "id": "chunk_03787",
    "text": "Condoms Characteristic Male Condoms Female Condoms How to wear Rolled onto man\u2019s penis. Inserted into the woman\u2019s Fits the penis tightly. vagina. Loosely lines the vagina and does not constrict the penis. When to put on Put on erect penis right Can be inserted up to before sex. 8 hours before sex.",
    "page_number": 472,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3787
  },
  {
    "id": "chunk_03788",
    "text": "be inserted up to before sex. 8 hours before sex. Material Most made of latex; some Most made of a thin, of synthetic materials or synthetic film; a few are latex. animal membranes. How they feel Change feeling of sex. Fewer complaints of changed during sex feeling of sex than with male condoms.",
    "page_number": 472,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3788
  },
  {
    "id": "chunk_03789",
    "text": "during sex feeling of sex than with male condoms. Noise during sex May make a rubbing noise May rustle or squeak during during sex. sex. Lubricants to use Users can add lubricants: Users can add lubricants: y Water-based or y Water-based, silicone- silicone-based only. based, or oil-based (but",
    "page_number": 472,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3789
  },
  {
    "id": "chunk_03790",
    "text": "one- silicone-based only. based, or oil-based (but not with latex condoms). y Applied to outside of condom. y Before insertion, applied to outside of condom. y After insertion, applied to inside of condom or to the penis. Breakage or Tend to break more often Tend to slip more often than",
    "page_number": 472,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3790
  },
  {
    "id": "chunk_03791",
    "text": "Comparing Condoms (continued) Characteristic Male Condoms Female Condoms When to remove Require withdrawing from Can remain in vagina after the vagina before the erection softens. Requires erection softens. removal before woman stands. What they protect Cover and protect most Cover both the woman\u2019s",
    "page_number": 473,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3791
  },
  {
    "id": "chunk_03792",
    "text": "tect Cover and protect most Cover both the woman\u2019s of the penis, protect the internal and external genitalia woman\u2019s internal genitalia. and the base of the penis. How to store Store away from heat, Plastic condoms are not light, and dampness. harmed by heat, light or dampness.",
    "page_number": 473,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3792
  },
  {
    "id": "chunk_03793",
    "text": ", and dampness. harmed by heat, light or dampness. Reuse Cannot be reused. Reuse not recommended (see Female Condoms, Question 5, p. 281). Cost and Generally low cost and Usually more expensive and availability widely available. less widely available than male condoms. Comparing Condoms 451",
    "page_number": 473,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3793
  },
  {
    "id": "chunk_03794",
    "text": "Comparing IUDs Levonorgestrel Characteristic Copper-Bearing IUD IUD Effectiveness Nearly equal. Both are among the most effective methods. Length of use Approved for 10 years. Approved for 3 to 5 years. Bleeding patterns Longer and heavier More irregular bleeding",
    "page_number": 474,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3794
  },
  {
    "id": "chunk_03795",
    "text": "atterns Longer and heavier More irregular bleeding monthly bleeding, and spotting in the first irregular bleeding, and few months. After 1 year more cramping or pain no monthly bleeding is during monthly bleeding. more common. Causes less bleeding than copper-bearing IUDs over time.",
    "page_number": 474,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3795
  },
  {
    "id": "chunk_03796",
    "text": "less bleeding than copper-bearing IUDs over time. Anemia May contribute to iron- May help prevent iron- deficiency anemia if a deficiency anemia. woman already has low iron blood stores before insertion. Main reasons for Increased bleeding and No monthly bleeding and",
    "page_number": 474,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3796
  },
  {
    "id": "chunk_03797",
    "text": "for Increased bleeding and No monthly bleeding and discontinuation pain. hormonal side effects. Noncontraceptive May help protect against Effective treatment for long benefits endometrial cancer. and heavy monthly bleeding (alternative to hysterectomy). May also help treat painful",
    "page_number": 474,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3797
  },
  {
    "id": "chunk_03798",
    "text": "tive to hysterectomy). May also help treat painful monthly bleeding. Can be used to provide the progestin in hormone replacement therapy. Postpartum use Can be inserted up to 48 hours postpartum. After 48 hours, delay until 4 weeks or more. Use as emergency Can be used within 5 days Not recommended.",
    "page_number": 474,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3798
  },
  {
    "id": "chunk_03799",
    "text": "ergency Can be used within 5 days Not recommended. contraception after unprotected sex. Insertion Requires specific training. Cost Less expensive. More expensive. 452 Family Planning: A Global Handbook for Providers",
    "page_number": 474,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3799
  },
  {
    "id": "chunk_03800",
    "text": "If You Miss Pills Always take a pill as soon as you remember, and continue taking pills, one each day. Also... If you miss pills 3 days or more in a row, or if you start a pack 3 days Use condoms or avoid sex or more late: for the next 7 days OR FOR Also, skip the nonhormonal pills",
    "page_number": 475,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3800
  },
  {
    "id": "chunk_03801",
    "text": "ext 7 days OR FOR Also, skip the nonhormonal pills If you miss (or skip the pill-free those 3 or more week) and start pills in a row in Use condoms or avoid taking pills at once week 3: sex for the next 7 days from the next pack OR FOR + If you miss any Discard the missed pills",
    "page_number": 475,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3801
  },
  {
    "id": "chunk_03802",
    "text": "OR FOR + If you miss any Discard the missed pills nonhormonal pills and continue taking pills, (last 7 pills in 28-pill one each day packs only): Nonhormonal pills If You Miss Pills 453 ygolosddoiAh tbeoMJ JOB AID",
    "page_number": 475,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3802
  },
  {
    "id": "chunk_03803",
    "text": "JOB AID Female Anatomy and How Contraceptives Work in Women Internal Anatomy Womb (uterus) Fallopian tube Where a fertilized egg grows and An egg travels along one of these develops into a fetus. IUDs are placed tubes once a month, starting from the",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3803
  },
  {
    "id": "chunk_03804",
    "text": "s are placed tubes once a month, starting from the in the uterus, but they prevent ovary. Fertilization of the egg (when fertilization in the fallopian tubes. sperm meets the egg) occurs in these Copper-bearing IUDs also kill sperm as tubes. Female sterilization involves",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3804
  },
  {
    "id": "chunk_03805",
    "text": "kill sperm as tubes. Female sterilization involves they move into the uterus. cutting or clipping the fallopian tubes. This prevents sperm and egg from Ovary meeting. IUDs cause a chemical change Where eggs develop that damages sperm before they can and one is released",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3805
  },
  {
    "id": "chunk_03806",
    "text": "damages sperm before they can and one is released meet the egg in the fallopian tube. each month. The lactational amenorrhea method (LAM) and hormonal methods, especially those with estrogen, prevent the release of eggs. Fertility awareness methods require avoiding unprotected sex around the",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3806
  },
  {
    "id": "chunk_03807",
    "text": "ethods require avoiding unprotected sex around the time when an ovary releases an egg. Uterine lining (endometrium) Lining of the uterus, which gradually thickens and then is shed during monthly bleeding. Cervix Vagina The lower portion of the uterus, which Joins the outer sexual organs with",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3807
  },
  {
    "id": "chunk_03808",
    "text": "e uterus, which Joins the outer sexual organs with extends into the upper vagina. It produces the uterus. The combined ring and mucus. Hormonal methods thicken this the progesterone-releasing vaginal ring mucus, which helps prevent sperm from are placed in the vagina, where they",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3808
  },
  {
    "id": "chunk_03809",
    "text": "nt sperm from are placed in the vagina, where they passing through the cervix. Some fertility release hormones that pass through awareness methods require monitoring the vaginal walls. The female condom cervical mucus. The diaphragm, cervical cap, is placed in the vagina, creating",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3809
  },
  {
    "id": "chunk_03810",
    "text": "m, cervical cap, is placed in the vagina, creating and sponge cover the cervix so that sperm a barrier to sperm. Spermicides cannot enter. inserted into the vagina kill sperm. 454 Family Planning: A Global Handbook for Providers",
    "page_number": 476,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3810
  },
  {
    "id": "chunk_03811",
    "text": "External Anatomy Pubic hair Hair that grows during puberty and surrounds the female organs Inner lips (labia minora) Clitoris Two folds of skin, inside Sensitive ball of tissue the outer lips, that creating sexual pleasure extend from the clitoris Urethra Outer lips Opening where (labia majora)",
    "page_number": 477,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3811
  },
  {
    "id": "chunk_03812",
    "text": "is Urethra Outer lips Opening where (labia majora) liquid waste (urine) Two folds of skin, one on leaves the body either side of the vaginal opening, that protect the female organs Vaginal opening Anus The man\u2019s penis is inserted here Opening where solid during sexual intercourse. Blood flows",
    "page_number": 477,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3812
  },
  {
    "id": "chunk_03813",
    "text": "where solid during sexual intercourse. Blood flows waste (feces) leaves from here during monthly bleeding. the body Female Anatomy 455 ygolosddoiAh tbeoMJ",
    "page_number": 477,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3813
  },
  {
    "id": "chunk_03814",
    "text": "The Menstrual Cycle Days 1\u20135: Usually lasts from 2\u20137 days, often about Monthly bleeding 5 days If there is no pregnancy, the thickened lining of the womb is shed. It leaves the body through the vagina. This monthly bleeding is also called menstruation. Contractions of",
    "page_number": 478,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3814
  },
  {
    "id": "chunk_03815",
    "text": "eding is also called menstruation. Contractions of the womb at this time can cause cramps. Some women bleed for a short time (for example, 2 days), while others bleed for up to 8 days. Bleeding can be heavy or light. If the egg is fertilized by a man\u2019s sperm, the",
    "page_number": 478,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3815
  },
  {
    "id": "chunk_03816",
    "text": "ht. If the egg is fertilized by a man\u2019s sperm, the woman may become pregnant, and monthly bleeding stops. D ays 1\u20135 Day 14: Release of egg 8 2 \u2013 5 1 s y a D D 4 1 ya U 7 s au na dll y 2 o 1c c ou f r ts h eb e ct yw ce lee , n o fd ta ey ns Days 15\u201328: around day 14",
    "page_number": 478,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3816
  },
  {
    "id": "chunk_03817",
    "text": "ce lee , n o fd ta ey ns Days 15\u201328: around day 14 Thickening of the Usually, one of the ovaries womb lining releases one egg in each cycle (usually once a month). The egg travels through a fallopian tube towards the womb. It may be fertilized in the tube at this time by a sperm cell that",
    "page_number": 478,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3817
  },
  {
    "id": "chunk_03818",
    "text": "ized in the tube at this time by a sperm cell that has travelled from the vagina. Usually about 14 days long, after ovulation The lining of the uterus (endometrium) becomes thicker during this time to prepare for a fertilized egg. Usually there",
    "page_number": 478,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3818
  },
  {
    "id": "chunk_03819",
    "text": "ime to prepare for a fertilized egg. Usually there is no pregnancy, and the unfertilized egg cell dissolves in the reproductive tract. 456 Family Planning: A Global Handbook for Providers",
    "page_number": 478,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3819
  },
  {
    "id": "chunk_03820",
    "text": "Male Anatomy and How Contraceptives Work in Men Penis Male sex organ made of spongy tissue. When a man becomes sexually excited, it grows larger and stiffens. Semen, containing sperm, is released from the penis (ejaculation) at the height of sexual excitement (orgasm).",
    "page_number": 479,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3820
  },
  {
    "id": "chunk_03821",
    "text": "tion) at the height of sexual excitement (orgasm). A male condom covers the erect penis, preventing sperm from entering the woman\u2019s vagina. Withdrawal of the penis from the vagina avoids the release of semen into the vagina. Urethra Seminal Tube through vesicles which semen is Where sperm is",
    "page_number": 479,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3821
  },
  {
    "id": "chunk_03822",
    "text": "ube through vesicles which semen is Where sperm is released from mixed with semen. the body. Liquid waste (urine) is released through the same tube. Prostate Foreskin Organ that produces Hood of some of the fluid in skin covering semen. the end of the penis. Circumcision removes the",
    "page_number": 479,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3822
  },
  {
    "id": "chunk_03823",
    "text": "en. the end of the penis. Circumcision removes the foreskin. Vas deferens Each of the 2 thin tubes that carry sperm from the testicles to the seminal vesicles. Vasectomy involves Scrotum Testicles cutting or blocking Sack of thin loose skin Organs that these tubes so that",
    "page_number": 479,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3823
  },
  {
    "id": "chunk_03824",
    "text": "of thin loose skin Organs that these tubes so that containing the testicles. produce sperm. no sperm enters the semen. Male Anatomy 457 ygolosddoiAh tbeoMJ JOB AID",
    "page_number": 479,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3824
  },
  {
    "id": "chunk_03825",
    "text": "JOB AID Identifying Migraine Headaches and Auras Identifying women who suffer from migraine headaches and/or auras is important because migraines, and aura in particular, are linked to higher risk of stroke. Some hormonal contraceptives can increase that risk further. Migraine Headaches",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3825
  },
  {
    "id": "chunk_03826",
    "text": "can increase that risk further. Migraine Headaches y Recurring, throbbing, severe head pain, often on one side of the head, that can last from 4 to 72 hours. y Moving about often makes the migraine headache worse. y Nausea, vomiting, and sensitivity to light or noise may also occur. Migraine Auras",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3826
  },
  {
    "id": "chunk_03827",
    "text": "y to light or noise may also occur. Migraine Auras y Nervous system disruptions that affect sight and sometimes touch and speech. y Almost all auras include a bright area of lost vision in one eye that increases in size and turns into a crescent shape with zigzag edges. y About 30% of auras",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3827
  },
  {
    "id": "chunk_03828",
    "text": "cent shape with zigzag edges. y About 30% of auras also include a feeling of \u201cpins and needles\u201d in one hand that spreads up the arm and to one side People describe visual auras as bright, of the face. Some auras shimmering lines or waves around a bright area also include trouble with",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3828
  },
  {
    "id": "chunk_03829",
    "text": "ves around a bright area also include trouble with of lost vision that increase in size and turn into a speaking. Seeing spots or crescent shape with zigzag edges. The black spot flashing lights, or having represents how the area of lost vision increases blurred vision, which often in size over time.",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3829
  },
  {
    "id": "chunk_03830",
    "text": "ses blurred vision, which often in size over time. occurs during migraine headaches, is not aura. y Auras develop slowly over several minutes and go away within an hour, typically before the headache starts. (In contrast, a sudden blackout in one",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3830
  },
  {
    "id": "chunk_03831",
    "text": "che starts. (In contrast, a sudden blackout in one eye, particularly with a feeling of \u201cpins and needles\u201d or weakness in the opposite arm or leg, may indicate a stroke.) 458 Family Planning: A Global Handbook for Providers",
    "page_number": 480,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3831
  },
  {
    "id": "chunk_03832",
    "text": "Identifying Migraine Headaches For women who want a hormonal method\u2021,\u00a7 or are using one. If a woman reports having very bad headaches, ask her these questions to tell the difference between a migraine headache and an ordinary headache. If she answers \u201cyes\u201d to any 2 of",
    "page_number": 481,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3832
  },
  {
    "id": "chunk_03833",
    "text": "rdinary headache. If she answers \u201cyes\u201d to any 2 of these questions, she probably suffers from migraine headaches. Continue to Identifying Migraine Auras, below. 1. Do your headaches make you feel sick to your stomach? 2. When you have a headache, do light and noise bother you",
    "page_number": 481,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3833
  },
  {
    "id": "chunk_03834",
    "text": "you have a headache, do light and noise bother you a lot more than when you do not have a headache? 3. Do you have headaches that stop you from working or carrying out your usual activities for one day or more? Identifying Migraine Auras Ask this question to identify the most common migraine aura.",
    "page_number": 481,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3834
  },
  {
    "id": "chunk_03835",
    "text": "uestion to identify the most common migraine aura. If a woman answers \u201cyes,\u201d she probably suffers from migraine auras. 1. Have you ever had a bright light in your eyes lasting 5 to 60 minutes, loss of clear vision usually to one side, and then a headache? (Women with such aura often bring one hand up",
    "page_number": 481,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3835
  },
  {
    "id": "chunk_03836",
    "text": "che? (Women with such aura often bring one hand up beside their heads when describing the vision change. In some cases the bright light is not followed by a headache.) If her headaches are not migraines and she does not have aura, she can start or continue hormonal methods if she is otherwise",
    "page_number": 481,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3836
  },
  {
    "id": "chunk_03837",
    "text": "t or continue hormonal methods if she is otherwise medically eligible. Any later changes in her headaches should be evaluated, however. Identifying Migraine Headaches and Auras 459 ygolosddoiAh tbeoMJ",
    "page_number": 481,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3837
  },
  {
    "id": "chunk_03838",
    "text": "Can a Woman With Migraines and/or Aura Use a Hormonal Method? Yes = Yes, can use No = No, do not use In situations where clinical judgment is limited: I = Initiation C = Continuation Combined methods\u2020 Progestin-only methods\u00a7 Migraine headaches I C I C Without aura Age < 35 Yes No Yes Yes",
    "page_number": 482,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3838
  },
  {
    "id": "chunk_03839",
    "text": "aches I C I C Without aura Age < 35 Yes No Yes Yes Age _> 35 No No Yes Yes With aura, at any age No No Yes No \u2020 Methods with estrogen and progestin: combined oral contraceptives, monthly injectables, combined patch, and combined vaginal ring",
    "page_number": 482,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3839
  },
  {
    "id": "chunk_03840",
    "text": "ctables, combined patch, and combined vaginal ring \u00a7 Methods with progestin only: progestin-only pills, progestin-only injectables, and implants 460 Family Planning: A Global Handbook for Providers",
    "page_number": 482,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3840
  },
  {
    "id": "chunk_03841",
    "text": "461 ygolodohteM Ruling Out Pregnancy Ruling out pregnancy is recommended before starting a hormonal contraceptive and before IUD insertion. Family planning providers have 3 tools available for this routine task: 1. Medical history (often collected using the Pregnancy Checklist shown on",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3841
  },
  {
    "id": "chunk_03842",
    "text": "n collected using the Pregnancy Checklist shown on the inside back cover) 2. Pregnancy tests 3. Delaying the start of the method until the client\u2019s next monthly bleeding. Which tool should a provider use first, and when? The job aid on the next page, How and When to Use the Pregnancy",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3842
  },
  {
    "id": "chunk_03843",
    "text": "n the next page, How and When to Use the Pregnancy Checklist and Pregnancy Tests, offers guidance based on the client\u2019s chosen method and on whether she has been having bleeding each month or she is not having monthly bleedings due to recent childbirth or other reasons.",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3843
  },
  {
    "id": "chunk_03844",
    "text": "eedings due to recent childbirth or other reasons. This job aid also addresses the situation for a woman who has been having monthly bleedings but now has missed her expected monthly bleeding. Important points to note y Unless the client has missed her monthly bleeding, ruling out pregnancy",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3844
  },
  {
    "id": "chunk_03845",
    "text": "missed her monthly bleeding, ruling out pregnancy starts with the Pregnancy Checklist. This checklist can provide reasonable certainty that a woman is not pregnant. y Pregnancy tests are not likely to work before the first day of missed monthly bleeding. Using a test earlier is pointless and",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3845
  },
  {
    "id": "chunk_03846",
    "text": "ly bleeding. Using a test earlier is pointless and wasteful. y The only contraceptive method known to pose a health risk if started during pregnancy is the IUD (either copper or hormonal). If the Pregnancy Checklist cannot rule out pregnancy, a",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3846
  },
  {
    "id": "chunk_03847",
    "text": "e Pregnancy Checklist cannot rule out pregnancy, a provider should use another tool to rule out pregnancy before inserting an IUD. y All hormonal methods except the LNG-IUD can be provided without delay even when uncertainty about pregnancy exists.",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3847
  },
  {
    "id": "chunk_03848",
    "text": "elay even when uncertainty about pregnancy exists. Follow-up is required in some cases (see job aid on next page). y Delaying the start of the method is the worst choice among the 3 tools for assessing pregnancy. She may become pregnant before",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3848
  },
  {
    "id": "chunk_03849",
    "text": "ssessing pregnancy. She may become pregnant before her next monthly bleeding. The other tools should be used first whenever possible. y Both the Pregnancy Checklist and a pregnancy test are highly accurate for ruling out pregnancy when used appropriately. When the",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3849
  },
  {
    "id": "chunk_03850",
    "text": "ng out pregnancy when used appropriately. When the checklist can be used, there is no reason to prefer a test. Ruling Out Pregnancy 461 ycnangeryPg otuloOd gonhitleuMR JOB AID",
    "page_number": 483,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3850
  },
  {
    "id": "chunk_03851",
    "text": "JOB AID How and When to Use the Pregnancy Checklist and Pregnancy Tests Match your client\u2019s menstrual status and chosen contraceptive method with one of the options below and follow the instructions. Client with amenorrhea Client between two regular",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3851
  },
  {
    "id": "chunk_03852",
    "text": "Client with amenorrhea Client between two regular (postpartum or other type) menses (monthly bleeding)* Implants, pills, IUDs Implants, pills, IUDs ring, injectables, Copper ring, injectables, Copper or patch or LNG or patch or LNG Use Pregnancy Checklist.1 Use Pregnancy Checklist.1",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3852
  },
  {
    "id": "chunk_03853",
    "text": "se Pregnancy Checklist.1 Use Pregnancy Checklist.1 Pregnancy ruled out: Provide method. Pregnancy ruled out: Provide method. Do not use a pregnancy test Pregnancy not ruled out: (in most cases it is too early for Use a pregnancy test. the test to be effective).",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3853
  },
  {
    "id": "chunk_03854",
    "text": "r Use a pregnancy test. the test to be effective). Pregnancy test is Pregnancy test is Pregnancy Pregnancy not ruled out: negative (or test negative (or test not ruled out: Do not provide method. is not immediately is not immediately Provide the Advise woman to return",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3854
  },
  {
    "id": "chunk_03855",
    "text": "not immediately Provide the Advise woman to return available): Provide available): Advise method now.2 for LNG-IUD insertion the method now.2 woman to use Return for a within 7 days of onset COCs, DMPA, or Schedule a follow-up pregnancy test of her next menses, condoms or abstain",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3855
  },
  {
    "id": "chunk_03856",
    "text": "gnancy test of her next menses, condoms or abstain pregnancy test in if next menses or within 12 days for a for 3\u20134 weeks, 3\u20134 weeks. are delayed. copper IUD; but in the then repeat the meantime, use COCs, pregnancy test. DMPA, or condoms Second pregnancy or abstain. test is negative:",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3856
  },
  {
    "id": "chunk_03857",
    "text": "oms Second pregnancy or abstain. test is negative: Return for a pregnancy Provide the IUD. test if next menses are delayed. 1 See inside back cover for Pregnancy Checklist. * If the client presents with a late/missed menses, use a pregnancy test to rule out",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3857
  },
  {
    "id": "chunk_03858",
    "text": "te/missed menses, use a pregnancy test to rule out 2 For implants, counsel about the need to remove the pregnancy. If using a highly sensitive pregnancy implant if pregnancy is confirmed and she wishes to test (for example, 25 mIU/ml) and it is negative, continue the pregnancy.",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3858
  },
  {
    "id": "chunk_03859",
    "text": "IU/ml) and it is negative, continue the pregnancy. provide her desired method. In cases where pregnancy cannot be ruled out, If using a test with lower sensitivity (for example, offer emergency contraception if the woman 50 mIU/ml) and it is negative during the time of",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3859
  },
  {
    "id": "chunk_03860",
    "text": "n 50 mIU/ml) and it is negative during the time of had unprotected sex within the last 5 days. her missed period, wait until at least 10 days after expected date of menses and repeat the test. Counsel all women to come back any time Advise the woman to use condoms or abstain in",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3860
  },
  {
    "id": "chunk_03861",
    "text": "time Advise the woman to use condoms or abstain in they have a reason to suspect pregnancy the meantime. If the test is still negative, provide her (for example, she misses a period). desired method. If test sensitivity is not specified, assume lower sensitivity.",
    "page_number": 484,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3861
  },
  {
    "id": "chunk_03862",
    "text": "SPINE What\u2019s New in This Edition? JOB AID New y Women and girls at high risk of HIV can use all hormonal family planning contraceptive methods Pregnancy recommendations y Self-injection is an additional approach to offer clients Checklist from WHO who use DMPA-SC",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3862
  },
  {
    "id": "chunk_03863",
    "text": "o offer clients Checklist from WHO who use DMPA-SC New chapters y Family Planning for Women at High Risk of HIV Ask the client questions 1\u20136. As soon as the client answers in this edition (Chapter 23) \u201cyes\u201d to any question, stop and follow the instructions below.",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3863
  },
  {
    "id": "chunk_03864",
    "text": "question, stop and follow the instructions below. y Providing Family Planning Services During an Epidemic (Chapter 27) NO YES 1 Did your last monthly bleeding start within the New coverage y Gender Equality and Gender Inclusiveness (pp. xv\u2013xvii) past 7 days?*",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3864
  },
  {
    "id": "chunk_03865",
    "text": "d Gender Inclusiveness (pp. xv\u2013xvii) past 7 days?* in this edition y Self-Injection Can Be an Option (in Chapter 4, p. 83\u201386) 2 Have you abstained from sexual intercourse y STI Signs and Symptoms (in Chapter 22, p. 343 since your last monthly bleeding, delivery,",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3865
  },
  {
    "id": "chunk_03866",
    "text": "p. 343 since your last monthly bleeding, delivery, y Screening and Treatment (in the section on Cervical abortion, or miscarriage? Cancer in Chapter 22, pp. 351\u2013354) 3 Have you been using a reliable contraceptive method consistently and correctly since your",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3866
  },
  {
    "id": "chunk_03867",
    "text": "ptive method consistently and correctly since your last monthly bleeding, delivery, abortion, or y Instructions on implant insertion and removal miscarriage? Expanded or (in Chapter 9, pp. 142\u2013148, pp. 157\u2013160) 4 Have you had a baby in the last 4 weeks?",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3867
  },
  {
    "id": "chunk_03868",
    "text": "57\u2013160) 4 Have you had a baby in the last 4 weeks? updated y Family Planning in Postabortion Care (in Chapter 25, coverage pp. 383\u2013387) 5 Did you have a baby less than 6 months ago, y Medical Eligibility Criteria for Contraceptive Use are you fully or nearly-fully breastfeeding, and",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3868
  },
  {
    "id": "chunk_03869",
    "text": "e are you fully or nearly-fully breastfeeding, and have you had no monthly bleeding since then? (Appendix D) 6 Have you had a miscarriage or abortion in the past 7 days?* * If the client is planning to use a copper-bearing IUD, the 7-day window is expanded to 12 days.",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3869
  },
  {
    "id": "chunk_03870",
    "text": "ring IUD, the 7-day window is expanded to 12 days. If the client answered If the client answered NO to all of the YES to at least one of questions, pregnancy the questions, you can be cannot be ruled out reasonably sure she is using the checklist. not pregnant. Rule out pregnancy by other means.",
    "page_number": 485,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3870
  },
  {
    "id": "chunk_03871",
    "text": "SPINE\nNEW\n2022\nFAMILY\nPLANNING\nA GLOBAL HANDBOOK FOR PROVIDERS\n2022 EDITION\nA\nGLOBAL\nHANDBOOK\nFOR\nPROVIDERS\nFAMILY\nPLANNING\n2022\nComparing\nEff\nectiveness\nof\nFamily\nPlanning\nMethods\nUNITED\nSTATES\nAGENCY\nFOR\nINTERNATIONAL\nDEVELOPMENT\nJOHN\u2019S\nHOPKINS\nBLOOMBERG\nSCHOOL\nOF\nPUBLIC\nHEALTH\nWORLD\nHEALTH\nORGANIZATION\nJOB AID",
    "page_number": 486,
    "source": "WHO_FP_Handbook_2022.pdf",
    "source_path": "data\\who\\WHO_FP_Handbook_2022.pdf",
    "chunk_index": 3871
  },
  {
    "id": "chunk_00000",
    "text": "PPooppuullaattiioonn CCoouunncciill KKnnoowwlleeddggee CCoommmmoonnss 2015 TThhee BBaallaanncceedd CCoouunnsseelliinngg SSttrraatteeggyy PPlluuss:: AA TToooollkkiitt ffoorr FFaammiillyy PPllaannnniinngg SSeerrvviiccee PPrroovviiddeerrss WWoorrkkiinngg iinn HHiigghh HHIIVV//SSTTII PPrreevvaalleennccee",
    "page_number": 1,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 0
  },
  {
    "id": "chunk_00001",
    "text": "iinn HHiigghh HHIIVV//SSTTII PPrreevvaalleennccee SSeettttiinnggss Population Council Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh Part of the International Public Health Commons, Obstetrics and Gynecology Commons, Public Health",
    "page_number": 1,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1
  },
  {
    "id": "chunk_00002",
    "text": ", Obstetrics and Gynecology Commons, Public Health and Community Nursing Commons, and the Women's Health Commons HHooww ddooeess aacccceessss ttoo tthhiiss wwoorrkk bbeenneefifitt yyoouu?? CClliicckk hheerree ttoo lleett uuss kknnooww!! RReeccoommmmeennddeedd CCiittaattiioonn",
    "page_number": 1,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 2
  },
  {
    "id": "chunk_00003",
    "text": "kknnooww!! RReeccoommmmeennddeedd CCiittaattiioonn Population Council. 2015. \"The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High HIV/STI Prevalence Settings.\" Washington, DC: Population Council. Licensed under CC BY-NC-SA 4.0",
    "page_number": 1,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 3
  },
  {
    "id": "chunk_00004",
    "text": "The Balanced Counseling Strategy Plus\nA Toolkit for Family Planning Service Providers\nWorking in High STI/HIV Prevalence Settings\nUSER\u2019S GUIDE\nThird Edition, 2015",
    "page_number": 2,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 4
  },
  {
    "id": "chunk_00005",
    "text": "\u00a9 2008, 2011, 2015 The Population Council, Inc. The Population Council confronts critical health and development issues\u2014from stopping the spread of HIV to improving reproductive health and ensuring that young people lead full and productive lives. Through biomedical, social science, and public",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 5
  },
  {
    "id": "chunk_00006",
    "text": "es. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programs, and",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 6
  },
  {
    "id": "chunk_00007",
    "text": "hat lead to more effective policies, programs, and technologies that improve lives around the world. Established in 1952 and headquartered in New York, the Council is a nongov- ernmental, nonprofit organization governed by an international board of trustees.",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 7
  },
  {
    "id": "chunk_00008",
    "text": "on governed by an international board of trustees. Any part of this publication may be photocopied without permission from the publisher provided that copies are distributed",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 8
  },
  {
    "id": "chunk_00009",
    "text": "the publisher provided that copies are distributed without charge and that full source citation is provided. The Population Council would appreciate receiving a copy of any materi- als in which the text is used.",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 9
  },
  {
    "id": "chunk_00010",
    "text": "copy of any materi- als in which the text is used. Suggested citation: Population Council. 2015. Balanced Counseling Strategy Plus Trainer\u2019s Guide Third Edition, part of The Balanced",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 10
  },
  {
    "id": "chunk_00011",
    "text": "rainer\u2019s Guide Third Edition, part of The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings, Third Edition, Washington, DC.",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 11
  },
  {
    "id": "chunk_00012",
    "text": "revalence Settings, Third Edition, Washington, DC. Note: This publication is part of a larger publication titled The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings. The Balanced Counseling Strategy Plus Toolkit",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 12
  },
  {
    "id": "chunk_00013",
    "text": "ngs. The Balanced Counseling Strategy Plus Toolkit includes the following: \u25aa Algorithm \u25aa Counseling cards \u25aa Method brochures \u25aa User\u2019s Guide \u25aa Trainer\u2019s Guide \u25aa WHO Medical Eligibility Criteria Wheel If any part is missing, please contact the Population Council at publications@popcouncil.org.",
    "page_number": 3,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 13
  },
  {
    "id": "chunk_00014",
    "text": "Preface to the Third Edition The Balanced Counseling Strategy Plus (BCS+) toolkit, developed and tested in Kenya (2005 to 2007) and South Africa (2004 to 2006) because both countries have high rates of STIs, including HIV, and",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 14
  },
  {
    "id": "chunk_00015",
    "text": "ntries have high rates of STIs, including HIV, and their contraceptive prevalence rates are relatively high for the region. The BCS+ provides the infor- mation and materials that healthcare facility providers need so they can offer complete, high-quality",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 15
  },
  {
    "id": "chunk_00016",
    "text": "ders need so they can offer complete, high-quality family planning counseling to clients living in areas with high rates of HIV and STIs. The BCS+ was adapted from the Balanced Counseling Strategy (Le\u00f3n 1999; Le\u00f3n et al. 2003a, b, c; Le\u00f3n, Ver-",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 16
  },
  {
    "id": "chunk_00017",
    "text": "gy (Le\u00f3n 1999; Le\u00f3n et al. 2003a, b, c; Le\u00f3n, Ver- non, Martin, and Bruce 2008). First edition of the Balanced Counseling Strategy and Balanced Counseling Strategy Plus toolkits are products of the Population Council\u2019s FRONTIERS program, supported",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 17
  },
  {
    "id": "chunk_00018",
    "text": "Population Council\u2019s FRONTIERS program, supported by the United States Agency for International Development (USAID), Cooperative Agreement HRN-A-00-98-00012-00. The Second Edition was updated based on the 2010 WHO Medical Eligibility Criteria (MEC) as",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 18
  },
  {
    "id": "chunk_00019",
    "text": "the 2010 WHO Medical Eligibility Criteria (MEC) as well as recommendations from authors and partners who have experienced and evaluated imple- mentation of the tool in settings and scenarios around the world and validated through the Integra",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 19
  },
  {
    "id": "chunk_00020",
    "text": "around the world and validated through the Integra Initiative, supported by the Bill and Melinda Gates Foundation. It included additional counseling cards on cervical cancer screening, postpartum and infant health.",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 20
  },
  {
    "id": "chunk_00021",
    "text": "al cancer screening, postpartum and infant health. This Third Edition of the BCS+ includes content updated according to the latest WHO Medical Eligibility Criteria (2015). It incorporates the most up-to-date evidence on clinical indications for",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 21
  },
  {
    "id": "chunk_00022",
    "text": "st up-to-date evidence on clinical indications for the provision of family planning methods, including new methods (Caya\u00ae/SILCS diaphragm and Progesterone Vaginal Ring), and includes five new counseling cards that address Adolescent Coun-",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 22
  },
  {
    "id": "chunk_00023",
    "text": "new counseling cards that address Adolescent Coun- seling, Male Services, Post Abortion Care, and Women\u2019s Support and Safety. The updated cards include instructions for providers, guiding them through supplemental counseling and services that",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 23
  },
  {
    "id": "chunk_00024",
    "text": "through supplemental counseling and services that family planning clients may need. Development of this Third Edition of the BCS+ toolkit was funded by the Evidence Project, USAID Cooperative agreement AID-OAA-A-13-00087 and the",
    "page_number": 4,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 24
  },
  {
    "id": "chunk_00025",
    "text": "Acknowledgments Development of The Balanced Counseling Strategy Plus (BCS+) could not have been possible without the invaluable support of the service providers who tested the toolkit and the program directors who authorized and supervised its application. The authors wish to thank the Department",
    "page_number": 5,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 25
  },
  {
    "id": "chunk_00026",
    "text": "lication. The authors wish to thank the Department of Health in South Africa and the Division of Reproductive Health and the National AIDS and STD Control Program of the Ministry of Health in Kenya. We would also like to thank the trainers",
    "page_number": 5,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 26
  },
  {
    "id": "chunk_00027",
    "text": "in Kenya. We would also like to thank the trainers at the Reproductive Health and HIV Research Unit (RHRU) of the University of Witwatersrand for their contribution to the study in South Africa. Development and production of the third edition of The Balanced Counseling Strategy Plus was",
    "page_number": 5,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 27
  },
  {
    "id": "chunk_00028",
    "text": "ition of The Balanced Counseling Strategy Plus was supported by the Population Council. Authors would like to acknowledge the following individuals for providing their technical expertise and invaluable contributions to this updated edition of the",
    "page_number": 5,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 28
  },
  {
    "id": "chunk_00029",
    "text": "uable contributions to this updated edition of the BCS+: Megan Christofield, Heather Clark, Mychelle Farmer, Kamlesh Giri, Joanne Gleason, Mark Hathaway, Anushka Kalyanpur, Maggie Kilbourne-Brook, Karen R. Kirk, Ricky Lu, Ruth Merkatz,",
    "page_number": 5,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 29
  },
  {
    "id": "chunk_00030",
    "text": "urne-Brook, Karen R. Kirk, Ricky Lu, Ruth Merkatz, Charity Ndigwa, Anne Pfitzer, Saumya RamaRao, Naomi Rijo, Elizabeth Rochette, Jill Schwartz, Leigh Stefanik, John Townsend, Chi-Chi Undie, Katie Unthank, Anneka Van Scoyoc, Charlotte Warren, Ellen Weiss, and Kelsey Wright. | iv |",
    "page_number": 5,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 30
  },
  {
    "id": "chunk_00031",
    "text": "Contents INTRODUCTION................................................................................................................................ 2 Algorithm for Using the Balanced Counseling Strategy Plus ....................................................6",
    "page_number": 6,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 31
  },
  {
    "id": "chunk_00032",
    "text": ".................................................6 GUIDE TO COUNSELING CLIENTS USING THE BCS+ TOOLKIT .....................................................8 Pre-Choice Stage .............................................................................................................................8",
    "page_number": 6,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 32
  },
  {
    "id": "chunk_00033",
    "text": ".................................................8 Method Choice Stage ....................................................................................................................13",
    "page_number": 6,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 33
  },
  {
    "id": "chunk_00034",
    "text": "................................................13 Post-Choice Stage .........................................................................................................................16",
    "page_number": 6,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 34
  },
  {
    "id": "chunk_00035",
    "text": "................................................16 Systematic Screening for Other Services Stage .......................................................................18 GUIDELINES FOR ADAPTING THE BCS+ JOB AIDS .....................................................................25",
    "page_number": 6,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 35
  },
  {
    "id": "chunk_00036",
    "text": "................................................25 REFERENCES ................................................................................................................................27 | v |",
    "page_number": 6,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 36
  },
  {
    "id": "chunk_00037",
    "text": "Introduction In the late 1990s, the Population Council\u2019s USAID-funded FRONTIERS in Reproductive Health Program (FRONTIERS) worked in collaboration with Ministries of Health in several Latin Amer- ican countries to develop and test a practical, interactive, and client-friendly strategy for improving",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 37
  },
  {
    "id": "chunk_00038",
    "text": "active, and client-friendly strategy for improving counseling within family planning consultations. This strategy is called the Balanced Counseling Strategy (BCS) (Le\u00f3n 1999; Le\u00f3n et al. 2004). The BCS uses key job aids for counseling clients about family",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 38
  },
  {
    "id": "chunk_00039",
    "text": "s key job aids for counseling clients about family planning: an algorithm to guide the provider through the counseling process, a set of counseling cards for contraceptive methods, and corresponding brochures for each method. The strategy,",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 39
  },
  {
    "id": "chunk_00040",
    "text": "esponding brochures for each method. The strategy, tested and refined in several countries, comprises a series of steps to determine the contraceptive method that best suits the client according to her/his preferences and needs. This strategy improves",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 40
  },
  {
    "id": "chunk_00041",
    "text": "/his preferences and needs. This strategy improves the quality of the provider\u2019s counseling and allows the client to take ownership of the decision. The BCS proved effective as a tool to assist family planning providers to improve the quality of care",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 41
  },
  {
    "id": "chunk_00042",
    "text": "planning providers to improve the quality of care (Le\u00f3n et al. 2003a, b, c). The approach is practical, low cost, and easy to adapt to local contexts. The Balanced Counseling Strategy: A Toolkit for Family Planning Service Providers was published to provide the",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 42
  },
  {
    "id": "chunk_00043",
    "text": "ing Service Providers was published to provide the information and tools needed for health care facility managers, supervisors, and service providers to implement the BCS in their family planning services (Le\u00f3n, Vernon, Martin, and Bruce 2008). WHY THE BALANCED COUNSELING STRATEGY PLUS?",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 43
  },
  {
    "id": "chunk_00044",
    "text": "2008). WHY THE BALANCED COUNSELING STRATEGY PLUS? In response to the need to incorporate counseling, screening, and services for sexually transmitted infections (STIs), including HIV, within routine family planning consultations in settings character-",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 44
  },
  {
    "id": "chunk_00045",
    "text": "mily planning consultations in settings character- ized by high prevalence of these infections, the BCS was revised to integrate STI/HIV prevention counseling, risk assessment, and HIV counseling and testing (HCT). The resulting Balanced Counseling",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 45
  },
  {
    "id": "chunk_00046",
    "text": "d testing (HCT). The resulting Balanced Counseling Strategy Plus (BCS+) toolkit improves the quality of the family planning service and enables provid- ers to address clients\u2019 needs related to STIs and HIV during the same consultation.",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 46
  },
  {
    "id": "chunk_00047",
    "text": "ated to STIs and HIV during the same consultation. Integration of health services has been defined as offering a range of services that can meet several needs simultaneously, usually in the same venue and through the same provider. Referrals to, or link-",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 47
  },
  {
    "id": "chunk_00048",
    "text": "through the same provider. Referrals to, or link- ages with, related services enable a client to receive a range of needed services, even if the services are not received simultaneously (Askew 2007). In reproductive health, the push for integration or",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 48
  },
  {
    "id": "chunk_00049",
    "text": "n reproductive health, the push for integration or linkage is guided both by many clients having the need for several services simultaneously (and so missed opportunities can be reduced) and by the expectation that the component services can be",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 49
  },
  {
    "id": "chunk_00050",
    "text": "the expectation that the component services can be provided more efficiently when integrated or linked than when delivered individually. Despite many calls for greater attention to integrating such services in high STI/HIV settings, surprisingly little",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 50
  },
  {
    "id": "chunk_00051",
    "text": "ices in high STI/HIV settings, surprisingly little attention has been paid to the development and empirical testing of practical tools that providers can use to strengthen their capacity to offer integrated services.",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 51
  },
  {
    "id": "chunk_00052",
    "text": "gthen their capacity to offer integrated services. The FRONTIERS program developed and piloted the BCS+ in Kenya (2005 to 2007) and South Africa (2004 to 2006) because both countries have high rates of STIs, including HIV, and their con-",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 52
  },
  {
    "id": "chunk_00053",
    "text": "high rates of STIs, including HIV, and their con- traceptive prevalence rates are relatively high for the region. This situation provides opportunities to reach a substantial proportion of the sexually active population (albeit predominantly female) that is",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 53
  },
  {
    "id": "chunk_00054",
    "text": "e population (albeit predominantly female) that is seeking to prevent pregnancy and that also may be at risk of exposure to an STI/HIV. As in most countries, their family planning and STI/HIV programs are implemented separately, although both",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 54
  },
  {
    "id": "chunk_00055",
    "text": "programs are implemented separately, although both countries are actively seeking ways to integrate services. Thus, both Ministries of Health were keen to develop practical tools for increasing the quality of services and numbers of clients receiving integrated services.",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 55
  },
  {
    "id": "chunk_00056",
    "text": "numbers of clients receiving integrated services. The study findings are described more fully elsewhere (see Liambila et al. 2008; Mullick et al. 2008), but both studies showed that: \u25aa Integrating STI/HIV prevention counseling and risk assessment with offering HCT during",
    "page_number": 7,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 56
  },
  {
    "id": "chunk_00057",
    "text": "\u25aa The quality of care for both family planning and STI/HIV counseling improved significantly with the use of the BCS+ tools. \u25aa Counseling on HCT increased substantially. In Kenya, more than 40 percent of clients were",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 57
  },
  {
    "id": "chunk_00058",
    "text": "ly. In Kenya, more than 40 percent of clients were offered HCT services, with almost half of these deciding to be tested, either on site or through referral. In South Africa, those offered testing increased to 29 percent. Furthermore, an overall",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 58
  },
  {
    "id": "chunk_00059",
    "text": "g increased to 29 percent. Furthermore, an overall increase in testing was observed in the district with a doubling of individuals tested. \u25aa Use of the BCS+ tools facilitated greater risk assessment for STIs and HIV. Also, decisions",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 59
  },
  {
    "id": "chunk_00060",
    "text": "risk assessment for STIs and HIV. Also, decisions about contraceptive method choice were made with a better understanding of their relation- ship to infection prevention. \u25aa Despite the concern that adding these services may have a negative impact on the family",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 60
  },
  {
    "id": "chunk_00061",
    "text": "services may have a negative impact on the family planning service, improved quality of counseling and no evidence of a decline in utilization showed that this concern was unfounded. THE BALANCED COUNSELING STRATEGY PLUS",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 61
  },
  {
    "id": "chunk_00062",
    "text": "s unfounded. THE BALANCED COUNSELING STRATEGY PLUS The BCS+ is divided into four counseling stages. Each stage contains a sequence of steps to follow. The BCS+ assumes that the motive of a client\u2019s visit is family planning but serves to also offer the",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 62
  },
  {
    "id": "chunk_00063",
    "text": "it is family planning but serves to also offer the client additional counseling and services in the same facility or through referral. The BCS+ inte- grates postpartum counseling messages to ensure health of the mother and the infant; an opportu-",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 63
  },
  {
    "id": "chunk_00064",
    "text": "e health of the mother and the infant; an opportu- nity to discuss healthy timing and spacing of pregnancies; counseling on STI/HIV transmission and prevention; screening for reproductive cancers; violence prevention; post-abortion care; and male",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 64
  },
  {
    "id": "chunk_00065",
    "text": "violence prevention; post-abortion care; and male and adolescent services. Information on the cards instructs providers through conducting an STI/ HIV risk assessment, discussing dual protection and positive health, and discussing and offering",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 65
  },
  {
    "id": "chunk_00066",
    "text": "n and positive health, and discussing and offering the client HIV counseling and testing. The BCS+ process can be summarized as a decision-making algorithm, which is described on the next three pages. Below is a summary of the four counseling stages:",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 66
  },
  {
    "id": "chunk_00067",
    "text": "Below is a summary of the four counseling stages: \u25aa Pre-Choice Stage: During this stage, the provider creates the conditions that help a client se- lect a family planning method. The provider cordially greets the client. The provider emphasiz-",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 67
  },
  {
    "id": "chunk_00068",
    "text": "ordially greets the client. The provider emphasiz- es to the client that, during the consultation, other reproductive health issues will be addressed depending on her/his individual circumstance. The provider reviews the client\u2019s fertility inten-",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 68
  },
  {
    "id": "chunk_00069",
    "text": "The provider reviews the client\u2019s fertility inten- tions and counsels her/him on healthy timing and spacing of pregnancy. Pregnancy is ruled out using the counseling card with the checklist of questions. If the client is not pregnant, the",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 69
  },
  {
    "id": "chunk_00070",
    "text": "t of questions. If the client is not pregnant, the provider displays all the method cards and asks questions described in the algorithm. As the client responds to each question, the provider sets aside the cards of the methods that are not",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 70
  },
  {
    "id": "chunk_00071",
    "text": "r sets aside the cards of the methods that are not appropriate for the client. Setting aside these cards helps to avoid giving information on meth- ods that are not relevant to the client\u2019s needs. If pregnancy cannot be ruled out, the provider skips to steps 13 to 19 to discuss other",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 71
  },
  {
    "id": "chunk_00072",
    "text": "provider skips to steps 13 to 19 to discuss other relevant services the client may need. The client is given a back-up method, such as condoms, and asked to return when she has her menstruation. \u25aa Method Choice Stage: During this stage, the provider offers more extensive information",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 72
  },
  {
    "id": "chunk_00073",
    "text": "ge, the provider offers more extensive information about the methods that have not been set aside, including their effectiveness. This helps the client select a method suited to her/his reproductive needs. Following the steps in the BCS+",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 73
  },
  {
    "id": "chunk_00074",
    "text": "eproductive needs. Following the steps in the BCS+ algorithm, the provider continues to narrow down the number of counseling method cards until a method is chosen. \u25aa Post-Choice Stage: During this stage, the provider uses the method brochure to give the cli-",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 74
  },
  {
    "id": "chunk_00075",
    "text": "provider uses the method brochure to give the cli- ent complete information about the method that s/he has chosen. If the client has conditions where the method is not advised or is not satisfied with the method, the provider returns to",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 75
  },
  {
    "id": "chunk_00076",
    "text": "satisfied with the method, the provider returns to the Method Choice Stage to help the client select another method. The provider also encour- ages the client to involve her/his partner(s) in decisions about contraception, either through discussion or visit to the clinic.",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 76
  },
  {
    "id": "chunk_00077",
    "text": "either through discussion or visit to the clinic. \u25aa Systematic Screening for Other Services Stage: During this stage, the provider uses infor- mation collected previously and targeted questions to determine additional health services and",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 77
  },
  {
    "id": "chunk_00078",
    "text": "stions to determine additional health services and counseling that the family planning client may need. Using the remaining counseling cards, the | 3 |",
    "page_number": 8,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 78
  },
  {
    "id": "chunk_00079",
    "text": "provider may review important information for a postpartum mother or infant; may refer him/ her to well-child services; discuss and offer cervical screening tests; discuss breast cancer; offer adolescent or male service counseling; discuss women\u2019s support and safety; offer post-abortion",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 79
  },
  {
    "id": "chunk_00080",
    "text": "ss women\u2019s support and safety; offer post-abortion care as appropriate; discuss STI/HIV transmission and prevention; conduct a risk assessment; discuss dual protection and positive health; and offer the client HIV counseling and testing.",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 80
  },
  {
    "id": "chunk_00081",
    "text": "; and offer the client HIV counseling and testing. The provider offers HIV testing to the client, following national protocols, and encourages the client to disclose her/his STI/HIV status to her/his partner(s), letting the client know both",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 81
  },
  {
    "id": "chunk_00082",
    "text": "o her/his partner(s), letting the client know both the benefits and risks of disclosure. Upon completion of the counseling session, the provider gives follow-up instructions on the chosen contraceptive method, the method brochure, and a",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 82
  },
  {
    "id": "chunk_00083",
    "text": "n contraceptive method, the method brochure, and a condom brochure. The provider and client also fix a date for a follow-up visit. WHAT IS INCLUDED IN THIS TOOLKIT? The BCS+ job aids and guides are intended for reproductive health programs interested in both",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 83
  },
  {
    "id": "chunk_00084",
    "text": "or reproductive health programs interested in both strengthening the quality of family planning counseling and responding to the additional service and counseling needs of clients. In addition to adding further guidance on other integrated services,",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 84
  },
  {
    "id": "chunk_00085",
    "text": "ing further guidance on other integrated services, the second edition incorporated an additional job aid, the World Health Organization\u2019s Medical Eligibility Criteria Wheel, to complement existing provider tools and facilitate comprehensive family",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 85
  },
  {
    "id": "chunk_00086",
    "text": "provider tools and facilitate comprehensive family planning service provision. Below is a list of the toolkit components: 1. BCS+ User\u2019s Guide on how to implement the BCS+. It explains how to use the job aids and can be distributed during training on the BCS+ or used for self-teaching with the BCS+",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 86
  },
  {
    "id": "chunk_00087",
    "text": "n the BCS+ or used for self-teaching with the BCS+ job aids. 2. BCS+ job aids, including: \u25aa The BCS+ algorithm that summarizes the 19 steps recommended to implement the BCS+ during a family planning consultation. These steps are organized under four stages",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 87
  },
  {
    "id": "chunk_00088",
    "text": "ation. These steps are organized under four stages of the consultation: pre-choice needs assessment; method choice; post-choice actions; and systematic screening for other services. During each stage of the consultation, the",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 88
  },
  {
    "id": "chunk_00089",
    "text": "rvices. During each stage of the consultation, the provider is given step-by-step guidance on how to use the BCS+ job aids. Depending on the client\u2019s response to the issues discussed, the algorithm outlines which actions to take.",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 89
  },
  {
    "id": "chunk_00090",
    "text": "sed, the algorithm outlines which actions to take. The BCS+ algorithm can be found on pages 6 to 8 as well as separately with the other job aids in the toolkit. \u25aa Counseling cards that the provider uses during a counseling session. There are 33",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 90
  },
  {
    "id": "chunk_00091",
    "text": "der uses during a counseling session. There are 33 counseling cards. The first card contains 6 questions that the service provider asks to rule out whether a client is pregnant (adopted from those developed by Stanback et al. 1999).",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 91
  },
  {
    "id": "chunk_00092",
    "text": "ted from those developed by Stanback et al. 1999). There are 18 method-specific cards that contain information about each family planning method. Each method card has an illustration of the contraceptive method on the front",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 92
  },
  {
    "id": "chunk_00093",
    "text": "ustration of the contraceptive method on the front side. The back of the card contains a list of key features of the method and describes the method\u2019s use, indications, risk factors, and level of effectiveness. These cards are used to",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 93
  },
  {
    "id": "chunk_00094",
    "text": "nd level of effectiveness. These cards are used to first exclude those methods that are inappropriate for the client\u2019s reproductive intentions and then to narrow the choice to reach a final decision. Fourteen (14) counseling cards",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 94
  },
  {
    "id": "chunk_00095",
    "text": "h a final decision. Fourteen (14) counseling cards provide information on additional counseling and services that a family planning client may need. These are: healthy timing and spacing of pregnancies; promoting healthy post-",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 95
  },
  {
    "id": "chunk_00096",
    "text": "nd spacing of pregnancies; promoting healthy post- partum period for the mother; post abortion care; promoting newborn and infant health; STI/HIV transmission and prevention; STI/HIV risk assessment; positive health, dignity",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 96
  },
  {
    "id": "chunk_00097",
    "text": "STI/HIV risk assessment; positive health, dignity and prevention; dual protection; HIV counseling and testing; screening for cervical can- cer; adolescent counseling; women\u2019s support and safety; male services; and breast cancer",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 97
  },
  {
    "id": "chunk_00098",
    "text": "pport and safety; male services; and breast cancer information and awareness. These cards are used during the fourth stage of the consulta- tion\u2014systematic screening for other services. \u25aa Method brochures on each of the 18 contraceptive methods. They are designed to help",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 98
  },
  {
    "id": "chunk_00099",
    "text": "8 contraceptive methods. They are designed to help the client better understand the method chosen. The provider gives the client the brochure for the selected method and a brochure with information on condoms to take home. Pro-",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 99
  },
  {
    "id": "chunk_00100",
    "text": "ure with information on condoms to take home. Pro- viders should encourage low-literate or illiterate clients to take the brochure home so that their partner or other trusted friend can review the brochure with them again. | 4 |",
    "page_number": 9,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 100
  },
  {
    "id": "chunk_00101",
    "text": "\u25aa WHO Medical Eligibility Criteria (MEC) Wheel (2015) which is a provider job aid based on the four eligibility categories for contraceptive use in relation to medical condi- tions described in the document Medical Eligibility Criteria for contraceptive use, Fifth",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 101
  },
  {
    "id": "chunk_00102",
    "text": "Eligibility Criteria for contraceptive use, Fifth edition, published by Department of Reproductive Health, World Health Organization. This tool guides providers through medical conditions and medications that may be con-",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 102
  },
  {
    "id": "chunk_00103",
    "text": "edical conditions and medications that may be con- traindications to use of particular contraceptive methods. The job aid has been field-test- ed in three countries by WHO, and is found to be very useful to providers who used it.",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 103
  },
  {
    "id": "chunk_00104",
    "text": "found to be very useful to providers who used it. 3. BCS+ Trainer\u2019s Guide that supervisors and others can use to train providers on how to use the BCS+. The guide includes exercises and activities to increase participants\u2019 comprehen- sion and proper utilization of the BCS+ toolkit.",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 104
  },
  {
    "id": "chunk_00105",
    "text": "- sion and proper utilization of the BCS+ toolkit. The BCS+ job aids BCS+ Trainer\u2019s Guide and BCS+ User\u2019s Guide incorporate the latest international family planning and STI/HIV norms and guidance as recommended by the World Health Organiza-",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 105
  },
  {
    "id": "chunk_00106",
    "text": "dance as recommended by the World Health Organiza- tion (WHO), including Medical Eligibility Criteria for Contraceptive Use (WHO 2015), Family Planning: A Global Handbook for Providers (WHO/RHR and JHU/CCP, INFO Project 2011 update), Contraceptive",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 106
  },
  {
    "id": "chunk_00107",
    "text": "JHU/CCP, INFO Project 2011 update), Contraceptive Technology (Hatcher et al. 2011), Sexually Transmitted and Other Reproductive Tract Infections: A Guide to Essen- tial Practice (WHO 2005), and Guidelines for the Management of Sexually Transmitted Infections (WHO 2003).",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 107
  },
  {
    "id": "chunk_00108",
    "text": "ent of Sexually Transmitted Infections (WHO 2003). These job aids can be revised depending on national and/or regional guidelines and protocols. Guidelines for adapting the BCS+ job aids are included in this document (page 29). Electronic",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 108
  },
  {
    "id": "chunk_00109",
    "text": "re included in this document (page 29). Electronic copies of the BCS+ materials are available so that the job aids and instructional guides can be easily printed or adapted to meet local needs. HOW SHOULD THIS TOOLKIT BE USED?",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 109
  },
  {
    "id": "chunk_00110",
    "text": "meet local needs. HOW SHOULD THIS TOOLKIT BE USED? 1. Read this entire BCS+ User\u2019s Guide on how to implement the Balanced Counseling Strategy Plus. 2. Refer to the BCS+ algorithm as a reminder of the 19 steps used to implement the BCS+. It",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 110
  },
  {
    "id": "chunk_00111",
    "text": "der of the 19 steps used to implement the BCS+. It is helpful to have a copy available on the provider\u2019s desk or on a wall in the consultation area so that the provider can refer to it easily. 3. Use the BCS+ counseling cards and WHO MEC Wheel to help a client choose a method",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 111
  },
  {
    "id": "chunk_00112",
    "text": "and WHO MEC Wheel to help a client choose a method based on her/his reproductive intentions. Use the first counseling card to rule out whether the client is pregnant. If she is not, use the method cards to help the client choose a contra-",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 112
  },
  {
    "id": "chunk_00113",
    "text": "e method cards to help the client choose a contra- ceptive method best suited to her/his reproductive health intentions by discarding those that are inappropriate. Emphasize dual protection throughout the counseling.",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 113
  },
  {
    "id": "chunk_00114",
    "text": "phasize dual protection throughout the counseling. 4. Once the client has chosen a contraceptive method, use the corresponding BCS+ method brochure to discuss contraindications to the chosen method. If there are none, review the",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 114
  },
  {
    "id": "chunk_00115",
    "text": "o the chosen method. If there are none, review the rest of the brochure with the client to reinforce information about the method chosen and to respond to questions. This helps to ensure that the client understands the method. Give",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 115
  },
  {
    "id": "chunk_00116",
    "text": "nsure that the client understands the method. Give the brochure to the client. S/he can refer to it at home or use it to talk to her/his partner. 5. Use the counseling cards to discuss additional reproductive health services that the family",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 116
  },
  {
    "id": "chunk_00117",
    "text": "ional reproductive health services that the family planning client may need during and after s/he has selected a contraceptive method. These include counseling on postpartum health for the mother and infant, cervical cancer screen-",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 117
  },
  {
    "id": "chunk_00118",
    "text": "for the mother and infant, cervical cancer screen- ing, breast cancer, adolescent needs, women\u2019s support and safety, post-abortion care, male services, STI/HIV transmission and prevention, conducting a risk assessment, defining dual protection, and discussing and offering HIV counseling and testing.",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 118
  },
  {
    "id": "chunk_00119",
    "text": "iscussing and offering HIV counseling and testing. 6. For trainers, use the BCS+ Trainer\u2019s Guide to familiarize health care staff with this new coun- seling approach and to build capacity to effectively use the BCS+. The exercises in the BCS+",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 119
  },
  {
    "id": "chunk_00120",
    "text": "ffectively use the BCS+. The exercises in the BCS+ Trainer\u2019s Guide can be given all together in a workshop and/or used separately during staff meetings or on-the-job training during supervisory visits. 7. The four BCS+ job aids, BCS+ User\u2019s Guide, and BCS+ Trainer\u2019s Guide are also available as",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 120
  },
  {
    "id": "chunk_00121",
    "text": "de, and BCS+ Trainer\u2019s Guide are also available as electronic files on Population Council\u2019s website, at http://www.popcouncil.org/research/ the-balanced-counseling-strategy-plus-a-toolkit-for-family-planning-service. Adapt these materials for use in your region or country as needed. | 5 |",
    "page_number": 10,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 121
  },
  {
    "id": "chunk_00122",
    "text": "Algorithm for Using the Balanced Counseling Strategy Plus PPRREE--CCHHOOIICCEE SSTTAAGGEE 1 Establish and maintain a warm, cordial relationship. 2 Inform client (and partner, if present) that there will be opportunities to address both health needs and family planning needs during this consultation.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 122
  },
  {
    "id": "chunk_00123",
    "text": "nd family planning needs during this consultation. 3 Ask client about current family size and current contraceptive practices. Counsel client on Healthy Timing and Spacing of Pregnancy using counseling card.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 123
  },
  {
    "id": "chunk_00124",
    "text": "ng and Spacing of Pregnancy using counseling card. a) If client is currently using a family planning method or delaying pregnancy, ask about her/his satisfaction with it and interest in continuing or changing the method. b) If partner is present, use the male services and support card.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 124
  },
  {
    "id": "chunk_00125",
    "text": "s present, use the male services and support card. 4 Rule out pregnancy using the Checklist to Make Reasonably Sure a Woman is not Pregnant card to be reasonably sure the woman is not pregnant. 5 Display all of the method cards. Ask client if she/he wants a particular method.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 125
  },
  {
    "id": "chunk_00126",
    "text": "s. Ask client if she/he wants a particular method. 6 Ask all of the following questions. Set aside method cards based on the client\u2019s responses. a) Do you wish to have children in the future? If \u201cYes,\u201d set aside vasectomy and tubal ligation cards. Explain Why. If \u201cNo,\u201d keep all cards and continue.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 126
  },
  {
    "id": "chunk_00127",
    "text": "Explain Why. If \u201cNo,\u201d keep all cards and continue. b) Have you given birth in the last 48 hours? If \u201cYes,\u201d set aside combined oral contraceptives (the Pill) and combined injectables. Explain why. If \u201cNo,\u201d continue with the next question. c) Are you breastfeeding an infant less than 6 months old?",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 127
  },
  {
    "id": "chunk_00128",
    "text": "ou breastfeeding an infant less than 6 months old? If \u201cYes,\u201d set aside the combined oral contraceptives (the Pill) and combined injectable cards. Explain why. If \u201cNo,\u201d or she has begun her monthly bleeding again, set aside the lactational amenorrhea (LAM) card. Explain why.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 128
  },
  {
    "id": "chunk_00129",
    "text": "he lactational amenorrhea (LAM) card. Explain why. d) Does your partner support you in family planning? If \u201cYes,\u201d continue with the next question If \u201cNo,\u201d set aside the following cards: female condom, male condom, Standard Days Method\u00a9, Two Days Method\u00a9, and withdrawal. Explain why.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 129
  },
  {
    "id": "chunk_00130",
    "text": "d\u00a9, Two Days Method\u00a9, and withdrawal. Explain why. e) Do you have any medical conditions? Are you taking any medications? If \u201cYes,\u201d ask further about which conditions or medications. Refer to WHO Medical Eligibility Criteria",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 130
  },
  {
    "id": "chunk_00131",
    "text": "cations. Refer to WHO Medical Eligibility Criteria Wheel or current national guidelines and set aside all contraindicated method cards. Explain why. If \u201cNo,\u201d keep all the cards and continue. f) Are there any methods that you do not want to use or have not tolerated in the past?",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 131
  },
  {
    "id": "chunk_00132",
    "text": "not want to use or have not tolerated in the past? If \u201cYes,\u201d set aside the cards the client does not want. If \u201cNo,\u201d keep the rest of the cards. METHOD CHOICE STAGE 7 Briefly review the methods that have not been set aside and indicate their effectiveness.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 132
  },
  {
    "id": "chunk_00133",
    "text": "t been set aside and indicate their effectiveness. a) Arrange the remaining cards in order of effectiveness (see back of each card). b) In order of effectiveness (highly effective to not effective), briefly review the attributes on each method card.",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 133
  },
  {
    "id": "chunk_00134",
    "text": "briefly review the attributes on each method card. 8 Ask the client to choose the method that is most convenient for her/him. a) If client is adolescent use the counseling card to inform her that she can get any method",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 134
  },
  {
    "id": "chunk_00135",
    "text": "ing card to inform her that she can get any method 9 Using the method-specific brochure, check whether the client has any condition for which the method is not advised. a) Review \u201cMethod not advised if you...\u201d section in the brochure",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 135
  },
  {
    "id": "chunk_00136",
    "text": "hod not advised if you...\u201d section in the brochure b) If the method is not advisable, ask the client to select another method from the cards that remain. Repeat the process from Step 8. | 6 |",
    "page_number": 11,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 136
  },
  {
    "id": "chunk_00137",
    "text": "POST-CHOICE STAGE 10 Discuss the method chosen with the client, using the method-specific brochure as a counseling tool. Determine the client\u2019s comprehension and reinforce key information. 11 Make sure the client has made a definite decision. Give her/him the method chosen, a referral,",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 137
  },
  {
    "id": "chunk_00138",
    "text": "ision. Give her/him the method chosen, a referral, and a back-up method depending on the method selected. 12 Encourage the client to involve partner(s) in decisions about/practice of contraception through discussion or a visit to the clinic. SYSTEMATIC SCREENING FOR OTHER SERVICES STAGE",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 138
  },
  {
    "id": "chunk_00139",
    "text": "nic. SYSTEMATIC SCREENING FOR OTHER SERVICES STAGE 13 Using information collected previously, determine client\u2019s need for postpartum, newborn, infant care, well-child services or post abortion care.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 139
  },
  {
    "id": "chunk_00140",
    "text": "t care, well-child services or post abortion care. a) If client reported giving birth recently, review the Promoting Healthy Postpartum Period and Promoting Newborn and Infant Health card with client. Provide or refer for services, if needed.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 140
  },
  {
    "id": "chunk_00141",
    "text": "client. Provide or refer for services, if needed. b) For clients with children less than 5 years of age, ask if children have been taken to well-child services. Provide or refer for immunizations and growth monitoring services, if needed.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 141
  },
  {
    "id": "chunk_00142",
    "text": "zations and growth monitoring services, if needed. c) If client reported a recent abortion, review the Post Abortion Care card with the client. Provide or refer post abortion care services, if needed. 14 Ask client when she had her last screening for cervical cancer (VIA/VILI or pap smear) or breast",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 142
  },
  {
    "id": "chunk_00143",
    "text": "cervical cancer (VIA/VILI or pap smear) or breast cancer. a) If her last Cervical Cancer screening was more than 3 years ago (*6-12 months if she is HIV positive) or she doesn\u2019t know, ask if she would like to have a screening today. Review the Screening for Cervical",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 143
  },
  {
    "id": "chunk_00144",
    "text": "screening today. Review the Screening for Cervical Cancer card. Provide or refer for services. b) If her last Cervical Cancer screening was less than 3 years ago continue with next question. c) Review Breast Cancer Information and Awareness counseling card with client.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 144
  },
  {
    "id": "chunk_00145",
    "text": "rmation and Awareness counseling card with client. 15 Discuss STI/HIV Transmission & Prevention and dual protection with client using counseling cards. Offer condoms and instructions on correct and consistent use.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 145
  },
  {
    "id": "chunk_00146",
    "text": "ms and instructions on correct and consistent use. 16 Conduct STI and HIV risk assessment using the counseling card. If symptoms are identified, treat her/him syndromically. 17 Ask client whether s/he knows her/his HIV status. a) If client knows s/he is living with HIV,",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 146
  },
  {
    "id": "chunk_00147",
    "text": "tatus. a) If client knows s/he is living with HIV, \u25aa Review Positive Health, Dignity, & Prevention counseling card with client. \u25aa Refer client to center for wellness care and treatment. b) If client knows s/he is HIV negative, \u25aa Discuss a time frame for repeat testing.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 147
  },
  {
    "id": "chunk_00148",
    "text": "gative, \u25aa Discuss a time frame for repeat testing. c) If client does not know her/his status, \u25aa Discuss HIV Counseling and Testing (HCT) with client, using counseling card. \u25aa Offer or initiate testing with client, according to national protocols.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 148
  },
  {
    "id": "chunk_00149",
    "text": "ting with client, according to national protocols. \u25aa Counsel client on test results. If client is living with HIV, review Positive Health, Dignity, & Prevention counseling card and refer client to center for wellness care and treatment. d) Counsel client using Women\u2019s Support & Safety Card.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 149
  },
  {
    "id": "chunk_00150",
    "text": "ounsel client using Women\u2019s Support & Safety Card. \u25aa If client shows any major Intimate Partner Violence (IPV) triggers, refer her for specialized services. 18 Give follow-up instructions, a condom brochure, and the brochure for the method chosen. Set a date for next visit.",
    "page_number": 12,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 150
  },
  {
    "id": "chunk_00151",
    "text": "Guide to Counseling Clients Using the BCS+ Toolkit Pre-Choice Stage During this stage, the provider creates the necessary conditions to help the client select a method. STEP 1. ESTABLISH AND MAINTAIN A WARM, CORDIAL RELATIONSHIP. \u25aa Establish a formal but friendly manner.",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 151
  },
  {
    "id": "chunk_00152",
    "text": "IONSHIP. \u25aa Establish a formal but friendly manner. \u25aa Call the client by her/his name. \u25aa Demonstrate interest in what the client tells you. \u25aa Establish eye contact with the client. \u25aa Listen to and answer her/his questions. \u25aa Show support and understanding without judgment.",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 152
  },
  {
    "id": "chunk_00153",
    "text": "\u25aa Show support and understanding without judgment. \u25aa Ask questions to encourage participation in the discussion. STEP 2. INFORM CLIENT THAT (AND PARTNER, IF PRESENT) THERE WILL BE AN OPPORTUNITY TO ADDRESS BOTH HEALTH NEEDS AND FAMILY PLANNING NEEDS DURING THIS CONSULTATION.",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 153
  },
  {
    "id": "chunk_00154",
    "text": "ND FAMILY PLANNING NEEDS DURING THIS CONSULTATION. \u25aa Inform client of other services available at your facility or available through referral. \u25aa Inquire and take note of other services she/he may be interested in receiving. \u25aa Ask whether the client would like a family planning method.",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 154
  },
  {
    "id": "chunk_00155",
    "text": "er the client would like a family planning method. STEP 3. ASK CLIENT ABOUT CURRENT FAMILY SIZE, DESIRE TO HAVE MORE CHILDREN, AND CURRENT CONTRACEPTIVE PRACTICES. COUNSEL THE CLIENT ON HEALTHY TIMING AND SPACING OF PREGNANCY USING COUNSELING CARD. \u25aa Ask client how many children she/he has.",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 155
  },
  {
    "id": "chunk_00156",
    "text": "G CARD. \u25aa Ask client how many children she/he has. \u25aa Ask client how many children she/he and her (his) partner wants. \u25aa Ask about client\u2019s current use of contraception. \u25aa If client is currently using contraception or is delaying pregnancy, ask about her/his satisfac-",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 156
  },
  {
    "id": "chunk_00157",
    "text": "is delaying pregnancy, ask about her/his satisfac- tion with it, and interest in continuing or changing the method. \u25aa Using the counseling card, explain the following points with the client: \u25aa For the health of the mother and her baby, wait at least 2",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 157
  },
  {
    "id": "chunk_00158",
    "text": "health of the mother and her baby, wait at least 2 years (24 months) but not more than 5 years before trying For women who desire to have more chil- to become pregnant again. dren after a live birth, advise \u25aa Use of a family planning method of her choice allows her to plan for a healthy pregnancy.",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 158
  },
  {
    "id": "chunk_00159",
    "text": "choice allows her to plan for a healthy pregnancy. \u25aa For the health of the mother and her baby, wait at least 6 For women who decide to have a child months before trying to become pregnant again. after a miscarriage or abortion, advise \u25aa Use of a family planning method of her choice allows her",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 159
  },
  {
    "id": "chunk_00160",
    "text": "a family planning method of her choice allows her to plan for a healthy pregnancy. \u25aa For the health of the mother and her baby, wait until at least 18 years of age before trying to become pregnant. For adolescents, advise \u25aa If she is sexually active, use of a family planning method",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 160
  },
  {
    "id": "chunk_00161",
    "text": "s sexually active, use of a family planning method of her choice allows her to prevent unintended pregnancy. \u25aa If client\u2019s partner is present, counsel using the Male Services & Support card. | 8 |",
    "page_number": 13,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 161
  },
  {
    "id": "chunk_00162",
    "text": "STEP 4. RULE OUT PREGNANCY USING THE PREGNANCY CHECKLIST CARD WITH 6 QUESTIONS. Pregnancy is a contraindication for the use of most family planning methods, except barrier meth- ods such as condoms. It is important to rule out the possibility of the client being pregnant, which",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 162
  },
  {
    "id": "chunk_00163",
    "text": "he possibility of the client being pregnant, which can be done by asking the 6 questions on the pregnancy checklist card. Checklist to be reasonably sure a woman is not pregnant: \u25aa Did you have a baby less than 6 months ago? If so, are you fully or nearly fully breastfeeding?",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 163
  },
  {
    "id": "chunk_00164",
    "text": "f so, are you fully or nearly fully breastfeeding? Have you had no monthly menstrual bleeding since giving birth? \u25aa Have you abstained from unprotected sex (no method of family planning) since your last men- strual bleeding or delivery? \u25aa Have you given birth during the last 4 weeks?",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 164
  },
  {
    "id": "chunk_00165",
    "text": "y? \u25aa Have you given birth during the last 4 weeks? \u25aa Did your last menstrual bleeding start within the past 7 days (or within 12 days if you plan to use an intrauterine device (IUD)? \u25aa Have you had a miscarriage or abortion in the last 7 days?",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 165
  },
  {
    "id": "chunk_00166",
    "text": "had a miscarriage or abortion in the last 7 days? \u25aa Have you been using a reliable contraceptive method consistently and correctly? Rule out pregnancy using the table below. If the client... Then... \u201cYes\u201d to any of the questions and is free of signs and symptoms of pregnancy",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 166
  },
  {
    "id": "chunk_00167",
    "text": "ons and is free of signs and symptoms of pregnancy 1. Pregnancy if unlikely. *Once the client has answered yes to one 2. Continue to Step 5. of the questions, it is not necessary to continue asking the remaining questions 1. Pregnancy cannot be ruled out.",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 167
  },
  {
    "id": "chunk_00168",
    "text": "aining questions 1. Pregnancy cannot be ruled out. 2. Give client pregnancy test if available, or refer her to an antenatal clinic. 3. Provide her with a back-up method, such as condoms, to \u201cNo\u201d to all of the questions use until she has her menstrual bleeding.",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 168
  },
  {
    "id": "chunk_00169",
    "text": "uestions use until she has her menstrual bleeding. 4. Provide in advance her preferred method (where possible) to use on the 1st day of her menses OR request that she return at that point to receive her preferred method. 5. Go to Step 13.",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 169
  },
  {
    "id": "chunk_00170",
    "text": "to receive her preferred method. 5. Go to Step 13. STEP 5. DISPLAY ALL OF THE METHOD CARDS. ASK CLIENT IF SHE/HE WANTS A PARTICULAR METHOD. 1. Display all the method cards on a desk or table, grouped by method type (temporary, fertility awareness, permanent) as shown in Figure 1 below.",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 170
  },
  {
    "id": "chunk_00171",
    "text": "awareness, permanent) as shown in Figure 1 below. 2. Each card has information about a different family planning method. 3. Ask whether the client has a particular method in mind. If the client... Do this... Answers \u201cno\u201d Continue to Step 6 Answers \u201cyes\u201d 1. Ask which method s/he wants.",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 171
  },
  {
    "id": "chunk_00172",
    "text": "ep 6 Answers \u201cyes\u201d 1. Ask which method s/he wants. 2. Ask what the client knows about the method. 3. If the information is correct, go to Step 9. Gives incomplete information about the 1. Correct any misinformation. method s/he has chosen 2. If necessary, go to Step 6 to help the client choose a",
    "page_number": 14,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 172
  },
  {
    "id": "chunk_00173",
    "text": "FIGURE 1. BCS+ METHOD CARDS STEP 6. ASK ALL OF THE FOLLOWING QUESTIONS. SET ASIDE METHOD CARDS BASED ON THE CLIENT\u2019S RESPONSES. 1. Using the display of method cards, begin the process by saying something like, \u201cNow we are",
    "page_number": 15,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 173
  },
  {
    "id": "chunk_00174",
    "text": "the process by saying something like, \u201cNow we are going to discuss your contraceptive needs. We will narrow down the number of methods that might be best for you. Then, I will discuss the key features of each method with you. This will help us to find the right method for your needs.\u201d",
    "page_number": 15,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 174
  },
  {
    "id": "chunk_00175",
    "text": "help us to find the right method for your needs.\u201d 2. Ask the 6 questions below. Based on the client\u2019s responses, set aside the method cards that do not suit her/his needs. Do you wish to have children in the future? If the client... Do this... 1. Set aside the vasectomy and tubal ligation cards.",
    "page_number": 15,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 175
  },
  {
    "id": "chunk_00176",
    "text": "Set aside the vasectomy and tubal ligation cards. Answers \u201cyes\u201d 2. Explain that sterilization is permanent and not suitable for someone who thinks s/he might want to have another child. Answers \u201cno\u201d Keep all cards and continue | 10 |",
    "page_number": 15,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 176
  },
  {
    "id": "chunk_00177",
    "text": "a. Do you wish to have children in the future? If the client... Do this... 1. Set aside combined oral contraceptives (the Pill), monthly injectable, implants, and tubal ligation cards. Answers \u201cyes\u201d 2. Explain that combined hormonal methods and tubal",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 177
  },
  {
    "id": "chunk_00178",
    "text": ". Explain that combined hormonal methods and tubal ligation are not safe for women to use immediately after giving birth. Answers \u201cno\u201d Keep all cards and continue b. Have you given birth in the last 48 hours? If the client... Do this... 1. Set aside the combined oral contraceptives (the Pill) and",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 178
  },
  {
    "id": "chunk_00179",
    "text": "de the combined oral contraceptives (the Pill) and combined injectable contraceptive (CIC) cards. Answers \u201cyes\u201d 2. Explain that the hormones in these methods affect breast- feeding. 1. Set aside the combined oral contraceptives (the Pill) and combined injectable contraceptive (CIC) cards.",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 179
  },
  {
    "id": "chunk_00180",
    "text": "and combined injectable contraceptive (CIC) cards. Answers \u201cno\u201d 2. Explain that the hormones in these methods affect breast- feeding. c. Are you breastfeeding an infant less than 6 months old? If the client... Do this... Answers \u201cyes\u201d Continue with the next question",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 180
  },
  {
    "id": "chunk_00181",
    "text": "s... Answers \u201cyes\u201d Continue with the next question 1. Set aside female condom, male condom, Standard Days Answers \u201cno\u201d Method\u00ae, TwoDay\u00ae Method, and withdrawal cards. 2. Explain that these methods require partner cooperation. d. Does your partner support you in family planning?",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 181
  },
  {
    "id": "chunk_00182",
    "text": "Does your partner support you in family planning? 3. Invite the client to bring her/his partner to a counseling session to discuss family planning with a provider. 4. Point out that male and female condoms are important for protecting against STIs, including HIV. 5. Continue with the next question.",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 182
  },
  {
    "id": "chunk_00183",
    "text": "including HIV. 5. Continue with the next question. e. Do you have any medical conditions? Are you taking any medications? If the client... Do this... 1. Ask further about which medical conditions the client has or medications she/he is taking.",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 183
  },
  {
    "id": "chunk_00184",
    "text": "ns the client has or medications she/he is taking. 2. Refer to the WHO Medical Eligibility Criteria Wheel (includ- ed), or current national guidelines, to identify contraindi- Answers \u201cyes\u201d cated methods. 3. Set aside all contraindicated method cards.",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 184
  },
  {
    "id": "chunk_00185",
    "text": "ds. 3. Set aside all contraindicated method cards. 4. Explain to client the reason for setting aside method cards, according to information provided in guidelines. Answers \u201cno\u201d Continue with next question | 11 |",
    "page_number": 16,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 185
  },
  {
    "id": "chunk_00186",
    "text": "NOTE The Medical Eligibility Criteria Wheel is a provider job aid guiding providers through client\u2019s eligibility for contraceptive use according to medical conditions the client may have. The wheel includes two discs stacked upon one another; the outer disc lists medical conditions around",
    "page_number": 17,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 186
  },
  {
    "id": "chunk_00187",
    "text": "er; the outer disc lists medical conditions around its outside and the inner disc identifies eligibility for particular methods. By rotating and lining up the two discs according to a particular condition, the provider can interpret the appropri-",
    "page_number": 17,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 187
  },
  {
    "id": "chunk_00188",
    "text": "ondition, the provider can interpret the appropri- ateness of the desired method according to four eligibility categories (1 through 4). Further instruction on the MEC Wheel is available on its reverse side. f. Are there any methods that you do not want to use or have not tolerated in the past?",
    "page_number": 17,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 188
  },
  {
    "id": "chunk_00189",
    "text": "not want to use or have not tolerated in the past? If the client... Do this... 1. Ask which methods s/he has used and her/his experience with each. Answers \u201cyes\u201d 2. Set aside the cards for the methods the client does not want. Answers \u201cno\u201d Keep the rest of the cards",
    "page_number": 17,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 189
  },
  {
    "id": "chunk_00190",
    "text": "not want. Answers \u201cno\u201d Keep the rest of the cards The client has eliminated a method be- 1. Provide the correct information. cause of rumors or false information. 2. Do not set aside the card for that method.",
    "page_number": 17,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 190
  },
  {
    "id": "chunk_00191",
    "text": "ion. 2. Do not set aside the card for that method. 6. If certain methods, such as the IUD, implants, tubal ligation, or vasectomy, are never of- ferred at your health care facility, still talk to the clients bout these methods, and provide a referral to another facility if selected. | 12 |",
    "page_number": 17,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 191
  },
  {
    "id": "chunk_00192",
    "text": "Method Choice Stage STEP 7. BRIEFLY REVIEW THE METHODS THAT HAVE NOT BEEN SET ASIDE AND INDICATE THEIR EFFECTIVENESS. 1. Arrange the remaining method cards that have not been set aside on your desk or table ac- cording to their level of effectiveness. See Figure 2 below.",
    "page_number": 18,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 192
  },
  {
    "id": "chunk_00193",
    "text": "their level of effectiveness. See Figure 2 below. FIGURE 2. METHOD CARDS ARRANGED ACCORDING TO EFFECTIVENESS 2. Display them with the lowest percentages first and the highest percentages last. (The per- centage is on the left-hand side of the back of the card and indicates the effectiveness of the",
    "page_number": 18,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 193
  },
  {
    "id": "chunk_00194",
    "text": "of the card and indicates the effectiveness of the method. The effectiveness of the method is also indicated by the green word in the bot- tom-left corner of the card: \u201chighly effective,\u201d \u201ceffective,\u201d or \u201cless effective.\u201d)",
    "page_number": 18,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 194
  },
  {
    "id": "chunk_00195",
    "text": "hly effective,\u201d \u201ceffective,\u201d or \u201cless effective.\u201d) 3. Explain the effectiveness of the methods. Effectiveness is measured as the number of pregnancies among 100 women in the first year of use. The higher the percentage, the more",
    "page_number": 18,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 195
  },
  {
    "id": "chunk_00196",
    "text": "t year of use. The higher the percentage, the more effective the method and the fewer women get pregnant using the method. See Figure 3 for example. | 13 |",
    "page_number": 18,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 196
  },
  {
    "id": "chunk_00197",
    "text": "FIGURE 3. EXAMPLES OF METHOD CARDS SHOWING EFFECTIVENESS FOR PREVENTING PREGNANCY 4. Begin with the card with the highest percentage. Read the key features of each method writ- ten on the cards displayed. You may also ask the client to read these attributes her/himself.",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 197
  },
  {
    "id": "chunk_00198",
    "text": "k the client to read these attributes her/himself. 5. Explain that the condom (male and female) is the only method that provides dual protection against pregnancy and STIs, including HIV. Emphasize the following:",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 198
  },
  {
    "id": "chunk_00199",
    "text": "and STIs, including HIV. Emphasize the following: \u25aa Male and female condoms significantly reduce the risk of infection with STIs, including HIV, when used correctly and consistently with every act of sex. \u25aa When used consistently and correctly, condom use prevents 80 percent to 95 percent of",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 199
  },
  {
    "id": "chunk_00200",
    "text": "y, condom use prevents 80 percent to 95 percent of HIV transmission that would have occurred without condoms. \u25aa Condoms reduce the risk of becoming infected with many STIs when used consistently and correctly: \u2013 Protect best against spread of STIs by discharge, such as HIV, gonorrhea, and chla-",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 200
  },
  {
    "id": "chunk_00201",
    "text": "Is by discharge, such as HIV, gonorrhea, and chla- mydia. \u2013 Also protect against spread of STIs from skin-to-skin contact, such as herpes and human papillomavirus (HPV). STEP 8. ASK THE CLIENT TO CHOOSE THE METHOD THAT IS MOST CONVENIENT FOR HER/HIM.",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 201
  },
  {
    "id": "chunk_00202",
    "text": "SE THE METHOD THAT IS MOST CONVENIENT FOR HER/HIM. 1. If the client is an adolescent use the Adolescent Counseling card to inform her that she can get any method. 2. Ask the client whether s/he has any questions or comments about the methods discussed.",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 202
  },
  {
    "id": "chunk_00203",
    "text": "questions or comments about the methods discussed. Respond to any questions. Resolve any doubts before proceeding. 3. Ask the client to choose a method that is most convenient for her/him. 4. If the client asks that you choose the method, explain that s/he is the only person who",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 203
  },
  {
    "id": "chunk_00204",
    "text": "e method, explain that s/he is the only person who knows her/his needs. You may give recommendations about a method, but allow the client to make the final choice. | 14 |",
    "page_number": 19,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 204
  },
  {
    "id": "chunk_00205",
    "text": "5. Once the client selects a method, do not take the remaining method cards off the table. You may need to return to them if the method chosen is not advised or the client changes her/ his mind. 6. If the client does not like any of the methods discussed or cannot make up her/his mind,",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 205
  },
  {
    "id": "chunk_00206",
    "text": "methods discussed or cannot make up her/his mind, give the client a back-up method, such as condoms, to use until s/he decides on a method of choice. Condoms can provide dual protection against pregnancy and STIs until the client has another or an additional method. Go to Step 13.",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 206
  },
  {
    "id": "chunk_00207",
    "text": "as another or an additional method. Go to Step 13. STEP 9. USING THE METHOD-SPECIFIC BROCHURE, CHECK WHETHER THE CLIENT HAS ANY CONDITIONS FOR WHICH THE METHOD IS NOT ADVISED. 1. Select the BCS+ method-specific brochure corresponding to the method chosen by the client.",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 207
  },
  {
    "id": "chunk_00208",
    "text": "corresponding to the method chosen by the client. 2. Together with the client, review the section entitled, \u201cMethod not advised if you\u2026\u201d in the method brochure. This lists conditions when the method is not advised. For the Pill: Method not advised if you:",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 208
  },
  {
    "id": "chunk_00209",
    "text": "advised. For the Pill: Method not advised if you: \u25aa Are breastfeeding an infant less than 6 months old. \u25aa Are within 21 days of giving birth, regardless of breastfeeding status. \u25aa Smoke cigarettes and are 35 years old or older. \u25aa Have high blood pressure, 140/90 or higher.",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 209
  },
  {
    "id": "chunk_00210",
    "text": "der. \u25aa Have high blood pressure, 140/90 or higher. \u25aa Have certain uncommon serious diseases of the heart or blood vessels. Discuss with your provider. \u25aa Have severe liver conditions. \u25aa Have blood clots, deep vein thrombosis, or pulmonary embolism, or are on anticoagulant ther-",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 210
  },
  {
    "id": "chunk_00211",
    "text": "pulmonary embolism, or are on anticoagulant ther- apy. Discuss with your provider. \u25aa Have lupus. \u25aa Have gall bladder disease, even if medically-treated. Discuss with your provider. \u25aa Have breast cancer or a history of breast cancer.",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 211
  },
  {
    "id": "chunk_00212",
    "text": "Have breast cancer or a history of breast cancer. \u25aa Have migraine headaches (a severe headache that does not go away with paracetamol) and are 35 years old or older. \u25aa Have migraine aura (sometimes seeing a growing bright spot in one eye)",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 212
  },
  {
    "id": "chunk_00213",
    "text": "sometimes seeing a growing bright spot in one eye) \u25aa Take medicine for seizures or take rifampicin (for tuberculosis or other infections). \u25aa Take ritonavir-boosted protease inhibitors as part of HAART. 3. Using simple, clear language, ask probing questions to make sure that the client does not",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 213
  },
  {
    "id": "chunk_00214",
    "text": "ng questions to make sure that the client does not have any conditions for which the method is not advised. 4. Based on the client\u2019s response, decide whether to provide the method or return to a previous step. If the client... Do this... Has no conditions Go to Step 10",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 214
  },
  {
    "id": "chunk_00215",
    "text": "ient... Do this... Has no conditions Go to Step 10 1. Explain the need to choose another method. Has any condition 2. Return to Step 7. Has any condition and reached this step from 1. Explain the need to choose another method. Step 5 (already had the method in mind) 2. Return to Step 6. | 15 |",
    "page_number": 20,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 215
  },
  {
    "id": "chunk_00216",
    "text": "Post-Choice Stage STEP 10. DISCUSS THE METHOD CHOSEN WITH THE CLIENT, USING THE METHOD BROCHURE AS A COUNSELING TOOL. DETERMINE CLIENT\u2019S COMPREHENSION AND REINFORCE KEY INFORMATION 1. Use the method brochure as a counseling tool to review all the information about the meth-",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 216
  },
  {
    "id": "chunk_00217",
    "text": "tool to review all the information about the meth- od chosen by the client. Begin by saying something like, \u201cMrs./Mr. (name), this brochure is for you to take home. Before you go, I would like to review the information with you.\u201d",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 217
  },
  {
    "id": "chunk_00218",
    "text": "I would like to review the information with you.\u201d 2. Using clear, simple language review the information about the method presented in the brochure: \u25aa General information (This is the same information as on each BCS+ method card.) \u25aa How the method works \u25aa Important facts about the method",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 218
  },
  {
    "id": "chunk_00219",
    "text": "he method works \u25aa Important facts about the method \u25aa When the method is not advised \u25aa Side effects \u25aa Health benefits (if applicable) \u25aa How to use \u25aa Follow-up (if applicable) \u25aa When to return to the health care facility",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 219
  },
  {
    "id": "chunk_00220",
    "text": "able) \u25aa When to return to the health care facility 3. Make sure the client fully understands all aspects of the method s/he has chosen. Compre- hension is key to healthy, effective use of the method. 4. Give the client the brochure. Encourage her/him to review the brochure again at home and",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 220
  },
  {
    "id": "chunk_00221",
    "text": "e her/him to review the brochure again at home and when s/he needs to remember anything about the method. 5. Validate comprehension by asking the client to answer the following questions in her/his own words. (S/he may refer to the brochure.) \u25aa How do you use the method you have chosen?",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 221
  },
  {
    "id": "chunk_00222",
    "text": "ure.) \u25aa How do you use the method you have chosen? \u25aa What side effects might you experience with the method? \u25aa Can the method protect you against getting an STI, including HIV? \u25aa What are the signs indicating when you should return to the health care facility?",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 222
  },
  {
    "id": "chunk_00223",
    "text": "hen you should return to the health care facility? 6. Assure the client that it is fine if s/he cannot remember all the details. Make sure the client can find the information in the brochure. (Note: If the client cannot read or has very low",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 223
  },
  {
    "id": "chunk_00224",
    "text": ". (Note: If the client cannot read or has very low literacy skills, ask the client to identify a person at home who can read the information to her/him.) 7. If the client selects a method not available on site, then: a. Still give client the brochure for the method chosen.",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 224
  },
  {
    "id": "chunk_00225",
    "text": "ll give client the brochure for the method chosen. b. Refer the client to a facility or commercial outlet where s/he can obtain the method. c. Provide client with an alternative, suitable method until s/he can obtain the method of choice.",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 225
  },
  {
    "id": "chunk_00226",
    "text": "method until s/he can obtain the method of choice. 8. If the client selects a method that is temporarily unavailable (out of stock), then: a. Give the client a brochure for the method chosen. b. Refer the client to a facility or commercial outlet where s/he can obtain the method.",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 226
  },
  {
    "id": "chunk_00227",
    "text": "ommercial outlet where s/he can obtain the method. c. Provide client with a back-up method until s/he can obtain the method of choice. d. Ask the client to return when the method is in stock at your health care facility. | 16 |",
    "page_number": 21,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 227
  },
  {
    "id": "chunk_00228",
    "text": "STEP 11. MAKE SURE THE CLIENT HAS MADE A DEFINITE DECISION. GIVE HER/HIM THE METHOD CHOSEN AND/OR A REFERRAL, AND BACK-UP METHOD, DEPENDING ON THE METHOD SELECTED. 1. Ask the client whether her/his choice is definite. Make sure s/he is happy with the choice of method. If the client is... Do this...",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 228
  },
  {
    "id": "chunk_00229",
    "text": "e choice of method. If the client is... Do this... 1. Give her/him the method and brochure. 2. If IUD, implant, tubal ligation, or vasectomy is chosen and not available on site, give a referral for the proce- dure, if needed.",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 229
  },
  {
    "id": "chunk_00230",
    "text": "e, give a referral for the proce- dure, if needed. Happy with the method chosen 3. If the client cannot immediately use the chosen meth- od, provide a back-up method (e.g., condoms). Give the BCS+ brochure on condoms. 4. Suggest that s/he may also abstain from sex until s/",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 230
  },
  {
    "id": "chunk_00231",
    "text": "ggest that s/he may also abstain from sex until s/ he obtains the method of choice. 1. Assure the client that it is fine to change her/his mind. Not happy with the method chosen and wish- The client has a right to informed choice. es to consider other options 2. Return to Step 7.",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 231
  },
  {
    "id": "chunk_00232",
    "text": "es to consider other options 2. Return to Step 7. 2. Do not let the client leave empty-handed. If a method is not available, make sure the client has a back-up method (e.g., condoms), a referral, and the BCS+ brochure on condoms. 3. Give the client his/her method brochure.",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 232
  },
  {
    "id": "chunk_00233",
    "text": "ndoms. 3. Give the client his/her method brochure. STEP 12. ENCOURAGE THE CLIENT TO INVOLVE PARTNER(S) IN DECISIONS ABOUT/ PRACTICE OF CONTRACEPTION THROUGH DISCUSSION OR A VISIT TO THE CLINIC. 1. Encourage the client to discuss her/his contraceptive method with her/his partner.",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 233
  },
  {
    "id": "chunk_00234",
    "text": "her/his contraceptive method with her/his partner. 2. Mention that this can help in the following manner: \u25aa Your partner can remind you of the time to take your method, if taking a method regu- larly, and follow-up dates. \u25aa You can negotiate condom use to prevent STI, including HIV.",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 234
  },
  {
    "id": "chunk_00235",
    "text": "egotiate condom use to prevent STI, including HIV. \u25aa You can discuss your plans to have children, regardless of whether you are HIV positive or negative. \u25aa You can discuss and help prevent mother to child transmission (PMTCT) of HIV during pregnancy.",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 235
  },
  {
    "id": "chunk_00236",
    "text": "hild transmission (PMTCT) of HIV during pregnancy. \u25aa Your partner can support you if you need wellness and HIV services, including antiretro- viral therapy. | 17 |",
    "page_number": 22,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 236
  },
  {
    "id": "chunk_00237",
    "text": "Systematic Screening for Other Services Stage Use the fourteen (14) counseling cards to discuss additional information and provide additional counseling and services that the client may need. STEP 13. USING INFORMATION COLLECTED PREVIOUSLY, DETERMINE CLIENT\u2019S NEED FOR",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 237
  },
  {
    "id": "chunk_00238",
    "text": "COLLECTED PREVIOUSLY, DETERMINE CLIENT\u2019S NEED FOR POSTPARTUM, NEWBORN, INFANT CARE, WELL-CHILD SERVICES, OR POST ABORTION CARE. 1. Consider information that the client has provided previously during the counseling session, including her responses to questions in Step 3 and Step 4.",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 238
  },
  {
    "id": "chunk_00239",
    "text": "g her responses to questions in Step 3 and Step 4. 2. If information was not revealed through previous questions, ask client the following two questions: \u25aa Have you given birth recently? \u25aa Do you have any children less than 5 years of age?",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 239
  },
  {
    "id": "chunk_00240",
    "text": "Do you have any children less than 5 years of age? 3. Use this information to determine whether the client needs additional information and coun- seling on postpartum, newborn, and infant care or a referral for well-child services.",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 240
  },
  {
    "id": "chunk_00241",
    "text": "infant care or a referral for well-child services. 4. If client has given birth recently (within the past 6 weeks), review the points below from the Promoting a Healthy Postpartum Period counseling card and provide instructed counseling and services. If the client has... Do this...",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 241
  },
  {
    "id": "chunk_00242",
    "text": "ling and services. If the client has... Do this... 1. Review Promoting a Healthy Postpartum Period for the Mother counseling card with client. Given birth recently 2. Review Newborn and Infant Health counseling card with client. 1. Ask if children have been taken to well-child services.",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 242
  },
  {
    "id": "chunk_00243",
    "text": "f children have been taken to well-child services. 2. Ask if children have received all immunizations. Children less than 5 years of age 3. Ask if children have had their height and weight mon- itored. 4. Provide or refer to well-child services if needed.",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 243
  },
  {
    "id": "chunk_00244",
    "text": "Provide or refer to well-child services if needed. \u25aa Ensure that the mother has support for the first few days after birth; encourage rest and sleep. \u25aa Recommend a nutritious diet for the mother that includes plenty of fluids and micronu- trients (including Vitamin A and iron).",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 244
  },
  {
    "id": "chunk_00245",
    "text": "d micronu- trients (including Vitamin A and iron). \u25aa Discuss normal postpartum bleeding and lochia. Counsel on maternal danger signs, such as bleeding or vaginal discharge that has a foul smell. \u25aa Discuss the need for four postnatal care visits: at 24-48 hours, 3 to 7 days, 4 to 6 weeks,",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 245
  },
  {
    "id": "chunk_00246",
    "text": "visits: at 24-48 hours, 3 to 7 days, 4 to 6 weeks, and 4 to 6 months. \u25aa Advise on maintaining personal hygiene, including care of perineum and breasts. \u25aa Counsel on return to sexual activity, which should be whenever the mother feels ready",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 246
  },
  {
    "id": "chunk_00247",
    "text": "y, which should be whenever the mother feels ready and usually after lochia stops. Advise that she can become pregnant again even before her menses returns, if she is not using contraceptives. \u25aa Counsel on postnatal depression, which may entail: crying easily; feeling tired, agitated, or",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 247
  },
  {
    "id": "chunk_00248",
    "text": "entail: crying easily; feeling tired, agitated, or irritable; lacking motivation; having difficulty sleeping; rejecting the baby. 5. If the client has given birth recently, review the points below from the Promoting Newborn",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 248
  },
  {
    "id": "chunk_00249",
    "text": "review the points below from the Promoting Newborn and Infant Health counseling card and provide instructed counseling and services: \u25aa Discuss careful hand washing to prevent infection prior to handling the baby and after changing diapers.",
    "page_number": 23,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 249
  },
  {
    "id": "chunk_00250",
    "text": "ger signs include: difficulty feeding and/or breathing; feeling too hot or too cold; being irritable for extended period of time. \u25aa Discuss the importance of providing good ventilation and keeping the baby warm. \u25aa Encourage exclusive breastfeeding for 6 months. Nothing else is necessary, not even wa-",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 250
  },
  {
    "id": "chunk_00251",
    "text": "6 months. Nothing else is necessary, not even wa- ter. Introduce complementary foods at 6 months and continue to breastfeed. \u25aa For infants exposed to HIV: \u2013 Advise mother to give infant anti-retroviral drugs (ARVs) daily while breastfeeding",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 251
  },
  {
    "id": "chunk_00252",
    "text": "-retroviral drugs (ARVs) daily while breastfeeding and continue for one week after cessation of breastfeeding (around one year) and advise mother to continue ARV per national protocols. \u2013 Recommend that HIV-exposed infants be tested for HIV at 6 weeks and start co-tri- moxazole prophylaxis (CTX).",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 252
  },
  {
    "id": "chunk_00253",
    "text": "eeks and start co-tri- moxazole prophylaxis (CTX). \u2013 Link mother and infant to HIV clinic. \u25aa Explain immunization schedule for infants using national or global guidelines, and in- clude recommendation for Vitamin A at 6 months.",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 253
  },
  {
    "id": "chunk_00254",
    "text": "n- clude recommendation for Vitamin A at 6 months. \u25aa Discuss the need to attend child-welfare clinic and the importance of receiving timely care and monitoring during the first five years of a child\u2019s life. The following services may be included in well-child services: \u2013 Immunizations",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 254
  },
  {
    "id": "chunk_00255",
    "text": "e included in well-child services: \u2013 Immunizations \u2013 Growth monitoring \u2013 Infant feeding support \u2013 Vitamin A provision at 6 months \u2013 Sick child services (including Integrated Management of Childhood Illnesses (IMCI))",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 255
  },
  {
    "id": "chunk_00256",
    "text": "tegrated Management of Childhood Illnesses (IMCI)) 6. If client reported a recent abortion, review the Post Abortion Care card with the client. Pro- vide or refer for post abortion care services, if needed.",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 256
  },
  {
    "id": "chunk_00257",
    "text": "refer for post abortion care services, if needed. 7. If not able counsel or provide services, refer her/him to the appropriate facility to receive this information and counseling. STEP 14. ASK CLIENT WHEN SHE HAD HER LAST SCREENING FOR CERVICAL CANCER (VIA/VILI OR PAP SMEAR) OR BREAST CANCER.",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 257
  },
  {
    "id": "chunk_00258",
    "text": "L CANCER (VIA/VILI OR PAP SMEAR) OR BREAST CANCER. 1. Briefly inform the client about cervical cancer. Explain that cervical cancer: \u25aa Results from uncontrolled, untreated growth of abnormal cells in the cervix. \u25aa Is caused by a sexually-transmitted infection, the human papillomavirus (HPV).",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 258
  },
  {
    "id": "chunk_00259",
    "text": "smitted infection, the human papillomavirus (HPV). \u25aa Takes 10 to 20 years to develop, so there is a long period of opportunity to detect and treat changes and growths before they cause cancer. 2. Explain to the client that screening for cervical cancer:",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 259
  },
  {
    "id": "chunk_00260",
    "text": "to the client that screening for cervical cancer: \u25aa Helps to detect any changes and precancerous growths before they become cancer. \u25aa Is simple, quick, and generally not painful. 3. Ask client when she had her last screening for cervical cancer.",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 260
  },
  {
    "id": "chunk_00261",
    "text": "en she had her last screening for cervical cancer. 4. Review Breast Cancer Information and Awareness counseling card with client. If the client... Do this... Provide Pap smear or VIA/VILI screening test Had her last screening more than 3 years ago OR OR",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 261
  },
  {
    "id": "chunk_00262",
    "text": "Had her last screening more than 3 years ago OR OR Refer for Pap smear or VIA/VILI screening test at appro- Does not know when her last screening was priate facility when test available Had her last screening less than 3 years ago Advise client when to seek next screening | 19 |",
    "page_number": 24,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 262
  },
  {
    "id": "chunk_00263",
    "text": "STEP 15. DISCUSS STI/HIV TRANSMISSION & PREVENTION AND DUAL PROTECTION WITH THE CLIENT USING THE COUNSELING CARD. OFFER CONDOMS AND INSTRUCT HER/HIM IN CORRECT AND CONSISTENT USE. 1. Explain to the client that if s/he is having unprotected sex, s/he is at risk for getting an STI, including HIV.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 263
  },
  {
    "id": "chunk_00264",
    "text": "s/he is at risk for getting an STI, including HIV. 2. Review the following points from the counseling card and assess the client\u2019s knowledge of STI/HIV. \u25aa A person can become infected with STIs, including HIV, through unsafe or unprotected sexual activity. \u25aa STIs are common.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 264
  },
  {
    "id": "chunk_00265",
    "text": "or unprotected sexual activity. \u25aa STIs are common. \u25aa A person living with STIs (including HIV) may have no symptoms, may look healthy, and may not be aware that s/he is infected. \u25aa Common STI symptoms include vaginal discharge, discharge from the penis, sores in the",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 265
  },
  {
    "id": "chunk_00266",
    "text": "discharge, discharge from the penis, sores in the genital area, burning on urination for men, lower abdominal pain for women. \u25aa Some STIs can be treated. To avoid re-infection, both partners must be treated. \u25aa Risk of infection can be reduced by using a condom, limiting the number of sex part-",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 266
  },
  {
    "id": "chunk_00267",
    "text": "y using a condom, limiting the number of sex part- ners, and delaying sex (adolescents). \u25aa HIV is a sexually transmitted infection. HIV is transmitted through an exchange of bodi- ly fluids such as semen, blood, breast milk, and during delivery.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 267
  },
  {
    "id": "chunk_00268",
    "text": "as semen, blood, breast milk, and during delivery. \u25aa Knowing your HIV status protects you, your partner, and your family. \u25aa Although HIV cannot be cured, early identification and treatment can allow a person to live a long, productive life and prevent his/her partner from becoming infected.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 268
  },
  {
    "id": "chunk_00269",
    "text": "nd prevent his/her partner from becoming infected. \u25aa Male circumcision reduces the risk of heterosexually acquired HIV infection in men by approximately 60% and should be one element of a comprehensive HIV-prevention package.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 269
  },
  {
    "id": "chunk_00270",
    "text": "element of a comprehensive HIV-prevention package. \u25aa Maternal transmission of HIV to the child can be substantially reduced by identifying women living with HIV and providing treatment or prophylactic ARV medicines during pregnancy. 3. Ask whether the client has any questions.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 270
  },
  {
    "id": "chunk_00271",
    "text": "ancy. 3. Ask whether the client has any questions. 4. Explain to the client that dual protection is the simultaneous prevention of STIs and preg- nancy. 5. Using the counseling card, review dual protection strategies with the client:",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 271
  },
  {
    "id": "chunk_00272",
    "text": "review dual protection strategies with the client: \u25aa Dual protection is the use of condoms consistently and correctly in combination with another family planning method. This provides added protection against pregnancy in case of condom failure.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 272
  },
  {
    "id": "chunk_00273",
    "text": "ction against pregnancy in case of condom failure. \u25aa Use a male or female condom correctly and consistently with every act of sex. This one method protects against STIs and pregnancy. \u25aa Engage only in safer sexual intimacy that prevents semen and vaginal fluids from coming",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 273
  },
  {
    "id": "chunk_00274",
    "text": "that prevents semen and vaginal fluids from coming in contact with each other\u2019s genitals or other vulnerable areas, such as the mouth and anus. \u25aa Delay or avoid sexual activity, especially with a partner whose STI/HIV status is not known. 6. Ask whether the client has any questions.",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 274
  },
  {
    "id": "chunk_00275",
    "text": "nown. 6. Ask whether the client has any questions. 7. Offer condoms. Ask whether the client knows how to use a condom. 8. Demonstrate use of the condom, if required. Ask the client to do a repeat demonstration. 9. Provide information about where the client can obtain condoms. | 20 |",
    "page_number": 25,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 275
  },
  {
    "id": "chunk_00276",
    "text": "STEP 16. CONDUCT STI AND HIV RISK ASSESSMENT USING THE COUNSELING CARD. IF SYMPTOMS ARE IDENTIFIED, TREAT HER/HIM SYNDROMICALLY. 1. Ask whether the client knows what puts her/his at risk for STIs/HIV. 2. Correct misinformation, fill in gaps, and answer any questions.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 276
  },
  {
    "id": "chunk_00277",
    "text": "formation, fill in gaps, and answer any questions. 3. Using the counseling card, discuss the following risk assessment factors with the client: \u25aa HIV status and HIV status of partner(s). If partner is positive, whether s/he is taking ARV medicines.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 277
  },
  {
    "id": "chunk_00278",
    "text": "is positive, whether s/he is taking ARV medicines. \u25aa Number of sexual partners, both current and in the past. \u25aa Knowledge of partner\u2019s sexual practices and past partners. \u25aa Knowledge of male partner\u2019s circumcision status.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 278
  },
  {
    "id": "chunk_00279",
    "text": "\u25aa Knowledge of male partner\u2019s circumcision status. \u25aa Past and present condom use (including perception of partner\u2019s attitude) and whether s/ he is aware that condoms protect against both STIs/HIV and pregnancy. \u25aa Type of sex or sexual activities and behaviors (for example, mutual monogamy, whether",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 279
  },
  {
    "id": "chunk_00280",
    "text": "d behaviors (for example, mutual monogamy, whether partner has other sexual partners, oral sex, anal sex, dry sex, or use of detergents and/or spermicides). \u25aa Home-life situation (for example, partner violence and social support). \u25aa Use of PMTCT services during pregnancy, delivery, and breastfeeding.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 280
  },
  {
    "id": "chunk_00281",
    "text": "ces during pregnancy, delivery, and breastfeeding. 4. If the client has STI symptoms, either treat her/him syndromically per national guidelines or refer her/him for tests, if available. 5. Help client make a plan to reduce risk. Strategies may include: \u25aa Reducing the number of sexual partners.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 281
  },
  {
    "id": "chunk_00282",
    "text": "include: \u25aa Reducing the number of sexual partners. \u25aa Using condoms (male or female) correctly and consistently with every act of sex. Con- doms are the only method that protects against STIs, including HIV. \u25aa Making condoms available to her/his partner and encourage their use correctly and",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 282
  },
  {
    "id": "chunk_00283",
    "text": "/his partner and encourage their use correctly and consistently. \u25aa Avoiding the use of unclean skin-cutting instruments and/or injection needles. \u25aa Having any STI or cervical infection detected and treated immediately. \u25aa Undergoing any procedures involving the genital tract in an aseptic environment.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 283
  },
  {
    "id": "chunk_00284",
    "text": "lving the genital tract in an aseptic environment. \u25aa Practicing dual protection. \u25aa Knowing your HIV status. STEP 17. ASK CLIENT WHETHER SHE/HE KNOWS HER/HIS HIV STATUS. 1. Ask client whether s/he knows her/his HIV status. 2. Gently inquire whether the client is willing to tell you her/his status",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 284
  },
  {
    "id": "chunk_00285",
    "text": "r the client is willing to tell you her/his status 3. Inform the client that you will not share her/his status without consent. If the client has... Do this... 1. Review Positive Health, Dignity, & Prevention counseling card with client.",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 285
  },
  {
    "id": "chunk_00286",
    "text": "Dignity, & Prevention counseling card with client. Knows HIV status and is 2. Ask when the client last attended a health facility for her/his monitoring living with HIV visit. 3. Refer client to center for wellness care and treatment, if necessary. Knows HIV status and is",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 286
  },
  {
    "id": "chunk_00287",
    "text": "d treatment, if necessary. Knows HIV status and is 1. Discuss time frame for repeat testing. negative 1. Discuss HIV Counseling and Testing (HCT) with client, using counseling card. 2. Offer or initiate HIV testing, according to national protocols. Does not know her/his",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 287
  },
  {
    "id": "chunk_00288",
    "text": "rding to national protocols. Does not know her/his 3. Counsel client on the test results. status 4. If client is living with HIV, review Positive Health, Dignity & Prevention coun- seling card and refer client to center for wellness care and treatment. | 21 |",
    "page_number": 26,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 288
  },
  {
    "id": "chunk_00289",
    "text": "If client knows her/his HIV status and is living with HIV: 1. Review the following points from the Positive Health, Dignity, & Prevention card with client: \u25aa People living with HIV should always use a condom correctly and consistently with their sexual partners.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 289
  },
  {
    "id": "chunk_00290",
    "text": "ectly and consistently with their sexual partners. \u25aa If a woman with HIV wants to get pregnant, the risk of her passing HIV to her newborn may be greatly reduced by taking antiretroviral (ARV) medicines and having a safe deliv-",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 290
  },
  {
    "id": "chunk_00291",
    "text": "etroviral (ARV) medicines and having a safe deliv- ery. It is important to receive care at an antenatal care clinic and an HIV treatment center. \u25aa People living with HIV need regular health checkups to see if they need ARV medicine,",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 291
  },
  {
    "id": "chunk_00292",
    "text": "health checkups to see if they need ARV medicine, to evaluate how they are doing on ARV medicines, and to rule out other infections or illnesses. \u25aa If client is taking ARV medicine, s/he should attend follow-up clinic visits as recom-",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 292
  },
  {
    "id": "chunk_00293",
    "text": "he should attend follow-up clinic visits as recom- mended by the provider. Visits may be more frequent when ARV medicines are initiated. \u25aa The client should do her/his best to adhere to the medication regimen prescribed and should not share medications.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 293
  },
  {
    "id": "chunk_00294",
    "text": "gimen prescribed and should not share medications. \u25aa Partners should get tested as well. The client can bring her/his partner in for counseling, to talk together, if this will help. \u25aa If currently taking medications for tuberculosis, s/he should follow up with provider.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 294
  },
  {
    "id": "chunk_00295",
    "text": "tuberculosis, s/he should follow up with provider. \u25aa Positive health results from taking care of oneself and being alert to health concerns that warrant attention, which may include physical and mental health issues as well as social support.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 295
  },
  {
    "id": "chunk_00296",
    "text": "nd mental health issues as well as social support. 2. Provide support and counseling to client on issues around disclosure of HIV status. Encour- age client to disclose her/his status to help them: \u25aa Get support from client\u2019s spouse, family, and health center.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 296
  },
  {
    "id": "chunk_00297",
    "text": "t from client\u2019s spouse, family, and health center. \u25aa Better plan and make appropriate decisions about HIV care and support and family matters. \u25aa Get early access to medicine and support that keeps client healthy. \u25aa Save an HIV-negative partner\u2019s and unborn child\u2019s life by not infecting them.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 297
  },
  {
    "id": "chunk_00298",
    "text": "r\u2019s and unborn child\u2019s life by not infecting them. \u25aa Better negotiate condom use with client partner to prevent them her/his being infected. \u25aa Avoid exposure to repeated infections that will compromise client\u2019s health.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 298
  },
  {
    "id": "chunk_00299",
    "text": "d infections that will compromise client\u2019s health. 3. Ask when the client last attended a health facility for her/his monitoring visit. Encourage client to follow all health and wellness recommendations. 4. Refer client to center for wellness care and treatment.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 299
  },
  {
    "id": "chunk_00300",
    "text": "client to center for wellness care and treatment. If client know her/his HIV status and is negative: 1. Discuss time frame for HIV retesting. Consider client\u2019s and risk assessment and sexual be- haviors to decide the most appropriate frequency for HIV testing.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 300
  },
  {
    "id": "chunk_00301",
    "text": "de the most appropriate frequency for HIV testing. 2. Refer to national guidelines and protocol to determine the appropriate time frame and rec- ommendations for HIV retesting. 3. Emphasize to the client that prevention, early detection, and prompt management of STIs,",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 301
  },
  {
    "id": "chunk_00302",
    "text": "n, early detection, and prompt management of STIs, including HIV, are beneficial to her/him, their partner and family, and the community at large. If client does not know her/his HIV status: 1. Using the HIV Counseling and Testing card, discuss the following points with the client:",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 302
  },
  {
    "id": "chunk_00303",
    "text": "ard, discuss the following points with the client: \u25aa Knowing your HIV status can help you make decisions about protecting yourself and your sexual partner(s). \u25aa Testing permits people living with HIV to seek treatment so that they can live a full life.",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 303
  },
  {
    "id": "chunk_00304",
    "text": "seek treatment so that they can live a full life. The test involves taking a small sample of blood. The test is free and available at clinics, hospitals, and HIV counseling and testing sites. \u25aa Test results are kept confidential. | 22 |",
    "page_number": 27,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 304
  },
  {
    "id": "chunk_00305",
    "text": "\u25aa When a person is first infected with HIV, it can take 3 or more months for the test to de- tect the infection. This is called the \u201cwindow period\u201d and is the reason why repeat testing is important. \u25aa A positive test result means the person is infected with HIV and can transmit the virus to others.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 305
  },
  {
    "id": "chunk_00306",
    "text": "ted with HIV and can transmit the virus to others. \u25aa A negative test result can mean the person is not infected or that s/he is in the \u201cwindow period\u201d. Another test should be taken within 3 months. If the second test is still negative,",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 306
  },
  {
    "id": "chunk_00307",
    "text": "in 3 months. If the second test is still negative, the person is currently not living with HIV but can still become infected with HIV. \u25aa HIV is a sexually transmitted infection (STI). It is important to ask your sexual partner(s) to be tested too.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 307
  },
  {
    "id": "chunk_00308",
    "text": "nt to ask your sexual partner(s) to be tested too. 2. Emphasize to the client that prevention, early detection, and prompt management of STIs, including HIV, are beneficial other/him, their partner and family, and the community at large.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 308
  },
  {
    "id": "chunk_00309",
    "text": "ir partner and family, and the community at large. 3. Offer or initiate HIV testing, according to national protocols. If testing is not available, refer client to specialized HTC services. 4. Counsel client on results of HIV test.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 309
  },
  {
    "id": "chunk_00310",
    "text": "ervices. 4. Counsel client on results of HIV test. \u25aa If test is positive, review Positive Health, Dignity, & Prevention counseling card and refer client to center for wellness care and treatment. Counsel client using Women\u2019s Support and Safety Card",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 310
  },
  {
    "id": "chunk_00311",
    "text": "unsel client using Women\u2019s Support and Safety Card 1. If client shows any major Intimate Partner Violence (IPV) triggers, refer her for specialized services. STEP 18. GIVE FOLLOW-UP INSTRUCTIONS, A CONDOM BROCHURE, AND THE BROCHURE FOR THE METHOD CHOSEN. SET A DATE FOR NEXT VISIT.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 311
  },
  {
    "id": "chunk_00312",
    "text": "FOR THE METHOD CHOSEN. SET A DATE FOR NEXT VISIT. 1. Summarize key points discussed about the contraceptive method chosen and about STI/ HIV and other services. Ask the client whether s/he has questions. Answer all questions before proceeding.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 312
  },
  {
    "id": "chunk_00313",
    "text": "questions. Answer all questions before proceeding. 2. Provide the client with follow-up instructions for the method chosen and the corresponding method brochure (if the client does not yet have one). NOTE In 2007, WHO and UNAIDS issued guidance on provider-initiated HIV testing and counseling (PITC)",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 313
  },
  {
    "id": "chunk_00314",
    "text": "ovider-initiated HIV testing and counseling (PITC) in health facilities to support increased uptake and improve access to HIV prevention, treatment and care. In order to increase uptake and improve access to HIV prevention, HIV counseling and",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 314
  },
  {
    "id": "chunk_00315",
    "text": "prove access to HIV prevention, HIV counseling and testing (HTC) should be expanded in antenatal care, STI and TB clinics, and other clinical settings as well as through outreach for most at risk populations. 3. Give the client a brochure on condoms. Reiterate the fact that only condoms provide dual",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 315
  },
  {
    "id": "chunk_00316",
    "text": "Reiterate the fact that only condoms provide dual protection against both STIs, including HIV, and pregnancy. 4. Make sure the client has his/her method or back-up method/referral, as needed. 5. Reiterate the importance of seeking other recommended services and provide a proper",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 316
  },
  {
    "id": "chunk_00317",
    "text": "ng other recommended services and provide a proper referral to the client. 6. Fix a date for the next visit with the client. The purpose of the appointment may be to: \u25aa Check on how the client is using the method. \u25aa Provide a new supply of the method.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 317
  },
  {
    "id": "chunk_00318",
    "text": "the method. \u25aa Provide a new supply of the method. \u25aa Provide information and support needed for the client to continue using the method correctly and consistently, or to select another method. \u25aa Bring the partner for further counseling on family planning and/or STI/HIV. \u25aa Have an HIV test.",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 318
  },
  {
    "id": "chunk_00319",
    "text": "amily planning and/or STI/HIV. \u25aa Have an HIV test. 7. Encourage the client to return to the facility any time s/he has a question or wishes to change methods. 8. To the extent possible, anticipate the client\u2019s future need | 23 |",
    "page_number": 28,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 319
  },
  {
    "id": "chunk_00320",
    "text": "STEP 19. THANK HER/HIM FOR THE VISIT. COMPLETE THE COUNSELING SESSION. 1. As you end the session, remember to be warm and cordial. This attitude will encourage the client to feel welcome to return. REMEMBER",
    "page_number": 29,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 320
  },
  {
    "id": "chunk_00321",
    "text": "age the client to feel welcome to return. REMEMBER A client has the right to change her/his reproductive goals and to stop using a family planning method if s/he wishes or when s/he wants to have a child. EXAMPLE",
    "page_number": 29,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 321
  },
  {
    "id": "chunk_00322",
    "text": "wishes or when s/he wants to have a child. EXAMPLE Explain to a client using the Pill that, if it is more convenient for her, she can get her supplies at a local pharmacy. Remind her that the pharmacy may have the 21-pill pack instead of the 28-pill",
    "page_number": 29,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 322
  },
  {
    "id": "chunk_00323",
    "text": "y may have the 21-pill pack instead of the 28-pill pack. In this case, she will need to follow the instructions for use in the pill pack\u2019s brochure or package insert. | 24 |",
    "page_number": 29,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 323
  },
  {
    "id": "chunk_00324",
    "text": "Guidelines for Adapting the BCS+ Job Aids The BCS+ job aids are generic and can be revised based on a region\u2019s or country\u2019s needs and norms. Below are guidelines for adapting the job aids. 1. Conduct a technical review of family planning and HCT norms and practices in your region",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 324
  },
  {
    "id": "chunk_00325",
    "text": "lanning and HCT norms and practices in your region or country. Below are some examples of the kinds of review that will help to give you appro- priate information needed to adapt the BCS+ and BCS+ job aids to your needs.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 325
  },
  {
    "id": "chunk_00326",
    "text": "to adapt the BCS+ and BCS+ job aids to your needs. a. Convene a meeting with representatives from the Ministry of Health and other experts on family planning and HCT to review the BCS+. Determine whether it needs to be",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 326
  },
  {
    "id": "chunk_00327",
    "text": "review the BCS+. Determine whether it needs to be adapted to include your country\u2019s norms and policies on family planning, integrated health services, and HCT. b. Ask service providers with experience in counseling clients on family planning and HIV CT to review the BCS+ job aids for content.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 327
  },
  {
    "id": "chunk_00328",
    "text": "nd HIV CT to review the BCS+ job aids for content. c. If the job aids will accompany training, work with the trainers to define the desired com- petencies (skills) from the training to be incorporated into the job aid.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 328
  },
  {
    "id": "chunk_00329",
    "text": "the training to be incorporated into the job aid. 2. Decide whether there are regional or local issues that you would like to incorporate into the BCS+ strategy (e.g., accessibility of certain methods, vulnerability to HIV and STIs through",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 329
  },
  {
    "id": "chunk_00330",
    "text": "ain methods, vulnerability to HIV and STIs through early marriage, female genital mutilation/cutting, or practice of dry sex). 3. Based on the technical review and local norms of the country, revise the steps in the BCS+,",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 330
  },
  {
    "id": "chunk_00331",
    "text": "orms of the country, revise the steps in the BCS+, as needed. If the BCS+ is revised, be sure to gather information to adjust the algorithm, counseling cards, and brochures accordingly. 4. Revise the BCS+ job aids based on the technical review. Below are simple guidelines for adapting the job aids:",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 331
  },
  {
    "id": "chunk_00332",
    "text": "w are simple guidelines for adapting the job aids: a. Adhere to the existing format of the BCS+ job aids as much as possible. They are written using a very specific methodology that has been field-tested and proven to help providers effectively act on the instructions.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 332
  },
  {
    "id": "chunk_00333",
    "text": "elp providers effectively act on the instructions. b. If adding/revising steps to the algorithm, write the steps using action verbs. For example, \u2013 Ask the client whether she has had her monthly bleeding. \u2013 Remind the client to take the pill every day at the same time.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 333
  },
  {
    "id": "chunk_00334",
    "text": "lient to take the pill every day at the same time. c. Include any sub-steps needed to perform the step. Do not assume that the provider knows how to perform the desired step or task. Begin each sub-step with an action. EXAMPLE Step: Remind a client what to do if she misses taking the pill once.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 334
  },
  {
    "id": "chunk_00335",
    "text": "ent what to do if she misses taking the pill once. Sub-steps: \u25aa Take a pill as soon as possible. \u25aa Continue taking pills as usual. (You may end up taking 2 pills at the same time or on the same day.) d. If a service provider needs to make a decision as part of a step, make a decision table. A",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 335
  },
  {
    "id": "chunk_00336",
    "text": "cision as part of a step, make a decision table. A decision table has two columns. The first column (the \u201cIf\u201d column) describes when to take action. The second column (the \u201cThen\u201d column) is used to describe what action to",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 336
  },
  {
    "id": "chunk_00337",
    "text": "\u201cThen\u201d column) is used to describe what action to take. When writing the actions, use the cookbook instruction format of Step 1, Step 2, Step 3, etc. Begin all action steps with action verbs. For example: If the client is... Do this...",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 337
  },
  {
    "id": "chunk_00338",
    "text": "verbs. For example: If the client is... Do this... 1. Set aside the Combined Oral Contraceptives (the Pill) card and explain that Breastfeeding an infant the hormones in the pills affect breastfeeding. less than 6 months old 2. Discuss the option of the minipill.",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 338
  },
  {
    "id": "chunk_00339",
    "text": "months old 2. Discuss the option of the minipill. Not breastfeeding an 1. Set aside the LAM card. infant 2. Explain that LAM is not appropriate for women who are not breastfeeding. | 25 |",
    "page_number": 30,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 339
  },
  {
    "id": "chunk_00340",
    "text": "e. If steps and sub-steps are sequential, number them. If the order of the steps is not im- portant, use bullets instead of numbers. TIP Place information that is important, but not an actual step or sub-step, in a box. 5. Pretest (validate) the revised BCS+ job aids.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 340
  },
  {
    "id": "chunk_00341",
    "text": ". 5. Pretest (validate) the revised BCS+ job aids. a. Ask service providers experienced in family planning and HCT to use the revised job aids as they counsel several family planning clients. b. Observe whether they follow the instructions in the job aids.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 341
  },
  {
    "id": "chunk_00342",
    "text": "ther they follow the instructions in the job aids. c. Note any actions the provider does not take (and that were in the job aid). After the counseling session, ask the provider why s/he did not take the described action. Be sure to explore the following: \u2013 Whether s/he understood the step/task.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 342
  },
  {
    "id": "chunk_00343",
    "text": "ollowing: \u2013 Whether s/he understood the step/task. \u2013 Whether s/he disagrees with the step/sub-step and why. \u2013 Whether the instructions were clear or confusing. If they were confusing, inquire how they could be made clearer.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 343
  },
  {
    "id": "chunk_00344",
    "text": "confusing, inquire how they could be made clearer. d. Similarly, note any actions that the health worker added to the counseling session that are not in the job aids. e. Ask why s/he added any extra steps not in the job aid. It is possible that the service",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 344
  },
  {
    "id": "chunk_00345",
    "text": "ot in the job aid. It is possible that the service provider added a step for clarity. If so, please add the step to the job aid. The idea is to describe the desired behavior of the service provider so she/he can accurately use the revised BCS+.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 345
  },
  {
    "id": "chunk_00346",
    "text": "der so she/he can accurately use the revised BCS+. f. Revise any instructions based on pretests with several service providers. g. Add or delete any steps/tasks or steps/sub-steps to enable the provider to carry out the BCS+ most effectively.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 346
  },
  {
    "id": "chunk_00347",
    "text": "e provider to carry out the BCS+ most effectively. 6. Ask two to three less experienced service providers to use the revised BCS+ job aids and ob- serve whether they were able to perform the tasks based on the instructions in the job aids.",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 347
  },
  {
    "id": "chunk_00348",
    "text": "e tasks based on the instructions in the job aids. 7. Revise the job aids accordingly. Take into consideration any additional input service provid- ers give you on how to improve the instructions. 8. If needed, translate revised job aids into the local language. Be sure to have another person",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 348
  },
  {
    "id": "chunk_00349",
    "text": "the local language. Be sure to have another person reverse- translate them to make sure the meaning has not changed in the translation process. 9. Incorporate the use of the job aids into existing training, or develop a short course to show service providers how to use the job aids. IMPORTANT!",
    "page_number": 31,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 349
  },
  {
    "id": "chunk_00350",
    "text": "References Askew, Ian. 2007. \u201cAchieving synergies in prevention through linking sexual and reproductive Health and HIV services,\u201d in Donta, Balaiah et al. (eds.), Proceedings of the International Conference on Actions to Strengthen Linkages between Sexual and Reproductive Health and HIV/AIDS. Mumbai:",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 350
  },
  {
    "id": "chunk_00351",
    "text": "xual and Reproductive Health and HIV/AIDS. Mumbai: Indian Society for the Study of Reproduction and Fertility and World Health Organization. Central Bureau of Statistics (CBS) [Kenya], Ministry of Health (MOH) [Kenya], and ORC Macro. 2004.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 351
  },
  {
    "id": "chunk_00352",
    "text": "stry of Health (MOH) [Kenya], and ORC Macro. 2004. Kenya Demographic and Health Survey 2003. Calverton, Maryland: CBS, MOH, and ORC Macro. Engenderhealth and Planned Parenthood Association of South Africa. 2001. Curriculum entitled: Men",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 352
  },
  {
    "id": "chunk_00353",
    "text": "on of South Africa. 2001. Curriculum entitled: Men As Partners: A Program for Supplementing the Training of Life Skills Educators, 2nd Edition. New York: Engenderhealth and Planned Parenthood of South Africa. 2002.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 353
  },
  {
    "id": "chunk_00354",
    "text": "alth and Planned Parenthood of South Africa. 2002. Hatcher, R.A. et al. 2011. Contraceptive Technology. Twentieth Revised Edition. New York: Ardent Me- dia. Le\u00f3n, Federico R. 1999. \u201cPeru: Providers\u2019 compliance with quality of care norms,\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 354
  },
  {
    "id": "chunk_00355",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2001. \u201cLength of counseling sessions and the amount of relevant information exchanged: A study in Peruvian clinics,\u201d International Family Planning Perspectives 27(1):28-33, 46.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 355
  },
  {
    "id": "chunk_00356",
    "text": "onal Family Planning Perspectives 27(1):28-33, 46. Le\u00f3n, Federico R. et al. 2003a. \u201cEffects of IGSS\u2019s job aids-assisted balanced counseling algorithms on quality of care and client outcomes (Guatemala),\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 356
  },
  {
    "id": "chunk_00357",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2003b. \u201cEnhancing quality for clients: The Balanced Counseling Strategy,\u201d FRONTIERS Program Brief No. 3. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 357
  },
  {
    "id": "chunk_00358",
    "text": "m Brief No. 3. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2003c. \u201cTesting balanced counseling to improve provider-client interaction in Guatemala\u2019s MOH clinics,\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 358
  },
  {
    "id": "chunk_00359",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2004. \u201cOne-year client impacts of quality of care improvements achieved in Peru,\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 359
  },
  {
    "id": "chunk_00360",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico, Ricardo Vernon, Antonieta Martin, and Linda Bruce. 2008. The Balanced Counseling Strategy: A Toolkit for Family Planning Service Providers. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 360
  },
  {
    "id": "chunk_00361",
    "text": "ice Providers. Washington, DC: Population Council. Liambila, Wilson et al. 2008. \u201cFeasibility, effectiveness and cost of models of integrating counseling and testing for HIV within family planning services in Kenya,\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 361
  },
  {
    "id": "chunk_00362",
    "text": "Final Report. Washington, DC: Population Council. Mullick, Saiqa, Mantshi Menziwa, Doctor Khoza, and Edwin Maroga. 2008. \u201cFeasibility, effectiveness and cost of models of integrating counseling and testing for HIV within family planning services",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 362
  },
  {
    "id": "chunk_00363",
    "text": "nd testing for HIV within family planning services in North West Province, South Africa,\u201d FRONTIERS Final Report. Washington, DC: Population Council. Stanback, J. et al. 1999. \u201cChecklist for ruling out pregnancy among family-planning clients in primary care,\u201d Lancet 354(9178):566.",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 363
  },
  {
    "id": "chunk_00364",
    "text": "ng clients in primary care,\u201d Lancet 354(9178):566. World Health Organization. 2003. Guidelines for the Management of Sexually Transmitted Infections. Geneva: WHO. \u2013\u2013\u2013. 2004. Medical Eligibility Criteria for Contraceptive Use, 3rd ed. Geneva: WHO. | 27 |",
    "page_number": 32,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 364
  },
  {
    "id": "chunk_00365",
    "text": "\u2013\u2013\u2013 . 2005. Sexually Transmitted and Other Reproductive Tract Infections: A Guide to Essential Practice. Geneva: WHO. \u2013\u2013\u2013 . 2015. Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: WHO. \u2013\u2013\u2013 . 2010. WHO Technical Consultation on Postpartum and Postnatal Care. Geneva: WHO.",
    "page_number": 33,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 365
  },
  {
    "id": "chunk_00366",
    "text": "ion on Postpartum and Postnatal Care. Geneva: WHO. World Health Organization, Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (JHU/CCP)",
    "page_number": 33,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 366
  },
  {
    "id": "chunk_00367",
    "text": "Health/Center for Communication Programs (JHU/CCP) INFO Project. 2011. Family Planning: A Global Handbook for Providers. Baltimore and Geneva: JHU/CCP and WHO. World Health Organization and Joint United Nations Programme on HIV/AIDS (UNAIDS). Guidance",
    "page_number": 33,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 367
  },
  {
    "id": "chunk_00368",
    "text": "The Population Council confronts critical health and development issues\u2014from stopping the spread of HIV to improving reproductive health and ensuring that young people lead full and productive lives. Through biomedical, social science,",
    "page_number": 37,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 368
  },
  {
    "id": "chunk_00369",
    "text": "ductive lives. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programs, and technologies that improve lives around the world. Established in 1952 and headquartered in New",
    "page_number": 37,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 369
  },
  {
    "id": "chunk_00370",
    "text": "orld. Established in 1952 and headquartered in New York, the Council is a nongovernmental, nonprofit organization governed by an international board of trustees. For additional information please contact: Population Council 4301 Connecticut Ave., NW, Suite 280 Washington, DC 20008 USA",
    "page_number": 37,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 370
  },
  {
    "id": "chunk_00371",
    "text": "ticut Ave., NW, Suite 280 Washington, DC 20008 USA Telephone: (202) 237-9400 Facsimile: (202) 237-8410 E-mail: publications@popcouncil.org www.popcouncil.org",
    "page_number": 37,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 371
  },
  {
    "id": "chunk_00372",
    "text": "The Balanced Counseling Strategy Plus\nA Toolkit for Family Planning Service Providers\nWorking in High STI/HIV Prevalence Settings\nTRAINER\u2019S GUIDE\nThird Edition, 2015",
    "page_number": 38,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 372
  },
  {
    "id": "chunk_00373",
    "text": "\u00a9 2008, 2011, 2015 The Population Council, Inc. The Population Council confronts critical health and development issues\u2014from stopping the spread of HIV to improving reproductive health and ensuring that young people lead full and productive lives. Through biomedical, social science, and public",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 373
  },
  {
    "id": "chunk_00374",
    "text": "es. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programs, and",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 374
  },
  {
    "id": "chunk_00375",
    "text": "hat lead to more effective policies, programs, and technologies that improve lives around the world. Established in 1952 and headquartered in New York, the Council is a nongov- ernmental, nonprofit organization governed by an international board of trustees.",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 375
  },
  {
    "id": "chunk_00376",
    "text": "on governed by an international board of trustees. Any part of this publication may be photocopied without permission from the publisher provided that copies are distributed",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 376
  },
  {
    "id": "chunk_00377",
    "text": "the publisher provided that copies are distributed without charge and that full source citation is provided. The Population Council would appreciate receiving a copy of any materi- als in which the text is used.",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 377
  },
  {
    "id": "chunk_00378",
    "text": "copy of any materi- als in which the text is used. Suggested citation: Population Council. 2015. Balanced Counseling Strategy Plus Trainer\u2019s Guide Third Edition, part of The Balanced",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 378
  },
  {
    "id": "chunk_00379",
    "text": "rainer\u2019s Guide Third Edition, part of The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings, Third Edition, Washington, DC.",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 379
  },
  {
    "id": "chunk_00380",
    "text": "revalence Settings, Third Edition, Washington, DC. Note: This publication is part of a larger publication titled The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings. The Balanced Counseling Strategy Plus Toolkit",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 380
  },
  {
    "id": "chunk_00381",
    "text": "ngs. The Balanced Counseling Strategy Plus Toolkit includes the following: \u25aa Algorithm \u25aa Counseling cards \u25aa Method brochures \u25aa User\u2019s Guide \u25aa Trainer\u2019s Guide \u25aa WHO Medical Eligibility Criteria Wheel If any part is missing, please contact the Population Council at publications@popcouncil.org.",
    "page_number": 39,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 381
  },
  {
    "id": "chunk_00382",
    "text": "Preface to Third Edition The Balanced Counseling Strategy Plus (BCS+) toolkit, developed and tested in Kenya (2005 to 2007) and South Africa (2004 to 2006) because both countries have high rates of STIs, including HIV, and",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 382
  },
  {
    "id": "chunk_00383",
    "text": "ntries have high rates of STIs, including HIV, and their contraceptive prevalence rates are relatively high for the region. The BCS+ provides the infor- mation and materials that healthcare facility providers need so they can offer complete, high-quality",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 383
  },
  {
    "id": "chunk_00384",
    "text": "ders need so they can offer complete, high-quality family planning counseling to clients living in areas with high rates of HIV and STIs. The BCS+ was adapted from the Balanced Counseling Strategy (Le\u00f3n 1999; Le\u00f3n et al. 2003a, b, c; Le\u00f3n, Ver-",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 384
  },
  {
    "id": "chunk_00385",
    "text": "gy (Le\u00f3n 1999; Le\u00f3n et al. 2003a, b, c; Le\u00f3n, Ver- non, Martin, and Bruce 2008). First edition of the Balanced Counseling Strategy and Balanced Counseling Strategy Plus toolkits are products of the Population Council\u2019s FRONTIERS program, supported",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 385
  },
  {
    "id": "chunk_00386",
    "text": "Population Council\u2019s FRONTIERS program, supported by the United States Agency for International Development (USAID), Cooperative Agreement HRN-A-00-98-00012-00. The Second Edition was updated based on the 2010 WHO Medical Eligibility Criteria (MEC) as",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 386
  },
  {
    "id": "chunk_00387",
    "text": "the 2010 WHO Medical Eligibility Criteria (MEC) as well as recommendations from authors and partners who have experienced and evaluated imple- mentation of the tool in settings and scenarios around the world and validated through the Integra",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 387
  },
  {
    "id": "chunk_00388",
    "text": "around the world and validated through the Integra Initiative, supported by the Bill and Melinda Gates Foundation. It included additional counseling cards on cervical cancer screening, postpartum and infant health.",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 388
  },
  {
    "id": "chunk_00389",
    "text": "al cancer screening, postpartum and infant health. This Third Edition of the BCS+ includes content updated according to the latest WHO Medical Eligibility Criteria (2015). It incorporates the most up-to-date evidence on clinical indications for",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 389
  },
  {
    "id": "chunk_00390",
    "text": "st up-to-date evidence on clinical indications for the provision of family planning methods, including new methods (Caya\u00ae/SILCS diaphragm and Progesterone Vaginal Ring), and includes five new counseling cards that address Adolescent Coun-",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 390
  },
  {
    "id": "chunk_00391",
    "text": "new counseling cards that address Adolescent Coun- seling, Male Services, Post Abortion Care, and Women\u2019s Support and Safety. The updated cards include instructions for providers, guiding them through supplemental counseling and services that",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 391
  },
  {
    "id": "chunk_00392",
    "text": "through supplemental counseling and services that family planning clients may need. Development of this Third Edition of the BCS+ toolkit was funded by the Evidence Project, USAID Cooperative agreement AID-OAA-A-13-00087 and the",
    "page_number": 40,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 392
  },
  {
    "id": "chunk_00393",
    "text": "Acknowledgments Development of The Balanced Counseling Strategy Plus (BCS+) could not have been possible without the invaluable support of the service providers who tested the toolkit and the program directors who authorized and supervised its application. The authors wish to thank the Department of",
    "page_number": 41,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 393
  },
  {
    "id": "chunk_00394",
    "text": "ation. The authors wish to thank the Department of Health in South Africa and the Division of Reproductive Health and the National AIDS and STD Control Program of the Ministry of Health in Kenya. We would also like to thank the trainers at the",
    "page_number": 41,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 394
  },
  {
    "id": "chunk_00395",
    "text": "a. We would also like to thank the trainers at the Reproductive Health and HIV Research Unit (RHRU) of the University of Witwatersrand for their contribution to the study in South Africa. Development and production of the third edition of The Balanced Counseling Strategy Plus was sup-",
    "page_number": 41,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 395
  },
  {
    "id": "chunk_00396",
    "text": "of The Balanced Counseling Strategy Plus was sup- ported by the Population Council. Authors would like to acknowledge the following individuals for providing their technical expertise and invaluable contributions to this updated edition of the",
    "page_number": 41,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 396
  },
  {
    "id": "chunk_00397",
    "text": "uable contributions to this updated edition of the BCS+: Megan Christofield, Heather Clark, Mychelle Farmer, Kamlesh Giri, Joanne Gleason, Mark Hathaway, Anushka Kalyanpur, Maggie Kilbourne-Brook, Karen R. Kirk, Ricky Lu, Ruth Merkatz,",
    "page_number": 41,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 397
  },
  {
    "id": "chunk_00398",
    "text": "urne-Brook, Karen R. Kirk, Ricky Lu, Ruth Merkatz, Charity Ndigwa, Anne Pfitzer, Saumya RamaRao, Naomi Rijo, Elizabeth Rochette, Jill Schwartz, Leigh Stefanik, John Townsend, Chi-Chi Undie, Katie Unthank, Anneka Van Scoyoc, Charlotte Warren, Ellen Weiss, and Kelsey Wright. | iv |",
    "page_number": 41,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 398
  },
  {
    "id": "chunk_00399",
    "text": "Contents INTRODUCTION.............................................................................................................................2 Algorithm for Using the Balanced Counseling Strategy Plus .................................................7",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 399
  },
  {
    "id": "chunk_00400",
    "text": ".................................................7 TIPS FOR TRAINERS ....................................................................................................................9",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 400
  },
  {
    "id": "chunk_00401",
    "text": ".................................................9 Sample Agenda: BCS+ Training ..............................................................................................11 BCS+ TRAINING FOR FAMILY PLANNING PROVIDERS ............................................................12",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 401
  },
  {
    "id": "chunk_00402",
    "text": "................................................12 Introduction ................................................................................................................................12",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 402
  },
  {
    "id": "chunk_00403",
    "text": "................................................12 Pre-Choice Stage .......................................................................................................................20",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 403
  },
  {
    "id": "chunk_00404",
    "text": "................................................20 Method Choice Stage ................................................................................................................27",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 404
  },
  {
    "id": "chunk_00405",
    "text": "................................................27 Post-Choice Stage .....................................................................................................................30",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 405
  },
  {
    "id": "chunk_00406",
    "text": "................................................30 Systematic Screening for Other Services Stage ...................................................................33 Next Steps and Closing .............................................................................................................48",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 406
  },
  {
    "id": "chunk_00407",
    "text": "................................................48 APPENDIX ...................................................................................................................................49",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 407
  },
  {
    "id": "chunk_00408",
    "text": "................................................49 FOR ADDITIONAL REFERENCE .................................................................................................50",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 408
  },
  {
    "id": "chunk_00409",
    "text": "................................................50 REFERENCES .............................................................................................................................51 | v |",
    "page_number": 42,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 409
  },
  {
    "id": "chunk_00410",
    "text": "Introduction In the late 1990s, the Population Council\u2019s USAID-funded FRONTIERS in Reproductive Health Program (FRONTIERS) worked in collaboration with Ministries of Health in several Latin Amer- ican countries to develop and test a practical, interactive, and client-friendly strategy for improving",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 410
  },
  {
    "id": "chunk_00411",
    "text": "active, and client-friendly strategy for improving counseling within family planning consultations. This strategy is called the Balanced Counseling Strategy (BCS) (Le\u00f3n 1999; Le\u00f3n et al. 2004). The BCS uses key job aids for counseling clients about family",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 411
  },
  {
    "id": "chunk_00412",
    "text": "s key job aids for counseling clients about family planning: an algorithm to guide the provider through the counseling process, a set of counseling cards for contraceptive methods, and corresponding brochures for each method. The strategy,",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 412
  },
  {
    "id": "chunk_00413",
    "text": "esponding brochures for each method. The strategy, tested and refined in several countries, comprises a series of steps to determine the contraceptive method that best suits the client according to her/his preferences and needs. This strategy improves",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 413
  },
  {
    "id": "chunk_00414",
    "text": "/his preferences and needs. This strategy improves the quality of the provider\u2019s counseling and allows the client to take ownership of the decision. The BCS proved effective as a tool to assist family planning providers to improve the quality of care",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 414
  },
  {
    "id": "chunk_00415",
    "text": "planning providers to improve the quality of care (Le\u00f3n et al. 2003a, b, c). The approach is practical, low cost, and easy to adapt to local contexts. The Balanced Counseling Strategy: A Toolkit for Family Planning Service Providers was published to provide the",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 415
  },
  {
    "id": "chunk_00416",
    "text": "ing Service Providers was published to provide the information and tools needed for health care facility managers, supervisors, and service providers to implement the BCS in their family planning services (Le\u00f3n, Vernon, Martin, and Bruce 2008). WHY THE BALANCED COUNSELING STRATEGY PLUS?",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 416
  },
  {
    "id": "chunk_00417",
    "text": "2008). WHY THE BALANCED COUNSELING STRATEGY PLUS? In response to the need to incorporate counseling, screening, and services for sexually transmitted infections (STIs), including HIV, within routine family planning consultations in settings character-",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 417
  },
  {
    "id": "chunk_00418",
    "text": "mily planning consultations in settings character- ized by high prevalence of these infections, the BCS was revised to integrate STI/HIV prevention counseling, risk assessment, and HIV counseling and testing (HCT). The resulting Balanced Coun-",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 418
  },
  {
    "id": "chunk_00419",
    "text": "ng and testing (HCT). The resulting Balanced Coun- seling Strategy Plus (BCS+) toolkit improves the quality of the family planning service and enables providers to address clients\u2019 needs related to STIs and HIV during the same consultation.",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 419
  },
  {
    "id": "chunk_00420",
    "text": "ated to STIs and HIV during the same consultation. Integration of health services has been defined as offering a range of services that can meet several needs simultaneously, usually in the same venue and through the same provider. Referrals to, or link-",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 420
  },
  {
    "id": "chunk_00421",
    "text": "through the same provider. Referrals to, or link- ages with, related services enable a client to receive a range of needed services, even if the services are not received simultaneously (Askew 2007). In reproductive health, the push for integration or",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 421
  },
  {
    "id": "chunk_00422",
    "text": "n reproductive health, the push for integration or linkage is guided both by many clients having the need for several services simultaneously (and so missed opportunities can be reduced) and by the expectation that the component services can be",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 422
  },
  {
    "id": "chunk_00423",
    "text": "the expectation that the component services can be provided more efficiently when integrated or linked than when delivered individually. Despite many calls for greater attention to integrating such services in high STI/HIV settings, surprisingly little",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 423
  },
  {
    "id": "chunk_00424",
    "text": "ices in high STI/HIV settings, surprisingly little attention has been paid to the development and empirical testing of practical tools that providers can use to strengthen their capacity to offer integrated services.",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 424
  },
  {
    "id": "chunk_00425",
    "text": "gthen their capacity to offer integrated services. The FRONTIERS program developed and piloted the BCS+ in Kenya (2005 to 2007) and South Africa (2004 to 2006) because both countries have high rates of STIs, including HIV, and their con-",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 425
  },
  {
    "id": "chunk_00426",
    "text": "high rates of STIs, including HIV, and their con- traceptive prevalence rates are relatively high for the region. This situation provides opportunities to reach a substantial proportion of the sexually active population (albeit predominantly female) that is",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 426
  },
  {
    "id": "chunk_00427",
    "text": "e population (albeit predominantly female) that is seeking to prevent pregnancy and that also may be at risk of exposure to an STI/HIV. As in most countries, their family planning and STI/HIV programs are implemented separately, although both",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 427
  },
  {
    "id": "chunk_00428",
    "text": "programs are implemented separately, although both countries are actively seeking ways to integrate services. Thus, both Ministries of Health were keen to develop practical tools for increasing the quality of services and numbers of clients receiving integrated services.",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 428
  },
  {
    "id": "chunk_00429",
    "text": "numbers of clients receiving integrated services. The study findings are described more fully elsewhere (see Liambila et al. 2008; Mullick et al. 2008). Both studies showed that: \u25aa Integrating STI/HIV prevention counseling and risk assessment with offering HCT during",
    "page_number": 43,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 429
  },
  {
    "id": "chunk_00430",
    "text": "\u25aa The quality of care for both family planning and STI/HIV counseling improved significantly with the use of the BCS+ tools. \u25aa Counseling on HCT increased substantially. In Kenya, more than 40 percent of clients were",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 430
  },
  {
    "id": "chunk_00431",
    "text": "ly. In Kenya, more than 40 percent of clients were offered HCT services, with almost half of these deciding to be tested, either on site or through referral. In South Africa, those offered testing increased to 29 percent. Furthermore, an overall",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 431
  },
  {
    "id": "chunk_00432",
    "text": "g increased to 29 percent. Furthermore, an overall increase in testing was observed in the district with a doubling of individuals tested. \u25aa Use of the BCS+ tools facilitated greater risk assessment for STIs and HIV. Also, decisions",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 432
  },
  {
    "id": "chunk_00433",
    "text": "risk assessment for STIs and HIV. Also, decisions about contraceptive method choice were made with a better understanding of their relation- ship to infection prevention. \u25aa Despite the concern that adding these services may have a negative impact on the family",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 433
  },
  {
    "id": "chunk_00434",
    "text": "services may have a negative impact on the family planning service, improved quality of counseling and no evidence of a decline in utilization showed that this concern was unfounded. THE BALANCED COUNSELING STRATEGY PLUS",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 434
  },
  {
    "id": "chunk_00435",
    "text": "s unfounded. THE BALANCED COUNSELING STRATEGY PLUS The BCS+ is divided into four counseling stages. Each stage contains a sequence of steps to follow. The BCS+ assumes that the motive of a client\u2019s visit is family planning but serves to also offer the",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 435
  },
  {
    "id": "chunk_00436",
    "text": "it is family planning but serves to also offer the client additional counseling and services in the same facility or through referral. The BCS+ inte- grates postpartum counseling messages to ensure health of the mother and the infant; an opportu-",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 436
  },
  {
    "id": "chunk_00437",
    "text": "e health of the mother and the infant; an opportu- nity to discuss healthy timing and spacing of pregnancies; counseling on STI/HIV transmission and prevention; screening for reproductive cancers; violence prevention; post-abortion care; and male",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 437
  },
  {
    "id": "chunk_00438",
    "text": "violence prevention; post-abortion care; and male and adolescent services. Information on the cards instructs providers through conducting an STI/ HIV risk assessment, discussing dual protection and positive health, and discussing and offering",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 438
  },
  {
    "id": "chunk_00439",
    "text": "n and positive health, and discussing and offering the client HIV counseling and testing. The BCS+ process can be summarized as a decision-making algorithm, which is described on the next three pages. Below is a summary of the four counseling stages:",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 439
  },
  {
    "id": "chunk_00440",
    "text": "Below is a summary of the four counseling stages: 1. Pre-Choice Stage: During this stage, the provider creates the conditions that help a cli- ent select a family planning method. The provider cordially greets the client. The provider",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 440
  },
  {
    "id": "chunk_00441",
    "text": "provider cordially greets the client. The provider emphasizes to the client that, during the consultation, other reproductive health issues will be addressed depending on her/his individual circumstance. The provider reviews the client\u2019s",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 441
  },
  {
    "id": "chunk_00442",
    "text": "al circumstance. The provider reviews the client\u2019s fertility intentions and counsels her/him on healthy timing and spacing of pregnancy. Preg- nancy is ruled out using the counseling card with the checklist of questions. If the client is",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 442
  },
  {
    "id": "chunk_00443",
    "text": "with the checklist of questions. If the client is not pregnant, the provider displays all the method cards and asks questions described in the algorithm. As the client responds to each question, the provider sets aside the cards of the",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 443
  },
  {
    "id": "chunk_00444",
    "text": "question, the provider sets aside the cards of the methods that are not appropriate for the client. Setting aside these cards helps to avoid giving information on methods that are not relevant to the client\u2019s needs.",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 444
  },
  {
    "id": "chunk_00445",
    "text": "thods that are not relevant to the client\u2019s needs. If pregnancy cannot be ruled out, the provider skips to steps 13 to 19 to discuss other relevant services the client may need. The client is given a back-up method, such as con- doms, and asked to return when she has her menstruation.",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 445
  },
  {
    "id": "chunk_00446",
    "text": "and asked to return when she has her menstruation. 2. Method Choice Stage: During this stage, the provider offers more extensive information about the methods that have not been set aside, including their effectiveness. This helps the",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 446
  },
  {
    "id": "chunk_00447",
    "text": "ide, including their effectiveness. This helps the client select a method suited to her/his reproductive needs. Following the steps in the BCS+ algorithm, the provider continues to narrow down the number of counseling method cards until a method is chosen.",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 447
  },
  {
    "id": "chunk_00448",
    "text": "counseling method cards until a method is chosen. 3. Post-Choice Stage: During this stage, the provider uses the method brochure to give the client complete information about the method that s/he has chosen. If the client has",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 448
  },
  {
    "id": "chunk_00449",
    "text": "the method that s/he has chosen. If the client has conditions where the method is not advised or is not satisfied with the method, the provider returns to the Method Choice Stage to help the client select another method. The provider",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 449
  },
  {
    "id": "chunk_00450",
    "text": "elp the client select another method. The provider also encourages the client to involve her/his partner(s) in decisions about contraception, either through discussion or visit to the clinic. 4. Systematic Screening for Other Services Stage: During this stage, the provider uses in-",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 450
  },
  {
    "id": "chunk_00451",
    "text": "es Stage: During this stage, the provider uses in- formation collected previously and targeted questions to determine additional health services and counseling that the family planning client may need. Using the remaining counseling | 3 |",
    "page_number": 44,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 451
  },
  {
    "id": "chunk_00452",
    "text": "cards, the provider may review important information for a postpartum mother or infant; may refer him/her to well-child services; discuss and offer cervical screening tests; discuss breast cancer; offer adolescent or male service counseling; discuss women\u2019s support and safe-",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 452
  },
  {
    "id": "chunk_00453",
    "text": "vice counseling; discuss women\u2019s support and safe- ty; offer post-abortion care as appropriate; discuss STI/HIV transmission and prevention; conduct a risk assessment; discuss dual protection and positive health; and offer the client",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 453
  },
  {
    "id": "chunk_00454",
    "text": "otection and positive health; and offer the client HIV counseling and testing. The provider offers HIV testing to the client, following national protocols, and encourages the client to disclose her/his STI/HIV status to her/his part-",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 454
  },
  {
    "id": "chunk_00455",
    "text": "o disclose her/his STI/HIV status to her/his part- ner(s), letting the client know both the benefits and risks of disclosure. Upon completion of the counseling session, the provider gives follow-up instructions on the chosen contraceptive",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 455
  },
  {
    "id": "chunk_00456",
    "text": "follow-up instructions on the chosen contraceptive method, the method brochure, and a condom brochure. The provider and client also fix a date for a follow-up visit. WHAT IS INCLUDED IN THIS TOOLKIT? The BCS+ job aids and guides are intended for reproductive health programs interested in both",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 456
  },
  {
    "id": "chunk_00457",
    "text": "or reproductive health programs interested in both strengthening the quality of family planning counseling and responding to the additional service and counseling needs of clients. In addition to adding further guidance on other integrated services,",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 457
  },
  {
    "id": "chunk_00458",
    "text": "ing further guidance on other integrated services, the second edition incorporated an additional job aid, the World Health Organization\u2019s Medical Eligibility Criteria Wheel, to complement existing provider tools and facilitate comprehensive family",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 458
  },
  {
    "id": "chunk_00459",
    "text": "provider tools and facilitate comprehensive family planning service provision. Below is a list of the toolkit components: 5. BCS+ User\u2019s Guide on how to implement the BCS+. It explains how to use the job aids and can be distributed during training on the BCS+ or used for self-teaching with the BCS+",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 459
  },
  {
    "id": "chunk_00460",
    "text": "n the BCS+ or used for self-teaching with the BCS+ job aids. 6. BCS+ job aids, including: \u25aa The BCS+ algorithm that summarizes the 19 steps recommended to implement the BCS+ during a family planning consultation. These steps are organized under four stages",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 460
  },
  {
    "id": "chunk_00461",
    "text": "ation. These steps are organized under four stages of the consultation: pre-choice needs assessment; method choice; post-choice actions; and systematic screening for other services. During each stage of the consultation, the",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 461
  },
  {
    "id": "chunk_00462",
    "text": "rvices. During each stage of the consultation, the provider is given step-by-step guidance on how to use the BCS+ job aids. Depending on the client\u2019s response to the issues discussed, the algorithm outlines which actions to take.",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 462
  },
  {
    "id": "chunk_00463",
    "text": "sed, the algorithm outlines which actions to take. The BCS+ algorithm can be found on pages 7 to 8 as well as separately with the other job aids in the toolkit. \u25aa Counseling cards that the provider uses during a counseling session. There are 33",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 463
  },
  {
    "id": "chunk_00464",
    "text": "der uses during a counseling session. There are 33 counseling cards. The first card contains 6 questions that the service provider asks to rule out whether a client is pregnant (adopted from those developed by Stanback et al. 1999).",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 464
  },
  {
    "id": "chunk_00465",
    "text": "ted from those developed by Stanback et al. 1999). There are 18 method-specific cards that contain information about each family planning method. Each method card has an illustration of the contraceptive method on the front",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 465
  },
  {
    "id": "chunk_00466",
    "text": "ustration of the contraceptive method on the front side. The back of the card contains a list of key features of the method and describes the method\u2019s use, indications, risk factors, and level of effectiveness. These cards are used to",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 466
  },
  {
    "id": "chunk_00467",
    "text": "nd level of effectiveness. These cards are used to first exclude those methods that are inappropriate for the client\u2019s reproductive intentions and then to narrow the choice to reach a final decision. Fourteen (14) counseling cards",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 467
  },
  {
    "id": "chunk_00468",
    "text": "h a final decision. Fourteen (14) counseling cards provide information on additional counseling and services that a family planning client may need. These are: healthy timing and spacing of pregnancies; promoting healthy post-",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 468
  },
  {
    "id": "chunk_00469",
    "text": "nd spacing of pregnancies; promoting healthy post- partum period for the mother; post abortion care; promoting newborn and infant health; STI/HIV transmission and prevention; STI/HIV risk assessment; positive health, dignity",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 469
  },
  {
    "id": "chunk_00470",
    "text": "STI/HIV risk assessment; positive health, dignity and prevention; dual protection; HIV counseling and testing; screening for cervical can- cer; adolescent counseling; women\u2019s support and safety; male services; and breast cancer",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 470
  },
  {
    "id": "chunk_00471",
    "text": "pport and safety; male services; and breast cancer information and awareness. These cards are used during the fourth stage of the consulta- tion\u2014systematic screening for other services. \u25aa Method brochures on each of the 18 contraceptive methods. They are designed to",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 471
  },
  {
    "id": "chunk_00472",
    "text": "the 18 contraceptive methods. They are designed to help the client better understand the method chosen. The provider gives the client the brochure for the selected method and a brochure with information on condoms to take",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 472
  },
  {
    "id": "chunk_00473",
    "text": "and a brochure with information on condoms to take home. Providers should encourage low-literate or illiterate clients to take the brochure home so that their partner or other trusted friend can review the brochure with them again. | 4 |",
    "page_number": 45,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 473
  },
  {
    "id": "chunk_00474",
    "text": "\u25aa WHO Medical Eligibility Criteria (MEC) Wheel (2015) which is a provider job aid based on the four eligibility categories for contraceptive use in relation to medical condi- tions described in the document Medical Eligibility Criteria for Contraceptive Use, Fifth edition,",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 474
  },
  {
    "id": "chunk_00475",
    "text": "ity Criteria for Contraceptive Use, Fifth edition, published by Department of Reproductive Health, World Health Organization. This tool guides providers through medical conditions and medications that may be contraindi-",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 475
  },
  {
    "id": "chunk_00476",
    "text": "conditions and medications that may be contraindi- cations to use of particular contraceptive methods. The job aid has been field-tested in three countries by WHO, and is found to be very useful to providers who used it.",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 476
  },
  {
    "id": "chunk_00477",
    "text": "found to be very useful to providers who used it. 7. BCS+ Trainer\u2019s Guide that supervisors and others can use to train providers on how to use the BCS+. The guide includes exercises and activities to increase participants\u2019 comprehen- sion and proper utilization of the BCS+ toolkit.",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 477
  },
  {
    "id": "chunk_00478",
    "text": "- sion and proper utilization of the BCS+ toolkit. The BCS+ job aids, BCS+ Trainer\u2019s Guide, and BCS+ User\u2019s Guide incorporate the latest international family planning and STI/HIV norms and guidance as recommended by the World Health Organiza-",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 478
  },
  {
    "id": "chunk_00479",
    "text": "dance as recommended by the World Health Organiza- tion (WHO), including Medical Eligibility Criteria for Contraceptive Use (WHO 2015), Family Planning: A Global Handbook for Providers (WHO/RHR and JHU/CCP, INFO Project 2011 update), Contraceptive",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 479
  },
  {
    "id": "chunk_00480",
    "text": "JHU/CCP, INFO Project 2011 update), Contraceptive Technology (Hatcher et al. 2011), Sexually Transmitted and Other Reproductive Tract Infections: A Guide to Essential Practice (WHO 2005), and Guidelines for the Management of Sexually Transmitted Infections (WHO 2003).",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 480
  },
  {
    "id": "chunk_00481",
    "text": "ent of Sexually Transmitted Infections (WHO 2003). These job aids can be revised depending on national and/or regional guidelines and protocols. Elec- tronic copies of the BCS+ materials are available so that the job aids and instructional guides can be easily printed or adapted to meet local needs.",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 481
  },
  {
    "id": "chunk_00482",
    "text": "be easily printed or adapted to meet local needs. HOW SHOULD THIS TOOLKIT BE USED? 1. Read this entire BCS+ User\u2019s Guide on how to implement the Balanced Counseling Strategy Plus. 2. Refer to the BCS+ algorithm as a reminder of the 19 steps used to implement the BCS+. It",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 482
  },
  {
    "id": "chunk_00483",
    "text": "der of the 19 steps used to implement the BCS+. It is helpful to have a copy available on the provider\u2019s desk or on a wall in the consultation area so that the provider can refer to it easily. 3. Use the BCS+ counseling cards and WHO MEC Wheel to help a client choose a method",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 483
  },
  {
    "id": "chunk_00484",
    "text": "and WHO MEC Wheel to help a client choose a method based on her/his reproductive intentions. Use the first counseling card to rule out whether the client is pregnant. If she is not, use the method cards to help the client choose a contra-",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 484
  },
  {
    "id": "chunk_00485",
    "text": "e method cards to help the client choose a contra- ceptive method best suited to her/his reproductive health intentions by discarding those that are inappropriate. Emphasize dual protection throughout the counseling.",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 485
  },
  {
    "id": "chunk_00486",
    "text": "phasize dual protection throughout the counseling. 4. Once the client has chosen a contraceptive method, use the corresponding BCS+ method brochure to discuss contraindications to the chosen method. If there are none, review the",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 486
  },
  {
    "id": "chunk_00487",
    "text": "o the chosen method. If there are none, review the rest of the brochure with the client to reinforce information about the method chosen and to respond to questions. This helps to ensure that the client understands the method. Give",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 487
  },
  {
    "id": "chunk_00488",
    "text": "nsure that the client understands the method. Give the brochure to the client. S/he can refer to it at home or use it to talk to her/his partner. 5. Use the counseling cards to discuss additional reproductive health services that the family",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 488
  },
  {
    "id": "chunk_00489",
    "text": "ional reproductive health services that the family planning client may need during and after s/he has selected a contraceptive method. These include counseling on postpartum health for the mother and infant, cervical cancer screen-",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 489
  },
  {
    "id": "chunk_00490",
    "text": "for the mother and infant, cervical cancer screen- ing, breast cancer, adolescent needs, women\u2019s support and safety, post-abortion care, male services, STI/HIV transmission and prevention, conducting a risk assessment, defining dual protection, and discussing and offering HIV counseling and testing.",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 490
  },
  {
    "id": "chunk_00491",
    "text": "iscussing and offering HIV counseling and testing. 6. For trainers, use the BCS+ Trainer\u2019s Guide to familiarize health care staff with this new counseling approach and to build capacity to effectively use the BCS+. The exercises in the",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 491
  },
  {
    "id": "chunk_00492",
    "text": "to effectively use the BCS+. The exercises in the trainer\u2019s guide can be given all together in a workshop and/or used separately during staff meetings or on-the-job training during supervisory visits. 7. The four BCS+ job aids, BCS+ User\u2019s Guide, and BCS+ Trainer\u2019s Guide are also available as",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 492
  },
  {
    "id": "chunk_00493",
    "text": "de, and BCS+ Trainer\u2019s Guide are also available as electronic files on Population Council\u2019s website, at http://www.popcouncil.org/research/ the-balanced-counseling-strategy-plus-a-toolkit-for-family-planning-service. Adapt these materials for use in your region or country as needed. | 5 |",
    "page_number": 46,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 493
  },
  {
    "id": "chunk_00494",
    "text": "WHY IS TRAINING SERVICE PROVIDERS ON BCS+ IMPORTANT? Poor provider compliance When the original BCS was developed in Peru, health care providers were given an initial two-day training (16 hours) and a one-day refresher course six months later. An assessment of the use of",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 494
  },
  {
    "id": "chunk_00495",
    "text": "urse six months later. An assessment of the use of the BCS revealed that there were significant improvements in quality of care and improved client knowledge of certain methods when the providers used the job aids. Only 37 percent of the pro-",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 495
  },
  {
    "id": "chunk_00496",
    "text": "ers used the job aids. Only 37 percent of the pro- viders trained on how to use the BCS model and job aids actually used them to counsel clients. This was attributed to the shortness of the training and weaknesses in the implementation component of",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 496
  },
  {
    "id": "chunk_00497",
    "text": "and weaknesses in the implementation component of the BCS model (Le\u00f3n et al. 2003b; Le\u00f3n et al. 2001). Furthermore, the benefits for clients were less marked when the providers received less than the three-day training. Much improved provider compliance",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 497
  },
  {
    "id": "chunk_00498",
    "text": "ee-day training. Much improved provider compliance When the BCS was adapted for use in Guatemala, special emphasis was placed on the reinforce- ment of learning through supervision. The eight-hour training included at least three hours of role",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 498
  },
  {
    "id": "chunk_00499",
    "text": "our training included at least three hours of role play and was followed by supervision and retraining. Eight weeks after the initial training, each pro- vider was monitored at least twice a week while s/he counseled clients. The provider was observed",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 499
  },
  {
    "id": "chunk_00500",
    "text": "s/he counseled clients. The provider was observed during counseling and given feedback as soon as the client left. Three to four counseling sessions were observed during each visit to a provider. An assessment of the BCS in Guatemala showed that",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 500
  },
  {
    "id": "chunk_00501",
    "text": "An assessment of the BCS in Guatemala showed that as a result of this more supportive training strategy, 70 percent of the service providers trained were using the job aids in their daily interactions with clients. Consequently, researchers found an improved",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 501
  },
  {
    "id": "chunk_00502",
    "text": "ients. Consequently, researchers found an improved quality of care among providers who used the BCS model (Le\u00f3n et al. 2003a; Le\u00f3n et al. 2003c). WHO SHOULD USE THE BCS+ TRAINER\u2019S GUIDE? Midwives, supervisors, program managers, or anyone responsible for training health care providers",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 502
  },
  {
    "id": "chunk_00503",
    "text": "one responsible for training health care providers can use this BCS+ Trainer\u2019s Guide. The trainer should be very familiar with using the BCS+ User\u2019s Guide and BCS+ job aids. HOW SHOULD THE BCS+ TRAINING BE IMPLEMENTED?",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 503
  },
  {
    "id": "chunk_00504",
    "text": "aids. HOW SHOULD THE BCS+ TRAINING BE IMPLEMENTED? The BCS+ can be used as outlined in this manual or introduced in more extensive training on fam- ily planning. For example, in Kenya, training on the BCS+ was offered as part of a longer training",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 504
  },
  {
    "id": "chunk_00505",
    "text": "the BCS+ was offered as part of a longer training session for family planning providers (degree nurses, registered nurses, and enrolled nurses). Any training on BCS+ should be followed up with periodic refresher training and/or on-the-job training during supervisory visits.",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 505
  },
  {
    "id": "chunk_00506",
    "text": "/or on-the-job training during supervisory visits. The BCS+ User\u2019s Guide is designed to reinforce training and serve as a reminder of the steps needed to implement the BCS+ model for counseling family planning clients. For optimal implementation",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 506
  },
  {
    "id": "chunk_00507",
    "text": "amily planning clients. For optimal implementation of the BCS+ strategy in family planning services, providers should receive the entire training and subsequent refresher training. The exercises in this BCS+ Trainer\u2019s Guide can be given all together in a workshop, used separately",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 507
  },
  {
    "id": "chunk_00508",
    "text": "given all together in a workshop, used separately during staff meetings or on-the-job training during supervisory visits, or incorporated into a larger training program. Trainers are encouraged to adapt any of the exercises in this module and/or add",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 508
  },
  {
    "id": "chunk_00509",
    "text": "apt any of the exercises in this module and/or add other exercises that are helpful for enabling providers to effectively use the BCS+ during family planning consultations. Be sure to allow for sufficient practice time. The importance of repetition",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 509
  },
  {
    "id": "chunk_00510",
    "text": "icient practice time. The importance of repetition for mastering any new skill or methodology cannot be emphasized enough. The success of the BCS+ lies in the provider\u2019s ability to use the BCS+ job aids. Thus, practice should be a priority during any training or supervisory event. | 6 |",
    "page_number": 47,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 510
  },
  {
    "id": "chunk_00511",
    "text": "Algorithm for Using the Balanced Counseling Strategy Plus PRE-CHOICE STAGE 1 Establish and maintain a warm, cordial relationship. 2 Inform client (and partner, if present) that there will be opportunities to address both health needs and family planning needs during this consultation.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 511
  },
  {
    "id": "chunk_00512",
    "text": "nd family planning needs during this consultation. 3 Ask client about current family size and current contraceptive practices. Counsel client on Healthy Timing and Spacing of Pregnancy using counseling card.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 512
  },
  {
    "id": "chunk_00513",
    "text": "ng and Spacing of Pregnancy using counseling card. a) If client is currently using a family planning method or delaying pregnancy, ask about her/his satisfaction with it and interest in continuing or changing the method. b) If partner is present, use the male services and support card.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 513
  },
  {
    "id": "chunk_00514",
    "text": "s present, use the male services and support card. 4 Rule out pregnancy using the Checklist to Make Reasonably Sure a Woman is not Pregnant card to be reasonably sure the woman is not pregnant. 5 Display all of the method cards. Ask client if she/he wants a particular method.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 514
  },
  {
    "id": "chunk_00515",
    "text": "s. Ask client if she/he wants a particular method. 6 Ask all of the following questions. Set aside method cards based on the client\u2019s responses. a) Do you wish to have children in the future? If \u201cYes,\u201d set aside vasectomy and tubal ligation cards. Explain Why. If \u201cNo,\u201d keep all cards and continue.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 515
  },
  {
    "id": "chunk_00516",
    "text": "Explain Why. If \u201cNo,\u201d keep all cards and continue. b) Have you given birth in the last 48 hours? If \u201cYes,\u201d set aside combined oral contraceptives (the Pill) and combined injectables. Explain why. If \u201cNo,\u201d continue with the next question. c) Are you breastfeeding an infant less than 6 months old?",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 516
  },
  {
    "id": "chunk_00517",
    "text": "ou breastfeeding an infant less than 6 months old? If \u201cYes,\u201d set aside the combined oral contraceptives (the Pill) and combined injectable cards. Explain why. If \u201cNo,\u201d or she has begun her monthly bleeding again, set aside the lactational amenorrhea (LAM) card. Explain why.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 517
  },
  {
    "id": "chunk_00518",
    "text": "he lactational amenorrhea (LAM) card. Explain why. d) Does your partner support you in family planning? If \u201cYes,\u201d continue with the next question If \u201cNo,\u201d set aside the following cards: female condom, male condom, Standard Days Method\u00a9, Two Days Method\u00a9, and withdrawal. Explain why.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 518
  },
  {
    "id": "chunk_00519",
    "text": "d\u00a9, Two Days Method\u00a9, and withdrawal. Explain why. e) Do you have any medical conditions? Are you taking any medications? If \u201cYes,\u201d ask further about which conditions or medications. Refer to WHO Medical Eligibility Criteria",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 519
  },
  {
    "id": "chunk_00520",
    "text": "cations. Refer to WHO Medical Eligibility Criteria Wheel or current national guidelines and set aside all contraindicated method cards. Explain why. If \u201cNo,\u201d keep all the cards and continue. f) Are there any methods that you do not want to use or have not tolerated in the past?",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 520
  },
  {
    "id": "chunk_00521",
    "text": "not want to use or have not tolerated in the past? If \u201cYes,\u201d set aside the cards the client does not want. If \u201cNo,\u201d keep the rest of the cards. METHOD CHOICE STAGE 7 Briefly review the methods that have not been set aside and indicate their effectiveness.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 521
  },
  {
    "id": "chunk_00522",
    "text": "t been set aside and indicate their effectiveness. a) Arrange the remaining cards in order of effectiveness (see back of each card). b) In order of effectiveness (highly effective to not effective), briefly review the attributes on each method card.",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 522
  },
  {
    "id": "chunk_00523",
    "text": "briefly review the attributes on each method card. 8 Ask the client to choose the method that is most convenient for her/him. a) If client is adolescent use the counseling card to inform her that she can get any method",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 523
  },
  {
    "id": "chunk_00524",
    "text": "ing card to inform her that she can get any method 9 Using the method-specific brochure, check whether the client has any condition for which the method is not advised. a) Review \u201cMethod not advised if you...\u201d section in the brochure",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 524
  },
  {
    "id": "chunk_00525",
    "text": "hod not advised if you...\u201d section in the brochure b) If the method is not advisable, ask the client to select another method from the cards that remain. Repeat the process from Step 8. | 7 |",
    "page_number": 48,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 525
  },
  {
    "id": "chunk_00526",
    "text": "POST-CHOICE STAGE 10 Discuss the method chosen with the client, using the method-specific brochure as a counseling tool. Determine the client\u2019s comprehension and reinforce key information. 11 Make sure the client has made a definite decision. Give her/him the method chosen, a referral,",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 526
  },
  {
    "id": "chunk_00527",
    "text": "ision. Give her/him the method chosen, a referral, and a back-up method depending on the method selected. 12 Encourage the client to involve partner(s) in decisions about/practice of contraception through discussion or a visit to the clinic. SYSTEMATIC SCREENING FOR OTHER SERVICES STAGE",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 527
  },
  {
    "id": "chunk_00528",
    "text": "nic. SYSTEMATIC SCREENING FOR OTHER SERVICES STAGE 13 Using information collected previously, determine client\u2019s need for postpartum, newborn, infant care, well-child services or post abortion care.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 528
  },
  {
    "id": "chunk_00529",
    "text": "t care, well-child services or post abortion care. a) If client reported giving birth recently, review the Promoting Healthy Postpartum Period and Promoting Newborn and Infant Health card with client. Provide or refer for services, if needed.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 529
  },
  {
    "id": "chunk_00530",
    "text": "client. Provide or refer for services, if needed. b) For clients with children less than 5 years of age, ask if children have been taken to well-child services. Provide or refer for immunizations and growth monitoring services, if needed.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 530
  },
  {
    "id": "chunk_00531",
    "text": "zations and growth monitoring services, if needed. c) If client reported a recent abortion, review the Post Abortion Care card with the client. Provide or refer post abortion care services, if needed. 14 Ask client when she had her last screening for cervical cancer (VIA/VILI or pap smear) or breast",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 531
  },
  {
    "id": "chunk_00532",
    "text": "cervical cancer (VIA/VILI or pap smear) or breast cancer. a) If her last Cervical Cancer screening was more than 3 years ago (*6-12 months if she is HIV positive) or she doesn\u2019t know, ask if she would like to have a screening today. Review the Screening for Cervical",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 532
  },
  {
    "id": "chunk_00533",
    "text": "screening today. Review the Screening for Cervical Cancer card. Provide or refer for services. b) If her last Cervical Cancer screening was less than 3 years ago continue with next question. c) Review Breast Cancer Information and Awareness counseling card with client.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 533
  },
  {
    "id": "chunk_00534",
    "text": "rmation and Awareness counseling card with client. 15 Discuss STI/HIV Transmission & Prevention and dual protection with client using counseling cards. Offer condoms and instructions on correct and consistent use.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 534
  },
  {
    "id": "chunk_00535",
    "text": "ms and instructions on correct and consistent use. 16 Conduct STI and HIV risk assessment using the counseling card. If symptoms are identified, treat her/him syndromically. 17 Ask client whether s/he knows her/his HIV status. a) If client knows s/he is living with HIV,",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 535
  },
  {
    "id": "chunk_00536",
    "text": "tatus. a) If client knows s/he is living with HIV, \u25aa Review Positive Health, Dignity, & Prevention counseling card with client. \u25aa Refer client to center for wellness care and treatment. b) If client knows s/he is HIV negative, \u25aa Discuss a time frame for repeat testing.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 536
  },
  {
    "id": "chunk_00537",
    "text": "gative, \u25aa Discuss a time frame for repeat testing. c) If client does not know her/his status, \u25aa Discuss HIV Counseling and Testing (HCT) with client, using counseling card. \u25aa Offer or initiate testing with client, according to national protocols.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 537
  },
  {
    "id": "chunk_00538",
    "text": "ting with client, according to national protocols. \u25aa Counsel client on test results. If client is living with HIV, review Positive Health, Dignity, & Prevention counseling card and refer client to center for wellness care and treatment. d) Counsel client using Women\u2019s Support & Safety Card.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 538
  },
  {
    "id": "chunk_00539",
    "text": "ounsel client using Women\u2019s Support & Safety Card. \u25aa If client shows any major Intimate Partner Violence (IPV) triggers, refer her for specialized services. 18 Give follow-up instructions, a condom brochure, and the brochure for the method chosen. Set a date for next visit.",
    "page_number": 49,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 539
  },
  {
    "id": "chunk_00540",
    "text": "Tips for Trainers 1. Read this entire BCS+ Trainer\u2019s Guide to prepare for the workshop. Flag pages to which you refer participants during the training. 2. Follow the detailed steps on how to conduct the training provided in this guide. Note that",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 540
  },
  {
    "id": "chunk_00541",
    "text": "uct the training provided in this guide. Note that there are more than 3 hours of role plays and practice exercises. It is important to adhere to the suggested timing to ensure sufficient time for practice. Feel free to adapt the exercises to your local situation.",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 541
  },
  {
    "id": "chunk_00542",
    "text": "ee to adapt the exercises to your local situation. 3. Practice using the BCS+ job aids to counsel clients on family planning and other related ser- vices. Familiarity with the job aids will enhance your capability as a trainer of the BCS+.",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 542
  },
  {
    "id": "chunk_00543",
    "text": "enhance your capability as a trainer of the BCS+. 4. Prior to the training, make enough copies of the BCS+ User\u2019s Guide and BCS+ job aids to give to each participant in the training. (Note: If available, give participants the original,",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 543
  },
  {
    "id": "chunk_00544",
    "text": "ote: If available, give participants the original, full-color copy of The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Pro- viders Working in High STI/HIV Prevalence Settings that contains the BCS+ User\u2019s Guide, job aids, and BCS+ Trainer\u2019s Guide.)",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 544
  },
  {
    "id": "chunk_00545",
    "text": "User\u2019s Guide, job aids, and BCS+ Trainer\u2019s Guide.) 5. Be sure there are enough BCS+ method brochures for providers to use in their practice after the training. 6. The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 545
  },
  {
    "id": "chunk_00546",
    "text": "Family Planning Service Providers Working in High STI/HIV Prevalence Settings is also available on the Population Council\u2019s website, at http:// www.popcouncil.org/research/the-balanced-counseling-strategy-plus-a-toolkit-for-fami-",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 546
  },
  {
    "id": "chunk_00547",
    "text": "anced-counseling-strategy-plus-a-toolkit-for-fami- ly-planning-service. Please use it to print more materials, such as the BCS+ brochures or BCS+ User\u2019s Guide. You can also photocopy these materials if printing is not an option.",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 547
  },
  {
    "id": "chunk_00548",
    "text": "copy these materials if printing is not an option. 7. As you deliver the training, be sure to keep these facilitation skills in mind: \u25aa Ask questions frequently. It is important to address any questions about how to use BCS+ job aids as they come up.",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 548
  },
  {
    "id": "chunk_00549",
    "text": "ns about how to use BCS+ job aids as they come up. \u25aa Use open-ended questions that begin with \u201chow,\u201d \u201cwhat,\u201d \u201cwhen,\u201d and \u201cwhy\u201d to invite discussion and feedback. \u25aa Handle difficult questions in the following way: \u2013 Acknowledge the effort of the participant, regardless of the type of question. \u201cThat",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 549
  },
  {
    "id": "chunk_00550",
    "text": "icipant, regardless of the type of question. \u201cThat is a good question\u201d is always a good response, no matter how difficult or inappropri- ate the question may be. \u2013 Invite the group to answer the participant\u2019s question. This approach also engages the group in the learning process.",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 550
  },
  {
    "id": "chunk_00551",
    "text": "ch also engages the group in the learning process. \u2013 Minimize potential embarrassment for wrong or inappropriate questions by waiting until the break to answer the question. For example, you could say, \u201cThat is a good question. Why don\u2019t we talk about it during the break?\u201d",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 551
  },
  {
    "id": "chunk_00552",
    "text": "ion. Why don\u2019t we talk about it during the break?\u201d \u2013 Defer until the break prolonged discussions that are taking you away from the topic. \u25aa Use good observation skills so that you know how well participants are understanding",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 552
  },
  {
    "id": "chunk_00553",
    "text": "t you know how well participants are understanding and receiving the training. As you observe how the training is being received, adjust the facilitation to meet participants\u2019 learning needs (see table on next page).",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 553
  },
  {
    "id": "chunk_00554",
    "text": "icipants\u2019 learning needs (see table on next page). 8. Remember: Effective training techniques keep participants engaged in the learning process, help trainers assess how the training is being received, and help trainers adjust the training process as needed. See table on next page for guidance. | 9 |",
    "page_number": 50,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 554
  },
  {
    "id": "chunk_00555",
    "text": "If participants seem... Try this... \u25aa Speed up the pace of the training \u25aa Take a break \u25aa Stop talking and invite more participation, such as asking questions or BORED getting participants to practice \u25aa Change your training style: use different training techniques, such as",
    "page_number": 51,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 555
  },
  {
    "id": "chunk_00556",
    "text": "style: use different training techniques, such as turning off PowerPoint and just talking \u25aa Conduct impromptu practice or small group work \u25aa Ask questions to clarify participant\u2019s understanding of the topic \u25aa Give examples or demonstrate CONFUSED \u25aa Have others in the group explain the topic",
    "page_number": 51,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 556
  },
  {
    "id": "chunk_00557",
    "text": "FUSED \u25aa Have others in the group explain the topic \u25aa Have participants practice. Provide hands-on assistance, if necessary \u25aa Make sure the room is not too warm or stuffy \u25aa Make sure there is enough light SLEEPY \u25aa Use a variety of training methods and aids \u25aa Conduct impromptu icebreakers",
    "page_number": 51,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 557
  },
  {
    "id": "chunk_00558",
    "text": "g methods and aids \u25aa Conduct impromptu icebreakers \u25aa Take a break \u25aa Stop talking and ask questions \u25aa Walk among the participants INATTENTIVE Talking, writing, looking \u25aa Have participants practice at their watches, shuf- \u25aa Ask others to explain the topic fling papers \u25aa Speed up the pace",
    "page_number": 51,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 558
  },
  {
    "id": "chunk_00559",
    "text": "Sample Agenda: BCS+ Training 8:00 am \u2013 8:40 am Welcome and Telephone Exercise 8:40 am \u2013 9:30 am Background on the Balanced Counseling Strategy Plus 9:30 am \u2013 11:00 am Pre-Choice Stage 11:00 am \u2013 11:15 am Break 11:15 am \u2013 12:00 pm Method Choice Stage 12:00 pm \u2013 12:45 pm Post-Choice Stage",
    "page_number": 52,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 559
  },
  {
    "id": "chunk_00560",
    "text": "Choice Stage 12:00 pm \u2013 12:45 pm Post-Choice Stage 12:45 pm \u2013 2:00 pm Lunch 2:00 pm \u2013 4:15 pm Systematic Screening for Other Services Stage 4:15 pm \u2013 4:45 pm Role Play #1 4:45 pm \u2013 5:00 pm Break 5:00 pm \u2013 5:30 pm Role Play #2 5:30 pm \u2013 5:45 pm Next Steps and Closing | 11 |",
    "page_number": 52,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 560
  },
  {
    "id": "chunk_00561",
    "text": "BCS+ Training for Family Planning Providers Introduction Total Time: 90 minutes By the end of this session, participants will: \u25aa Know each other \u25aa Be able to describe why and how the BCS+ was developed WELCOME Time: 20 minutes Materials and Advance Preparation",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 561
  },
  {
    "id": "chunk_00562",
    "text": "Time: 20 minutes Materials and Advance Preparation \u25aa Have flipchart (newsprint) paper and markers available. \u25aa Prepare a flipchart paper with the workshop objective ahead of time. Instructions 1. Use the following exercise to help participants get to know each other. Feel free to use an-",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 562
  },
  {
    "id": "chunk_00563",
    "text": "pants get to know each other. Feel free to use an- other icebreaker, if desired. a. Divide participants into pairs. b. Ask participants to tell their partner something interesting about her/himself that col- leagues may not know about them.",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 563
  },
  {
    "id": "chunk_00564",
    "text": "himself that col- leagues may not know about them. c. Allow a couple of minutes for the first partner to tell her/his story. d. After 5 minutes, have the pairs switch roles and ask the other partner to tell something about her/himself.",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 564
  },
  {
    "id": "chunk_00565",
    "text": "other partner to tell something about her/himself. e. Allow a couple of minutes for the second partner to relate her/his story. f. Once the group is finished (do not let them linger too long), ask each participant to: (1)",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 565
  },
  {
    "id": "chunk_00566",
    "text": "hem linger too long), ask each participant to: (1) introduce her/his partner by name and (2) tell one interesting thing about her/him. g. You might begin by introducing yourself and telling the group something interesting about yourself. 8. Review the objective of the training:",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 566
  },
  {
    "id": "chunk_00567",
    "text": "yourself. 8. Review the objective of the training: 3. Housekeeping: Review where the bathrooms are located, whether there will be refreshments, where lunch will be held, and any other housekeeping items. OBJECTIVE",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 567
  },
  {
    "id": "chunk_00568",
    "text": "held, and any other housekeeping items. OBJECTIVE By the end of the training, participants will be able to use the BCS+ job aids to counsel a client on family planning and HIV counseling and testing (HCT). 4. Ground rules: Ask participants to suggest any ground rules that they think the group should",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 568
  },
  {
    "id": "chunk_00569",
    "text": "any ground rules that they think the group should abide by. Write the ground rules on flipchart paper. (Note: If not mentioned by participants, include a ground rule about use of cell phones.) 5. Begin the session with the telephone exercise that follows. This is a fun and participatory",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 569
  },
  {
    "id": "chunk_00570",
    "text": "cise that follows. This is a fun and participatory exercise to introduce the need for the BCS+. It also involves participants from the outset of the training. | 12 |",
    "page_number": 53,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 570
  },
  {
    "id": "chunk_00571",
    "text": "TELEPHONE EXERCISE Time: 20 minutes Materials and Advance Preparation \u25aa Have flipchart (newsprint) paper and markers available. \u25aa Have four to five blank sheets of paper available. \u25aa Make a transparency or PowerPoint of Slide #1 (found on page 14). If an overhead projector",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 571
  },
  {
    "id": "chunk_00572",
    "text": "de #1 (found on page 14). If an overhead projector or computer and projector are not available, draw the graph from Slide #1 on flipchart paper Instructions 1. Ask everyone to stand up and form a semicircle. (Try to find a space in the room not inter- rupted by the tables and chairs.)",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 572
  },
  {
    "id": "chunk_00573",
    "text": "room not inter- rupted by the tables and chairs.) 2. Give the first person in the semicircle a blank sheet of paper and a pen or marker. Then give every 4th or 5th person and the last person in the semicircle the same.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 573
  },
  {
    "id": "chunk_00574",
    "text": "on and the last person in the semicircle the same. 3. Mention that you are going to read something to the first person in the semicircle. 4. Explain that this person will repeat what s/he heard you say to the next person in the line.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 574
  },
  {
    "id": "chunk_00575",
    "text": "s/he heard you say to the next person in the line. Subsequently, the next person repeats what s/he heard to the next person and so forth, until the information reaches the end of the line. 5. Cover these two rules: 1. Whisper the information to your partner so that others do not hear it.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 575
  },
  {
    "id": "chunk_00576",
    "text": "ion to your partner so that others do not hear it. 2. You may only say the information once; you may not repeat it. 6. Ask the participants with the blank sheet of paper to write down exactly what they hear. Here are their rules:",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 576
  },
  {
    "id": "chunk_00577",
    "text": "down exactly what they hear. Here are their rules: 1. They may not ask the person who gave them the information to repeat anything. 2. They must not let anyone see what they write. 7. Remind participants that when it is their turn, they may speak slowly, but they may not repeat the information.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 577
  },
  {
    "id": "chunk_00578",
    "text": "k slowly, but they may not repeat the information. 8. Be aware that participants may begin to giggle. Smile and encourage them to be as quiet as possible so that their fellow participants can hear the sentence.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 578
  },
  {
    "id": "chunk_00579",
    "text": "t their fellow participants can hear the sentence. 9. Quietly read the following information to the first person in the semicircle. Speak slowly and clearly. Take care that the person cannot see what you are reading. READ THIS",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 579
  },
  {
    "id": "chunk_00580",
    "text": "person cannot see what you are reading. READ THIS People remember 25 percent of what they hear; 45 percent of what they hear and see; and 70 percent or more of what they see, hear, and experience on their own. 10. Tell the first person to repeat what s/he heard to the next person and so forth.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 580
  },
  {
    "id": "chunk_00581",
    "text": "t what s/he heard to the next person and so forth. 11. Remind the participants with the sheet of paper to write down exactly what they hear. 12. Encourage participants to be as quiet as possible so that the receiver of the information can hear what is being said.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 581
  },
  {
    "id": "chunk_00582",
    "text": "er of the information can hear what is being said. 13. Wait until the last person in the semicircle has heard the sentence and has written it down on her/his sheet of paper. 14. Read aloud exactly what you (the trainer) read to the first participant.",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 582
  },
  {
    "id": "chunk_00583",
    "text": "t you (the trainer) read to the first participant. 15. Ask the first person in the semicircle with the sheet of paper to read what s/he wrote on the paper. 16. Going along the semicircle ask the rest of the participants with a sheet of paper to read what",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 583
  },
  {
    "id": "chunk_00584",
    "text": "he participants with a sheet of paper to read what they wrote, including the last person in the semicircle. 17. Expect the message to be substantially distorted by the time the last person has read what s/ he wrote down. 18. After participants have settled down, ask them to take a seat. | 13 |",
    "page_number": 54,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 584
  },
  {
    "id": "chunk_00585",
    "text": "Instructions for Processing Exercise 1. Ask why the message got so distorted. 2. Ask how we could have avoided such a distortion of the message. How could it have been improved so that more people would remember it?",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 585
  },
  {
    "id": "chunk_00586",
    "text": "en improved so that more people would remember it? 3. Write participants\u2019 responses on flipchart paper. If not mentioned, suggest the following: \u25aa The message could have been shorter. \u25aa The message could have come with visual aids.",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 586
  },
  {
    "id": "chunk_00587",
    "text": "r. \u25aa The message could have come with visual aids. \u25aa The person could have been given printed material to read to remind her/him of the message. 4. Ask whether participants could remember the same message one week from now. (Expect them to say \u201cno.\u201d) SLIDE #1: RETENTION RATES AFTER 60 DAYS",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 587
  },
  {
    "id": "chunk_00588",
    "text": "say \u201cno.\u201d) SLIDE #1: RETENTION RATES AFTER 60 DAYS 5. Show slide #1 of retention rates and ask the following questions: \u25aa What would it have been like if I (you the trainer) had told you the message using the slide?",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 588
  },
  {
    "id": "chunk_00589",
    "text": "trainer) had told you the message using the slide? \u25aa If you were given a copy of the slide to take home, could you remember the message a week from now? 6. Explain that the point of this exercise is for participants to: \u25aa Reflect on how difficult it is to remember what one hears.",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 589
  },
  {
    "id": "chunk_00590",
    "text": "on how difficult it is to remember what one hears. \u25aa Realize that less information enhances learning. \u25aa Understand the need to reinforce verbal information with written materials. 7. Emphasize the fact that too much information is often given to clients when choosing a contraceptive method.",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 590
  },
  {
    "id": "chunk_00591",
    "text": "n to clients when choosing a contraceptive method. 8. Ask how the inability to remember information could affect the client and his/her use of a contraceptive method. Write responses on the flipchart. 9. Mention that if the participants could not remember the simple message from the exercise",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 591
  },
  {
    "id": "chunk_00592",
    "text": "not remember the simple message from the exercise we just played, how can we expect family planning clients to remember all the information we give them? 10. Mention that you are now going to discuss the link between the objectives of the telephone exercise and why the BCS+ was developed. | 14 |",
    "page_number": 55,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 592
  },
  {
    "id": "chunk_00593",
    "text": "BACKGROUND ON THE BALANCED COUNSELING STRATEGY PLUS Time: 50 minutes Materials and Advance Preparation \u25aa Have flipchart (newsprint) paper and markers available. \u25aa Prepare a flipchart paper with the workshop objective ahead of time.",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 593
  },
  {
    "id": "chunk_00594",
    "text": "t paper with the workshop objective ahead of time. \u25aa Have enough copies of the BCS+ Toolkit for each participant in the training. They will need it during the practice sessions and to take home with them to use in the clinic. (Note: If the",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 594
  },
  {
    "id": "chunk_00595",
    "text": "home with them to use in the clinic. (Note: If the entire toolkit is not available, at least make sure there are enough copies of the BCS+ User\u2019s Guide and the BCS+ job aids.) \u25aa If you have not already done so, review the BCS+ User\u2019s Guide prior to the training and have a",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 595
  },
  {
    "id": "chunk_00596",
    "text": "BCS+ User\u2019s Guide prior to the training and have a copy of the BCS+ Toolkit to use during the training. \u25aa Have flipchart (newsprint) paper and markers available. \u25aa Prepare a flipchart paper or PowerPoint with a summary of the three key findings mentioned",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 596
  },
  {
    "id": "chunk_00597",
    "text": "with a summary of the three key findings mentioned in \u201cInstructions for Balanced Counseling Strategy\u2013The Beginning Explanation\u201d point #1 (page 15). \u25aa Prepare a flipchart paper or PowerPoint with the definition of a job aid in the box labeled",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 597
  },
  {
    "id": "chunk_00598",
    "text": "ith the definition of a job aid in the box labeled \u201cclarify\u201d under \u201cInstructions for Balanced Counseling Strategy\u2013The Beginning Explanation\u201d point #4 (page 16). \u25aa Prepare a flipchart paper or PowerPoint of the operations research studies mentioned under",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 598
  },
  {
    "id": "chunk_00599",
    "text": "of the operations research studies mentioned under \u201cInstructions for Balanced Counseling Strategy Plus Explanation\u201d point #7 (page 16). \u25aa Prepare a flipchart paper with the list of considerations to be taken into account when con-",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 599
  },
  {
    "id": "chunk_00600",
    "text": "considerations to be taken into account when con- ducting client counseling with awareness and respect, mentioned in \u201cInstructions for The Third Edition of the Balanced Counseling Strategy Plus Explanation\u201d (page 17). Instructions for Balanced Counseling Strategy\u2014The Beginning Explanation",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 600
  },
  {
    "id": "chunk_00601",
    "text": "nced Counseling Strategy\u2014The Beginning Explanation 1. Explain that in the late 1990s, the FRONTIERS Program worked in collaboration with Min- istries of Health in several Latin American countries to develop a practical, interactive, and",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 601
  },
  {
    "id": "chunk_00602",
    "text": "countries to develop a practical, interactive, and client-friendly strategy for improving counseling within family planning consultations. This was in response to a study to assess providers\u2019 compliance with new national guidelines on",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 602
  },
  {
    "id": "chunk_00603",
    "text": "viders\u2019 compliance with new national guidelines on family planning care. Three main findings emerged: (Note: As you discuss the findings, show the flipchart or PowerPoint prepared beforehand.) \u25aa Providers failed to discuss the client\u2019s wishes.",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 603
  },
  {
    "id": "chunk_00604",
    "text": "\u25aa Providers failed to discuss the client\u2019s wishes. \u2013 Providers mainly asked medical questions, such as the date of the client\u2019s last men- struation. \u2013 Providers failed to ask the client basic questions about her reproductive intentions\u2014",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 604
  },
  {
    "id": "chunk_00605",
    "text": "basic questions about her reproductive intentions\u2014 such as whether she wanted more children or whether her partner cooperated in contraceptive use. \u2013 Information obtained from the client, such as blood pressure, often had limited prac- tical use in the method selection process.",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 605
  },
  {
    "id": "chunk_00606",
    "text": "d prac- tical use in the method selection process. \u25aa Providers often gave excessive information. \u2013 Providers furnished excessive detail on most of the contraceptive methods available at Ministry of Health clinics, regardless of whether the methods suited the client\u2019s needs.",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 606
  },
  {
    "id": "chunk_00607",
    "text": "of whether the methods suited the client\u2019s needs. \u2013 This overloaded clients with more information than they could remember, and they could not use much of it. \u25aa Information provided about the chosen contraceptive method was sparse.",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 607
  },
  {
    "id": "chunk_00608",
    "text": "about the chosen contraceptive method was sparse. \u2013 Most of the counseling time was spent describing numerous method options. Im- portant information for both provider and client\u2014such as contraindications, side effects, and warning signs related to the chosen method\u2014was neglected.",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 608
  },
  {
    "id": "chunk_00609",
    "text": "signs related to the chosen method\u2014was neglected. \u2013 Subsequently, clients interviewed after the consultation knew little about the method they had chosen. | 15 |",
    "page_number": 56,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 609
  },
  {
    "id": "chunk_00610",
    "text": "2. Mention that as a result of these findings, the Population Council and the Peruvian Ministry of Health developed and tested an interactive, client-friendly counseling strategy that sought to simplify decision-making and respond more appropriately to the client\u2019s needs and repro-",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 610
  },
  {
    "id": "chunk_00611",
    "text": "ore appropriately to the client\u2019s needs and repro- ductive intentions. 3. Explain that this new family planning counseling approach was called the Balanced Counseling Strategy or BCS. Easy-to-use job aids are a key component of the BCS strategy.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 611
  },
  {
    "id": "chunk_00612",
    "text": "job aids are a key component of the BCS strategy. 4. Clarify what a job aid is. (Note: Refer to the flipchart paper prepared beforehand). CLARIFY A job aid is a storage place for information, other than long-term memory, which is ac- cessed in real time on the job. Characteristics of a job aid:",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 612
  },
  {
    "id": "chunk_00613",
    "text": "eal time on the job. Characteristics of a job aid: \u25aa More reliable than memory \u25aa Describes the desired on-the-job behavior \u25aa Minimizes trial and error and reduces the amount of recall necessary to perform on- the-job tasks Instructions for Balanced Counseling Strategy Plus Explanation",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 613
  },
  {
    "id": "chunk_00614",
    "text": "for Balanced Counseling Strategy Plus Explanation 1. Mention that current efforts by family planning services to avoid STI/HIV have been mostly limited to education on risk reduction, STIs, encouraging use of condoms, and providing",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 614
  },
  {
    "id": "chunk_00615",
    "text": "n, STIs, encouraging use of condoms, and providing family planning choices to infected clients to avoid unwanted pregnancy. 2. Mention that HIV counseling and testing (HCT) in many African countries is often limited to antenatal care settings and a few stand-alone centers.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 615
  },
  {
    "id": "chunk_00616",
    "text": "natal care settings and a few stand-alone centers. 3. Explain that the large proportion of sexually active women using family planning offers an opportunity for providers to integrate information about other services.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 616
  },
  {
    "id": "chunk_00617",
    "text": "ers to integrate information about other services. 4. Point out that in response to the need to incorporate counseling, screening, and services for STIs, including HIV, within routine family planning consultations in settings characterized by",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 617
  },
  {
    "id": "chunk_00618",
    "text": "lanning consultations in settings characterized by high prevalence of these infections, the original BCS was revised to integrate HIV preven- tion counseling, risk assessment, and HCT. 5. Mention that the FRONTIERS Program developed and piloted the BCS+ through op-",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 618
  },
  {
    "id": "chunk_00619",
    "text": "Program developed and piloted the BCS+ through op- erations research studies in Kenya (2005 to 2007) and South Africa (2004 to 2006). Both countries have high rates of STIs, including HIV, and their contraceptive prevalence rates are relatively high for the region.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 619
  },
  {
    "id": "chunk_00620",
    "text": "evalence rates are relatively high for the region. 6. Explain that the Ministries of Health in both countries were keen to develop practical tools for increasing the quality of services and numbers of clients receiving integrated services.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 620
  },
  {
    "id": "chunk_00621",
    "text": "numbers of clients receiving integrated services. 7. Point out the key findings of the operations research studies conducted in Kenya and South Africa on the use of the BCS+. (Note: Show overhead or flipchart of these findings as you discuss.)",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 621
  },
  {
    "id": "chunk_00622",
    "text": "ad or flipchart of these findings as you discuss.) \u25aa Integrating STI/HIV prevention counseling and risk assessment with offering HCT during family planning consultations is feasible and acceptable to clients and providers.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 622
  },
  {
    "id": "chunk_00623",
    "text": "feasible and acceptable to clients and providers. \u25aa The quality of care for both family planning and STI/HIV counseling improved signifi- cantly with the use of the BCS+ tools. \u25aa Counseling on HCT increased substantially. In Kenya, more than 40 percent of clients",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 623
  },
  {
    "id": "chunk_00624",
    "text": "ntially. In Kenya, more than 40 percent of clients were offered HCT services, with almost half of these deciding to be tested, either on site or through referral. In South Africa, those offered testing increased to 29 percent.",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 624
  },
  {
    "id": "chunk_00625",
    "text": "ca, those offered testing increased to 29 percent. Furthermore, an overall increase in testing was observed in the district, with a doubling of individuals tested. \u25aa Use of the BCS+ tools facilitated greater risk assessment for STIs and HIV. Also, deci-",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 625
  },
  {
    "id": "chunk_00626",
    "text": "ater risk assessment for STIs and HIV. Also, deci- sions about contraceptive method choice were made with a better understanding of their relationship to infection prevention. | 16 |",
    "page_number": 57,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 626
  },
  {
    "id": "chunk_00627",
    "text": "\u25aa Despite the concern that adding these services may have a negative impact on family planning services, improved quality of counseling and no evidence of a decline in utiliza- tion showed that this concern was unfounded.",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 627
  },
  {
    "id": "chunk_00628",
    "text": "liza- tion showed that this concern was unfounded. Instructions for The Third Edition of the Balanced Counseling Strategy Plus Explanation 1. Explain that since its publication in 2008, many organizations and governments have used",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 628
  },
  {
    "id": "chunk_00629",
    "text": "2008, many organizations and governments have used the BCS+ toolkit. Based on their experiences, some partners made modifications to the tool, added questions, or rephrased the toolkit according to the local context or a specific topic",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 629
  },
  {
    "id": "chunk_00630",
    "text": "according to the local context or a specific topic that their program was focused on. Others incorporated the toolkit into larger training ac- tivities and systems, including many governments and ministries of health that have adopted",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 630
  },
  {
    "id": "chunk_00631",
    "text": "rnments and ministries of health that have adopted the toolkit as their family planning service provision tool for providers. An updated second edition of the BCS+ was developed in 2011 to reflect some of these partner experiences and needs and updates on WHO Medical Eligibility Criteria (MEC) 2010.",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 631
  },
  {
    "id": "chunk_00632",
    "text": "es on WHO Medical Eligibility Criteria (MEC) 2010. 2. Indicate that experiences with using the second edition of the BCS+ toolkit in various settings and contexts, as well as the compilation of feedback and experiences from other or-",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 632
  },
  {
    "id": "chunk_00633",
    "text": "ilation of feedback and experiences from other or- ganizations, new contraceptive technologies, and additional WHO updates to MEC in 2015 made it clear that the toolkit would benefit from another review and update. This update responded to several developments since its previous publication:",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 633
  },
  {
    "id": "chunk_00634",
    "text": "veral developments since its previous publication: \u25aa Partners and colleagues implementing the tool mentioned a need and an interest in inte- grating additional services into the Balanced Counseling Strategy Plus algorithm and associ-",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 634
  },
  {
    "id": "chunk_00635",
    "text": "ced Counseling Strategy Plus algorithm and associ- ated toolkit components. There is also widespread interest in integrating family planning into other services for which clients may have an unmet need in addition to those already",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 635
  },
  {
    "id": "chunk_00636",
    "text": "ay have an unmet need in addition to those already covered in the BCS+. Such topics include breast cancer information, post-abortion care, women\u2019s support and safety, and male- and adolescent-specific counseling. \u25aa The World Health Organization published the fifth edition of the Medical Eligibility",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 636
  },
  {
    "id": "chunk_00637",
    "text": "ished the fifth edition of the Medical Eligibility Criteria for Contraceptive Use in 2015, updating guidance on the safety and efficacy of some methods. \u25aa Two new contraceptive technologies were developed and approved for use in family",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 637
  },
  {
    "id": "chunk_00638",
    "text": "gies were developed and approved for use in family planning services and were included in WHO MEC 2015: the Caya\u00ae/Silcs Diaphragm and the Progesterone Vaginal Ring. 3. Mention that the previous two editions were tested in Kenya and are now part of national guidelines for family planning.",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 638
  },
  {
    "id": "chunk_00639",
    "text": "w part of national guidelines for family planning. Instructions for Counseling with Awareness and Respect Explanation 1. Explain to participants that counseling family planning clients on other health issues entails",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 639
  },
  {
    "id": "chunk_00640",
    "text": "ly planning clients on other health issues entails asking questions that may be uncomfortable and different from those normally addressed in a family planning session. 2. Explain that it can be difficult to begin a conversation about these issues with a client be-",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 640
  },
  {
    "id": "chunk_00641",
    "text": "conversation about these issues with a client be- cause you will need to ask very personal questions. 3. Explain that beginning a consultation with questions about a woman\u2019s general health can set the scene for more sensitive questions about sexual practices and HIV.",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 641
  },
  {
    "id": "chunk_00642",
    "text": "ensitive questions about sexual practices and HIV. 4. Review the following list of questions that might be used when talking to a client and review them with participants. (Note: Have these questions prepared on flipchart beforehand. Feel free to adjust the questions as needed.)",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 642
  },
  {
    "id": "chunk_00643",
    "text": "and. Feel free to adjust the questions as needed.) \u25aa Have you ever talked to your partner about when you want to have children and how many you want to have? \u25aa Have you ever talked to your partner about family planning? \u25aa Have you ever talked to your partner about your sexual life in general?",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 643
  },
  {
    "id": "chunk_00644",
    "text": "to your partner about your sexual life in general? \u25aa Do you have other sexual partners? \u25aa How many sexual partners have you had in the past? \u25aa Do you ever use condoms? \u25aa Have you ever had a cervical cancer screening? | 17 |",
    "page_number": 58,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 644
  },
  {
    "id": "chunk_00645",
    "text": "\u25aa Have you ever used any form of contraception? Which ones? How often? How does your partner feel about it? \u25aa Have you ever talked to your partner about STIs or HIV? \u25aa Have you ever had an STI? \u25aa Have you ever been tested for HIV? \u25aa Has your partner ever been tested for HIV?",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 645
  },
  {
    "id": "chunk_00646",
    "text": "HIV? \u25aa Has your partner ever been tested for HIV? \u25aa How likely do you think it is that you may be at risk for STIs or HIV? How likely do you think it is that your partner could be at risk for STIs or HIV? \u25aa Do you think you or your partner may have an STI now? Do you have any symptoms",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 646
  },
  {
    "id": "chunk_00647",
    "text": "tner may have an STI now? Do you have any symptoms that worry you? \u25aa Has anyone ever been violent with you and demanded sex? \u25aa Has anyone ever forced you to have sex? \u25aa Have you ever been depressed after having a baby? \u25aa Have you ever talked to your partner about having sex after pregnancy?",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 647
  },
  {
    "id": "chunk_00648",
    "text": "to your partner about having sex after pregnancy? 5. Ask participants to pair up and ask each other some of the questions. Have them note which questions they feel uncomfortable asking or answering. 6. Remind participants that discussing these topics can be an uncomfortable experience, even",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 648
  },
  {
    "id": "chunk_00649",
    "text": "se topics can be an uncomfortable experience, even for health professionals. 7. Point out that in order for clients to receive comprehensive health services, we must have these conversations and be confident doing so.",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 649
  },
  {
    "id": "chunk_00650",
    "text": "ave these conversations and be confident doing so. 8. Mention that to reduce the stigma around these issues we must begin to talk more freely about these issues, sex, and women\u2019s and men\u2019s health in general. Instructions for The Balanced Counseling Strategy Plus Toolkit Explanation",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 650
  },
  {
    "id": "chunk_00651",
    "text": "anced Counseling Strategy Plus Toolkit Explanation 1. Ask participants to open their copy of The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings. Allow them a minute or so to open the package and look at its contents.",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 651
  },
  {
    "id": "chunk_00652",
    "text": "r so to open the package and look at its contents. 2. Review the contents of the toolkit. If the entire toolkit is not available, review the BCS+ job aids and BCS+ User\u2019s Guide and describe the following: \u25aa BCS+ User\u2019s Guide on how to implement the BCS+. It is a detailed explanation of the",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 652
  },
  {
    "id": "chunk_00653",
    "text": "ment the BCS+. It is a detailed explanation of the 19-step BCS+ algorithm. \u25aa BCS+ algorithm that summarizes the 19 steps recommended to implement the BCS+ during a family planning consultation. These steps are organized under four stages of",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 653
  },
  {
    "id": "chunk_00654",
    "text": "on. These steps are organized under four stages of the consultation: pre-choice needs assessment; method choice; post-choice actions; and systematic screening of other service needs. During each stage of the consultation, the",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 654
  },
  {
    "id": "chunk_00655",
    "text": "needs. During each stage of the consultation, the provider is given step-by-step guidance on how to use the BCS+ job aids. Depending on the client\u2019s response to the issues discussed, the algorithm outlines which actions to take.",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 655
  },
  {
    "id": "chunk_00656",
    "text": "sed, the algorithm outlines which actions to take. \u25aa Counseling cards that the provider uses during a counseling session. There are 33 coun- seling cards. The first card contains six questions that the service provider asks to rule",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 656
  },
  {
    "id": "chunk_00657",
    "text": "x questions that the service provider asks to rule out whether a client is pregnant (adopted from those developed by Stanback et al. 1999). There are 18 method-specific cards that contain information about each family planning",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 657
  },
  {
    "id": "chunk_00658",
    "text": "hat contain information about each family planning method. Each method card has an illustration of the contraceptive method on the front side. The back of the card contains a list of key features of the method and describes the",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 658
  },
  {
    "id": "chunk_00659",
    "text": "st of key features of the method and describes the method\u2019s effectiveness. These cards are used to first exclude those methods that are inap- propriate for the client\u2019s reproductive intentions and then to narrow the choice to reach",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 659
  },
  {
    "id": "chunk_00660",
    "text": "intentions and then to narrow the choice to reach a final decision. Fourteen counseling cards provide information on additional counseling and services that a family planning client may need. These include: healthy timing and",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 660
  },
  {
    "id": "chunk_00661",
    "text": "client may need. These include: healthy timing and spacing of pregnancies; healthy postpartum period for the mother and the newborn; cervical cancer screening; breast cancer; adolescent counseling; women\u2019s support and",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 661
  },
  {
    "id": "chunk_00662",
    "text": "cancer; adolescent counseling; women\u2019s support and safety; male services; post-abortion care; STI/HIV transmission and prevention; risk assessment; dual protection; positive health, dignity, and prevention; and HIV counseling and testing. | 18 |",
    "page_number": 59,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 662
  },
  {
    "id": "chunk_00663",
    "text": "\u25aa Method brochures on each of the 18 contraceptive methods. They are designed to help the client better understand the method chosen. The provider gives the client the brochure for the selected method and a brochure with information on condoms to take",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 663
  },
  {
    "id": "chunk_00664",
    "text": "and a brochure with information on condoms to take home. Providers should encourage low-literate or illiterate clients to take the brochure home so that their partner or other trusted friend can review the brochure with them again.",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 664
  },
  {
    "id": "chunk_00665",
    "text": "ed friend can review the brochure with them again. \u25aa WHO Medical Eligibility Wheel (2015) is a provider job aid based on the four eligi- bility categories for contraceptive use in relation to medical conditions described in the",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 665
  },
  {
    "id": "chunk_00666",
    "text": "in relation to medical conditions described in the document Medical Eligibility Criteria for Contraceptive Use, fifth edition, published by the Department of Reproductive Health, World Health Organization. The job aid is an",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 666
  },
  {
    "id": "chunk_00667",
    "text": "alth, World Health Organization. The job aid is an interactive tool to identify contraindicated methods for specific medical conditions. It has been field-tested in three countries and found to be very useful to providers who used it.",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 667
  },
  {
    "id": "chunk_00668",
    "text": "found to be very useful to providers who used it. 3. Point out that the BCS+ job aids and BCS+ User\u2019s Guide incorporate the latest international norms and guidance as recommended by the WHO (2015). 4. Explain that participants should refer to the BCS+ User\u2019s Guide when they need details on",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 668
  },
  {
    "id": "chunk_00669",
    "text": "to the BCS+ User\u2019s Guide when they need details on how to use the BCS+. The BCS+ User\u2019s Guide is more comprehensive than the BCS+ algo- rithm. 5. Ask whether there are any questions before proceeding. 6. Mention that participants are now going to learn how to implement the BCS+ using the",
    "page_number": 60,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 669
  },
  {
    "id": "chunk_00670",
    "text": "Pre-Choice Stage Total time: 90 minutes By the end of this session, participants will: \u25aa Be able to counsel a family planning client on the BCS+ pre-choice stage VALUES CLARIFICATION Time: 20 minutes Materials and Advance Preparation \u25aa Have flipchart (newsprint) paper and markers available.",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 670
  },
  {
    "id": "chunk_00671",
    "text": "flipchart (newsprint) paper and markers available. \u25aa Have list of value statements ready to read aloud to participants. Feel free to add to or subtract from the value statements under sentence #5. Instructions",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 671
  },
  {
    "id": "chunk_00672",
    "text": "e value statements under sentence #5. Instructions 1. Explain that our values form a fundamental part of our lives and, as such, have an effect on how we behave both personally and professionally. 2. Point out that it is important to be aware of our values regarding health and sexual health",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 672
  },
  {
    "id": "chunk_00673",
    "text": "e of our values regarding health and sexual health matters and avoid making value judgments that affect our work professionally. 3. Mention that you are going to read some statements and after each one vote whether you agree with it or not. Then we will discuss the statements as a group.",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 673
  },
  {
    "id": "chunk_00674",
    "text": "t. Then we will discuss the statements as a group. 4. Point out that there are no \u201cright\u201d or \u201cwrong\u201d answers with respect to values. 5. Read the statements, one at a time, and have the group vote on them. \u25aa It is acceptable for someone to have more than one sexual partner at a time.",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 674
  },
  {
    "id": "chunk_00675",
    "text": "ne to have more than one sexual partner at a time. \u25aa It is more acceptable for men to have multiple sexual partners than for women to have multiple sexual partners. \u25aa People who don\u2019t use condoms can only blame themselves for getting HIV.",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 675
  },
  {
    "id": "chunk_00676",
    "text": "condoms can only blame themselves for getting HIV. \u25aa Health care providers have the right to know the HIV status of their patients. \u25aa A woman who knows she is infected with HIV should not have a baby. \u25aa Oral sex should be encouraged to reduce risk of HIV.",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 676
  },
  {
    "id": "chunk_00677",
    "text": "al sex should be encouraged to reduce risk of HIV. \u25aa Children should be taught about HIV as early as possible. \u25aa Teenage girls should be discouraged from using family planning. \u25aa Educating parents about condoms will help protect teenagers from HIV.",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 677
  },
  {
    "id": "chunk_00678",
    "text": "bout condoms will help protect teenagers from HIV. \u25aa Most uneducated women are incapable of making their own decisions about their sexual and reproductive life. 6. Once you have discussed the above-mentioned statements and how they might affect their",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 678
  },
  {
    "id": "chunk_00679",
    "text": "ntioned statements and how they might affect their behavior with clients, encourage a discussion about how to respect the values of others de- spite one\u2019s own values. (Note: Write responses on flipchart.) 7. Point out that providers must be aware of their own beliefs and avoid imposing them on",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 679
  },
  {
    "id": "chunk_00680",
    "text": "re of their own beliefs and avoid imposing them on their clients. STEPS 1 TO 6 Time: 45 minutes Materials and Advance Preparation \u25aa Have flipchart (newsprint) paper and markers available. \u25aa Make sure all participants have a copy of the BCS+ User\u2019s Guide and counseling cards. | 20 |",
    "page_number": 61,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 680
  },
  {
    "id": "chunk_00681",
    "text": "Instructions STEP 1. ESTABLISH AND MAINTAIN A WARM, CORDIAL RELATIONSHIP. 1. Ask participants to open their BCS+ User\u2019s Guide and go to Step 1. Review the following actions that help to accomplish Step 1: \u25aa Establish a formal but friendly manner. \u25aa Call the client by her/his name.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 681
  },
  {
    "id": "chunk_00682",
    "text": "riendly manner. \u25aa Call the client by her/his name. \u25aa Demonstrate interest in what the client tells you. \u25aa Establish eye contact with the client. \u25aa Listen to and answer her/his questions. \u25aa Show support and understanding without judgment. \u25aa Ask questions to encourage participation in the discussion.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 682
  },
  {
    "id": "chunk_00683",
    "text": "ions to encourage participation in the discussion. 2. Ask participants whether there are other actions that are good for establishing a warm and cordial relationship. (Note: Write responses on flipchart.) STEP 2. INFORM CLIENT (AND PARTNER, IF PRESENT) THAT THERE WILL BE AN OPPORTUNITY TO",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 683
  },
  {
    "id": "chunk_00684",
    "text": ", IF PRESENT) THAT THERE WILL BE AN OPPORTUNITY TO ADDRESS BOTH HEALTH NEEDS AND FAMILY PLANNING NEEDS DURING THIS CONSULTATION. 1. Explain that family planning clients may have questions about other health issues or a need",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 684
  },
  {
    "id": "chunk_00685",
    "text": "have questions about other health issues or a need for other health services. These questions and services may be addressed during the same consultation and are included in the Systematic Screening for Other Services Stage.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 685
  },
  {
    "id": "chunk_00686",
    "text": "the Systematic Screening for Other Services Stage. 2. Ask participants to think about other services that are available in the facility where BCS+ will be implemented. Ask about those services a client may need that are available by referral.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 686
  },
  {
    "id": "chunk_00687",
    "text": "a client may need that are available by referral. 3. Instruct participants to inform each client of these services and take note of any specific services that she/he requests so that you can address them after going through the BCS+ algorithm.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 687
  },
  {
    "id": "chunk_00688",
    "text": "dress them after going through the BCS+ algorithm. 4. Explain that the primary goal of the BCS+ is to guide providers through family planning counseling and assist in the selection of an appropriate family planning method and, there- fore, this issue will be addressed first.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 688
  },
  {
    "id": "chunk_00689",
    "text": ", there- fore, this issue will be addressed first. STEP 3. ASK CLIENT ABOUT CURRENT FAMILY SIZE, DESIRE TO HAVE MORE CHILDREN, AND CURRENT CONTRACEPTIVE PRACTICES. COUNSEL THE CLIENT ON HEALTHY TIMING AND SPACING OF PREGNANCY USING COUNSELING CARD.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 689
  },
  {
    "id": "chunk_00690",
    "text": "NG AND SPACING OF PREGNANCY USING COUNSELING CARD. 1. Explain that all couples and individuals have the right to decide freely and responsibly the number and spacing of their children and to have access to information and education about family planning.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 690
  },
  {
    "id": "chunk_00691",
    "text": "o information and education about family planning. 2. Explain that data show higher rates of maternal and/or infant and perinatal death and illness when a pregnancy following a live birth is spaced less than two years or more than five years.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 691
  },
  {
    "id": "chunk_00692",
    "text": "paced less than two years or more than five years. 3. Explain that data show a similar negative effect on mother\u2019s and her baby\u2019s health when a pregnancy occurs less than six months after an induced or spontaneous abortion.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 692
  },
  {
    "id": "chunk_00693",
    "text": "x months after an induced or spontaneous abortion. 4. Explain that research clearly shows that young women who become pregnant before the age of 18 face a number of negative health and social outcomes, as do their children. Young",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 693
  },
  {
    "id": "chunk_00694",
    "text": "h and social outcomes, as do their children. Young women ages 15 to 19 are twice as likely to die of pregnancy-related complications as their peers over the age of 20, and young women under the age of 15 are five times more likely to die.",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 694
  },
  {
    "id": "chunk_00695",
    "text": "r the age of 15 are five times more likely to die. 5. Instruct participants to ask the following questions of their clients: \u25aa How many children do you have? \u25aa How many children do you (and your partner) want? \u25aa Are you currently using contraception or delaying pregnancy?",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 695
  },
  {
    "id": "chunk_00696",
    "text": "rrently using contraception or delaying pregnancy? \u25aa If yes, what method are you using? Are you happy with your current method or would you like to change your method? | 21 |",
    "page_number": 62,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 696
  },
  {
    "id": "chunk_00697",
    "text": "6. Review counseling points listed on the Healthy Timing and Spacing of Pregnancy counseling card with participants. Read the following points out loud with participants: \u25aa For women who want to have more children after a live birth, advise:",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 697
  },
  {
    "id": "chunk_00698",
    "text": "to have more children after a live birth, advise: \u2013 For the health of the mother and baby, wait at least 2 years (24 months) but not more than 5 years before trying to become pregnant again. \u2013 Use of a family planning method of her choice allows a woman to plan for a healthy pregnancy.",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 698
  },
  {
    "id": "chunk_00699",
    "text": "ce allows a woman to plan for a healthy pregnancy. \u25aa For women who decide to have a child after a miscarriage or abortion, advise: \u2013 For the health of the mother and baby, wait at least 6 months before trying to be- come pregnant again.",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 699
  },
  {
    "id": "chunk_00700",
    "text": "6 months before trying to be- come pregnant again. \u2013 Use of a family planning method of her choice allows a woman to plan for a healthy pregnancy. \u25aa For adolescents, advise: \u2013 For the health of the mother and baby, wait until at least 18 years of age before try- ing to become pregnant.",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 700
  },
  {
    "id": "chunk_00701",
    "text": "8 years of age before try- ing to become pregnant. \u2013 If sexually active, use of a family planning method of her choice allows a young woman to prevent unintended pregnancy. 7. If client\u2019s partner is present, counsel using the Male Services & Support card.",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 701
  },
  {
    "id": "chunk_00702",
    "text": "t, counsel using the Male Services & Support card. 8. Ask participants if they have any questions. STEP 4. RULE OUT PREGNANCY USING THE PREGNANCY CHECKLIST CARD WITH 6 QUESTIONS. 1. Explain that it is important to rule out the possibility of the client being pregnant before",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 702
  },
  {
    "id": "chunk_00703",
    "text": "he possibility of the client being pregnant before proceeding with a family planning consultation. Pregnancy is a contraindication for most methods except barrier methods such as condoms. 2. Ask participants to take out their BCS+ counseling cards and locate the pregnancy checklist",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 703
  },
  {
    "id": "chunk_00704",
    "text": "ounseling cards and locate the pregnancy checklist card for ruling out pregnancy. 3. Review the 6 questions on the card: \u25aa Did you have a baby less than 6 months ago? If so, are you fully or nearly fully breast- feeding? Have you had no monthly menstrual bleeding since giving birth?",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 704
  },
  {
    "id": "chunk_00705",
    "text": "no monthly menstrual bleeding since giving birth? \u25aa Have you abstained from unprotected sex (no method of family planning) since your last menstrual bleeding or delivery? \u25aa Have you given birth during the last 4 weeks?",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 705
  },
  {
    "id": "chunk_00706",
    "text": "y? \u25aa Have you given birth during the last 4 weeks? \u25aa Did your last menstrual bleeding start within the past 7 days (or within 12 days if you plan to use an intrauterine device (IUD)? \u25aa Have you had a miscarriage or abortion in the last 7 days?",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 706
  },
  {
    "id": "chunk_00707",
    "text": "had a miscarriage or abortion in the last 7 days? \u25aa Have you been using a reliable contraceptive method consistently and correctly? 4. Refer participants to the first table on the next page which also appears in the BCS+ User\u2019s",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 707
  },
  {
    "id": "chunk_00708",
    "text": "he next page which also appears in the BCS+ User\u2019s Guide, and review which actions to take based on how a client answers each of the 6 ques- tions. | 22 |",
    "page_number": 63,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 708
  },
  {
    "id": "chunk_00709",
    "text": "If the client answers... Then... \u201cYes\u201d to any of the questions and is free of signs and symptoms of pregnancy, 1. Pregnancy is unlikely *Once the client has answered yes to one 2. Continue to Step 5 of the questions, it is not necessary to continue asking the remaining questions",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 709
  },
  {
    "id": "chunk_00710",
    "text": "cessary to continue asking the remaining questions 1. Pregnancy cannot be ruled out. 2. Give client a pregnancy test if available, or refer her to an antenatal clinic. 3. Provide her with a back-up method, such as condoms, to \u201cNo\u201d to all of the questions use until she has her menstrual bleeding.",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 710
  },
  {
    "id": "chunk_00711",
    "text": "uestions use until she has her menstrual bleeding. 4. Provide in advance her preferred method (where possible) to use on the 1st day of her menses OR request that she return at that point to receive her preferred method. 5. Go to Step 13",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 711
  },
  {
    "id": "chunk_00712",
    "text": "to receive her preferred method. 5. Go to Step 13 STEP 5. DISPLAY ALL OF THE METHOD CARDS. ASK CLIENT IF SHE/HE WANTS A PARTICULAR METHOD. 1. Display all of the method cards as shown in Figure 1 (see Appendix) of the BCS+ User\u2019s Guide.",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 712
  },
  {
    "id": "chunk_00713",
    "text": "Figure 1 (see Appendix) of the BCS+ User\u2019s Guide. 2. Mention that before narrowing down a client\u2019s method choices, the provider should first ask whether a client has a method in mind. 3. Refer participants to the table below in the BCS+ User\u2019s Guide and review what to do as the",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 713
  },
  {
    "id": "chunk_00714",
    "text": "the BCS+ User\u2019s Guide and review what to do as the client responds to the question, \u201cDo you have a particular method in mind?\u201d If the client... Do this... Answers \u201cno\u201d Continue to Step 6 1. Ask which method s/he wants. Answers \u201cyes\u201d 2. Ask what the client knows about the method.",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 714
  },
  {
    "id": "chunk_00715",
    "text": "es\u201d 2. Ask what the client knows about the method. 3. If the information is correct, go to Step 9. Gives incomplete information about the method s/he has chosen 1. Correct any misinformation. OR 2. If necessary, go to Step 6 to help the client choose a Does not know other alternatives that method.",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 715
  },
  {
    "id": "chunk_00716",
    "text": "se a Does not know other alternatives that method. might be more convenient STEP 6. ASK ALL OF THE FOLLOWING QUESTIONS. SET ASIDE METHOD CARDS BASED ON THE CLIENT\u2019S RESPONSES. 1. Point out that this step is the heart of the BCS+ model. Refer participants to Step 6 in the BCS+ User\u2019s Guide.",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 716
  },
  {
    "id": "chunk_00717",
    "text": "r participants to Step 6 in the BCS+ User\u2019s Guide. 2. Explain that there are six key questions under Step 6. These questions help the provider identify a client\u2019s reproductive intentions. They also help the client choose the family plan- ning method that best suits her/his intentions.",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 717
  },
  {
    "id": "chunk_00718",
    "text": "n- ning method that best suits her/his intentions. 3. Mention that participants may want to begin the process by saying something like this to the client, \u201cNow we are going to discuss your contraceptive needs. We will narrow down the number of methods",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 718
  },
  {
    "id": "chunk_00719",
    "text": "e needs. We will narrow down the number of methods that might be best for you. Then, I will discuss the key features of each method with you. This will help us to find the right method for your needs.\u201d 4. As you explain this step, demonstrate with a participant how to ask the questions and set",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 719
  },
  {
    "id": "chunk_00720",
    "text": "ith a participant how to ask the questions and set aside the counseling cards. Select a participant from the group (or use a co-trainer) and give her/him the following script: | 23 |",
    "page_number": 64,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 720
  },
  {
    "id": "chunk_00721",
    "text": "SCENARIO You are a 28-year-old woman who has three children. You gave birth to a baby 5 months ago. You are breastfeeding your baby and have a history of uterine fibroids. You are tired and do not want to have more children for a while. Your husband is not very cooperative when it",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 721
  },
  {
    "id": "chunk_00722",
    "text": "hile. Your husband is not very cooperative when it comes to family planning. He does not want anything to interfere with having sex when he wants it. You have used spermicides in the past. Their failure resulted in pregnancy with your",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 722
  },
  {
    "id": "chunk_00723",
    "text": "ast. Their failure resulted in pregnancy with your third child. You are interested in a method that you can use without your husband noticing. 5. Refer participants to the table under Step 6 in the BCS+ User\u2019s Guide and have them follow along.",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 723
  },
  {
    "id": "chunk_00724",
    "text": "the BCS+ User\u2019s Guide and have them follow along. 6. Begin with the question: \u201cDo you wish to have children in the future?\u201d 7. Demonstrate keeping or setting aside the method cards per the instructions in the table below. If the client... Do this...",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 724
  },
  {
    "id": "chunk_00725",
    "text": "ns in the table below. If the client... Do this... 1. Set aside the vasectomy and tubal ligation cards. Answers \u201cyes\u201d 2. Explain that sterilization is permanent and not suitable for someone who thinks s/he might want to have another child. Answers \u201cno\u201d Keep all cards and continue",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 725
  },
  {
    "id": "chunk_00726",
    "text": "er child. Answers \u201cno\u201d Keep all cards and continue 8. Ask the next question: \u201cHave you given birth in the last 48 hours?\u201d 9. Demonstrate keeping or setting aside the method cards per the instructions in the table below. If the client... Do this...",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 726
  },
  {
    "id": "chunk_00727",
    "text": "ns in the table below. If the client... Do this... 1. Set aside combined oral contraceptives (the Pill), monthly injectable, implants, and tubal ligation cards. Answers \u201cyes\u201d 2. Explain that combined hormonal methods and tubal ligation are not safe for women to use immediately after giving birth.",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 727
  },
  {
    "id": "chunk_00728",
    "text": "e for women to use immediately after giving birth. Answers \u201cno\u201d Keep all cards and continue 10. Ask next question: \u201cAre you breastfeeding an infant less than 6 months old?\u201d 11. Demonstrate keeping or setting aside the counseling cards per the instructions in the table below.",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 728
  },
  {
    "id": "chunk_00729",
    "text": "ing cards per the instructions in the table below. If the client... Do this... 1. Set aside the combined oral contraceptives (the Pill) and combined Answers \u201cyes\u201d injectable contraceptive (CIC) cards. 2. Explain that the hormones in these methods affect breastfeeding.",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 729
  },
  {
    "id": "chunk_00730",
    "text": "he hormones in these methods affect breastfeeding. 1. Set aside the Lactational Amenorrhea Method (LAM) card and the pro- gesterone vaginal ring (PVR) card aside. Answers \u201cno\u201d 2. Explain that LAM and PVR are not suitable for women who are not breastfeeding or are having menstrual bleeding again.",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 730
  },
  {
    "id": "chunk_00731",
    "text": "astfeeding or are having menstrual bleeding again. 12. Ask whether there are any questions so far. 13. Ask the next question: \u201cDoes your partner support you in family planning?\u201d 14. Demonstrate keeping or setting aside the counseling cards per the instructions in the follow- ing table. | 24 |",
    "page_number": 65,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 731
  },
  {
    "id": "chunk_00732",
    "text": "If the client... Do this... Answers \u201cyes\u201d Continue with the next question 1. Set aside female condom, male condom, Standard Days Method\u00ae, Answers \u201cno\u201d TwoDay\u00ae Method, and withdrawal cards. 2. Explain that these methods require partner cooperation.",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 732
  },
  {
    "id": "chunk_00733",
    "text": "in that these methods require partner cooperation. 15. Explain to participants that they should invite the client to bring her/his partner to a coun- seling session to discuss family planning with a provider.",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 733
  },
  {
    "id": "chunk_00734",
    "text": "ession to discuss family planning with a provider. 16. Point out that male and female condoms are important for protecting against STIs, including HIV, and also require partner cooperation. 17. Ask the next question: \u201cDo you have any medical conditions? Are you taking any med- ications?\u201d",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 734
  },
  {
    "id": "chunk_00735",
    "text": "cal conditions? Are you taking any med- ications?\u201d 18. Demonstrate use of the WHO Medical Eligibility Criteria Wheel to determine contraceptive methods that are contraindicated according to a condition the client has or a medication the client is taking. Follow instructions in the table below.",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 735
  },
  {
    "id": "chunk_00736",
    "text": "is taking. Follow instructions in the table below. If the client... Do this... 1. Ask further about which medical conditions the client has or medica- tions she/he is taking. 2. Refer to the WHO Medical Eligibility Criteria Wheel (included), or current",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 736
  },
  {
    "id": "chunk_00737",
    "text": "Eligibility Criteria Wheel (included), or current Answers \u201cyes\u201d national guidelines, to identify contraindicated methods. 3. Set aside all contraindicated method cards. 4. Explain to client the reason for setting aside method cards, according to information provided in guidelines.",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 737
  },
  {
    "id": "chunk_00738",
    "text": ", according to information provided in guidelines. Answers \u201cno\u201d Continue with next question 19. Read out loud the following note about the WHO Medical Eligibility Criteria Wheel: \u25aa The WHO Medical Eligibility Criteria (MEC) Wheel which is a provider job aid based",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 738
  },
  {
    "id": "chunk_00739",
    "text": "eria (MEC) Wheel which is a provider job aid based on the four eligibility categories for contraceptive use in relation to medical conditions described in the document Medical Eligibility Criteria for contraceptive use, Fifth edition,",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 739
  },
  {
    "id": "chunk_00740",
    "text": "ity Criteria for contraceptive use, Fifth edition, published by Department of Reproductive Health, World Health Organization. This tool guides providers through medical conditions and medications that may be contraindi-",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 740
  },
  {
    "id": "chunk_00741",
    "text": "conditions and medications that may be contraindi- cations to use of particular contraceptive methods. The job aid has been field-tested in three countries by WHO, and is found to be very useful to providers who used it.",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 741
  },
  {
    "id": "chunk_00742",
    "text": "found to be very useful to providers who used it. 20. Ask participants if they have any questions about the WHO Medical Eligibility Criteria, the WHO MEC Wheel, or their national guidelines concerning contraindications.",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 742
  },
  {
    "id": "chunk_00743",
    "text": "national guidelines concerning contraindications. 21. Ask the last question: \u201cAre there any methods that you do not want to use or have not tolerated in the past?\u201d 22. Demonstrate keeping or setting aside the counseling cards per the instructions in the table below. If the client... Do this...",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 743
  },
  {
    "id": "chunk_00744",
    "text": "ns in the table below. If the client... Do this... 1. Ask which methods s/he has used and her/his experience with each. Answers \u201cyes\u201d 2. Set aside the cards for the methods the client does not want. Answers \u201cno\u201d Keep the rest of the cards The client has eliminated a",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 744
  },
  {
    "id": "chunk_00745",
    "text": "the rest of the cards The client has eliminated a 1. Provide the correct information. method because of rumors 2. Do not set aside the card for that method. or false information. | 25 |",
    "page_number": 66,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 745
  },
  {
    "id": "chunk_00746",
    "text": "PRACTICE Time: 25 minutes Instructions 1. Have participants conduct a short role play to practice the BCS+ pre-choice stage using Steps 1 to 6. a. Ask participants to pick a partner, preferably someone sitting next to them.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 746
  },
  {
    "id": "chunk_00747",
    "text": "partner, preferably someone sitting next to them. b. Have one person in the pair play the \u201cservice provider\u201d and the other person play the \u201cclient.\u201d c. Ask the person playing the provider to use the counseling cards to go through the BCS+ pre-choice stage.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 747
  },
  {
    "id": "chunk_00748",
    "text": "ing cards to go through the BCS+ pre-choice stage. d. Ask the person playing the \u201cclient\u201d to think of a family planning client they counseled recently and to play that role when their partner asks the pre-choice questions.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 748
  },
  {
    "id": "chunk_00749",
    "text": "when their partner asks the pre-choice questions. e. Ask the person playing the \u201cclient\u201d to think of a contraceptive method s/he plans to use and whether or not s/he will have a condition for which it is not advised.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 749
  },
  {
    "id": "chunk_00750",
    "text": "will have a condition for which it is not advised. f. If the \u201cclient\u201d decides to have a contraindication to the first method chosen, be sure to have another method in mind to allow the service provider to discover what that method is.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 750
  },
  {
    "id": "chunk_00751",
    "text": "service provider to discover what that method is. g. Tell the person playing the provider that after Step 6 s/he should hold on to the remaining method cards that have not been set aside during the role play. (Note: As participants conduct the role play, walk around to observe and gently correct, if",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 751
  },
  {
    "id": "chunk_00752",
    "text": "lay, walk around to observe and gently correct, if needed.) h. Remind the \u201cprovider\u201d to use good counseling skills. i. Allow about 15 minutes for this role play. j. After 15 minutes, ask participants to switch roles. Allow about 15 minutes for the second role play.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 752
  },
  {
    "id": "chunk_00753",
    "text": ". Allow about 15 minutes for the second role play. k. Be sure to ask the participant playing the provider to hold onto any remaining method cards that have not been set aside. 2. Ask whether participants have any questions. Address all comments and questions before proceeding.",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 753
  },
  {
    "id": "chunk_00754",
    "text": "ress all comments and questions before proceeding. 3. Remind participants that the BCS+ was developed in response to the finding that provid- ers were giving clients too much information on all the methods. They did so regardless of",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 754
  },
  {
    "id": "chunk_00755",
    "text": "tion on all the methods. They did so regardless of whether the method was relevant to the client\u2019s needs or reproductive intentions. 4. Mention that the method cards remaining from their role play are an example of how to",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 755
  },
  {
    "id": "chunk_00756",
    "text": "ning from their role play are an example of how to narrow down contraceptive methods that are more suitable to a client\u2019s needs and intentions. 5. Explain that this helps to reduce the amount of information we give clients. It also helps",
    "page_number": 67,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 756
  },
  {
    "id": "chunk_00757",
    "text": "Method Choice Stage Total time: 45 minutes By the end of this session, participants will: \u25aa Be able to counsel a family planning client on the BCS+ method choice stage STEPS 7 TO 9 Time: 30 minutes Materials and Advance Preparation \u25aa Make sure participants have their BCS+ method brochures.",
    "page_number": 68,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 757
  },
  {
    "id": "chunk_00758",
    "text": "ure participants have their BCS+ method brochures. Instructions 1. Ask participants to look at the back of the method cards that were not set aside during their role play. 2. Review the section on method effectiveness, pointing out: \u25aa The written description of the method\u2019s effectiveness",
    "page_number": 68,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 758
  },
  {
    "id": "chunk_00759",
    "text": "written description of the method\u2019s effectiveness \u25aa The percentage on the left-hand side of the card that also represents the effectiveness 3. Explain that method effectiveness is measured as the number of pregnancies among 100 women in the first year of using the method.",
    "page_number": 68,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 759
  },
  {
    "id": "chunk_00760",
    "text": "g 100 women in the first year of using the method. 4. Point out that the higher the percentage, the more effective the method. A higher percentage means that there are fewer pregnancies occurring among 100 women using that method per year.",
    "page_number": 68,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 760
  },
  {
    "id": "chunk_00761",
    "text": "urring among 100 women using that method per year. 5. Point to the method effectiveness information on the Tubal Ligation and TwoDay Method counseling cards as examples. Refer participants to Figure 3 in the BCS+ User\u2019s Guide.",
    "page_number": 68,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 761
  },
  {
    "id": "chunk_00762",
    "text": "STEP 7. BRIEFLY REVIEW THE METHODS THAT HAVE NOT BEEN SET ASIDE AND INDICATE THEIR EFFECTIVENESS. 1. Point out the features of the method located to the right of the information on method effectiveness. 2. Ask participants to arrange the remaining method cards in order of their level of effective-",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 762
  },
  {
    "id": "chunk_00763",
    "text": "method cards in order of their level of effective- ness. The cards should go from the most effective (highest percentage) to the least effective (lowest percentage). 3. Demonstrate how to display the cards with the highest percentage of effectiveness first and the lowest percentages last.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 763
  },
  {
    "id": "chunk_00764",
    "text": "fectiveness first and the lowest percentages last. 4. Explain that beginning with the card with the highest percentage (most effective), the provid- er reviews with the client the features of each of the remaining method cards.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 764
  },
  {
    "id": "chunk_00765",
    "text": "he features of each of the remaining method cards. 5. Explain that in this way, the provider is giving information only on family planning methods that are relevant to the client\u2019s needs and reproductive intentions.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 765
  },
  {
    "id": "chunk_00766",
    "text": "to the client\u2019s needs and reproductive intentions. 6. Point out that by beginning with the card with the highest percentage the provider discusses the most effective method first. 7. Emphasize that condoms (male or female) are the only method that offers dual protection:",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 766
  },
  {
    "id": "chunk_00767",
    "text": ") are the only method that offers dual protection: protection against pregnancy and STIs, including HIV. Emphasize the following: \u25aa Male and female condoms significantly reduce the risk of infection with STIs, including HIV, when used correctly and consistently with every act of sex.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 767
  },
  {
    "id": "chunk_00768",
    "text": "correctly and consistently with every act of sex. \u25aa When used correctly and consistently, condom use prevents 80 percent to 95 percent of HIV transmission that would have occurred without the use of condoms. \u25aa Condoms reduce the risk of becoming infected with many STIs when used consistently",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 768
  },
  {
    "id": "chunk_00769",
    "text": "ing infected with many STIs when used consistently and correctly: \u2013 Protect best against spread of STIs by discharge, such as HIV, gonorrhea, and chla- mydia. \u2013 Also protect against spread of STIs from skin-to-skin contact, such as herpes and human papillomavirus.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 769
  },
  {
    "id": "chunk_00770",
    "text": "contact, such as herpes and human papillomavirus. STEP 8. ASK THE CLIENT TO CHOOSE THE METHOD THAT IS MOST CONVENIENT FOR HER/HIM. 1. Explain that if the client is an adolescent, the provider should use the Adolescent Counseling card to inform her that she can get any method.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 770
  },
  {
    "id": "chunk_00771",
    "text": "ng card to inform her that she can get any method. 2. Mention that, at this point, the provider asks whether the client has any questions, doubts, or comments about the methods discussed. 3. Explain that after answering any questions, the provider asks the client to choose a method",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 771
  },
  {
    "id": "chunk_00772",
    "text": "s, the provider asks the client to choose a method from the method cards that have been discussed. 4. Emphasize that once the method is chosen a provider should not take the method cards off the table. S/he may need them again if there are conditions where the method is not advised",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 772
  },
  {
    "id": "chunk_00773",
    "text": "ere are conditions where the method is not advised for the client, or the client may change her/his mind. 5. Mention that if the client does not like any of the methods discussed or cannot make up her/his mind, give the client a method to use until s/he decides and go to Step 13.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 773
  },
  {
    "id": "chunk_00774",
    "text": "ethod to use until s/he decides and go to Step 13. 6. Point out the importance of not letting a client leave empty-handed. Condoms can provide dual protection until the client has selected another method. 7. Ask whether participants have any questions or comments. Be sure to answer all questions",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 774
  },
  {
    "id": "chunk_00775",
    "text": "tions or comments. Be sure to answer all questions before proceeding to Step 9. STEP 9. USING THE METHOD-SPECIFIC BROCHURE, CHECK WHETHER THE CLIENT HAS ANY CONDITIONS FOR WHICH THE METHOD IS NOT ADVISED.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 775
  },
  {
    "id": "chunk_00776",
    "text": "NY CONDITIONS FOR WHICH THE METHOD IS NOT ADVISED. 1. Explain that contraindications to a method were initially reviewed in Step 6, and this step is intended to confirm that the client does not have any contraindications.",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 776
  },
  {
    "id": "chunk_00777",
    "text": "at the client does not have any contraindications. 2. Explain that the provider selects the brochure for the method chosen by the client. Let\u2019s pretend that it is the Pill. | 28 |",
    "page_number": 69,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 777
  },
  {
    "id": "chunk_00778",
    "text": "3. Point out that the provider should review the \u201cMethod not advised if you\u201d section of the brochure. For the Pill, it would be: \u25aa Are breastfeeding an infant less than 6 months old. \u25aa If you are within 21 days of giving birth, regardless of breastfeeding status.",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 778
  },
  {
    "id": "chunk_00779",
    "text": "giving birth, regardless of breastfeeding status. \u25aa Smoke cigarettes and are 35 years old or older. \u25aa Have high blood pressure, 140/90 or higher. \u25aa Have certain uncommon serious diseases of the heart or blood vessels. Discuss with your provider. \u25aa Have severe liver conditions.",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 779
  },
  {
    "id": "chunk_00780",
    "text": "ith your provider. \u25aa Have severe liver conditions. \u25aa Have blood clots, deep vein thrombosis, or pulmonary embolism, or are on anticoagulant therapy. Discuss with your provider. \u25aa Have lupus. \u25aa Have gall bladder disease, even if medically-treated. Discuss with your provider.",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 780
  },
  {
    "id": "chunk_00781",
    "text": "if medically-treated. Discuss with your provider. \u25aa Have breast cancer or a history of breast cancer. \u25aa Have migraine headaches (a severe headache that does not go away with paracetamol) and are 35 years old or older. \u25aa Have migraine aura (sometimes seeing a growing bright spot in one eye)",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 781
  },
  {
    "id": "chunk_00782",
    "text": "sometimes seeing a growing bright spot in one eye) \u25aa Take medicine for seizures or take rifampicin (for tuberculosis or other infections). \u25aa Take ritonavir-boosted protease inhibitors as part of HAART. 4. Explain that if the client has a condition for which the method chosen is not advised, there",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 782
  },
  {
    "id": "chunk_00783",
    "text": "for which the method chosen is not advised, there is no need to give further information available in the brochure and the client will need to select another method. 5. Refer participants to the table below and in the BCS+ User\u2019s Guide and review how the pro-",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 783
  },
  {
    "id": "chunk_00784",
    "text": "d in the BCS+ User\u2019s Guide and review how the pro- vider decides whether to provide the method or return to a previous step. If the client... Do this... Has no conditions Go to Step 10. 1. Explain the need to choose another method. Has any condition 2. Return to Step 7.",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 784
  },
  {
    "id": "chunk_00785",
    "text": "her method. Has any condition 2. Return to Step 7. Has any condition and reached this step from 1. Explain the need to choose another method. Step 5 (already had the method in mind) 2. Return to Step 6. PRACTICE Time: 15 minutes",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 785
  },
  {
    "id": "chunk_00786",
    "text": "nd) 2. Return to Step 6. PRACTICE Time: 15 minutes 1. Ask participants to turn to their partner and explain Steps 7 to 9. They do not need to role- play, just explain the process. 2. After about 7 to 8 minutes, ask them to reverse roles and have the listener explain Steps 7 to 9. | 29 |",
    "page_number": 70,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 786
  },
  {
    "id": "chunk_00787",
    "text": "Post-Choice Stage Total time: 45 minutes By the end of this session, participants will: \u25aa Be able to counsel a family planning client on the BCS+ post-choice stage STEPS 10 TO 12 Time: 20 minutes Materials and Advance Preparation \u25aa None Instructions",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 787
  },
  {
    "id": "chunk_00788",
    "text": "erials and Advance Preparation \u25aa None Instructions STEP 10. DISCUSS THE METHOD CHOSEN WITH THE CLIENT, USING THE METHOD BROCHURE AS A COUNSELING TOOL. DETERMINE THE CLIENT\u2019S COMPREHENSION AND REINFORCE KEY INFORMATION",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 788
  },
  {
    "id": "chunk_00789",
    "text": "IENT\u2019S COMPREHENSION AND REINFORCE KEY INFORMATION 1. Explain that at this point, the client has selected a method and is now ready to hear more about the method chosen. 2. Explain that it is important to make sure the client understands the method s/he has chosen.",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 789
  },
  {
    "id": "chunk_00790",
    "text": "the client understands the method s/he has chosen. Comprehension is key to effective use of the method and maintaining the client\u2019s health. 3. Mention ways to begin the conversation, such as, \u201cMrs./Mr. {name}, this brochure is for you to",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 790
  },
  {
    "id": "chunk_00791",
    "text": "as, \u201cMrs./Mr. {name}, this brochure is for you to take home. Before you go, I would like to review the information with you.\u201d 4. Use the BCS+ method brochure on the Pill to demonstrate how a provider reviews the fol- lowing information in the method brochure with a client:",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 791
  },
  {
    "id": "chunk_00792",
    "text": "information in the method brochure with a client: \u25aa General information (This is the same information as on the BCS+ counseling card.) \u25aa How method works \u25aa Important facts (about the method) \u25aa Method not advised if you \u25aa Side effects \u25aa Health benefits (if applicable) \u25aa How to use",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 792
  },
  {
    "id": "chunk_00793",
    "text": "cts \u25aa Health benefits (if applicable) \u25aa How to use \u25aa Follow-up (if applicable) \u25aa When to return to the health care facility 5. Explain that after the provider discusses the information in the method brochure, s/he gives",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 793
  },
  {
    "id": "chunk_00794",
    "text": "the information in the method brochure, s/he gives the brochure to the client. S/he encourages the client to review the brochure again at home and when s/he needs to remember anything about the method. 6. Mention that a provider can validate the client\u2019s understanding of the method by asking her/",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 794
  },
  {
    "id": "chunk_00795",
    "text": "lient\u2019s understanding of the method by asking her/ him to answer the following questions in her/his own words. The client may refer to the brochure. \u25aa How do you use the method you have chosen? \u25aa What side effects might you experience with the method?",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 795
  },
  {
    "id": "chunk_00796",
    "text": "side effects might you experience with the method? \u25aa Can the method protect you against getting an STI, including HIV? \u25aa What are the signs indicating when you should return to the health care facility?",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 796
  },
  {
    "id": "chunk_00797",
    "text": "hen you should return to the health care facility? 7. The provider should assure the client that it is fine if s/he cannot remember all the details of the method. Make sure the client can find the information in the brochure.",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 797
  },
  {
    "id": "chunk_00798",
    "text": "e client can find the information in the brochure. 8. Remember to ask the client whether s/he has any questions. Reinforce the basic information on the method chosen, as needed. | 30 |",
    "page_number": 71,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 798
  },
  {
    "id": "chunk_00799",
    "text": "What if methods are not available? 1. Ask participants what they would do if methods such as the IUD, tubal ligation, and/or vasectomy were not offered in your health care facility. 2. Review the following, if not mentioned by participants:",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 799
  },
  {
    "id": "chunk_00800",
    "text": "w the following, if not mentioned by participants: \u25aa Still talk to the client about these methods (if they meet the client\u2019s reproductive inten- tions). \u25aa Give the client the brochure for the method chosen. \u25aa Refer the client to a facility or commercial outlet where s/he can obtain the method.",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 800
  },
  {
    "id": "chunk_00801",
    "text": "ommercial outlet where s/he can obtain the method. \u25aa Provide the client with an alternative, suitable method until s/he can obtain the method of choice. 3. Reinforce the importance of never letting a client go away empty-handed. This may be her/",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 801
  },
  {
    "id": "chunk_00802",
    "text": "ng a client go away empty-handed. This may be her/ his first and/or only consultation. It is important to respond to a client\u2019s needs even if you do not have the method on hand. 4. Review what to do if a client selects a method that is temporarily unavailable (out of stock).",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 802
  },
  {
    "id": "chunk_00803",
    "text": "od that is temporarily unavailable (out of stock). \u25aa Give the client a brochure for the method chosen. \u25aa Refer the client to another facility or commercial outlet for the method. \u25aa Provide the client with a back-up method until s/he can obtain the method of choice.",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 803
  },
  {
    "id": "chunk_00804",
    "text": "method until s/he can obtain the method of choice. \u25aa Ask client to return to the facility when the method is in stock. 5. Ask whether there are any questions or comments. STEP 11. MAKE SURE THE CLIENT HAS MADE A DEFINITE DECISION. GIVE HER/HIM THE METHOD",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 804
  },
  {
    "id": "chunk_00805",
    "text": "MADE A DEFINITE DECISION. GIVE HER/HIM THE METHOD CHOSEN, A REFERRAL, AND A BACK-UP METHOD DEPENDING ON THE METHOD SELECTED. 1. Explain that providers should ask the client if her/his choice is a definite one. Make sure the client is happy with the method.",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 805
  },
  {
    "id": "chunk_00806",
    "text": "ne. Make sure the client is happy with the method. 2. Refer participants to the table below and in the BCS+ User\u2019s Guide and review what to do based on the client\u2019s responses. If the client is... Do this... 1. Give her/him the method and brochure.",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 806
  },
  {
    "id": "chunk_00807",
    "text": "o this... 1. Give her/him the method and brochure. 2. If IUD, implant, tubal ligation, or vasectomy is chosen and not available on site, give a referral for the procedure, if needed. Happy with the method chosen 3. If the client cannot immediately use the chosen method,",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 807
  },
  {
    "id": "chunk_00808",
    "text": "e client cannot immediately use the chosen method, provide a back-up method (e.g. condoms). Give the BCS+ brochure on condoms. 4. Suggest that s/he may also abstain from sex until s/he obtains the method of choice. 1. Assure the client that it is fine to change her/his mind.",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 808
  },
  {
    "id": "chunk_00809",
    "text": "the client that it is fine to change her/his mind. Not happy with the method chosen and The client has a right to informed choice. wishes to consider other options 2. Return to Step 7. 3. Emphasize the importance of not letting the client leave empty-handed. If a method is",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 809
  },
  {
    "id": "chunk_00810",
    "text": "ting the client leave empty-handed. If a method is not available, make sure the client has a back-up method, a referral, and the BCS+ brochure on condoms. STEP 12. ENCOURAGE THE CLIENT TO INVOLVE PARTNER(S) IN DECISIONS ABOUT/PRACTICE OF CONTRACEPTION THROUGH DISCUSSION OR A VISIT TO THE CLINIC.",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 810
  },
  {
    "id": "chunk_00811",
    "text": "PTION THROUGH DISCUSSION OR A VISIT TO THE CLINIC. 1. Ask participants the ways in which a client can involve her/his partner in contraception. 2. If not mentioned by participants, review the following: \u25aa Your partner can remind you of the time to take your method, if taking a method regu-",
    "page_number": 72,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 811
  },
  {
    "id": "chunk_00812",
    "text": "\u25aa You can negotiate condom use to prevent STI, including HIV. \u25aa You can discuss your plans to have children, regardless of whether you are HIV positive or negative. \u25aa You can let your partner know that prevention of mother-to-child transmission",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 812
  },
  {
    "id": "chunk_00813",
    "text": "ow that prevention of mother-to-child transmission (PMTCT) during pregnancy can reduce transmission of HIV to infants. \u25aa Your partner can support you if you need wellness or HIV services (antiretroviral thera- py [ART] and wellness sites).",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 813
  },
  {
    "id": "chunk_00814",
    "text": "ntiretroviral thera- py [ART] and wellness sites). 3. Encourage participants to adapt this list based on what works for them and their clients. PRACTICE Time: 25 minutes 1. Ask participants to pair up with same partner.",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 814
  },
  {
    "id": "chunk_00815",
    "text": "1. Ask participants to pair up with same partner. 2. Have one person in the pair play the \u201cservice provider\u201d and the other person play the \u201cclient.\u201d 3. Explain that the provider will help the client to select a method following Steps 7 to 12 and using the method cards and method brochures.",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 815
  },
  {
    "id": "chunk_00816",
    "text": "2 and using the method cards and method brochures. 4. Explain that the person playing the \u201cservice provider\u201d may refer to Steps 7 to 12 in the BCS+ algorithm as support. Remind him/her to use good counseling skills. (Note: As par-",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 816
  },
  {
    "id": "chunk_00817",
    "text": "/her to use good counseling skills. (Note: As par- ticipants conduct the role play, walk around to observe and gently correct, if needed.) 5. Allow about 10 minutes for this role play. Then, ask the pairs to switch roles and repeat the process. 6. Allow about 10 minutes for the second role play.",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 817
  },
  {
    "id": "chunk_00818",
    "text": ". Allow about 10 minutes for the second role play. 7. After the second role play, ask participants for comments and questions. Address them all before proceeding. | 32 |",
    "page_number": 73,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 818
  },
  {
    "id": "chunk_00819",
    "text": "Systematic Screening for Other Services Stage Total time: 135 minutes By the end of this session, participants will be able to: \u25aa Identify clients\u2019 need for postpartum, newborn, infant, child health, or post abortion care counseling or services. \u25aa Counsel clients on appropriate and necessary services",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 819
  },
  {
    "id": "chunk_00820",
    "text": "nsel clients on appropriate and necessary services \u25aa Identify need for cervical or breast cancer screening. Provide or refer for services \u25aa Identify the level of HIV risk associated with various behaviors \u25aa Provide HIV counseling and testing",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 820
  },
  {
    "id": "chunk_00821",
    "text": "ous behaviors \u25aa Provide HIV counseling and testing \u25aa Counsel clients on HIV prevention, risk reduction, dual protection, and positive health, dignity. and prevention, where appropriate. \u25aa Counsel clients on women\u2019s support and safety. \u25aa Identify need for adolescent services counseling",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 821
  },
  {
    "id": "chunk_00822",
    "text": "\u25aa Identify need for adolescent services counseling \u25aa Provide counseling for male services \u25aa Counsel clients on appropriate and necessary services or provide referral. POSTNATAL CARE EXERCISE1 Time: 25 minutes Materials and Advance Preparation",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 822
  },
  {
    "id": "chunk_00823",
    "text": "Time: 25 minutes Materials and Advance Preparation \u25aa In large letters, print each of the following titles on cards (or pieces of paper), one title per card: First visit (24 to 48 hours); Second visit (3 to 7 days); Third visit (4 to 6 weeks); Fourth visit (4 to 6 months).",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 823
  },
  {
    "id": "chunk_00824",
    "text": "isit (4 to 6 weeks); Fourth visit (4 to 6 months). \u25aa Tape the signs high on the wall with room for participants to gather around. \u25aa Prepare four markers for distribution. Instructions 1. Inform participants that they will complete an activity that looks at the services that are",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 824
  },
  {
    "id": "chunk_00825",
    "text": "te an activity that looks at the services that are entailed in postnatal care. 2. Define targeted postnatal care to the participants and explain the rationale for postnatal care services. 3. Refer to national guidelines for specific information and services to be included in postnatal NOTE",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 825
  },
  {
    "id": "chunk_00826",
    "text": "tion and services to be included in postnatal NOTE The postnatal period is the time beginning immediately after the birth of a baby and extend- ing for about six weeks thereafter. Postpartum period and puerperium are other terms used",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 826
  },
  {
    "id": "chunk_00827",
    "text": "tpartum period and puerperium are other terms used for the same period. Targeted postnatal care is a set of postnatal care services delivered to both the mother and the baby in a minimum of four visits spread throughout the first six months. The recommended schedule is as follows: \u25aa Within 48 hours",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 827
  },
  {
    "id": "chunk_00828",
    "text": "ommended schedule is as follows: \u25aa Within 48 hours \u25aa 3 to 7 days \u25aa 4 to 6 weeks \u25aa 4 to 6 months Postnatal care meets the needs of both the mother and the baby, reduces the risk of mor- bidity and mortality, and promotes health and wellbeing.",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 828
  },
  {
    "id": "chunk_00829",
    "text": "and mortality, and promotes health and wellbeing. 1 This exercise was adapted from the curriculum titled: Community Based Maternal and Newborn Care (Ministry of Public Health and Sanitation and Ministry of Medical Services, Kenya, 2008). | 33 |",
    "page_number": 74,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 829
  },
  {
    "id": "chunk_00830",
    "text": "care and to be emphasized among the group of providers being trained. 4. Ask participants to count off, one at a time, 1, 2, 3 and 4. Let all participants who counted to 1 come together, then 2, 3 and 4, to make four individual groups. Each group will stand in",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 830
  },
  {
    "id": "chunk_00831",
    "text": "e four individual groups. Each group will stand in front of the print chart corresponding to their number. Give a marker to each group. 5. Ask participants to take 5 minutes to brainstorm on the services for mother and baby that should be included in the visit to which their group corresponds.",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 831
  },
  {
    "id": "chunk_00832",
    "text": "ded in the visit to which their group corresponds. 6. Ask one of the participants from each group to divide the print chart in two equal parts. Using the marker, write Mother on one side and Baby on the other side.",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 832
  },
  {
    "id": "chunk_00833",
    "text": "ite Mother on one side and Baby on the other side. 7. Referring to what the group has brainstormed, have each group write the services for moth- er and baby on each side. 8. Once the four groups are done, ask each group to review what other groups have written.",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 833
  },
  {
    "id": "chunk_00834",
    "text": "ch group to review what other groups have written. 9. To begin discussion and feedback, ask each group to report if there are listed services that they disagree with, that they do not understand, or that they have difficulty with.",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 834
  },
  {
    "id": "chunk_00835",
    "text": "not understand, or that they have difficulty with. 10. Discuss the services listed for each visit. Refer to national guidelines for postnatal care services or the WHO guidelines on postpartum and postnatal care to see the full list of key",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 835
  },
  {
    "id": "chunk_00836",
    "text": "tum and postnatal care to see the full list of key elements and correct timing for postnatal care for mother and baby. 11. Once participants have reviewed key elements and timing of postnatal care services, briefly discuss major danger signs during the postnatal period.",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 836
  },
  {
    "id": "chunk_00837",
    "text": "ss major danger signs during the postnatal period. 12. Explain that danger signs are conditions about which providers should counsel the woman and her family at each visit. Providers should advise the woman to go to the health center",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 837
  },
  {
    "id": "chunk_00838",
    "text": "should advise the woman to go to the health center immediately, day or night, if she or her baby experiences these danger signs. 13. Read out the following list with participants: 14. Ask participants if they have any questions about the above danger signs. Answer any ques- tions before proceeding.",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 838
  },
  {
    "id": "chunk_00839",
    "text": "r signs. Answer any ques- tions before proceeding. Mother Baby \u25aa Vaginal bleeding \u25aa Difficulty breathing \u25aa Fits \u25aa Convulsions (fits) \u25aa Fast or difficult breathing \u25aa Fever \u25aa Fever and too weak to get out of bed \u25aa Feels cold \u25aa Severe abdominal pain \u25aa Bleeding \u25aa Severe headaches with blurred vision",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 839
  },
  {
    "id": "chunk_00840",
    "text": "\u25aa Bleeding \u25aa Severe headaches with blurred vision \u25aa Stops feeding \u25aa Diarrhea and vomiting HIV RISK ASSESSMENT EXERCISE Time: 20 minutes Materials and Advance Preparation \u25aa In large letters, print each of the following titles on cards (or pieces of paper), one title per",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 840
  },
  {
    "id": "chunk_00841",
    "text": "itles on cards (or pieces of paper), one title per card: Higher Risk, Medium Risk, Low Risk, and No Risk. \u25aa Tape the signs (Higher Risk, Medium Risk, Low Risk, and No Risk) on the wall. \u25aa In clear, large letters, print each of the following sexual behaviors (or other behaviors applica-",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 841
  },
  {
    "id": "chunk_00842",
    "text": "wing sexual behaviors (or other behaviors applica- ble to your area or client population) on index cards, post-its, or pieces of paper, one behavior per card: \u2013 Abstinence \u2013 Masturbation \u2013 Vaginal sex without a condom \u2013 Vaginal sex with a condom | 34 |",
    "page_number": 75,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 842
  },
  {
    "id": "chunk_00843",
    "text": "\u2013 Hugging a person with HIV \u2013 Kissing \u2013 Dry sex without a condom \u2013 Massage \u2013 Performing oral sex on a man without a condom \u2013 Performing oral sex on a man with a condom \u2013 Performing oral sex on a woman without a dental dam \u2013 Performing oral sex on a woman with a dental dam",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 843
  },
  {
    "id": "chunk_00844",
    "text": "\u2013 Performing oral sex on a woman with a dental dam \u2013 Infant breastfeeding by an HIV-infected mother \u2013 Anal sex without a condom \u2013 Anal sex with a condom Instructions 1. Inform participants that they will complete an activity that looks at the behaviors that carry risk for contracting HIV.",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 844
  },
  {
    "id": "chunk_00845",
    "text": "the behaviors that carry risk for contracting HIV. 2. Place the sexual behavior cards face down in a stack. Ask participants to pick a card and place it on the wall under the appropriate risk category (Higher Risk, Medium Risk, Low",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 845
  },
  {
    "id": "chunk_00846",
    "text": "riate risk category (Higher Risk, Medium Risk, Low Risk, or No Risk) with respect to HIV transmission. (Note: Give participants some tape to affix the card on the wall under the appropriate sign.) 3. Once all the cards are on the wall, ask participants to review where the cards have been",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 846
  },
  {
    "id": "chunk_00847",
    "text": "k participants to review where the cards have been placed. Then ask participants to state whether they: \u25aa Disagree with the placement of any of the cards \u25aa Do not understand the placement of any of the cards \u25aa Had difficulty placing any of the cards",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 847
  },
  {
    "id": "chunk_00848",
    "text": "he cards \u25aa Had difficulty placing any of the cards 4. Begin by asking participants why they think the card was placed in a certain category. Discuss the placement of selected cards, particularly those that are not clear-cut in terms of risk,",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 848
  },
  {
    "id": "chunk_00849",
    "text": "rly those that are not clear-cut in terms of risk, or cards that are clearly misplaced. Consult the correct answers on the next page if you are unsure about where a certain behavior belongs. 5. Ask participants to look at the behaviors in the Low Risk and No Risk categories. Ask the",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 849
  },
  {
    "id": "chunk_00850",
    "text": "rs in the Low Risk and No Risk categories. Ask the group to identify other behaviors that could fit in these categories. Point out that some plea- surable sexual behaviors involve low or no risk. 6. Conclude by emphasizing that risk depends on the context of the behavior and other factors, such as:",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 850
  },
  {
    "id": "chunk_00851",
    "text": "ontext of the behavior and other factors, such as: \u25aa Gender \u25aa Whether or not the partner is infected \u25aa Whether or not the partner is the \u201cgiver\u201d or \u201creceiver\u201d of the sexual behavior \u25aa The difficulty of knowing whether or not one\u2019s partner is infected",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 851
  },
  {
    "id": "chunk_00852",
    "text": "f knowing whether or not one\u2019s partner is infected 7. Remind participants that they need to consider their values when talking about STI/HIV so that they do not impose their own values on others. Correct Answers NO RISK \u25aa Abstinence \u25aa Masturbation \u25aa Hugging a person with HIV \u25aa Kissing \u25aa Massage",
    "page_number": 76,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 852
  },
  {
    "id": "chunk_00853",
    "text": "\u25aa Performing oral sex on a man with a condom \u25aa Performing oral sex on a woman with a dental dam MEDIUM RISK \u25aa Performing oral sex on a man without a condom \u25aa Performing oral sex on a woman without a dental dam \u25aa Infant breastfeeding by an HIV-infected mother who is taking ARV medicines",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 853
  },
  {
    "id": "chunk_00854",
    "text": "an HIV-infected mother who is taking ARV medicines \u25aa Anal sex with a condom HIGHER RISK \u25aa Vaginal sex without a condom \u25aa Anal sex without a condom \u25aa Dry sex without a condom \u25aa Infant breastfeeding by an HIV-infected mother who is NOT taking ARV medicines STEPS 13 TO 19 Time: 90 minutes",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 854
  },
  {
    "id": "chunk_00855",
    "text": "king ARV medicines STEPS 13 TO 19 Time: 90 minutes Materials and Advance Preparation \u25aa None Instructions STEP 13. USING INFORMATION COLLECTED PREVIOUSLY, DETERMINE CLIENT\u2019S NEED FOR NATAL, NEWBORN, AND INFANT CARE OR WELL-CHILD SERVICES.",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 855
  },
  {
    "id": "chunk_00856",
    "text": ", NEWBORN, AND INFANT CARE OR WELL-CHILD SERVICES. 1. Explain that this step is the integration of postnatal, newborn, and infant care, and well-child services into the family planning session. 2. Refer to Step 13 on the algorithm with the participants.",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 856
  },
  {
    "id": "chunk_00857",
    "text": "to Step 13 on the algorithm with the participants. 3. Instruct participants to consider information that the client has provided previously during the counseling session, including her/his responses to questions in Step 3 and Step 4, to determine the client\u2019s needs for these services.",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 857
  },
  {
    "id": "chunk_00858",
    "text": "o determine the client\u2019s needs for these services. 4. Instruct participants that if information was not revealed already, they should ask the follow- ing two questions of the family planning client: \u25aa Have you given birth recently? \u25aa Do you have any children less than 5 years of age?",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 858
  },
  {
    "id": "chunk_00859",
    "text": "Do you have any children less than 5 years of age? If the client has... Do this... 1. Review Promoting a Healthy Postpartum Period for the Mother counseling card with client. Given birth recently 2. Review Newborn and Infant Health counseling card with client.",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 859
  },
  {
    "id": "chunk_00860",
    "text": "orn and Infant Health counseling card with client. 1. Ask if children have been taken to well-child services. 2. Ask if children have received all immunizations. Children less than 5 years of age 3. Ask if children have had their height and weight moni- tored.",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 860
  },
  {
    "id": "chunk_00861",
    "text": "dren have had their height and weight moni- tored. 4. Refer to well-child services if needed. 5. Refer participants to the BCS+ User\u2019s Guide and the table below to review what to do based on the client\u2019s responses.",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 861
  },
  {
    "id": "chunk_00862",
    "text": "review what to do based on the client\u2019s responses. 6. Refer to the counseling card on Promoting a Healthy Postpartum Period. Review the fol- lowing points that providers can use to discuss postpartum health with the client, if she has | 36 |",
    "page_number": 77,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 862
  },
  {
    "id": "chunk_00863",
    "text": "given birth recently: \u25aa Ensure that the mother has support for the first few days after birth; encourage rest and sleep. \u25aa Recommend a nutritious diet for the mother that includes plenty of fluids and micronu- trients (including Vitamin A and iron).",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 863
  },
  {
    "id": "chunk_00864",
    "text": "d micronu- trients (including Vitamin A and iron). \u25aa Discuss normal postpartum bleeding and lochia (postpartum vaginal discharge). Counsel on maternal danger signs, such as bleeding or vaginal discharge that has a foul smell.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 864
  },
  {
    "id": "chunk_00865",
    "text": "eeding or vaginal discharge that has a foul smell. \u25aa Discuss the need for four postnatal care visits: at 24 to 48 hours, 3 to 7 days, 4 to 6 weeks, and 4 to 6 months. \u25aa Advise on maintaining personal hygiene, including care of perineum and breasts.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 865
  },
  {
    "id": "chunk_00866",
    "text": "l hygiene, including care of perineum and breasts. \u25aa Counsel on return to sexual activity, which should be whenever the mother feels ready and usually after lochia stops. Advise that she can become pregnant again even before her menses returns, if she is not using contraceptives.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 866
  },
  {
    "id": "chunk_00867",
    "text": "enses returns, if she is not using contraceptives. \u25aa Counsel on postnatal depression, which may entail: crying easily; feeling tired, agitated, or irritable; lacking motivation; having difficulty sleeping; rejecting the baby.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 867
  },
  {
    "id": "chunk_00868",
    "text": "n; having difficulty sleeping; rejecting the baby. 7. Instruct providers that if they are unable to counsel or provide postpartum services, they should refer the client to the appropriate facility where the client can receive these services.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 868
  },
  {
    "id": "chunk_00869",
    "text": "ility where the client can receive these services. 8. Refer to the counseling card on Promoting Newborn and Infant Health and provide in- structed counseling and services. Review the following points that providers can use to",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 869
  },
  {
    "id": "chunk_00870",
    "text": "iew the following points that providers can use to discuss newborn and infant health with the client, if she has given birth recently: \u25aa Discuss careful hand washing to prevent infection prior to handling the baby and after changing diapers.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 870
  },
  {
    "id": "chunk_00871",
    "text": "r to handling the baby and after changing diapers. \u25aa Counsel the mother on newborn danger signs and when to seek care immediately. Dan- ger signs include: difficulty feeding and/or breathing; feeling too hot or too cold; being irritable for extended period of time.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 871
  },
  {
    "id": "chunk_00872",
    "text": "cold; being irritable for extended period of time. \u25aa Discuss the importance of providing good ventilation and keeping the baby warm. \u25aa Encourage exclusive breastfeeding for 6 months. Nothing else is necessary, not even water. Introduce complementary foods at 6 months and continue to breastfeed.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 872
  },
  {
    "id": "chunk_00873",
    "text": "tary foods at 6 months and continue to breastfeed. \u25aa For infants exposed to HIV: \u2013 Advise mother to give infant anti-retroviral drugs (ARVs) daily while breastfeeding and continue for one week after cessation of breastfeeding (around one year) and advise mother to continue ARV per national protocols.",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 873
  },
  {
    "id": "chunk_00874",
    "text": "ise mother to continue ARV per national protocols. \u2013 Recommend that HIV-exposed infants be tested for HIV at 6 weeks and start co-tri- moxazole prophylaxis (CTX). \u2013 Link mother and infant to HIV clinic. \u25aa Explain immunization schedule for infants using national or global guidelines, and in-",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 874
  },
  {
    "id": "chunk_00875",
    "text": "fants using national or global guidelines, and in- clude recommendation for Vitamin A at 6 months. \u25aa Discuss the need to attend child-welfare clinic (including key activities such as growth monitoring). 9. Instruct providers that if they are unable to counsel or provide infant or newborn services,",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 875
  },
  {
    "id": "chunk_00876",
    "text": "to counsel or provide infant or newborn services, they should refer the client to the appropriate facility where she can receive this counseling and services. 10. Explain to participants the types of services that are included in well-child services and the",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 876
  },
  {
    "id": "chunk_00877",
    "text": "s that are included in well-child services and the importance of receiving timely care and monitoring during the first five years of a child\u2019s life. Read them the list of services that may be included in well-child services, below: \u25aa Immunizations \u25aa Growth monitoring \u25aa Infant feeding support",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 877
  },
  {
    "id": "chunk_00878",
    "text": "tions \u25aa Growth monitoring \u25aa Infant feeding support \u25aa Vitamin A provision at 6 months \u25aa Sick child services (including Integrated Management of Childhood Illnesses, IMCI) | 37 |",
    "page_number": 78,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 878
  },
  {
    "id": "chunk_00879",
    "text": "11. Instruct providers that if the client has a child under 5 years of age, they should ask her/ him if the child has been taken to well-child services, and provide or refer client for these services, if needed.",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 879
  },
  {
    "id": "chunk_00880",
    "text": "ide or refer client for these services, if needed. 12. If client reported a recent abortion, review the Post Abortion Care card with the client. Pro- vide or refer for post abortion care services, if needed. 13. Ask participants if there are any questions about postpartum,well-child, or post abortion",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 880
  },
  {
    "id": "chunk_00881",
    "text": "ions about postpartum,well-child, or post abortion care services. STEP 14. ASK CLIENT WHEN SHE HAD HER LAST SCREENING FOR CERVICAL CANCER (VIA/VILI OR PAP SMEAR) OR BREAST CANCER. 1. Referring to User\u2019s Manual, explain to participants that cervical cancer:",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 881
  },
  {
    "id": "chunk_00882",
    "text": "ual, explain to participants that cervical cancer: \u25aa Results from uncontrolled, untreated growth of abnormal cells in the cervix. \u25aa Is caused by a sexually-transmitted infection, the human papillomavirus (HPV). \u25aa Takes 10 to 20 years to develop, so there is a long period of opportunity to detect and",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 882
  },
  {
    "id": "chunk_00883",
    "text": "here is a long period of opportunity to detect and treat changes and growths before they cause cancer. 2. Referring to User\u2019s Manual, explain to participants that screening for cervical cancer: \u25aa Helps to detect any changes and precancerous growths before they become cancer.",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 883
  },
  {
    "id": "chunk_00884",
    "text": "nd precancerous growths before they become cancer. \u25aa Is simple, quick, and generally not painful. 3. Instruct providers that after informing client about cervical cancer, they should ask her when she had her last screening for cervical cancer.",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 884
  },
  {
    "id": "chunk_00885",
    "text": "en she had her last screening for cervical cancer. 4. Refer participants to the BCS+ User\u2019s Guide and the table below to review what to do based on the client\u2019s responses. If the client has... Do this... Had her last screening more than 3 years Provide Pap smear or VIA/VILI screening test. ago OR OR",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 885
  },
  {
    "id": "chunk_00886",
    "text": "de Pap smear or VIA/VILI screening test. ago OR OR Refer for Pap smear or VIA/VILI screening test at appropriate Does not know when her last screening facility when test available. was Had her last screening less than 3 years Advise client when to seek next screening ago",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 886
  },
  {
    "id": "chunk_00887",
    "text": "ears Advise client when to seek next screening ago 5. Ask participants if they have any questions about cervical cancer screening. 6. Review Breast Cancer Information and Awareness counseling card with client. 7. Ask participants if they have questions about breast cancer information and awareness.",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 887
  },
  {
    "id": "chunk_00888",
    "text": "ons about breast cancer information and awareness. STEP 15. DISCUSS STI/HIV TRANSMISSION & PREVENTION AND DUAL PROTECTION WITH THE CLIENT USING THE COUNSELING CARD. OFFER CONDOMS AND INSTRUCT HER/HIM IN CORRECT AND CONSISTENT USE.",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 888
  },
  {
    "id": "chunk_00889",
    "text": "ND INSTRUCT HER/HIM IN CORRECT AND CONSISTENT USE. 1. Explain that this is the first part of integrating STI/HIV counseling and testing into the family planning session. 2. Refer to the counseling card on STI/HIV Transmission & Prevention. Review the following",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 889
  },
  {
    "id": "chunk_00890",
    "text": "IV Transmission & Prevention. Review the following points that providers can use to discuss STIs/HIV with the client: \u25aa A person can become infected with STIs, including HIV, through unsafe or unprotected sexual activity. \u25aa STIs are common.",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 890
  },
  {
    "id": "chunk_00891",
    "text": "or unprotected sexual activity. \u25aa STIs are common. \u25aa A person living with STIs (including HIV) may have no symptoms, may look healthy, and may not be aware that s/he is infected. \u25aa Common STI symptoms include vaginal discharge, discharge from the penis, sores in the",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 891
  },
  {
    "id": "chunk_00892",
    "text": "discharge, discharge from the penis, sores in the genital area, burning on urination for men, lower abdominal pain for women. \u25aa Some STIs can be treated. To avoid re-infection, both partners must be treated. | 38 |",
    "page_number": 79,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 892
  },
  {
    "id": "chunk_00893",
    "text": "\u25aa Risk of infection can be reduced by using a condom, limiting the number of sex part- ners, and delaying sex (adolescents). \u25aa HIV is a sexually transmitted infection. HIV is transmitted through an exchange of bodi- ly fluids such as semen, blood, breast milk, and during delivery.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 893
  },
  {
    "id": "chunk_00894",
    "text": "as semen, blood, breast milk, and during delivery. \u25aa Knowing your HIV status protects you, your partner, and your family. \u25aa Although HIV cannot be cured, early identification and treatment can allow a person to live a long, productive life and prevent his/her partner from becoming infected.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 894
  },
  {
    "id": "chunk_00895",
    "text": "nd prevent his/her partner from becoming infected. \u25aa Male circumcision reduces the risk of heterosexually acquired HIV infection in men by approximately 60% and should be one element of a comprehensive HIV-prevention package.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 895
  },
  {
    "id": "chunk_00896",
    "text": "element of a comprehensive HIV-prevention package. \u25aa Maternal transmission of HIV to the child can be substantially reduced by identifying women living with HIV and providing treatment or prophylactic ARV medicines during pregnancy.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 896
  },
  {
    "id": "chunk_00897",
    "text": "nt or prophylactic ARV medicines during pregnancy. 3. Instruct participants that after discussing HIV transmission and prevention, s/he should ask the client whether s/he has any questions. 4. Explain to the participants that dual protection is the simultaneous prevention of STIs and pregnancy.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 897
  },
  {
    "id": "chunk_00898",
    "text": "the simultaneous prevention of STIs and pregnancy. 5. Refer to counseling card on Dual Protection. Review the following points that providers can use to discuss Dual Protection with the client: \u25aa Dual protection is the use of condoms consistently and correctly in combination with",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 898
  },
  {
    "id": "chunk_00899",
    "text": "oms consistently and correctly in combination with another family planning method. This provides added protection against pregnancy in case of condom failure. \u25aa Use a male or female condom correctly and consistently with every act of sex. This one method protects against STIs and pregnancy.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 899
  },
  {
    "id": "chunk_00900",
    "text": "is one method protects against STIs and pregnancy. \u25aa Only engage in safer sexual intimacy that prevents semen and vaginal fluids from coming in contact with partner\u2019s genitals or other vulnerable areas, such as the mouth and anus.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 900
  },
  {
    "id": "chunk_00901",
    "text": "ther vulnerable areas, such as the mouth and anus. \u25aa Delay or avoid sexual activity, especially with a partner whose STI/HIV status is not known. 6. Instruct providers to ask client if she/he has any questions.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 901
  },
  {
    "id": "chunk_00902",
    "text": "oviders to ask client if she/he has any questions. 7. Instruct providers to offer condoms, if available, to clients. If not available, providers should tell clients where to get them. 8. Point out that providers should also show the client how to properly use a condom.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 902
  },
  {
    "id": "chunk_00903",
    "text": "also show the client how to properly use a condom. 9. Demonstrate how to use a condom in front of the class. If participants are comfortable with condoms, have one of them demonstrate how to use it. STEP 16. CONDUCT STI AND HIV RISK ASSESSMENT USING THE COUNSELING CARD. IF SYMPTOMS",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 903
  },
  {
    "id": "chunk_00904",
    "text": "ASSESSMENT USING THE COUNSELING CARD. IF SYMPTOMS ARE IDENTIFIED, TREAT HER/HIM SYNDROMICALLY. 1. Explain that at this stage, the provider should explore what the client knows about STIs, HIV, and AIDS in order to correct any misinformation, fill in gaps, and answer questions.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 904
  },
  {
    "id": "chunk_00905",
    "text": "isinformation, fill in gaps, and answer questions. 2. Ask participants to refer to the BCS+ counseling card on STI and HIV Risk Assessment. It contains the following points that a provider discusses with clients to help them perceive their risk of STI/HIV:",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 905
  },
  {
    "id": "chunk_00906",
    "text": "ients to help them perceive their risk of STI/HIV: \u25aa HIV status and HIV status of partner(s). If partner is positive, whether s/he is taking ARV medicines. \u25aa Number of sexual partners, both current and in the past. \u25aa Knowledge of partner\u2019s sexual practices and past partners.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 906
  },
  {
    "id": "chunk_00907",
    "text": "e of partner\u2019s sexual practices and past partners. \u25aa Knowledge of male partner\u2019s circumcision status. \u25aa Past and present condom use (including perception of partner\u2019s attitude) and whether s/ he is aware that condoms protect against both STIs/HIV and pregnancy.",
    "page_number": 80,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 907
  },
  {
    "id": "chunk_00908",
    "text": "partner has other sexual partners, oral sex, anal sex, dry sex, or use of detergents and/or spermicides). \u25aa Home-life situation (for example, partner violence and social support). \u25aa Use of PMTCT services during pregnancy, delivery, and breastfeeding.",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 908
  },
  {
    "id": "chunk_00909",
    "text": "ces during pregnancy, delivery, and breastfeeding. 3. Ask participants whether they have any questions about the STI and HIV risk assessment or the above-mentioned points. 4. Explain that at this point the provider has an opportunity to correct misinformation, fill in",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 909
  },
  {
    "id": "chunk_00910",
    "text": "an opportunity to correct misinformation, fill in the gaps, and answer any questions the client may have about STIs and HIV. 5. Mention that once the provider has a clearer picture of the client\u2019s sexual risks and social con-",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 910
  },
  {
    "id": "chunk_00911",
    "text": "cture of the client\u2019s sexual risks and social con- text, s/he can help the client make a plan to reduce risk using any of the following strategies: \u25aa Reducing the number of sexual partners. \u25aa Using condoms (male or female) correctly and consistently with every act of sex. Con-",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 911
  },
  {
    "id": "chunk_00912",
    "text": "ectly and consistently with every act of sex. Con- doms are the only method that protects against STIs, including HIV. \u25aa Making condoms available to her/his partner and encourage their use correctly and consistently. \u25aa Avoiding the use of unclean skin-cutting instruments and/or injection needles.",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 912
  },
  {
    "id": "chunk_00913",
    "text": "skin-cutting instruments and/or injection needles. \u25aa Having any STI or cervical infection detected and treated immediately. \u25aa Undergoing any procedures involving the genital tract in an aseptic environment. \u25aa Practicing dual protection. \u25aa Knowing your HIV status.",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 913
  },
  {
    "id": "chunk_00914",
    "text": "ticing dual protection. \u25aa Knowing your HIV status. 6. Inform providers that they have a responsibility to help the client reduce her/his risk of acquiring HIV and STIs. 7. Instruct participants that, if client has STI, they should treat her/him syndromically accord-",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 914
  },
  {
    "id": "chunk_00915",
    "text": "I, they should treat her/him syndromically accord- ing to national guidelines or refer her/him for tests, if available. 8. Refer participants to guidelines for STIs or national guidelines for STI management. STEP 17. ASK CLIENT WHETHER SHE/HE KNOWS HER/HIS HIV STATUS.",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 915
  },
  {
    "id": "chunk_00916",
    "text": "SK CLIENT WHETHER SHE/HE KNOWS HER/HIS HIV STATUS. 1. Instruct participants to gently inquire whether the client knows her/his HIV status. 2. Inform the client that you will not share her/his status without consent.",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 916
  },
  {
    "id": "chunk_00917",
    "text": "you will not share her/his status without consent. 3. Review the following table in User Manual with participants and walk through instructions on appropriate HIV counseling and testing according to client\u2019s knowledge of HIV status and testing status. If the client has: Do this:",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 917
  },
  {
    "id": "chunk_00918",
    "text": "us and testing status. If the client has: Do this: 1. Review Positive Health, Dignity, & Prevention counseling card with client. 2. Ask when the client last attended a health facility for her/ Knows HIV status and is living with HIV his monitoring visit.",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 918
  },
  {
    "id": "chunk_00919",
    "text": "tatus and is living with HIV his monitoring visit. 3. Refer client to center for wellness care and treatment, if necessary. Knows HIV status and is negative Discuss time frame for repeat testing If client knows her/his HIV status and is living with HIV:",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 919
  },
  {
    "id": "chunk_00920",
    "text": "t knows her/his HIV status and is living with HIV: \u25aa Review counseling points listed on the Positive Health, Dignity, & Prevention counseling card with participants. Read the following points out loud to participants:",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 920
  },
  {
    "id": "chunk_00921",
    "text": "ead the following points out loud to participants: \u2013 People living with HIV should always use a condom correctly and consistently with their sexual partners. \u2013 If a woman with HIV wants to get pregnant, the risk of her passing HIV to her newborn",
    "page_number": 81,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 921
  },
  {
    "id": "chunk_00922",
    "text": "It is important to receive care at an antenatal care clinic and an HIV treatment center. \u2013 People living with HIV need regular health checkups to see if they need ARV medicine, to evaluate how they are doing on ARV medicines, and to rule out other infections or illnesses.",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 922
  },
  {
    "id": "chunk_00923",
    "text": "es, and to rule out other infections or illnesses. \u2013 If a client is taking ARV medicine, s/he should attend follow-up clinic visits as recommend- ed by the provider. Visits may be more frequent when ARV medicines are initiated.",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 923
  },
  {
    "id": "chunk_00924",
    "text": "be more frequent when ARV medicines are initiated. \u2013 The client should do her/his best to adhere to the medication regimen prescribed and should not share medications. \u2013 Partners should get tested as well. The client can bring her/his partner in for counseling, to talk together, if this will help.",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 924
  },
  {
    "id": "chunk_00925",
    "text": "r counseling, to talk together, if this will help. \u2013 If currently taking medications for tuberculosis, s/he should follow up with provider. \u2013 Positive health results from taking care of oneself and being alert to health concerns that",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 925
  },
  {
    "id": "chunk_00926",
    "text": "of oneself and being alert to health concerns that warrant attention, which may include physical and mental health issues as well as social support. \u25aa Instruct participants that they should give support to clients and encourage them to disclose",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 926
  },
  {
    "id": "chunk_00927",
    "text": "support to clients and encourage them to disclose their status with their partners. Explain to participants that there are benefits to disclosing one\u2019s status. Read the following benefits out loud, and explain that disclosing one\u2019s HIV status will help the client:",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 927
  },
  {
    "id": "chunk_00928",
    "text": "disclosing one\u2019s HIV status will help the client: \u2013 Get support from their spouse, family, and health center. \u2013 Better plan and make appropriate decisions about HIV care and support and family matters. \u2013 Get early access to medicine and support that keeps them healthy.",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 928
  },
  {
    "id": "chunk_00929",
    "text": "s to medicine and support that keeps them healthy. \u2013 Save an HIV-negative partner\u2019s and unborn child\u2019s life by not infecting them. \u2013 Better negotiate condom use with their partner to prevent them from being infected. \u2013 Avoid exposure to repeated infections that will compromise their health.",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 929
  },
  {
    "id": "chunk_00930",
    "text": "ated infections that will compromise their health. \u25aa Read the following risks of disclosing one\u2019s HIV status and explain that there may be risks associated with disclosing one\u2019s status as well: \u2013 Stigmatization and discrimination from family, friends, and community. \u2013 Abuse from spouse.",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 930
  },
  {
    "id": "chunk_00931",
    "text": "mily, friends, and community. \u2013 Abuse from spouse. \u2013 Divorce from spouse. \u25aa Inform participants that they should be sensitive and receptive to all concerns and questions clients may have. \u25aa Explain that they should be prepared to offer resources, if available, to people living with HIV",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 931
  },
  {
    "id": "chunk_00932",
    "text": "resources, if available, to people living with HIV who face abuse or difficult family situations because of their status. \u25aa Point out that as providers, they should be able to inform clients about the importance of",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 932
  },
  {
    "id": "chunk_00933",
    "text": "be able to inform clients about the importance of being healthy, answer questions, and refer clients to appropriate facility for comprehensive care. \u25aa Instruct participants to become aware of HIV health and wellness centers and services avail-",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 933
  },
  {
    "id": "chunk_00934",
    "text": "IV health and wellness centers and services avail- able. Explain that they should refer clients to the appropriate services when needed. If client know her/his HIV status and is negative: \u25aa Instruct participants to discuss HIV retesting with a client who knows her/his HIV status and",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 934
  },
  {
    "id": "chunk_00935",
    "text": "ing with a client who knows her/his HIV status and is HIV negative. The provider should consider the client\u2019s risk assessment and sexual behaviors to decide the most appropriate frequency for HIV testing. \u25aa Explain HIV retesting to participants, including the fact that global recommendations on HIV",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 935
  },
  {
    "id": "chunk_00936",
    "text": "luding the fact that global recommendations on HIV retesting, including frequency of testing, vary depending on client\u2019s risk behaviors and sexual practices. \u25aa Instruct providers to refer to their national guidelines and protocol to determine the appropri-",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 936
  },
  {
    "id": "chunk_00937",
    "text": "guidelines and protocol to determine the appropri- ate time frame and recommendations for HIV retesting. \u25aa Explain that providers should emphasize that prevention, early detection, and prompt manage- ment of STIs, including HIV, are beneficial to clients, their partner and family, and the com-",
    "page_number": 82,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 937
  },
  {
    "id": "chunk_00938",
    "text": "If client does not know her/his HIV status: \u25aa Mention that the provider should use the HIV Counseling and Testing (HCT) card to guide the discussion about HIV testing. Below are the key points providers should cover with the client:",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 938
  },
  {
    "id": "chunk_00939",
    "text": "key points providers should cover with the client: \u2013 Knowing your HIV status can help you make decisions about protecting yourself and your sexual partner(s). \u2013 Testing permits people living with HIV to seek treatment so that they can live a full life. The",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 939
  },
  {
    "id": "chunk_00940",
    "text": "k treatment so that they can live a full life. The test involves taking a small sample of blood. The test is free and available at clinics, hospi- tals, and HIV counseling and testing sites. \u2013 Test results are kept confidential.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 940
  },
  {
    "id": "chunk_00941",
    "text": "sting sites. \u2013 Test results are kept confidential. \u2013 When a person is first infected with HIV, it can take 3 or more months or the test to detect the infection. This is called the \u201cwindow period\u201d and is the reason why repeat testing is important.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 941
  },
  {
    "id": "chunk_00942",
    "text": "and is the reason why repeat testing is important. \u2013 A positive test result means the person is infected with HIV and can transmit the virus to others. \u2013 A negative test result can mean the person is not infected or that s/he is in the \u201cwindow",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 942
  },
  {
    "id": "chunk_00943",
    "text": "son is not infected or that s/he is in the \u201cwindow period.\u201d Another test should be taken within 3 months. If the second test is still negative, the person is currently not living with HIV but can still become infected with HIV.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 943
  },
  {
    "id": "chunk_00944",
    "text": "g with HIV but can still become infected with HIV. \u2013 HIV is a sexually transmitted infection (STI). It is important to ask your sexual partner(s) to be tested too. \u25aa Instruct providers to emphasize to the client that prevention, early detection, and prompt",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 944
  },
  {
    "id": "chunk_00945",
    "text": "lient that prevention, early detection, and prompt management of STIs, including HIV, are beneficial to them, their partner and family, and the community at large. \u25aa Explain to participants that testing for HIV is often a very frightening event for individuals.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 945
  },
  {
    "id": "chunk_00946",
    "text": "is often a very frightening event for individuals. Many people who know they should be tested do not do so out of fear and other reasons. \u25aa Point out that as providers, they should be able to respond to the fears, excuses, and arguments that clients offer as to why they will not or cannot be tested.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 946
  },
  {
    "id": "chunk_00947",
    "text": "offer as to why they will not or cannot be tested. \u25aa Refer to User\u2019s Manual and briefly discuss WHO\u2019s policy on provider-initiated HIV testing and counseling (PITC). \u25aa Instruct providers to offer or initiate HIV testing, according to national protocols, in the family",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 947
  },
  {
    "id": "chunk_00948",
    "text": "ng, according to national protocols, in the family planning clinic. If testing services are not provided, explain to providers that they should refer the client to specialized HTC services. \u25aa Explain that participants should be prepared to counsel client on the results of the HIV test.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 948
  },
  {
    "id": "chunk_00949",
    "text": "to counsel client on the results of the HIV test. \u25aa Point out that if the client\u2019s test is positive, participants should review the Positive Health, Dignity, & Prevention card with the client and should refer client to a center for wellness care",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 949
  },
  {
    "id": "chunk_00950",
    "text": "should refer client to a center for wellness care and treatment to receive necessary HIV-related services. Counsel client using Women\u2019s Support and Safety Card \u25aa If client shows any major Intimate Partner Violence (IPV) triggers, refer her for specialized services.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 950
  },
  {
    "id": "chunk_00951",
    "text": "IPV) triggers, refer her for specialized services. STEP 18. GIVE FOLLOW-UP INSTRUCTIONS, A CONDOM BROCHURE, AND THE BROCHURE FOR THE METHOD CHOSEN. SET A DATE FOR NEXT VISIT. 1. Remind participants that the provider should summarize the key points mentioned during the consultation.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 951
  },
  {
    "id": "chunk_00952",
    "text": "the key points mentioned during the consultation. 2. Explain that the provider then gives the client follow-up instructions for the method chosen along with the corresponding method brochure. 3. Mention that the provider also gives the client a brochure on condoms, reiterating the fact",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 952
  },
  {
    "id": "chunk_00953",
    "text": "client a brochure on condoms, reiterating the fact that only condoms provide dual protection against both STIs and unintended pregnancy. 4. Mention that providers may need to give the client a follow-up appointment, depending on the method provided.",
    "page_number": 83,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 953
  },
  {
    "id": "chunk_00954",
    "text": "\u25aa Check on how the client is using the method. \u25aa Provide a new supply of the method. \u25aa Provide information and support needed for the client to continue using the method correctly and consistently, or to select another method.",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 954
  },
  {
    "id": "chunk_00955",
    "text": "tly and consistently, or to select another method. \u25aa Bring the partner for further counseling on family planning and/or STI/HIV. \u25aa Have an HIV test. 6. Explain that it is important to encourage the client to return to the health care facility any time s/he has a question or wishes to change methods.",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 955
  },
  {
    "id": "chunk_00956",
    "text": "e s/he has a question or wishes to change methods. STEP 19. THANK HER/HIM FOR THE VISIT. COMPLETE THE COUNSELING SESSION. 1. Mention that the provider should be warm and cordial when ending the session. This atti- tude will encourage the client to feel welcome to return.",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 956
  },
  {
    "id": "chunk_00957",
    "text": "ll encourage the client to feel welcome to return. 2. Remind participants that a client has the right to change her/his reproductive goals and to stop using the family planning method if s/he wishes. PRACTICE SESSION ROLE PLAYS Total Time: 90 minutes",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 957
  },
  {
    "id": "chunk_00958",
    "text": "PRACTICE SESSION ROLE PLAYS Total Time: 90 minutes By the end of this session, participants will be able to: \u25aa Counsel clients using the BCS+ job aids Materials and Advance Preparation \u25aa Divide the number of participants expected for the workshop by two. This is the number of",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 958
  },
  {
    "id": "chunk_00959",
    "text": "ted for the workshop by two. This is the number of role-play scripts you will need. \u25aa Make enough copies of the role-play scripts (found at the end of this exercise) to accommo- date the number of participants who will need a script. It is okay if a couple of participants are",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 959
  },
  {
    "id": "chunk_00960",
    "text": "script. It is okay if a couple of participants are playing the same role of client. (Note: There are two role plays. You can use the same role-play scripts, just make sure participants get a different script for the second role play.) \u25aa Feel free to make up your own scripts or roles.",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 960
  },
  {
    "id": "chunk_00961",
    "text": "\u25aa Feel free to make up your own scripts or roles. \u25aa Cut along the lines so that you can give each participant playing the role of client a script to use. \u25aa Note that the ideal method for each role is written in parentheses at the end of each script. ROLE PLAY #1 Time: 30 minutes",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 961
  },
  {
    "id": "chunk_00962",
    "text": "end of each script. ROLE PLAY #1 Time: 30 minutes Instructions for Role Play #1 1. Ask the participants to stand up. Have them count off \u201c1,\u201d \u201c2,\u201d \u201c1,\u201d \u201c2,\u201d etc. 2. Explain that all of the \u201c1s\u201d will play the \u201cfamily planning providers,\u201d and all of the \u201c2s\u201d will be \u201cfamily planning clients.\u201d",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 962
  },
  {
    "id": "chunk_00963",
    "text": "all of the \u201c2s\u201d will be \u201cfamily planning clients.\u201d 3. Ask all of the \u201c2s\u201d to raise their hands. 4. Ask the \u201c1s\u201d to find a participant to work with. 5. Once participants have found partners, give each participant playing the \u201cclient\u201d a script. Conducting the Role Play #1",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 963
  },
  {
    "id": "chunk_00964",
    "text": "the \u201cclient\u201d a script. Conducting the Role Play #1 1. Tell participants to find a place in the room where they will conduct their counseling session. (Note: Do not let them sit down yet.) 2. Ask participants to begin the role play standing so that they can greet the client. After greet-",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 964
  },
  {
    "id": "chunk_00965",
    "text": "ng so that they can greet the client. After greet- ing the client, they may sit down and begin the counseling session. 3. Allow about 30 minutes for the role play. | 43 |",
    "page_number": 84,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 965
  },
  {
    "id": "chunk_00966",
    "text": "4. After 25 minutes, tell participants that they have 5 minutes to conclude their counseling session. (Note: During the role play, walk around and observe how participants are doing. Note anything you see that is not being done well and recount that information when you evaluate the role play.)",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 966
  },
  {
    "id": "chunk_00967",
    "text": "that information when you evaluate the role play.) Evaluating the Role Play 1. When the time is up, ask the participants who played the providers what it was like going through the entire BCS+ process, using the algorithm and job aids.",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 967
  },
  {
    "id": "chunk_00968",
    "text": "re BCS+ process, using the algorithm and job aids. 2. Ask whether they have any questions or comments about using the BCS+ algorithm, coun- seling cards, WHO MEC wheel, or method brochures to counsel their client.",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 968
  },
  {
    "id": "chunk_00969",
    "text": "heel, or method brochures to counsel their client. 3. Answer all questions and address all comments before proceeding. (Note: It is important that you be familiar with using the BCS+ job aids to counsel family planning clients. This",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 969
  },
  {
    "id": "chunk_00970",
    "text": "job aids to counsel family planning clients. This experience will help you better answer participants\u2019 questions and comments.) 4. Ask the participants who played the clients the following questions: \u25aa What was it like to be counseled using the BCS+ approach?",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 970
  },
  {
    "id": "chunk_00971",
    "text": "s it like to be counseled using the BCS+ approach? \u25aa Was anything confusing to you? If so, what? \u25aa Do you have any tips for the participants who played the provider? (Note: Write the tips on newsprint or flipchart paper.)",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 971
  },
  {
    "id": "chunk_00972",
    "text": ": Write the tips on newsprint or flipchart paper.) 5. Provide any positive reinforcement and input based on your observations during the role plays. ROLE PLAY #2 Time: 30 minutes Instructions for Role Play #2",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 972
  },
  {
    "id": "chunk_00973",
    "text": "#2 Time: 30 minutes Instructions for Role Play #2 1. Tell participants that they are going to reverse roles. The person who was the client is going to play the provider, and the provider will now be the client.",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 973
  },
  {
    "id": "chunk_00974",
    "text": "provider, and the provider will now be the client. 2. Give each client a script with a role on it. (See scripts for role play #2 at the end of this section.) Conducting the Role Play 1. Ask participants to begin the role play by greeting each other as in the previous role play.",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 974
  },
  {
    "id": "chunk_00975",
    "text": "greeting each other as in the previous role play. 2. Allow about 30 minutes for the second role play. 3. During the role play, walk around and observe how participants are doing. Note anything you see that is not being done well and recount that information for when you evaluate the role play.",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 975
  },
  {
    "id": "chunk_00976",
    "text": "t information for when you evaluate the role play. Evaluating the Role Play 1. When the time is up, ask the participants who played the providers what it was like to use the BCS+ algorithm and job aids. 2. Ask whether they have any questions about how to use the BCS+ algorithm, counseling",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 976
  },
  {
    "id": "chunk_00977",
    "text": "ns about how to use the BCS+ algorithm, counseling cards, WHO MEC Wheel, or method brochures. Answer all questions before proceeding. 3. Ask the participants who played the clients the following questions: \u25aa What was it like to be counseled using the BCS+ approach?",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 977
  },
  {
    "id": "chunk_00978",
    "text": "s it like to be counseled using the BCS+ approach? \u25aa Was anything confusing to you? If so, what? \u25aa Do you have any tips for the participants who played the provider? (Note: Write the tips on newsprint or flipchart paper.) 4. Mention your comments based on your observations during the role plays.",
    "page_number": 85,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 978
  },
  {
    "id": "chunk_00979",
    "text": "Client Scripts for Practice Session Role Plays You are a 23-year-old married woman who has two young children. You want to wait 2 to 3 years before getting pregnant again. Your husband is not interested in family planning. You have not used",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 979
  },
  {
    "id": "chunk_00980",
    "text": "t interested in family planning. You have not used modern contraceptive methods before. Your last child is 5 months old, and you are breastfeeding. You are very worried about using the IUD and refuse it if offered. You are not sure of your HIV",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 980
  },
  {
    "id": "chunk_00981",
    "text": "refuse it if offered. You are not sure of your HIV status, but think your husband had many partners before marriage. You have never been screened for cervical cancer. (Combined Injectable Contraceptive [CIC]) ____________________________________________________________________",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 981
  },
  {
    "id": "chunk_00982",
    "text": "__________________________________________________ You are a 26-year-old woman who gave birth a week ago. You mix feed because you are at work during the day and do not have enough milk to express. You previously used a 3-month injectable",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 982
  },
  {
    "id": "chunk_00983",
    "text": "express. You previously used a 3-month injectable but now want to change to a different method since you are tired of an injection. You are on an- ti-hypertensive medication and your blood pressure is controlled. (Progestin-only oral contraceptive\u2014Minipill)",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 983
  },
  {
    "id": "chunk_00984",
    "text": "lled. (Progestin-only oral contraceptive\u2014Minipill) ____________________________________________________________________ You are a 40-year-old woman who has tested HIV positive a month ago. Your CD4 count is <200",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 984
  },
  {
    "id": "chunk_00985",
    "text": "d HIV positive a month ago. Your CD4 count is <200 and you have uncontrolled high blood pressure. The doctor has initiated you on ARVs. You would like to continue using a 3-month injectable which has never given you problems since you were a teenager. (Progestin-only injectable)",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 985
  },
  {
    "id": "chunk_00986",
    "text": "e you were a teenager. (Progestin-only injectable) ____________________________________________________________________ You are an 18-year-old girl. You started your menstrual bleeding 10 days ago. You are sexually active",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 986
  },
  {
    "id": "chunk_00987",
    "text": "rual bleeding 10 days ago. You are sexually active and have a boyfriend. You want to avoid getting pregnant and want the Pill, because you heard the Pill prevents pregnancy. Neither you nor your boyfriend wants to use condoms. Later on in the con-",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 987
  },
  {
    "id": "chunk_00988",
    "text": "yfriend wants to use condoms. Later on in the con- sultation you reveal that you had unprotected sex 2 days ago. You have a slight vaginal discharge. (Emergency Contraceptive Pills [ECPs] and the Pill) ____________________________________________________________________",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 988
  },
  {
    "id": "chunk_00989",
    "text": "__________________________________________________ You are 25 years old and have multiple sexual partners. You slowly reveal that you are a sex worker trying to earn enough money to support your two children. Your (paying) partners do not like to use",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 989
  },
  {
    "id": "chunk_00990",
    "text": "hildren. Your (paying) partners do not like to use condoms. You have heard of sexually transmitted diseases and are afraid of getting one. You also cannot afford to get pregnant again. (Female condom) ____________________________________________________________________",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 990
  },
  {
    "id": "chunk_00991",
    "text": "__________________________________________________ You are an adolescent boy who has come to the clinic with an STI but not HIV. You are concerned about getting an STI again. You have had several girlfriends. Your current girlfriend wants to get",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 991
  },
  {
    "id": "chunk_00992",
    "text": "girlfriends. Your current girlfriend wants to get pregnant to show you that she loves you, but you are not so happy about the idea. If the \u201cprovider\u201d offers you condoms, agree. Before you leave, ask the provider how your girlfriend can avoid getting pregnant.",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 992
  },
  {
    "id": "chunk_00993",
    "text": "er how your girlfriend can avoid getting pregnant. (Male condom and the provider should encourage the girlfriend to come in.) ____________________________________________________________________ | 45 |",
    "page_number": 86,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 993
  },
  {
    "id": "chunk_00994",
    "text": "You are a 30-year-old married woman who does not want to have any more children. You already have four (your latest child is 3 months old) and are tired and fed up with being pregnant. Your partner is interested in more children. Your husband likes having sex frequently and does not like",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 994
  },
  {
    "id": "chunk_00995",
    "text": "band likes having sex frequently and does not like using condoms. You are afraid of injections. You have had mild seizures in the past and sometimes take medicine for them. If offered the minipill, explain that you are afraid you will forget to take the",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 995
  },
  {
    "id": "chunk_00996",
    "text": "in that you are afraid you will forget to take the pill every day. Your husband travels occasionally and you are not sure if he is faithful. (IUD) ____________________________________________________________________",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 996
  },
  {
    "id": "chunk_00997",
    "text": "__________________________________________________ You are a 20-year-old woman with a 4-month-old child that you are breastfeeding. Your husband is working on a farm as a migrant laborer and is gone 22 days of the month. You have never used",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 997
  },
  {
    "id": "chunk_00998",
    "text": "is gone 22 days of the month. You have never used family planning but want to control your fertility. You are about to start your menstruation. It is Monday, and your husband is coming home this weekend. He does not like to use condoms and is",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 998
  },
  {
    "id": "chunk_00999",
    "text": "is weekend. He does not like to use condoms and is not supportive of family planning. If offered the IUD, explain that you cannot afford to go to the hospital, which is 100 miles away. (Progestin-only oral contraceptive\u2014Minipill) ____________________________________________________________________",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 999
  },
  {
    "id": "chunk_01000",
    "text": "__________________________________________________ You are a 35-year-old married woman with 3 children. The youngest child is 6 weeks old. You are not ready to have another child. Your husband does not cooperate with family planning. You live",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1000
  },
  {
    "id": "chunk_01001",
    "text": "does not cooperate with family planning. You live fairly far from the health center. You have heard negative things about the IUD and refuse it if offered. If offered implants, explain that your husband would notice and be angry. You had an extramarital affair several years ago.",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1001
  },
  {
    "id": "chunk_01002",
    "text": "You had an extramarital affair several years ago. (Progestin-only injectable \u2014 DMPA only requires client to return every 3 months) ____________________________________________________________________ You are 18 years old and single. You have a boyfriend and do not want to get pregnant. You and",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1002
  },
  {
    "id": "chunk_01003",
    "text": "boyfriend and do not want to get pregnant. You and your boyfriend go to school. You are about to begin your menstruation. If offered the IUD or Norplant, reveal that you do not want something foreign in your body. If offered injectables, scream",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1003
  },
  {
    "id": "chunk_01004",
    "text": "reign in your body. If offered injectables, scream and say you hate needles. If offered the minipill, explain that you have come to the clinic before for the minipill, but they are always out of stock. You have no conditions that prevent you from taking",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1004
  },
  {
    "id": "chunk_01005",
    "text": "ou have no conditions that prevent you from taking the Pill. Besides, there is a pharmacy in your community that carries the most popular Pill. You have had several boyfriends in the past. (Combined oral contraceptives) ____________________________________________________________________",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1005
  },
  {
    "id": "chunk_01006",
    "text": "__________________________________________________ You are 29 years old and have been fully breastfeeding your child and using LAM as a birth con- trol method. You are beginning to give your infant food. You want to make sure that using LAM is",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1006
  },
  {
    "id": "chunk_01007",
    "text": "fant food. You want to make sure that using LAM is still effective. You have chosen LAM because you want to breastfeed your baby, and you are very religious. You and your husband do not believe in modern contraceptive methods. Your husband",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1007
  },
  {
    "id": "chunk_01008",
    "text": "ieve in modern contraceptive methods. Your husband supports you in wanting to space your children. If TwoDay Method is offered, you do not want to touch your genitals. Both you and your husband are monogamously faithful. (Standard Days Method)",
    "page_number": 87,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1008
  },
  {
    "id": "chunk_01009",
    "text": "You are a 22-year-old woman with a 1-year-old child. You are in a stable marriage, and your husband supports family planning. You do not like modern contraceptive methods. Sometimes he will use a condom but not consistently because it reduces feeling for him. You do not like the side effects of",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1009
  },
  {
    "id": "chunk_01010",
    "text": "eling for him. You do not like the side effects of hormonal methods. You are religious and would not like a modern method. If the provider offers you a fertility awareness method, such as Standard Days Method or TwoDay Method, appear to be",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1010
  },
  {
    "id": "chunk_01011",
    "text": "tandard Days Method or TwoDay Method, appear to be interested. Then, reveal that your monthly menstruation cycles are very irregular. (Female condom) ____________________________________________________________________",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1011
  },
  {
    "id": "chunk_01012",
    "text": "__________________________________________________ You are 39 years old and have 6 children. You are tired and do not want any more children. Your husband cooperates with family planning but will not use a condom. You have tried hormonal",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1012
  },
  {
    "id": "chunk_01013",
    "text": "but will not use a condom. You have tried hormonal methods in the past but do not like the side effects. Furthermore, you were not good at remember- ing to take the pill, which resulted in your fifth pregnancy. You are afraid of the IUD and you have",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1013
  },
  {
    "id": "chunk_01014",
    "text": "pregnancy. You are afraid of the IUD and you have heard that women can get pregnant with it. You live far away from the hospital, but with planning could go there. Despite your dislike of the side effects of the Pill, you would be open to a month-",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1014
  },
  {
    "id": "chunk_01015",
    "text": "effects of the Pill, you would be open to a month- ly injectable until you get a tubal ligation at the hospital. You suspect your husband has not been faithful. (Combined Injectable Contraceptive [CIC] until client can get a tubal ligation at the hospital)",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1015
  },
  {
    "id": "chunk_01016",
    "text": "l client can get a tubal ligation at the hospital) ____________________________________________________________________ You are a 38-year-old man who has come to the clinic with his wife who wants family planning.",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1016
  },
  {
    "id": "chunk_01017",
    "text": "he clinic with his wife who wants family planning. You cannot afford to have any more children\u2014you have 5 children now. Your wife has used several methods, but she has still had 5 pregnancies. You both feel you have enough children. If tubal",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1017
  },
  {
    "id": "chunk_01018",
    "text": ". You both feel you have enough children. If tubal ligation is offered, mention that your wife just discovered she is pregnant. Toward the end of the consultation, also reveal that you are HIV positive. You confess that you have had many women in the past. (Vasectomy)",
    "page_number": 88,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1018
  },
  {
    "id": "chunk_01019",
    "text": "Next Steps and Closing Total Time: 15 minutes By the end of this exercise, participants will have: \u25aa Made a plan to incorporate the BCS+ in their counseling work in their health care facility Materials and Advance Preparation \u25aa Have flipchart (newsprint) paper and markers available.",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1019
  },
  {
    "id": "chunk_01020",
    "text": "flipchart (newsprint) paper and markers available. \u25aa If certificates of completion will be given to participants, have them made, signed, and ready to distribute at the end of the workshop. Instructions 1. Ask participants how they like using the BCS+ and job aids.",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1020
  },
  {
    "id": "chunk_01021",
    "text": "cipants how they like using the BCS+ and job aids. 2. Remind participants that the 19-step BCS+ algorithm is a summary of the BCS+ User\u2019s Guide and is easier to refer to when on the job. 3. Encourage participants to review sections of the BCS+ User\u2019s Guide to remind them exactly",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1021
  },
  {
    "id": "chunk_01022",
    "text": "ns of the BCS+ User\u2019s Guide to remind them exactly how to conduct each of the 19 steps. 4. Ask participants what steps they will take to implement the BCS+ model at work. In other words, how will they do things differently when they go back to the clinic?",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1022
  },
  {
    "id": "chunk_01023",
    "text": "hings differently when they go back to the clinic? 5. Write their responses on newsprint or flipchart paper. 6. Ask participants what they can do to promote the use of the BCS+ in their health care facili- ties. (Note: Write responses on newsprint or flipchart paper.)",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1023
  },
  {
    "id": "chunk_01024",
    "text": "Write responses on newsprint or flipchart paper.) 7. Ask whether there are any comments or questions before closing the workshop. 8. Remind participants that the BCS+ Toolkit is also available electronically. The job aids (algo-",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1024
  },
  {
    "id": "chunk_01025",
    "text": "also available electronically. The job aids (algo- rithm, counseling cards, and method brochures) can be easily adapted or revised to support national and/or regional protocols. Guidelines for adapting these job aids are provided in the BCS+ User\u2019s Guide.",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1025
  },
  {
    "id": "chunk_01026",
    "text": "se job aids are provided in the BCS+ User\u2019s Guide. 9. Thank participants for their participation. 10. Conduct any closing activities and distribute certificates of completion, if available. | 48 |",
    "page_number": 89,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1026
  },
  {
    "id": "chunk_01027",
    "text": "For Additional Reference FRONTIERS Journal Article: Liambila, W., Askew, I., Mwangi, J., Ayisi, R., Kibaru, J., & Mullick, S. (2009). Feasi- bility and effectiveness of integrating provider-initiated testing and counseling within family plan-",
    "page_number": 91,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1027
  },
  {
    "id": "chunk_01028",
    "text": "itiated testing and counseling within family plan- ning services in Kenya. AIDS (London, England), 23 Suppl 1, S115\u201321. Report: Feasibility, Acceptability, Effect and Cost of Integrating Counseling and Testing for HIV",
    "page_number": 91,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1028
  },
  {
    "id": "chunk_01029",
    "text": "Cost of Integrating Counseling and Testing for HIV within Family Planning Counseling and Testing for HIV within Family Planning Services in Kenya http://pdf.usaid.gov/pdf_docs/Pnadn569.pdf Video: Using the Balanced Counseling Strategy Plus in South Africa http://www.popcouncil.org/",
    "page_number": 91,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1029
  },
  {
    "id": "chunk_01030",
    "text": "gy Plus in South Africa http://www.popcouncil.org/ research/using-bcs-in-south-africa INTEGRA INITIATIVE Journal Article: Ndwiga, C., Abuya, T., Mutemwa, R., Kimani, J. K., Colombini, M., Mayhew, S., \u2026",
    "page_number": 91,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1030
  },
  {
    "id": "chunk_01031",
    "text": "a, R., Kimani, J. K., Colombini, M., Mayhew, S., \u2026 Warren, C. E. (2014). Exploring experiences in peer mentoring as a strategy for capacity building in sexual reproductive health and HIV service integration in Kenya. BMC Health Services Research, 14, 98.",
    "page_number": 91,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1031
  },
  {
    "id": "chunk_01032",
    "text": "on in Kenya. BMC Health Services Research, 14, 98. Policy Brief: http://www.integrainitiative.org/wp/wp-content/uploads/2015/09/Integ- ra-Steps02-peer-mentoring.pdf Website: http://www.integrainitiative.org/projects/integrainitiative/overview-and-objectives/ | 50 |",
    "page_number": 91,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1032
  },
  {
    "id": "chunk_01033",
    "text": "References Askew, Ian. 2007. \u201cAchieving synergies in prevention through linking sexual and reproductive Health and HIV services,\u201d in Donta, Balaiah et al. (eds.), Proceedings of the International Conference on Actions to Strengthen Linkages between Sexual and Reproductive Health",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1033
  },
  {
    "id": "chunk_01034",
    "text": "en Linkages between Sexual and Reproductive Health and HIV/AIDS. Mumbai: Indian Society for the Study of Reproduction and Fertility and World Health Organization. Central Bureau of Statistics (CBS) [Kenya], Ministry of Health (MOH) [Kenya], and ORC Mac-",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1034
  },
  {
    "id": "chunk_01035",
    "text": "a], Ministry of Health (MOH) [Kenya], and ORC Mac- ro. 2004. Kenya Demographic and Health Survey 2003. Calverton, Maryland: CBS, MOH, and ORC Macro. Engenderhealth and Planned Parenthood Association of South Africa. 2001. Curriculum enti-",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1035
  },
  {
    "id": "chunk_01036",
    "text": "ssociation of South Africa. 2001. Curriculum enti- tled: Men As Partners: A Program for Supplementing the Training of Life Skills Educators, 2nd Edition. New York: Engenderhealth and Planned Parenthood of South Africa. 2002.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1036
  },
  {
    "id": "chunk_01037",
    "text": "alth and Planned Parenthood of South Africa. 2002. Hatcher, R.A. et al. 2011. Contraceptive Technology. Twentieth Revised Edition. New York: Ardent Media. Le\u00f3n, Federico R. 1999. \u201cPeru: Providers\u2019 compliance with quality of care norms,\u201d FRON- TIERS Final Report. Washington, DC: Population Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1037
  },
  {
    "id": "chunk_01038",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2001. \u201cLength of counseling sessions and the amount of relevant infor- mation exchanged: A study in Peruvian clinics,\u201d International Family Planning Perspectives 27(1):28-33, 46.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1038
  },
  {
    "id": "chunk_01039",
    "text": "onal Family Planning Perspectives 27(1):28-33, 46. Le\u00f3n, Federico R. et al. 2003a. \u201cEffects of IGSS\u2019s job aids-assisted balanced counseling algo- rithms on quality of care and client outcomes (Guatemala),\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1039
  },
  {
    "id": "chunk_01040",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2003b. \u201cEnhancing quality for clients: The Balanced Counseling Strate- gy,\u201d FRONTIERS Program Brief No. 3. Washington, DC: Population Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1040
  },
  {
    "id": "chunk_01041",
    "text": "m Brief No. 3. Washington, DC: Population Council. Le\u00f3n, Federico R. et al. 2003c. \u201cTesting balanced counseling to improve provider-client interac- tion in Guatemala\u2019s MOH clinics,\u201d FRONTIERS Final Report. Washington, DC: Popula- tion Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1041
  },
  {
    "id": "chunk_01042",
    "text": "inal Report. Washington, DC: Popula- tion Council. Le\u00f3n, Federico R. et al. 2004. \u201cOne-year client impacts of quality of care improvements achieved in Peru,\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1042
  },
  {
    "id": "chunk_01043",
    "text": "Final Report. Washington, DC: Population Council. Le\u00f3n, Federico, Ricardo Vernon, Antonieta Martin, and Linda Bruce. 2008. The Balanced Coun- seling Strategy: A Toolkit for Family Planning Service Providers. Washington, DC: Popula- tion Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1043
  },
  {
    "id": "chunk_01044",
    "text": "e Providers. Washington, DC: Popula- tion Council. Liambila, Wilson et al. 2008. \u201cFeasibility, effectiveness and cost of models of integrating coun- seling and testing for HIV within family planning services in Kenya,\u201d FRONTIERS Final Report. Washington, DC: Population Council.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1044
  },
  {
    "id": "chunk_01045",
    "text": "Final Report. Washington, DC: Population Council. Mullick, Saiqa, Mantshi Menziwa, Doctor Khoza, and Edwin Maroga. 2008. \u201cFeasibility, effec- tiveness and cost of models of integrating counseling and testing for HIV within family",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1045
  },
  {
    "id": "chunk_01046",
    "text": "ating counseling and testing for HIV within family planning services in North West Province, South Africa,\u201d FRONTIERS Final Report. Washington, DC: Population Council. Stanback, J. et al. 1999. \u201cChecklist for ruling out pregnancy among family-planning clients in primary care,\u201d Lancet 354(9178):566.",
    "page_number": 92,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1046
  },
  {
    "id": "chunk_01047",
    "text": "World Health Organization. 2003. Guidelines for the Management of Sexually Transmitted In- fections. Geneva: WHO. \u2013\u2013\u2013. 2004. Medical Eligibility Criteria for Contraceptive Use, 3rd ed. Geneva: WHO. \u2013\u2013\u2013 . 2005. Sexually Transmitted and Other Reproductive Tract Infections: A Guide to Essential",
    "page_number": 93,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1047
  },
  {
    "id": "chunk_01048",
    "text": "eproductive Tract Infections: A Guide to Essential Practice. Geneva: WHO. \u2013\u2013\u2013 . 2015. Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: WHO. \u2013\u2013\u2013 . 2010. WHO Technical Consultation on Postpartum and Postnatal Care. Geneva: WHO.",
    "page_number": 93,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1048
  },
  {
    "id": "chunk_01049",
    "text": "ion on Postpartum and Postnatal Care. Geneva: WHO. World Health Organization, Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Pro- grams (JHU/CCP) INFO Project. 2011. Family Planning: A Global Handbook for Provid-",
    "page_number": 93,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1049
  },
  {
    "id": "chunk_01050",
    "text": "11. Family Planning: A Global Handbook for Provid- ers. Baltimore and Geneva: JHU/CCP and WHO. World Health Organization and Joint United Nations Programme on HIV/AIDS (UNAIDS). Guidance on Provider-Initiated HIV Testing and Counseling in Health Facilities. Geneva: WHO. | 52 |",
    "page_number": 93,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1050
  },
  {
    "id": "chunk_01051",
    "text": "The Population Council confronts critical health and development issues\u2014from stopping the spread of HIV to improving reproductive health and ensuring that young people lead full and productive lives. Through biomedical, social science,",
    "page_number": 94,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1051
  },
  {
    "id": "chunk_01052",
    "text": "ductive lives. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programs, and technologies that improve lives around the world. Established in 1952 and headquartered in New",
    "page_number": 94,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1052
  },
  {
    "id": "chunk_01053",
    "text": "orld. Established in 1952 and headquartered in New York, the Council is a nongovernmental, nonprofit organization governed by an international board of trustees. For additional information please contact: Population Council 4301 Connecticut Ave., NW, Suite 280 Washington, DC 20008 USA",
    "page_number": 94,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1053
  },
  {
    "id": "chunk_01054",
    "text": "ticut Ave., NW, Suite 280 Washington, DC 20008 USA Telephone: (202) 237-9400 Facsimile: (202) 237-8410 E-mail: publications@popcouncil.org www.popcouncil.org",
    "page_number": 94,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1054
  },
  {
    "id": "chunk_01055",
    "text": "tablish and maintain a warm, cordial relationship. 2 Inform client (and partner, if present) that there will be opportunities to address both health needs and family planning needs during this consultation.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1055
  },
  {
    "id": "chunk_01056",
    "text": "nd family planning needs during this consultation. 3 Ask client about current family size and current contraceptive practices. Counsel client on Healthy Timing and Spacing of Pregnancy using counseling card.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1056
  },
  {
    "id": "chunk_01057",
    "text": "ng and Spacing of Pregnancy using counseling card. a) If client is currently using a family planning method or delaying pregnancy, ask about her/his satisfaction with it and interest in continuing or changing the method. b) If partner is present, use the male services and support card.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1057
  },
  {
    "id": "chunk_01058",
    "text": "s present, use the male services and support card. 4 Rule out pregnancy using the Checklist to Make Reasonably Sure a Woman is not Pregnant card to be reasonably sure the woman is not pregnant. 5 Display all of the method cards. Ask client if she/he wants a particular method.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1058
  },
  {
    "id": "chunk_01059",
    "text": "s. Ask client if she/he wants a particular method. 6 Ask all of the following questions. Set aside method cards based on the client\u2019s responses. a) Do you wish to have children in the future? If \u201cYes,\u201d set aside vasectomy and tubal ligation cards. Explain Why. If \u201cNo,\u201d keep all cards and continue.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1059
  },
  {
    "id": "chunk_01060",
    "text": "Explain Why. If \u201cNo,\u201d keep all cards and continue. b) Have you given birth in the last 48 hours? If \u201cYes,\u201d set aside combined oral contraceptives (the Pill) and combined injectables. Explain why. If \u201cNo,\u201d continue with the next question. c) Are you breastfeeding an infant less than 6 months old?",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1060
  },
  {
    "id": "chunk_01061",
    "text": "ou breastfeeding an infant less than 6 months old? If \u201cYes,\u201d set aside the combined oral contraceptives (the Pill) and combined injectable cards. Explain why. If \u201cNo,\u201d or she has begun her monthly bleeding again, set aside the lactational amenorrhea (LAM) card. Explain why.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1061
  },
  {
    "id": "chunk_01062",
    "text": "he lactational amenorrhea (LAM) card. Explain why. d) Does your partner support you in family planning? If \u201cYes,\u201d continue with the next question If \u201cNo,\u201d set aside the following cards: female condom, male condom, Standard Days Method\u00a9, Two Days Method\u00a9, and withdrawal. Explain why.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1062
  },
  {
    "id": "chunk_01063",
    "text": "d\u00a9, Two Days Method\u00a9, and withdrawal. Explain why. e) Do you have any medical conditions? Are you taking any medications? If \u201cYes,\u201d ask further about which conditions or medications. Refer to WHO Medical Eligibility Criteria Wheel or current national guidelines and set aside all",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1063
  },
  {
    "id": "chunk_01064",
    "text": "l or current national guidelines and set aside all contraindicated method cards. Explain why. If \u201cNo,\u201d keep all the cards and continue. f) Are there any methods that you do not want to use or have not tolerated in the past? If \u201cYes,\u201d set aside the cards the client does not want.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1064
  },
  {
    "id": "chunk_01065",
    "text": "es,\u201d set aside the cards the client does not want. If \u201cNo,\u201d keep the rest of the cards. METHOD CHOICE STAGE 7 Briefly review the methods that have not been set aside and indicate their effectiveness. a) Arrange the remaining cards in order of effectiveness (see back of each card).",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1065
  },
  {
    "id": "chunk_01066",
    "text": "in order of effectiveness (see back of each card). b) In order of effectiveness (highly effective to not effective), briefly review the attributes on each method card. 8 Ask the client to choose the method that is most convenient for her/him.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1066
  },
  {
    "id": "chunk_01067",
    "text": "se the method that is most convenient for her/him. a) If client is adolescent use the counseling card to inform her that she can get any method 9 Using the method-specific brochure, check whether the client has any condition for which the method is not advised.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1067
  },
  {
    "id": "chunk_01068",
    "text": "any condition for which the method is not advised. a) Review \u201cMethod not advised if you...\u201d section in the brochure b) If the method is not advisable, ask the client to select another method from the cards that remain. Repeat the process from Step 8. POST-CHOICE STAGE",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1068
  },
  {
    "id": "chunk_01069",
    "text": "Repeat the process from Step 8. POST-CHOICE STAGE 10 Discuss the method chosen with the client, using the method-specific brochure as a counseling tool. Determine the client\u2019s comprehension and reinforce key information.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1069
  },
  {
    "id": "chunk_01070",
    "text": "ent\u2019s comprehension and reinforce key information. 11 Make sure the client has made a definite decision. Give her/him the method chosen, a referral, and a back-up method depending on the method selected.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1070
  },
  {
    "id": "chunk_01071",
    "text": "a back-up method depending on the method selected. 12 Encourage the client to involve partner(s) in decisions about/practice of contraception through discussion or a visit to the clinic. SYSTEMATIC SCREENING FOR OTHER SERVICES STAGE",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1071
  },
  {
    "id": "chunk_01072",
    "text": "nic. SYSTEMATIC SCREENING FOR OTHER SERVICES STAGE 13 Using information collected previously, determine client\u2019s need for postpartum, newborn, infant care, well-child services or post abortion care.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1072
  },
  {
    "id": "chunk_01073",
    "text": "t care, well-child services or post abortion care. a) If client reported giving birth recently, review the Promoting Healthy Postpartum Period and Promoting Newborn and Infant Health card with client. Provide or refer for services, if needed.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1073
  },
  {
    "id": "chunk_01074",
    "text": "client. Provide or refer for services, if needed. b) For clients with children less than 5 years of age, ask if children have been taken to well-child services. Provide or refer for immunizations and growth monitoring services, if needed.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1074
  },
  {
    "id": "chunk_01075",
    "text": "zations and growth monitoring services, if needed. c) If client reported a recent abortion, review the Post Abortion Care card with the client. Provide or refer post abortion care services, if needed.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1075
  },
  {
    "id": "chunk_01076",
    "text": "e or refer post abortion care services, if needed. 14 Ask client when she had her last screening for cervical cancer (VIA/VILI or pap smear) or breast cancer.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1076
  },
  {
    "id": "chunk_01077",
    "text": "l cancer (VIA/VILI or pap smear) or breast cancer. a) If her last Cervical Cancer screening was more than 3 years ago (*6-12 months if she is HIV positive) or she doesn\u2019t know, ask if she would like to have a screening",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1077
  },
  {
    "id": "chunk_01078",
    "text": "\u2019t know, ask if she would like to have a screening today. Review the Screening for Cervical Cancer card. Provide or refer for services. b) If her last Cervical Cancer screening was less than 3 years ago continue with next question.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1078
  },
  {
    "id": "chunk_01079",
    "text": "less than 3 years ago continue with next question. c) Review Breast Cancer Information and Awareness counseling card with client. 15 Discuss STI/HIV Transmission & Prevention and dual protection with client using counseling cards. Offer condoms and instructions on correct and consistent use.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1079
  },
  {
    "id": "chunk_01080",
    "text": "ms and instructions on correct and consistent use. 16 Conduct STI and HIV risk assessment using the counseling card. If symptoms are identified, treat her/him syndromically. 17 Ask client whether s/he knows her/his HIV status. a) If client knows s/he is living with HIV,",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1080
  },
  {
    "id": "chunk_01081",
    "text": "tatus. a) If client knows s/he is living with HIV, \u25aa Review Positive Health, Dignity, & Prevention counseling card with client. \u25aa Refer client to center for wellness care and treatment. b) If client knows s/he is HIV negative, \u25aa Discuss a time frame for repeat testing.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1081
  },
  {
    "id": "chunk_01082",
    "text": "gative, \u25aa Discuss a time frame for repeat testing. c) If client does not know her/his status, \u25aa Discuss HIV Counseling and Testing (HCT) with client, using counseling card. \u25aa Offer or initiate testing with client, according to national protocols.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1082
  },
  {
    "id": "chunk_01083",
    "text": "ting with client, according to national protocols. \u25aa Counsel client on test results. If client is living with HIV, review Positive Health, Dignity, & Prevention counseling card and refer client to center for wellness care and treatment. d) Counsel client using Women\u2019s Support & Safety Card.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1083
  },
  {
    "id": "chunk_01084",
    "text": "ounsel client using Women\u2019s Support & Safety Card. \u25aa If client shows any major Intimate Partner Violence (IPV) triggers, refer her for specialized services. 18 Give follow-up instructions, a condom brochure, and the brochure for the method chosen. Set a date for next visit.",
    "page_number": 95,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1084
  },
  {
    "id": "chunk_01085",
    "text": "Monthly Injectable Combined Injectable Contraceptives (CICs) EFFECTIVENESS Typical use 94% Some missed or late injections: 6 pregnancies per 100 women GENERAL INFORMATION \u25aa Requires that you get an injection every 4 weeks (30 days) to prevent pregnancy.",
    "page_number": 97,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1085
  },
  {
    "id": "chunk_01086",
    "text": "tion every 4 weeks (30 days) to prevent pregnancy. \u25aa More regular monthly bleeding than with DMPA or NET-EN injectables. \u25aa Delayed return of fertility after woman stops method. It takes an average of about 1 month longer than with most other methods.",
    "page_number": 97,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1086
  },
  {
    "id": "chunk_01087",
    "text": "about 1 month longer than with most other methods. \u25aa Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS",
    "page_number": 97,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1087
  },
  {
    "id": "chunk_01088",
    "text": "ctions (STIs), including HIV. HOW THE METHOD WORKS \u25aa The injection contains two hormones, progestin and estrogen. \u25aa These hormones stop the release of eggs from the ovaries (ovulation). They also make cervical mucus thick. This stops sperm from meeting an egg.",
    "page_number": 97,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1088
  },
  {
    "id": "chunk_01089",
    "text": "mucus thick. This stops sperm from meeting an egg. \u25aa You get an injection every 4 weeks (30 days). IMPORTANT FACTS \u25aa Method does not require daily action by user. \u25aa Private. No one else can tell you are using an injectable. \u25aa Does not interfere with sex.",
    "page_number": 97,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1089
  },
  {
    "id": "chunk_01090",
    "text": "sing an injectable. \u25aa Does not interfere with sex. \u25aa Return of fertility is about 1 month longer than with most other methods. \u25aa Use condoms (male or female) if you feel at risk of STIs or HIV (dual protection). | 2 |",
    "page_number": 97,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1090
  },
  {
    "id": "chunk_01091",
    "text": "METHOD NOT ADVISED IF YOU... \u25aa Are within 21 days of giving birth (regardless of breastfeeding status). \u25aa Breastfeed an infant less than 6 months old. \u25aa Smoke cigarettes and are 35 years old or older. \u25aa Have high blood pressure, 140/90 or higher",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1091
  },
  {
    "id": "chunk_01092",
    "text": "lder. \u25aa Have high blood pressure, 140/90 or higher \u25aa Have a combination of cardiovascular risk factors such as diabetes, hypertension, older age and/or are a smoker. Discuss with your provider. \u25aa Have severe liver disease. \u25aa Have breast cancer or risk factors of heart disease: older age, stroke,",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1092
  },
  {
    "id": "chunk_01093",
    "text": "risk factors of heart disease: older age, stroke, smoking, diabetes, high blood pressure, or high cholesterol levels. \u25aa Have migraine headaches (a severe headache that does not go away with paracetamol) and are 35 years old or older.",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1093
  },
  {
    "id": "chunk_01094",
    "text": "y with paracetamol) and are 35 years old or older. \u25aa Have migraine aura (sometimes seeing a growing bright spot in one eye) at any age. \u25aa Have a history of blood clot, called thrombosis, or major surgery with prolonged immobilization. \u25aa Have lupus.",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1094
  },
  {
    "id": "chunk_01095",
    "text": "rgery with prolonged immobilization. \u25aa Have lupus. \u25aa HIV positive and are on ritonavir-boosted protease inhibitors as part of HAART. SIDE EFFECTS \u25aa Common side effects include: - Lighter bleeding and fewer days of bleeding - Irregular bleeding - Infrequent or prolonged bleeding - No monthly bleeding",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1095
  },
  {
    "id": "chunk_01096",
    "text": "equent or prolonged bleeding - No monthly bleeding \u25aa Changes in monthly bleeding are normal. These changes usually lessen or stop within 3 months of starting injections. \u25aa After stopping the injections, changes in monthly bleeding do not stop until the injection wears off (2-3 months or more).",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1096
  },
  {
    "id": "chunk_01097",
    "text": "ntil the injection wears off (2-3 months or more). \u25aa Some women may have weight gain, headaches, dizziness, or breast tenderness. \u25aa These are not signs of illness. \u25aa Not all women have these side effects. | 3 |",
    "page_number": 98,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1097
  },
  {
    "id": "chunk_01098",
    "text": "HOW TO USE \u25aa A provider will give you the injection. \u25aa You return every 4 weeks (30 days) to get another injection. \u25aa Even if you are late, come back. You may still be able to get your injection. \u25aa If you switch to another brand of injectable, get instructions on how to use it. FOLLOW-UP",
    "page_number": 99,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1098
  },
  {
    "id": "chunk_01099",
    "text": "able, get instructions on how to use it. FOLLOW-UP \u25aa Return every 4 weeks (30 days) to get your next injection. \u25aa Try to come on time. You may come up to 7 days early or 7 days late and still get an injection. No matter how late you are, come back for your next injection.",
    "page_number": 99,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1099
  },
  {
    "id": "chunk_01100",
    "text": "w late you are, come back for your next injection. \u25aa If you are more than 7 days late, abstain from sex or use condoms until you can get an injection. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You need another injection.",
    "page_number": 99,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1100
  },
  {
    "id": "chunk_01101",
    "text": "estions or problems. \u25aa You need another injection. \u25aa You develop any health problems. \u25aa You are late for your injection, had sex in the past 5 days, and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs). \u25aa You think you may be pregnant.",
    "page_number": 99,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1101
  },
  {
    "id": "chunk_01102",
    "text": "Emergency Contraceptive Pills ECPs EFFECTIVENESS Correct use Most effective if taken within first 24 hours; can be taken within 5 98 - 99% days of having unprotected sex: 1-2 pregnancies per 100 women after one instance of unprotected sex depending on the ECP GENERAL INFORMATION",
    "page_number": 101,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1102
  },
  {
    "id": "chunk_01103",
    "text": "ected sex depending on the ECP GENERAL INFORMATION \u25aa One of the only methods that can help prevent pregnancy after a woman has had unprotected sex. \u25aa Not recommended for regular use. A woman using ECP repeatedly should receive additional family planning counseling in order to select the most",
    "page_number": 101,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1103
  },
  {
    "id": "chunk_01104",
    "text": "ly planning counseling in order to select the most appropriate continuous method. \u25aa Must be used within 5 days (120 hours) of unprotected sex. \u25aa Safe for women who cannot use regular hormonal contraceptive methods including postpartum breastfeeding women.",
    "page_number": 101,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1104
  },
  {
    "id": "chunk_01105",
    "text": "methods including postpartum breastfeeding women. \u25aa Breastfeeding not recommended for 1 week after using ulipristal acetate (UPA). \u25aa ECPs do not disrupt existing pregnancy. \u25aa Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines.",
    "page_number": 101,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1105
  },
  {
    "id": "chunk_01106",
    "text": "even if she takes antiretroviral (ARV) medicines. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS \u25aa ECPs contain the same hormones as combined or progestin-only oral contraceptive pills, but in higher doses.",
    "page_number": 101,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1106
  },
  {
    "id": "chunk_01107",
    "text": "IMPORTANT FACTS \u25aa All women can use EC pills safely and effectively, including women who cannot use ongoing hormonal contraceptive methods. \u25aa You can use ECPs for any act of unprotected sex, including forced sex (rape). \u25aa You can also use them if there have been contraceptive mistakes or failures,",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1107
  },
  {
    "id": "chunk_01108",
    "text": "here have been contraceptive mistakes or failures, such as: - Condom broke, slipped, or was not used correctly. - You missed 3 or more combined oral contraceptive pills. - You started a new packet of pills 3 or more days late. - You are more than 7 days or 2 weeks late for a repeat injection of",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1108
  },
  {
    "id": "chunk_01109",
    "text": "n 7 days or 2 weeks late for a repeat injection of injectable contraceptive (depending on type of injection). - Your IUD has come out of place. - You used TwoDay or Standard Days Method incorrectly. For example, you failed to abstain from sex or use condoms during the days you can get pregnant.",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1109
  },
  {
    "id": "chunk_01110",
    "text": "use condoms during the days you can get pregnant. \u25aa ECPs reduce the need to seek abortion. \u25aa Dedicated ECP products, combined oral contraceptives (the pill), or progestin- only oral contraceptives (minipill) can all be used as ECPs.",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1110
  },
  {
    "id": "chunk_01111",
    "text": "contraceptives (minipill) can all be used as ECPs. \u25aa Have an ECP method on hand in case of an emergency (unprotected sex). \u25aa They should not be used in place of an ongoing contraception method. \u25aa You can become pregnant immediately after taking ECPs if you have",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1111
  },
  {
    "id": "chunk_01112",
    "text": "pregnant immediately after taking ECPs if you have unprotected sex (even 1 day after taking ECPs). \u25aa Use another method of contraception at once to continue to protect against pregnancy. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. METHOD NOT ADVISED IF YOU...",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1112
  },
  {
    "id": "chunk_01113",
    "text": "STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Are on medicine for seizures or you take rifampicin. SIDE EFFECTS \u25aa You may have light vaginal bleeding for 1-2 days after taking ECPs. \u25aa In the week after taking ECPs, you may have nausea, abdominal pain, fatigue,",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1113
  },
  {
    "id": "chunk_01114",
    "text": "CPs, you may have nausea, abdominal pain, fatigue, headache, breast tenderness, dizziness, or vomiting. \u25aa Your monthly bleeding may start earlier or later than expected. | 3 |",
    "page_number": 102,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1114
  },
  {
    "id": "chunk_01115",
    "text": "HOW TO USE \u25aa Take the ECPs as soon as possible within 5 days (120 hours) of having unprotected sex. The sooner you take them, the better. The effectiveness of ECPs decreases over time. \u25aa Take the pills as directed by your provider.",
    "page_number": 103,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1115
  },
  {
    "id": "chunk_01116",
    "text": "me. \u25aa Take the pills as directed by your provider. Important: Dosage varies according to brand. Your provider will give you dosage information according to the brand or type of pill. \u25aa If you vomit within 2 hours of taking ECPs, take another dose. If you vomit 2",
    "page_number": 103,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1116
  },
  {
    "id": "chunk_01117",
    "text": "of taking ECPs, take another dose. If you vomit 2 hours after taking ECPs, you do not need to take another dose. \u25aa Start another method of contraception at once. ECPs are not effective as an ongoing method of contraception.",
    "page_number": 103,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1117
  },
  {
    "id": "chunk_01118",
    "text": "t effective as an ongoing method of contraception. \u25aa Take a packet of ECPs (or oral contraceptive pills, with instructions on how to use them as ECPs) home to use when you need them. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have questions or problems. \u25aa You think you might be pregnant.",
    "page_number": 103,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1118
  },
  {
    "id": "chunk_01119",
    "text": "Female Condoms TYPES \u25aa Female Condom 2 / FC2 \u25aa Cupid EFFECTIVENESS Typical Use 79% Not used consistently 21 pregnancies per 100 women GENERAL INFORMATION \u25aa The female condom is a sheath made of a transparent latex with flexible rings at both ends. It is the same length as a male condom.",
    "page_number": 105,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1119
  },
  {
    "id": "chunk_01120",
    "text": "both ends. It is the same length as a male condom. \u25aa Before having sex, place the female condom into your vagina. It fits loosely inside the vagina. \u25aa You must use a new condom for each act of sex. \u25aa Protect against pregnancy and sexually transmitted infections (STIs), including HIV.",
    "page_number": 105,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1120
  },
  {
    "id": "chunk_01121",
    "text": "ally transmitted infections (STIs), including HIV. \u25aa Preserve feeling of sex for men and women. \u25aa Require partner\u2019s cooperation. HOW THE METHOD WORKS \u25aa Before having sex, place the female condom into your vagina. \u25aa The condom forms a barrier that keeps sperm out of the vagina during sex.",
    "page_number": 105,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1121
  },
  {
    "id": "chunk_01122",
    "text": "ier that keeps sperm out of the vagina during sex. This prevents pregnancy. \u25aa The condom covers the cervix inside the vagina. The cervix is a closed space, so the female condom cannot disappear inside the body. \u25aa It also protects you from getting or giving STIs including HIV. | 2 |",
    "page_number": 105,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1122
  },
  {
    "id": "chunk_01123",
    "text": "IMPORTANT FACTS \u25aa Can be used as a temporary or backup method. \u25aa Can be used without seeing a health provider. \u25aa Can be initiated by the woman. \u25aa Must not be used if the partner is using a male condom. The friction between the two condoms may cause one or both to break.",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1123
  },
  {
    "id": "chunk_01124",
    "text": "en the two condoms may cause one or both to break. \u25aa May be relatively expensive and hard to find. \u25aa Require you to touch your genitals. \u25aa May make noises during intercourse; adding lubricant can help. \u25aa Can be used during pregnancy to protect mother and fetus against STIs. HOW TO USE",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1124
  },
  {
    "id": "chunk_01125",
    "text": "protect mother and fetus against STIs. HOW TO USE 1. Use a new female condom for each act of sex. 2. Check th condom package. Do not use if torn or damaged. Avoid using a condom past the expiration date. Do so only if newer condoms are not available.",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1125
  },
  {
    "id": "chunk_01126",
    "text": "te. Do so only if newer condoms are not available. 3. Insert up to 8 hours before sex. For the most protection, insert the condom before the penis comes into contact with the vagina. 4. Rub the sides of the female condom together to spread the lubricant evenly and insert:",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1126
  },
  {
    "id": "chunk_01127",
    "text": "ogether to spread the lubricant evenly and insert: - Hold the condom with the larger, open end hanging down. - Choose a position that is comfortable for insertion. You can squat, raise one leg, sit, or lie down. - Grasp the inner ring at the closed end. Squeeze it so that it becomes long and narrow.",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1127
  },
  {
    "id": "chunk_01128",
    "text": "nd. Squeeze it so that it becomes long and narrow. - Find the opening of the vagina and separate outer lips (labia). With the other hand gently push the inner ring into the vagina as far up as it will go. - Insert a finger into the condom to push it into place. Allow up 2 to 3 cm of",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1128
  },
  {
    "id": "chunk_01129",
    "text": "ondom to push it into place. Allow up 2 to 3 cm of the condom and outer ring to remain outside the vagina. 5. When you are ready for sex, guide the penis into the condom. Make sure it does not slip outside. If the penis goes outside the condom, withdraw the penis. Help guide it in again.",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1129
  },
  {
    "id": "chunk_01130",
    "text": "ondom, withdraw the penis. Help guide it in again. 6. If the outer ring is pushed into the vagina or the condom is pulled out of the vagina during sex, put the condom back into place. 7. After having sex, remove the condom before standing to prevent leakage of",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1130
  },
  {
    "id": "chunk_01131",
    "text": "e the condom before standing to prevent leakage of semen. To remove the female condom, grasp the outer ring, twist it to seal in the fluid and gently pull it out of the vagina. 8. Place the condom in a tissue or in the empty package. Throw it into the",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1131
  },
  {
    "id": "chunk_01132",
    "text": "tissue or in the empty package. Throw it into the rubbish or latrine. Do not put it into a flush toilet. This can cause problems with plumbing. | 3 |",
    "page_number": 106,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1132
  },
  {
    "id": "chunk_01133",
    "text": "SIDE EFFECTS None RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You had unprotected sex in the past 5 days and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs).",
    "page_number": 107,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1133
  },
  {
    "id": "chunk_01134",
    "text": "You can take emergency contraceptive pills (ECPs). Important: If you did not use a condom for an act of sex, try to use one the next time. A mistake once or twice does not mean that it is too late to use condoms in the future.",
    "page_number": 107,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1134
  },
  {
    "id": "chunk_01135",
    "text": "Hormonal Implants TYPES \u25aa Single Rod (Implanon, Nexplanon/Implanon NXT) \u25aa Double Rod (Jadelle, Sino-plan II) EFFECTIVENESS First year of use 99% Less than 1 pregnancy per 100 women GENERAL INFORMATION \u25aa Are small rods or capsules (about the size of a matchstick) put under the skin.",
    "page_number": 109,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1135
  },
  {
    "id": "chunk_01136",
    "text": "bout the size of a matchstick) put under the skin. \u25aa Provide long-term protection from pregnancy for 3 to 5 years. Length of protection depends on the implant. \u25aa A trained provider must insert and remove implant(s). \u25aa Safe for women who are breastfeeding. You may get implants after giving birth.",
    "page_number": 109,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1136
  },
  {
    "id": "chunk_01137",
    "text": "tfeeding. You may get implants after giving birth. \u25aa Often cause changes in monthly bleeding. May cause absence of bleeding or temporary heavy bleeding for a few months. \u25aa Safe for women living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines.",
    "page_number": 109,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1137
  },
  {
    "id": "chunk_01138",
    "text": "even if she takes antiretroviral (ARV) medicines. \u25aa Do not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS \u25aa A trained provider inserts the implant(s) under the skin, usually on the inside of your upper arm.",
    "page_number": 109,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1138
  },
  {
    "id": "chunk_01139",
    "text": "the skin, usually on the inside of your upper arm. \u25aa The implant(s) slowly release a hormone (progestin). Progestin makes the mucus around the cervix thick. This stops sperm from meeting an egg. \u25aa This hormone also prevents the release of eggs from your ovaries (ovulation). | 2 |",
    "page_number": 109,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1139
  },
  {
    "id": "chunk_01140",
    "text": "IMPORTANT FACTS \u25aa One of the most effective and long-last methods. \u25aa Must be inserted and removed by a trained provider. \u25aa Can help reduce anemia. \u25aa Do not interfere with sex. \u25aa May be difficult to obtain locally. \u25aa Use condoms (male or female) to protect against STIs, including HIV.",
    "page_number": 110,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1140
  },
  {
    "id": "chunk_01141",
    "text": "or female) to protect against STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Have unexpected vaginal bleeding. \u25aa Have breast cancer or history of breast cancer in last 5 years. \u25aa Take medicine for seizures or take reifampicin (as it may reduce effectiveness of contraceptive).",
    "page_number": 110,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1141
  },
  {
    "id": "chunk_01142",
    "text": "(as it may reduce effectiveness of contraceptive). \u25aa Currently have blood clots. \u25aa Have lupus. \u25aa Have history of severe liver disease. SIDE EFFECTS \u25aa During the first several months, common side effects include: - Lighter monthly bleeding and fewer days of bleeding",
    "page_number": 110,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1142
  },
  {
    "id": "chunk_01143",
    "text": "ighter monthly bleeding and fewer days of bleeding - Irregular monthly bleeding that lasts more than 8 days - Infrequent monthly bleeding or no bleeding (amenorrhea) \u25aa After about 1 year, common side effects include: - Lighter monthly bleeding and fewer days of bleeding",
    "page_number": 110,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1143
  },
  {
    "id": "chunk_01144",
    "text": "ighter monthly bleeding and fewer days of bleeding - Irregular monthly bleeding or infrequent bleeding \u25aa Implanon causes less irregular prolonged monthly bleeding than Jadelle. But, Implanon is more likely to cause infrequent monthly bleeding or no bleeding at all.",
    "page_number": 110,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1144
  },
  {
    "id": "chunk_01145",
    "text": "infrequent monthly bleeding or no bleeding at all. \u25aa May cause headaches, abdominal pain, breast tenderness, or other side effects. \u25aa These are common and not signs of illness. | 3 |",
    "page_number": 110,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1145
  },
  {
    "id": "chunk_01146",
    "text": "HOW TO USE \u25aa A trained provider gives you an anesthetic in the arm to prevent pain. S/he inserts the implants just under the skin. \u25aa The procedure takes only a few minutes. You are fully awake during the procedure. You may feel some tugging, pressure, or slight pain when the",
    "page_number": 111,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1146
  },
  {
    "id": "chunk_01147",
    "text": "el some tugging, pressure, or slight pain when the provider inserts the implants. \u25aa After the procedure, get the following information from your provider: - Type of implant - Date of insertion - Month and year when they need to be removed or replaced FOLLOW-UP",
    "page_number": 111,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1147
  },
  {
    "id": "chunk_01148",
    "text": "when they need to be removed or replaced FOLLOW-UP \u25aa Keep the insertion area dry for 4 days. \u25aa Your arm may be sore for a few days. You may also have swelling and bruising at the insertion site. \u25aa This is normal. It will go away without treatment. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF...",
    "page_number": 111,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1148
  },
  {
    "id": "chunk_01149",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any inflammation, pus, or redness at the insertion site that gets worse or does not go away. \u25aa You see an implant coming out. \u25aa You have any questions or problems. \u25aa It is time to replace the implant(s).",
    "page_number": 111,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1149
  },
  {
    "id": "chunk_01150",
    "text": "problems. \u25aa It is time to replace the implant(s). \u25aa You want to have the implant(s) removed. \u25aa You have gained a lot of weight. Implant(s) may not protect you from pregnancy as well if you weigh more than 70 kilos. \u25aa You develop any health problems. \u25aa You think you may be pregnant.",
    "page_number": 111,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1150
  },
  {
    "id": "chunk_01151",
    "text": "Intrauterine Device Copper-bearing IUD EFFECTIVENESS First year of use 99% Less than 1 pregnancy per 100 women GENERAL INFORMATION \u25aa Provides long-term protection against pregnancy for 5 - 12 years. \u25aa Is a small, flexible, plastic and copper device place din the uterus. Most IUDs",
    "page_number": 113,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1151
  },
  {
    "id": "chunk_01152",
    "text": "and copper device place din the uterus. Most IUDs have 1 or 2 thin strings that hang from the cervix into the vagina. \u25aa It is a safe and effective method for almost all women. Including women in the postabortion or postpartum period. \u25aa A trained provider must insert and remove the IUD.",
    "page_number": 113,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1152
  },
  {
    "id": "chunk_01153",
    "text": "A trained provider must insert and remove the IUD. \u25aa Can be inserted immediately after childbirth (within 48 hours) or after 4 weeks postpartum. \u25aa Typically causes longer and heavier bleeding and more cramps or pain during monthly bleeding.",
    "page_number": 113,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1153
  },
  {
    "id": "chunk_01154",
    "text": "g and more cramps or pain during monthly bleeding. \u25aa Safe for a woman living with HIV or with AIDS who is clinically well on antiretroviral (ARV) therapy. \u25aa Not advised for a woman at very high risk of having a sexually transmitted infection (STI).",
    "page_number": 113,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1154
  },
  {
    "id": "chunk_01155",
    "text": "of having a sexually transmitted infection (STI). \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS \u25aa A trained provider inserts the IUD into your uterus, where it stays. \u25aa The plastic and copper device prevents the sperm and egg from meeting.",
    "page_number": 113,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1155
  },
  {
    "id": "chunk_01156",
    "text": "IMPORTANT FACTS \u25aa One of the most effective and long-lasting methods. \u25aa Must be inserted and removed by a trained provider. \u25aa Immediate return to fertility after IUD is removed. \u25aa Does not interfere with sex. \u25aa Does not require you to do anything once the IUD is inserted.",
    "page_number": 114,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1156
  },
  {
    "id": "chunk_01157",
    "text": "quire you to do anything once the IUD is inserted. \u25aa Can be used as emergency contraception, if inserted within five days of unprotected intercourse or five days after estimated time of ovulation. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. METHOD NOT ADVISED IF YOU...",
    "page_number": 114,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1157
  },
  {
    "id": "chunk_01158",
    "text": "STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Are pregnant or think you might be pregnant. \u25aa Have unusual vaginal bleeding. Seek further assessment from provider. \u25aa Have gonorrhea or Chlamydia. \u25aa Are living with HIV and are not doing well clinically. \u25aa Are at very high risk of having an STI.",
    "page_number": 114,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1158
  },
  {
    "id": "chunk_01159",
    "text": "nically. \u25aa Are at very high risk of having an STI. SIDE EFFECTS \u25aa Some bleeding or spotting after insertion. This may continue for 3 to 6 months. \u25aa Cramping and some pain for a few days after insertion. \u25aa Changes in bleeding patterns. They include decreased amount of monthly",
    "page_number": 114,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1159
  },
  {
    "id": "chunk_01160",
    "text": "patterns. They include decreased amount of monthly bleeding, irregular bleeding, and/or less pain and cramps during monthly bleeding. These are normal, especially in the first 3 to 6 months after insertion. Some users may experience no monthly bleeding at all. \u25aa These are not signs of illness.",
    "page_number": 114,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1160
  },
  {
    "id": "chunk_01161",
    "text": "bleeding at all. \u25aa These are not signs of illness. \u25aa Side effects usually lessen after the first several months. HEALTH BENEFITS \u25aa May help protect against cancer of the uterus. | 3 |",
    "page_number": 114,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1161
  },
  {
    "id": "chunk_01162",
    "text": "HOW TO USE \u25aa Have a pelvic exam to rule out genital infections. \u25aa Take ibuprofen, paracetamol, or other pain reliever 30 minutes before insertion to reduce cramping and pain. \u25aa A trained provider inserts the IUD in a place with the necessary supplies and equipment.",
    "page_number": 115,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1162
  },
  {
    "id": "chunk_01163",
    "text": "a place with the necessary supplies and equipment. \u25aa The provider inserts the IUD into your uterus through your vagina and cervix. S/he cuts the strings on the IUD, leaving about 3 cm hanging out of the cervix. \u25aa You will feel some discomfort or cramping during the procedure. This is normal.",
    "page_number": 115,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1163
  },
  {
    "id": "chunk_01164",
    "text": "or cramping during the procedure. This is normal. \u25aa After the procedure get the following information from your provider: - Type of IUD you have - Date of insertion - Date when IUD will need to be removed or replaced RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have questions or problems.",
    "page_number": 115,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1164
  },
  {
    "id": "chunk_01165",
    "text": "Y ANY TIME IF... \u25aa You have questions or problems. \u25aa You have any of the following, especially in the first 20 days after insertion: - increasing or severe pain in the lower abdomen - pain during sex - unusual vaginal discharge - fever, chills, nausea, or vomiting",
    "page_number": 115,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1165
  },
  {
    "id": "chunk_01166",
    "text": "nal discharge - fever, chills, nausea, or vomiting \u25aa Your provider scheduled a post-insertion visit 3 to 6 weeks after insertion of the IUD. \u25aa You think the IUD may have slipped out of place (you do not feel the strings or",
    "page_number": 115,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1166
  },
  {
    "id": "chunk_01167",
    "text": "ipped out of place (you do not feel the strings or you feel the hard plastic of an IUD that has partially come out of the uterus). \u25aa You miss your menstrual period or think you may be pregnant. \u25aa You want to remove the IUD for any reason.",
    "page_number": 115,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1167
  },
  {
    "id": "chunk_01168",
    "text": "Intrauterine Device/System LNG IUD/IUS EFFECTIVENESS First year of use 99% Less than 1 pregnancy per 100 women GENERAL INFORMATION \u25aa Provides long-term protection against pregnancy for up to 5 years. \u25aa Is a small, flexible, platic device in the uterus with an inner reservoir of",
    "page_number": 117,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1168
  },
  {
    "id": "chunk_01169",
    "text": "ic device in the uterus with an inner reservoir of levonorgestrel, a progestin hormone. The LNG IUD/IUS has 1 or 2 thin strings that hang from the cervix into the vagina. \u25aa A trained provider must insert and remove the LNG IUD/IUS.",
    "page_number": 117,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1169
  },
  {
    "id": "chunk_01170",
    "text": "d provider must insert and remove the LNG IUD/IUS. \u25aa Causes lighter and shorter monthly periods of bleeding and may cause periods to stop all together. \u25aa Safe for a woman living with HIV or with AIDS who is clinically well on antiretroviral (ARV) therapy.",
    "page_number": 117,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1170
  },
  {
    "id": "chunk_01171",
    "text": "s clinically well on antiretroviral (ARV) therapy. \u25aa Not advised for a woman at very high risk of having a sexually transmitted infection (STI). \u25aa Does not protect against sexually transmitted infections (STIs), including HIV.",
    "page_number": 117,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1171
  },
  {
    "id": "chunk_01172",
    "text": "ally transmitted infections (STIs), including HIV. \u25aa Can be inserted immediately after childbirth (within 48 hours) or after 4 weeks postpartum. HOW THE METHOD WORKS \u25aa A trained provider inserts the LNG IUD/IUS into your uterus, where it stays.",
    "page_number": 117,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1172
  },
  {
    "id": "chunk_01173",
    "text": "the LNG IUD/IUS into your uterus, where it stays. \u25aa The levonorgestrel (progesterone hormone) is released into uterus and inhibits fertilization of the egg by thickening the cervical mucus, inhibitin sperm movement, and hindering sperm and egg transport. | 2 |",
    "page_number": 117,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1173
  },
  {
    "id": "chunk_01174",
    "text": "IMPORTANT FACTS \u25aa One of the most effective and long-lasting methods. \u25aa Must be inserted and removed by a trained provider. \u25aa Immediate return to fertility after LNG IUD/IUS is removed. \u25aa Does not interfere with sex. \u25aa Does not require you to do anything once LNG IUD/IUS is inserted.",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1174
  },
  {
    "id": "chunk_01175",
    "text": "e you to do anything once LNG IUD/IUS is inserted. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Are pregnant or think you might be pregnant. \u25aa Have unusual vaginal bleeding. Seek further assessment from health provider.",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1175
  },
  {
    "id": "chunk_01176",
    "text": "ing. Seek further assessment from health provider. \u25aa Have gonorrhea or Chlamydia. \u25aa Have AIDS and are not taking ARV medicine or are not doing well clinically. \u25aa Are at very high risk of having an STI. \u25aa Have history of breast cancer. SIDE EFFECTS",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1176
  },
  {
    "id": "chunk_01177",
    "text": "STI. \u25aa Have history of breast cancer. SIDE EFFECTS \u25aa Some bleeding or spotting after insertion. This may continue for 3 to 6 months. \u25aa Cramping and some pain for a few days after insertion. \u25aa Changes in bleeding patterns. They include prolonged and heavy monthly",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1177
  },
  {
    "id": "chunk_01178",
    "text": "patterns. They include prolonged and heavy monthly bleeding, irregular bleeding, or more cramps and pain during monthly bleeding. These are normal, especially in the first 3 to 6 months after insertion. \u25aa Symptoms associated with hormones, including headaches, breast tenderness or weight gain.",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1178
  },
  {
    "id": "chunk_01179",
    "text": "uding headaches, breast tenderness or weight gain. \u25aa These are not signs of illness. \u25aa Side effects usually lessen after the first several months. HEALTH BENEFITS \u25aa May help protect against cancer of the uterus. \u25aa There are many additional health benefits to LNG IUD/IUS including its role",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1179
  },
  {
    "id": "chunk_01180",
    "text": "health benefits to LNG IUD/IUS including its role as treatment for heavy or prolonged bleeding, as treatment for menstruation and endometrium disorders such as endometriosis, adenomyosis or dysmenorrheal, as an alternative for hysterectomy. | 3 |",
    "page_number": 118,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1180
  },
  {
    "id": "chunk_01181",
    "text": "HOW TO USE \u25aa Have a pelvic exam to rule out genital infections. \u25aa Take ibuprofen, paracetamol, or other pain reliever 30 minutes before insertion to reduce cramping and pain. \u25aa A trained provider inserts the IUD/IUS in a place with the necessary supplies and equipment.",
    "page_number": 119,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1181
  },
  {
    "id": "chunk_01182",
    "text": "a place with the necessary supplies and equipment. \u25aa The provider inserts the IUD/IUS into your uterus through your vagina and cervix. S/he cuts the strings on the IUD/IUS, leaving about 3 cm hanging out of the cervix. \u25aa You will feel some discomfort or cramping during the procedure. This is normal.",
    "page_number": 119,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1182
  },
  {
    "id": "chunk_01183",
    "text": "or cramping during the procedure. This is normal. \u25aa After the procedure, get the following information from your provider: - Type of IUD/IUS you have - Date of insertion - Date when IUD/IUS will need to be removed or replaced RETURN TO THE HEALTH CARE FACILITY ANY TIME IF...",
    "page_number": 119,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1183
  },
  {
    "id": "chunk_01184",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have questions or problems. \u25aa You have any of the following, especially in the first 20 days after insertion: - increasing or severe pain in the lower abdomen - pain during sex - unusual vaginal discharge - fever, chills, nausea, or vomiting",
    "page_number": 119,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1184
  },
  {
    "id": "chunk_01185",
    "text": "nal discharge - fever, chills, nausea, or vomiting \u25aa Your provider scheduled a post-insertion visit 3 to 6 weeks after insertion of the LNG IUD/IUS. \u25aa You think the LNG IUD/IUS may have slipped out of place (you do not feel the",
    "page_number": 119,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1185
  },
  {
    "id": "chunk_01186",
    "text": "may have slipped out of place (you do not feel the strings or you feel the hard plastic of an IUD/IUS that has partially come out of the uterus). \u25aa You want to remove the IUD/IUS for any reason.",
    "page_number": 119,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1186
  },
  {
    "id": "chunk_01187",
    "text": "Lactational Amenorrhea Method LAM EFFECTIVENESS Typical use 98% First 6 months after childbirth when all 3 criteria are met: 2 pregnancies per 100 women GENERAL INFORMATION \u25aa LAM is the use of fully breastfeeding after having a baby to delay the woman\u2019s return to fertility.",
    "page_number": 121,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1187
  },
  {
    "id": "chunk_01188",
    "text": "g a baby to delay the woman\u2019s return to fertility. \u25aa LAM requires 3 conditions. All 3 must be met: 1. Your monthly bleeding has not returned since giving birth 2. The baby is fully exclusively breastfed, day and night 3. The baby is less than 6 months old",
    "page_number": 121,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1188
  },
  {
    "id": "chunk_01189",
    "text": "ay and night 3. The baby is less than 6 months old \u25aa LAM is a temporary family planning method to use after pregnancy, when women can think about which method to use after LAM no longer protects you from pregnancy. \u25aa Safe for a woman living with HIV/AIDS. There is a chance, however, that",
    "page_number": 121,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1189
  },
  {
    "id": "chunk_01190",
    "text": "ng with HIV/AIDS. There is a chance, however, that mothers with HIV will transmit HIV to their infants through breastfeeding. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS",
    "page_number": 121,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1190
  },
  {
    "id": "chunk_01191",
    "text": "ctions (STIs), including HIV. HOW THE METHOD WORKS \u25aa Fully breastfeeding stops the release of hormones that cause a woman to release eggs from her ovaries (ovulate). | 2 |",
    "page_number": 121,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1191
  },
  {
    "id": "chunk_01192",
    "text": "IMPORTANT FACTS \u25aa Does not interfere with sex. \u25aa No costs and no supplies needed. \u25aa Effectiveness after 6 months postpartum is not certain. \u25aa Fully and exclusively breastfeeding may be inconvenient or difficult for some women. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV.",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1192
  },
  {
    "id": "chunk_01193",
    "text": "emale) if you feel at risk of STIs, including HIV. \u25aa Once you begin feeding your baby food or liquids other than your breast milk, LAM no longer protects you from pregnancy. Contact your provider to begin using another method of contraception immediately.",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1193
  },
  {
    "id": "chunk_01194",
    "text": "using another method of contraception immediately. \u25aa Have ECP method on hand in case you have unprotected sex when all 3 criteria are no longer met or you have not gone to facility. \u25aa Before you start to use supplemental feeding talk to your provider about switching to another modern method.",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1194
  },
  {
    "id": "chunk_01195",
    "text": "provider about switching to another modern method. METHOD NOT ADVISED IF YOU... \u25aa You last gave birth over 6 months ago. \u25aa Your monthly bleeding has returned. \u25aa You are offering your baby any foods or liquids other than breast milk. SIDE EFFECTS None USE CAUTION WHEN LIVING WITH HIV/AIDS:",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1195
  },
  {
    "id": "chunk_01196",
    "text": "FFECTS None USE CAUTION WHEN LIVING WITH HIV/AIDS: \u25aa Mothers living with HIV should: - Exclusively breastfeed for 6 months and continue breastfeeding, with complementary food, up to 12 months. - Upon decision to stop breastfeeding, stop gradually within one month.",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1196
  },
  {
    "id": "chunk_01197",
    "text": "op breastfeeding, stop gradually within one month. Stopping breastfeeding abruptly is not advised and you must have a reliable safe alternative to breast milk. \u25aa Giving anti-retroviral drugs (ARVs) to mother living with HIV or HIV-exposed",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1197
  },
  {
    "id": "chunk_01198",
    "text": "gs (ARVs) to mother living with HIV or HIV-exposed infant during breastfeeding can significantly reduce the risk of HIV- transmission through breastfeeding. \u25aa Mothers or infants who have been receiving ARV prophylaxis should continue prophylaxis for one week after breastfeeding is fully stopped.",
    "page_number": 122,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1198
  },
  {
    "id": "chunk_01199",
    "text": "HEALTH BENEFITS OF BREASTFEEDING \u25aa Provides the healthiest food for the baby. \u25aa Protects the baby from diarrhea. \u25aa Reduces bleeding after childbirth. \u25aa Passes on the mother\u2019s immunities to the baby. This helps protect the baby from diseases such as measles and pneumonia. These diseases can kill",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1199
  },
  {
    "id": "chunk_01200",
    "text": "as measles and pneumonia. These diseases can kill babies. \u25aa Helps develop a close bond between the mother and baby. HOW TO USE \u25aa Start breastfeeding as soon as possible after the baby is born. Breast feeding initiated within one hour of birth will allow baby the full benefit of colostrums.",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1200
  },
  {
    "id": "chunk_01201",
    "text": "th will allow baby the full benefit of colostrums. \u25aa Breastfeed your baby exclusively for the first six months. \u25aa Feed only breast milk day and night. You are protected against pregnancy if all 3 conditions are present: 1. Your menstrual bleeding has not returned",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1201
  },
  {
    "id": "chunk_01202",
    "text": "esent: 1. Your menstrual bleeding has not returned 2. Your baby is fully breastfed. You must breastfeed both day and night. 3. Your baby is less than 6 months old. \u25aa If and when any of these conditions are not present, you should:",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1202
  },
  {
    "id": "chunk_01203",
    "text": "y of these conditions are not present, you should: - Use another method for effective family planning that will not interfere with breastfeeding. - Keep breastfeeding your baby. Breastfeed even while feeding your baby other food or liquids.",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1203
  },
  {
    "id": "chunk_01204",
    "text": "ven while feeding your baby other food or liquids. \u25aa Complementary foods must be introduced to six months, however breastfeeding should also continue up to 2 years and longer. Women should discuss infant feeding with their health care provider. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF...",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1204
  },
  {
    "id": "chunk_01205",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa Any 1 of the 3 conditions needed for LAM changes, and you need another method. \u25aa Before your baby is 6 months old so you can choose another method.",
    "page_number": 123,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1205
  },
  {
    "id": "chunk_01206",
    "text": "Male Condoms EFFECTIVENESS Typical use 82% Not used consistently: 18 pregnancies per 100 women GENERAL INFORMATION \u25aa Most condoms are made of thin latex rubber. Some condoms are coated with a lubricant and/or spermicide. \u25aa If you have had an allergic reaction to latex rubber, you should not use latex",
    "page_number": 125,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1206
  },
  {
    "id": "chunk_01207",
    "text": "reaction to latex rubber, you should not use latex condoms. \u25aa Before having sex, place the condom over the erect penis. \u25aa You must use a new condom for each act of sex. \u25aa Protect against pregnancy and sexually transmitted infections (STIs), including HIV.",
    "page_number": 125,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1207
  },
  {
    "id": "chunk_01208",
    "text": "ally transmitted infections (STIs), including HIV. \u25aa Require partner\u2019s cooperation to use consistently and correctly. HOW THE METHOD WORKS \u25aa Before having sex, place the condom on the erect penis. \u25aa The condom forms a barrier that keeps sperm out of the vagina during sex. This prevents pregnancy.",
    "page_number": 125,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1208
  },
  {
    "id": "chunk_01209",
    "text": "of the vagina during sex. This prevents pregnancy. IMPORTANT FACTS \u25aa Can be used without seeing a health provider. \u25aa Can be used as a temporary or backup method. \u25aa Condoms, both male and female, are the only method that prevents from STIs and HIV.",
    "page_number": 125,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1209
  },
  {
    "id": "chunk_01210",
    "text": "e the only method that prevents from STIs and HIV. \u25aa May decrease sensation, making sex less enjoyable for either partner. \u25aa You must take time to put the condom on the erect penis before the penis touches the woman\u2019s genitals. \u25aa Increase male participation in family planning. | 2 |",
    "page_number": 125,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1210
  },
  {
    "id": "chunk_01211",
    "text": "METHOD NOT ADVISED IF YOUR PARTNER... \u25aa Has had an allergic reaction to latex rubber. Some people may just be allergic to a specific brand of condoms. If it is not a latex allergy, switch to another brand. SIDE EFFECTS None HOW TO USE \u25aa Use a new condom for each act of sex.",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1211
  },
  {
    "id": "chunk_01212",
    "text": "HOW TO USE \u25aa Use a new condom for each act of sex. \u25aa Check the condom package. Do not use if torn or damaged. Avoid using a condom past the expiration date. Do so only if newer condoms are not available. \u25aa Open the package carefully. Do not use fingernails, teeth, or anything that",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1212
  },
  {
    "id": "chunk_01213",
    "text": "y. Do not use fingernails, teeth, or anything that could damage the condom. \u25aa Before any vaginal contact, place the condom on the tip of the erect penis. The rolled side should be on the outside. \u25aa Unroll the condom all the way to the base of the erect penis. If the condom",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1213
  },
  {
    "id": "chunk_01214",
    "text": "way to the base of the erect penis. If the condom does not unroll, it may be on backwards, damaged, or too old. Throw it away. Use a new condom. If the condom is on backwards and another is not available, turn it over and unroll onto the penis.",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1214
  },
  {
    "id": "chunk_01215",
    "text": "available, turn it over and unroll onto the penis. \u25aa If desired, use water or a water-based lubricant on the outside of the condom. This helps prevent breaks. Do not use creams, oils, or petroleum jelly. \u25aa Immediately after ejaculation, hold the rim of the condom in place. Withdraw",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1215
  },
  {
    "id": "chunk_01216",
    "text": "ion, hold the rim of the condom in place. Withdraw the penis will it is still erect. Be careful not to spill semen when withdrawing the penis or taking off the condom. \u25aa Place the condom in a tissue or in the empty package. Throw it into the",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1216
  },
  {
    "id": "chunk_01217",
    "text": "tissue or in the empty package. Throw it into the rubbish. Do not put it into a flush toilet. This may cause problems with plumbing. \u25aa Store condoms in a dark, cool, dry place if possible. Important: If you did not use a condom for an act of sex, try to use one the next",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1217
  },
  {
    "id": "chunk_01218",
    "text": "condom for an act of sex, try to use one the next time. A mistake once or twice does not mean that it is too late to use condoms in the future. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems.",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1218
  },
  {
    "id": "chunk_01219",
    "text": "Y TIME IF... \u25aa You have any questions or problems. \u25aa You had unprotected sex in the past 5 days and want to avoid pregnancy. The woman can take emergency contraceptive pills (ECPs). | 3 |",
    "page_number": 126,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1219
  },
  {
    "id": "chunk_01220",
    "text": "Minipill Progestin-only Oral Contraceptives EFFECTIVENESS Typical use in first year 90 - 97% Some missed pills: 3 to 10 pregnancies per 100 women For breastfeeding women in first year 99% 1 pregnancy per 100 women GENERAL INFORMATION \u25aa Requires that you take 1 pill every day.",
    "page_number": 128,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1220
  },
  {
    "id": "chunk_01221",
    "text": "RMATION \u25aa Requires that you take 1 pill every day. \u25aa Safe for women who are breastfeeding. \u25aa You may begin the minipill after giving birth. \u25aa May cause irregular monthly bleeding. For breastfeeding women, causes delayed return of monthly bleeding.",
    "page_number": 128,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1221
  },
  {
    "id": "chunk_01222",
    "text": "women, causes delayed return of monthly bleeding. \u25aa Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS",
    "page_number": 128,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1222
  },
  {
    "id": "chunk_01223",
    "text": "ctions (STIs), including HIV. HOW THE METHOD WORKS \u25aa You take 1 pill every day. The minipill is most effective when you take the pill at the same time every day. \u25aa The minipill has small amounts of progestin. Progestin makes the mucus around the cervix thick. This stops sperm from meeting an egg.",
    "page_number": 128,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1223
  },
  {
    "id": "chunk_01224",
    "text": "IMPORTANT FACTS \u25aa Can be stopped at any time without a provider\u2019s help. \u25aa You control the method. \u25aa Does not interfere with sex. \u25aa Can cause irregular monthly bleeding. \u25aa You have to remember to take a pill once a day, every day.",
    "page_number": 129,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1224
  },
  {
    "id": "chunk_01225",
    "text": "to remember to take a pill once a day, every day. \u25aa All of the pills have the hormone progestin in them; there are no placebos or sugar pills. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. SIDE EFFECTS",
    "page_number": 129,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1225
  },
  {
    "id": "chunk_01226",
    "text": "feel at risk of STIs, including HIV. SIDE EFFECTS \u25aa May cause frequent or irregular monthly bleeding for the first several months or the entire time you use the minipill. \u25aa May cause headaches, dizziness, breast tenderness, mood changes, or other possible side effects.",
    "page_number": 129,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1226
  },
  {
    "id": "chunk_01227",
    "text": "ess, mood changes, or other possible side effects. \u25aa For breastfeeding women, it takes longer for monthly bleeding to return after giving birth. \u25aa These are normal and not signs of illness. \u25aa Not all women have these side effects. HOW TO USE",
    "page_number": 129,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1227
  },
  {
    "id": "chunk_01228",
    "text": "Not all women have these side effects. HOW TO USE \u25aa Begin with the first pill in the packet as directed by your provider. \u25aa Take 1 pill every day until you finish the packet. \u25aa Take the pill at the same time every day. Do not miss any pills.",
    "page_number": 129,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1228
  },
  {
    "id": "chunk_01229",
    "text": "at the same time every day. Do not miss any pills. \u25aa Have a new packet of pills on hand before you finish your packet. \u25aa If you get your pills from a pharmacy, you can use the instructions in this brochure. \u25aa If you miss taking your pills, follow the guidelines on the next page. | 3 |",
    "page_number": 129,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1229
  },
  {
    "id": "chunk_01230",
    "text": "FOLLOW THESE GUIDELINES IF YOU MISS 1 OR MORE PILLS If you: Do this: \u25aa Are 3 or more \u25aa Take a pill as soon as possible. hours late in \u25aa Keep taking the pill every day at the same time. (This taking the pill means that you may end up taking 2 pills at the OR same time or on the same day).",
    "page_number": 130,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1230
  },
  {
    "id": "chunk_01231",
    "text": "g 2 pills at the OR same time or on the same day). \u25aa Miss taking 1 pill \u25aa Use a backup method (condoms) or avoid sex for the next 2 days. \u25aa If you have unprotected sex in the past 5 days, consider taking emergency contraception pills (ECPs).",
    "page_number": 130,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1231
  },
  {
    "id": "chunk_01232",
    "text": "sider taking emergency contraception pills (ECPs). \u25aa Vomit within 2 \u25aa Take another pill from your packet as soon as hours of taking a possible. pill \u25aa Continue taking the pills as usual. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You need more pills.",
    "page_number": 130,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1232
  },
  {
    "id": "chunk_01233",
    "text": "any questions or problems. \u25aa You need more pills. \u25aa You develop any health problems. \u25aa You were late or missed a pill, had sex in the past 5 days, and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs). \u25aa You think you may be pregnant.",
    "page_number": 130,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1233
  },
  {
    "id": "chunk_01234",
    "text": "The Pill Combined Oral Contraceptives EFFECTIVENESS Typical use in first year 91% Some missed pills: 9 pregnancies per 100 women GENERAL INFORMATION \u25aa Requires that you take 1 pill every day. \u25aa May cause irregular bleeding during the first few months of use.",
    "page_number": 132,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1234
  },
  {
    "id": "chunk_01235",
    "text": "gular bleeding during the first few months of use. \u25aa Safe for a woman with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. \u25aa There are many different brands and regimens of combined oral contraceptives. Discuss available and most appropriate method with provider.",
    "page_number": 132,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1235
  },
  {
    "id": "chunk_01236",
    "text": "ailable and most appropriate method with provider. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS \u25aa You take 1 pill every day. The pill is most effective when you take the pill at the same time every day.",
    "page_number": 132,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1236
  },
  {
    "id": "chunk_01237",
    "text": "when you take the pill at the same time every day. \u25aa The pill contains small amounts of the hormones estrogen and progestin. \u25aa These hormones make the mucus around the cervix thick. This stops sperm from meeting an egg. \u25aa They also prevent the release of eggs from the ovaries (ovulation).",
    "page_number": 132,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1237
  },
  {
    "id": "chunk_01238",
    "text": "the release of eggs from the ovaries (ovulation). IMPORTANT FACTS \u25aa You control the method. \u25aa Can be stopped at any time without a provider\u2019s help. \u25aa Does not interfere with sex. \u25aa You have to remember to take a pill once a day, every day. \u25aa Use condoms (male or female) if you feel at risk of STIs.",
    "page_number": 132,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1238
  },
  {
    "id": "chunk_01239",
    "text": "METHOD NOT ADVISED IF YOU... \u25aa Are breastfeeding an infant less than 6 months old. \u25aa Smoke cigarettes and are 35 years old or older. \u25aa If you are at risk of heart disease, stroke, smoking, diabetes, high blood pressure, or high cholesterol.",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1239
  },
  {
    "id": "chunk_01240",
    "text": "iabetes, high blood pressure, or high cholesterol. \u25aa Have certain uncommon series diseases of the heart or blood vessels. Discus with your provider. \u25aa Have blood clots, deep vein thrombosis, or pulmonary embolism, or are on an anticoagulant therapy. Discuss with your provider.",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1240
  },
  {
    "id": "chunk_01241",
    "text": "anticoagulant therapy. Discuss with your provider. \u25aa Have lupus or severe liver disease or gall bladder disease, even if medically- treated. Discuss with your provider. \u25aa Have breast cancer or a history of breast cancer. \u25aa Have migraine aura. HOW TO USE",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1241
  },
  {
    "id": "chunk_01242",
    "text": "of breast cancer. \u25aa Have migraine aura. HOW TO USE \u25aa Begin with the first pill in the packet as directed by your provider. \u25aa Take 1 pill every day until you finish the packet. \u25aa Take the pill at the same time every day. Do not miss any pills.",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1242
  },
  {
    "id": "chunk_01243",
    "text": "at the same time every day. Do not miss any pills. \u25aa Have a new packet of pills on hand before you finish your packet. \u25aa If you get your pills from a pharmacy, you can use the instructions in this brochure. \u25aa If you miss taking your pills, follow the guidelines on the next page.",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1243
  },
  {
    "id": "chunk_01244",
    "text": "our pills, follow the guidelines on the next page. FOLLOW THESE GUIDELINES IF YOU MISS 1 OR MORE PILLS If you: Do this: \u25aa Are 3 or more \u25aa Take a pill as soon as possible. hours late in \u25aa Keep taking the pill every day at the same time. (This",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1244
  },
  {
    "id": "chunk_01245",
    "text": "taking the pill every day at the same time. (This taking the pill means that you may end up taking 2 pills at the OR same time or on the same day). \u25aa Miss taking 1 pill \u25aa Use a backup method (condoms) or avoid sex for the next 2 days. \u25aa If you have unprotected sex in the past 5 days,",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1245
  },
  {
    "id": "chunk_01246",
    "text": "\u25aa If you have unprotected sex in the past 5 days, consider taking emergency contraception pills (ECPs). \u25aa Vomit within 2 \u25aa Take another pill from your packet as soon as hours of taking a possible. pill \u25aa Continue taking the pills as usual. | 3 |",
    "page_number": 133,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1246
  },
  {
    "id": "chunk_01247",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF...\n\u25aa You have any questions or problems.\n\u25aa You need more pills.\n\u25aa You develop any health problems.\n\u25aa You were late or missed a pill, had sex in the past 5 days, and want to avoid\npregnancy. You can take emergency contraceptive pills (ECPs).\n\u25aa You think you may be pregnant.",
    "page_number": 134,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1247
  },
  {
    "id": "chunk_01248",
    "text": "Progestin-only Injectables DMPA or NET-EN EFFECTIVENESS Typical use in first year 94% Some missed or late injections: 6 pregnancies per 100 women GENERAL INFORMATION \u25aa You get an injection very 2 or 3 months, depending on type of injectable.",
    "page_number": 136,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1248
  },
  {
    "id": "chunk_01249",
    "text": "ry 2 or 3 months, depending on type of injectable. \u25aa Fertility can return as early as 3 weeks postpartum so you should use a backup method such as condoms until you begin the injection. \u25aa Safe for women who are breastfeeding. You may begin the method 6 weeks after giving birth.",
    "page_number": 136,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1249
  },
  {
    "id": "chunk_01250",
    "text": "u may begin the method 6 weeks after giving birth. \u25aa May cause irregular or no menstrual bleeding. \u25aa There is a delayed return to fertility after you stop the method. It takes longer than with most other methods to conceive (1 months for NET-EN, 4 months for DMPA, up to 1 year for Sayana Press\u00ae).",
    "page_number": 136,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1250
  },
  {
    "id": "chunk_01251",
    "text": "months for DMPA, up to 1 year for Sayana Press\u00ae). \u25aa Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS",
    "page_number": 136,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1251
  },
  {
    "id": "chunk_01252",
    "text": "ctions (STIs), including HIV. HOW THE METHOD WORKS \u25aa Progestin-only injectables contain the hormone progestin. Progestin makes the mucus around the cervix thick. This stops the sperm from meeting the egg. \u25aa This hormone also stops the release of eggs from the ovaries (ovulation).",
    "page_number": 136,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1252
  },
  {
    "id": "chunk_01253",
    "text": "the release of eggs from the ovaries (ovulation). \u25aa DMPA, NET-EN, and Sayana Press are different types of injectables. \u25aa If using DMPA, you get an injection once every 3 months (90 days). \u25aa If using NET-EN, you get an injection once every 2 months (60 days).",
    "page_number": 136,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1253
  },
  {
    "id": "chunk_01254",
    "text": "IMPORTANT FACTS \u25aa Method is reversible. \u25aa Can be stopped at any time, either to switch to another method or to get pregnant. \u25aa Private. No one can tell you are using an injectable. \u25aa Do not interfere with sex. \u25aa Use condoms (male or female) if you feel at risk of getting STIs, including HIV.",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1254
  },
  {
    "id": "chunk_01255",
    "text": "f you feel at risk of getting STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Are breastfeeding an infant less than 6 weeks of age. \u25aa Have very high blood pressure, over 160/100. \u25aa Have major cardiovascular risk factors such as hypertension, obesity, older",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1255
  },
  {
    "id": "chunk_01256",
    "text": "risk factors such as hypertension, obesity, older age, stroke, smoking, diabetes, high cholesterol, or certain uncommon diseases of the heart or blood vessels. Discuss with your provider. \u25aa Have or have history of breast cancer. \u25aa Have unexplained vaginal bleeding.",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1256
  },
  {
    "id": "chunk_01257",
    "text": "reast cancer. \u25aa Have unexplained vaginal bleeding. \u25aa Take medications for seizures or take rifampicin. \u25aa Have lupus or take Ritonavir-boosted protease inhibitors as part of HAART (Efavirenz or Neviripine) may cause lower effectiveness of NET-EN. \u25aa History of severe liver disease. SIDE EFFECTS",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1257
  },
  {
    "id": "chunk_01258",
    "text": "N. \u25aa History of severe liver disease. SIDE EFFECTS \u25aa In the beginning, you may have irregular bleeding, prolonged bleeding, or frequent bleeding. Later on there is no monthly bleeding. \u25aa Menstrual changes do not stop until the injection wears off (2-3 months or more).",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1258
  },
  {
    "id": "chunk_01259",
    "text": "ntil the injection wears off (2-3 months or more). \u25aa Some women have weight gain, headaches, dizziness, and other side effects. These are not signs of illness. \u25aa Not all women have these side effects. HEALTH BENEFITS \u25aa Help prevent cancer of the lining of the uterus. Also help prevent uterine",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1259
  },
  {
    "id": "chunk_01260",
    "text": "he lining of the uterus. Also help prevent uterine fibroids. \u25aa May help protect against pelvic inflammatory disease (PID). \u25aa May help prevent iron deficiency anemia. \u25aa Reduce symptoms of endometriosis (pelvic pain, irregular bleeding). | 3 |",
    "page_number": 137,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1260
  },
  {
    "id": "chunk_01261",
    "text": "HOW TO USE \u25aa Go to a provider to get an injection. \u25aa Get your injections every 3 months (DMPA), 2 months (NET-EN), or self administer according to instructions every 3 months (Sayana Press). If you do not get your injection, you can get pregnant if you have sex.",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1261
  },
  {
    "id": "chunk_01262",
    "text": "r injection, you can get pregnant if you have sex. \u25aa Even if you are late, come back. You may still be able to get your injection. \u25aa If you switch to another brand of injectable, use this brochure on how to use the method. FOLLOW-UP For DMPA users",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1262
  },
  {
    "id": "chunk_01263",
    "text": "on how to use the method. FOLLOW-UP For DMPA users \u25aa Return every 3 months or 13 weeks to get the next injection. \u25aa Try to come on time. You may come up to 2 weeks early or 4 weeks late and get an injection. No matter how late you are, come back for your next injection.",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1263
  },
  {
    "id": "chunk_01264",
    "text": "w late you are, come back for your next injection. \u25aa If you are more than 4 weeks late, abstain from sex or use condoms until you can get an injection. For NET-EN users \u25aa Return every 2 months or 9 weeks to get the next injection.",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1264
  },
  {
    "id": "chunk_01265",
    "text": "ery 2 months or 9 weeks to get the next injection. \u25aa Try to come on time. You may come up to 2 weeks early or 2 weeks late and get an injection. No matter how late you are, come back for your next injection. \u25aa If you are more than 2 weeks late, abstain from sex or use condoms until you",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1265
  },
  {
    "id": "chunk_01266",
    "text": "ks late, abstain from sex or use condoms until you get an injection. For Sayana Press\u00ae users \u25aa Return for periodic re-evaluation and to receive new injection. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You need another injection.",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1266
  },
  {
    "id": "chunk_01267",
    "text": "estions or problems. \u25aa You need another injection. \u25aa You develop any health problems. \u25aa You are late for your injection, had sex in the past 5 days, and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs). \u25aa You think you may be pregnant.",
    "page_number": 138,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1267
  },
  {
    "id": "chunk_01268",
    "text": "Standard Days Method\u00ae SDM EFFECTIVENESS Typical use in first year 88% 12 pregnancies per 100 women GENERAL INFORMATION \u25aa Ideal for women whose menstrual cycles are usually between 26-32 days long. Women who have their regular monthly bleeding fall within this range.",
    "page_number": 140,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1268
  },
  {
    "id": "chunk_01269",
    "text": "r regular monthly bleeding fall within this range. \u25aa You use a calendar or CycleBeads\u00ae, a string of color-coded beads, to track the days you can get pregnant and the days you are not likely to get pregnant. \u25aa On the days you can get pregnant, you must not have sex or you must use a",
    "page_number": 140,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1269
  },
  {
    "id": "chunk_01270",
    "text": "pregnant, you must not have sex or you must use a condom or other barrier method. \u25aa Postpartum or breastfeeding women must have 3 regular menstrual cycles before they can use SDM. Use an alternative method during this period.",
    "page_number": 140,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1270
  },
  {
    "id": "chunk_01271",
    "text": "SDM. Use an alternative method during this period. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. \u25aa Requires partner\u2019s cooperation. HOW THE METHOD WORKS \u25aa Make a calendar or use CycleBeads\u00ae to track the days when you can get",
    "page_number": 140,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1271
  },
  {
    "id": "chunk_01272",
    "text": "use CycleBeads\u00ae to track the days when you can get pregnant. You also track the days when you are not likely to get pregnant. \u25aa The days you can get pregnant are days 8 to 19 of your menstrual cycle. \u25aa On those days you must not have sex or you must use condoms to avoid getting pregnant. SIDE EFFECTS",
    "page_number": 140,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1272
  },
  {
    "id": "chunk_01273",
    "text": "IMPORTANT FACTS \u25aa There are no costs needed, and no supplies if you choose to use calendar to track the days. \u25aa There are 12 days during the month when you can get pregnant. On those days, you must abstain from sex or use a barrier method. This may be difficult for some couples.",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1273
  },
  {
    "id": "chunk_01274",
    "text": "er method. This may be difficult for some couples. \u25aa You will need counseling on how to use the method correctly. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Do not have regular monthly bleeding, that means, if your cycles are not",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1274
  },
  {
    "id": "chunk_01275",
    "text": "nthly bleeding, that means, if your cycles are not between 26-32 days long. \u25aa Are not willing or able to abstain from sex or use a condom or other barrier method during the days you can get pregnant. \u25aa Cannot keep track of the days of your menstrual cycle.",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1275
  },
  {
    "id": "chunk_01276",
    "text": "ot keep track of the days of your menstrual cycle. \u25aa Have not had at least 3 consecutive menstrual cycles since giving birth. \u25aa Do not have regular monthly bleeding after discontinuing a hormonal method. HEALTH BENEFITS \u25aa It is natural, there are no hormones, devices or medical procedures required.",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1276
  },
  {
    "id": "chunk_01277",
    "text": "hormones, devices or medical procedures required. \u25aa Promotes male involvement and couple communication. \u25aa No delay in return to fertility. HOW TO USE To use SDM with CycleBeads\u00ae: Each bead represents a day of your menstrual cycle. The RED bead marks the first day of your monthly bleeding.",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1277
  },
  {
    "id": "chunk_01278",
    "text": "bead marks the first day of your monthly bleeding. All BROWN beads mark the days when you are not likely to get pregnant. All WHITE beads mark the days you can get pregnant. 1. On the first day of your monthly bleeding, move the ring to the RED bead. Also mark that day on",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1278
  },
  {
    "id": "chunk_01279",
    "text": "ve the ring to the RED bead. Also mark that day on a calendar. This will help you remember where to put the ring if one day you forget to move it. 2. Move the ring to the next bead each day. Always move the ring in the direction of the arrow.",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1279
  },
  {
    "id": "chunk_01280",
    "text": "lways move the ring in the direction of the arrow. 3. Move the ring even on the days that you have your monthly bleeding. 4. When the ring is on a BROWN bead you are not likely to get pregnant. You can have unprotected sex. | 3 |",
    "page_number": 141,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1280
  },
  {
    "id": "chunk_01281",
    "text": "5. When the ring is on a WHITE bead, you can get pregnant. Abstain from vaginal sex or use a condom or other barrier method. 6. On the day your monthly bleeding begins again, move the ring to the RED bead to start a new cycle. Skip over any beads that are left.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1281
  },
  {
    "id": "chunk_01282",
    "text": "rt a new cycle. Skip over any beads that are left. 7. There is one DARK BROWN bead. If your monthly bleeding begins before you reach the DARK BROWN bead, it is too soon. This means that your menstrual cycle is shorter than 26 days.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1282
  },
  {
    "id": "chunk_01283",
    "text": "that your menstrual cycle is shorter than 26 days. 8. If your monthly bleeding does not start the day after you reach the last BROWN bead, it is too long. This means that your menstrual cycle is longer than 32 days. 9. If more than once in a year you have a cycle that is too short or too long, you",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1283
  },
  {
    "id": "chunk_01284",
    "text": "ou have a cycle that is too short or too long, you should use another method. IF USING A CALENDAR: 1. On the first day of your monthly bleeding, mark that day on the calendar. This is day 1 of your cycle. 2. Days 1 to 7 of your cycle are days when you are not likely to get pregnant.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1284
  },
  {
    "id": "chunk_01285",
    "text": "are days when you are not likely to get pregnant. You can have unprotected sex. 3. Days 8 to 19 of your cycle are days when you can get pregnant if you have unprotected sex. Abstain from vaginal sex or use a condom or other barrier method.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1285
  },
  {
    "id": "chunk_01286",
    "text": "ginal sex or use a condom or other barrier method. 4. From day 20 until your monthly bleeding begins again are days when you are not likely to get pregnant. You can have unprotected sex. 5. To know if the method works for you, always check if you get your monthly bleeding every 26 to 32 days.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1286
  },
  {
    "id": "chunk_01287",
    "text": "you get your monthly bleeding every 26 to 32 days. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You have difficulty abstaining from sex or using a condom or other barrier method during the days you can get pregnant. You may want to choose another method.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1287
  },
  {
    "id": "chunk_01288",
    "text": "t pregnant. You may want to choose another method. \u25aa You get your monthly bleeding before you reach the DARK BROWN bead. \u25aa You do not get your monthly bleeding by the day after you reach the BROWN bead. \u25aa You have sex on a day when you can get pregnant (WHITE bead days or days",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1288
  },
  {
    "id": "chunk_01289",
    "text": "when you can get pregnant (WHITE bead days or days 8 to 19 on calendar) and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs). \u25aa You think you may be pregnant.",
    "page_number": 142,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1289
  },
  {
    "id": "chunk_01290",
    "text": "Withdrawal Coitus Interruptus/\u201cPulling Out\u201d EFFECTIVENESS Typical use 78% 22 pregnancies per 100 women GENERAL INFORMATION \u25aa The man withdraws his penis from his partner\u2019s vagina before ejaculation and he ejaculates outside of the vagina.",
    "page_number": 144,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1290
  },
  {
    "id": "chunk_01291",
    "text": "aculation and he ejaculates outside of the vagina. \u25aa Is one of the least effective methods, yet offers better protection than no method at all. \u25aa Not suitable for men who cannot sense consistently when ejaculation is about to occur or ejaculate prematurely.",
    "page_number": 144,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1291
  },
  {
    "id": "chunk_01292",
    "text": "lation is about to occur or ejaculate prematurely. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. \u25aa Requires partner\u2019s cooperation. HOW THE METHOD WORKS \u25aa Works by keeping sperm out of the woman\u2019s vagina. IMPORTANT FACTS",
    "page_number": 144,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1292
  },
  {
    "id": "chunk_01293",
    "text": "g sperm out of the woman\u2019s vagina. IMPORTANT FACTS \u25aa Effectiveness depends on willingness and ability of the male partner to use withdrawal with every act of intercourse. \u25aa Pre-ejaculatory fluid contains sperm and may flow out during intercourse. \u25aa Couples can use withdrawal as a backup method.",
    "page_number": 144,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1293
  },
  {
    "id": "chunk_01294",
    "text": ". \u25aa Couples can use withdrawal as a backup method. \u25aa May be appropriate for couples who need a temporary method while awaiting the start of another method. \u25aa Requires no supplies and no clinic or pharmacy visit. | 2 |",
    "page_number": 144,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1294
  },
  {
    "id": "chunk_01295",
    "text": "METHOD NOT ADVISED IF... \u25aa Male partner cannot sense consistently when ejaculation is about to occur. \u25aa Male partner ejaculates prematurely. \u25aa Couple is at high risk of infections, they should use a condom with each act of sex. Withdrawal does not protect from STIs, including HIV. SIDE EFFECTS None",
    "page_number": 145,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1295
  },
  {
    "id": "chunk_01296",
    "text": "rotect from STIs, including HIV. SIDE EFFECTS None HEALTH BENEFITS \u25aa Promotes male involvement and couple communication. \u25aa No delay in return to fertility after use of withdrawal is stopped. HOW TO USE \u25aa When the man feels close to ejaculation he should withdraw his penis from",
    "page_number": 145,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1296
  },
  {
    "id": "chunk_01297",
    "text": "e to ejaculation he should withdraw his penis from the woman\u2019s vagina and ejaculate outside the vagina. \u25aa The man should keep his semen away from the woman\u2019s genitals. \u25aa If the man has ejaculated recently, he should urinate and wipe the tip of his penis, to remove any remaining sperm, before sex.",
    "page_number": 145,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1297
  },
  {
    "id": "chunk_01298",
    "text": "penis, to remove any remaining sperm, before sex. \u25aa Learning to properly use withdrawal may take time. The couple can also use another method until the man feels that he can use withdrawal correctly with every act of sex. RETURN TO THE HEALTH CARE FACILITY AT ANY TIME IF...",
    "page_number": 145,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1298
  },
  {
    "id": "chunk_01299",
    "text": "TURN TO THE HEALTH CARE FACILITY AT ANY TIME IF... \u25aa You have any questions or problems. \u25aa Your male partner has difficulty predicting and/or controlling the timing of his ejaculation. You may want to choose another method. \u25aa Your partner has ejaculated inside your vagina before withdrawing. You can",
    "page_number": 145,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1299
  },
  {
    "id": "chunk_01300",
    "text": "ted inside your vagina before withdrawing. You can take emergency contraceptive pills (ECPs). \u25aa You want an additional or alternative method of family planning for greater protection from pregnancy. You think you may be pregnant. | 3 |",
    "page_number": 145,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1300
  },
  {
    "id": "chunk_01301",
    "text": "Tubal Ligation Female Sterilization EFFECTIVENESS In first year 99% Less than 1 pregnancy per 100 women Over 10 years 99% 2 pregnancies per 100 women GENERAL INFORMATION \u25aa Permanent method for women who do not want more children.",
    "page_number": 147,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1301
  },
  {
    "id": "chunk_01302",
    "text": "nt method for women who do not want more children. \u25aa Involves a surgical procedure. There are both benefits and certain risks i the procedure. \u25aa Protects against pregnancy right away. \u25aa Safe for a woman with HIV/AIDS, even if she takes antiretroviral (ARV) medicines.",
    "page_number": 147,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1302
  },
  {
    "id": "chunk_01303",
    "text": "even if she takes antiretroviral (ARV) medicines. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS \u25aa A trained provider makes a small incision on your abdomen. S/he then ties",
    "page_number": 147,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1303
  },
  {
    "id": "chunk_01304",
    "text": "s a small incision on your abdomen. S/he then ties off (or cuts) the two fallopian tubes. These tubes normally carry eggs from the ovaries to the uterus. \u25aa With the tubes blocked, the eggs cannot move down the tubes. They cannot meet with the man\u2019s sperm. \u25aa The method is intended to be permanent.",
    "page_number": 147,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1304
  },
  {
    "id": "chunk_01305",
    "text": "IMPORTANT FACTS \u25aa No need to worry about contraception again. The method is very effective. \u25aa Easy to use, nothing to do or remember. \u25aa Does not affect sexual desire. \u25aa Complications of surgery and anesthesia are possible. But they are uncommon and extremely rare.",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1305
  },
  {
    "id": "chunk_01306",
    "text": "ossible. But they are uncommon and extremely rare. \u25aa Special arrangements are needed to perform a tubal ligation on a woman with AIDS. \u25aa Use condoms (male or female) if you feel you are at risk of STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Are pregnant \u25aa Are depressed",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1306
  },
  {
    "id": "chunk_01307",
    "text": "T ADVISED IF YOU... \u25aa Are pregnant \u25aa Are depressed \u25aa Have certain medical conditions that make it necessary to delay the procedure. HEALTH BENEFITS \u25aa Protects against risks of pregnancy and pelvic inflammatory infections (PID). \u25aa May help protect against ovarian cancer. INFORMED CONSENT",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1307
  },
  {
    "id": "chunk_01308",
    "text": "p protect against ovarian cancer. INFORMED CONSENT \u25aa Informed consent is required for this method. \u25aa Before you give informed consent, you must understand the following points: - Temporary contraceptives are also available. - Tubal ligation is a surgical procedure.",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1308
  },
  {
    "id": "chunk_01309",
    "text": "ailable. - Tubal ligation is a surgical procedure. - There are certain risks of the procedure as well as benefits (both risks and benefits must be explained in a way that you understand them). - If successful, the procedure will prevent you from ever having any more children.",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1309
  },
  {
    "id": "chunk_01310",
    "text": "ll prevent you from ever having any more children. - The procedure is considered permanent and probably cannot be reversed. - You can decide against the procedure at any time before it takes place. You will not lose rights to other medical, health, or other services or benefits.",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1310
  },
  {
    "id": "chunk_01311",
    "text": "er medical, health, or other services or benefits. \u25aa Before the procedure you may need to sign a consent form. If you cannot read or write, someone will read the form to you and a witness can sign for you. | 3 |",
    "page_number": 148,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1311
  },
  {
    "id": "chunk_01312",
    "text": "FOLLOW-UP \u25aa After the procedure, rest for 2 days. \u25aa Avoid vigorous work and heavy lifting for 1 week. \u25aa Abdominal pain and swelling after the procedure is common. It usually goes away within a few days. \u25aa Take paracetamol or ibuprofen in case of pain. Do not take aspirin. It slows",
    "page_number": 149,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1312
  },
  {
    "id": "chunk_01313",
    "text": "fen in case of pain. Do not take aspirin. It slows healing. You rarely need a stronger pain reliever. \u25aa Keep the incision clean and dry for 1 or 2 days. Avoid rubbing the incision for 1 week. \u25aa Do not have sex for at least 1 week. If pain lasts more than 1 week, avoid sex until all pain is gone.",
    "page_number": 149,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1313
  },
  {
    "id": "chunk_01314",
    "text": "ore than 1 week, avoid sex until all pain is gone. \u25aa If possible, after 7-14 days, return to the health care facility. The health care provider will check the incision site. S/he will look for signs of any infection and remove any stitches. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF...",
    "page_number": 149,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1314
  },
  {
    "id": "chunk_01315",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You develop any health problems. \u25aa You think you may be pregnant.",
    "page_number": 149,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1315
  },
  {
    "id": "chunk_01316",
    "text": "TwoDay Method\u00ae EFFECTIVENESS Typical use 86% 14 pregnancies per 100 women GENERAL INFORMATION \u25aa Ideal for women who have healthy cervical secretions. \u25aa Healthy secretions do not have a foul smell or cause itchiness or pain.",
    "page_number": 151,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1316
  },
  {
    "id": "chunk_01317",
    "text": "not have a foul smell or cause itchiness or pain. \u25aa You have to check your cervical secretions at least once a day to know which days you can get pregnant (fertile days). \u25aa If you note secretions of any type, color, or consistency on the day you check,",
    "page_number": 151,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1317
  },
  {
    "id": "chunk_01318",
    "text": "type, color, or consistency on the day you check, then this is a fertile day and you can get pregnant. \u25aa On days you can get pregnant, you must abstain from unprotected sex or you can use a condom or other barrier method.",
    "page_number": 151,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1318
  },
  {
    "id": "chunk_01319",
    "text": "x or you can use a condom or other barrier method. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. \u25aa Requires partner\u2019s cooperation. HOW THE METHOD WORKS \u25aa Check your secretions at least twice a day.",
    "page_number": 151,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1319
  },
  {
    "id": "chunk_01320",
    "text": "ORKS \u25aa Check your secretions at least twice a day. \u25aa For this method, any type of cervical secretions indicates the woman is fertile. Secretions are anything that you perceive as coming from your vagina, except menstrual bleeding.",
    "page_number": 151,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1320
  },
  {
    "id": "chunk_01321",
    "text": "oming from your vagina, except menstrual bleeding. \u25aa If you saw or felt any secretions either today or yesterday, you can get pregnant today. \u25aa If today or yesterday you had secretions, abstain from sex or use a condom or other barrier method today. SIDE EFFECTS None | 2 |",
    "page_number": 151,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1321
  },
  {
    "id": "chunk_01322",
    "text": "IMPORTANT FACTS \u25aa No costs and no supplies needed. \u25aa Can be used by women with any cycle length and can be started at any point in their cycle. \u25aa You will need some counseling on how to use the method correctly. \u25aa If you have a vaginal infection or another condition that changes your cervical",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1322
  },
  {
    "id": "chunk_01323",
    "text": "on or another condition that changes your cervical secretions, the TwoDay Method will be difficult to use. \u25aa On fertile days, you must abstain form unprotected sex or use a barrier method. This may be difficult for some couples.",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1323
  },
  {
    "id": "chunk_01324",
    "text": "er method. This may be difficult for some couples. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. METHOD NOT ADVISED IF YOU... \u25aa Are not willing or able to abstain from sex or use a condom or other barrier method during the days you can get pregnant.",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1324
  },
  {
    "id": "chunk_01325",
    "text": "rrier method during the days you can get pregnant. \u25aa Cannot tell whether or not you have cervical secretions. \u25aa Have an infection that may affect your cervical secretions. \u25aa Have not had at least 3 consecutive menstrual cycles since giving birth.",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1325
  },
  {
    "id": "chunk_01326",
    "text": "3 consecutive menstrual cycles since giving birth. \u25aa Have not resumed menstruation after discontinuing a hormonal method. HEALTH BENEFITS \u25aa It is natural, there are no hormones, devices or medical procedures required. \u25aa Promotes male involvement and couple communications.",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1326
  },
  {
    "id": "chunk_01327",
    "text": "omotes male involvement and couple communications. \u25aa No delay in return to fertility. HOW TO USE \u25aa Check for secretions as soon as your monthly bleeding stops. Check every day for any secretions. Secretions are anything that you perceive as coming from your vagina, except menstrual bleeding.",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1327
  },
  {
    "id": "chunk_01328",
    "text": "oming from your vagina, except menstrual bleeding. \u25aa You may feel wetness at the opening of your vagina or see secretions on your finger, underpants, or tissue paper. \u25aa If you did not notice any secretions today AND yesterday (two days in a row",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1328
  },
  {
    "id": "chunk_01329",
    "text": "secretions today AND yesterday (two days in a row without secretions), it is not likely you can get pregnant today. \u25aa If you are not sure whether or not you have secretions, avoid sex or use a condom or other barrier method.",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1329
  },
  {
    "id": "chunk_01330",
    "text": "avoid sex or use a condom or other barrier method. Note: Secretions may change in quantity or look different on different days. ANY type of secretion indicates that you can get pregnant. | 3 |",
    "page_number": 152,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1330
  },
  {
    "id": "chunk_01331",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have difficulty knowing whether or not you have secretions. \u25aa You or your partner has difficulty using condoms or abstaining from sex during the days you can get pregnant. You may want to choose another method.",
    "page_number": 153,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1331
  },
  {
    "id": "chunk_01332",
    "text": "t pregnant. You may want to choose another method. \u25aa You have fewer than 5 days with secretions. \u25aa You have more than 14 days in a row with secretions. \u25aa You have sex on a fertile day and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs). \u25aa You think you may be pregnant.",
    "page_number": 153,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1332
  },
  {
    "id": "chunk_01333",
    "text": "Vasectomy Male Sterilization EFFECTIVENESS In first year 99% Less than 1 pregnancy per 100 women whose partner has had a vasectomy Over 3 years 96% 4 pregnancies per 100 women whose partner has had a vasectomy GENERAL INFORMATION \u25aa Permanent, safe method for men who do not want more children.",
    "page_number": 155,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1333
  },
  {
    "id": "chunk_01334",
    "text": "safe method for men who do not want more children. \u25aa A safe, simple surgical procedure. \u25aa Does not affect male sexual performance. \u25aa Does not protect from pregnancy immediately. There is a 3-month delay before the method takes effect.",
    "page_number": 155,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1334
  },
  {
    "id": "chunk_01335",
    "text": "is a 3-month delay before the method takes effect. \u25aa You must use condoms or another method for 3 months after the procedure. \u25aa Safe for a man with HIV/AIDS, even if he takes antiretroviral (ARV) medicines. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV.",
    "page_number": 155,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1335
  },
  {
    "id": "chunk_01336",
    "text": "ally transmitted infections (STIs), including HIV. HOW THE METHOD WORKS \u25aa You undergo a safe, simple, and quick surgical procedure. \u25aa A trained provider makes a simple cut and closes off the tubes from the testicles to the penis (vas deferns). \u25aa Closing off the tubes keeps sperm out of the semen.",
    "page_number": 155,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1336
  },
  {
    "id": "chunk_01337",
    "text": "losing off the tubes keeps sperm out of the semen. \u25aa You can still have erections and ejaculate semen. Your semen does not have sperm in it, so you cannot make a woman pregnant. | 2 |",
    "page_number": 155,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1337
  },
  {
    "id": "chunk_01338",
    "text": "IMPORTANT FACTS \u25aa One of the most effective methods, but it carries a small risk of failure. \u25aa Vasectomy is not fully effective until 3 months after the procedure. You must use condoms or another method for 3 months. \u25aa Pregnancies can occur within the first year for several reasons:",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1338
  },
  {
    "id": "chunk_01339",
    "text": "n occur within the first year for several reasons: - During the first 3 months after the procedure, you do not always use a condom or other method during sex. - The provider makes a mistake during the procedure. - The cut ends of the vas deferens grow back together.",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1339
  },
  {
    "id": "chunk_01340",
    "text": "e cut ends of the vas deferens grow back together. \u25aa Increases enjoyment and frequency of sex because there are no worries about pregnancy. \u25aa There are no particular health risks or benefits from this procedure. \u25aa Special arrangements are needed to perform the procedure on a man with AIDS.",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1340
  },
  {
    "id": "chunk_01341",
    "text": "eeded to perform the procedure on a man with AIDS. \u25aa Use condoms (male or female) if you feel at risk of STIs, including HIV. METHOD NOT ADVISED IF... \u25aa You have a medical condition where it may be necessary to delay this procedure. INFORMED CONSENT \u25aa Informed consent is required for this method.",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1341
  },
  {
    "id": "chunk_01342",
    "text": "NT \u25aa Informed consent is required for this method. \u25aa Before you give informed consent, you must understand the following points: - Temporary contraceptives are also available to you - Voluntary vasectomy is a surgical procedure",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1342
  },
  {
    "id": "chunk_01343",
    "text": "you - Voluntary vasectomy is a surgical procedure - There are certain risks of the procedure as well as benefits (both risks and benefits must be explained in a way that you understand them). - If successful, the procedure will prevent you from ever having any more children.",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1343
  },
  {
    "id": "chunk_01344",
    "text": "ll prevent you from ever having any more children. - The procedure is considered permanent and probably cannot be reversed. - You can decide against the procedure at any time before it takes place. You will not lose rights to other medical, health, or other services or benefits.",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1344
  },
  {
    "id": "chunk_01345",
    "text": "er medical, health, or other services or benefits. \u25aa Before the procedure you may need to sign a consent form. If you cannot read, a witness can sign for you. | 3 |",
    "page_number": 156,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1345
  },
  {
    "id": "chunk_01346",
    "text": "HOW TO USE \u25aa A trained medical provider performs the procedure in a place that has the necessary medical supplies and equipment. \u25aa The provider injects a local anesthetic into your scrotum. You will stay awake during the procedure. \u25aa The provider performs the procedure.",
    "page_number": 157,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1346
  },
  {
    "id": "chunk_01347",
    "text": "procedure. \u25aa The provider performs the procedure. \u25aa You can usually leave the clinic within an hour. FOLLOW-UP \u25aa It is common to feel discomfort in the scrotum. This usually lasts 2 to 3 days. \u25aa Take paracetamol or ibuprofen for pain. Do not take aspirin. It slows healing.",
    "page_number": 157,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1347
  },
  {
    "id": "chunk_01348",
    "text": "n for pain. Do not take aspirin. It slows healing. \u25aa Rest for 2 days, if possible. \u25aa Keep incision clean and dry for 2 or 3 days. \u25aa Do not have sex for at least 2 or 3 days. \u25aa During the first 3 months after the procedure, use condoms or another effective family planning method.",
    "page_number": 157,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1348
  },
  {
    "id": "chunk_01349",
    "text": "ndoms or another effective family planning method. \u25aa If possible, return to the clinic to have your semen examined. If it does not contain sperm, the vasectomy is working. This is helpful but not required. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have questions or problems.",
    "page_number": 157,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1349
  },
  {
    "id": "chunk_01350",
    "text": "Y ANY TIME IF... \u25aa You have questions or problems. \u25aa You develop any health problems. \u25aa Within the first 3 months of having the vasectomy you and your partner have unprotected sex and want to avoid pregnancy. Your partner can take emergency contraceptive pills (ECPs).",
    "page_number": 157,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1350
  },
  {
    "id": "chunk_01351",
    "text": "Progesterone Vaginal Ring PVR EFFECTIVENESS Correct use 98% Consistent use every 3 months: 2 pregnancies per 100 women GENERAL INFORMATION \u25aa Can help prevent pregnancy in women who breastfeed at least 4 times per day for the first year postpartum.",
    "page_number": 159,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1351
  },
  {
    "id": "chunk_01352",
    "text": "ast 4 times per day for the first year postpartum. \u25aa Soft, flexible ring-shaped device made of silicone rubber and containing natural progesterone hormone. \u25aa Can begin using method \u2265 4 weeks after childbirth. \u25aa Each ring can be used continuously for 90 days; 4 rings can be used",
    "page_number": 159,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1352
  },
  {
    "id": "chunk_01353",
    "text": "used continuously for 90 days; 4 rings can be used consecutively, each changed every 3 months, for up to 12 months. \u25aa Self-inserted and removed from the vagina. \u25aa Safe for mothers and baby. \u25aa Does not protect against sexually transmitted infections (STIs), including HIV. HOW THE METHOD WORKS",
    "page_number": 159,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1353
  },
  {
    "id": "chunk_01354",
    "text": "ctions (STIs), including HIV. HOW THE METHOD WORKS \u25aa It releases a constant level of the hormone progesterone that spreads to the walls of the vagina and then into the blood stream. \u25aa Progesterone prevents the start of ovulation. It reinforces the inhibitory effect",
    "page_number": 159,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1354
  },
  {
    "id": "chunk_01355",
    "text": "of ovulation. It reinforces the inhibitory effect of breastfeeding on ovulation suppression. - Inhibits growth of follicles (which contain an egg) and therefore prevents ovulation. \u25aa Extends the period of lactational amenorrhea which means you will likely not get your menses.",
    "page_number": 159,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1355
  },
  {
    "id": "chunk_01356",
    "text": "a which means you will likely not get your menses. \u25aa Progesterone thickens the mucus around your cervix. This makes it difficult for sperm to meet the egg. | 2 |",
    "page_number": 159,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1356
  },
  {
    "id": "chunk_01357",
    "text": "IMPORTANT FACTS \u25aa No harmful effects on frequency of breastfeeding, volume of breast milk or infant growth. \u25aa Does not interfere with sex although your partner may be able to feel the ring. \u25aa User-initiated and reversible. \u25aa Natural progesterone hormone is released in a continuous low dose which",
    "page_number": 160,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1357
  },
  {
    "id": "chunk_01358",
    "text": "hormone is released in a continuous low dose which results in few side effects. \u25aa Can be stopped at any time without a provider\u2019s help. \u25aa Removing the ring for any period of time may reduce efficacy. \u25aa The ring might become discolored with use. METHOD NOT ADVISED IF YOU...",
    "page_number": 160,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1358
  },
  {
    "id": "chunk_01359",
    "text": "discolored with use. METHOD NOT ADVISED IF YOU... \u25aa Are not breastfeeding at least 4 times per day. \u25aa Have a genital or urinary tract infection (method can be initiated after treatment), or have had pelvic inflammatory disease or salpingitis since delivery.",
    "page_number": 160,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1359
  },
  {
    "id": "chunk_01360",
    "text": "nflammatory disease or salpingitis since delivery. \u25aa Have a history of uterine disease (endometrial or cervical) or recurrent urinary tract infections. \u25aa Have sensitivity to silicone. POSSIBLE SIDE EFFECTS \u25aa Vaginal discharge \u25aa Spotting or bleeding \u25aa Breast discomfort \u25aa Lower abdominal pain",
    "page_number": 160,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1360
  },
  {
    "id": "chunk_01361",
    "text": "leeding \u25aa Breast discomfort \u25aa Lower abdominal pain HEALTH BENEFITS \u25aa Efficacy of the method depends on continued breastfeeding which has benefits for baby and mother. | 3 |",
    "page_number": 160,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1361
  },
  {
    "id": "chunk_01362",
    "text": "HOW TO USE \u25aa Using proper hygiene, place the ring as far back into the vagina as possible with your fingers until you do not feel it. \u25aa If experiencing difficulty with insertion try inserting while in a different position (for example, one leg raised on a stool, or on your back).",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1362
  },
  {
    "id": "chunk_01363",
    "text": "mple, one leg raised on a stool, or on your back). \u25aa If you feel the ring slipping, use your fingers to push up and reposition the ring so you no longer feel it. \u25aa If the ring comes out, reinsert it as soon as possible. Be sure the ring is clean",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1363
  },
  {
    "id": "chunk_01364",
    "text": "it as soon as possible. Be sure the ring is clean enough to reinsert. If necessary wash with mild soap or water. Do not use bleach or other cleaning products. \u25aa If constipated, ring can be removed briefly before toileting. Reinsert using proper hygiene.",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1364
  },
  {
    "id": "chunk_01365",
    "text": "y before toileting. Reinsert using proper hygiene. \u25aa If the ring continues to come out, this method may not be appropriate for you. It may not be suitable for women with severe pelvic relaxation problems. \u25aa If the ring is removed for more than 2 hours, reinsert if possible, and contact",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1365
  },
  {
    "id": "chunk_01366",
    "text": "re than 2 hours, reinsert if possible, and contact your health care provider (use another method of contraception such as condom until you get proper advice). \u25aa Replace the ring with a new one after 90 days if continued birth spacing is",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1366
  },
  {
    "id": "chunk_01367",
    "text": "ew one after 90 days if continued birth spacing is desired, and you are continuing to breastfeed at least 4 times per day. RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have questions or problems. \u25aa You think you might be pregnant. \u25aa Your menses returns.",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1367
  },
  {
    "id": "chunk_01368",
    "text": "hink you might be pregnant. \u25aa Your menses returns. \u25aa More than 12 months have passed since starting the method. \u25aa You discontinue breastfeeding and/or wish to choose another method.",
    "page_number": 161,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1368
  },
  {
    "id": "chunk_01369",
    "text": "Caya\u00ae/SILCS Diaphragm EFFECTIVENESS Typical use 82% Not used consistently: 18 pregnancies per 100 women GENERAL INFORMATION \u25aa The diaphragm is a soft flexible cup that a woman inserts into her vagina to cover her cervix. \u25aa Caya must be used in combination with contraceptive gel.",
    "page_number": 163,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1369
  },
  {
    "id": "chunk_01370",
    "text": "ust be used in combination with contraceptive gel. \u25aa It is controlled by the woman, has no hormonal effects and is inserted ahead of time so does not interfere with sex. \u25aa It is made of silicone and can be re-used for up to 2 years.",
    "page_number": 163,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1370
  },
  {
    "id": "chunk_01371",
    "text": "of silicone and can be re-used for up to 2 years. \u25aa When a woman inserts the diaphragm correctly she should not feel any pain of discomfort. \u25aa It is safe for breastfeeding women. \u25aa Women should wait until 6 weeks after childbirth or second trimester",
    "page_number": 163,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1371
  },
  {
    "id": "chunk_01372",
    "text": "until 6 weeks after childbirth or second trimester abortion before using the diaphragm so that the cervix has returned to normal size. HOW THE METHOD WORKS \u25aa The diaphragm covers the cervix. It blocks the sperm from entering the cervix.",
    "page_number": 163,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1372
  },
  {
    "id": "chunk_01373",
    "text": "vix. It blocks the sperm from entering the cervix. \u25aa The diaphragm can be reused. Wash it with soap and water and let it dry. \u25aa You can store it in its case until next time you want to use it. \u25aa Never leave the diaphragm for more than 24 hours without taking it out and washing it. | 2 |",
    "page_number": 163,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1373
  },
  {
    "id": "chunk_01374",
    "text": "IMPORTANT FACTS \u25aa Private. No one else can tell you are using it. \u25aa Does not interfere with sex. \u25aa You will need counseling/ instructions on how to use it correctly. \u25aa Can be stopped at any time without providers help. \u25aa Has no hormonal side effects. \u25aa Does not protect against STIs, including HIV.",
    "page_number": 164,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1374
  },
  {
    "id": "chunk_01375",
    "text": "s. \u25aa Does not protect against STIs, including HIV. \u25aa Use condoms (male or female) if you feel at risk of STIs. METHOD NOT ADVISED IF YOU... \u25aa Gave birth in the last 6 weeks. \u25aa Had an abortion (second trimester) in last 6 weeks SIDE EFFECTS None HOW TO USE \u25aa Wash your hands with soap and water.",
    "page_number": 164,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1375
  },
  {
    "id": "chunk_01376",
    "text": "HOW TO USE \u25aa Wash your hands with soap and water. \u25aa Check diaphragm for holes and tears. \u25aa Place 4 ml of contraceptive gel into silicone diaphragm. \u25aa Insert the diaphragm into your vagina and cover the cervix. \u25aa For greatest protection, insert the diaphragm before sex begins and wear it",
    "page_number": 164,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1376
  },
  {
    "id": "chunk_01377",
    "text": "insert the diaphragm before sex begins and wear it for at least 6 hours after sex ends. \u25aa Six hours after sex, remove diaphragm. Wash with soap and water and let dry. \u25aa Store Caya diaphragm in the original case. FOLLOW-UP None RETURN TO THE HEALTH CARE FACILITY ANY TIME IF...",
    "page_number": 164,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1377
  },
  {
    "id": "chunk_01378",
    "text": "RETURN TO THE HEALTH CARE FACILITY ANY TIME IF... \u25aa You have any questions or problems. \u25aa You develop any health problems. \u25aa You had sex in the past 5 days, did not use any method and want to avoid pregnancy. You can take emergency contraceptive pills (ECPs). \u25aa You think you may be pregnant. | 3 |",
    "page_number": 164,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1378
  },
  {
    "id": "chunk_01379",
    "text": "The Balanced Counseling Strategy Plus\nA Toolkit for Family Planning Service Providers\nWorking in High STI/HIV Prevalence Settings\nCOUNSELING CARDS\nThird Edition, 2015",
    "page_number": 165,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1379
  },
  {
    "id": "chunk_01380",
    "text": "Checklist to be Reasonably Sure a Promoting Newborn and Progestin-only Injectables Woman is not Pregnant Infant Health STI and HIV Transmission and Monthly Injectable Standard Days Method\u00ae Prevention Emergency Contraception Withdrawal STI and HIV Risk Assessment Positive Health, Dignity and",
    "page_number": 166,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1380
  },
  {
    "id": "chunk_01381",
    "text": "d HIV Risk Assessment Positive Health, Dignity and Female Condoms Tubal Ligation Prevention Hormonal Implants TwoDay Method Dual Protection Intrauterine Device Vasectomy HIV Counseling and Testing Copper Bearing IUD Levonorgestrel Intrauterine Progesterone Vaginal Ring Screening for Cervical Cancer",
    "page_number": 166,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1381
  },
  {
    "id": "chunk_01382",
    "text": "sterone Vaginal Ring Screening for Cervical Cancer System Lactational Amenorrhea Method Caya\u00ae/Silcs Diaphragm Adolescent Counseling Healthy Timing and Spacing of Male Condoms Women\u2019s Support and Safety Pregnancy Promoting a Healthy Postpartum Minipill Male Services Period for the Mother",
    "page_number": 166,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1382
  },
  {
    "id": "chunk_01383",
    "text": "Effectiveness Ratings\nMETHODS ARE DEFINED FOR TYPICAL USE AS FOLLOWS:\nHIGHLY EFFECTIVE <5 pregnancies per 100 women in designated\ntime period\nEFFECTIVE 5-10 pregnancies per 100 women in designated\ntime period\nLESS EFFECTIVE >10 pregnancies per 100 women in designated\ntime period\nBalanced Counseling Strategy Plus (3rd ed.)",
    "page_number": 167,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1383
  },
  {
    "id": "chunk_01384",
    "text": "HIGHLY EFFECTIVE <5 pregnancies per 100 women in designated time period Intrauterine Device Levonorgestrel Intrauterine Copper Bearing IUD System Emergency Contraception Progesterone Vaginal Ring Hormonal Implants Tubal Ligation Lactational Amenorrhea Method Vasectomy",
    "page_number": 168,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1384
  },
  {
    "id": "chunk_01385",
    "text": "l Ligation Lactational Amenorrhea Method Vasectomy The Pill Progestin-only Injectables Monthly Injectable Minipill Caya\u00ae/Silcs Diaphragm Standard Days Method\u00ae Female Condoms TwoDay Method Male Condoms Withdrawal LESS EFFECTIVE >10 pregnancies per 100 women in designated time period",
    "page_number": 168,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1385
  },
  {
    "id": "chunk_01386",
    "text": "Checklist to be The goal of FP provision is to provide the client with her preferred method on the same day as her visit. It is preferable Reasonably Sure a to give a contraceptive method instead of having her leave and Woman is not Pregnant becoming pregnant. The risks associated with offering any",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1386
  },
  {
    "id": "chunk_01387",
    "text": "g pregnant. The risks associated with offering any contraceptive method to a woman who may be pregnant and not aware of it are low. ASK THESE 6 QUESTIONS: If \u201cNo\u201d to all of the questions: If \u201cYes\u201d to any of",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1387
  },
  {
    "id": "chunk_01388",
    "text": "f \u201cNo\u201d to all of the questions: If \u201cYes\u201d to any of 1. Did you have a baby less than 6 months ago? If these questions, 1. Pregnancy cannot be ruled out. so, are you breastfeeding? Have you had no and client is free 2. Give client pregnancy test if",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1388
  },
  {
    "id": "chunk_01389",
    "text": "nd client is free 2. Give client pregnancy test if menstrual bleeding since giving birth? of signs and available, or refer her to an symptoms of antenatal clinic. 2. Have you abstained from unprotected [no pregnancy, method of FP] sex since your last menstrual 3. Provide her with a back-up",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1389
  },
  {
    "id": "chunk_01390",
    "text": "your last menstrual 3. Provide her with a back-up bleeding or delivery? method, such as condoms, to use *Once the client has answered yes to one until she has her menstrual 3. Have you given birth in the last 4 weeks? of the questions, it is bleeding.",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1390
  },
  {
    "id": "chunk_01391",
    "text": "he last 4 weeks? of the questions, it is bleeding. 4. Did your last menstrual bleeding start within the not necessary to continue asking the 4. Provide in advance her past 7 days (or within 12 days if you plan to use remaining questions preferred method (where a copper-bearing IUD)?",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1391
  },
  {
    "id": "chunk_01392",
    "text": "ons preferred method (where a copper-bearing IUD)? possible) to use on the 1st day of 5. Have you had a miscarriage or abortion in the 1. Pregnancy is her menses OR request that she past 7 days? unlikely return at that point to receive her 2. Continue to preferred method.",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1392
  },
  {
    "id": "chunk_01393",
    "text": "nt to receive her 2. Continue to preferred method. 6. Have you been using a reliable contraceptive Step 5 method consistently and correctly? 5. Go to Step 13",
    "page_number": 170,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1393
  },
  {
    "id": "chunk_01394",
    "text": "\u2022 Requires that the client get an injection every 4 weeks Monthly Injectable (30 days) to prevent pregnancy. Combined Injectable \u2022 More regular monthly bleeding than with DMPA or NET-EN injectables. Contraceptives (CICs) \u2022 Delayed return of fertility after woman stops method. It takes an",
    "page_number": 172,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1394
  },
  {
    "id": "chunk_01395",
    "text": "of fertility after woman stops method. It takes an average of about 1 month longer than with most other methods. EFFECTIVENESS \u2022 Not advised if woman is within 21 days of giving birth, regardless of breastfeeding status. Typical use",
    "page_number": 172,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1395
  },
  {
    "id": "chunk_01396",
    "text": "h, regardless of breastfeeding status. Typical use 94% Some missed or late injections \u2013 \u2022 Not advised if woman is breastfeeding an infant less than 6 6 pregnancies per 100 women months old. \u2022 Not advised if a woman has migraines and is 35 years or older.",
    "page_number": 172,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1396
  },
  {
    "id": "chunk_01397",
    "text": "if a woman has migraines and is 35 years or older. \u2022 Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. \u2022 Not advised if woman has a history of breast cancer or if woman has major risk factors for venous cardiovascular",
    "page_number": 172,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1397
  },
  {
    "id": "chunk_01398",
    "text": "n has major risk factors for venous cardiovascular disease, including older age, stroke, smoking, diabetes, hypertension or known dyslipidaemia. \u2022 Does not protect against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the client. EFFECTIVE",
    "page_number": 172,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1398
  },
  {
    "id": "chunk_01399",
    "text": "Emergency \u2022 One of the only methods that can help prevent pregnancy after a woman has had unprotected sex. Other effective Contraceptive Pills emergency contraception includes Copper-bearing or LNG-containing IUDs. ECPs \u2022 Not recommended for regular use, but there is no harm to the",
    "page_number": 174,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1399
  },
  {
    "id": "chunk_01400",
    "text": "ended for regular use, but there is no harm to the user if used repeatedly. However, a woman using ECPs repeatedly should receive additional family planning TYPES counseling in order to select the most appropriate continuous \u2022 Progestin only method. \u2022 Combined progestin and estrogen",
    "page_number": 174,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1400
  },
  {
    "id": "chunk_01401",
    "text": "tin only method. \u2022 Combined progestin and estrogen \u2022 Breastfeeding not recommended for one week after using UPA. \u2022 Ulipristal acetate (UPA) \u2022 Must be used within 5 days (120 hours) of unprotected sex. EFFECTIVENESS \u2022 Safe for women who cannot use regular hormonal",
    "page_number": 174,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1401
  },
  {
    "id": "chunk_01402",
    "text": "S \u2022 Safe for women who cannot use regular hormonal contraceptive methods, including postpartum breastfeeding Correct use women. Most effective if taken within first 24 hours; can be taken \u2022 ECPs do not disrupt existing pregnancy. within 5 days of having",
    "page_number": 174,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1402
  },
  {
    "id": "chunk_01403",
    "text": "isrupt existing pregnancy. within 5 days of having \u2022 Safe for a woman living with HIV/AIDS, even if she takes any 98 - 99% unprotected sex \u2013 type of antiretroviral (ARV) medicines. 1-2 pregnancies per 100 women after one instance of \u2022 Does not protect against sexually transmitted infections (STIs),",
    "page_number": 174,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1403
  },
  {
    "id": "chunk_01404",
    "text": "ct against sexually transmitted infections (STIs), unprotected sex depending on including HIV. Emphasize the need for dual protection with the the ECP client. HIGHLY EFFECTIVE - EFFECTIVE",
    "page_number": 174,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1404
  },
  {
    "id": "chunk_01405",
    "text": "Female Condoms \u2022 The female condom is a sheath made of transparent plastic film (polyurethane). FC2 has a flexible ring at both ends. Cupid has a medical grade sponge at one end. It is the same length as a male condom. \u2022 Before having sex, the woman places the female condom into",
    "page_number": 176,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1405
  },
  {
    "id": "chunk_01406",
    "text": "aving sex, the woman places the female condom into her vagina up to eight hours before an anticipated sexual act. It fits loosely inside the vagina. TYPES \u2022 The client must use a new condom for each act of sex. \u2022 Female Condom 2 / FC2 \u2022 Protects against pregnancy and sexually transmitted \u2022 Cupid",
    "page_number": 176,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1406
  },
  {
    "id": "chunk_01407",
    "text": "against pregnancy and sexually transmitted \u2022 Cupid infections (STIs), including HIV, if used consistently and correctly. EFFECTIVENESS \u2022 Preserves feeling of sex for men and women. Typical use \u2022 Requires partner\u2019s cooperation. 79% Not used consistently \u2013 21 pregnancies per 100 women LESS EFFECTIVE",
    "page_number": 176,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1407
  },
  {
    "id": "chunk_01408",
    "text": "Hormonal Implants \u2022 Either 2 small rods or 1 small rod (about the size of a matchstick) put under the skin. \u2022 Provides long-term protection from pregnancy. Length of protection depends on the implant: \u2013 Jadelle: 5 years \u2013 Sino-plant II: 4 years TYPES \u2013 Implanon or Nexplanon: 3 years",
    "page_number": 178,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1408
  },
  {
    "id": "chunk_01409",
    "text": "II: 4 years TYPES \u2013 Implanon or Nexplanon: 3 years \u2022 Single rod (Implanon, Nexplanon/Im- \u2022 A trained provider must insert and remove implants. planon NXT) \u2022 If a woman has unexplained vaginal bleeding, she should be \u2022 Double rod (Jadelle, Sino-plant II)",
    "page_number": 178,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1409
  },
  {
    "id": "chunk_01410",
    "text": "he should be \u2022 Double rod (Jadelle, Sino-plant II) further evaluated and treated prior to initiating this method. \u2022 Safe for women who are breastfeeding. Women may get implants EFFECTIVENESS after giving birth. First year of use \u2022 Not advised if a woman has a history of breast cancer.",
    "page_number": 178,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1410
  },
  {
    "id": "chunk_01411",
    "text": "advised if a woman has a history of breast cancer. 99% Less than 1 pregnancy per \u2022 Causes changes in monthly bleeding. May cause absence of 100 women bleeding or temporary heavy bleeding for a few months. \u2022 Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines.",
    "page_number": 178,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1411
  },
  {
    "id": "chunk_01412",
    "text": "even if she takes antiretroviral (ARV) medicines. \u2022 Does not protect against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the client. HIGHLY EFFECTIVE",
    "page_number": 178,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1412
  },
  {
    "id": "chunk_01413",
    "text": "\u2022 Provides long-term protection against pregnancy for 5 - 12 Intrauterine Device years. \u2022 Is a small, flexible, plastic and copper device placed in the uterus. Copper-bearing IUD Most IUDs have 1 or 2 thin strings that hang from the cervix into the vagina.",
    "page_number": 180,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1413
  },
  {
    "id": "chunk_01414",
    "text": "strings that hang from the cervix into the vagina. \u2022 It is a safe and effective method for almost all women, including women in the postabortion or postpartum period. EFFECTIVENESS \u2022 A trained provider must insert and remove the IUD. This method can be used as emergency contraception.",
    "page_number": 180,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1414
  },
  {
    "id": "chunk_01415",
    "text": "his method can be used as emergency contraception. First year of use \u2022 Can be inserted immediately after childbirth (within 48 hours) or 99% Less than 1 pregnancy per after 4 weeks postpartum. 100 women \u2022 Typically causes slightly longer and heavier bleeding and more",
    "page_number": 180,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1415
  },
  {
    "id": "chunk_01416",
    "text": "uses slightly longer and heavier bleeding and more cramps or pain during monthly bleeding. \u2022 If a woman has unexplained vaginal bleeding, she should be further evaluated and treated prior to initiating this method. \u2022 Safe for a woman living with HIV/AIDS who is clinically well (WHO",
    "page_number": 180,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1416
  },
  {
    "id": "chunk_01417",
    "text": "n living with HIV/AIDS who is clinically well (WHO Stage 1 or 2 of HIV clinical disease) on antiretroviral (ARV) medicines. \u2022 Not advised for a woman with very high risk of having sexually transmitted infections (STIs), particularly chlamydia or gonorrhea.",
    "page_number": 180,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1417
  },
  {
    "id": "chunk_01418",
    "text": "tions (STIs), particularly chlamydia or gonorrhea. Evaluate the client for STI risk prior to initiating this method. (See STI and HIV Risk Assessment Card). HIGHLY EFFECTIVE \u2022 Does not protect against sexually transmitted infections (STIs),",
    "page_number": 180,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1418
  },
  {
    "id": "chunk_01419",
    "text": "\u2022 Provides long-term protection against pregnancy for up to 5 years. Intrauterine \u2022 Is a small, flexible, plastic device placed in the uterus with an inner Device/System reservoir of levonorgestrel, a progestin hormone. The LNG IUS has 1 or 2 thin strings that hang from the cervix into the vagina.",
    "page_number": 182,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1419
  },
  {
    "id": "chunk_01420",
    "text": "strings that hang from the cervix into the vagina. Levonorgestrel LNG IUD/IUS \u2022 A trained provider must insert and remove the LNG IUS. \u2022 Can be inserted immediately after childbirth (within 48 hours) or after 4 weeks postpartum. EFFECTIVENESS",
    "page_number": 182,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1420
  },
  {
    "id": "chunk_01421",
    "text": "hours) or after 4 weeks postpartum. EFFECTIVENESS \u2022 Typically causes lighter and shorter monthly periods of bleeding First year of use and may cause periods to stop all together. 99% Less than 1 pregnancy per \u2022 If a woman has unexplained vaginal bleeding, she should be 100 women",
    "page_number": 182,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1421
  },
  {
    "id": "chunk_01422",
    "text": "xplained vaginal bleeding, she should be 100 women further evaluated and treated prior to initiating this method. \u2022 Not advised if a woman has a history of breast cancer. \u2022 Safe for a woman living with HIV/AIDS who is clinically well (WHO Stage 1 or 2 of HIV clinical disease) on antiretroviral (ARV)",
    "page_number": 182,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1422
  },
  {
    "id": "chunk_01423",
    "text": "2 of HIV clinical disease) on antiretroviral (ARV) medicines. \u2022 Not advised for a woman with very high risk of having sexually transmitted infections (STIs), particularly chlamydia or gonorrhea. Evaluate the client for STI risk prior to initiating this method. (See STI and HIV Risk Assessment Card).",
    "page_number": 182,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1423
  },
  {
    "id": "chunk_01424",
    "text": "is method. (See STI and HIV Risk Assessment Card). \u2022 Does not protect against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the HIGHLY EFFECTIVE client.",
    "page_number": 182,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1424
  },
  {
    "id": "chunk_01425",
    "text": "\u2022 LAM is for women who are exclusively breastfeeding their baby. Lactational All women who have infants six months or younger should be encouraged to exclusively breastfeed for the well-being of their baby. Amenorrhea Method \u2022 LAM requires 3 conditions. All 3 must be met:",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1425
  },
  {
    "id": "chunk_01426",
    "text": "od \u2022 LAM requires 3 conditions. All 3 must be met: LAM 1) The client\u2019s monthly bleeding has not returned since giving birth 2) The baby is exclusively breastfed, day and night EFFECTIVENESS 3) The baby is less than 6 months old \u2022 LAM is a temporary family planning method used after pregnancy. A",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1426
  },
  {
    "id": "chunk_01427",
    "text": "ary family planning method used after pregnancy. A Typical use woman using LAM should plan to visit her provider before she starts 98% First 6 months after childbirth to use supplemental feeding to talk about switching to another",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1427
  },
  {
    "id": "chunk_01428",
    "text": "emental feeding to talk about switching to another when all 3 criteria are met \u2014 modern method once the 3 conditions for LAM are no longer met. If 2 pregnancies per 100 women the woman is willing, initiate the conversation now about what method she plans to use once LAM is no longer effective.",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1428
  },
  {
    "id": "chunk_01429",
    "text": "she plans to use once LAM is no longer effective. \u2022 Safe for a woman living with HIV/AIDS when she exclusively breastfeeds. There is a chance, however, that mothers with HIV may transmit HIV to their infants through breastfeeding if they are not on",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1429
  },
  {
    "id": "chunk_01430",
    "text": "r infants through breastfeeding if they are not on ARVs. Does not protect against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the client. \u2022 Dispensing ECP when counseling on LAM increases pregnancy",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1430
  },
  {
    "id": "chunk_01431",
    "text": "ing ECP when counseling on LAM increases pregnancy protection and timely transition to another method. Counseling on ECP should suggest to clients to use it as a backup if they fail to meet one of the LAM criteria before they are able to obtain another HIGHLY EFFECTIVE method.",
    "page_number": 184,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1431
  },
  {
    "id": "chunk_01432",
    "text": "Male Condoms \u2022 Most condoms are made of thin latex rubber. Some condoms are coated with a lubricant and/or spermicide. \u2022 If the client has had an allergic reaction to latex rubber, they should not use latex condoms. Use polyurethane condoms as",
    "page_number": 186,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1432
  },
  {
    "id": "chunk_01433",
    "text": "not use latex condoms. Use polyurethane condoms as a safe and effective alternative for people with a latex allergy. \u2022 Before having sex, place the condom over the erect penis. EFFECTIVENESS \u2022 The client must use a new condom for each act of sex.",
    "page_number": 186,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1433
  },
  {
    "id": "chunk_01434",
    "text": "client must use a new condom for each act of sex. Typical use \u2022 Protects against pregnancy and sexually transmitted Not used consistently \u2014 infections (STIs), including HIV. 82% 18 pregnancies per 100 \u2022 Requires partner\u2019s cooperation to use consistently and women correctly. LESS EFFECTIVE",
    "page_number": 186,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1434
  },
  {
    "id": "chunk_01435",
    "text": "Minipill \u2022 Requires that the client takes 1 pill every day. \u2022 Safe for women who are breastfeeding. Women may begin Progestin-only Oral the minipill after giving birth. Contraceptives \u2022 May cause irregular monthly bleeding. For breastfeeding women, causes delayed return of monthly bleeding.",
    "page_number": 188,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1435
  },
  {
    "id": "chunk_01436",
    "text": "women, causes delayed return of monthly bleeding. \u2022 Safe for a woman living with HIV/AIDS, even if she takes EFFECTIVENESS antiretroviral (ARV) medicines. Typical use in first year \u2022 Not advised if a woman takes medicine for seizures or takes",
    "page_number": 188,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1436
  },
  {
    "id": "chunk_01437",
    "text": "ed if a woman takes medicine for seizures or takes Some missed pills \u2014 Rifampicin (for tuberculosis or other infections). 90-97% 3 to 10 pregnancies per 100 \u2022 Does not protect against sexually transmitted infections (STIs), women including HIV. Emphasize the need for dual protection with the client.",
    "page_number": 188,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1437
  },
  {
    "id": "chunk_01438",
    "text": "\u2022 Requires that the client takes 1 pill every day. The Pill \u2022 Not advised if breastfeeding an infant less than 6 months old. Combined Oral Contraceptives \u2022 Not advised if woman is within 21 days of giving birth, regardless of breastfeeding status.",
    "page_number": 190,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1438
  },
  {
    "id": "chunk_01439",
    "text": "giving birth, regardless of breastfeeding status. \u2022 May cause irregular bleeding during the first few months of use, after which users may experience lighter and more regular bleeding. EFFECTIVENESS \u2022 In some cases, may cause other side effects including nausea,",
    "page_number": 190,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1439
  },
  {
    "id": "chunk_01440",
    "text": "es, may cause other side effects including nausea, headache, bloating, breast tenderness, or weight change. Typical use \u2022 Not advised if woman takes medicine for seizures or takes Rifampicin Some missed pills \u2013 91% (for tuberculosis or other infections). 9 pregnancies per 100",
    "page_number": 190,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1440
  },
  {
    "id": "chunk_01441",
    "text": "ulosis or other infections). 9 pregnancies per 100 women \u2022 Not advised if a woman has history of breast cancer. \u2022 Not advised if a woman has migraines and is 35 years or older. \u2022 Not advised if woman has major risk factors for venous cardiovascular",
    "page_number": 190,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1441
  },
  {
    "id": "chunk_01442",
    "text": "n has major risk factors for venous cardiovascular disease, including older age, stroke, smoking, diabetes, hypertension or known dyslipidaemia. \u2022 Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines.",
    "page_number": 190,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1442
  },
  {
    "id": "chunk_01443",
    "text": "even if she takes antiretroviral (ARV) medicines. \u2022 There are many different brands and formulations of combined oral contraceptives. Discuss available and most appropriate method with the client. EFFECTIVE \u2022 Does not protect against sexually transmitted infections (STIs),",
    "page_number": 190,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1443
  },
  {
    "id": "chunk_01444",
    "text": "\u2022 The client gets an injection every 2 or 3 months, depending on type of Progestin-only injection. Injectables \u2022 Safe for women who are breastfeeding a baby. For a woman who is breastfeed- ing but not using LAM, injectables can be started after 6 weeks. Fertility can",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1444
  },
  {
    "id": "chunk_01445",
    "text": "tables can be started after 6 weeks. Fertility can return as early as 3 weeks postpartum, so clients should use a backup DMPA or NET-EN method such as condoms until they begin injectables. \u2022 May cause irregular or no menstrual bleeding.",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1445
  },
  {
    "id": "chunk_01446",
    "text": "s. \u2022 May cause irregular or no menstrual bleeding. TYPES \u2022 There is a delayed return to fertility after the client stops the method. It takes longer than with most other methods. Return to fertility is, on average, 1 \u2022 Intramuscular DMPA 150mg or NET-EN month for NET-EN and 4 months for DMPA.",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1446
  },
  {
    "id": "chunk_01447",
    "text": "or NET-EN month for NET-EN and 4 months for DMPA. \u2022 Subcutaneous DMPA 104mg (Sayana Press) \u2022 Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. Does not protect against sexually transmitted infections (STIs),",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1447
  },
  {
    "id": "chunk_01448",
    "text": "ct against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the client. EFFECTIVENES \u2022 If a woman has unexplained vaginal bleeding, she should be further evaluated and treated prior to initiating this method. Typical use in first year",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1448
  },
  {
    "id": "chunk_01449",
    "text": "initiating this method. Typical use in first year \u2022 Not advised if woman has a history of breast cancer or if woman has major risk Some missed or late factors for venous cardiovascular disease, including older age, stroke, 94% injections \u2013 smoking, diabetes, hypertension or known dyslipidaemia.",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1449
  },
  {
    "id": "chunk_01450",
    "text": "ng, diabetes, hypertension or known dyslipidaemia. 6 pregnancies per 100 women \u2022 NET-EN: \u2013 NET-EN is not advised if a woman takes medicine for seizures or takes Rifampicin (for tuberculosis or other infections). \u2013 If on NNRTIs (specifically Efavirenz or Nevirapine) or Ritonavir-boosted",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1450
  },
  {
    "id": "chunk_01451",
    "text": "ally Efavirenz or Nevirapine) or Ritonavir-boosted protease inhibitors as part of HAART, there may be lower effectiveness of EFFECTIVE NET-EN injectables. Emphasize dual protection if using NET-EN to reduce chance of pregnancy.",
    "page_number": 192,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1451
  },
  {
    "id": "chunk_01452",
    "text": "Standard Days \u2022 Ideal for women whose menstrual cycles are usually between 26 and 32 days long. Women who have regular Method\u00ae monthly bleeding fall within this range. \u2022 The client keeps track of their menstrual cycle to know the SDM days they can get pregnant (fertile days).",
    "page_number": 194,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1452
  },
  {
    "id": "chunk_01453",
    "text": "the SDM days they can get pregnant (fertile days). \u2022 The client uses a calendar or CycleBeads\u00ae, a string of color-coded beads, to track the days they can get pregnant EFFECTIVENESS and the days they are not likely to get pregnant.",
    "page_number": 194,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1453
  },
  {
    "id": "chunk_01454",
    "text": "and the days they are not likely to get pregnant. Typical use in first year \u2022 On the days the client can get pregnant, they must abstain 88% 12 pregnancies per 100 from having unprotected sex. Or, they can use a condom or women other barrier method.",
    "page_number": 194,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1454
  },
  {
    "id": "chunk_01455",
    "text": "ey can use a condom or women other barrier method. \u2022 Postpartum or breastfeeding women must have 3 regular menstrual cycles before they can use SDM. An alternate method should be used in the interim. \u2022 Does not protect against sexually transmitted infections (STIs),",
    "page_number": 194,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1455
  },
  {
    "id": "chunk_01456",
    "text": "ct against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the client. \u2022 Requires partner\u2019s cooperation. LESS EFFECTIVE",
    "page_number": 194,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1456
  },
  {
    "id": "chunk_01457",
    "text": "Withdrawal \u2022 The man withdraws his penis from his partner\u2019s vagina before ejaculation, and he ejaculates outside of the vagina. Coitus Interruptus/ \u2022 Is one of the least effective methods, yet offers better \u201cPulling Out\u201d protection than no method at all.",
    "page_number": 196,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1457
  },
  {
    "id": "chunk_01458",
    "text": "er \u201cPulling Out\u201d protection than no method at all. \u2022 Not suitable for men who cannot sense consistently when ejaculation is about to occur or ejaculate prematurely. EFFECTIVENESS \u2022 Does not protect against sexually transmitted infections (STIs),",
    "page_number": 196,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1458
  },
  {
    "id": "chunk_01459",
    "text": "ct against sexually transmitted infections (STIs), including HIV. Emphasize the need for dual protection with the Typical use client. 78% 22 pregnancies per 100 \u2022 Requires partner\u2019s cooperation. women LESS EFFECTIVE",
    "page_number": 196,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1459
  },
  {
    "id": "chunk_01460",
    "text": "Tubal Ligation \u2022 Permanent method for women who do not want more children. Female Sterilization \u2022 Involves a surgical procedure. There are both benefits and certain risks involved in the procedure. \u2022 Protects against pregnancy right away.",
    "page_number": 198,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1460
  },
  {
    "id": "chunk_01461",
    "text": "rocedure. \u2022 Protects against pregnancy right away. \u2022 Safe for a woman with HIV/AIDS, even if she takes antiretroviral EFFECTIVENESS (ARV) medicines. \u2022 Does not protect against sexually transmitted infections (STIs), In first year including HIV. Emphasize the need for dual protection with the",
    "page_number": 198,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1461
  },
  {
    "id": "chunk_01462",
    "text": "V. Emphasize the need for dual protection with the 99% Less than 1 pregnancy per client. 100 women Over 10 years 98% 2 pregnancies per 100 women HIGHLY EFFECTIVE",
    "page_number": 198,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1462
  },
  {
    "id": "chunk_01463",
    "text": "TwoDay Method\u00ae \u2022 Ideal for women who have healthy cervical secretions. \u2022 Healthy secretions do not have a foul smell or cause itchiness or pain. \u2022 The client monitors her cervical secretions at least twice a day. If she notices secretions of any type, color or consistency",
    "page_number": 200,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1463
  },
  {
    "id": "chunk_01464",
    "text": "tices secretions of any type, color or consistency the day of her monitoring or the day prior to her monitoring, she can likely get pregnant (fertile days). EFFECTIVENESS \u2022 On days the client can get pregnant, they must abstain from",
    "page_number": 200,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1464
  },
  {
    "id": "chunk_01465",
    "text": "he client can get pregnant, they must abstain from Typical use unprotected sex or they can use a condom or other barrier 86% 14 pregnancies per 100 method. women \u2022 Does not protect against sexually transmitted infections (STIs), including HIV. LESS EFFECTIVE",
    "page_number": 200,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1465
  },
  {
    "id": "chunk_01466",
    "text": "Vasectomy \u2022 Permanent, safe method for men who do not want more children. Male Sterilization \u2022 A safe, simple surgical procedure. \u2022 Does not affect male sexual performance. \u2022 Does not protect from pregnancy immediately. There is a 3-month delay before the method takes effect. EFFECTIVENESS",
    "page_number": 202,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1466
  },
  {
    "id": "chunk_01467",
    "text": "elay before the method takes effect. EFFECTIVENESS \u2022 The client must use condoms or another method for 3 months In first year after the procedure. 99% Less than 1 pregnancy per \u2022 Safe for a man with HIV/AIDS, even if he takes antiretroviral 100 women whose partner ARV) medicines. has had a vasectomy",
    "page_number": 202,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1467
  },
  {
    "id": "chunk_01468",
    "text": "whose partner ARV) medicines. has had a vasectomy \u2022 Does not protect against sexually transmitted infections (STIs), Over 3 years including HIV. Emphasize the need for dual protection with the 4 pregnancies per 100 96% client. women whose partner has had a vasectomy HIGHLY EFFECTIVE",
    "page_number": 202,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1468
  },
  {
    "id": "chunk_01469",
    "text": "Progesterone \u2022 Used to space pregnancies for up to one year. \u2022 Smooth, soft, flexible, silicone ring containing natural progesterone. Vaginal Ring \u2022 Easily inserted and removed from the vagina by the woman. PVR \u2022 Each ring is effective up to 3 months; method can be used",
    "page_number": 204,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1469
  },
  {
    "id": "chunk_01470",
    "text": "ng is effective up to 3 months; method can be used successively up to one year (4 rings in 1 year). \u2022 For use by women beginning 30-90 days postpartum who breastfeed at least 4 times per day. EFFECTIVENESS \u2022 Initiation of method should be inclusive of counseling on proper",
    "page_number": 204,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1470
  },
  {
    "id": "chunk_01471",
    "text": "method should be inclusive of counseling on proper use (including insertion and removal). Correct use \u2022 May cause irregular or no menstrual bleeding. Consistent use every 3 98% months \u2014 \u2022 As with other progesterone only methods, spotting or irregular 2 pregnancies per 100 bleeding can occur. women",
    "page_number": 204,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1471
  },
  {
    "id": "chunk_01472",
    "text": "ar 2 pregnancies per 100 bleeding can occur. women \u2022 There is no effect on breastmilk production; method supports continued breastfeeding/infant nutrition. \u2022 Rapid return to fertility following discontinuation. \u2022 Partner may be able to feel the ring.",
    "page_number": 204,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1472
  },
  {
    "id": "chunk_01473",
    "text": "tinuation. \u2022 Partner may be able to feel the ring. \u2022 Safe for a woman living with HIV/AIDS, even if she takes antiretroviral (ARV) medicines. \u2022 Does not protect against sexually transmitted infections (STIs), HIGHLY EFFECTIVE including HIV. Emphasize the need for dual protection with the client.",
    "page_number": 204,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1473
  },
  {
    "id": "chunk_01474",
    "text": "Caya\u00ae/SILCS \u2022 The diaphragm is a soft, flexible cup that a woman inserts in her vagina to cover her cervix. It blocks sperm from entering the cervix. The Diaphragm diaphragm is recommended for use with a contraceptive gel. \u2022 The diaphragm is controlled by the woman, has no hormonal side",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1474
  },
  {
    "id": "chunk_01475",
    "text": "m is controlled by the woman, has no hormonal side effects, and is inserted ahead of time so it does not interfere with sex. \u2022 The diaphragm should be used each time the client has sex. For greatest protection, insert the diaphragm before sex begins and wear EFFECTIVENESS",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1475
  },
  {
    "id": "chunk_01476",
    "text": "diaphragm before sex begins and wear EFFECTIVENESS the diaphragm for at least 6 hours after sex ends. Then remove the Typical use diaphragm, wash it with soap and water, rinse and let it dry. The client Not used consistently \u2013 can store the diaphragm in its case until next time she wants to use it.",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1476
  },
  {
    "id": "chunk_01477",
    "text": "m in its case until next time she wants to use it. 82% Never leave the diaphragm in the vagina for more than 24 hours 18 pregnancies per 100 without taking it out to wash it. women \u2022 The Caya diaphragm is made of silicone and is very strong. It is reusable for up to 2 years.",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1477
  },
  {
    "id": "chunk_01478",
    "text": "is very strong. It is reusable for up to 2 years. \u2022 The Caya diaphragm fits most women. When the woman correctly inserts the Caya, she should not feel pain or discomfort. Practice inserting, checking that the client\u2019s cervix is covered, and removing the",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1478
  },
  {
    "id": "chunk_01479",
    "text": "t the client\u2019s cervix is covered, and removing the Caya to ensure the client is comfortable with this method. \u2022 The diaphragm can be used by almost all women, and it is safe for breastfeeding women. Women should wait 6 weeks after childbirth or",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1479
  },
  {
    "id": "chunk_01480",
    "text": "men. Women should wait 6 weeks after childbirth or second-trimester abortion before using a diaphragm so the cervix and uterus have returned to normal size. LESS EFFECTIVE \u2022 Does not protect against sexually transmitted infections (STIs), including",
    "page_number": 206,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1480
  },
  {
    "id": "chunk_01481",
    "text": "\u2022 For women who want to have additional children after a live Healthy Timing birth, advise: and Spacing of \u2013 For the health of the mother and baby, wait at least 2 years (24 months) before trying to become pregnant again. Pregnancy \u2013 Use of a family planning method of her choice allows a woman",
    "page_number": 208,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1481
  },
  {
    "id": "chunk_01482",
    "text": "amily planning method of her choice allows a woman to plan for a healthy pregnancy and provides better health outcomes for her newborn baby and any other children she may Advise on healthy timing and have. spacing of pregnancy. \u2022 For women who decide to have a child after a miscarriage or",
    "page_number": 208,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1482
  },
  {
    "id": "chunk_01483",
    "text": "who decide to have a child after a miscarriage or abortion, advise: \u2013 For the health of the mother and baby, wait at least 6 months before trying to become pregnant again. \u2013 Use of a family planning method of her choice allows a woman to plan for a healthy pregnancy. \u2022 For adolescents, advise:",
    "page_number": 208,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1483
  },
  {
    "id": "chunk_01484",
    "text": "or a healthy pregnancy. \u2022 For adolescents, advise: \u2013 For the health of the mother and the baby, wait until 18 years of age before trying to become pregnant. For teen parents, counsel on waiting until 18 years of age for next pregnancy.",
    "page_number": 208,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1484
  },
  {
    "id": "chunk_01485",
    "text": "waiting until 18 years of age for next pregnancy. \u2013 If sexually active, early adoption and initiation of a FP method of her choice allows a young woman to prevent unintended pregnancy and preserve her health. \u2022 For women over 35 or with 5 or more term pregnancies, additional",
    "page_number": 208,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1485
  },
  {
    "id": "chunk_01486",
    "text": "Promoting a Healthy \u2022 Discuss the need for four postnatal care visits: at 24-48 hours, 3 to 7 days, 4 to 6 weeks, and 4 to 6 months. Postpartum Period \u2022 If a woman plans to start supplemental feeding before 6 months for the Mother postpartum, discuss transition to a FP method prior to starting",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1486
  },
  {
    "id": "chunk_01487",
    "text": "iscuss transition to a FP method prior to starting supplemental feeding. \u2022 Advise on maintaining personal hygiene, including care of \u2022 Ensure that the mother has support perineum and breasts. for the first few days after birth; \u2022 Counsel on return to sexual activity, which should be whenever",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1487
  },
  {
    "id": "chunk_01488",
    "text": "eturn to sexual activity, which should be whenever encourage rest and sleep. the mother feels ready and usually after lochia stops. After that \u2022 Recommend a nutritious diet for the she can become pregnant again even before her menses",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1488
  },
  {
    "id": "chunk_01489",
    "text": "e can become pregnant again even before her menses mother that includes plenty of fluids returns. Pregnancy can occur even if she is still partially breast- and micronutrients (including Vitamin feeding and is more likely with older infants. A and iron).",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1489
  },
  {
    "id": "chunk_01490",
    "text": "nd is more likely with older infants. A and iron). \u2022 Encourage her to use FP. Most methods are safe for breastfeed- \u2022 Discuss normal postpartum bleeding ing mothers. Consider providing emergency contraception with",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1490
  },
  {
    "id": "chunk_01491",
    "text": "s. Consider providing emergency contraception with and lochia. Counsel on maternal instructions to use if she stops exclusively breastfeeding or if she danger signs, such as heavy bleeding resumes menses and has sex before starting another family or vaginal discharge that has a foul planning method.",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1491
  },
  {
    "id": "chunk_01492",
    "text": "vaginal discharge that has a foul planning method. smell and fever, severe headaches, \u2022 Counsel on postnatal depression, which may entail: crying easily; or convulsions. feeling tired, agitated, or irritable; lacking motivation; having difficulty sleeping; rejecting the baby.",
    "page_number": 210,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1492
  },
  {
    "id": "chunk_01493",
    "text": "Post Abortion Care \u2022 After any evacuation of the uterus, discuss and help the woman pick a contraceptive method of her choice. If it is not PAC available or she is undecided, provide her with either condoms or emergency contraception, and offer to refer her to the nearest",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1493
  },
  {
    "id": "chunk_01494",
    "text": "ntraception, and offer to refer her to the nearest health center if she hasn\u2019t decided before being discharged. \u2022 Inform client on the quick return to \u2022 Inform the woman of the advantage of condoms as a fertility, within 2 weeks after the event, dual-protection method.",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1494
  },
  {
    "id": "chunk_01495",
    "text": "n 2 weeks after the event, dual-protection method. for a 1st trimester miscarriage. \u2022 A woman who has been treated with misoprostol can be \u2022 For better health of mother and child, immediately offered any contraceptive method except an IUD. If couples should wait 6 months before",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1495
  },
  {
    "id": "chunk_01496",
    "text": "ept an IUD. If couples should wait 6 months before the woman prefers an IUD, ask her to return following complete trying to get pregnant. evacuation of the uterus and verification that she does not have \u2022 Counsel on return to sexual activity, any infections. which should be when the woman",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1496
  },
  {
    "id": "chunk_01497",
    "text": "ty, any infections. which should be when the woman \u2022 Discuss normal post-abortion bleeding. Counsel on maternal feels ready (unless the woman has a danger signs, such as heavy bleeding or vaginal discharge that history of infection or trauma, then wait has a foul smell.",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1497
  },
  {
    "id": "chunk_01498",
    "text": "f infection or trauma, then wait has a foul smell. until condition is treated and resolved). \u2022 Ensure that the woman has support for the first few days. \u2022 Advise that she can become pregnant Encourage rest and sleep. even before her menses returns.",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1498
  },
  {
    "id": "chunk_01499",
    "text": "ge rest and sleep. even before her menses returns. Encourage her to use FP. \u2022 If the woman is a survivor of rape and sexual assault, refer her to other supportive care services. \u2022 Most contraceptive methods can be",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1499
  },
  {
    "id": "chunk_01500",
    "text": "care services. \u2022 Most contraceptive methods can be used by a woman presenting for PAC - \u2022 Recognize that accessing PAC can be emotionally traumatic and with the exception of tubal ligation and inform her what psychosocial services are available and offer for",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1500
  },
  {
    "id": "chunk_01501",
    "text": "psychosocial services are available and offer for IUD if there is infection or trauma to her to share her feelings about the process. the cervix or vagina.",
    "page_number": 212,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1501
  },
  {
    "id": "chunk_01502",
    "text": "Promoting Newborn \u2022 Encourage exclusive breastfeeding for 6 months. Nothing else is necessary, not even water. Introduce complementary and Infant Health foods at 6 months and continue to breastfeed. Exclusive breastfeeding during the first 6 months and the absence of a",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1502
  },
  {
    "id": "chunk_01503",
    "text": "ing during the first 6 months and the absence of a period/menses during this time is the Lactational Amenor- rhea Method (LAM) (see LAM card). \u2022 Discuss careful hand washing to \u2022 For infants exposed to HIV: prevent infection prior to handling the",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1503
  },
  {
    "id": "chunk_01504",
    "text": "ed to HIV: prevent infection prior to handling the \u2013Advise mother to give infant antiretroviral (ARV) medicines baby and after cleaning the baby's daily while breastfeeding and to continue for 1 week after bottom or changing diapers. cessation of breastfeeding (around 1 year), or for mother",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1504
  },
  {
    "id": "chunk_01505",
    "text": "on of breastfeeding (around 1 year), or for mother \u2022 Put nothing on the baby's cord and do to continue ARV treatment per national protocols. not get the cord area wet until it dries \u2013Recommend that HIV-exposed infants get tested for HIV at up and falls off, about 2 weeks after",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1505
  },
  {
    "id": "chunk_01506",
    "text": "d for HIV at up and falls off, about 2 weeks after 6 weeks and start co-trimoxazole prophylaxis (CTX). birth. \u2013Link mother and infant to HIV clinic. \u2022 Counsel the mother on newborn danger signs and when to seek care \u2022 Explain immunization schedule for infants using national or",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1506
  },
  {
    "id": "chunk_01507",
    "text": "mmunization schedule for infants using national or immediately. Danger signs include: global guidelines, and include recommendation for Vitamin A difficulty feeding and/or breathing; at 6 months. feeling too hot or too cold; being \u2022 Discuss the need to attend child-welfare clinic (including key",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1507
  },
  {
    "id": "chunk_01508",
    "text": "need to attend child-welfare clinic (including key irritable for an extended period of activities such as growth monitoring). time. \u2022 Discuss the importance of providing good ventilation and keeping the baby warm.",
    "page_number": 214,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1508
  },
  {
    "id": "chunk_01509",
    "text": "STI/HIV \u2022 Some STIs can be treated. To avoid re-infection, both partners must be treated and must abstain from unprotected Transmission & sex unti lboth partners have completed treatment. Prevention \u2022 Risk of infection can be reduced by using a condom, limiting",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1509
  },
  {
    "id": "chunk_01510",
    "text": "fection can be reduced by using a condom, limiting the number of sex partners, and delaying sex. Discuss the following facts specifically about HIV: Discuss the following about all \u2022 HIV is a sexually transmitted infection. HIV is transmitted sexually transmitted infections",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1510
  },
  {
    "id": "chunk_01511",
    "text": "HIV is transmitted sexually transmitted infections through an exchange of bodily fluids such as semen, blood, (STIs), including HIV: breast milk, and during delivery. \u2022 A person can become infected with \u2022 Knowing the client\u2019s HIV status protects them, their partner,",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1511
  },
  {
    "id": "chunk_01512",
    "text": "client\u2019s HIV status protects them, their partner, STIs, including HIV, through unsafe or and their family. Clients can be offered testing today if it is unprotected sexual activity. available, or offered a referral to a testing facility \u2022 STIs are common.",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1512
  },
  {
    "id": "chunk_01513",
    "text": "referral to a testing facility \u2022 STIs are common. \u2022 Although HIV cannot be cured, early identification and \u2022 A person living with STIs (including treatment can allow a person to live a long productive life and HIV) may have no symptoms, may prevent his/her partner from becoming infected.",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1513
  },
  {
    "id": "chunk_01514",
    "text": "ay prevent his/her partner from becoming infected. look healthy and may not be aware \u2022 Male circumcision significantly reduces the risk of HIV that s/he is infected. infection in heterosexual couples. \u2022 Common STI symptoms include \u2022 Maternal transmission of HIV to the child can be substantially",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1514
  },
  {
    "id": "chunk_01515",
    "text": "nsmission of HIV to the child can be substantially vaginal discharge, discharge from the reduced by identifying women living with HIV and providing penis, sores in the genital area, treatment or prophylactic ARV medicines during pregnancy burning on urination for men, lower",
    "page_number": 216,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1515
  },
  {
    "id": "chunk_01516",
    "text": "STI and HIV Risk \u2022 Discuss risks associated with multiple or concurrent partners. This includes increased risk for sexually transmitted infections Assessment (STIs) and HIV. \u2022 Ask whether the client has knowledge of their male partner\u2019s circumcision status. Explain that male circumcision reduces the",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1516
  },
  {
    "id": "chunk_01517",
    "text": "status. Explain that male circumcision reduces the transmission risk of STIs or HIV to the male\u2019s partner. Discuss the following issues to \u2022 Discuss with clients the types of sex or sexual activities and assess the client\u2019s risk of STIs behaviors that can increase risk for getting an STI or HIV (for",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1517
  },
  {
    "id": "chunk_01518",
    "text": "t can increase risk for getting an STI or HIV (for and HIV: example, if partner or self has multiple sexual partners, oral sex, \u2022 Ask client about past and present anal sex, dry sex, use of detergents or spermicides).",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1518
  },
  {
    "id": "chunk_01519",
    "text": "l sex, dry sex, use of detergents or spermicides). condom use (including perception of \u2022 Discuss whether the client has knowledge of partner\u2019s sexual partner\u2019s attitude) and ask whether history, including multiple or concurrent partners. If partner or self",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1519
  },
  {
    "id": "chunk_01520",
    "text": "ultiple or concurrent partners. If partner or self s/he is aware that condoms protect has history of multiple or concurrent partners, counsel client to against both STIs/HIV and attend couples\u2019 counseling or voluntary testing and counseling pregnancy. (VCT) to determine HIV status.",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1520
  },
  {
    "id": "chunk_01521",
    "text": "unseling pregnancy. (VCT) to determine HIV status. \u2022 Ask the client whether they know \u2022 Ask about client\u2019s home-life situation (for example, partner their HIV status and the HIV status of violence and social support). If they mention violence, refer to",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1521
  },
  {
    "id": "chunk_01522",
    "text": "ocial support). If they mention violence, refer to partner(s). If partner is positive, ask Women\u2019s Support and Safety card. whether s/he is taking ARV \u2022 Ask whether client has ever used PMTCT during pregnancy. medicines. Discuss benefits of PMTCT to prevent HIV transmission during pregnancy.",
    "page_number": 218,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1522
  },
  {
    "id": "chunk_01523",
    "text": "Positive Health, Discuss the following with the client: \u2022 People living with HIV need regular checkups to see if they need Dignity & Prevention antiretroviral (ARV) medicine, to evaluate how they are doing on ARVs, and to rule out other infections or illnesses. Visits may be",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1523
  },
  {
    "id": "chunk_01524",
    "text": "e out other infections or illnesses. Visits may be frequent when ARV medicine is started. \u2022 A person on ARVs should do her/his best to take the medication as prescribed and should not share medication. Provide support and counseling \u2022 Partners should get tested as well. The client can bring her/his",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1524
  },
  {
    "id": "chunk_01525",
    "text": "d get tested as well. The client can bring her/his on issues relating to disclosure of partner in for counseling and to talk together. HIV status. Be sure that client \u2022 If currently taking medication for tuberculosis, s/he should follow up knows it is her/his decision to with the provider.",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1525
  },
  {
    "id": "chunk_01526",
    "text": "knows it is her/his decision to with the provider. disclose her/his status and that \u2022 If a woman with HIV wants to get pregnant: the provider will not share status \u2013 The risk of passing HIV to her newborn may be greatly reduced by taking",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1526
  },
  {
    "id": "chunk_01527",
    "text": "IV to her newborn may be greatly reduced by taking without consent. ARV medicine and having a safe delivery. It is important to receive care at an antenatal clinic and an HIV treatment center. \u2022 If a woman is in a serodiscordant relationship (one partner has HIV",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1527
  },
  {
    "id": "chunk_01528",
    "text": "a serodiscordant relationship (one partner has HIV and the other doesn\u2019t) and is trying to get pregnant: \u2013 The risk of transmitting HIV can be reduced by only engaging in unprotected sex (sex without condoms) during a woman\u2019s fertile period.",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1528
  },
  {
    "id": "chunk_01529",
    "text": "without condoms) during a woman\u2019s fertile period. The seropositive partner should continue ARVs to reduce the amount of virus in her/his body. \u2022 Positive health results from taking care of oneself and being alert to health concerns that need attention, which may include physical and",
    "page_number": 220,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1529
  },
  {
    "id": "chunk_01530",
    "text": "Dual Protection Discuss the following with the client: \u2022 Dual protection is the use of condoms consistently and correctly in combination with another family planning method. This provides added protection against pregnancy in case of condom failure.",
    "page_number": 222,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1530
  },
  {
    "id": "chunk_01531",
    "text": "ction against pregnancy in case of condom failure. \u2022 Use a male or female condom correctly and consistently with every act of sex. This one method protects against STIs and pregnancy. \u2022 Only engage in safer sexual intimacy that prevents semen and",
    "page_number": 222,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1531
  },
  {
    "id": "chunk_01532",
    "text": "e in safer sexual intimacy that prevents semen and vaginal fluids from coming in contact with partner\u2019s genitals or other vulnerable areas, such as the mouth and anus. \u2022 Delay or avoid sexual activity, especially with a partner whose STI/HIV status is not known.",
    "page_number": 222,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1532
  },
  {
    "id": "chunk_01533",
    "text": "HIV Counseling and Discuss the following with the client: Testing \u2022 Knowing the client\u2019s HIV status can help them make decisions about protecting themselves and their sexual partner(s). HCT \u2022 Testing permits people living with HIV to seek treatment so",
    "page_number": 224,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1533
  },
  {
    "id": "chunk_01534",
    "text": "ermits people living with HIV to seek treatment so that they can live a full life. The test involves taking a small sample of blood. The test is free and available at clinics, hospitals, and HIV counseling and testing sites. \u2022 Test results are kept confidential.",
    "page_number": 224,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1534
  },
  {
    "id": "chunk_01535",
    "text": "sting sites. \u2022 Test results are kept confidential. \u2022 When a person is first infected with HIV, it can take 3 or more months for the test to detect the infection. This is called the \u201cwindow period\u201d and is the reason why repeat testing is important.",
    "page_number": 224,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1535
  },
  {
    "id": "chunk_01536",
    "text": "and is the reason why repeat testing is important. \u2022 A positive test result means the person is infected with HIV and can transmit the virus to others. \u2022 A negative test result can mean the person is not infected or that s/he is in the \u201cwindow period\u201d. Another test should be",
    "page_number": 224,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1536
  },
  {
    "id": "chunk_01537",
    "text": "is in the \u201cwindow period\u201d. Another test should be taken within 3 months. If the second test is still negative, the person is currently not living with HIV but can still become infected with HIV. \u2022 HIV is a sexually transmitted infection (STI). It is important to",
    "page_number": 224,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1537
  },
  {
    "id": "chunk_01538",
    "text": "Screening for \u2022 Cancer of the cervix is a common cancer of the reproductive tract. It is preventable, easily detectable, and curable in the early Cervical Cancer stages. \u2022 Cervical cancer results from infection with a virus known as HPV. \u2013 Most infections clear up, but those that are persistent may",
    "page_number": 226,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1538
  },
  {
    "id": "chunk_01539",
    "text": "ctions clear up, but those that are persistent may lead to cervical cancer. If the client is 30-49 years of age or \u2022Describe how cervical cancer presents: HIV positive at any age, ask if the \u2013 Cancer of the cervix is painless and progresses slowly. client has ever been screened for",
    "page_number": 226,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1539
  },
  {
    "id": "chunk_01540",
    "text": "ogresses slowly. client has ever been screened for cancer of the cervix. \u2013 It occurs at the opening of the uterus. \u2013 When advanced, a woman may experience an abnor- mal/unusual smell or odor from her vagina, painful sexual intercourse, bleeding after sex and lower abdominal and back pain.",
    "page_number": 226,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1540
  },
  {
    "id": "chunk_01541",
    "text": "eding after sex and lower abdominal and back pain. \u2022 Detection is through a quick, simple, and generally not painful test done by a trained provider (HPV test, VIA or Pap smear). \u2022 Screening for cancer of the cervix should be done every 3-5 years",
    "page_number": 226,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1541
  },
  {
    "id": "chunk_01542",
    "text": "ancer of the cervix should be done every 3-5 years (depending on national guidelines). Women living with HIV should be screened every 3 years. If the test is positive, then treatment is recommended. Early treatment involves freezing pre-cancerous",
    "page_number": 226,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1542
  },
  {
    "id": "chunk_01543",
    "text": "d. Early treatment involves freezing pre-cancerous sores (cryotherapy) and can be done as an outpatient procedure. \u2022 Clients with advanced cancerous sore/s are referred for special treatment.",
    "page_number": 226,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1543
  },
  {
    "id": "chunk_01544",
    "text": "Adolescent \u2022 All modern contraceptive methods are generally safe for adolescents. Counseling \u2022 For married adolescents, discuss desired family size (refer to HTSP card). \u2022 For unmarried adolescents, describe the importance of delaying marriage and pregnancy: If a client is younger than 18",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1544
  },
  {
    "id": "chunk_01545",
    "text": "iage and pregnancy: If a client is younger than 18 \u2013 For the health of the mother and baby, wait until at least age years, discuss adolescent health 18 before trying to become pregnant. needs. \u2013 Early marriage and pregnancy should be avoided in order to \u2022 Adolescence is a time of transition",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1545
  },
  {
    "id": "chunk_01546",
    "text": "in order to \u2022 Adolescence is a time of transition allow for girls\u2019 full mental and physical development. marked by physical, psychological and \u2013 To prevent unintended pregnancy, it is important for a young social milestones. woman to consistently use a modern contraceptive method.",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1546
  },
  {
    "id": "chunk_01547",
    "text": "to consistently use a modern contraceptive method. \u2022 Adolescents have unique reproductive \u2022 Describe other health issues facing adolescent girls: health needs that can be addressed through health services, including \u2013 Adolescent girls who are sexually active are at risk for STIs,",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1547
  },
  {
    "id": "chunk_01548",
    "text": "irls who are sexually active are at risk for STIs, counseling. including HIV. Using a condom in addition to another family planning method can provide added STI and HIV prevention, \u2022 Ask clients about resources in their (refer to STI/HIV Transmission & Prevention). communities:",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1548
  },
  {
    "id": "chunk_01549",
    "text": "o STI/HIV Transmission & Prevention). communities: \u2013 Girls have important nutritional needs to ensure their healthy \u2013 Are there supportive and positive development. individuals that you can go to for advice or support? These can \u2022 Discuss available youth-focused services, including sports clubs,",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1549
  },
  {
    "id": "chunk_01550",
    "text": "le youth-focused services, including sports clubs, include partners, parents, support clubs, young mothers clubs, faith groups or teachers and community leaders. community-based groups. Refer the client to services as needed.",
    "page_number": 228,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1550
  },
  {
    "id": "chunk_01551",
    "text": "\u2022 Any intimate partner violence involves harm to a human that can evolve Women\u2019s Support into other health risks, not only for the woman but for her child or children as well. This includes increased risk for: chronic diseases, depres- and Safety",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1551
  },
  {
    "id": "chunk_01552",
    "text": "sed risk for: chronic diseases, depres- and Safety sion, suicide, lowered immune system, low birth weight, child abuse and intergenerational violence. Ask the following questions to screen for IPV: \u2022 Are you currently in a relationship with a person who threatens, frightens,",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1552
  },
  {
    "id": "chunk_01553",
    "text": "lationship with a person who threatens, frightens, Take the time to assess the woman's or insults you, or treats you badly? risk for intimate partner violence and \u2022 Is there anyone who forces you to participate in sexual activities that are the potential risks that accompany FP",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1553
  },
  {
    "id": "chunk_01554",
    "text": "ies that are the potential risks that accompany FP unwanted or make you feel uncomfortable? use for the woman. If the client mentions fear of or experience with intimate partner violence Begin by sharing some information on OR if the client exhibits clinical indications of intimate partner violence",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1554
  },
  {
    "id": "chunk_01555",
    "text": "clinical indications of intimate partner violence intimate partner violence with the client: (including chronic or acute pain with unknown origin, frequent sexual or \u2022 We want to ensure that women and their gynecological problems, or depression and anxiety), follow these steps:",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1555
  },
  {
    "id": "chunk_01556",
    "text": "s, or depression and anxiety), follow these steps: families thrive in a safe and supportive \u2022 Be supportive and validate their experience. environment. This includes ensuring that \u2022 Assess whether the client is living in a situation of risk\u2014if she is, and if you",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1556
  },
  {
    "id": "chunk_01557",
    "text": "iving in a situation of risk\u2014if she is, and if you women feel that they and their children are have been appropriately trained, develop a safety plan or refer to another safe at home. We share the following resource that can provide immediate assistance. information with all of our clients and ask",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1557
  },
  {
    "id": "chunk_01558",
    "text": "tance. information with all of our clients and ask \u2022 Assess whether the client is in crisis, e.g. if she is in extreme emotional some confidential questions. distress\u2014if she is, provide her with the necessary emotional support or \u2022 1 out of 3 women worldwide have",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1558
  },
  {
    "id": "chunk_01559",
    "text": "ional support or \u2022 1 out of 3 women worldwide have immediately refer her to another resource that can provide immediate experienced either intimate partner assistance. violence or non-partner sexual violence in \u2022 Counsel the client on available referral services in their community. These",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1559
  },
  {
    "id": "chunk_01560",
    "text": "ilable referral services in their community. These their lifetime. can include: women\u2019s centers, shelters or safe houses, psychological counseling, couples counseling programs, and legal and medical services. Provide client with support and referral to the service(s) of her choice.",
    "page_number": 230,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1560
  },
  {
    "id": "chunk_01561",
    "text": "Male Services and If the man is present during an FP and HIV services consultations: Support for their \u2022 Congratulate the man for his presence and tell him about the Partners services available for men, and explain the benefits of family planning and birth spacing.",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1561
  },
  {
    "id": "chunk_01562",
    "text": "the benefits of family planning and birth spacing. \u2013 Family planning allows the client(s) to plan the number of Discuss men\u2019s responsibility in sexual children they want to have and when they want to have and reproductive decision-making them. Waiting for 24 months between the births of their",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1562
  },
  {
    "id": "chunk_01563",
    "text": "Waiting for 24 months between the births of their children improves their partner\u2019s health, all of their \u2022 Men can also use contraception children\u2019s health, and the available resources they have \u2022 Men should be active in parenting to support their family. and being fathers. Men can jointly",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1563
  },
  {
    "id": "chunk_01564",
    "text": "t their family. and being fathers. Men can jointly \u2022 Describe services that are available to men, in addition to decide with their partners: family planning, such as STI screening and treatment, HIV \u2013 The number of children they testing and counseling, hypertension screening, obesity",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1564
  },
  {
    "id": "chunk_01565",
    "text": "ng and counseling, hypertension screening, obesity want to have. counseling, and smoking counseling. \u2013 When and how to use family \u2022 If the clinic has any of the services mentioned above, planning methods. including contraceptives for men, offer the services or refer",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1565
  },
  {
    "id": "chunk_01566",
    "text": "ontraceptives for men, offer the services or refer the man within the facilities. If these services are not \u2013 Where to seek family planning available, inform the man where the services are available services, maternity services and and offer a referral to these facility. child health services.",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1566
  },
  {
    "id": "chunk_01567",
    "text": "referral to these facility. child health services. \u2022 They are also partners in preventing and treating sexually transmitted infection (STIs), including HIV.",
    "page_number": 232,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1567
  },
  {
    "id": "chunk_01568",
    "text": "About self-breast examination: Breast Cancer \u2022 Explain that SBE is easy to perform. It can be done at any time; when lying Information and down, taking a shower or bathing. \u2022 SBE is simple and important; it allows for early detection of breast lumps Awareness",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1568
  },
  {
    "id": "chunk_01569",
    "text": "lows for early detection of breast lumps Awareness and clients presentating themselves for treatment. \u2022 Early treatment increases chance of complete cure. Monthly/correct exams Discuss the following with the client: help detect changes in the breast early.",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1569
  },
  {
    "id": "chunk_01570",
    "text": "e client: help detect changes in the breast early. \u2022 \u201cBreast cancer\u201d is a malignant tumor that Women should conduct a SBE at least once every month at the same time develops from cells in the breast. each menstrual cycle as breast shape and feel change at different stages of",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1570
  },
  {
    "id": "chunk_01571",
    "text": "reast shape and feel change at different stages of the cycle. The best time is immediately after the menses (period). If she is on \u2022 Breast cancer is the second leading cause the pill, the best day is the first day of the new pill pack. For women who are of death and second most common",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1571
  },
  {
    "id": "chunk_01572",
    "text": "For women who are of death and second most common on Depo Provera, Norplant, have reached menopause, or whose menses are cancer. It is curable if detected early. not regular, SBE should be done on the first day of each calendar month.",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1572
  },
  {
    "id": "chunk_01573",
    "text": "d be done on the first day of each calendar month. \u2022 All women and men are at risk. Men also should examine themselves regularly; ideally on the first day of each calendar month. Screening and early detection of breast cancer Presentation of breast cancer:",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1573
  },
  {
    "id": "chunk_01574",
    "text": "on of breast cancer Presentation of breast cancer: \u2022 Screening for breast cancer involves \u2022 Majority cases: a painless lump in the breast self-breast examination (SBE), clinical \u2022 Other symptoms: nipple retraction, skin changes such as darkening and breast examination and breast imaging",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1574
  },
  {
    "id": "chunk_01575",
    "text": "arkening and breast examination and breast imaging dimpling (appearance like the skin of an orange), and nipple discharge that (mammography and/or ultrasound may be bloody. scanning). \u2022 Late presentations: ulceration, enlarged lymph nodes in the armpit and Note: not all breast cancers are palpable",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1575
  },
  {
    "id": "chunk_01576",
    "text": "mpit and Note: not all breast cancers are palpable neck. Pain is usually a late symptom. therefore, clinical breast examination and imaging are recommended in combination \u2022 Report to your nearest health care provider if you notice any of the above",
    "page_number": 234,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1576
  },
  {
    "id": "chunk_01577",
    "text": "Balanced Counseling Strategy Plus Third Edition The Balanced Counseling Strategy Plus (BCS+) toolkit, Note: These cards are part of a larger publication titled The Balanced developed and tested in Kenya and South Africa, provides the Counseling Strategy Plus: A Toolkit for Family Planning Service",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1577
  },
  {
    "id": "chunk_01578",
    "text": "rategy Plus: A Toolkit for Family Planning Service information and materials that health-care facility providers Providers Working in High STI/HIV Prevalence Settings. need so they can offer complete, high-quality family planning The BCS+ toolkit is comprised of the following:",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1578
  },
  {
    "id": "chunk_01579",
    "text": "ng The BCS+ toolkit is comprised of the following: counseling to clients living in areas with high rates of HIV and \u2022 Algorithm STIs. The BCS+ was adapted from the Balanced Counseling \u2022 Counseling cards Strategy (L\u00e9on 1999; L\u00e9on et al. 2003a, b, c; L\u00e9on et al. 2008). \u2022 Method brochures",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1579
  },
  {
    "id": "chunk_01580",
    "text": "2003a, b, c; L\u00e9on et al. 2008). \u2022 Method brochures First and second editions of the Balanced Counseling Strategy \u2022 User\u2019s Guide and the Balanced Counseling Strategy Plus toolkits are products \u2022 Trainer\u2019s Guide of Population Council\u2019s FRONTIERS program, supported by",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1580
  },
  {
    "id": "chunk_01581",
    "text": "pulation Council\u2019s FRONTIERS program, supported by United States Agency for International Development (USAID), \u2022 WHO Medical Eligibility Criteria Wheel Cooperative Agreement HRN-A-00-98-00012-00. We would like to acknowledge the following individuals for",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1581
  },
  {
    "id": "chunk_01582",
    "text": "like to acknowledge the following individuals for This Third Edition of the BCS+ includes content updated contributing their time and technical expertise to this edition of the",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1582
  },
  {
    "id": "chunk_01583",
    "text": "ime and technical expertise to this edition of the according to the latest WHO Medical Eligibility Criteria (2015). It BCS+: Megan Christofield, Heather Clark, Mychelle Farmer,",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1583
  },
  {
    "id": "chunk_01584",
    "text": "egan Christofield, Heather Clark, Mychelle Farmer, incorporates the most up to date evidence on clinical indications Kamlesh Giri, Joanne Gleason, Mark Hathaway, Anushka Kalyanpur, for the provision of family planning methods, including new Maggie Kilbourne-Brook, Karen Kirk, Ricky Lu, Ruth Merkatz,",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1584
  },
  {
    "id": "chunk_01585",
    "text": "lbourne-Brook, Karen Kirk, Ricky Lu, Ruth Merkatz, methods, and includes four new counseling cards that address Charity Ndwiga, Anne Pfitzer, Saumya Ramarao, Naomi Rijo, Adolescent Counseling, Male Services, Post Abortion Care, and Elizabeth Rochette, Jill Schwartz, Leigh Stefanik, John Townsend,",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1585
  },
  {
    "id": "chunk_01586",
    "text": "tte, Jill Schwartz, Leigh Stefanik, John Townsend, Women's Support and Safety. These updated cards include Chi-Chi Undie, Katie Unthank, Anneka Van Scoyoc, Charlotte instructions for providers, guiding them through supplemental Warren, Ellen Weiss, Kelsey Wright.",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1586
  },
  {
    "id": "chunk_01587",
    "text": "h supplemental Warren, Ellen Weiss, Kelsey Wright. counseling and services that family planning clients may need. For the full Toolkit, please visit http://www.popcouncil.org/bcsplus Development of this Third Edition of the BCS+ counseling cards",
    "page_number": 235,
    "source": "BCS_Plus_Toolkit.pdf",
    "source_path": "data\\bcs\\BCS_Plus_Toolkit.pdf",
    "chunk_index": 1587
  }
]